Rank,NCT Number,Status,Study Results,Conditions,Interventions,Gender,Age,Phases,Enrollment,Funded Bys,Study Type,Study Designs,Start Date,Completion Date
1,NCT04785898,"Active, not recruiting",No Results Available,Covid19,Diagnostic Test: ID Now™ COVID-19 Screening Test,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"November 9, 2020","April 30, 2021"
2,NCT04595136,Not yet recruiting,No Results Available,SARS-CoV-2 Infection,Drug: Drug COVID19-0001-USR|Drug: normal saline,All,"Adult, Older Adult",Phase 1|Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 2, 2020","January 29, 2021"
3,NCT04395482,Recruiting,No Results Available,covid19,Other: Lung CT scan analysis in COVID-19 patients,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 7, 2020","June 15, 2021"
4,NCT04416061,"Active, not recruiting",No Results Available,COVID,Diagnostic Test: COVID 19 Diagnostic Test,All,"Child, Adult, Older Adult",,2500.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 25, 2020","August 31, 2020"
5,NCT04395924,Recruiting,No Results Available,Maternal Fetal Infection Transmission|COVID-19|SARS-CoV 2,"Diagnostic Test: Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta",Female,Adult,,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 5, 2020",May 2021
6,NCT04516954,Enrolling by invitation,No Results Available,COVID 19,Biological: Convalescent COVID 19 Plasma,All,"Adult, Older Adult",Early Phase 1,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","December 30, 2020"
7,NCT04476940,Not yet recruiting,No Results Available,Covid19|Exclusive Breastfeeding,Behavioral: COVID-19 Breastfeeding Support,Female,Adult,Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,September 2020,June 2022
8,NCT04634214,Not yet recruiting,No Results Available,Covid19|Type2 Diabetes,,All,"Adult, Older Adult",,1050.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"November 16, 2020","May 16, 2021"
9,NCT04602884,Suspended,No Results Available,Covid19,Diagnostic Test: Breath biopsy sampling using the ReCIVA Breath Sampler,All,Adult,Not Applicable,50.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 22, 2020","December 30, 2021"
10,NCT04384588,Recruiting,No Results Available,COVID-19 Infection|Cancer Patients|General Population,Biological: Convalescent Plasma from COVID-19 donors,All,"Child, Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 7, 2020","April 6, 2021"
11,NCT04355897,Recruiting,No Results Available,COVID 19,Biological: Convalescent COVID 19 Plasma,All,"Adult, Older Adult",Early Phase 1,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 28, 2020",August 2020
12,NCT04412265,Recruiting,No Results Available,Covid19,Other: Relation between frailty and clinical outcomes in elderly patients with COVID-19.,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 16, 2020","March 1, 2021"
13,NCT04659759,Recruiting,No Results Available,Covid19,Other: COVID-19 exposure|Biological: COVID-19 vaccine,Female,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 17, 2020","June 30, 2022"
14,NCT04427332,Completed,No Results Available,covid19,Other: Investigation of smell and taste disorders,All,"Adult, Older Adult",,376.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 11, 2020","October 16, 2020"
15,NCT04842708,Recruiting,No Results Available,Covid19,Diagnostic Test: vaccination against COVID19,All,"Adult, Older Adult",Not Applicable,50.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"December 24, 2020","October 24, 2021"
16,NCT04367805,Recruiting,No Results Available,Hepatocellular Carcinoma|COVID-19,Diagnostic Test: nasopharyngeal Covid 19 RT-PCR,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 27, 2020",October 2020
17,NCT04609969,Completed,No Results Available,Covid19|SARS-CoV-2 Infection,Diagnostic Test: RT-qPCR test|Diagnostic Test: COVID-VIRO® test,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"October 13, 2020","October 17, 2020"
18,NCT04817553,Recruiting,No Results Available,IgG4 Related Disease|Covid19,Other: exposure to COVID19,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 24, 2021",October 2021
19,NCT04632355,Not yet recruiting,No Results Available,Covid19,Other: Interview,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 1, 2020","July 31, 2021"
20,NCT04407585,Recruiting,No Results Available,Covid-19,Diagnostic Test: Covid-19 swab PCR test,All,"Adult, Older Adult",,1000000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","May 10, 2021"
21,NCT04657510,Recruiting,No Results Available,Covid19|Femur Fracture|Fragility Fracture,Other: COVID-19,All,"Adult, Older Adult",,140.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"November 14, 2020","December 31, 2020"
22,NCT04473170,Completed,No Results Available,Coronavirus Disease 2019 (COVID-19),Biological: Autologous Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC)|Drug: COVID-19 standard care,All,"Adult, Older Adult",Phase 1|Phase 2,146.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 4, 2020","July 14, 2020"
23,NCT04497298,"Active, not recruiting",No Results Available,COVID-19,Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - Low dose|Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - High dose|Biological: One COVID-19 vaccine candidate (TMV-083) administration - High dose|Other: Placebo,All,Adult,Phase 1,90.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 10, 2020",July 2021
24,NCT04549831,Recruiting,No Results Available,COVID-19,Genetic: Massive parallel sequencing of host genome,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 8, 2020","April 8, 2026"
25,NCT04706390,Recruiting,No Results Available,Covid19,Biological: covid-19 vaccine,All,"Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 12, 2021","January 12, 2024"
26,NCT04632719,Recruiting,No Results Available,"Cognitive Impairment|Covid19|Cognitive Dysfunction|Depression, Anxiety|Quality of Life",Device: The use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19,All,"Child, Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 8, 2020","December 29, 2023"
27,NCT04427345,Recruiting,No Results Available,covid19,Other: Predictive factors for clinical response in patients with COVID-19.,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 30, 2020","April 30, 2021"
28,NCT04424004,"Active, not recruiting",No Results Available,COVID 19,Other: COVID-19 PCR and serology testing,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"June 9, 2020","June 30, 2021"
29,NCT04407494,Completed,No Results Available,COVID-19,"Biological: Reporting of anosmia, ageusia and other clinical symptoms",All,"Adult, Older Adult",,809.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","April 30, 2020"
30,NCT04360811,Recruiting,No Results Available,Pregnancy,Diagnostic Test: COVID 19 diagnostic test by PCR,Female,"Adult, Older Adult",Not Applicable,3600.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 17, 2020",April 2022
31,NCT04403672,Recruiting,No Results Available,High Sensitivity and Specificity (With 95% Confidence Interval) of RealDetect™ COVID-19 RT-PCR Kit,Device: performance evaluation study of RealDetect RT-PCR Kit for COVID-19 detection,All,"Child, Adult, Older Adult",,120.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 18, 2020","July 24, 2020"
32,NCT04363099,Recruiting,No Results Available,Covid-19,Other: observational,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 1, 2020","December 31, 2020"
33,NCT04377425,Withdrawn,No Results Available,"Neurological Diseases or Conditions|Stroke, Acute|Seizure Disorder",Diagnostic Test: COVID-19 swap test PCR,All,"Adult, Older Adult",,0.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 7, 2020","June 30, 2022"
34,NCT04602871,Completed,No Results Available,Covid19,Diagnostic Test: Breath Biopsy,All,"Adult, Older Adult",Not Applicable,108.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"July 3, 2020","January 30, 2021"
35,NCT04691895,"Active, not recruiting",No Results Available,COVID19 Disease,Other: SARS-CoV2 infection,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 1, 2020","December 31, 2021"
36,NCT04645498,Not yet recruiting,No Results Available,"Covid19|Metabolism, Inborn Errors",,All,"Child, Adult, Older Adult",,77.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,January 2021,January 2023
37,NCT04747821,"Active, not recruiting",No Results Available,Covid19,Biological: Adsorbed COVID-19 (Inactivated) Vaccine,All,"Adult, Older Adult",Phase 4,27711.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 7, 2021",February 2022
38,NCT04372004,Recruiting,No Results Available,COVID-19,Diagnostic Test: diagnostic tests for COVID-19 infection,All,"Adult, Older Adult",Phase 1,100.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 8, 2020",June 2021
39,NCT04377685,Recruiting,No Results Available,COVID 19,Other: CT-Scan,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","June 30, 2021"
40,NCT04717011,Recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: PCR test,Male,"Adult, Older Adult",,100.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,February 2021,July 2021
41,NCT04412486,Recruiting,No Results Available,COVID-19,Biological: COVID Convalescent Plasma,All,"Adult, Older Adult",Early Phase 1,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","May 31, 2022"
42,NCT04581135,Recruiting,No Results Available,COVID-19,Other: COVID-19,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","June 1, 2023"
43,NCT04387968,Recruiting,No Results Available,Coronavirus Infection,Diagnostic Test: Covid-19 presto test,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"August 24, 2020","March 24, 2021"
44,NCT04845048,Not yet recruiting,No Results Available,Covid19,Biological: Adsorbed COVID-19 (Inactivated) Vaccine,All,"Adult, Older Adult",,900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,November 2021
45,NCT04490837,"Active, not recruiting",No Results Available,Covid-19,Diagnostic Test: ELISA and Rapid test to detect antibodies against COVID-19,All,"Adult, Older Adult",,3500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 22, 2020","September 30, 2020"
46,NCT04834908,Not yet recruiting,No Results Available,SARS-CoV-2 Infection,Biological: Equine COVID-19 Antiserum|Drug: Standard of care,All,"Adult, Older Adult",Phase 1|Phase 2,160.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,May 2021,September 2022
47,NCT04730401,Recruiting,No Results Available,Covid19,Biological: Convalescent plasma from COVID-19 donors|Biological: Placebo,All,"Adult, Older Adult",Phase 2,390.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","January 27, 2021","December 31, 2021"
48,NCT04799444,Recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","June 30, 2022"
49,NCT04425707,Recruiting,No Results Available,Covid19,Drug: Ivermectin,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 9, 2020","September 1, 2020"
50,NCT04356560,Enrolling by invitation,No Results Available,COVID-19,"Diagnostic Test: COVID-19 test, polymerase chain reaction for SARS-CoV-2",All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2020","December 31, 2020"
51,NCT04598620,Recruiting,No Results Available,Covid19|Corona Virus Infection,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"September 19, 2020","October 1, 2021"
52,NCT04386109,Recruiting,No Results Available,Neonatal COVID-19 Disease,Other: No intervention - exposure is to COVID-19,All,Child,,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","September 30, 2021"
53,NCT04575168,Recruiting,No Results Available,Covid19,Diagnostic Test: Spartan COVID-19 Test,All,"Adult, Older Adult",,100.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"October 30, 2020",November 2020
54,NCT04437940,Completed,No Results Available,COVID|Sars-CoV2,Diagnostic Test: Vaginal fluid Covid-19 PCR test,Female,"Adult, Older Adult",,38.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2020","November 30, 2020"
55,NCT04508075,"Active, not recruiting",No Results Available,SARS-CoV2 Infection,Biological: SARS-CoV-2 vaccine (inactivated)|Biological: Placebo,All,Adult,Phase 3,1620.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","August 10, 2020",September 2021
56,NCT04628208,Recruiting,No Results Available,Covid19,Diagnostic Test: Spartan COVID-19 v2 System,All,"Adult, Older Adult",,60.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"November 17, 2020",January 2021
57,NCT04750330,Not yet recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,April 2021,"March 31, 2022"
58,NCT04602949,Recruiting,No Results Available,Covid19,Diagnostic Test: Breath Biopsy Analysis,All,"Adult, Older Adult",Not Applicable,4000.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"November 12, 2020","July 28, 2021"
59,NCT04376398,Completed,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 6, 2020","August 30, 2020"
60,NCT04563247,Completed,No Results Available,Covid19,Diagnostic Test: IgG SARS CoV 2 antibodies,All,Adult,,970.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 1, 2020","February 8, 2021"
61,NCT04379310,Completed,No Results Available,Covid-19,Drug: ACE Inhibitors and Calcium Channel Blockers,All,"Adult, Older Adult",,54.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 1, 2020","May 8, 2020"
62,NCT04682132,"Active, not recruiting",No Results Available,Covid19,"Diagnostic Test: COVID-19 antigen and antibody tests, and influenza rapid test",All,"Adult, Older Adult",,686.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 26, 2020",January 2021
63,NCT04390074,Completed,No Results Available,COVID-19|Critical Illness,Other: COVID-19 and Intensive Care,All,"Adult, Older Adult",,9905.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"May 27, 2020","June 4, 2020"
64,NCT04353206,Recruiting,No Results Available,Covid-19|Sars-CoV2,Biological: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Early Phase 1,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 27, 2020",May 2021
65,NCT04460274,Completed,No Results Available,Covid-19,Other: Model Building|Other: Model validation,All,"Child, Adult, Older Adult",,7882471.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"December 31, 2019","June 20, 2020"
66,NCT04366271,Recruiting,No Results Available,COVID,Biological: Mesenchymal cells|Drug: Standard of care,All,"Adult, Older Adult",Phase 2,106.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 7, 2020","May 31, 2021"
67,NCT04345679,Recruiting,No Results Available,COVID 19,Biological: anti-SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Early Phase 1,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 14, 2020","September 1, 2021"
68,NCT04668404,Recruiting,No Results Available,Covid19|Hypercoagulable States Nec,Diagnostic Test: Sonoclot,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"August 24, 2020","February 1, 2021"
69,NCT04355715,Completed,No Results Available,COVID 19|SARS-Cov-2,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2019","October 20, 2020"
70,NCT04339322,Not yet recruiting,No Results Available,"Characteristics Diseases|Outcome, Fatal",Other: Follow up,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","July 30, 2020"
71,NCT04674644,Completed,Has Results,COVID-19 Pandemic,Behavioral: The psychosocial effects of COVID-19 pandemic on dental professionals,All,"Adult, Older Adult",Not Applicable,850.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"October 16, 2020","October 23, 2020"
72,NCT04453748,Enrolling by invitation,No Results Available,COVID-19|Coronavirus Infection|Sars-CoV2|Complications,Other: Complex diagnostic panel,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 8, 2020","November 30, 2021"
73,NCT04811391,Recruiting,No Results Available,Covid19,Biological: COVID-19 vaccine,All,"Child, Adult, Older Adult",,1500.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 19, 2021","May 20, 2022"
74,NCT04381871,Not yet recruiting,No Results Available,COVID 19,Dietary Supplement: Acacia Senegal|Dietary Supplement: Pectin,All,"Child, Adult, Older Adult",Phase 2|Phase 3,110.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2020","September 1, 2020"
75,NCT04323787,Recruiting,No Results Available,Coronavirus,Other: observational,All,"Child, Adult, Older Adult",,50000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 30, 2020","April 30, 2021"
76,NCT04510207,Recruiting,No Results Available,COVID-19,Biological: Inactivated SARS-CoV-2 Vaccine (Vero cell)|Biological: Placebo,All,"Adult, Older Adult",Phase 3,45000.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 16, 2020","September 16, 2021"
77,NCT04760990,Recruiting,No Results Available,Multiple Sclerosis|COVID-19 (Severe Coronavirus Disease 2019),Other: data collection|Other: analysis of blood samples,All,"Adult, Older Adult",,1400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2021",December 2023
78,NCT04387929,Recruiting,No Results Available,COVID-19,Diagnostic Test: Detection of anti-COVID-19 antibody level,All,"Adult, Older Adult",,6000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 4, 2020","May 30, 2021"
79,NCT04330261,Recruiting,No Results Available,"COVID-19|SARS-CoV-2 Infection|Pediatric ALL|Pneumonia, Viral|Pandemic Response",Other: Exposure (not intervention) - SARS-CoV-2 infection,All,"Child, Adult",,12500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 18, 2020","March 17, 2022"
80,NCT04529460,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: COVID-19 antibody point of care test kit,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","April 30, 2021"
81,NCT04392323,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: COVID-19 PCR and Serology,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 13, 2020","July 31, 2020"
82,NCT04565522,Not yet recruiting,No Results Available,Covid19|Dialysis|Nurse-Patient Relations,Other: Prospective observation,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 21, 2020","October 31, 2021"
83,NCT04799392,Recruiting,No Results Available,COVID-19|SARS-CoV-2|Coronavirus,Device: NOWDx COVID-19 Test,All,"Child, Adult, Older Adult",Not Applicable,339.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 1, 2021","April 30, 2021"
84,NCT04816318,Not yet recruiting,No Results Available,Covid19|Infectious Disease|Death|SARS-CoV Infection,Other: Social and public health measures against COVID-19|Other: Control,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"March 22, 2021","May 31, 2021"
85,NCT04690413,Completed,No Results Available,COVID-19|SARS-CoV-2|Coronavirus,Device: NOWDx COVID-19 Test,All,"Adult, Older Adult",Not Applicable,129.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 1, 2020","December 31, 2020"
86,NCT04349202,Recruiting,No Results Available,COVID-19|Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2,Diagnostic Test: EUROIMMUN assay,All,"Adult, Older Adult",,56000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020",June 2021
87,NCT04474496,Completed,Has Results,COVID-19,Other: Assessing the impact of COVID-19,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"July 27, 2020","November 30, 2020"
88,NCT04466657,Not yet recruiting,No Results Available,Covid-19,Dietary Supplement: Antioxidation Therapy|Other: Standard of Care,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"November 1, 2020","April 30, 2021"
89,NCT04427358,Completed,No Results Available,Covid-19,,All,Older Adult,,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"May 7, 2020","September 7, 2020"
90,NCT04811664,Recruiting,No Results Available,SARS-CoV-2 Infection,Biological: Moderna COVID-19 Vaccine,All,Adult,Phase 3,37500.0,NIH,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 22, 2021","December 22, 2021"
91,NCT04664023,Recruiting,No Results Available,Covid19,"Procedure: Blood collection at Day 8, Day 16, Day 24, Month 6 and Month 12 after first symptoms from SARS-CoV-2 infection",All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 9, 2020","July 30, 2022"
92,NCT04404062,"Active, not recruiting",No Results Available,COVID-19,Diagnostic Test: Covid-19 Rapid Test Kit (RAPG-COV-019)|Diagnostic Test: Quantitative IgG Test,All,"Adult, Older Adult",,500.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 16, 2020",August 2020
93,NCT04376996,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Diagnostic Test: NO intervention planned due to the observational study design - only a diagnostic testing,All,"Child, Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020",December 2020
94,NCT04370288,Recruiting,No Results Available,Covid-19,"Drug: MCN (Methylene blue, vitamin C, N-acetyl cysteine)",All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 19, 2020","September 21, 2020"
95,NCT04706403,"Active, not recruiting",No Results Available,Covid19,Behavioral: Healthcare Providers' Communication about the COVID-19 Vaccine,All,"Adult, Older Adult",Not Applicable,3000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 4, 2021","December 26, 2021"
96,NCT04393402,Recruiting,No Results Available,COVID,Procedure: lung ultrasound (LUS),All,"Adult, Older Adult",,14.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020","December 31, 2020"
97,NCT04548908,Recruiting,No Results Available,Covid19,"Diagnostic Test: Serelogy testing, RT PCR",All,"Adult, Older Adult",,1300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 3, 2020","June 30, 2021"
98,NCT04582331,Recruiting,No Results Available,Covid19,Other: Smartphone-based voice and self-reported symptom collection,All,"Child, Adult, Older Adult",,300.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 10, 2020","April 30, 2021"
99,NCT04379284,Recruiting,No Results Available,COVID19,Other: Biospecimen collection,Female,Adult,,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 8, 2020","July 31, 2021"
100,NCT04352764,Recruiting,No Results Available,Covid19,Diagnostic Test: CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 27, 2020","January 31, 2021"
101,NCT04780698,Recruiting,No Results Available,Covid19,Diagnostic Test: SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection,All,"Adult, Older Adult",Not Applicable,160.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,March 2021,March 2022
102,NCT04598334,Not yet recruiting,No Results Available,"Cytokine Storm, COVID-19",,All,"Adult, Older Adult",,75.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2021",October 2021
103,NCT04418245,"Active, not recruiting",No Results Available,Covid-19,Diagnostic Test: Imaging by thoracic scanner,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 1, 2020",July 2020
104,NCT04416373,Recruiting,No Results Available,Coronavirus Infection|Pregnancy Complications|Vertical Transmission of Infectious Disease|Breastfeeding|Neonatal Infection,Diagnostic Test: RT PCR SARS-CoV-2,Female,"Child, Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 22, 2020",December 2023
105,NCT04342637,Completed,No Results Available,COVID-19,Other: Practice details,All,"Adult, Older Adult",,163.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020","May 1, 2020"
106,NCT04382235,"Active, not recruiting",No Results Available,Covid-19,Device: Non-invasive ventilatory support,All,"Adult, Older Adult",,900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 26, 2020","December 30, 2020"
107,NCT04694703,Recruiting,No Results Available,Covid19,Drug: Covid-19 group,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 6, 2021",March 2021
108,NCT04361422,Not yet recruiting,No Results Available,COVID-19,Drug: Isotretinoin Only Product in Oral Dose Form,All,Adult,Phase 3,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020",December 2021
109,NCT04332380,Completed,No Results Available,Coronavirus|Coronavirus Infection,Drug: Plasma,All,Adult,Phase 2,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","July 28, 2020"
110,NCT04410471,Recruiting,No Results Available,Liver Transplant Infection|Covid19|Mortality|Immune Response,Diagnostic Test: CLIA of IgG and IgM against SARS-Cov-2,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 29, 2020","June 30, 2021"
111,NCT04595110,Recruiting,No Results Available,Covid19|Thrombosis,Other: Observational study,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 25, 2020","May 10, 2021"
112,NCT04713163,Not yet recruiting,No Results Available,Covid19,Drug: covid19 vaccine,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,January 2021,December 2021
113,NCT04481633,Recruiting,No Results Available,COVID-19,Diagnostic Test: COVID 19 serology|Other: COVID 19 Self-Questionnaire,All,"Adult, Older Adult",Not Applicable,800.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 9, 2020",September 2021
114,NCT04780126,Recruiting,No Results Available,Sarcopenia|Covid19,Other: Sarcopenia diagnosis,All,"Adult, Older Adult",,64.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"February 26, 2021","May 31, 2021"
115,NCT04706039,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: Performance evaluation (sensitivity and specificity) for COVID-19 diagnosis of the Vocus PTR-TOF process,All,"Child, Adult, Older Adult",Not Applicable,3000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,January 2021,March 2021
116,NCT04365959,"Active, not recruiting",No Results Available,Sars-CoV2,Procedure: Prone position,All,"Adult, Older Adult",,56.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 20, 2020","December 31, 2020"
117,NCT04332835,Completed,No Results Available,Coronavirus|Coronavirus Infection,Drug: Plasma|Drug: Standard Therapy,All,"Adult, Older Adult",Phase 2|Phase 3,92.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"August 8, 2020","November 15, 2020"
118,NCT04834752,Not yet recruiting,No Results Available,COVID-19,Other: No intervention (Retrospective Cohort Observational),All,"Adult, Older Adult",,400000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 1, 2021","December 31, 2021"
119,NCT04384887,Completed,No Results Available,"COVID|Anxiety|Depression, Postpartum",Behavioral: covid-19 positive pregnant women,Female,Adult,,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 25, 2020","August 26, 2020"
120,NCT04363489,Recruiting,No Results Available,Covid19,Device: Wearable Medical Device (Empatica E4)|Diagnostic Test: COVID-19 PCR Swab|Diagnostic Test: Pulse Oximeter,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 20, 2020","June 30, 2021"
121,NCT04420468,Completed,No Results Available,COVID-19,,All,Child,,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 10, 2020","June 30, 2020"
122,NCT03305341,"Active, not recruiting",No Results Available,Covid19,Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection,All,"Adult, Older Adult",Early Phase 1,20.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 18, 2020","June 28, 2021"
123,NCT04441502,Recruiting,No Results Available,Covid19|Interstitial Pneumonia,,All,"Adult, Older Adult",,240.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2020","December 31, 2021"
124,NCT04822012,Recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: Anti COVID19 IgG Antibodies,All,Adult,,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","June 1, 2021"
125,NCT04364828,Recruiting,No Results Available,COVID-19,Genetic: Whole Genome Analysis|Genetic: T-cell receptor (TCR) repertoire|Genetic: SARS-CoV-2 viral composition,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"October 21, 2020",August 2022
126,NCT04410549,Recruiting,No Results Available,Covid19|Pulmonary Embolism,Diagnostic Test: Optical Coherence Tomography (OCT),All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 1, 2020","December 31, 2021"
127,NCT04303299,Recruiting,No Results Available,SARS-COV-2 Infections|COVID-19,Drug: Oral,All,"Child, Adult, Older Adult",Phase 3,320.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 19, 2020","December 31, 2021"
128,NCT04337996,Completed,No Results Available,COVID-19,Diagnostic Test: COVID-19 diagnostic test,All,"Adult, Older Adult",Not Applicable,8.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"July 13, 2020","January 13, 2021"
129,NCT04716543,Not yet recruiting,No Results Available,Influenza -Like Illness|Covid19,Diagnostic Test: ILI and COVID-19 detection,All,"Child, Adult, Older Adult",,5400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,March 2021,March 2022
130,NCT04463472,"Active, not recruiting",No Results Available,COVID-19,Biological: AG0301-COVID19,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 29, 2020","July 31, 2021"
131,NCT04794361,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 5, 2020","May 5, 2020"
132,NCT04542421,Recruiting,No Results Available,Covid19,Diagnostic Test: Lung ultrasound use in patients hospitalized with COVID,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"July 1, 2020","December 1, 2021"
133,NCT04771559,Not yet recruiting,No Results Available,Covid19|Cancer,Other: COVID-19 antibody test,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 1, 2021","July 1, 2021"
134,NCT04695756,Recruiting,No Results Available,Covid19|Liver Transplant,Other: COVID-19 pandemic,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Retrospective,"December 15, 2020","July 15, 2021"
135,NCT04473248,Completed,No Results Available,Covid19,Device: Spartan COVID-19 System,All,"Adult, Older Adult",Not Applicable,27.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,"June 28, 2020","August 30, 2020"
136,NCT04431310,Recruiting,No Results Available,"Covid-19|Health Personnel|Personnel, Hospital",Other: Serial seroconversion measurements in hospital employees during the COVID-19 pandemic,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 27, 2020","August 1, 2025"
137,NCT04334291,Completed,No Results Available,COVID 19,Combination Product: Observational (registry),All,"Child, Adult, Older Adult",,8168.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 23, 2020","May 31, 2020"
138,NCT04413045,Completed,No Results Available,COVID-19,Other: Prevalence of COVID-19,All,"Child, Adult, Older Adult",,61.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"May 20, 2020","July 28, 2020"
139,NCT04817319,Not yet recruiting,No Results Available,Contamination by COVID 19 During Oral Care,Procedure: Oral care with/without aerosolization,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 30, 2021","March 30, 2022"
140,NCT04333862,Recruiting,No Results Available,SARS-CoV-2,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 19, 2020","January 31, 2022"
141,NCT04521036,Not yet recruiting,No Results Available,COVID 19,Biological: Convalescent Plasma as Therapy for Covid-19 patients,All,"Adult, Older Adult",Phase 1|Phase 2,44.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","October 30, 2021"
142,NCT04343781,Completed,No Results Available,SARS-CoV-2|COVID-19,Other: observation,All,Older Adult,,353.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 22, 2020","April 5, 2020"
143,NCT04720235,Completed,No Results Available,Covid19|Corona Virus Infection,Device: Lucira COVID-19 All-In-One test kit,All,"Child, Adult, Older Adult",Not Applicable,304.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"December 9, 2020","March 30, 2021"
144,NCT04460690,Enrolling by invitation,No Results Available,COVID-19|Sars-CoV2,Device: Rapid Onsite COVID-19 Detection,All,"Child, Adult, Older Adult",Not Applicable,10000.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"July 13, 2020",July 2021
145,NCT04424849,Recruiting,No Results Available,COVID-19,Diagnostic Test: CT-Scan,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 15, 2020","July 15, 2020"
146,NCT04578158,Recruiting,No Results Available,COVID-19,Drug: Standard COVID-19 care|Dietary Supplement: Quercetin Phytosome,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 29, 2020","June 28, 2021"
147,NCT04344912,Recruiting,No Results Available,Acute Coronary Syndrome|Heart Failure|COVID,Other: Data collection,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 20, 2020",August 2020
148,NCT04707833,Recruiting,No Results Available,Corona Virus Infection,Diagnostic Test: Serological testing for COVID-19 infection,All,"Adult, Older Adult",Not Applicable,385.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"November 26, 2020","December 1, 2023"
149,NCT04768244,Recruiting,No Results Available,Covid19,Other: maternal SARS-CoV-2 infection,Female,Adult,,100.0,Other|Industry,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 1, 2020",December 2021
150,NCT04347278,Recruiting,No Results Available,SARS-CoV-2,Drug: Patients with the treatment agains COVID19,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"April 22, 2020","January 1, 2021"
151,NCT04391738,Completed,No Results Available,SARS-CoV 2,Other: Patients admitted to Intensive Care Unit with SARS-CoV2,All,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 1, 2020","September 1, 2020"
152,NCT04331834,Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebos,All,"Adult, Older Adult",Phase 3,275.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 3, 2020","December 31, 2020"
153,NCT04333732,Recruiting,No Results Available,COVID 19,Drug: MR or M-M-R II ® vaccine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,30000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","September 4, 2020",August 2021
154,NCT04416256,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,230000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2020",February 2022
155,NCT04767958,Recruiting,No Results Available,Covid19,Diagnostic Test: Spartan COVID-19 Platform,All,"Adult, Older Adult",Not Applicable,2500.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 19, 2021","July 31, 2022"
156,NCT04424992,Recruiting,No Results Available,Sars-CoV2,Other: Observational cohort study on the natural history of hospitalized SARS-COV-2 patients.,All,"Adult, Older Adult",,1433.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 28, 2020",December 2021
157,NCT04452682,Completed,No Results Available,COVID|Critical Limb Ischemia,Other: COVID 19 impact,,"Child, Adult, Older Adult",,998.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 25, 2020","June 21, 2020"
158,NCT04808986,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: Serological test for the detection of IgG anti-SARS-CoV-2,All,"Child, Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 2, 2021","November 15, 2021"
159,NCT04756869,"Active, not recruiting",No Results Available,Covid19,Other: COVID-19 Monitoring Using Wearable Sensors and Smartphone Technology,All,"Adult, Older Adult",,226.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 28, 2020",January 2023
160,NCT04614883,Recruiting,No Results Available,Covid19,Device: Volatile Organic Compounds analysis|Other: Canine odor detection of Volatile Organic Compounds,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"October 21, 2020",October 2021
161,NCT04378452,Completed,No Results Available,SARS-CoV 2|COVID-19|Quality of Life|Mental Health Wellness 1|Social Distance|SARS (Disease)|Psychological,Behavioral: COM-COVID anonimous survey,All,"Child, Adult, Older Adult",,56656.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 31, 2020","April 7, 2021"
162,NCT04413864,Recruiting,No Results Available,SARS-CoV 2,Other: Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 24, 2020","February 28, 2021"
163,NCT04649879,Not yet recruiting,No Results Available,Covid19,Biological: SARS-CoV-2 convalescent plasma|Other: Standard of care,All,"Adult, Older Adult",Phase 2|Phase 3,920.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 3, 2020","February 1, 2022"
164,NCT04583982,Completed,No Results Available,Coronavirus Disease (COVID-19)|SARS-CoV-2 Infection,Other: T-Detect™ SARS-CoV-2 Assay,All,"Adult, Older Adult",,180.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 9, 2020","December 4, 2020"
165,NCT04496141,"Active, not recruiting",No Results Available,Covid19,Diagnostic Test: SARS-CoV-2 antibody immunoassays,All,"Child, Adult, Older Adult",,70.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 27, 2020","November 30, 2020"
166,NCT04375098,Completed,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Biological: COVID-19 convalescent plasma,All,"Adult, Older Adult",Phase 2,58.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 4, 2020","August 17, 2020"
167,NCT04805892,Recruiting,No Results Available,Covid19,Diagnostic Test: BIOZEK COVID-19 Antigen Rapid Test,All,"Adult, Older Adult",Not Applicable,250.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 17, 2021","May 17, 2021"
168,NCT04534595,Recruiting,No Results Available,COVID-19 Experience,Other: COVID-19,All,Child,,1500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 30, 2019",March 2021
169,NCT04615208,Recruiting,No Results Available,Covid19,Diagnostic Test: suspected of COVID-19 infection,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 19, 2020","December 30, 2021"
170,NCT04728828,Recruiting,No Results Available,Covid19,Biological: Serological COVID-19 vaccine immunogenicity,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 25, 2021","August 15, 2023"
171,NCT04497272,Recruiting,No Results Available,COVID 19,Other: COVID-19 patients,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"August 7, 2020","October 7, 2021"
172,NCT04404179,Completed,No Results Available,COVID-19,Other: COVID-19 FACILITY,All,"Child, Adult, Older Adult",,69.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 27, 2020","May 2, 2020"
173,NCT04374838,Recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 15, 2020","September 1, 2021"
174,NCT04367402,Recruiting,No Results Available,COVID-19,Other: BioMedomics COVID-19 IgM-IgG Rapid Test,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 30, 2020",September 2020
175,NCT04347174,Completed,No Results Available,COVID-19,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Drug: Placebo,All,"Adult, Older Adult",Not Applicable,40.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 30, 2020","August 21, 2020"
176,NCT04408001,"Active, not recruiting",No Results Available,Sars-CoV2,Other: Clinical interview|Biological: Blood collection|Biological: Saliva collection,All,"Adult, Older Adult",,499.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 4, 2020","June 4, 2021"
177,NCT04839068,Not yet recruiting,No Results Available,Covid19,Device: covid 19 on pregnancy outcomes,Female,"Child, Adult, Older Adult",,7000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 1, 2021",June 2022
178,NCT04477889,Recruiting,No Results Available,COVID-19,Other: Treatment for COVID-19,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 20, 2020",December 2026
179,NCT04470557,Not yet recruiting,No Results Available,COVID-19,"Diagnostic Test: D-dimer,CBC.ESR,CRP,|Diagnostic Test: Liver function tests ,serum ferritin and PCR for COVID-19 .",All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"July 15, 2020","December 1, 2020"
180,NCT04445415,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: COVID-19 antibodies testing,All,"Child, Adult, Older Adult",,250.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"July 1, 2020","September 1, 2021"
181,NCT04581148,Not yet recruiting,No Results Available,SARS-Cov2,Diagnostic Test: Blood test for IgG antibodies against SARS-CoV-2,All,"Child, Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 5, 2020",May 2022
182,NCT04803370,Recruiting,No Results Available,Covid19,Other: Convalescent Plasma with antibody against SARS-CoV-2.|Other: Standard treatment for COVID-19,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 8, 2020","September 1, 2021"
183,NCT04336956,Recruiting,No Results Available,COVID-19,Other: hospitalized children with Covid19,All,"Child, Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 7, 2020","June 30, 2021"
184,NCT04629001,"Active, not recruiting",No Results Available,Pregnancy Without Complications Except Getting Covid-19 Infection,"Diagnostic Test: Covid-19 PCR , IGM",Female,Adult,,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","December 1, 2021"
185,NCT04483622,Recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 12, 2020","February 15, 2021"
186,NCT04632732,Recruiting,No Results Available,Covid19,Diagnostic Test: COVID-19 test|Diagnostic Test: Blood sampling,All,"Adult, Older Adult",,140.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 26, 2020","December 1, 2021"
187,NCT04420260,Not yet recruiting,No Results Available,COVID,Dietary Supplement: Group A: oropharygeal spray and immunostimulant|Dietary Supplement: Group B: Placebo oropharyngeal spray + Active principle immunostimulant|Dietary Supplement: Group C:Active principle oropharyngeal spray + Placebo taken PO|Dietary Supplement: Group D:Placebo oropharyngeal spray + Placebo taken PO,All,Adult,Not Applicable,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",July 2020,September 2020
188,NCT04318301,Completed,No Results Available,COVID-19|Hypertension,,All,"Adult, Older Adult",,275.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 21, 2020","March 30, 2020"
189,NCT04366882,Recruiting,No Results Available,COVID-19,Procedure: CT-scan with minimal invasive autopsy,All,"Child, Adult, Older Adult",Not Applicable,45.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"April 14, 2020",December 2020
190,NCT04420312,Completed,No Results Available,Pulmonary Embolism|Covid-19,,All,"Adult, Older Adult",,1024.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 1, 2020","April 20, 2020"
191,NCT04437693,Not yet recruiting,No Results Available,COVID 19,Drug: Hydroxychloroquine,All,Adult,Phase 2|Phase 3,500.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"August 31, 2020","December 31, 2021"
192,NCT04347070,"Active, not recruiting",No Results Available,Sars-CoV2|COVID-19,Other: Phsyiotherapy,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2017","December 1, 2022"
193,NCT04720794,Completed,No Results Available,Covid19|SARS (Severe Acute Respiratory Syndrome)|Corona Virus Infection,Device: Lucira COVID-19 All-In-One test kit,All,"Adult, Older Adult",Not Applicable,101.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 25, 2020","October 20, 2020"
194,NCT04799834,Recruiting,No Results Available,Covid19,"Other: Questionnaire administration,blood sampling and genetic analyses.",All,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"November 30, 2020",October 2021
195,NCT04795414,Recruiting,No Results Available,SARS-CoV-2 Infection|Covid19,"Biological: SARS-CoV-2 Vaccine(Vero Cell), Inactivated",All,Adult,,1370.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 14, 2021","January 31, 2023"
196,NCT04775563,Recruiting,No Results Available,Covid19,Other: COVID-19 vaccine hesitancy scale in rheumatic diseases|Other: COVID-19 vaccine hesitancy associated factors,All,"Adult, Older Adult",,740.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"February 1, 2021","October 1, 2021"
197,NCT04736732,Recruiting,No Results Available,Covid19,Other: Medical follow-up,All,"Adult, Older Adult",,570.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2021","December 12, 2023"
198,NCT04784689,Recruiting,No Results Available,COVID-19 Vaccine|Cancer,Biological: COVID-19 Vaccine,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 24, 2021",January 2024
199,NCT04350320,Completed,No Results Available,COVID19,Drug: Colchicine Tablets|Drug: Standard therapy for COVID-19 according to the stablished hospital protocols.,All,"Adult, Older Adult",Phase 3,102.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","December 30, 2020"
200,NCT04507893,Recruiting,No Results Available,Covid19|Interstitial Pneumonia,"Other: Clinical, laboratory and imaging characteristics of pneumonia",All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 15, 2020","December 1, 2022"
201,NCT04457726,Recruiting,No Results Available,COVID-19,Biological: SARS-CoV-2 Specific T Cells,All,"Child, Adult, Older Adult",Phase 1|Phase 2,18.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 1, 2020",December 2022
202,NCT04537338,Not yet recruiting,No Results Available,COVID-19,Genetic: 1. Characterize the immune response after infection with SARS-CoV-2,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"September 14, 2020","September 14, 2022"
203,NCT04647994,Recruiting,No Results Available,Pregnant Women|Covid19,Diagnostic Test: SARS-CoV-2 serology,Female,"Child, Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 21, 2020","June 13, 2022"
204,NCT04474483,Recruiting,No Results Available,COVID-19,Drug: Melatonin|Other: Placebo (Methylcellulose) capsule,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 6, 2020","March 31, 2021"
205,NCT04740658,Not yet recruiting,No Results Available,Covid19,Other: No intervention,All,"Child, Adult, Older Adult",,9600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 1, 2021","July 1, 2021"
206,NCT04636294,Completed,No Results Available,Covid19|Virus,Diagnostic Test: SARS-CoV-2 PCR,All,"Child, Adult, Older Adult",,30000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"August 1, 2020","February 15, 2021"
207,NCT04610502,Completed,No Results Available,Covid19,Biological: Administration of Equine immunoglobulin anti SARS-CoV-2,All,"Adult, Older Adult",Phase 2,26.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 6, 2020","December 6, 2020"
208,NCT04354831,"Active, not recruiting",No Results Available,COVID-19,Biological: anti-SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Phase 2,131.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 11, 2020","May 1, 2023"
209,NCT04780334,Not yet recruiting,No Results Available,SARS-CoV Infection|Covid19,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: Biosensor,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,April 2021,April 2022
210,NCT04596098,Recruiting,No Results Available,SARS-CoV 2,Other: Blood sampling,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 30, 2020","September 30, 2021"
211,NCT04453969,Recruiting,No Results Available,SARS-CoV2|Breastmilk,Other: COVID-19,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 24, 2020",January 2021
212,NCT04605952,Completed,No Results Available,Covid19,Diagnostic Test: Repeat SARS-CoV-2 IgG antibodies at 45-65 days,All,Adult,,201.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 1, 2020","August 30, 2020"
213,NCT04558307,Enrolling by invitation,No Results Available,Coronavirus Disease (COVID-19),Diagnostic Test: Pilot a rapid SARS-CoV-2 testing strategy|Other: Community-driven messages to promote COVID-19 testing,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"June 3, 2020","December 1, 2021"
214,NCT04432103,Not yet recruiting,No Results Available,Covid-19,Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients|Biological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients,All,"Adult, Older Adult",Phase 3,36.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 19, 2020","September 30, 2020"
215,NCT04393428,Completed,No Results Available,COVID-19|Renal Replacement Therapy|Acute Kidney Injury,Other: [TIMP-2]*[IGFBP-7],All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","June 30, 2020"
216,NCT04579289,Completed,No Results Available,Covid19,Other: questionnaire,All,"Child, Adult, Older Adult",,230.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Retrospective,"June 15, 2020","September 1, 2020"
217,NCT04488484,"Active, not recruiting",No Results Available,COVID-19,Other: Serology test follow-up,All,"Adult, Older Adult",Not Applicable,450.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"July 1, 2020","December 31, 2021"
218,NCT04771117,Completed,No Results Available,Health Behavior|Risk-Taking|Covid19,Behavioral: Fear of Covid-19 Scale,All,"Child, Adult, Older Adult",,4004.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 1, 2020","December 1, 2020"
219,NCT04761822,Recruiting,No Results Available,SARS-CoV Infection|COVID-19|Allergic Reaction|Mast Cell Disorder|Non-atopic,Biological: Moderna COVID-19 Vaccine|Biological: Pfizer-BioNTech COVID-19 Vaccine|Biological: Placebo,All,"Adult, Older Adult",Phase 2,3400.0,NIH|Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2021",July 2021
220,NCT04376788,Recruiting,No Results Available,COVID-19,Biological: exchange blood transfusion from normal donor|Biological: plasma from convalescent patients with COVID-19|Drug: Methylene Blue 5 MG/ML,All,"Adult, Older Adult",Phase 2,15.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020","September 1, 2020"
221,NCT04567173,Recruiting,No Results Available,Covid19,Drug: Anti-SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Phase 2|Phase 3,136.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 21, 2020","June 30, 2021"
222,NCT04488081,Recruiting,No Results Available,COVID-19,Drug: Remdesivir|Drug: Cenicriviroc|Drug: Icatibant|Drug: Pulmozyme|Drug: IC14|Drug: Celecoxib Famotidine|Drug: Narsoplimab,All,"Adult, Older Adult",Phase 2,1500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 31, 2020","November 1, 2022"
223,NCT04636021,Recruiting,No Results Available,Corona Virus Infection,Diagnostic Test: COVID-19 testing,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"August 1, 2020","June 30, 2022"
224,NCT04527081,"Active, not recruiting",No Results Available,COVID-19,Biological: AG0302-COVID19,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 31, 2020","September 30, 2021"
225,NCT04461340,Recruiting,No Results Available,COVID 19,Drug: Sirolimus,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"August 15, 2020","November 30, 2020"
226,NCT04480060,Completed,No Results Available,Covid19,Diagnostic Test: COVID-19 diagnostic PCR,All,Adult,,100000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 10, 2020","July 14, 2020"
227,NCT04649840,Enrolling by invitation,No Results Available,Covid19,Diagnostic Test: Humoral and cellular immunity,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"October 1, 2020","December 31, 2021"
228,NCT04342156,Withdrawn,No Results Available,Coronavirus Infection|Hydroxychloroquine Adverse Reaction,Drug: Hydroxychloroquine Sulfate 200 milligram (mg) Tab,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,April 2020,October 2020
229,NCT04345991,Recruiting,No Results Available,Covid19,Drug: Transfusion of COVID-19 convalescent plasma,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","June 1, 2020"
230,NCT04386252,Not yet recruiting,No Results Available,COVID-19,Biological: AV-COVID-19,All,"Adult, Older Adult",Phase 1|Phase 2,175.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,June 2021,June 2022
231,NCT04354610,"Active, not recruiting",No Results Available,COVID 19,Procedure: Biological samples specific to research|Procedure: Clinical examination|Procedure: Telephone follow-up,All,"Adult, Older Adult",Not Applicable,57.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 27, 2020","March 19, 2021"
232,NCT04364698,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 7, 2020",June 2020
233,NCT04355741,Completed,No Results Available,COVID-19,Other: Exposure,All,"Adult, Older Adult",,115.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"April 20, 2020","July 16, 2020"
234,NCT04347681,Recruiting,No Results Available,Convalescent Plasma for COVID 19,Other: convalescent plasma from recovered COVID 19 donor,All,"Adult, Older Adult",Phase 2,575.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 18, 2020","April 11, 2021"
235,NCT04421404,"Active, not recruiting",No Results Available,COVID-19|Sars-CoV2,Biological: COVID-19 Convalescent Plasma (CCP)|Biological: Placebo,All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 9, 2020","April 30, 2021"
236,NCT04453280,Completed,No Results Available,COVID|SARS-CoV-2,Diagnostic Test: Quantitative analysis of anti-SARS-CoV-2-antibodies|Diagnostic Test: SARS-CoV-2 diagnostic rapid test,All,"Child, Adult, Older Adult",,695.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 18, 2020","June 3, 2020"
237,NCT04361981,Not yet recruiting,No Results Available,COVID-19,Other: Deep Venous Disease Diagnostic,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2020,"December 31, 2020"
238,NCT04470648,Recruiting,No Results Available,SARS-COV2 Infection,Diagnostic Test: blood test for SARS-COV2 serology,All,"Adult, Older Adult",,183.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"July 22, 2020",August 2021
239,NCT04710381,Not yet recruiting,No Results Available,Covid19,Drug: IMUNOR,All,Adult,Phase 4,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 1, 2021","June 30, 2021"
240,NCT04470258,Recruiting,No Results Available,COVID-19|Respiratory Failure With Hypoxia,Other: ELMO PROJECT AT COVID-19: STUDY IN HUMANS|Device: ELMO PROJECT AT COVID-19: PROOF OF CONCEPT AND USABILITY,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,"August 2, 2020",December 2020
241,NCT04355871,Completed,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,4035.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 18, 2020","April 17, 2020"
242,NCT04705116,Not yet recruiting,No Results Available,Covid19,Biological: COVID-19 vaccine,Female,Adult,,5000.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2021","December 31, 2025"
243,NCT04482673,Recruiting,No Results Available,COVID-19|Vitamin D Deficiency|Respiratory Viral Infection,Drug: Daily Vitamin D3|Drug: Daily placebo|Drug: Bolus vitamin D3|Drug: Bolus placebo,All,"Adult, Older Adult",Phase 4,140.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 31, 2020","December 31, 2021"
244,NCT04733807,Recruiting,No Results Available,Covid-19,Biological: BNT162b2 mRNA Covid-19 Vaccine,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"January 28, 2021","February 1, 2022"
245,NCT04336384,Completed,No Results Available,Congenital Heart Disease|Covid-19,,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","December 30, 2020"
246,NCT04470583,Recruiting,No Results Available,COVID-19|2019 Novel Coronavirus Infection|COVID-19 Infection,,All,Adult,,116.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 9, 2020","December 2, 2021"
247,NCT04465981,Recruiting,No Results Available,COVID-19|Corona Virus Infection,Diagnostic Test: Sampling,All,"Adult, Older Adult",,80.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Other,July 2020,June 2021
248,NCT04614012,Recruiting,No Results Available,Covid19,Other: treated with hyperimmune plasma,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 2, 2020","July 2, 2022"
249,NCT04526821,Not yet recruiting,No Results Available,SARS-CoV-2,Dietary Supplement: Bovine Lactoferrin|Dietary Supplement: Maltodextrin,All,Adult,Phase 2,336.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","September 1, 2020","November 1, 2021"
250,NCT04430049,Recruiting,No Results Available,Covid-19|Family Members|Critical Illness,Procedure: Covid ICU containment measures,All,"Adult, Older Adult",,480.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 22, 2020","January 22, 2023"
251,NCT04341441,Terminated,No Results Available,COVID-19|Coronavirus|Coronavirus Infections|SARS-CoV 2,Drug: Hydroxychloroquine - Daily Dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Placebo oral tablet|Diagnostic Test: Monitoring Visit - Baseline|Diagnostic Test: Monitoring Visit - Week 4|Diagnostic Test: Monitoring Visit - Week 8|Other: Weekly Assessment,All,"Adult, Older Adult",Phase 3,624.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","April 7, 2020","December 15, 2020"
252,NCT04588363,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|Multisystem Inflammatory Syndrome in Children (MIS-C)|Coronavirus Disease 2019 (COVID-19),Other: SARS-CoV-2 and/or MIS-C Exposure,All,"Child, Adult",,250.0,NIH|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 19, 2020",November 2022
253,NCT04376879,Recruiting,No Results Available,COVID-19,Other: Data monitoring for 48h within the first 24 hours of admission for COVID-19,All,"Adult, Older Adult",,384.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 16, 2020",May 2022
254,NCT04358536,Completed,No Results Available,COVID-19,Device: CovX,All,"Adult, Older Adult",,230.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","April 17, 2020"
255,NCT04564716,"Active, not recruiting",No Results Available,Covid19,Biological: Gam-COVID-Vac|Other: Placebo,All,Adult,Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","September 28, 2020","April 10, 2021"
256,NCT04533360,Enrolling by invitation,No Results Available,Covid19,Diagnostic Test: VITROS Anti-SARS-CoV-2 IgG test,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"September 28, 2020","May 1, 2021"
257,NCT04832919,Not yet recruiting,No Results Available,COVID-19,Behavioral: Nurse-Community-Family Partnership Intervention,All,"Child, Adult, Older Adult",Not Applicable,810.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,April 2021,May 2022
258,NCT04685447,Recruiting,No Results Available,Covid19|Hemodialysis Complication|Inflammatory Response,Procedure: Expanded Hemodialysis for Covid19 maintenance hemodialysis patients|Procedure: Hemodialysis by protein-leaking dialyzer for Covid19 maintenance hemodialysis patients,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 16, 2020","December 1, 2021"
259,NCT04716907,Recruiting,No Results Available,Covid19,Genetic: Single-Nucleotide Polymorphisms (SNP) within the TCRA/D region|Biological: Blood sample|Diagnostic Test: CT Scan,All,"Adult, Older Adult",,36.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 19, 2021","March 19, 2023"
260,NCT04816084,Completed,No Results Available,Covid19,Diagnostic Test: Anti-SARS-CoV2 Serology,All,"Adult, Older Adult",Not Applicable,389.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"November 5, 2020","March 15, 2021"
261,NCT04613297,Recruiting,No Results Available,Covid19,Other: Baseline and during hospitalization blood samples|Other: Baseline blood sample,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"October 19, 2020",October 2021
262,NCT04483908,Recruiting,No Results Available,COVID-19 Infection,Diagnostic Test: blood draw|Diagnostic Test: fingertip tests for POC assays|Diagnostic Test: saliva collection|Diagnostic Test: collection of swabs,All,"Adult, Older Adult",,550.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020","May 30, 2022"
263,NCT04789356,Recruiting,No Results Available,Covid19,Biological: Adsorbed SARS-CoV-2 (inactivated) vaccine,All,Adult,Phase 4,10156.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 18, 2021",March 2022
264,NCT04459390,Recruiting,No Results Available,COVID19,Diagnostic Test: realtime PCR,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 20, 2020","November 20, 2020"
265,NCT04406090,Completed,No Results Available,Ischemic Stroke|Covid 19,Other: Mechanical Trombectomy,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","June 30, 2020"
266,NCT04387838,Completed,No Results Available,Sars-CoV2,Diagnostic Test: Anti-SARS-CoV2 Serology|Other: Questionnaire,All,Adult,,845.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 14, 2020","August 15, 2020"
267,NCT04685603,Recruiting,No Results Available,COVID-19,Biological: AV-COVID-19,All,"Adult, Older Adult",Phase 1,27.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","December 7, 2020","January 31, 2022"
268,NCT04411602,Recruiting,No Results Available,Severe Acute Respiratory Syndrome|COVID,Drug: SARS-CoV-2 plasma,All,"Adult, Older Adult",Phase 1,90.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 7, 2020","November 1, 2021"
269,NCT04695678,"Active, not recruiting",No Results Available,COVID-19,Diagnostic Test: COVID-19 nasal/pharyngeal swab,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","June 30, 2021"
270,NCT04709744,Completed,No Results Available,Covid19,Drug: Vitamin D|Diagnostic Test: ELISA,All,"Adult, Older Adult",,38.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 1, 2020","December 30, 2020"
271,NCT04712344,Recruiting,No Results Available,Severe COVID-19,Biological: COVID-19 convalescent plasma,All,"Adult, Older Adult",Phase 2,58.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 18, 2021",September 2021
272,NCT04456595,"Active, not recruiting",No Results Available,COVID-19,Biological: Adsorbed COVID-19 (inactivated) Vaccine|Biological: Placebo,All,"Adult, Older Adult",Phase 3,12688.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 21, 2020",February 2022
273,NCT04799600,Recruiting,No Results Available,COVID19|Acute Renal Failure,Other: BRESCİA-COVİD Respiratory Severity Scale,All,"Child, Adult, Older Adult",,158.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"September 1, 2020","July 1, 2021"
274,NCT04763395,Recruiting,No Results Available,Liver Function Tests Abnormalities,Other: No intervention,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"January 29, 2021","March 1, 2021"
275,NCT04768257,Not yet recruiting,No Results Available,Covid19,Behavioral: Physical activity,All,"Adult, Older Adult",,195.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,"December 1, 2022"
276,NCT04842305,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: Blood- and saliva tests,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,April 2021,"March 15, 2024"
277,NCT04427878,Not yet recruiting,No Results Available,Covid-19 Patients,Procedure: biopsies of subcutaneous adipose tissue,All,"Adult, Older Adult",Not Applicable,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 1, 2020","July 9, 2021"
278,NCT04590378,Recruiting,No Results Available,Covid-19|Pulmonary Embolism,Other: intensive care unit admission ratio,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","December 1, 2020"
279,NCT04832932,Not yet recruiting,No Results Available,COVID-19 Vaccines,Biological: COVID-19 vaccine,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 1, 2021","December 31, 2022"
280,NCT04655625,"Active, not recruiting",No Results Available,COVID-19,Biological: Group A (AG0302-COVID19)|Biological: Group A (Placebo)|Biological: Group B (AG0302-COVID19)|Biological: Group B (Placebo),All,"Adult, Older Adult",Phase 2|Phase 3,500.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","November 23, 2020","March 31, 2022"
281,NCT04468256,Recruiting,No Results Available,COVID-19|Cardiomyopathies,Other: COVID-19 experience surveys,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 26, 2020",July 2022
282,NCT04542395,Not yet recruiting,No Results Available,Coronavirus,Behavioral: Increasing Willingness and Uptake of COVID-19 Testing and Vaccination,All,"Adult, Older Adult",Not Applicable,310.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 1, 2021","November 30, 2022"
283,NCT04399681,Recruiting,No Results Available,"COVID|Pneumonia, Viral",Device: Bedside lung ultrasound,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 10, 2020","September 10, 2020"
284,NCT04382781,Recruiting,No Results Available,COVID-19 Infection,Drug: NO-Immunosuppressive|Drug: Immunosuppressive|Drug: Immunoglubulins,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,May 2020,May 2020
285,NCT04428021,"Active, not recruiting",No Results Available,COVID-19,Drug: Standard Therapy Protocol (STP)|Other: STP + Standard Plasma (SP)|Other: STP + COVID-19 Convalescent Plasma (CP),All,"Adult, Older Adult",Phase 2,180.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","June 15, 2020","October 31, 2021"
286,NCT04482023,Recruiting,No Results Available,COVID-19,"Behavioral: Training video on anxiety, fear and loneliness in the COVID-19 environment.",All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"March 23, 2021","April 30, 2021"
287,NCT04397757,"Active, not recruiting",No Results Available,COVID-19,Biological: COVID-19 Convalescent Plasma,All,"Adult, Older Adult",Phase 1,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 13, 2020","May 30, 2021"
288,NCT04519502,Recruiting,No Results Available,COVID-19|Pregnancy Complications,,Female,"Child, Adult, Older Adult",,26400.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 23, 2020","December 31, 2021"
289,NCT04836351,Recruiting,No Results Available,Covid19,Other: Concentrated rehabilitation for patients with persistent symptoms post COVID-19,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 1, 2021","December 30, 2023"
290,NCT04381858,Completed,No Results Available,COVID-19 Pneumonia,Drug: Plasma from COVID-19 convalescent patient|Drug: Human immunoglobulin,All,"Child, Adult, Older Adult",Phase 3,196.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","May 6, 2020","November 26, 2020"
291,NCT04543006,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: serology,All,"Adult, Older Adult",Not Applicable,170.0,Other,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 8, 2020","December 31, 2021"
292,NCT04530370,Recruiting,No Results Available,Covid19,Biological: recovered covid 19 patients plasma,All,"Adult, Older Adult",Early Phase 1,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 29, 2020","September 1, 2020"
293,NCT04627519,Recruiting,No Results Available,Covid19,Dietary Supplement: Rhea Health Tone®,All,Adult,Not Applicable,85.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"December 9, 2020","March 15, 2021"
294,NCT04422535,Recruiting,No Results Available,Coronavirus Infection|Intensive Care Patients,,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 29, 2020","December 1, 2020"
295,NCT04331899,"Active, not recruiting",No Results Available,COVID-19,Drug: Peginterferon Lambda-1a|Other: Placebo,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"April 24, 2020",May 2021
296,NCT04358835,Withdrawn,No Results Available,COVID-19,Dietary Supplement: Ketogenic diet|Other: standard of care,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","December 31, 2021"
297,NCT04459637,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","March 10, 2021"
298,NCT04402853,Completed,No Results Available,Sars-CoV2|Tear,Diagnostic Test: Tears swab,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Prospective,"February 1, 2020","May 20, 2020"
299,NCT04590365,Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2,Device: Carrageenan nasal and throat spray|Device: Saline nasal and throat spray,All,"Adult, Older Adult",Not Applicable,480.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 30, 2021","December 1, 2021"
300,NCT04459962,Completed,No Results Available,Covid-19 Infection,Diagnostic Test: Breath Test & Cheek Swab,All,"Child, Adult, Older Adult",Not Applicable,330.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 29, 2020","January 7, 2021"
301,NCT04398264,Recruiting,No Results Available,Corona Virus Infection|Pregnancy Related,Other: COVID-19 positive via testing,Female,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 22, 2020","March 31, 2021"
302,NCT04401072,Recruiting,No Results Available,Covid 19,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 24, 2020",October 2020
303,NCT04560881,"Active, not recruiting",No Results Available,COVID-19 Virus Infection,Biological: Inactivated SARS-CoV-2 vaccine (Vero cell)|Biological: Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine,All,"Adult, Older Adult",Phase 3,3000.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","September 16, 2020","December 1, 2021"
304,NCT04465656,Recruiting,No Results Available,Pulmonary Embolism,Diagnostic Test: Serology test for COVID-19,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 7, 2020","April 30, 2021"
305,NCT04388436,"Active, not recruiting",No Results Available,COVID,,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","October 10, 2021"
306,NCT04741386,"Active, not recruiting",No Results Available,Covid19|Chronic Kidney Diseases,Biological: SARS-CoV-2 vaccination,All,"Adult, Older Adult",,849.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 17, 2021","December 31, 2022"
307,NCT04331574,Recruiting,No Results Available,COVID-19|Hypertension|Cardiovascular Diseases,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"March 10, 2020","April 30, 2020"
308,NCT04508777,Enrolling by invitation,No Results Available,Covid19,Behavioral: Saliva-based testing,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 9, 2020",July 2021
309,NCT04375761,Completed,No Results Available,Coronavirus Disease 2019 (COVID-19)|SARS-CoV-2,Procedure: Collection of Biological Samples|Procedure: Symptom and Exposure Surveys,All,"Child, Adult, Older Adult",,5599.0,NIH|Industry,Observational,Observational Model: Family-Based|Time Perspective: Prospective,"May 1, 2020","January 24, 2021"
310,NCT04522830,Completed,No Results Available,SARS-CoV-2 Infection,Drug: BTL-TML-COVID|Drug: Placebo,All,"Adult, Older Adult",Phase 2,28.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 30, 2020","February 28, 2021"
311,NCT04403828,Completed,No Results Available,COVID 19,Other: Survey,All,"Adult, Older Adult",,323.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 20, 2020","July 15, 2020"
312,NCT04395170,Not yet recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19),Biological: COVID-19 convalescent plasma|Biological: Anti-COVID-19 human immunoglobulin|Drug: Standard (specific) therapy for COVID-19,All,"Adult, Older Adult",Phase 2|Phase 3,75.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,September 2020,June 2021
313,NCT04473690,Recruiting,No Results Available,Covid19,Biological: Low Dose of KBP-COVID-19|Biological: High Dose of KBP-COVID-19|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,180.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 30, 2020","March 23, 2022"
314,NCT04337320,Completed,No Results Available,Covid19|Maternal-Fetal Relations,Other: newborns from covid 19 positive mothers,All,Child,,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 15, 2020","May 30, 2020"
315,NCT03348670,"Active, not recruiting",No Results Available,Covid19,Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection,All,"Adult, Older Adult",Early Phase 1,20.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 20, 2020","June 28, 2021"
316,NCT04432948,Recruiting,No Results Available,Covid-19|Maternal Psychological Distress|Anesthesia,Other: PHQ-9 Depression Scale|Other: GAD-7 General anxiety disorder scale|Other: 38-questions questionnaire,Female,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 15, 2020",December 2020
317,NCT04666116,Recruiting,No Results Available,COVID-19,Dietary Supplement: Dietary supplementation in patients with covid disease admitted to hospital,All,"Adult, Older Adult",Not Applicable,96.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 1, 2020",February 2021
318,NCT04525716,Recruiting,No Results Available,Covid19|Surgery,Other: COVID-19 infection status,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","December 31, 2020"
319,NCT04625075,Recruiting,No Results Available,Covid19,Diagnostic Test: Cardiac MRI|Diagnostic Test: Cardiac CT|Diagnostic Test: Electrocardiogram (ECG)|Diagnostic Test: Blood samples,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"June 10, 2020","June 10, 2022"
320,NCT04416139,Recruiting,No Results Available,Covid 19,Biological: Infusion IV of Mesenchymal Stem cells,All,"Adult, Older Adult",Phase 2,10.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","May 1, 2021"
321,NCT04380532,"Active, not recruiting",No Results Available,Covid19,Biological: V-SARS,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 15, 2020","June 15, 2021"
322,NCT04653857,"Active, not recruiting",No Results Available,Covid19,,All,"Child, Adult",,250.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 1, 2020","January 1, 2021"
323,NCT04421625,Recruiting,No Results Available,COVID-19,Diagnostic Test: Diagnostic test for SARS-Cov2 for patients and health staff,All,"Adult, Older Adult",Not Applicable,12000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"June 15, 2020","June 15, 2022"
324,NCT04568811,"Active, not recruiting",No Results Available,Adenovirus Type-5 Vectored COVID-19 Vaccine,Biological: Adenovirus Type-5 Vectored COVID-19 Vaccine,All,"Child, Adult, Older Adult",Phase 1,89.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 26, 2020","September 27, 2021"
325,NCT04467047,Not yet recruiting,No Results Available,COVID-19|Sars-CoV2,Biological: Mesenchymal Stromal Cells infusion,All,"Child, Adult, Older Adult",Phase 1,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 25, 2020","December 30, 2020"
326,NCT04779138,Not yet recruiting,No Results Available,Coronavirus|Vaccine Refusal,Behavioral: Increasing Willingness and Uptake of COVID-19 Vaccination,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"September 11, 2021","November 30, 2023"
327,NCT04800133,Recruiting,No Results Available,Covid19,Biological: Tozinameran|Biological: Oxford-AstraZeneca COVID-19 vaccine|Biological: CoronaVac,All,"Child, Adult, Older Adult",Phase 2,900.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,April 2021,"March 31, 2025"
328,NCT04839315,Recruiting,No Results Available,Systemic Lupus Erythematosus|Sjogren's Syndrome|Inflammatory Myositis|Psoriatic Arthritis|Gout|Ankylosing Spondylitis|Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis)|Osteoarthritis,Biological: mRNA COVD19 vaccine,All,"Adult, Older Adult",Early Phase 1,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"February 15, 2021",December 2021
329,NCT04756830,Not yet recruiting,No Results Available,COVID-19,Biological: Adsorbed COVID-19 (inactivated) Vaccine,All,"Adult, Older Adult",Phase 4,1200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,February 2021,June 2023
330,NCT04535791,Recruiting,No Results Available,Covid19|Vitamin D,Drug: Cholecalciferol,All,"Adult, Older Adult",Phase 3,400.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 15, 2020",July 2021
331,NCT04412382,Recruiting,No Results Available,Covid-19,Diagnostic Test: NETosis markers,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 1, 2020","December 31, 2021"
332,NCT04422379,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,314.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 7, 2020","August 30, 2020"
333,NCT04586413,Recruiting,No Results Available,Covid19,Other: No intervention - quality of life measure,All,"Adult, Older Adult",,100.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 7, 2020",October 2025
334,NCT04367142,Not yet recruiting,No Results Available,Sars-CoV2,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: Biosensor,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,September 2020,December 2020
335,NCT04366960,Recruiting,No Results Available,Covid19,Drug: Enoxaparin,All,"Adult, Older Adult",Phase 3,2712.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 14, 2020",November 2021
336,NCT04359927,Recruiting,No Results Available,Sars-CoV2|Covid19|Cardiovascular Diseases|Cardiovascular Risk Factor,,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"April 20, 2020","August 31, 2025"
337,NCT04348877,Not yet recruiting,No Results Available,Coronavirus Disease (COVID-19),Other: Antibody-Rich Plasma from COVID-19 recovered patients,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020",December 2020
338,NCT04582344,Recruiting,No Results Available,COVID-19,Biological: CoronaVac|Biological: Placebo,All,Adult,Phase 3,13000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","September 14, 2020","April 15, 2021"
339,NCT04376476,Recruiting,No Results Available,"Infection, Coronavirus|Severe Acute Respiratory Syndrome Coronavirus 2",Biological: Blood sample|Biological: Low or upper respiratory tract sample|Biological: Stool collection or fecal swab|Genetic: Blood sample for whole genome sequencing|Other: phone call,All,"Child, Adult, Older Adult",Not Applicable,450.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 5, 2020","June 5, 2021"
340,NCT04813497,Recruiting,No Results Available,Covid19,Diagnostic Test: Serology to determine SARS-CoV-2 infection,All,"Adult, Older Adult",Not Applicable,4000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 5, 2021","December 31, 2021"
341,NCT04357028,Suspended,No Results Available,Covid19,Drug: Measles-Mumps-Rubella Vaccine|Drug: Placebos,All,Adult,Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"July 13, 2020","January 1, 2021"
342,NCT04833101,Recruiting,No Results Available,COVID-19,Biological: recombinant Ad5 vectored COVID-19 vaccine|Biological: RBD-based protein subunit vaccine (ZF2001) against COVID-19|Biological: trivalent split influenza vaccine,All,"Adult, Older Adult",Phase 4,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 7, 2021","December 15, 2021"
343,NCT04351802,Recruiting,No Results Available,COVID-19,Diagnostic Test: Lung ultrasound,All,"Adult, Older Adult",,180.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","January 20, 2021"
344,NCT04775407,Recruiting,No Results Available,Covid19|Severe Mental Disorder,Procedure: blood sampling,All,"Adult, Older Adult",,1400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 18, 2021","September 1, 2022"
345,NCT04479319,Recruiting,No Results Available,Covid19,Diagnostic Test: Thorax CT,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"December 31, 2020",October 2021
346,NCT04664049,Recruiting,No Results Available,SARS-CoV-2|Covid 19,Dietary Supplement: NRICM101,All,"Child, Adult, Older Adult",,51000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 23, 2020","December 31, 2022"
347,NCT04631367,Not yet recruiting,No Results Available,"Knowledge, Attitudes, Practice|Covid19",Behavioral: Kukaa Salama: mHealth intervention|Device: Face Mask + Soap,All,"Child, Adult",Not Applicable,404.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 1, 2021","September 20, 2021"
348,NCT04818892,Recruiting,No Results Available,IBD|Covid19 Vaccine,Diagnostic Test: Serological Assay for SARS-CoV-2,All,"Adult, Older Adult",,210.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,April 2021,April 2023
349,NCT04377646,Not yet recruiting,No Results Available,Sars-CoV2|COVID19,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine (placebo)|Drug: Zinc|Drug: Zinc (Placebo),All,"Adult, Older Adult",Phase 3,660.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","May 4, 2020","July 31, 2020"
350,NCT04401436,Recruiting,No Results Available,Corona Virus Disease 2019,,All,"Adult, Older Adult",,350.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 22, 2020","June 30, 2022"
351,NCT04624048,Not yet recruiting,No Results Available,Infection Viral|Exercise|Coronavirus|Habits,Diagnostic Test: COVID-19 survey,All,"Child, Adult, Older Adult",,30000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Retrospective,"December 4, 2020","April 4, 2021"
352,NCT04570254,"Active, not recruiting",No Results Available,"Pneumonia, Viral|Covid19|ARDS|Oxidative Stress",Drug: Vitamin C|Drug: Vitamin E|Drug: Melatonin|Drug: N-acetyl cysteine|Drug: Pentoxifylline,All,"Child, Adult, Older Adult",Not Applicable,11.0,Other,Interventional,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 19, 2020","November 15, 2020"
353,NCT04392414,Completed,No Results Available,COVID-19,Biological: COVID-19 convalescent hyperimmune plasma|Biological: Non-convalescent fresh frozen plasma (Standard plasma),All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","September 23, 2020"
354,NCT04361591,Recruiting,No Results Available,Liver Transplant; Complications|COVID19|Respiratory Failure,Other: Observational only,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020",March 2021
355,NCT04797858,Not yet recruiting,No Results Available,Covid19,Behavioral: COVID-19 self-test|Behavioral: COVID-19 test referral,All,"Adult, Older Adult",Not Applicable,1048.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","April 1, 2021","October 31, 2022"
356,NCT04403581,Not yet recruiting,No Results Available,Covid-19,Other: Questionnaire,All,Adult,,384.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,May 2020,June 2020
357,NCT04454307,Not yet recruiting,No Results Available,COVID-19,Drug: Tramadol|Other: Standard care delivered in the isolation hospitals.,All,"Adult, Older Adult",Phase 1|Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",July 2020,October 2020
358,NCT04583995,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19,Biological: SARS-CoV-2 rS/Matrix M1-Adjuvant|Other: Placebo|Biological: Licensed seasonal influenza vaccine,All,"Adult, Older Adult",Phase 3,15000.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 28, 2020","January 14, 2022"
359,NCT04818281,Recruiting,No Results Available,Covid19,Biological: SARS-CoV-2 VLP Vaccine|Biological: Placebo,All,Adult,Phase 1,36.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","March 27, 2021",March 2022
360,NCT04642014,Not yet recruiting,No Results Available,COVID-19 Convalescent Plasma Treatment,Biological: COVID-19 convalescent plasma treatment,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","May 1, 2022"
361,NCT04656691,"Active, not recruiting",No Results Available,Covid19,Drug: bamlanivimab,All,Older Adult,Phase 4,4000.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 4, 2021",May 2021
362,NCT04481477,Recruiting,No Results Available,Covid19,"Other: Nursing care to reduce anxiety, fear and loneliness",All,"Adult, Older Adult",,450.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"November 27, 2020","April 15, 2021"
363,NCT04347850,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Other: blood sample,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2020","December 30, 2022"
364,NCT04579471,Recruiting,No Results Available,Covid19|SARS-CoV Infection|Transplantation Infection,Diagnostic Test: SARS-CoV-2 IgG,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","December 31, 2021"
365,NCT04500639,Recruiting,No Results Available,SARS-CoV-2 Infection|Covid19,,All,"Child, Adult, Older Adult",,14000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 23, 2020","March 31, 2023"
366,NCT04374513,Completed,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,318.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 2, 2020","July 1, 2020"
367,NCT04436471,Completed,No Results Available,Preventive Immunization COVID-19,Biological: Gam-COVID-Vac,All,Adult,Phase 1|Phase 2,38.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 17, 2020","August 10, 2020"
368,NCT04351659,Recruiting,No Results Available,COVID-19,Other: Blood donation from convalescent donor,All,"Adult, Older Adult",,8.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 14, 2020",August 2020
369,NCT04422574,Completed,No Results Available,Covid 19,,All,"Adult, Older Adult",,97.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"May 1, 2020","May 30, 2020"
370,NCT04651387,Not yet recruiting,No Results Available,SARS-CoV Infection,Dietary Supplement: Ozonized oil (HOO,All,"Adult, Older Adult",Not Applicable,74.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,January 2021,August 2021
371,NCT04530396,"Active, not recruiting",No Results Available,Covid19 Prevention,Biological: Gam-COVID-Vac|Other: placebo,All,"Adult, Older Adult",Phase 3,33758.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","September 7, 2020","May 1, 2021"
372,NCT04839913,Completed,No Results Available,SARS-CoV Infection|Seroprevalence|Covid19,Diagnostic Test: Antibodies testing,All,"Adult, Older Adult",,121.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"September 1, 2020","January 10, 2021"
373,NCT04354857,Recruiting,No Results Available,COVID-19,Other: olfactory and gustatory tests,All,"Adult, Older Adult",,454.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 27, 2020",November 2020
374,NCT04368338,Recruiting,No Results Available,Covid-19|Lung Ultrasound|Respiratory Complication,Diagnostic Test: COVID-19 RT-PCR|Procedure: lung ultrasound,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 28, 2020","September 28, 2021"
375,NCT04813575,Enrolling by invitation,No Results Available,Covid19|Pulmonary Fibrosis|Organising Pneumonia|Thromboembolism,Other: Cryo lung biopsies,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 1, 2021","June 1, 2022"
376,NCT04350073,Recruiting,No Results Available,COVID-19,Device: Q-NRG Metobolic Cart Device|Device: MuscleSound Ultrasound|Device: Multifrequency Bioimpedance Spectroscopy,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","December 1, 2021"
377,NCT04642339,Not yet recruiting,No Results Available,Covid19,Biological: Gam-COVID-Vac|Biological: Placebo,All,"Adult, Older Adult",Phase 3,2000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",November 2020,December 2021
378,NCT04627467,"Active, not recruiting",No Results Available,Covid19,Drug: Chloroquine,All,"Adult, Older Adult",Phase 2,3217.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 28, 2020",July 2021
379,NCT04386759,Not yet recruiting,No Results Available,COVID-19,Other: Cohort,All,"Adult, Older Adult",,6000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,May 2020,October 2020
380,NCT04695158,Recruiting,No Results Available,"Covid19|Diabetes Mellitus, Type 2",Drug: COVID-19 group (Group I)|Drug: Type II Diabetes Mellitus and COVID-19 group (Group II),All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 6, 2021",March 2021
381,NCT04762186,Not yet recruiting,No Results Available,Moderate COVID-19-infection,"Drug: IMP 1,000 plus SoC|Drug: IMP 5,000 plus SoC|Drug: IMP RP2D plus SoC|Drug: SoC",All,"Adult, Older Adult",Phase 1|Phase 2,51.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2021","December 1, 2022"
382,NCT04575545,Not yet recruiting,No Results Available,Covid19|Virus-HIV,Diagnostic Test: Serology test for COVID-19,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,October 2020,April 2022
383,NCT04525417,Completed,No Results Available,Covid-19 Immune Status of Healthcare Workers,Diagnostic Test: AAZ Covid-19 rapid test,All,"Adult, Older Adult",Not Applicable,75.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 25, 2020","October 25, 2020"
384,NCT04813770,Not yet recruiting,No Results Available,Vaccination|Covid19,Behavioral: Theory-based messages|Behavioral: General messages,All,"Adult, Older Adult",Not Applicable,1094.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research,March 2021,March 2021
385,NCT04563442,Not yet recruiting,No Results Available,Covid19,Other: complication,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"October 15, 2020","February 25, 2023"
386,NCT04408157,"Active, not recruiting",No Results Available,COVID,Behavioral: Self-management booklet (SWitCh: Stay well during COVID-19),All,"Adult, Older Adult",Not Applicable,185.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020","December 22, 2021"
387,NCT04359537,Recruiting,No Results Available,COVID 19,Drug: Hydroxychloroquine Sulfate 200 MG|Other: Placebo,All,Adult,Phase 2,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"May 1, 2020","September 25, 2020"
388,NCT04434261,Recruiting,No Results Available,SARS-CoV-2|Oncology|Surgery,Diagnostic Test: PT-PCR test for SARS-CoV-2,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","September 30, 2021"
389,NCT04423640,Recruiting,No Results Available,SARS-CoV-2,Other: Active COVID-19 disease,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","August 15, 2020"
390,NCT04786197,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,603.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 17, 2020","December 31, 2021"
391,NCT04838821,Not yet recruiting,No Results Available,Covid19,Biological: Anti SARS-CoV-2 equine hyperimmune serum|Biological: placebo,All,"Adult, Older Adult",Phase 2|Phase 3,156.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 29, 2021","September 29, 2021"
392,NCT04444687,Not yet recruiting,No Results Available,COVID,Diagnostic Test: Test for SARS-CoV-2,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,August 2020,February 2021
393,NCT04680819,Not yet recruiting,No Results Available,Covid19,Dietary Supplement: Anatolian Propolis,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 25, 2020","January 25, 2021"
394,NCT04822402,Not yet recruiting,No Results Available,Covid-19 in Pregnancy,,Female,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,May 2021,June 2022
395,NCT04611802,"Active, not recruiting",No Results Available,SARS-CoV Infection|Covid19,Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)|Other: Placebo (Initial Vaccination Period)|Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Crossover Vaccination period)|Other: Placebo (Crossover Vaccination period),All,"Adult, Older Adult",Phase 3,30000.0,Industry|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 27, 2020","December 30, 2022"
396,NCT04411576,Recruiting,No Results Available,SARS-CoV 2,Diagnostic Test: Throat swab sample for measuring current infection with SARS-CoV-2|Diagnostic Test: Blood sample for serology to measure past infection with SARS-CoV-2,All,"Adult, Older Adult",,40000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020","December 31, 2020"
397,NCT04569292,Recruiting,No Results Available,Covid19,Other: No intervention on patients,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"January 1, 2020",August 2021
398,NCT04388618,Recruiting,No Results Available,Anosmia|Ageusia|Covid19|Corona Virus Infection,Other: NHANES smell and taste tests,All,"Child, Adult, Older Adult",,250.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 15, 2020","November 30, 2021"
399,NCT04347889,Withdrawn,No Results Available,Covid-19,Drug: Hydroxychloroquine|Other: Vitamin C,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"April 20, 2020","December 30, 2020"
400,NCT04810117,Not yet recruiting,No Results Available,COVID-19 Infections,Diagnostic Test: Serodiagnosis of IgG and IgM,All,Adult,,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2021","October 30, 2021"
401,NCT04558385,Completed,No Results Available,Covid19,Diagnostic Test: IgG SARS CoV2,All,"Child, Adult, Older Adult",,275.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"July 1, 2020","March 31, 2021"
402,NCT04388683,"Active, not recruiting",No Results Available,COVID-19,Drug: Nitric Oxide,All,"Adult, Older Adult",Phase 2,42.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 12, 2020","July 31, 2021"
403,NCT04607928,Recruiting,No Results Available,Fibrotic Pulmonary Sequelae Post-COVID19 Infection,Drug: Pirfenidone|Drug: Placebo,All,"Adult, Older Adult",Phase 2,148.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","August 1, 2020","August 1, 2021"
404,NCT04474288,Recruiting,No Results Available,Covid19 Immunology,Diagnostic Test: SARS-CoV-2 antibody testing,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"July 16, 2020",July 2021
405,NCT04359862,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID19 Infection,Drug: Sevoflurane|Drug: Propofol,All,"Adult, Older Adult",Phase 4,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","April 30, 2021"
406,NCT04602442,Enrolling by invitation,No Results Available,Covid19|SARS-CoV-2 PNEUMONIA|COVID-19,Drug: EXO 1 inhalation|Drug: EXO 2 inhalation|Drug: Placebo inhalation,All,"Adult, Older Adult",Phase 2,90.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Other","October 1, 2020","December 30, 2021"
407,NCT04399733,Not yet recruiting,No Results Available,"COVID-19, SARS-CoV 2 Infection|Health Disparities",,All,"Child, Adult, Older Adult",,12800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2021","February 1, 2024"
408,NCT04357990,Recruiting,No Results Available,COVID-19,Device: Viruxal Oral and Nasal Spray|Other: Placebo,All,"Adult, Older Adult",Not Applicable,128.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 4, 2020",March 2021
409,NCT04502472,Recruiting,No Results Available,Covid-19,Biological: Convalescent plasma transfusion,All,"Adult, Older Adult",Phase 2|Phase 3,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 6, 2020","December 31, 2021"
410,NCT04387890,Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2|Health Personnel,Diagnostic Test: Serologic SARS-CoV-2 screening,All,"Adult, Older Adult",,50.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","August 31, 2020"
411,NCT04738695,Recruiting,No Results Available,Covid19|SARS-CoV-2 Infection,Diagnostic Test: Point-of-care rapid anti-SARS-CoV-2 antibody test (Orient Gene Biotech) and Dry Blood Spot collection (Euroimmun),All,"Adult, Older Adult",,3036.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2021","March 31, 2022"
412,NCT04336462,Recruiting,No Results Available,COVID-19,Device: oxyhydrogen|Device: Oxygen,All,"Adult, Older Adult",Not Applicable,100.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 15, 2020","August 1, 2020"
413,NCT04453852,Recruiting,No Results Available,Coronavirus Infection|COVID,Biological: COVID19 vaccine|Biological: Saline,All,"Adult, Older Adult",Phase 1,40.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 30, 2020","July 1, 2021"
414,NCT04726176,Recruiting,No Results Available,Covid19|Brain|Neurocognition|fMRI,Biological: Exposure to COVID-19,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 30, 2021","July 1, 2021"
415,NCT04506528,Recruiting,No Results Available,Covid19|Cancer|Nicotine Dependence|Pulmonary Disease|Cardiovascular Diseases|Immunosuppression Disorders,,All,"Child, Adult, Older Adult",,170000.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Other,"August 10, 2020",December 2023
416,NCT04348422,Recruiting,No Results Available,COVID-19,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: COVID-19 Serology|Other: Symptoms questionnare,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","December 31, 2021"
417,NCT04830683,Recruiting,No Results Available,Covid19|Hypoxemic Respiratory Failure,,All,"Adult, Older Adult",,85.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","April 1, 2021"
418,NCT04706156,Recruiting,No Results Available,Oral Manifestations|Covid19|Vaccine Adverse Reaction,Biological: COVID-19 Vaccine,All,"Adult, Older Adult",,1540.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"January 27, 2021","March 31, 2021"
419,NCT04701944,Recruiting,No Results Available,Covid-19,,Female,"Adult, Older Adult",,54.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 21, 2020","April 21, 2021"
420,NCT04374123,Completed,No Results Available,COVID,Diagnostic Test: Serological screening for IgG and IgM antibodies against COVID-19,All,"Adult, Older Adult",,111.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","June 15, 2020"
421,NCT04389476,Not yet recruiting,No Results Available,The Psychological Impact of COVID-19,Other: Standardized crisis management and coping protocol plan toward Coronavirus disease 2019 (COVID-19),All,"Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 15, 2020","July 31, 2023"
422,NCT04470414,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: IgG antibodies immunoassay,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 1, 2020","September 1, 2021"
423,NCT04709302,Recruiting,No Results Available,Covid19|Hiv|ART,Biological: COVID-19|Biological: HIV|Drug: ART,All,"Adult, Older Adult",,342.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,February 2021,December 2022
424,NCT04753463,Not yet recruiting,No Results Available,SARS-CoV-2,Other: Survey,All,Adult,,130.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2021","April 15, 2021"
425,NCT04516928,Completed,No Results Available,SARS-CoV Infection|Covid19,Diagnostic Test: Anti-SARS-CoV2 Serology|Other: Questionnaire,All,"Adult, Older Adult",,392.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 21, 2020","September 25, 2020"
426,NCT04573855,Not yet recruiting,No Results Available,Covid19,Biological: Anti-SARS-CoV-2 immunoglobulin,All,"Adult, Older Adult",Phase 1|Phase 2,41.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","March 31, 2021"
427,NCT04501458,"Active, not recruiting",No Results Available,Covid19,"Other: Training of youth, community health assistants and community health workers.|Other: Training clinicians in basic critical care and the management of severe COVID-19 cases",All,"Adult, Older Adult",Not Applicable,200000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 10, 2020","June 10, 2021"
428,NCT04651790,Recruiting,No Results Available,Covid19|Vaccines,Biological: SARS-CoV-2 inactivated vaccine,All,"Adult, Older Adult",Phase 3,2300.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 27, 2020",March 2022
429,NCT04393961,Recruiting,No Results Available,COVID19|COVID-19|Coronavirus,Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette,All,"Adult, Older Adult",Not Applicable,600.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,"April 5, 2020","August 29, 2020"
430,NCT04423315,Completed,No Results Available,Corona Virus Infection|Thromboembolic Disease,,All,"Adult, Older Adult",,70.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 8, 2020","July 20, 2020"
431,NCT04361916,Terminated,No Results Available,COVID-19,Other: home care monitoring,All,"Adult, Older Adult",Not Applicable,37.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"April 21, 2020","June 30, 2020"
432,NCT04367740,Enrolling by invitation,No Results Available,Asymptomatic Condition|Infection Viral|Coronavirus Infections|Severe Acute Respiratory Syndrome Coronavirus 2|Coronaviridae Infections|RNA Virus Infections|Virus Diseases|Communicable Disease,Diagnostic Test: To assess for development of IgG antibodies against SARS-CoV2,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"April 28, 2020",December 2021
433,NCT04515199,Recruiting,No Results Available,Covid19|Telemedicine|Quality of Life|Safety Issues|Symptoms,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020",March 2021
434,NCT04404270,"Active, not recruiting",No Results Available,Sars-CoV2,Diagnostic Test: Anti-SARS-CoV2 Serology|Behavioral: Questionnaire|Diagnostic Test: Anti-SARS-CoV2 serological controls and serum neutralization,All,"Adult, Older Adult",,1146.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 26, 2020",March 2021
435,NCT04554979,Completed,No Results Available,Covid19|Diarrhea,Drug: Hydroxychloroquine Pill,All,"Adult, Older Adult",,199.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020","July 15, 2020"
436,NCT04832022,Not yet recruiting,No Results Available,Rheumatic Diseases|SARS-CoV Infection|COVID-19,Other: Biological samples,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,April 2021,August 2023
437,NCT04388527,"Active, not recruiting",No Results Available,Covid-19,Biological: COVID-19 Convalescent Plasma,All,"Adult, Older Adult",Phase 1,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","May 30, 2021"
438,NCT04368234,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,100000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 18, 2020","April 30, 2025"
439,NCT04760184,Not yet recruiting,No Results Available,Covid19|Myeloma Multiple|Malignant Lymphoma|Hematologic Neoplasms|Stem Cell Transplant Complications,Other: Autologous stem cell transplantation,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2021","December 31, 2021"
440,NCT04390165,Completed,No Results Available,SARS-CoV Infection|COVID-19|Anosmia|Dysgeusia,Other: Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances,All,"Adult, Older Adult",,498.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"June 6, 2020","November 30, 2020"
441,NCT04589936,Recruiting,No Results Available,Pneumonia|Covid19,Procedure: Prone positioning,All,"Adult, Older Adult",Not Applicable,56.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 3, 2020","June 30, 2021"
442,NCT04605757,Recruiting,No Results Available,SARS-COV-2 Pneumonia,"Other: Clinical, functional and radiological lung involvement evolution",All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 30, 2020","July 30, 2021"
443,NCT04490174,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,2500.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 8, 2020","June 1, 2022"
444,NCT04710316,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: SARS-CoV-2 screening by molecular biology|Diagnostic Test: Serological screening,All,"Adult, Older Adult",Not Applicable,450.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"January 30, 2021","September 30, 2022"
445,NCT04581863,"Active, not recruiting",No Results Available,Covid19,Device: pulse oximeter|Other: COVID Watch,All,"Adult, Older Adult",Not Applicable,850.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"November 30, 2020","October 31, 2021"
446,NCT04358029,Recruiting,No Results Available,COVID 19 Cardiac|COVID 16 Arrhythmia|COVID 19 Death,,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 9, 2020",May 2022
447,NCT04527601,Completed,No Results Available,Extreme Prematurity|Covid19,,All,Child,,885.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 21, 2020","September 13, 2020"
448,NCT04475562,Completed,No Results Available,SARS-CoV Infection|Covid19,Device: Aeonose,All,"Adult, Older Adult",Not Applicable,219.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 6, 2020","July 1, 2020"
449,NCT04372368,No longer available,No Results Available,COVID-19|SARS-CoV 2,Biological: COVID-19 Convalescent Plasma,All,"Adult, Older Adult",,,Other,Expanded Access:Treatment IND/Protocol,,,
450,NCT04679584,Recruiting,No Results Available,COVID-19,Other: Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 16, 2020","December 31, 2030"
451,NCT04525742,Completed,No Results Available,COVID-19|Disabilities Multiple|Cerebral Palsy|Muscular Dystrophies,Other: Difficulties lived by disabled children's parents in the period of COVID-19 pandemic,All,"Adult, Older Adult",Not Applicable,309.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"July 5, 2020","September 15, 2020"
452,NCT04568356,Completed,No Results Available,SARS CoV-2,Diagnostic Test: Direct Antigen Tests for COVID-19,All,"Adult, Older Adult",Not Applicable,200.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 24, 2020","September 24, 2020"
453,NCT04550325,Completed,No Results Available,"Covid19|Pneumonia, Viral",Biological: Kamada Anti-SARS-CoV-2,All,"Adult, Older Adult",Phase 1|Phase 2,12.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 5, 2020","November 26, 2020"
454,NCT04341766,Completed,No Results Available,"Pneumonia, Viral|COVID-19",Other: No special intervention,All,"Adult, Older Adult",,106.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 31, 2020","June 30, 2020"
455,NCT04569344,Enrolling by invitation,No Results Available,Venous Thromboembolism|Covid19,Other: Laboratory test positive for SARS-CoV-2 virus,All,"Adult, Older Adult",,40000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2020","June 21, 2022"
456,NCT04368390,Recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"April 3, 2020",April 2021
457,NCT04359667,Recruiting,No Results Available,COVID-19|Severe Pneumonia,Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA],All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 16, 2020","May 15, 2021"
458,NCT04819165,Completed,No Results Available,"Respiration, Artificial|COVID-19|Health Care Associated Infection",Other: COVID-19,All,"Adult, Older Adult",,252.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","January 31, 2021"
459,NCT04416347,Recruiting,No Results Available,COVID|SARS-CoV 2,Other: SARS-CoV2 Infection,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 15, 2020","April 30, 2022"
460,NCT04606732,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"September 20, 2020","December 31, 2021"
461,NCT04794387,Recruiting,No Results Available,Covid19,Biological: Observational study: This registry data will provide more specific information about how people with blood cancer respond to COVID-19 virus and/or a COVID-19 vaccination.,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 23, 2021","February 23, 2031"
462,NCT04321811,"Active, not recruiting",No Results Available,Coronavirus,"Other: Observation of patients with known, suspected, or at risk for COVID-19 infection",All,"Adult, Older Adult",,100000.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 21, 2020","March 20, 2022"
463,NCT04463862,Recruiting,No Results Available,COVID-19 Confirmed Cases|COVID-19 Mortality,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 4, 2020","September 4, 2020"
464,NCT04383548,Not yet recruiting,No Results Available,COVID19,Other: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin,All,Adult,Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","January 1, 2021"
465,NCT04418206,Recruiting,No Results Available,Covid 19,Other: patients COVID 19,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 1, 2020","June 1, 2021"
466,NCT04545047,"Active, not recruiting",No Results Available,Coronavirus Disease 2019 (COVID-19),Biological: COVID-19 convalescent plasma,All,"Adult, Older Adult",,10000.0,U.S. Fed|Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 1, 2020","June 30, 2022"
467,NCT04348864,Recruiting,No Results Available,Communicable Disease|COVID-19|Sars-CoV2|Infectious Disease|Coronavirus|Virus,"Diagnostic Test: COVID-19 Antigen/Antibody Rapid Testing, mobile device image capture and telemedicine support|Other: Telemedicine",All,"Adult, Older Adult",Not Applicable,200.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 16, 2020",April 2021
468,NCT04352348,Recruiting,No Results Available,COVID-19,Other: blood samples|Other: feces samples (COVI-BIOME ancillary study)|Other: sweat samples (COVIDOG ancillary study)|Other: saliva samples|Other: 6 minutes walk test|Other: Phone call|Other: Urine samples,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"March 31, 2020","March 31, 2022"
469,NCT04510233,Not yet recruiting,No Results Available,Covid19,Drug: Ivermectin nasal|Drug: Ivermectin oral|Other: standard care,All,Adult,Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,September 2020,December 2020
470,NCT04673214,Recruiting,No Results Available,Covid19,Drug: Azithromycin / Ivermectin / Ribaroxaban / Paracetamol|Drug: Azithromycin / Ribaroxaban / Paracetamol,All,"Adult, Older Adult",Phase 3,62.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"December 16, 2020","February 12, 2021"
471,NCT04665245,Enrolling by invitation,No Results Available,Covid19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 15, 2020",April 2021
472,NCT04437875,Completed,No Results Available,Preventive Immunization COVID-19,Biological: Gam-COVID-Vac Lyo,All,Adult,Phase 1|Phase 2,38.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 17, 2020","August 10, 2020"
473,NCT04334876,Not yet recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: SARS-CoV-2 IgG Antibody Testing Kit,All,"Adult, Older Adult",,340.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"April 1, 2020","January 1, 2021"
474,NCT04604249,"Active, not recruiting",No Results Available,Covid19|High Altitude,"Diagnostic Test: SARS-CoV-2 rapid diagnostic test (COVID-PRESTO® IgM/IgG, AAZ, Boulogne-Billancourt, France)",All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"October 26, 2020","December 31, 2021"
475,NCT04558372,Completed,No Results Available,COVID-19,Other: exhaled breath sampling,All,"Child, Adult, Older Adult",Not Applicable,1999.0,Other,Interventional,"Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic","April 1, 2020","December 12, 2020"
476,NCT04469647,Enrolling by invitation,No Results Available,COVID 19,Diagnostic Test: Serology Test,All,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"July 19, 2020","June 15, 2021"
477,NCT04784403,Completed,No Results Available,SARS-CoV-2 Infection,Diagnostic Test: SARS-CoV-2 PCR and serology tests,All,"Adult, Older Adult",,3356.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"December 14, 2020","February 24, 2021"
478,NCT04452630,Recruiting,No Results Available,Cardiovascular Consequences After an Episode of COVID 19,Other: Infectious Disease and Cardiology Clinical Consultations,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 23, 2020","November 30, 2021"
479,NCT04366739,Not yet recruiting,No Results Available,COVID-19,Drug: CHLORPROMAZINE (CPZ)|Combination Product: Standard of Care (SOC),All,"Adult, Older Adult",Phase 3,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 29, 2020","September 30, 2020"
480,NCT04514627,Recruiting,No Results Available,COVID-19,Device: Auricular percutaneous neurostimulation,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 13, 2020","July 31, 2021"
481,NCT04399109,Recruiting,No Results Available,COVID,Device: TCC-COVID mHealth solution,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 20, 2020","May 19, 2021"
482,NCT04384614,Withdrawn,No Results Available,Covid 19|BCG Vaccination,Diagnostic Test: Test PCR|Genetic: TDR|Other: Clinical Examination,All,"Adult, Older Adult",,0.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 15, 2020","July 15, 2020"
483,NCT04616976,Completed,No Results Available,COVID-19 Convalescent Plasma Treatment,Biological: convalescent plasma,All,"Adult, Older Adult",,78.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"January 1, 2020","November 1, 2020"
484,NCT04408378,Recruiting,No Results Available,Coronavirus Infection,Other: observation of covid 19 pneumonia,All,"Adult, Older Adult",,156.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"June 5, 2020","August 20, 2020"
485,NCT04367896,Completed,No Results Available,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION,Other: Survey Group,,"Child, Adult, Older Adult",,1819.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"March 24, 2020","April 17, 2020"
486,NCT04373460,Recruiting,No Results Available,SARS-CoV 2,Biological: SARS-CoV-2 convalescent plasma|Biological: Plasma from a volunteer donor,All,"Adult, Older Adult",Phase 2,1344.0,Other|U.S. Fed|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 3, 2020","January 31, 2023"
487,NCT04800731,Not yet recruiting,No Results Available,Lymphopenia|Covid19|Older People,Other: observation no intervention,All,Older Adult,,300.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"June 30, 2021","December 31, 2023"
488,NCT04379063,"Active, not recruiting",No Results Available,"Burnout, Professional|Psychological Distress",Other: COVID-19 pandemic,All,"Child, Adult, Older Adult",,342.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 13, 2020",May 2022
489,NCT04362865,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,360.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","December 1, 2024"
490,NCT04714333,Enrolling by invitation,No Results Available,Covid19,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 6, 2020","May 5, 2021"
491,NCT04386239,Recruiting,No Results Available,COVID19,Drug: Sarilumab Prefilled Syringe,All,"Adult, Older Adult",Early Phase 1,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,December 2021
492,NCT04463706,Recruiting,No Results Available,Covid19,Other: Predictors adverse evolution|Other: Predictors of health care provide,All,"Child, Adult, Older Adult",,20000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020","December 31, 2021"
493,NCT04385017,Recruiting,No Results Available,COVID-19 by SARS-CoV-2 Infection,Other: COVID-19 patients,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 11, 2020","June 12, 2021"
494,NCT04756518,Recruiting,No Results Available,COVID-19|COVID|SARS-CoV 2,,All,"Adult, Older Adult",,785.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 6, 2020","July 1, 2021"
495,NCT04764773,Recruiting,No Results Available,Corona Virus Infection,Other: No intervention,All,"Child, Adult, Older Adult",,250.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 1, 2020","March 31, 2021"
496,NCT04479982,Recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,70.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"September 24, 2020","December 31, 2020"
497,NCT04401098,Recruiting,No Results Available,COVID 19,,All,"Child, Adult, Older Adult",,700.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 2, 2020","April 1, 2021"
498,NCT04359849,Recruiting,No Results Available,Coronavirus Infection,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,May 2020,September 2022
499,NCT04347798,Enrolling by invitation,No Results Available,Covid-19 Infection|Rheumatoid Arthritis|Psoriatic Arthritis|Hydroxychloroquine,Other: Hydroxychloroquine/Chloroquine,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,September 2020,April 2021
500,NCT04579458,Withdrawn,No Results Available,Covid19|Ophthalmopathy|Eye Diseases,Procedure: Collection of tears and saliva.,All,"Adult, Older Adult",,0.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 28, 2020","January 22, 2021"
501,NCT04374526,Recruiting,No Results Available,Coronavirus Disease 2019 )COVID-19),Biological: COVID-19 Convalescent Plasma,All,Older Adult,Phase 2|Phase 3,182.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 27, 2020","June 30, 2021"
502,NCT04771052,Enrolling by invitation,No Results Available,Covid19,Other: COVID Rehabilitation Program for the Elderly (CORE),All,"Child, Adult, Older Adult",,128.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"September 1, 2020",April 2021
503,NCT04459286,Recruiting,No Results Available,Covid-19,Drug: Nitazoxanide and atazanavir/ritonavir|Other: Standard of Care,All,"Adult, Older Adult",Phase 2,98.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"October 9, 2020","April 30, 2021"
504,NCT04386564,Completed,No Results Available,COVID-19|Kidney Injury,Diagnostic Test: mRNA in urine test,All,"Adult, Older Adult",,340.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020","September 1, 2020"
505,NCT04453670,Completed,No Results Available,COVID 19,Procedure: autopsy,All,"Adult, Older Adult",,7.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 10, 2020","May 15, 2020"
506,NCT04479137,Completed,No Results Available,"Covid-19|Risk Factor, Mortality",Diagnostic Test: PCR for COVID-19,All,Adult,,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 10, 2020","July 14, 2020"
507,NCT04765475,Recruiting,No Results Available,COVID-19,Behavioral: Motivational Interviewing|Behavioral: COVID-19 Symptom Monitoring System|Behavioral: Motivational Interviewing and COVID-19 Symptom Monitoring System|Other: Supportive Services,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,"March 8, 2021",September 2022
508,NCT04471649,Recruiting,No Results Available,COVID,,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"June 15, 2020",November 2020
509,NCT04631172,Completed,No Results Available,SARS-CoV-2|Anxiety and Fear|Parents,"Other: Coronavirus Anxiety Scale , COVID-19 Phobia Scale",All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 1, 2020","October 15, 2020"
510,NCT04723446,Not yet recruiting,No Results Available,Covid19|Coronavirus,Drug: Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate|Drug: Colgate Peroxyl® -1.5% Hydrogen peroxide|Other: Oral-B® Gum & Enamel Care -Cetylpyridinium chloride|Other: No rinsing,All,"Adult, Older Adult",Not Applicable,40.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Other,"February 1, 2021","January 1, 2022"
511,NCT04480580,Completed,No Results Available,Covid19|Surgery|SARS (Severe Acute Respiratory Syndrome),Diagnostic Test: SARS-CoV-2 Ab,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 30, 2020","June 30, 2020"
512,NCT04383626,Completed,No Results Available,COVID,,All,"Adult, Older Adult",,216.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 2, 2020","May 5, 2020"
513,NCT04298814,Withdrawn,No Results Available,COVID-19|Endotracheal Intubation,Other: severe covid-19 pneumonia with ET,All,"Adult, Older Adult",,0.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"August 7, 2020","December 30, 2020"
514,NCT04699903,Not yet recruiting,No Results Available,"SARS-Cov-2, Covid19",Diagnostic Test: POC SARS-Cov-2 IgG Antibody test,All,"Child, Adult, Older Adult",,215.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 28, 2020","February 5, 2021"
515,NCT04432272,"Active, not recruiting",No Results Available,COVID-19|Severe Acute Respiratory Syndrome (SARS)|Coronavirus Infections,Biological: COVID-19 convalescent plasma,All,"Adult, Older Adult",Phase 2,500.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 16, 2020",August 2021
516,NCT04316728,Not yet recruiting,No Results Available,Coronavirus Infections,Device: VivaDiag™ COVID-19 lgM/IgG Rapid Test,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,March 2020,November 2020
517,NCT04359810,Recruiting,No Results Available,SARS-CoV-2 Infection,Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Non-convalescent Plasma (control plasma),All,"Adult, Older Adult",Phase 2,219.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","April 21, 2020",April 2021
518,NCT04554992,"Active, not recruiting",No Results Available,Covid19,Biological: COVID 19 Convalescent Plasma,All,"Adult, Older Adult",Phase 1,350.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 20, 2020",June 2022
519,NCT04584450,Completed,No Results Available,Covid19,Other: Questionnaire,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"September 2, 2020","December 31, 2020"
520,NCT04437719,Recruiting,No Results Available,Oncology|COVID-19,Other: Obvio-19 app,All,"Adult, Older Adult",Not Applicable,100.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"June 29, 2020","December 31, 2021"
521,NCT04370223,Not yet recruiting,No Results Available,COVID-19 Pneumonia,Biological: Ozone auto-hemotherapy,All,"Adult, Older Adult",Phase 3,208.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 25, 2020","December 25, 2020"
522,NCT04615000,Recruiting,No Results Available,"Covid19|Children, Only",Diagnostic Test: SARS-CoV-2 serological assessment (IgG),All,"Child, Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 29, 2020","November 1, 2021"
523,NCT04583189,Completed,No Results Available,Covid19,Diagnostic Test: Performance of the test antigenic and test RT-PCR,All,"Child, Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"October 1, 2020","November 25, 2020"
524,NCT04696913,Not yet recruiting,No Results Available,Covid19|Pulmonary Embolism,Diagnostic Test: Exposure: Positive COVID-19 infection|Diagnostic Test: Exposure: Negative COVID-19 infection,All,"Child, Adult, Older Adult",,347.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"January 1, 2021","November 22, 2021"
525,NCT04465058,Recruiting,No Results Available,COVID19,Other: COVID19,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"July 8, 2020","August 10, 2020"
526,NCT04380987,Recruiting,No Results Available,Covid19,Biological: Biological sampling,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 4, 2020","December 31, 2021"
527,NCT04335136,Completed,No Results Available,COVID-19,Drug: RhACE2 APN01|Drug: Physiological saline solution,All,"Adult, Older Adult",Phase 2,200.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 30, 2020","December 26, 2020"
528,NCT04390503,Recruiting,No Results Available,SARS-CoV 2|COVID-19,Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Control (albumin 5%),All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",March 2021,April 2022
529,NCT04474340,Recruiting,No Results Available,"Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia|Pneumonia, Viral",Drug: COVID-19 Convalscent Plasma,All,"Child, Adult, Older Adult",Phase 1,300.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 21, 2020","December 30, 2020"
530,NCT04667442,Recruiting,No Results Available,Covid19,Diagnostic Test: Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional),All,"Adult, Older Adult",,60.0,Industry,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"December 1, 2020",March 2021
531,NCT04339608,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 2, 2020","June 30, 2020"
532,NCT04649918,"Active, not recruiting",No Results Available,Covid19|SARS-CoV Infection|Pulmonary Rehabilitation|Quality of Life,Other: pulmonary rehabilitation,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 25, 2020","April 30, 2021"
533,NCT04678687,"Active, not recruiting",No Results Available,Covid19|Postmortem Changes,"Procedure: Liver, lung, heart and kidney biopsy",All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"January 1, 2021","January 1, 2022"
534,NCT04382092,Completed,No Results Available,COVID-19,Diagnostic Test: FilmArray Pneumonia,All,"Adult, Older Adult",Not Applicable,32.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 23, 2020","April 24, 2020"
535,NCT04425837,Not yet recruiting,No Results Available,Sars-CoV2|Covid-19,Biological: SARS-CoV-2 convalescent plasma treatment|Other: Standard care,All,"Adult, Older Adult",Phase 2|Phase 3,236.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,July 2020,February 2021
536,NCT04765436,Recruiting,No Results Available,Covid19 Vaccine,Biological: PTX-COVID19-B|Biological: Placebo,All,Adult,Phase 1,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 14, 2021","February 14, 2022"
537,NCT04584567,Recruiting,No Results Available,Covid19,Drug: Doxycyclin,All,"Adult, Older Adult",Phase 3,1100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","November 20, 2020","March 1, 2021"
538,NCT04682041,Recruiting,No Results Available,Covid19,Dietary Supplement: Bovine Plasma-Derived Immunoglobulin Concentrate|Other: Standard of care,All,"Adult, Older Adult",Not Applicable,420.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 22, 2020","June 30, 2021"
539,NCT04657419,Not yet recruiting,No Results Available,Covid19,Other: survey,All,Adult,,720.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 5, 2020","June 30, 2021"
540,NCT04462627,Recruiting,No Results Available,COVID 19,Diagnostic Test: Blood group determination|Diagnostic Test: Antibody titration|Dietary Supplement: Probiotic,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 14, 2020",December 2021
541,NCT04474457,"Active, not recruiting",No Results Available,COVID-19,Drug: Favipiravir,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 11, 2020","June 1, 2021"
542,NCT04747158,Completed,No Results Available,SARS-CoV-2 Infection|COVID-19 Infection,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 2|Phase 3,350.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 10, 2020","January 10, 2021"
543,NCT04425915,Recruiting,No Results Available,COVID,Biological: Convalescent Plasma|Other: Standard of Care,All,"Adult, Older Adult",Phase 3,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 14, 2020","May 30, 2021"
544,NCT04339634,"Active, not recruiting",No Results Available,COVID|Drug Effect|Drug Interaction|Adverse Drug Event,Other: Simulation of Repurposed Drugs for COVID-19,All,"Adult, Older Adult",,12123.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 7, 2020","April 6, 2021"
545,NCT04817371,Recruiting,No Results Available,Covid19,Device: Volatile Organic Compounds analysis (e-noses)|Other: Canine odor detection of Volatile Organic Compounds|Device: Volatile Organic Compounds analysis (mass spectrometry)|Device: Volatile Organic Compounds analysis in sweat (mass spectrometry),All,"Adult, Older Adult",Not Applicable,192.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 1, 2021",March 2022
546,NCT04695652,"Active, not recruiting",No Results Available,Covid19 Vaccine,Biological: MVC-COV1901(S protein with adjuvant)|Biological: MVC-COV1901(Saline),All,"Adult, Older Adult",Phase 2,3700.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","December 30, 2020",June 2022
547,NCT04636320,Recruiting,No Results Available,COVID-19|Virus Disease,Device: Contrast-enhanced CMR|Diagnostic Test: Exercise test ECG|Biological: Blood sample|Diagnostic Test: Resting 12 lead ECG|Diagnostic Test: 24 hour Holter ECG,All,"Adult, Older Adult",Not Applicable,240.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 13, 2020","April 13, 2021"
548,NCT04492865,Not yet recruiting,No Results Available,COVID-19,Device: MSCT,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 30, 2020","October 30, 2020"
549,NCT04443881,Recruiting,No Results Available,COVID-19 Pnemonia,Drug: Anakinra 149 MG/ML Prefilled Syringe [Kineret],All,"Adult, Older Adult",Phase 2|Phase 3,180.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020",March 2021
550,NCT04527458,Completed,No Results Available,Covid19,Other: Patient Characteristics|Other: COVID-19 treatments|Other: Differences in triage|Other: Surge capacity,All,"Child, Adult, Older Adult",,70000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 24, 2020","August 2, 2020"
551,NCT04352933,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine - Daily dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Matched Placebo Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 11, 2020",April 2021
552,NCT04318418,Completed,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,3400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 23, 2020","June 30, 2020"
553,NCT04376580,Enrolling by invitation,No Results Available,COVID 19,,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"April 30, 2020","November 30, 2020"
554,NCT04345523,Recruiting,No Results Available,COVID-19,Other: Blood and derivatives.|Drug: Standard of Care,All,"Adult, Older Adult",Phase 2,278.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020",April 2021
555,NCT04343755,"Active, not recruiting",No Results Available,COVID-19,Biological: Convalescent Plasma,All,"Adult, Older Adult",Phase 2,52.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 9, 2020",April 2021
556,NCT04420182,Recruiting,No Results Available,Covid-19,Other: Virtual Care at Home,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 17, 2020","December 31, 2021"
557,NCT04467151,Withdrawn,No Results Available,COVID-19,Drug: anti-SARS-CoV-2 plasma|Other: Placebo,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",October 2020,December 2021
558,NCT04397523,Recruiting,No Results Available,Convalescent Plasma|COVID-19|SARS-CoV 2,Biological: anti-SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","April 29, 2021"
559,NCT04362930,Recruiting,No Results Available,Neurologic Manifestations|Psychiatric Disorders|COVID-19,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 27, 2020","April 24, 2022"
560,NCT04723394,Recruiting,No Results Available,COVID-19,Drug: AZD7442|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1700.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","January 28, 2021","May 27, 2022"
561,NCT04372979,Recruiting,No Results Available,COVID-19,Drug: Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.,All,"Adult, Older Adult",Phase 3,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 14, 2020",June 2021
562,NCT04329559,Completed,No Results Available,COVID-19|Liver Cirrhosis,,All,"Adult, Older Adult",,21.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 30, 2020","February 10, 2021"
563,NCT04383535,Completed,No Results Available,SARS Virus|SARS-CoV-2|COVID-19,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,All,"Adult, Older Adult",Not Applicable,333.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 15, 2020","September 27, 2020"
564,NCT04824664,Completed,No Results Available,Surgery and covid19,Other: survey,All,"Child, Adult, Older Adult",,400.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"January 1, 2020","December 30, 2020"
565,NCT04313946,Recruiting,No Results Available,"COVID-19|Pneumonia, Viral|Influenza With Pneumonia|Flu Symptom|Flu Like Illness|Pneumonia, Interstitial|Pneumonia, Ventilator-Associated|Pneumonia Atypical",Diagnostic Test: Scanning Chest X-rays and performing AI algorithms on images,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"March 18, 2020","August 18, 2020"
566,NCT04387799,Completed,No Results Available,"Pneumonia, Viral|Pneumonia, Bacterial|Coronavirus Infection|Obstructive Lung Disease",Diagnostic Test: Serology for Covid-19,All,"Adult, Older Adult",,520.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 13, 2020","June 17, 2020"
567,NCT04554433,Not yet recruiting,No Results Available,Covid-19|Drug Effect,Drug: Ethanol with Asprin,All,Adult,Phase 3,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","June 1, 2022"
568,NCT04465552,Recruiting,No Results Available,Coronavirus Infections,Other: Patients received standard of care treatment during hospitalization,All,"Adult, Older Adult",,750.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"July 10, 2020",October 2021
569,NCT04818736,Not yet recruiting,No Results Available,Vaccine Preventable Disease,Biological: COVID-19 Vaccination|Other: Usual care,All,"Child, Adult, Older Adult",Phase 4,4000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 15, 2021",December 2021
570,NCT04757818,Recruiting,No Results Available,SARS-CoV-2 Infection,Other: 0.07% cetylpyridinium chloride (CPC) in mouthwash|Other: Distilled water with the same colorant as the experimental product,All,"Adult, Older Adult",Not Applicable,140.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","February 4, 2021","March 25, 2021"
571,NCT04603729,Completed,No Results Available,Covid 19 Disease,Drug: Dexamethasone 2 MG/ML|Drug: Methylprednisolone Injection,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 30, 2020","July 1, 2020"
572,NCT04733170,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: KnowNow SARS-CoV-2 Rapid Antigen Test,All,"Adult, Older Adult",,600.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 15, 2021","August 31, 2021"
573,NCT04401241,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,257.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"February 1, 2020","May 15, 2020"
574,NCT04418557,Recruiting,No Results Available,COVID|Pregnancy Complications,Diagnostic Test: RT-PCR and antibody testing,Female,Adult,,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 28, 2020","July 31, 2021"
575,NCT04444596,Recruiting,No Results Available,COVID-19|SARS-CoV 2,Diagnostic Test: Conjunctival swab and nasopharyngeal swab,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 17, 2020","March 31, 2021"
576,NCT04674553,Completed,No Results Available,Obesity|Covid19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"November 10, 2020","December 10, 2020"
577,NCT04374695,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"May 1, 2020","July 1, 2020"
578,NCT04359264,"Active, not recruiting",No Results Available,COVID-19,Other: Cash transfer,All,"Adult, Older Adult",Not Applicable,392.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 20, 2020","December 30, 2020"
579,NCT04490850,Recruiting,No Results Available,Coronavirus Infection|Severe Acute Respiratory Syndrome|SARS-CoV Infection|Covid19,Procedure: Blood sample,All,"Child, Adult, Older Adult",Not Applicable,1500.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 15, 2020","July 15, 2021"
580,NCT04377789,Completed,No Results Available,COVID-19,Dietary Supplement: Quercetin Prophylaxis|Dietary Supplement: Quercetin Treatment,All,"Adult, Older Adult",Not Applicable,447.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 20, 2020","August 31, 2020"
581,NCT04521088,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 2, 2020","December 31, 2020"
582,NCT04394884,Suspended,No Results Available,COVID-19,,All,"Adult, Older Adult",,120.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 9, 2021","April 30, 2023"
583,NCT04344457,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Indomethacin|Drug: Zithromax Oral Product,All,"Adult, Older Adult",Phase 1|Phase 2,80.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","September 30, 2020"
584,NCT04608383,Recruiting,No Results Available,Covid19,Other: Additional and minimal collection of products of the human body carried out during a sample for standard of care,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"November 19, 2020","January 1, 2022"
585,NCT04817332,Completed,No Results Available,Covid19,Drug: Brensocatib|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 3,400.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 5, 2020","February 28, 2021"
586,NCT04364815,Withdrawn,No Results Available,COVID-19,Drug: Hydroxychloroquine plus standard preventive measures|Drug: Placebo plus standard preventive measures,All,Adult,Phase 3,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",December 2020,May 2021
587,NCT04663737,Recruiting,No Results Available,Covid19,Drug: Silmitasertib|Drug: SOC,All,"Adult, Older Adult",Phase 2,20.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 3, 2020","June 30, 2021"
588,NCT04437342,Completed,No Results Available,Postpartum Depression|Psychological Stress|Maternal Distress,Other: PHQ-9 (Patient Health Questionnaire) Depression Scale|Other: GAD-7 (General Anxiety Disorder) scale|Other: 38 questions questionnaire|Other: EPDS (Edinburgh Postnatal Depression Scale),Female,"Adult, Older Adult",,330.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 30, 2020","October 27, 2020"
589,NCT04420988,Available,No Results Available,COVID-19|SARS-CoV 2|SARS-CoV Infection,Biological: COVID-19 Convalescent Plasma,All,"Adult, Older Adult",,,Other,Expanded Access:Individual Patients|Intermediate-size Population,,,
590,NCT04514874,Completed,No Results Available,Covid19|SARS-CoV Infection,Other: Questionnaire,All,"Adult, Older Adult",,479.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","October 5, 2020"
591,NCT04800965,Enrolling by invitation,No Results Available,"Covid19, Vaccines",Behavioral: Patient MyChart Scheduling Link|Behavioral: Patient Educational Video|Behavioral: Enhanced Follow through Message,All,"Adult, Older Adult",Not Applicable,400000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research","January 31, 2021","January 1, 2022"
592,NCT04666064,Recruiting,No Results Available,Covid19|Lung Ultrasound|Respiratory Complication,Diagnostic Test: Covid19 RT-PCR|Other: lung ultrasound,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 10, 2020",July 2021
593,NCT04801940,Not yet recruiting,No Results Available,Covid19,Drug: Apixaban|Drug: Atorvastatin,All,"Adult, Older Adult",Phase 3,2631.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,"January 31, 2024"
594,NCT04382794,Completed,No Results Available,Covid19,Drug: Retrospective case-control analysis,All,"Adult, Older Adult",,338.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"May 14, 2020","June 15, 2020"
595,NCT04563156,Enrolling by invitation,No Results Available,Covid19,Diagnostic Test: Lung Function Test,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 23, 2020","December 31, 2021"
596,NCT04393155,Terminated,No Results Available,COVID-19|Acute Respiratory Failure,Other: COVID-19+ observational,All,"Adult, Older Adult",,16.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","January 25, 2021"
597,NCT04490824,Recruiting,No Results Available,Covid19,Device: KELEA Excellerated Water|Device: Water Without an Elevated Level of KELEA,All,"Child, Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"October 1, 2020","April 30, 2021"
598,NCT04466644,Completed,No Results Available,COVID-19,Diagnostic Test: ELISA|Diagnostic Test: RT-PCR,All,"Adult, Older Adult",,340.0,Industry,Observational,Observational Model: Other|Time Perspective: Prospective,"June 8, 2020","August 25, 2020"
599,NCT04525911,Recruiting,No Results Available,Covid19,Diagnostic Test: Diagnostic Test: serology test for COVID-19,All,"Adult, Older Adult",,258.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 26, 2020",October 2022
600,NCT04484597,Recruiting,No Results Available,Positive COVID-19 by PCR,Diagnostic Test: Rt PCR,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"March 15, 2020","September 15, 2020"
601,NCT04524156,Not yet recruiting,No Results Available,COVID|Acute Respiratory Distress Syndrome|Endothelial Dysfunction,Other: Physiology,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"October 4, 2020","May 4, 2023"
602,NCT04724538,Recruiting,No Results Available,"Covid19|Pneumonia, Viral",Radiation: 99mTc-pertechnetate|Radiation: 99mTc-pertechnetate aerosol|Drug: 99mTc-pertechnetate aerosol,All,"Adult, Older Adult",Phase 1|Phase 2,15.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 15, 2020","March 15, 2021"
603,NCT04353609,Recruiting,No Results Available,Sars-CoV2|Chronic Inflammatory Rheumatism|Autoimmune Diseases,,All,"Child, Adult, Older Adult",,13770.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 18, 2020",December 2020
604,NCT04334252,Completed,No Results Available,COVID 19,Other: Questionnaire,All,"Adult, Older Adult",,528.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 17, 2020","December 20, 2020"
605,NCT04473131,Recruiting,No Results Available,COVID-19,Other: No intervention,All,"Adult, Older Adult",,300.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020",June 2022
606,NCT04745377,Recruiting,No Results Available,Cancer,Diagnostic Test: IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 12, 2021","January 31, 2022"
607,NCT04352634,Recruiting,No Results Available,Covid-19|Mental Health Disorder|Stress Disorder|Anxiety|Depression|SARS-CoV-2,Other: Exposure to the SARS-CoV-2 and its consequences,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 26, 2020","December 31, 2021"
608,NCT04591704,Recruiting,No Results Available,Covid19|Diabetes Mellitus,"Other: hospitalisation, necessity of ICU, mortality rate, lung involvement",All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 20, 2020","November 1, 2020"
609,NCT04317040,Completed,No Results Available,Covid19,Drug: CD24Fc|Drug: Placebo,All,"Adult, Older Adult",Phase 3,243.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 24, 2020","October 20, 2020"
610,NCT04572360,Not yet recruiting,No Results Available,Coronavirus Disease (COVID-19),Other: Cardiorespiratory Exercise|Other: Modified Bai He Gu Jin Tang,All,"Adult, Older Adult",Not Applicable,172.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 1, 2020","June 30, 2023"
611,NCT04497818,Completed,No Results Available,Covid19|Fear|Dental Anxiety,Other: Cross Sectional study using scientifically validated psychometric Scales,All,"Adult, Older Adult",,385.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 16, 2020","July 25, 2020"
612,NCT04381312,Recruiting,No Results Available,Risk Factors for COVID-19 Outcomes in Elderly Populations,,All,Older Adult,,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2020","October 9, 2021"
613,NCT04438629,Recruiting,No Results Available,Allergy and Immunology|Infection Viral,Drug: COVID-19 treatment,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 26, 2020","November 26, 2020"
614,NCT04610138,Not yet recruiting,No Results Available,Covid19,Drug: CNM-ZnAg|Drug: Placebo,All,"Adult, Older Adult",Phase 2,276.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",February 2021,August 2021
615,NCT04659941,Recruiting,No Results Available,COVID 19 Vaccine,Biological: BCG vaccine,All,"Adult, Older Adult",Phase 2,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention","October 1, 2020","October 1, 2022"
616,NCT04475575,Completed,No Results Available,SARS-CoV Infection|Covid19,Device: Aeonose,All,"Adult, Older Adult",Not Applicable,222.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 6, 2020","July 1, 2020"
617,NCT04345692,Terminated,No Results Available,COVID-19,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,17.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 26, 2020","August 31, 2020"
618,NCT04824313,"Active, not recruiting",No Results Available,"Covid19|Pneumonia, Viral|Pulmonary Embolism",Diagnostic Test: Chest CT|Diagnostic Test: Chest CTA,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 1, 2020","March 31, 2021"
619,NCT04718467,Not yet recruiting,No Results Available,COVID-19,Biological: Recombinant COVID-19 vaccine (Sf9 cells)|Biological: Placebo,All,"Adult, Older Adult",Phase 2,4000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","February 1, 2021","March 15, 2022"
620,NCT04780659,Recruiting,No Results Available,Covid19,"Biological: Comirnaty (COVID-19, mRNA vaccine)",All,"Adult, Older Adult",Phase 4,540.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 23, 2021","December 31, 2022"
621,NCT04815018,Recruiting,No Results Available,SARS-CoV-2 Infection|Bacterial Respiratory Tract Infection|Viral Respiratory Tract Infection,,All,"Adult, Older Adult",,300.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 7, 2020",May 2021
622,NCT04624997,Recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,Other: biological sample,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 8, 2020",December 2020
623,NCT04325061,Terminated,No Results Available,Acute Respiratory Distress Syndrome Caused by COVID-19,Drug: Dexamethasone,All,"Adult, Older Adult",Phase 4,19.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020","June 19, 2020"
624,NCT04743908,Not yet recruiting,No Results Available,Covid19,Other: Social Network Strategy + COVID-19 messaging,All,"Adult, Older Adult",Not Applicable,2400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,February 2021,December 2023
625,NCT04407559,Completed,No Results Available,COVID-19|Rheumatoid Arthritis,Other: Serological analyses to be lead on a pre-existing biobank,All,"Adult, Older Adult",,216.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 1, 2020","September 30, 2020"
626,NCT04828915,Recruiting,No Results Available,Covid19,Other: Machine learning|Other: Machine based evaluation,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2021","December 31, 2021"
627,NCT04343261,Completed,Has Results,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|COVID|Coronavirus,Biological: Convalescent Plasma,All,"Adult, Older Adult",Phase 2,48.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 10, 2020","August 13, 2020"
628,NCT04568655,Completed,No Results Available,Noninvavie Ventilation to Patients With COVID-19,Device: noninvasive ventilation,All,"Adult, Older Adult",,23.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 1, 2020","July 1, 2020"
629,NCT04495933,Recruiting,No Results Available,SARS-CoV2|Covid19,Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg|Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 15mcg|Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 45mcg|Other: Placebo,All,"Adult, Older Adult",Phase 1,216.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","July 13, 2020",September 2021
630,NCT04837651,Recruiting,No Results Available,"Multiple Sclerosis|Demyelinating Autoimmune Diseases, CNS|Autoimmune Diseases of the Nervous System|Nervous System Diseases|Demyelinating Diseases|Autoimmune Diseases|Immune System Diseases|Pathologic Processes",Device: Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test,All,Adult,,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 8, 2021","September 8, 2022"
631,NCT04756609,Not yet recruiting,No Results Available,SARS-CoV Infection|Nurse's Role,Procedure: Systematic offer of nurse-driven SARS-CoV-2 screening combined with usual practice|Other: Usual emergency department practice with physician-directed diagnostic testing,All,"Adult, Older Adult",Not Applicable,104000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"February 12, 2021","June 1, 2021"
632,NCT04377737,Withdrawn,No Results Available,"Infection; Viral, Coronavirus",Diagnostic Test: RT-PCR Covid-19,All,Child,Not Applicable,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 15, 2020",September 2020
633,NCT04760730,Not yet recruiting,No Results Available,Covid19,Biological: AZD1222|Biological: rAd26-S,All,"Adult, Older Adult",Phase 1|Phase 2,100.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"March 17, 2021","December 31, 2021"
634,NCT04577235,Completed,No Results Available,COVID-19,Other: severity of lung involvement with COVID-19.,All,"Adult, Older Adult",Not Applicable,29.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Diagnostic","June 5, 2020","September 5, 2020"
635,NCT04347460,Recruiting,No Results Available,COVID,,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 27, 2020","August 31, 2020"
636,NCT04361903,Not yet recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Drug: Ruxolitinib Oral Tablet,All,"Adult, Older Adult",,13.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 25, 2020","May 31, 2020"
637,NCT04346147,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Imatinib tablets|Drug: Baricitinib Oral Tablet|Other: Supportive tratment,All,"Adult, Older Adult",Phase 2,165.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 7, 2020",September 2021
638,NCT04568421,Recruiting,No Results Available,Rheumatic Diseases,Drug: Immunosuppressive Agents,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 18, 2020","December 31, 2021"
639,NCT04530500,Enrolling by invitation,No Results Available,Covid19|Androgen Receptor Gene Overexpression,Genetic: COVID-19 Androgen Sensitivity Test (CoVAST),Male,"Adult, Older Adult",,200.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 13, 2020","June 24, 2023"
640,NCT04805840,Recruiting,No Results Available,Covid19,Device: CoV-SCAN rapid COVID-19 antigen test,All,"Adult, Older Adult",,4400.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"February 19, 2021","July 31, 2021"
641,NCT04359212,Completed,No Results Available,"COVID-19 Disease|Thromboembolism, Venous",Drug: thromboprophylaxis with low-molecular-weight heparin or fondaparinux,All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","July 31, 2020"
642,NCT04342663,Completed,No Results Available,COVID 19|Coronavirus,Drug: Fluvoxamine|Drug: Placebo,All,"Adult, Older Adult",Phase 2,152.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 10, 2020","December 12, 2020"
643,NCT04536363,Not yet recruiting,No Results Available,Covid19,"Drug: Analogs, Prostaglandin E1|Drug: Standard therapeutic protocol",All,"Adult, Older Adult",Phase 2,284.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2020","March 1, 2021"
644,NCT04506229,Recruiting,No Results Available,Covid19,Genetic: Whole exome sequencing,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"August 20, 2020",September 2021
645,NCT04370275,Recruiting,No Results Available,"COVID-19|Pneumonia, Viral",,All,"Adult, Older Adult",,235.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020","May 31, 2020"
646,NCT04667780,Recruiting,No Results Available,COVID-19,Drug: Colchicine|Drug: Standard COVID-19 care,All,"Adult, Older Adult",Phase 3,102.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 10, 2020","July 9, 2021"
647,NCT04482361,Completed,No Results Available,COVID-19,Diagnostic Test: Presence of specific anti-SARS-CoV-2 antibodies,All,"Adult, Older Adult",,5900.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"August 6, 2020","December 22, 2020"
648,NCT04358809,Recruiting,No Results Available,COVID-19,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Other: Placebo,All,"Adult, Older Adult",Phase 3,480.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 30, 2020","April 30, 2021"
649,NCT04449965,Not yet recruiting,No Results Available,Covid19,Drug: Povidone-iodine|Drug: Placebo,All,"Adult, Older Adult",Early Phase 1,81.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 1, 2020","December 1, 2020"
650,NCT04742595,Recruiting,No Results Available,COVID-19-Associated Acute Respiratory Distress Syndrome|COVID-19-Associated Pneumonia|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed,Biological: SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes,All,"Adult, Older Adult",Early Phase 1,16.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 18, 2020","March 31, 2022"
651,NCT04764032,Recruiting,No Results Available,Covid19|Right Ventricular Dysfunction|ARDS,Diagnostic Test: Echocardiography,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 2, 2020","April 30, 2021"
652,NCT04427254,Recruiting,No Results Available,COVID19,"Drug: Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies",All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"June 26, 2020",January 2023
653,NCT04386369,Completed,No Results Available,ARDS|COVID19,Other: Airway pressure release ventilation,All,"Adult, Older Adult",,17.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 15, 2020","June 1, 2020"
654,NCT04371926,Withdrawn,No Results Available,COVID-19,Drug: Hydroxychloroquine Sulfate,All,"Child, Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,June 2020,July 2021
655,NCT04373161,Completed,No Results Available,Sars-CoV2|COVID-19|COVID,Device: Home Pulse Oximetry Monitoring,All,"Adult, Older Adult",Not Applicable,209.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 20, 2020","April 22, 2020"
656,NCT04750720,Recruiting,No Results Available,Covid19|SARS-CoV-2,Other: Sampling by venipuncture (and eventually by nasopharyngeal swab),All,"Adult, Older Adult",Not Applicable,300.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"August 27, 2020",December 2023
657,NCT04395391,Completed,No Results Available,COVID-19,Diagnostic Test: SARS-CoV-2,All,"Adult, Older Adult",,30.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 18, 2020","June 16, 2020"
658,NCT04825301,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,325.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 21, 2020","July 21, 2021"
659,NCT04734223,Completed,No Results Available,Neuroimaging|COVID-19,Diagnostic Test: Neuroimaging Findings in Patients With COVID-19,All,"Adult, Older Adult",,436.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"April 1, 2020","December 31, 2020"
660,NCT04533347,Recruiting,No Results Available,COVID 19 Disease,Drug: Tafenoquine Oral Tablet|Drug: Placebo,All,"Adult, Older Adult",Phase 2,275.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 19, 2021","June 22, 2021"
661,NCT04602832,Enrolling by invitation,No Results Available,Well-Being,Other: Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,All,"Adult, Older Adult",Not Applicable,350.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"October 14, 2020",December 2020
662,NCT04448717,Recruiting,No Results Available,SARS-CoV 2|COVID-19,Diagnostic Test: COVID-19 Antibody testing,All,"Child, Adult, Older Adult",,8000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 16, 2020",March 2021
663,NCT04701996,Recruiting,No Results Available,Covid19,Biological: serological surveillance,All,"Child, Adult, Older Adult",,1600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 23, 2020","December 31, 2021"
664,NCT04519372,"Active, not recruiting",No Results Available,Covid19|SARS-CoV-2,Diagnostic Test: Testing for SARS-CoV-2,All,"Adult, Older Adult",,4099.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"April 1, 2020","March 31, 2021"
665,NCT04599998,Enrolling by invitation,No Results Available,Covid19,"Diagnostic Test: spirometry, thoracic CT, CPET, 6 minute walking test, SF-36 questionnaire",All,"Adult, Older Adult",,37.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 15, 2020","March 1, 2021"
666,NCT04657263,Recruiting,No Results Available,Covid19,Other: Vaccine coverage assessment,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 1, 2020","May 30, 2021"
667,NCT04374903,Not yet recruiting,No Results Available,COVID-19 Patients,Drug: HCQ & AZ vs HCQ+SIR,All,"Adult, Older Adult",Not Applicable,58.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","September 1, 2020"
668,NCT04491240,Completed,Has Results,Covid19|SARS-CoV-2 PNEUMONIA|COVID-19,Drug: EXO 1 inhalation|Drug: EXO 2 inhalation|Drug: Placebo inhalation,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Other","July 20, 2020","October 20, 2020"
669,NCT04445597,Recruiting,No Results Available,SARS-CoV-2,Other: Sampling of tissue,All,"Child, Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"May 7, 2020","December 31, 2022"
670,NCT04395794,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: SARS-CoV-2-test|Other: SARS-CoV-2 questionnaire survey,All,"Adult, Older Adult",,900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 7, 2020","November 30, 2020"
671,NCT04801524,Enrolling by invitation,No Results Available,"Covid19, Vaccines",Behavioral: Self-benefit|Behavioral: Prosocial-benefit|Behavioral: Early access|Behavioral: Fresh start,All,"Adult, Older Adult",Not Applicable,250000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research","February 7, 2021","January 1, 2022"
672,NCT04828772,"Active, not recruiting",No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,9282.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 17, 2020","June 30, 2021"
673,NCT04610801,Recruiting,No Results Available,Covid19,Drug: Nasal Spray,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,"August 8, 2020","August 8, 2021"
674,NCT04408066,Recruiting,No Results Available,COVID-19,Diagnostic Test: Sample Collection/Performance Evaluation (A)|Diagnostic Test: Sample Collection/Performance Evaluation (B),All,"Adult, Older Adult",Not Applicable,2000.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 30, 2020","April 30, 2022"
675,NCT04379154,Recruiting,No Results Available,COVID-19,Device: Volatile Organic Compounds analysis,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 14, 2020",April 2021
676,NCT04405232,Recruiting,No Results Available,COVID|Thrombosis|Bleeding|Anticoagulation,Other: Non-interventional,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 25, 2020","June 25, 2021"
677,NCT04361318,Not yet recruiting,No Results Available,COVID-19,Combination Product: Hydroxychloroquine plus Nitazoxanide|Other: Standard care,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",May 2020,December 2020
678,NCT04371679,Recruiting,No Results Available,Covid-19,Other: No interventions planned,All,"Child, Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","December 1, 2020"
679,NCT04344002,Recruiting,No Results Available,Covid-19|Lung Cancer,,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 21, 2020","June 30, 2021"
680,NCT04834934,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,2000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 16, 2020",June 2021
681,NCT04604678,Not yet recruiting,No Results Available,Covid19,Drug: Metformin|Drug: Naltrexone,All,"Adult, Older Adult",Phase 2,80.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,February 2021,October 2021
682,NCT04568707,Recruiting,No Results Available,Covid19|Neurologic Manifestations|Psychiatric Manifestations,Other: blood sample,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"October 23, 2020","October 15, 2022"
683,NCT04648410,Recruiting,No Results Available,Severe COVID-19,Other: questionnaire,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 16, 2021","December 1, 2021"
684,NCT04513964,Recruiting,No Results Available,Heart Failure|Covid19,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"November 1, 2020","June 30, 2021"
685,NCT04409899,"Active, not recruiting",No Results Available,COVID-19|Urologic Diseases|Surgery--Complications|Epidemic Disease,Diagnostic Test: Blood tests,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020","December 31, 2020"
686,NCT04768179,Not yet recruiting,No Results Available,Covid19,Drug: 3-dayIVM 200 mcg/kg/day/14-day 75mgASA/day + standard of care (intervention 1),All,Adult,Phase 2|Phase 3,490.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 19, 2021","September 30, 2021"
687,NCT04542044,Completed,No Results Available,Covid19|Pneumonia,Other: management strategy of outpatient with mild to moderate SARS-CoV-2 pneumonia,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 2, 2020","June 30, 2020"
688,NCT04363840,Not yet recruiting,No Results Available,COVID|Vitamin D Deficiency|Coagulopathy|Disseminated Intravascular Coagulation,Drug: Aspirin 81 mg|Dietary Supplement: Vitamin D,All,"Adult, Older Adult",Phase 2,1080.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,May 2020,December 2020
689,NCT04384497,Recruiting,No Results Available,COVID-19,Biological: SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Phase 1|Phase 2,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 7, 2020",December 2020
690,NCT04766294,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,70.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 25, 2020","April 1, 2021"
691,NCT04401085,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,All,"Child, Adult, Older Adult",,27000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 23, 2020","May 1, 2020"
692,NCT04623138,Not yet recruiting,No Results Available,Covid19|SARS-CoV Infection,,All,"Adult, Older Adult",,950.0,Industry|U.S. Fed|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,November 2020,May 2021
693,NCT04420741,"Active, not recruiting",No Results Available,COVID-19|Respiratory Failure,Drug: Iloprost|Drug: Isotonic saline,All,"Adult, Older Adult",Phase 2,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 15, 2020","April 23, 2021"
694,NCT04824365,Recruiting,No Results Available,Covid19|Influenza,Drug: Sodium Pyruvate|Other: Saline,All,Adult,Phase 2|Phase 3,60.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","April 3, 2021",June 2022
695,NCT04355702,Completed,No Results Available,Systemic Lupus Erythematosus|Covid-19,,All,"Adult, Older Adult",,130.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","December 30, 2020"
696,NCT04432779,Recruiting,No Results Available,Pregnancy|Covid-19,Other: no intervention,All,"Child, Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 25, 2020",June 2024
697,NCT04818489,Recruiting,No Results Available,Covid19|Pulmonary Fibrosis Interstitial,Drug: Colchicine 0.5 MG|Other: the standard protocol only,All,"Adult, Older Adult",Phase 4,250.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 25, 2021","July 10, 2021"
698,NCT04333693,Not yet recruiting,No Results Available,Vascular Surgical Procedures|COVID-19|Postoperative Complications,Procedure: Vascular surgery,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","November 1, 2020"
699,NCT04709003,Recruiting,No Results Available,Covid19|Corona Virus Infection|Vaccine Effectiveness,Diagnostic Test: Serologic test|Diagnostic Test: Respiratory swabs,All,"Adult, Older Adult",,4504.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 23, 2020",June 2022
700,NCT04844632,Recruiting,No Results Available,Health Care Utilization|Health Care Associated Infection,Biological: Vaccine anti-Covid19,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 11, 2021","May 21, 2022"
701,NCT04534621,Not yet recruiting,No Results Available,Covid19,Other: Electronic survey,All,"Child, Adult, Older Adult",,948.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"August 26, 2020","September 18, 2020"
702,NCT04357496,Not yet recruiting,No Results Available,Fever|Pneumonia|Cough,,All,"Adult, Older Adult",,400.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 20, 2020","November 30, 2021"
703,NCT04741178,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 20, 2020","December 31, 2021"
704,NCT04542980,Not yet recruiting,No Results Available,SARS-CoV 2 Infection|Covid19,Diagnostic Test: SARS-CoV2 Autoantibody detection,All,"Adult, Older Adult",,200.0,Industry,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"September 15, 2020","December 31, 2020"
705,NCT04565067,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,120.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 19, 2021","September 1, 2022"
706,NCT04809948,Not yet recruiting,No Results Available,COVID 19 Vaccine,Biological: viral vector vaccine,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,March 2021,"December 30, 2021"
707,NCT04562285,Recruiting,No Results Available,Covid19,Diagnostic Test: Serologic immunoassays to SARS-CoV-2 antibodies,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 23, 2020",June 2021
708,NCT04701658,Recruiting,No Results Available,COVID-19,Drug: Bamlanivimab,All,"Child, Adult, Older Adult",Phase 2,3000.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021","August 7, 2021"
709,NCT04359303,Not yet recruiting,No Results Available,COVID,Other: Systemic indirect endovenous ozone therapy,All,"Adult, Older Adult",Phase 3,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",July 2020,December 2020
710,NCT04395599,Not yet recruiting,No Results Available,Sars-CoV2|Surgery|COVID,"Other: Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients.",All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,May 2020,October 2020
711,NCT04772833,Recruiting,No Results Available,Covid19,Other: Autopsy,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 5, 2020","December 31, 2021"
712,NCT04676867,Recruiting,No Results Available,Covid19,Drug: Dalcetrapib|Other: Placebo,All,"Adult, Older Adult",Phase 2,208.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 11, 2021",May 2021
713,NCT04604704,Recruiting,No Results Available,Covid19|Long COVID-19|Post-COVID-19 Syndrome,Drug: Naltrexone|Dietary Supplement: NAD+|Other: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","January 28, 2021",October 2021
714,NCT04337762,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,100000.0,Industry,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 6, 2020",July 2021
715,NCT04834947,Not yet recruiting,No Results Available,"Covid19|Pneumonia, Viral",Procedure: prone position,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2021","December 15, 2021"
716,NCT04533399,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19,Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant|Other: Placebo,All,"Adult, Older Adult",Phase 2,4400.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 17, 2020",November 2021
717,NCT04753476,Recruiting,No Results Available,Covid-19|Cytokine Storm,Biological: Injection of Secretome-MSCs|Drug: Standard treatment of Covid-19,All,"Child, Adult, Older Adult",Phase 2,48.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 8, 2020","August 8, 2021"
718,NCT04341506,Recruiting,No Results Available,COVID-19,Device: Non-contact ECG,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 8, 2020","December 15, 2021"
719,NCT04361604,Not yet recruiting,No Results Available,Adult Patients Living With HIV (PLWHIV) With Confirmed Infection With SARS-CoV-2 Since 1st January 2020,Biological: Biological collection (patients co infected HIV Sras-CoV-2)|Other: Auto-questionnaires (patients co infected HIV Sras-CoV-2)|Other: Qualitative interviews (in 40 patients : 20 with COVID-19 and 20 without COVID-19),All,"Adult, Older Adult",,270.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,April 2020,October 2020
720,NCT04729140,Recruiting,No Results Available,Covid19,Drug: Ivermectin Tablets|Drug: Doxycycline Tablets|Drug: Placebo,All,"Adult, Older Adult",Phase 4,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","December 28, 2020","March 28, 2022"
721,NCT04621123,Recruiting,No Results Available,SARS-CoV-2 Infection|Safety and Efficacy,Biological: Convalescent anti-SARS-CoV-2 MBT plasma|Other: Control Group,All,"Adult, Older Adult",Phase 2,474.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 30, 2020",October 2021
722,NCT04751734,Enrolling by invitation,No Results Available,COVID-19 Vaccines,Biological: Covid vaccines,Female,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 16, 2021",December 2021
723,NCT04526054,Recruiting,No Results Available,Olfaction Disorders|COVID-19,Diagnostic Test: ENT exam|Diagnostic Test: Olfactometry|Diagnostic Test: Brain MRI,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 3, 2020","September 3, 2021"
724,NCT04506268,Completed,No Results Available,Covid19,Behavioral: Opt-out Recruitment Email|Behavioral: Opt-in Recruitment Email,All,"Adult, Older Adult",Not Applicable,412.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Screening","September 9, 2020","October 30, 2020"
725,NCT04365985,Recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Severe Acute Respiratory Syndrome (SARS)|Coronavirus Infections,Drug: Naltrexone|Drug: Ketamine|Other: Placebo,All,"Adult, Older Adult",Phase 2,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 29, 2020",August 2021
726,NCT04786353,Not yet recruiting,No Results Available,Covid-19,Other: LongCOVIDkidsDK,All,"Child, Adult, Older Adult",,300000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,April 2021,April 2023
727,NCT04335747,Recruiting,No Results Available,Rheumatoid Arthritis|Psoriatic Arthritis|Axial Spondyloarthritis|Systemic Lupus Erythematosus|Giant Cell Arteritis,Other: COVID-19 infection,All,"Adult, Older Adult",,333.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020","September 1, 2021"
728,NCT04659239,Enrolling by invitation,No Results Available,COVID-19,Biological: Inactivated SARS-CoV-2 Vaccine (Vero cell)|Biological: Placebo,All,"Adult, Older Adult",Phase 3,34020.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 28, 2021",July 2022
729,NCT04390178,"Active, not recruiting",No Results Available,COVID-19,Biological: SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Phase 1|Phase 2,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 10, 2020",December 2020
730,NCT04338360,Approved for marketing,No Results Available,COVID19,Biological: COVID-19 convalescent plasma,All,"Adult, Older Adult",,,Other,Expanded Access:Intermediate-size Population,,,
731,NCT04438941,Recruiting,No Results Available,Sars-CoV2,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"March 25, 2020","June 20, 2020"
732,NCT04340050,Completed,No Results Available,Coronavirus,Biological: anti-SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Early Phase 1,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 10, 2020","December 23, 2020"
733,NCT04406324,Recruiting,No Results Available,COVID-19,Other: No intervention,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","March 5, 2026"
734,NCT04516746,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV-2,Biological: AZD1222|Biological: Placebo,All,"Adult, Older Adult",Phase 3,32459.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 28, 2020","February 14, 2023"
735,NCT04716179,Recruiting,No Results Available,Covid19|Fertility Issues,"Diagnostic Test: Sperm test|Diagnostic Test: hormone levels (testosterone, FSH, LH, prolactin)|Diagnostic Test: SARS-CoV-2 Ig G levels|Other: Testis pathology samples",Male,"Adult, Older Adult",Not Applicable,88.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"January 18, 2021","May 18, 2021"
736,NCT04584671,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: Hyperpolarized Xenon-129 MRI of the lungs|Diagnostic Test: Computed Tomography (CT)|Diagnostic Test: Pulmonary Function Tests (PFT)|Diagnostic Test: Six Minute Walk Test (6MWT)|Diagnostic Test: Sputum analysis|Diagnostic Test: Blood analysis|Other: Questionnaires,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 1, 2020","December 1, 2024"
737,NCT04448119,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Favipiravir|Drug: Favipiravir Placebo,All,Older Adult,Phase 2,760.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 16, 2020",March 2021
738,NCT04555109,Recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 30, 2020","March 31, 2022"
739,NCT04369859,Recruiting,No Results Available,Pregnant Women,Behavioral: Examine the impact of COVID-19 during pregnancy,Female,"Adult, Older Adult",,1300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020","April 22, 2021"
740,NCT04412746,Recruiting,No Results Available,Coronavirus Infections|Diabetes Mellitus|Prevalence|Risk Factors|Patient Outcome Assessment|Severe Acute Respiratory Syndrome,Drug: MANAGEMENT OF COVID-19,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","June 30, 2020"
741,NCT04524507,Recruiting,No Results Available,COVID-19,Biological: High-titer Convalescent COVID-19 Plasma (CCP1)|Biological: Standard-titer Convalescent COVID-19 plasma (CCP2),All,"Adult, Older Adult",Phase 2,56.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 27, 2020",May 2021
742,NCT04753242,Recruiting,No Results Available,Covid-19|COVID-19 Related Psychosocial Burden,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"December 8, 2020","July 31, 2021"
743,NCT04539626,Recruiting,No Results Available,Covid-19,Drug: Estrogen Therapy,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"October 1, 2020",December 2022
744,NCT04591015,Recruiting,No Results Available,"Diabetes Mellitus, Type 2|Covid19",Behavioral: Hospital: DD-CA|Behavioral: Hospital: Usual Care (UC),All,"Adult, Older Adult",Phase 3,172.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"February 1, 2021","August 31, 2021"
745,NCT04610554,Completed,No Results Available,COVID-19 Pneumonia,,All,"Child, Adult, Older Adult",,74.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 14, 2020","October 12, 2020"
746,NCT04369820,Recruiting,No Results Available,COVID-19,Other: draw blood,All,"Adult, Older Adult",Not Applicable,100.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 31, 2020",November 2020
747,NCT04788394,Recruiting,No Results Available,Acute Kidney Injury|Covid19|Renal Dysfunction|Coronavirus Infection|AKI|Pediatric Kidney Disease|Renal Insufficiency,Other: To determine the prevalence of renal dysfunction in hospitalized children with COVID19 in Qatar.,All,Child,,500.0,Industry,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 1, 2021","December 31, 2021"
748,NCT04503525,Recruiting,No Results Available,SARS-CoV|Nutrition Disorders,Other: Nutritional assessment,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 25, 2020","June 30, 2021"
749,NCT04625738,Not yet recruiting,No Results Available,COVID19 ARDS,Biological: Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells|Biological: Placebo,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 6, 2020","August 6, 2022"
750,NCT04395872,Not yet recruiting,No Results Available,"Covid19|Psychiatric Problem|Isolation, Social",Behavioral: Psychiatric counseling,All,"Child, Adult, Older Adult",,54.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 28, 2020","December 31, 2020"
751,NCT04497441,Recruiting,No Results Available,"Covid19|Information Seeking Behavior|Social Media|Perception, Self",Other: Electronic Survey questionnaire,All,"Adult, Older Adult",,385.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 10, 2020","August 15, 2020"
752,NCT04402892,Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,"Other: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (hospitalized Patients )|Other: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (cured Patients)",All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"June 1, 2020","March 1, 2021"
753,NCT04609774,Completed,No Results Available,Coronavirus Disease (COVID-19),Other: Severe Acute Respiratory Syndrome CoronaVirus 2 detection,All,"Adult, Older Adult",,8.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"October 8, 2020","December 1, 2020"
754,NCT04552951,Recruiting,No Results Available,COVID-19,Drug: Cholecalciferol,All,"Child, Adult, Older Adult",Phase 4,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","April 4, 2020","December 30, 2020"
755,NCT04383444,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,1050.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 7, 2020","August 1, 2023"
756,NCT04434118,Enrolling by invitation,No Results Available,Rheumatoid Arthritis|COVID,Drug: Traditional antirheumatic drugs,All,Adult,,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 20, 2020","December 30, 2021"
757,NCT04473352,Not yet recruiting,No Results Available,Covid19,,Male,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,September 2020,November 2021
758,NCT04406493,Recruiting,No Results Available,ARDS|COVID,Diagnostic Test: Lung impedance technique,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 28, 2020","April 28, 2021"
759,NCT04425889,Completed,No Results Available,COVID-19|SARS-CoV 2,"Diagnostic Test: COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)",All,"Adult, Older Adult",,156.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 5, 2020","June 1, 2020"
760,NCT04408170,Recruiting,No Results Available,Coronavirus Infection|COVID-19,Diagnostic Test: Point-of-care test for SARS-CoV-2,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 19, 2020","June 30, 2021"
761,NCT04323514,Recruiting,No Results Available,Hospitalized Patients With Covid-19 Pneumonia,Dietary Supplement: Vitamin C,All,"Child, Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 13, 2020","March 13, 2021"
762,NCT04323800,"Active, not recruiting",No Results Available,Coronavirus|Convalescence,Biological: Anti- SARS-CoV-2 Plasma|Biological: SARS-CoV-2 non-immune Plasma,All,"Adult, Older Adult",Phase 2,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 10, 2020",January 2023
763,NCT04501822,Recruiting,No Results Available,Covid19|Cardiac Complication,"Diagnostic Test: Evaluation of clinical, instrumental and laboratory diagnostics tests",All,"Adult, Older Adult",,380.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 19, 2020","December 31, 2021"
764,NCT04705844,Not yet recruiting,No Results Available,Mild to Moderate COVID-19,Drug: Adalimumab|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1444.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",May 2021,January 2022
765,NCT04716426,Completed,Has Results,COVID-19,Drug: Tetracycline hydrochloride 3%|Drug: Placebo,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 28, 2021","March 25, 2021"
766,NCT04491994,Completed,Has Results,Covid19|Progression,Drug: HCQ,All,"Adult, Older Adult",Phase 3,540.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 10, 2020","May 31, 2020"
767,NCT04826640,Not yet recruiting,No Results Available,Pregnancy,Other: Observational,Female,Adult,,350.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2021","May 1, 2023"
768,NCT04389515,Recruiting,No Results Available,COVID-19|Prenatal Care|Postoperative Care,,Female,Adult,,75.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"May 14, 2020","September 30, 2020"
769,NCT04526769,Not yet recruiting,No Results Available,COVID|COVID-19|Corona Virus Infection|SARS-CoV-2,Diagnostic Test: Tear Collection,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,September 2020,April 2021
770,NCT04836065,Completed,No Results Available,COVID-19 Infection,,All,"Adult, Older Adult",,4995.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","December 31, 2020"
771,NCT04389294,Completed,No Results Available,COVID,Diagnostic Test: SARS-CoV2 serum antibody testing,All,"Adult, Older Adult",Not Applicable,143.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 5, 2020","September 4, 2020"
772,NCT04405271,Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1378.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 31, 2020","November 15, 2020"
773,NCT04380896,Recruiting,No Results Available,SARS-CoV-2 Infection,Other: Blood test|Other: Standardised questionnaires,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","July 27, 2026"
774,NCT04527575,"Active, not recruiting",No Results Available,Covid19,"Biological: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)|Other: Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)",All,Adult,Phase 1|Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","July 27, 2020",May 2021
775,NCT04369300,Recruiting,No Results Available,COVID-19,Behavioral: Registery Data Collection,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 24, 2020","February 24, 2021"
776,NCT04573634,Recruiting,No Results Available,Covid19|SARS-CoV Infection,,All,"Adult, Older Adult",,960.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020","December 31, 2023"
777,NCT04628637,Completed,No Results Available,Covid19|Endoplasmic Reticulum Stress,Other: Serum protein level analysis,All,"Adult, Older Adult",,144.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 16, 2020","October 10, 2020"
778,NCT04394026,Recruiting,No Results Available,Viral Pneumonia|COVID,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 16, 2020","July 31, 2021"
779,NCT04384055,Enrolling by invitation,No Results Available,"COVID-19|Pneumonia, Viral",Diagnostic Test: Lung Ultrasound,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 21, 2020","December 31, 2021"
780,NCT04327505,Recruiting,No Results Available,"SARS (Severe Acute Respiratory Syndrome)|Cytokine Storm|ARDS, Human|COVID-19|Sars-CoV2|Acute Respiratory Failure",Drug: Hyperbaric oxygen,All,"Adult, Older Adult",Phase 2|Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 3, 2020","December 31, 2022"
781,NCT04405934,Not yet recruiting,No Results Available,Covid-19|Nosocomial Infection|Coronavirus|Coronavirus Infection|SARS-CoV 2,Other: Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures,All,"Child, Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,July 2020,April 2021
782,NCT04435587,Recruiting,No Results Available,Asymptomatic Infections|SARS-CoV2 Infection,Drug: Ivermectin Pill|Drug: Combined ART/hydroxychloroquine,All,"Adult, Older Adult",Phase 4,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 13, 2020",November 2021
783,NCT04578132,Recruiting,No Results Available,Covid19|Genito Urinary Cancer,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Other,"November 24, 2020",October 2021
784,NCT04521309,Completed,No Results Available,COVID-19,Biological: SARS-CoV-2 antibody based IVIG therapy,All,"Adult, Older Adult",Phase 1|Phase 2,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 19, 2020","February 8, 2021"
785,NCT04322682,Completed,No Results Available,Corona Virus Infection,Drug: Colchicine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,4506.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","March 23, 2020","January 21, 2021"
786,NCT04471766,"Active, not recruiting",No Results Available,COVID-19|Respiratory Illness,Other: Certified cloth face mask plus preventive information|Behavioral: Preventive information,All,"Child, Adult, Older Adult",Not Applicable,40000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"July 20, 2020",August 2021
787,NCT04441684,Recruiting,No Results Available,SARS-CoV-2 Serological Status|SARS-CoV-2 Seroprevalence,Diagnostic Test: Blood sample for serological test,All,"Adult, Older Adult",Not Applicable,1800.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"April 17, 2020",August 2021
788,NCT04362943,Recruiting,No Results Available,COVID-19,Drug: Baricitinib or Anakinra,All,Older Adult,,576.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"April 20, 2020","July 31, 2020"
789,NCT04795583,Not yet recruiting,No Results Available,Covid19,Drug: Prednisone|Device: Point of Care testing device for C-reactive protein,All,"Adult, Older Adult",Phase 3,1526.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",April 2021,August 2022
790,NCT04529447,Completed,No Results Available,Covid19,Other: Survey,All,"Child, Adult, Older Adult",,485.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"June 10, 2020","August 10, 2020"
791,NCT04646551,Not yet recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,165.0,Other,Observational,Observational Model: Other|Time Perspective: Other,December 2020,January 2022
792,NCT04364022,Completed,No Results Available,Prevention of COVID-19,Drug: Lopinavir/ritonavir,All,"Child, Adult, Older Adult",Phase 3,326.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 23, 2020","March 24, 2021"
793,NCT04460638,Recruiting,No Results Available,SARS-CoV 2,Biological: Saliva collection|Other: Clinical assessment,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 23, 2020",July 2022
794,NCT04540926,Not yet recruiting,No Results Available,COVID 19 Pneumonia,Drug: Cyclosporin A,All,"Adult, Older Adult",Phase 1|Phase 2,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,September 2020,"September 30, 2020"
795,NCT04590794,"Active, not recruiting",No Results Available,Covid19,Diagnostic Test: Soluble Urokinase Plasminogen Activator Receptor,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 11, 2020","April 2, 2021"
796,NCT04389658,Completed,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,1526.0,Industry,Observational,Observational Model: Other|Time Perspective: Retrospective,"May 7, 2020","August 25, 2020"
797,NCT04368871,Recruiting,No Results Available,COVID,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 28, 2020","May 30, 2021"
798,NCT04733651,Not yet recruiting,No Results Available,Covid19,Drug: Hospital standard of care for COVID-19|Drug: Isoquercetin,All,"Adult, Older Adult",Phase 2,250.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 20, 2021","August 15, 2021"
799,NCT04476589,Recruiting,No Results Available,Covid19|Coma|Consciousness Disorder,Diagnostic Test: Functional MRI,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","March 30, 2023"
800,NCT04370808,Not yet recruiting,No Results Available,COVID-19,Other: Exposure,All,"Adult, Older Adult",,500.0,Other|Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,June 2020,March 2021
801,NCT04355338,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,4100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 25, 2020","May 30, 2022"
802,NCT04427098,Recruiting,No Results Available,COVID-19,Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution|Drug: Enoxaparin,All,"Adult, Older Adult",Phase 2,300.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 22, 2020","October 30, 2020"
803,NCT04438239,Completed,No Results Available,Covid-19,"Other: none, this study is observational",All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","December 31, 2020"
804,NCT04359095,Recruiting,No Results Available,COVID-19,Drug: Emtricitabine/tenofovir|Drug: Colchicine Pill|Drug: Rosuvastatin|Other: Standard treatment,All,"Adult, Older Adult",Phase 2|Phase 3,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 18, 2020","May 31, 2021"
805,NCT04542967,Recruiting,No Results Available,Severe COVID-19 Disease,Biological: Biological,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","June 23, 2020","September 30, 2020"
806,NCT04767087,Recruiting,No Results Available,Covid19,Drug: Honey|Drug: Nigella sativa seed|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 5, 2021","July 15, 2021"
807,NCT04353518,Recruiting,No Results Available,COVID-19,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Other: Placebo,All,"Adult, Older Adult",Phase 3,4000.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 30, 2020","May 30, 2021"
808,NCT04357639,Recruiting,No Results Available,HIV Patients,Other: No intervention,All,"Adult, Older Adult",,1040.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 28, 2020","July 31, 2021"
809,NCT04603664,Recruiting,No Results Available,"Biochemical Markers ,NGAL,Cystatin c, Acute Kidneyinjury, Covid 19",Diagnostic Test: serum NGAL and cystatin c,All,"Adult, Older Adult",,88.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"October 30, 2020",March 2021
810,NCT04794374,Recruiting,No Results Available,Covid19,Other: Telerehabilitation,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 16, 2020","January 16, 2022"
811,NCT04519034,Not yet recruiting,No Results Available,Covid19,Other: no intervention,All,"Child, Adult, Older Adult",,27000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"September 1, 2020","December 31, 2020"
812,NCT04644159,Recruiting,No Results Available,SARS (Severe Acute Respiratory Syndrome)|Covid19,Other: Human biological samples,All,"Child, Adult, Older Adult",,2000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 13, 2020","November 1, 2023"
813,NCT04389944,Completed,No Results Available,Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection),Other: convalescent plasma application to SARS-CoV-2 infected patients,All,"Adult, Older Adult",Not Applicable,15.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 31, 2020","June 30, 2020"
814,NCT04828564,Not yet recruiting,No Results Available,SARS-CoV2|COVID-19,Drug: Ribavirin Capsules|Drug: Favipiravir,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,"December 31, 2021"
815,NCT04702945,Recruiting,No Results Available,Covid-19,,All,"Child, Adult, Older Adult",,200000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Other,"March 1, 2020","December 31, 2023"
816,NCT04391946,Recruiting,No Results Available,"Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease",Behavioral: Data registry,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 14, 2020","December 31, 2022"
817,NCT04388670,Recruiting,No Results Available,COVID-19|Critical Illness,,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"February 22, 2020","August 31, 2020"
818,NCT04824222,Not yet recruiting,No Results Available,Covid19,"Drug: Human fecal microbiota, MBiotix HBI|Drug: Placebo|Drug: SOC",All,"Adult, Older Adult",Phase 3,366.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,December 2022
819,NCT04367792,"Active, not recruiting",No Results Available,COVID-19,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"April 23, 2020",March 2021
820,NCT04790240,Recruiting,No Results Available,Covid19 Virus Infection,Dietary Supplement: Inflammation (I)|Dietary Supplement: Inflammation (II)|Dietary Supplement: Inflammation (III)|Drug: Standard of care,All,"Child, Adult, Older Adult",Phase 1|Phase 2,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","February 1, 2021",March 2023
821,NCT04493359,Recruiting,No Results Available,Covid19|Angiotensin II Receptor Antagonist Adverse Reaction,Drug: Renin-angiotensin system inhibitors,All,"Adult, Older Adult",Phase 2|Phase 3,240.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 25, 2020","February 14, 2022"
822,NCT04618796,Not yet recruiting,No Results Available,Vaccine Refusal,Other: vaccine,All,Child,,100.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"April 1, 2021","May 1, 2022"
823,NCT04384042,Recruiting,No Results Available,SARS-CoV Infection|COVID-19|Anosmia|Dysgeusia,Other: Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"June 6, 2020","March 31, 2021"
824,NCT04513158,Recruiting,No Results Available,Covid19,Biological: Convalescent Plasma,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 14, 2020","December 31, 2021"
825,NCT04344249,Recruiting,No Results Available,IBD|COVID,,All,"Adult, Older Adult",,850.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020","September 1, 2021"
826,NCT04828629,Recruiting,No Results Available,Covid19|Heart Failure,Diagnostic Test: Diagnostic tests,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"December 23, 2020","December 1, 2022"
827,NCT04358211,No longer available,No Results Available,COVID-19,Biological: Biological: COVID-19 convalescent plasma,All,"Adult, Older Adult",,,Other,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,
828,NCT04372056,Recruiting,No Results Available,COVID-19|Critical Care|Intensive Care Units|Health Personnel,Behavioral: Views and experiences of health care professionals working in intensive care units during the COVID-19 pandemic,All,"Adult, Older Adult",,2200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 6, 2020","May 6, 2021"
829,NCT04794998,Recruiting,No Results Available,COVID 19,Drug: Recommended treatment schedule|Drug: Control treatment schedule,All,"Adult, Older Adult",,216.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 8, 2021","March 30, 2021"
830,NCT04416893,Not yet recruiting,No Results Available,COVID19,Diagnostic Test: RT-PCR SARS-Cov2|Diagnostic Test: Sars-Cov2 serology,All,Child,,630.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 7, 2020","November 15, 2020"
831,NCT04429815,Not yet recruiting,No Results Available,Smoking Behaviors,Diagnostic Test: Serological test for COVID-19.,All,"Adult, Older Adult",,489.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","April 1, 2021"
832,NCT04385043,Recruiting,No Results Available,COVID-19,Other: plasma hyperimmune|Drug: standard therapy,All,Adult,Phase 2|Phase 3,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","May 15, 2021"
833,NCT04401228,"Active, not recruiting",No Results Available,"COVID19|Pneumonia, Viral|Inflammatory Response","Other: predict admission of covid-19 patients to ICU and death with routine and quickly avalaible clinical, biological and radiological variables?",All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","January 1, 2021"
834,NCT04723290,Completed,No Results Available,Covid19,Diagnostic Test: Serological tests for SARS Cov-2,All,"Adult, Older Adult",Not Applicable,2817.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 20, 2020","December 31, 2020"
835,NCT04584411,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: Cardiac Magnetic resonance imaging,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 1, 2020","January 1, 2024"
836,NCT04434248,"Active, not recruiting",No Results Available,COVID-19,Drug: Favipiravir|Drug: Standard of Care,All,"Adult, Older Adult",Phase 2|Phase 3,330.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 23, 2020",July 2020
837,NCT04523831,Completed,Has Results,Covid19,Drug: Ivermectin and Doxycycline|Drug: Standard of care,All,"Adult, Older Adult",Phase 3,400.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 1, 2020","September 10, 2020"
838,NCT04438070,Recruiting,No Results Available,COVID-19,Diagnostic Test: COVID-19 Swab,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"April 10, 2020",June 2020
839,NCT04652115,Not yet recruiting,No Results Available,Covid19,Drug: Defibrotide,All,"Adult, Older Adult",Phase 2,42.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 1, 2021","November 1, 2023"
840,NCT04358783,"Active, not recruiting",No Results Available,Coronavirus Infection,Biological: Plasma|Other: Best Available Therapy,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 27, 2020","May 30, 2021"
841,NCT04343794,Recruiting,No Results Available,COVID19,Device: BIOVITALS,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 1, 2020","January 31, 2022"
842,NCT04800146,Recruiting,No Results Available,Covid19|Cancer,Procedure: Blood sample,All,"Child, Adult, Older Adult",,240.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 25, 2021","December 30, 2022"
843,NCT04568499,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,1000.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 27, 2020",September 2021
844,NCT04519398,Recruiting,No Results Available,"Covid19|Corona Virus Infection|Thrombosis|ARDS|Thrombophilia|Thromboses, Intracranial|Thromboses, Deep Vein|RAAS",Genetic: Complete thrombophilic profile testing by multiplex PCR,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"August 18, 2020","August 18, 2021"
845,NCT04375176,Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Immunomodulation,Diagnostic Test: Study of immune-mediated mechanisms in patients tested positive for SARS-CoV-2,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 27, 2020","October 31, 2020"
846,NCT04621071,Recruiting,No Results Available,COVID-19,Dietary Supplement: Probiotics (2 strains 10x10^9 UFC)|Dietary Supplement: Placebo (potato starch and magnesium stearate),All,"Adult, Older Adult",Not Applicable,84.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 12, 2021",July 2021
847,NCT04357444,"Active, not recruiting",No Results Available,COVID 19,Drug: 1: ILT101|Drug: 2: Placebo Comparator,All,"Adult, Older Adult",Phase 2,30.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 23, 2020","April 23, 2021"
848,NCT04487977,Recruiting,No Results Available,Airway Management,Other: Survey,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 22, 2020","September 30, 2020"
849,NCT04449731,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,30000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"March 20, 2020","June 30, 2021"
850,NCT04420286,Recruiting,No Results Available,Coronavirus Infections|COVID19 Outbreak in France,,All,"Child, Adult, Older Adult",,9000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"May 6, 2020","June 5, 2021"
851,NCT04333355,Terminated,No Results Available,COVID-19,Biological: Convalescent Plasma,All,"Adult, Older Adult",Phase 1,12.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","August 20, 2020"
852,NCT04621903,Completed,No Results Available,Covid19,Other: Shanshamani Vati Plus,All,"Adult, Older Adult",Not Applicable,26.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"October 8, 2020","November 3, 2020"
853,NCT04625972,Recruiting,No Results Available,COVID-19,Drug: AZD7442|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1125.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","December 2, 2020","January 21, 2022"
854,NCT04784468,Recruiting,No Results Available,Covid19,Other: No intervention,All,"Adult, Older Adult",,135.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"November 19, 2020","September 30, 2021"
855,NCT04668911,Recruiting,No Results Available,Covid19|Periodontitis,Other: Swab,All,"Adult, Older Adult",,150.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"December 13, 2020","December 12, 2021"
856,NCT04299724,Recruiting,No Results Available,Treat and Prevent Covid-19 Infection,Biological: Pathogen-specific aAPC,All,"Child, Adult, Older Adult",Phase 1,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 15, 2020","December 31, 2024"
857,NCT04418375,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 8, 2020",March 2022
858,NCT04384549,Recruiting,No Results Available,"Infection|Viral, Agent as Cause of Disease Classified Elsewhere",Biological: BCG GROUP|Other: PLACEBO GROUP,All,"Adult, Older Adult",Phase 3,1120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"May 20, 2020","February 20, 2021"
859,NCT04339686,Recruiting,No Results Available,The Gold Standard for Current SARS CoV2 Detection is RT-PCR,Diagnostic Test: Thoracic CT Scan,All,"Adult, Older Adult",,56000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 20, 2020",November 2020
860,NCT04503447,Completed,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,330.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"August 1, 2020","September 9, 2020"
861,NCT04483830,Completed,No Results Available,Covid19,Drug: Sulodexide|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,243.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 5, 2020","September 7, 2020"
862,NCT04739020,Recruiting,No Results Available,SARS-CoV-2 Infection|Covid19,Diagnostic Test: Resp-Aer-Meter|Diagnostic Test: Spirometry|Diagnostic Test: Qualitative and quantitative virus PCR of respiratory secretions in patients with high aerosol concentrations,All,"Child, Adult, Older Adult",Not Applicable,525.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"January 18, 2021","December 31, 2021"
863,NCT04424446,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,5000.0,NIH,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"July 13, 2020","June 1, 2021"
864,NCT04363749,Recruiting,No Results Available,Covid19|Neurological Complication,"Other: hypoxia : 14.3 and 12.7% FIO2, hypercapnia 7% CO2, inspiratory mechanical constraint",All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"April 27, 2020","November 27, 2021"
865,NCT04424017,Completed,No Results Available,COVID|Corona Virus Infection,Biological: Specific anti-SARS-CoV-2 antibodies,All,Adult,,1546.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 7, 2020","October 30, 2020"
866,NCT04349540,"Active, not recruiting",No Results Available,COVID19,Other: no intervention,All,"Child, Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 15, 2020","January 15, 2021"
867,NCT04717024,Recruiting,No Results Available,Covid19,Device: Observational Study - no intervention,All,"Adult, Older Adult",,100.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 15, 2020","December 31, 2021"
868,NCT04535063,Recruiting,No Results Available,Covid19 Pneumonia,Biological: COVID19 convalescent plasma infusion,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 18, 2020","February 25, 2021"
869,NCT04380662,Not yet recruiting,No Results Available,Covid19,Other: Risk factors,All,"Child, Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 30, 2020","December 30, 2020"
870,NCT04359953,Recruiting,No Results Available,COVID-19 Infection,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Telmisartan,All,"Adult, Older Adult",Phase 3,1600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 25, 2020","June 1, 2021"
871,NCT04824677,Recruiting,No Results Available,Covid19,Other: Hospital treatment of COVID disease,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 18, 2020",December 2021
872,NCT04678700,Recruiting,No Results Available,Covid19- Coronavirus- Sars-cov-2,Other: Chest physiotherapy post-covid19,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 1, 2021","August 1, 2021"
873,NCT04342689,Recruiting,No Results Available,COVID-19,Drug: Dietary Supplement containing resistant starch|Dietary Supplement: Placebo Starch,All,"Adult, Older Adult",Phase 2|Phase 3,1500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 3, 2020","June 1, 2021"
874,NCT04381273,Recruiting,No Results Available,Covid-19|Periodontal Diseases,Other: No intervention,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 8, 2020","July 31, 2020"
875,NCT04561102,Enrolling by invitation,No Results Available,SARS-CoV-2,Diagnostic Test: Diagnostic test for detection of SARS-CoV-2,All,"Adult, Older Adult",,2500.0,Industry|Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"September 11, 2020","April 30, 2021"
876,NCT04521322,Recruiting,No Results Available,Covid19,Drug: Iota-Carrageenan,All,"Adult, Older Adult",Phase 4,400.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","July 24, 2020","November 30, 2020"
877,NCT04764721,Not yet recruiting,No Results Available,Covid-19,Device: 18F-FDG PET-CT,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 12, 2021","May 12, 2022"
878,NCT04563676,Recruiting,No Results Available,Covid19|TSH|Cortisol,Biological: blood test,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"September 22, 2020",March 2021
879,NCT04367662,Completed,No Results Available,COVID-19,Procedure: blood sampling,All,"Adult, Older Adult",Not Applicable,99.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 9, 2020","May 14, 2020"
880,NCT04760132,Recruiting,No Results Available,SARS-CoV Infection,Biological: COMIRNATY - BioNTech Manufacturing GmbH|Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH|Biological: COVID-19 Vaccine AstraZeneca suspension for injection,All,"Adult, Older Adult",Phase 4,10000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"February 8, 2021","December 31, 2024"
881,NCT04459819,Completed,No Results Available,COVID-19,Other: Respiratory physiotherapy,All,"Adult, Older Adult",,84.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 1, 2020","September 30, 2020"
882,NCT04691921,Completed,No Results Available,COVID-19,Behavioral: Current clinical practices of participating physicians,All,"Adult, Older Adult",,1055.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"January 4, 2021","January 31, 2021"
883,NCT04583566,Recruiting,No Results Available,Corona Virus Infection,Genetic: COVID-19 Diagnostic and Assessment Tests,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 4, 2020","October 3, 2022"
884,NCT04385160,Recruiting,No Results Available,Myeloproliferative Neoplasm|COVID,,All,"Adult, Older Adult",,552.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"May 13, 2020","August 31, 2022"
885,NCT04351139,Completed,No Results Available,Gynecologic Cancer|Breast Neoplasm Female|Uterine Neoplasms|Ovarian Neoplasms|Uterine Cervical Neoplasms|Vulvar Neoplasms|Vaginal Neoplasms,Other: modification of the planned therapeutic management,Female,"Adult, Older Adult",,205.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"May 6, 2020","November 30, 2020"
886,NCT04341168,Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2,Other: this study is non- interventional,All,"Child, Adult, Older Adult",,160.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2020,October 2020
887,NCT04458519,Recruiting,No Results Available,COVID-19 Infection,Other: Probiorinse|Other: Saline solution,All,Adult,Not Applicable,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","July 16, 2020","April 30, 2021"
888,NCT04689477,Recruiting,No Results Available,COVID-19|Endothelial Function,Device: Vascular occlusion test,All,"Adult, Older Adult",,612.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 25, 2020",December 2021
889,NCT04312464,Enrolling by invitation,No Results Available,COVID-19|Cardiovascular Diseases,Other: non,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"January 1, 2020","March 18, 2020"
890,NCT04389385,"Active, not recruiting",No Results Available,Corona Virus Infection|Pneumonia,Biological: COVID-19 Specific T Cell derived exosomes (CSTC-Exo),All,"Adult, Older Adult",Phase 1,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 1, 2020","May 31, 2021"
891,NCT04625725,"Active, not recruiting",No Results Available,COVID-19,Drug: AZD7442|Drug: Placebo,All,"Adult, Older Adult",Phase 3,5247.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","November 21, 2020","June 22, 2022"
892,NCT04387656,Recruiting,No Results Available,COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm,Procedure: Biospecimen Collection|Other: Data Collection|Other: Quality-of-Life Assessment|Other: Questionnaire Administration,All,"Child, Adult, Older Adult",,2000.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 21, 2020","May 31, 2023"
893,NCT04815096,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine),All,"Adult, Older Adult",Early Phase 1,20.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"April 15, 2021","March 1, 2023"
894,NCT04467008,Completed,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,113.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 15, 2020","August 15, 2020"
895,NCT04698993,Recruiting,No Results Available,Covid19,Diagnostic Test: Dräger Antigen Test SARS-CoV-2,All,"Adult, Older Adult",Not Applicable,831.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"February 12, 2021",March 2021
896,NCT04649944,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: Serological test and phone interview,All,"Child, Adult, Older Adult",,40.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 5, 2021","December 31, 2021"
897,NCT04612972,Recruiting,No Results Available,Covid19,Biological: Inactivated SARS CoV 2 vaccine (Vero cell). Wuhan,All,Adult,Phase 3,6000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 10, 2020","September 1, 2021"
898,NCT04371406,Withdrawn,No Results Available,Covid-19,Drug: Hydroxychloroquine and Azithromycin|Dietary Supplement: Azinc,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2020,September 2020
899,NCT04389359,Withdrawn,No Results Available,COVID-19,Drug: Hydroxychloroquine Sulfate 200 MG,All,"Adult, Older Adult",Phase 2|Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,September 2020,August 2025
900,NCT04838080,Recruiting,No Results Available,COVID-19 Vaccine,Biological: Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine 4 µg/0.5 ml Vaccine|Biological: Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine 6 µg/0.5 ml Vaccine|Biological: Placebo,All,Adult,Phase 1,38.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","March 19, 2021","October 20, 2021"
901,NCT04464395,Recruiting,No Results Available,COVID-19,Drug: CPI-006|Other: Standard of Care,All,"Adult, Older Adult",Phase 1,70.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 1, 2020","August 31, 2021"
902,NCT04370171,Completed,No Results Available,Diabetes|Covid-19,Other: care modalities|Other: Teleconsultation either by phone or by computer consultation,All,"Adult, Older Adult",,610.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 4, 2020","May 29, 2020"
903,NCT04347915,Recruiting,No Results Available,COVID-19,Drug: Clevudine|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"May 6, 2020","March 31, 2021"
904,NCT04362176,Recruiting,No Results Available,COVID-19|Coronavirus|SARS-CoV-2,Biological: pathogen reduced SARS-CoV-2 convalescent plasma|Biological: Placebo,All,"Adult, Older Adult",Phase 3,1000.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","April 24, 2020",April 2021
905,NCT04479293,Recruiting,No Results Available,COVID-19|Coronavirus Disease|SARS-CoV-2,Other: Post COVID-19 Functional Satus Scale,All,"Child, Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","November 30, 2020"
906,NCT04817293,Not yet recruiting,No Results Available,Covid19,Other: Questionnaire|Other: medical consultation,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,March 2021,December 2021
907,NCT04584593,Recruiting,No Results Available,Covid19,Biological: Sample,Male,Adult,Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"October 2, 2020",February 2022
908,NCT04438694,Recruiting,No Results Available,COVID19,Biological: Convalescent Plasma|Drug: Standard of Care,All,"Adult, Older Adult",Phase 1|Phase 2,67.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","December 31, 2021"
909,NCT04497402,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,88.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","June 1, 2022"
910,NCT04593940,Recruiting,No Results Available,Covid19,Drug: Infliximab|Drug: Abatacept|Drug: Remdesivir|Drug: cenicriviroc,All,"Adult, Older Adult",Phase 3,2160.0,Other|NIH|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 15, 2020",September 2021
911,NCT04492202,Not yet recruiting,No Results Available,"COVID|Knowledge, Attitudes, Practice",Other: Survey,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"August 1, 2020","December 10, 2020"
912,NCT04407195,"Active, not recruiting",No Results Available,COVID-19|Mental Health Disorder,Other: Exposure to the SARS-CoV-2,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","June 1, 2021"
913,NCT04407286,Completed,No Results Available,Covid 19|Vitamin D Deficiency,Dietary Supplement: Vitamin D3,All,"Adult, Older Adult",Phase 1,41.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 19, 2020","November 30, 2020"
914,NCT04367064,Recruiting,No Results Available,COVID,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 25, 2020","December 25, 2020"
915,NCT04405726,Recruiting,No Results Available,SARS-CoV-2,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"March 27, 2020",March 2022
916,NCT04404244,Recruiting,No Results Available,Coronavirus COVID-19,,All,"Child, Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"January 1, 2020","June 1, 2021"
917,NCT04531748,Not yet recruiting,No Results Available,Covid19,Drug: Toremifene|Drug: Melatonin|Other: Placebo,All,"Adult, Older Adult",Phase 2,390.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",March 2021,September 2021
918,NCT04360538,Recruiting,No Results Available,Critical Illness|Corona Virus Infection|Respiratory Failure|Covid-19,Other: Quality of Life|Other: Impact Event Score|Other: Hospital anxiety and depression scale,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 8, 2020","December 30, 2021"
919,NCT04381884,Completed,No Results Available,COVID-19 Drug Treatment,Drug: IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care.,All,"Adult, Older Adult",Phase 2,45.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 18, 2020","September 29, 2020"
920,NCT04523012,Recruiting,No Results Available,Covid19,Other: Seroprevalence of SARS-CoV-2 infection in patients with HIV infection,All,"Adult, Older Adult",,2200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 1, 2020","June 30, 2022"
921,NCT04824469,Not yet recruiting,No Results Available,COVID-19,Other: intervention group,All,"Adult, Older Adult",Not Applicable,128.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care",May 2021,June 2022
922,NCT04318366,Recruiting,No Results Available,Coronavirus Infections,Other: Observational Study,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 19, 2020","March 19, 2022"
923,NCT04340921,Recruiting,No Results Available,Cardiovascular Disease Acute|Cardiomyopathies|COVID,Biological: COVID-19 exposure,All,"Adult, Older Adult",,140.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 14, 2020","November 10, 2021"
924,NCT04475302,Recruiting,No Results Available,COVID,Biological: BCG vaccine (Freeze-dried),All,"Adult, Older Adult",Phase 3,2175.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 1, 2020",May 2021
925,NCT04386850,Recruiting,No Results Available,COVID 19,Drug: Oral 25-Hydroxyvitamin D3,All,"Adult, Older Adult",Phase 2|Phase 3,1500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 14, 2020","March 15, 2021"
926,NCT04413838,Not yet recruiting,No Results Available,"Obesity, COVID-19 Infection",Drug: NIVOLUMAB|Other: Routine standard of care,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 15, 2020","September 15, 2021"
927,NCT04805203,Recruiting,No Results Available,Multiple Myeloma|Covid19,Other: blood sample analyses,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"December 16, 2020",December 2022
928,NCT04516850,Not yet recruiting,No Results Available,Covid19,Genetic: Expression of receptors and activating proteases|Genetic: Polymorphism of the HSD3B1,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"September 1, 2020","August 31, 2021"
929,NCT04360356,Not yet recruiting,No Results Available,COVID-19,Combination Product: Ivermectin plus Nitazoxanide|Other: Standard Care,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",May 2020,December 2020
930,NCT04783025,Not yet recruiting,No Results Available,Infection Control|COVID-19,"Behavioral: Blended Gaming COVID-19 Training System (BGCTS)|Behavioral: Usual care, infection control briefing",All,"Adult, Older Adult",Not Applicable,188.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"March 1, 2021","March 1, 2022"
931,NCT04343976,Enrolling by invitation,No Results Available,COVID-19|COVID,Drug: Pegylated interferon lambda,All,"Adult, Older Adult",Phase 2,20.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 22, 2020","December 30, 2021"
932,NCT04570397,Recruiting,No Results Available,Covid19|Thrombotic Microangiopathies|Acute Kidney Injury,Drug: Ravulizumab,All,"Adult, Older Adult",Phase 3,32.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 18, 2020",November 2021
933,NCT04388631,Recruiting,No Results Available,Coronavirus Disease 2019,Other: Coronavirus Disease 2019,Male,Adult,,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 10, 2020","May 1, 2021"
934,NCT04416048,Recruiting,No Results Available,COVID-19,Drug: Rivaroxaban|Other: Standard Of Care (SOC),All,"Adult, Older Adult",Phase 3,400.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 30, 2020","May 30, 2021"
935,NCT04371432,Recruiting,No Results Available,COVID-19|Coronavirus 2019,,All,"Child, Adult, Older Adult",,2500.0,NIH,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 5, 2020","June 1, 2025"
936,NCT04679428,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,230.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 7, 2020","May 7, 2023"
937,NCT04368884,Recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 22, 2020","July 30, 2021"
938,NCT04428073,Not yet recruiting,No Results Available,COVID,Biological: Covax-19™,All,Adult,Phase 1,32.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,July 2020,December 2021
939,NCT04370197,Recruiting,No Results Available,"Stroke, Acute",,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"March 3, 2020","April 30, 2020"
940,NCT04690387,Completed,No Results Available,COVID-19,Biological: AV-COVID-19|Other: GM-CSF,All,"Adult, Older Adult",Phase 1,27.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"December 7, 2020","January 15, 2021"
941,NCT04843774,Not yet recruiting,No Results Available,Multiple Sclerosis,Drug: SARS-COV-2 mRNA Vaccine,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 19, 2021","October 14, 2022"
942,NCT04370119,Recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: Nasal swab|Diagnostic Test: Serum testing,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020",May 2025
943,NCT04384029,"Active, not recruiting",No Results Available,COVID|CVD,Other: Covid-19 + patients,All,"Adult, Older Adult",,7000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 24, 2020","March 31, 2022"
944,NCT04473547,Completed,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,144.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"July 10, 2020","February 15, 2021"
945,NCT04458363,Completed,No Results Available,COVID,Biological: Convalescent Plasma (CP)|Drug: Standard COVID-19 therapies,All,"Child, Adult",Early Phase 1,3.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 4, 2020","September 1, 2020"
946,NCT04707664,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: Sargramostim|Drug: Placebo,All,"Adult, Older Adult",Phase 2,400.0,Industry|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,June 2021
947,NCT04493242,Not yet recruiting,No Results Available,"Covid19|ARDS|Pneumonia, Viral",Biological: DB-001,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"September 1, 2020","December 31, 2020"
948,NCT04361942,Recruiting,No Results Available,COVID-19 Pneumonia,Biological: Mesenchymal Stromal Cells|Other: Placebo,All,"Adult, Older Adult",Phase 2,24.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 1, 2020","December 31, 2021"
949,NCT04448769,Completed,No Results Available,Coronavirus Infection|Prevalence,Biological: Anti-SARS-CoV-2 IgT seropositivity,All,"Child, Adult, Older Adult",Not Applicable,2006.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"June 26, 2020","July 24, 2020"
950,NCT04466839,Completed,No Results Available,Parkinson Disease|COVID,Other: Questionnaire and interview,All,"Child, Adult, Older Adult",,411.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 2, 2020","December 18, 2020"
951,NCT04583410,Recruiting,No Results Available,Covid19|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,Drug: Nicotine patch|Drug: Placebo patch,All,"Adult, Older Adult",Phase 3,1633.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 22, 2020",June 2022
952,NCT04810728,Completed,No Results Available,Covid19,Drug: Extract Psidii guava|Combination Product: Standard therapy for Covid-19 patient,All,"Child, Adult",Phase 3,90.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 20, 2020","January 30, 2021"
953,NCT04387279,Recruiting,No Results Available,"COVID-19|Perception, Self|Facilities and Services Utilization",Other: Interview,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 24, 2020","March 30, 2021"
954,NCT04830020,Recruiting,No Results Available,Covid19,Drug: HMW-HA,All,"Adult, Older Adult",Phase 2,200.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 26, 2021","August 31, 2021"
955,NCT04411147,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,900.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 17, 2020","December 31, 2027"
956,NCT04816630,Recruiting,No Results Available,Covid19|Sepsis|Adults|Emergency Department,Device: CBC-Diff Monocyte Volume Width Distribution,All,"Adult, Older Adult",,500.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 21, 2020","May 31, 2021"
957,NCT04558996,Recruiting,No Results Available,Covid19|Pregnancy Complications|Premature Rupture of Membrane|Abruptio Placentae|Prelabor Rupture of Membranes|Stillbirth,,Female,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","March 31, 2021"
958,NCT04459520,Completed,No Results Available,COVID-19,Behavioral: Positive COVID Test Result - Hypothetical Scenario|Behavioral: Negative COVID Test Result - Hypothetical Scenario|Behavioral: Unavailable COVID Test Result - Hypothetical Scenario,All,"Adult, Older Adult",Not Applicable,1400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"July 23, 2020","July 29, 2020"
959,NCT04451577,Recruiting,No Results Available,COVID,Other: No intervention,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"June 1, 2020","June 1, 2023"
960,NCT04433026,Not yet recruiting,No Results Available,COVID-19,"Diagnostic Test: N terminal pro B type natriuretic peptide (NTproBNP), D-Dimer, and serum Tropinin - I",All,"Child, Adult, Older Adult",,90.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,August 2020,"September 1, 2021"
961,NCT04475107,Recruiting,No Results Available,COVID-19,Drug: Pyronaridine-Artesunate|Drug: Placebo,All,"Adult, Older Adult",Phase 2,110.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 9, 2020",September 2021
962,NCT04480593,Completed,No Results Available,Covid19,Drug: Brazilian Green Propolis Extract (EPP-AF)|Other: Standard care,All,"Adult, Older Adult",Phase 2|Phase 3,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 2, 2020","August 30, 2020"
963,NCT04447235,Recruiting,No Results Available,Cancer|COVID|Coronavirus Infection,Drug: Placebo|Drug: Ivermectin|Drug: Losartan,All,"Adult, Older Adult",Phase 2,176.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","July 23, 2020",February 2021
964,NCT04338945,Completed,No Results Available,COVID,Behavioral: COVID-surgRES questionaire,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2020","May 1, 2020"
965,NCT04343404,Completed,No Results Available,Respiratory Distress Syndrome,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 1, 2020","April 15, 2020"
966,NCT04780035,"Active, not recruiting",No Results Available,COVID-19,"Biological: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)|Other: Placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",All,"Adult, Older Adult",Phase 3,3000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","November 18, 2020",September 2021
967,NCT04678830,"Active, not recruiting",No Results Available,Coronavirus Disease 2019,Drug: Placebos|Drug: Leronlimab (700mg),All,"Adult, Older Adult",Phase 2,56.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 1, 2021","July 23, 2021"
968,NCT04535869,Recruiting,No Results Available,COVID-19,Drug: Sofosbuvir 400 MG plus Daclatasvir 200mg,All,"Adult, Older Adult",Phase 3,50.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 28, 2020","September 3, 2021"
969,NCT04352491,Completed,No Results Available,COVID 19,Other: No intervention,All,"Adult, Older Adult",,347.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"April 24, 2020","May 31, 2020"
970,NCT04518735,Completed,No Results Available,Covid19,Other: Antithrombotic Therapy (anticoagulant and/or antiplatelet) before admission for Covid19,All,"Child, Adult, Older Adult",,1707.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"April 1, 2020","June 30, 2020"
971,NCT04487951,Recruiting,No Results Available,COVID19 Pneumonia,"Other: Pro BNP , Vitamin D",All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"July 1, 2020","January 1, 2021"
972,NCT04609839,Recruiting,No Results Available,Patient Admitted to Intensive Care Unit for COVID-19,Other: Follow-up of patients with COVID-19,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"October 27, 2020","April 27, 2023"
973,NCT04451889,Recruiting,No Results Available,COVID-19,Device: miniprobe Alveoflex,All,"Adult, Older Adult",Not Applicable,15.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"August 1, 2020","September 1, 2021"
974,NCT04345445,Not yet recruiting,No Results Available,COVID-19,Drug: Tocilizumab|Drug: Methylprednisolone,All,"Adult, Older Adult",Phase 3,310.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","October 31, 2020"
975,NCT04362813,Completed,No Results Available,Pneumonia and Cytokine Release Syndrome (Covid-19),Drug: Canakinumab|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 3,451.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 30, 2020","December 22, 2020"
976,NCT04371315,Recruiting,No Results Available,Corona Virus Infection|Pediatric Cancer|Adult Children|Cancer,,All,"Child, Adult",,400.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 27, 2020","June 30, 2022"
977,NCT04392427,Not yet recruiting,No Results Available,COVID|Drug Effect,"Drug: Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :",All,"Child, Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,October 2020,May 2022
978,NCT04678193,Enrolling by invitation,No Results Available,Covid19,Drug: Coromec Registry with ECL-19,All,"Adult, Older Adult",,27000.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Other,"December 24, 2020","June 30, 2022"
979,NCT04694573,Recruiting,No Results Available,Covid19|Kidney Transplant; Complications|Kidney Transplant Failure and Rejection|Liver Transplant; Complications|Liver Transplant Failure and Rejection,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"December 28, 2020","December 28, 2022"
980,NCT04723589,Not yet recruiting,No Results Available,COVID-19,Biological: Thawed plasma,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021","December 1, 2021"
981,NCT04703608,Recruiting,No Results Available,Covid-19,Drug: Ivermectin|Drug: ASP|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 3,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"January 22, 2021",July 2022
982,NCT04522076,"Active, not recruiting",No Results Available,COVID 19,,All,"Adult, Older Adult",,1124.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 6, 2020","May 1, 2022"
983,NCT04757298,Recruiting,No Results Available,COVID-19 Testing,Behavioral: Navigation Services|Behavioral: Critical Dialogue|Behavioral: Brief Counseling|Behavioral: Referral and Digital Brochure,All,"Adult, Older Adult",Not Applicable,670.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 12, 2021","December 31, 2022"
984,NCT04658121,Enrolling by invitation,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,3920.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"February 4, 2021","May 30, 2021"
985,NCT04514003,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 1, 2020","December 31, 2035"
986,NCT04378829,Recruiting,No Results Available,Covid-19|Mean Platelet Volume|Platelet Destruction,"Diagnostic Test: Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19",All,"Child, Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"September 12, 2020","October 21, 2020"
987,NCT04780373,Completed,No Results Available,Covid19 Prognostic Parameters,Other: data collection,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 27, 2020","May 15, 2020"
988,NCT04412395,Not yet recruiting,No Results Available,Corona Virus Infection|Middle East Respiratory Syndrome (MERS)|Acute Respiratory Distress Syndrome|Coronavirus Infection|COVID-19|SARS-CoV 2,Dietary Supplement: Lactoferrin (Apolactoferrin)|Drug: Placebo of excipient(s) will be administered,All,"Adult, Older Adult",Phase 2,516.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2021","September 30, 2021"
989,NCT04482699,Recruiting,No Results Available,Severe COVID-19 Disease,Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,88.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 30, 2020","June 1, 2022"
990,NCT04459533,Completed,No Results Available,Neuromuscular Blockade|Human Characteristics|Complication of Medical Care|Intensive Care Unit Acquired Weakness,Device: TOF protocol,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"June 1, 2020","June 1, 2020"
991,NCT04513470,"Active, not recruiting",No Results Available,COVID-19,Biological: Allocetra-OTS,All,"Adult, Older Adult",Phase 1,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 1, 2020",February 2021
992,NCT04471051,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 30, 2020",April 2021
993,NCT04734171,Completed,No Results Available,Covid19|Fear|Loneliness,Behavioral: Digital social activity video intervention|Behavioral: Informational sheet|Behavioral: Stigma awareness video intervention,All,"Adult, Older Adult",Not Applicable,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 2, 2020","April 16, 2020"
994,NCT04323228,Recruiting,No Results Available,COVID-19,Dietary Supplement: Oral supplement enriched in antioxidants|Dietary Supplement: cellulose-containing placebo capsules,All,"Adult, Older Adult",Phase 2|Phase 3,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care","September 1, 2020","December 30, 2020"
995,NCT04785157,Not yet recruiting,No Results Available,Covid19|Delirium|Post-traumatic Stress Disorder,Biological: serology testing profiles description|Biological: immune response characterization|Other: in vivo brain PET-TSPO acquisitions|Other: brain MRI assessment|Behavioral: neurocognitive assessment,All,"Adult, Older Adult",,25.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,August 2022
996,NCT04836806,Not yet recruiting,No Results Available,Covid19,Drug: Cetirizine and Famotidine|Drug: Placebo,All,"Adult, Older Adult",Phase 4,160.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,July 2022
997,NCT04627623,Recruiting,No Results Available,Covid19|Respiratory Tract Infections|Severe Acute Respiratory Syndrome|Corona Virus Infection|RNA Virus Infections|Virus Disease|Respiratory Tract Disease,Diagnostic Test: IgM and IgG antibodies assay,All,"Child, Adult, Older Adult",,6000.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"June 22, 2020","April 22, 2021"
998,NCT04575532,Enrolling by invitation,No Results Available,Covid19,"Device: Use of the pinpointIQ solution (physIQ, Inc.)",All,"Adult, Older Adult",,400.0,Industry|NIH|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 5, 2020","January 22, 2021"
999,NCT04745533,Not yet recruiting,No Results Available,SARS-CoV Infection,Diagnostic Test: Antigen detection test,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 15, 2021","June 30, 2021"
1000,NCT04643522,Completed,No Results Available,"Sperm Count, Low|Hormone Disturbance|Covid19",Other: Clinical assessment,Male,Adult,,21.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 7, 2020","October 10, 2020"
1001,NCT04341207,Recruiting,No Results Available,Cancer & COVID 19,Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Adult, Older Adult",Phase 2,1000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020",April 2022
1002,NCT04651413,Recruiting,No Results Available,Covid19,Diagnostic Test: PCR Value,All,"Child, Adult, Older Adult",,800.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"November 24, 2020","March 31, 2021"
1003,NCT04401254,Recruiting,No Results Available,COVID-19|Critical Illness,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020",April 2022
1004,NCT04553575,Recruiting,No Results Available,Coronavirus Infections,Biological: serology,All,"Child, Adult, Older Adult",,499.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 25, 2020",September 2022
1005,NCT04756128,Enrolling by invitation,No Results Available,Covid19,Drug: Colchicine 0.6 mg|Drug: Naltrexone,All,"Adult, Older Adult",Phase 2,164.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 25, 2021","December 31, 2021"
1006,NCT04405492,Not yet recruiting,No Results Available,SARS-CoV 2|COVID-19,"Device: Taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling.|Device: Capillary and salivary sampling",All,"Adult, Older Adult",Not Applicable,1210.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 25, 2020","March 25, 2021"
1007,NCT04374565,"Active, not recruiting",No Results Available,Corona Virus Infection|SARS-CoV 2|SARS Pneumonia|Pneumonia,Drug: High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma,All,"Adult, Older Adult",Phase 2,29.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 5, 2020","April 5, 2021"
1008,NCT04351529,Recruiting,No Results Available,Infectious Disease|COVID-19,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"April 1, 2020",December 2021
1009,NCT04510623,Recruiting,No Results Available,COVID-19|SARS-CoV2,Other: ARBs and/or ACE inhibitors|Other: Usual Care,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 17, 2020","June 30, 2022"
1010,NCT04450017,Recruiting,No Results Available,SARS-CoV2,"Diagnostic Test: The demographic, clinical, laboratory, and instrumental data",All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 6, 2020",August 2020
1011,NCT04769700,Recruiting,No Results Available,"Breast Feeding, Exclusive|Post Partum Depression|Covid19",Behavioral: Edinburgh Postnatal Depression Scale|Behavioral: Breast Feeding Adherence|Behavioral: Fear of Covid-19 Scale,Female,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"January 1, 2021","June 1, 2021"
1012,NCT04649827,Recruiting,No Results Available,COVID-19,Other: Clinical Observation,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"April 2, 2020","December 30, 2021"
1013,NCT04252274,Recruiting,No Results Available,"Pneumonia, Pneumocystis|Coronavirus",Drug: Darunavir and Cobicistat,All,"Child, Adult, Older Adult",Phase 3,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 30, 2020","December 31, 2020"
1014,NCT04391829,Recruiting,No Results Available,COVID-19|Sars-CoV2|Corona Virus Infection|Semen,Diagnostic Test: Ejaculated semen sample,Male,Adult,Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"August 31, 2020","August 31, 2021"
1015,NCT04359459,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,June 2020,June 2022
1016,NCT04352751,Recruiting,No Results Available,Covid-19,Other: convalescent plasma,All,Adult,Not Applicable,2000.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 1, 2020",April 2021
1017,NCT04367207,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","December 31, 2020"
1018,NCT04363450,Recruiting,No Results Available,COVID-19|Corona Virus Infection|Wuhan Coronavirus|Prophylaxis|Healthcare Worker|Sars-CoV2|Hydroxychloroquine,Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1700.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 27, 2020","June 1, 2021"
1019,NCT04373486,Completed,No Results Available,Covid-19 With Positive RT-PCR,,All,"Adult, Older Adult",,160.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"March 3, 2020","May 1, 2020"
1020,NCT04715243,Recruiting,No Results Available,Acute Respiratory Distress Syndrome Caused by COVID-19,Device: High flow nasal cannula (HFNC)|Device: Helmet NIV|Device: Face-mask NIV,All,"Adult, Older Adult",Not Applicable,360.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,"July 30, 2021"
1021,NCT04474249,Recruiting,No Results Available,COVID19|ARDS|AKI|Circulatory Failure|Coagulation Disorder|Inflammatory Response,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 25, 2020",December 2022
1022,NCT04539834,"Active, not recruiting",No Results Available,Electrolyte Imbalance,Other: electrolytes,All,"Adult, Older Adult",,52.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 1, 2020","October 1, 2020"
1023,NCT04492371,Recruiting,No Results Available,Multiple Myeloma|Covid19|Corona Virus Infection,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 1, 2020",July 2021
1024,NCT04685512,Recruiting,No Results Available,Covid19,Drug: tenofovir disoproxil and emtricitabine,All,"Adult, Older Adult",Phase 2|Phase 3,180.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"November 18, 2020","April 1, 2021"
1025,NCT04812327,Not yet recruiting,No Results Available,Covid19|SARS CoV-2,Diagnostic Test: BD Veritor Plus System for Rapid Detection of SARS CoV-2|Diagnostic Test: rt-PCR|Diagnostic Test: viral culture,All,"Adult, Older Adult",,150.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,June 2021,November 2021
1026,NCT04333225,Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 2,228.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 3, 2020","June 30, 2020"
1027,NCT04603677,Enrolling by invitation,No Results Available,Covid19,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 8, 2020","July 30, 2022"
1028,NCT04463849,Recruiting,No Results Available,COVID19|BETA-CELL FUNCTION,Diagnostic Test: Stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by COVID-19 infection,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 30, 2020","June 30, 2021"
1029,NCT04649320,Recruiting,No Results Available,Covid19,Other: questionnaire,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"November 23, 2020","December 31, 2020"
1030,NCT04355533,Recruiting,No Results Available,COVID-19 Infection,Biological: serology test|Biological: nasopharyngeal swab|Biological: rectal swab|Biological: saliva sample,All,"Child, Adult, Older Adult",Not Applicable,1000.0,Other|Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"July 29, 2020",December 2022
1031,NCT04431908,Recruiting,No Results Available,COVID-19,Device: olfactory device,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2020","October 1, 2020"
1032,NCT04370249,Completed,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Other: pulmonary ultrasound,All,"Adult, Older Adult",,313.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 9, 2020","August 31, 2020"
1033,NCT04841759,Recruiting,No Results Available,COVID-19,Other: Exercise,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"April 1, 2021","October 31, 2021"
1034,NCT04364594,Completed,No Results Available,COVID 19|Pulmonary Disease,Diagnostic Test: conjunctival swab,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 26, 2020","May 30, 2020"
1035,NCT04426344,Withdrawn,No Results Available,COVID 19,Device: ensoETM device,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,October 2020,December 2020
1036,NCT04590053,Recruiting,No Results Available,Covid19,Biological: Allocetra-OTS,All,"Adult, Older Adult",Phase 2,24.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 20, 2020",March 2021
1037,NCT04516512,Not yet recruiting,No Results Available,COVID-19,Biological: Blood draw,All,"Adult, Older Adult",Not Applicable,2500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"September 1, 2020","January 1, 2021"
1038,NCT04508556,Completed,No Results Available,Covid19,Device: Breath Biopsy face masks with removable filters and fitted PVA strip|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: oropharyngeal swabs,All,"Adult, Older Adult",,40.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"September 30, 2020","December 19, 2020"
1039,NCT04330586,Recruiting,No Results Available,COVID-19,Drug: Ciclesonide Metered Dose Inhaler [Alvesco],All,"Adult, Older Adult",Phase 2,66.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","March 31, 2021"
1040,NCT04592055,Recruiting,No Results Available,Diabetes Mellitus|Covid19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 20, 2020","November 1, 2020"
1041,NCT04654325,Not yet recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: conjunctival swab,All,"Adult, Older Adult",Not Applicable,1280.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,December 2020,December 2021
1042,NCT04646655,Recruiting,No Results Available,Covid19|Thrombosis,Drug: Enoxaparin,All,"Adult, Older Adult",Phase 3,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 27, 2020","July 31, 2021"
1043,NCT04610567,Recruiting,No Results Available,Coronavirus|Inflammation|Covid19,Drug: Methotrexate-LDE phase 1|Drug: Methotrexate-LDE phase 2|Drug: Placebo-LDE phase 2,All,"Adult, Older Adult",Phase 1|Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","October 27, 2020","July 15, 2021"
1044,NCT04433364,Recruiting,No Results Available,Sars-CoV2|Covid-19|Pregnancy Complications|Pregnancy Preterm|Pregnancy in Diabetic|Neonatal Infection,"Other: biological samples, questionnaires and interviews",Female,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 2, 2020","June 2, 2041"
1045,NCT04505709,Enrolling by invitation,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 1, 2020","August 1, 2021"
1046,NCT04428008,Recruiting,No Results Available,COVID-19,Drug: Thymalfasin,All,"Adult, Older Adult",Phase 2,240.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 12, 2021",January 2022
1047,NCT04514302,Not yet recruiting,No Results Available,COVID-19,Drug: Placebo|Drug: Anti-SARS-CoV-2 equine immunoglobulin fragments (INOSARS),All,"Adult, Older Adult",Phase 1|Phase 2,51.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 20, 2020","June 20, 2021"
1048,NCT04341415,Terminated,No Results Available,Covid19|SARS-CoV Infection,Procedure: Auricular neuromodulation|Procedure: Control,All,"Adult, Older Adult",Not Applicable,31.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","April 9, 2020","January 15, 2021"
1049,NCT04447131,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Other: venipuncture in peripheral vein,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 29, 2020","July 30, 2021"
1050,NCT04329611,Terminated,No Results Available,COVID-19,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,148.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 13, 2020","July 20, 2020"
1051,NCT04407390,Recruiting,No Results Available,COVID,Dietary Supplement: Nicotinamide riboside|Dietary Supplement: Placebo,All,Older Adult,Phase 2,100.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2020","May 1, 2022"
1052,NCT04313023,Recruiting,No Results Available,COVID-19,Drug: PUL-042 Inhalation Solution|Drug: Placebo,All,"Adult, Older Adult",Phase 2,200.0,Industry|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 9, 2020",June 2021
1053,NCT04753762,Recruiting,No Results Available,COVID-19 Virus Disease|Cardiac Complication,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 1, 2020","November 1, 2022"
1054,NCT04347876,Recruiting,No Results Available,COVID-19|BCG Vaccination,Diagnostic Test: Tuberculin test,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 11, 2020","June 30, 2020"
1055,NCT04689672,Recruiting,No Results Available,Covid19,Diagnostic Test: Lung ultrasound,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"December 16, 2020","May 10, 2021"
1056,NCT04549376,Recruiting,No Results Available,COVID19,Drug: Povidone-Iodine 0.4% NI|Drug: Povidone-Iodine 0.5% NI|Drug: Povidone-Iodine 0.6% NI|Drug: Povidone-Iodine 0.5% NS|Drug: Povidone-Iodine 0.6% NS|Other: Placebo comparator: DW-NI|Other: Placebo comparator: DW-NS,All,"Child, Adult, Older Adult",Phase 2,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 1, 2020","October 30, 2020"
1057,NCT04568044,Recruiting,No Results Available,"COVID-19|Pregnancy Related|Influenza, Human",Procedure: Blood sample,All,Adult,,128.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 16, 2020","July 3, 2023"
1058,NCT04689724,Recruiting,No Results Available,Covid-19_airways Management,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 10, 2020",May 2022
1059,NCT04534725,Recruiting,No Results Available,Cancer|Covid19|Respiratory Viral Infection,Drug: Interferon alfa|Drug: Selinexor|Drug: Lenzilumab,All,"Adult, Older Adult",Phase 3,2282.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 17, 2020",December 2021
1060,NCT04401410,Recruiting,No Results Available,SARS-CoV 2|Viral Infection|COVID 19,Biological: Dose Finding Phase (MTD)|Biological: Partially HLA-matched SARS-CoVSTs|Other: Routine care (no SARS-CoVSTs),All,"Adult, Older Adult",Phase 1,58.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 4, 2020","August 15, 2021"
1061,NCT04422444,Recruiting,No Results Available,COVID19|Post Intensive Care Unit Syndrome,Diagnostic Test: Questionnaires,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","June 1, 2022"
1062,NCT04471636,Recruiting,No Results Available,Covid-19|Cardiovascular Risk Factor,Device: Withings ScanWatch,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 18, 2020",December 2021
1063,NCT04422977,Not yet recruiting,No Results Available,Sars-CoV2,Diagnostic Test: Sars-Cov-2 serology,All,"Adult, Older Adult",Not Applicable,900.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 8, 2020","June 30, 2020"
1064,NCT04515108,Completed,No Results Available,"Pregnancy, Infections in|Covid19",Other: Clinical assessment,Female,Adult,,108.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 10, 2020","August 10, 2020"
1065,NCT04376658,Recruiting,No Results Available,Quality of Life|Long-term Outcomes|Coronavirus Infection,Other: COVID-19,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 15, 2020","July 15, 2022"
1066,NCT04323878,Recruiting,No Results Available,Early CPAP Ventilation in COVID-19 Patients,,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020",December 2021
1067,NCT04405973,Completed,No Results Available,COVID-19|SARS-CoV 2|Extracorporeal Membrane Oxygenation|ARDS,Device: vv-ECMO,All,"Adult, Older Adult",,133.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 19, 2020","September 30, 2020"
1068,NCT04635592,Not yet recruiting,No Results Available,SARS-CoV Infection,Diagnostic Test: SARS-CoV2 nasal swab,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,November 2020,"January 31, 2021"
1069,NCT04379089,Recruiting,No Results Available,COVID|Neurologic Manifestations,Other: Observational study only,All,Child,,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020","December 31, 2022"
1070,NCT04438837,Not yet recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19)|Post-Exposure Prophylaxis,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Not Applicable,582.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,July 2020,June 2022
1071,NCT04649515,Recruiting,No Results Available,Coronavirus Disease-2019 (COVID-19),Biological: TY027|Other: 0.9% saline,All,"Adult, Older Adult",Phase 3,1305.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 4, 2020","December 30, 2021"
1072,NCT04477213,Not yet recruiting,No Results Available,COVID19|Healthcare Workers,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 15, 2021","February 15, 2021"
1073,NCT04493307,Recruiting,No Results Available,COVID-19,Diagnostic Test: Phlebotomy,All,"Child, Adult, Older Adult",,100.0,Other|Industry,Observational,Observational Model: Other|Time Perspective: Prospective,"June 30, 2020",June 2021
1074,NCT04493294,Not yet recruiting,No Results Available,COVID-19 Pneumonitis,Radiation: Low dose whole lung radiotherapy for older patients with COVID-19 pneumonitis,All,Older Adult,Phase 1|Phase 2,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,November 2020,December 2021
1075,NCT04656613,Not yet recruiting,No Results Available,Covid19|SARS-CoV Infection,Biological: Gam-COVID-Vac|Other: placebo,All,"Adult, Older Adult",Phase 3,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention",December 2020,December 2021
1076,NCT04625036,Recruiting,No Results Available,COVID-19 Pneumonia,Diagnostic Test: Single passive leg movement,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"May 30, 2020",June 2021
1077,NCT04654442,Recruiting,No Results Available,Covid19|SARS-CoV-2,Diagnostic Test: TestNPass,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"March 4, 2021","May 15, 2021"
1078,NCT04492358,Recruiting,No Results Available,Covid19,Drug: Colchicine|Drug: Prednisone tablet|Drug: standard of care,All,Older Adult,Phase 2|Phase 3,144.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 22, 2020",October 2021
1079,NCT04408456,Completed,No Results Available,CoVID-19,Drug: HCQ|Other: Standard therapy,All,"Adult, Older Adult",Phase 3,325.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 1, 2020","July 31, 2020"
1080,NCT04345406,Not yet recruiting,No Results Available,COVID,Drug: ACEIs|Drug: Conventional treatment,All,"Child, Adult, Older Adult",Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","December 1, 2029"
1081,NCT04706143,Not yet recruiting,No Results Available,COVID-19 Vaccines,Biological: COVID-19 Vaccines,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 15, 2021","August 1, 2021"
1082,NCT04344977,Completed,No Results Available,Coronavirus Disease 2019 (COVID-19),,All,"Adult, Older Adult",,151.0,NIH,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 1, 2020","March 3, 2021"
1083,NCT04659356,Recruiting,No Results Available,Coronavirus Infectious Disease (COVID-19)|Nosocomial Infection|Nosocomial COVID-19,Other: Patients admitted in Intensive Care Units,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","July 14, 2021"
1084,NCT04542941,Completed,No Results Available,Covid19,Biological: COVID Convalescent Plasma,All,"Adult, Older Adult",Not Applicable,136.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 16, 2020","December 31, 2020"
1085,NCT04456413,Recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma|Other: Best Supportive Care,All,"Adult, Older Adult",Phase 2,306.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 6, 2020",November 2021
1086,NCT04830774,Not yet recruiting,No Results Available,COVID-19|Atrial Fibrillation New Onset,"Device: ILR, PMK, ICD",All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"April 15, 2021","December 31, 2023"
1087,NCT04569877,Recruiting,No Results Available,Severe Acute Respiratory Syndrome (SARS) Pneumonia|COVID-19 Pneumonia,Drug: Molgramostim nebuliser solution|Other: Placebo nebuliser solution,All,"Adult, Older Adult",Phase 2,238.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 24, 2020","December 25, 2022"
1088,NCT04536285,Completed,No Results Available,Type 1 Diabetes|Covid19,,All,"Child, Adult",,36.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"May 1, 2020","August 31, 2020"
1089,NCT04381338,Not yet recruiting,No Results Available,Corona Virus Disease 19 (COVID-19)|COVID|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Critical Illness,Other: Pulmonary and Motor Rehabilitation,All,"Adult, Older Adult",Not Applicable,92.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 10, 2020","September 30, 2020"
1090,NCT04343742,Recruiting,No Results Available,COVID-19,Drug: chlorine dioxide 3000 ppm,All,"Child, Adult, Older Adult",,20.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 1, 2020","June 1, 2020"
1091,NCT04729153,Not yet recruiting,No Results Available,Covid19,Drug: DAAD Compound,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,February 2021,March 2022
1092,NCT04531345,Completed,No Results Available,Covid19,Diagnostic Test: Flow cytometric analysis,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 1, 2020","November 15, 2020"
1093,NCT04457349,Recruiting,No Results Available,COVID 19,Procedure: Therapeutic Plasma Exchange (TPE),All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 25, 2020","January 20, 2021"
1094,NCT04363008,Recruiting,No Results Available,COVID 19,Diagnostic Test: serum inflammatory biomarkers,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2020","September 30, 2021"
1095,NCT04346602,Recruiting,No Results Available,COVID-2019,Other: all treatment about COVID-2019,All,"Child, Adult, Older Adult",,132.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2020","December 1, 2020"
1096,NCT04327531,Completed,No Results Available,COVID-19|Physician-Patient Relations,Behavioral: turkish physicians,All,Adult,,200.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"March 26, 2020","May 28, 2020"
1097,NCT04366141,Completed,No Results Available,COVID-19,Device: COVID-19 barrier box,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 1, 2020","February 1, 2021"
1098,NCT04542343,Recruiting,No Results Available,Coronavirus,"Behavioral: Change in knowledge, motivation, skills, resources",All,Older Adult,Not Applicable,265.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"November 1, 2020","September 30, 2021"
1099,NCT04510454,Recruiting,No Results Available,Cancer|COVID,Diagnostic Test: Nasopharyngeal and throat/oropharyngeal swabs analyses by RT-PCR and ddPCR,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"November 2, 2020",May 2021
1100,NCT04329507,Recruiting,No Results Available,COVID-19|Respiratory Disease,Diagnostic Test: Breath test,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 25, 2020","March 25, 2021"
1101,NCT04668469,Completed,No Results Available,Covid19,Drug: Ivermectin|Drug: Hydroxychloroquine|Behavioral: personal protective Measures,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 8, 2020","October 30, 2020"
1102,NCT04353596,Completed,No Results Available,SARS-CoV-2|COVID-19,"Drug: ACE inhibitor, angiotensin receptor blocker",All,"Adult, Older Adult",Phase 4,216.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 20, 2020","February 24, 2021"
1103,NCT04408209,Recruiting,No Results Available,COVID-19 Infection,Procedure: Convalescent Plasma,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 23, 2020","September 15, 2021"
1104,NCT04816656,Completed,No Results Available,Covid19|Oncology|PROMs|Chemotherapeutic Toxicity,Other: ePROMs assessment,All,"Adult, Older Adult",Not Applicable,43.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 3, 2020","March 22, 2021"
1105,NCT04392141,Recruiting,No Results Available,COVID-19,Drug: Standard Treatment|Drug: Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions,All,"Child, Adult, Older Adult",Phase 1|Phase 2,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 1, 2020","November 1, 2020"
1106,NCT04355234,"Active, not recruiting",No Results Available,Pregnancy,Diagnostic Test: identify SARS-CoV-2 infection by serology|Biological: collection of biological samples,Female,"Adult, Older Adult",Not Applicable,2500.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"May 4, 2020","August 31, 2021"
1107,NCT04695457,Completed,No Results Available,Covid19|Nursing Home,,All,"Child, Adult, Older Adult",,74.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 15, 2020","November 16, 2020"
1108,NCT04703452,Recruiting,No Results Available,Covid19,Other: Indicators of central sensitisation,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"January 19, 2021",January 2022
1109,NCT04391127,Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Ivermectin|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 3,108.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","May 4, 2020","November 6, 2020"
1110,NCT04525443,Completed,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,110.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 3, 2020","February 11, 2021"
1111,NCT04562246,Recruiting,No Results Available,Covid19,Diagnostic Test: Serologic assays for antibodies to SARS-CoV-2,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 14, 2020",August 2021
1112,NCT04796584,Not yet recruiting,No Results Available,Multiple Sclerosis,Other: Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus,All,Adult,,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 17, 2021","June 17, 2022"
1113,NCT04659187,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,4000.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 26, 2020","July 1, 2021"
1114,NCT04555187,"Active, not recruiting",No Results Available,Covid19|Cardiovascular Risk Factor,,All,"Adult, Older Adult",,60000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 8, 2020",December 2021
1115,NCT04474067,Recruiting,No Results Available,COVID-19,Other: No intervention,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 28, 2020",March 2021
1116,NCT04433013,Not yet recruiting,No Results Available,COVID-19,Drug: Lianhua Qingwen|Drug: Placebo,All,"Adult, Older Adult",Phase 3,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment",July 2020,February 2021
1117,NCT04318314,Recruiting,No Results Available,Health Care Worker Patient Transmission|Coronavirus|Coronavirus Infections|Immunological Abnormality,Diagnostic Test: COPAN swabbing and blood sample collection,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 18, 2020","December 31, 2021"
1118,NCT04366180,Recruiting,No Results Available,Covid-19,Dietary Supplement: Probiotic|Dietary Supplement: Control,All,"Adult, Older Adult",Not Applicable,314.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 24, 2020",October 2020
1119,NCT04701892,Recruiting,No Results Available,Covid19,Other: Indicators of central sensitisation,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 19, 2021",January 2023
1120,NCT04544033,Recruiting,No Results Available,Covid19,Diagnostic Test: interleuken 6 level measurment|Diagnostic Test: Interleukin-6 Gene-174C detection,All,"Child, Adult, Older Adult",,120.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"September 15, 2020",May 2021
1121,NCT04356534,Completed,No Results Available,SARS-CoV 2|COVID-19,Other: plasma therapy using convalescent plasma with antibody against SARS-CoV-2|Other: Routine care for COVID-19 patients,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 19, 2020","July 9, 2020"
1122,NCT04765839,"Active, not recruiting",No Results Available,Vaccine Preventable Disease,"Other: Educational, culturally appropriate COVID-19 messages",All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"February 12, 2021","March 22, 2021"
1123,NCT04349618,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID19|Sars-CoV2|Pneumonia,Other: PROTECTIVE VENTILATION|Other: ULTRAPROTECTIVE VENTILATION,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","April 15, 2023"
1124,NCT04389489,Recruiting,No Results Available,COVID-19|Dyspareunia|Postpartum Period,,Female,Adult,,140.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"May 14, 2020","September 30, 2020"
1125,NCT04371692,Not yet recruiting,No Results Available,Sars-CoV2,Other: self-administered questionnaire|Diagnostic Test: SARS-Cov2 testing,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2020,September 2020
1126,NCT04449042,Recruiting,No Results Available,Airway Management|COVID19,Procedure: airway management during sedation or general anesthesia,All,"Child, Adult",,15000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020",December 2025
1127,NCT04716465,Recruiting,No Results Available,Covid19,Other: Dysautonomia,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 19, 2021",January 2023
1128,NCT04622826,Recruiting,No Results Available,Covid-19 Pneumonia,Biological: immune plasma,All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 15, 2020","December 31, 2020"
1129,NCT04367857,Recruiting,No Results Available,Covid-19|Coronavirus Infection|Coronavirus,Other: COVID-19 Serology|Behavioral: Health Care Worker Survey,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 18, 2020",October 2021
1130,NCT04565080,Recruiting,No Results Available,Parkinson's Disease|Functional Movement Disorders|COVID-19,,All,"Adult, Older Adult",,150.0,NIH,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"April 19, 2021","December 31, 2021"
1131,NCT04379479,Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,Drug: Dialyzable Leukocyte Extract|Drug: Placebo oral,All,"Adult, Older Adult",Phase 2,562.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",May 2020,December 2020
1132,NCT04583306,Recruiting,No Results Available,Covid19,"Other: Raman analysis of saliva, characterization of the Raman database and building of the classification model",All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 1, 2020","June 1, 2021"
1133,NCT04397822,Recruiting,No Results Available,COVID-19,Biological: Blood samples,All,"Adult, Older Adult",,110.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020",April 2022
1134,NCT04376853,Recruiting,No Results Available,COVID-19,Device: Apple Watch Series 5,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020",July 2020
1135,NCT04537559,Enrolling by invitation,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,40000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","October 31, 2020"
1136,NCT04387760,Recruiting,No Results Available,SARS-CoV 2|COVID-19,Drug: Hydroxychloroquine|Drug: Favipiravir|Other: Routine care for COVID-19 patients,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 11, 2020","May 14, 2021"
1137,NCT04381845,Not yet recruiting,No Results Available,COVID|Psychiatric Disorders,Diagnostic Test: COVID19 immunization testing,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"December 10, 2020","March 10, 2021"
1138,NCT04379466,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 5, 2020",April 2021
1139,NCT04345510,Recruiting,No Results Available,COVID-19 Infection,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","September 30, 2021"
1140,NCT04469153,Recruiting,No Results Available,the Prognostic Value of Ferritin|Glycosylated Ferritin in SARS-CoV-2 Infection in Hospitalized COVID-19 Patients,Other: No intervention / Evaluation of the ferritin and glycosylated ferritin by standard approved serological tests,All,"Adult, Older Adult",,57.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 29, 2020","December 31, 2020"
1141,NCT04725097,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 10, 2020","August 30, 2021"
1142,NCT04414098,Not yet recruiting,No Results Available,COVID-19,Drug: INC424 / Ruxolitinib,All,"Adult, Older Adult",Phase 2,100.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","September 15, 2020"
1143,NCT04550338,Not yet recruiting,No Results Available,COVID-19,Drug: Tranexamic acid|Drug: Placebo,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 1, 2021","March 31, 2023"
1144,NCT04377464,Not yet recruiting,No Results Available,COVID-19|Quality of Life,"Other: SF12, EQ-5D-5L and work status standardized quantitative assessments",All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 5, 2020","April 30, 2022"
1145,NCT04431466,Recruiting,No Results Available,Coronavirus Infection,Drug: Ivermectin|Other: Standard treatment for COVID-19,All,"Adult, Older Adult",Phase 2,64.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 1, 2020","July 1, 2021"
1146,NCT04393974,Recruiting,No Results Available,Cancer|Sars-CoV2,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 24, 2020","March 24, 2022"
1147,NCT04492904,Recruiting,No Results Available,Covid19,Other: Home-use Test and Follow-up Questionnaire,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"July 23, 2020","March 31, 2021"
1148,NCT04816942,Completed,No Results Available,Convalescent Plasma|Covid19|Immunoglobulins|Plasma|Egypt,Biological: Convalescent Plasma,All,"Adult, Older Adult",Phase 3,102.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 23, 2020","October 12, 2020"
1149,NCT04364802,Recruiting,No Results Available,COVID-19|SARS-CoV 2,Drug: Povidone-Iodine Nasal Spray and Gargle,All,"Adult, Older Adult",Phase 2,300.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 29, 2020",May 2021
1150,NCT04704466,Recruiting,No Results Available,Head and Neck Cancer|Covid19|Patient Care,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 7, 2021",July 2021
1151,NCT04690816,Recruiting,No Results Available,Systemic Autoimmune Diseases,,All,"Child, Adult, Older Adult",,350.0,NIH,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"February 11, 2021","December 31, 2024"
1152,NCT04528368,Recruiting,No Results Available,COVID-19,Biological: Convalescent plasma,All,"Child, Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 11, 2020","May 30, 2021"
1153,NCT04712175,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: Nasopharyngeal sampling|Diagnostic Test: Saliva sampling,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,January 2021,July 2021
1154,NCT04531111,Recruiting,No Results Available,Type 1 Diabetes|Covid19,,All,"Child, Adult",,150.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"July 7, 2020",August 2020
1155,NCT04462393,Completed,No Results Available,COVID-19|Critical Illness,Other: Admission to ICU for COVID-19,All,"Adult, Older Adult",,1563.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 6, 2020","May 6, 2020"
1156,NCT04359615,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 4,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 20, 2020","May 5, 2020"
1157,NCT04381819,Recruiting,No Results Available,SARS Virus|Severe Acute Respiratory Syndrome,Diagnostic Test: SARS-CoV-2 PCR,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 2, 2020","December 31, 2023"
1158,NCT04685213,Recruiting,No Results Available,Covid19|Pain|Muscle Atrophy,Device: Electrical Stimulation|Device: Electrical Stimulation - Sham,All,"Adult, Older Adult",Phase 1,20.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care","August 18, 2020","August 18, 2021"
1159,NCT04380766,Completed,No Results Available,Pancreatic Cancer,Procedure: Evaluation of changes in the diagnostic-therapeutic pathway for patients affected by pancreatic cancer,All,"Adult, Older Adult",,730.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 1, 2019","July 31, 2020"
1160,NCT04312243,"Active, not recruiting",No Results Available,Coronavirus Infections|Healthcare Associated Infection,Drug: Inhaled nitric oxide gas,All,"Adult, Older Adult",Phase 2,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 7, 2020","April 7, 2022"
1161,NCT04842435,Not yet recruiting,No Results Available,COVID-19,Drug: COVID-globulin|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,376.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 9, 2021","October 5, 2021"
1162,NCT04355624,Recruiting,No Results Available,COVID|Kidney Injury,,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","July 30, 2020"
1163,NCT04371510,Recruiting,No Results Available,COVID-19 by SARS-CoV-2 Infection,Other: blood sample,All,"Adult, Older Adult",Not Applicable,115.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 22, 2020","February 22, 2021"
1164,NCT04359316,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Adult, Older Adult",Phase 4,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 20, 2020","May 5, 2020"
1165,NCT04827160,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,280.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 2, 2020","August 11, 2020"
1166,NCT04731051,Not yet recruiting,No Results Available,2019 Novel Coronavirus,Drug: HCQ01|Drug: standard of care (SOC) for COVID-19,All,"Adult, Older Adult",Phase 1|Phase 2,28.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,September 2021
1167,NCT04789460,Not yet recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 5, 2021","March 28, 2021"
1168,NCT04560608,Recruiting,No Results Available,Covid19,,All,Older Adult,,255.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 15, 2020","January 31, 2021"
1169,NCT04402814,Recruiting,No Results Available,SARS-CoV 2,Diagnostic Test: Clungene rapid test cassette,All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 5, 2020","December 1, 2020"
1170,NCT04354519,Recruiting,No Results Available,Multiple Sclerosis|COVID-19,,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 14, 2020","July 14, 2022"
1171,NCT04537117,Completed,No Results Available,COVID-19,Other: Questionaire,All,"Child, Adult, Older Adult",,202.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 20, 2020","May 5, 2020"
1172,NCT04345536,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2020","May 1, 2022"
1173,NCT04490486,Not yet recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Corona Virus Infection,Biological: UCMSCs|Other: Placebo,All,"Adult, Older Adult",Phase 1,21.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 1, 2021","June 1, 2024"
1174,NCT04473261,Recruiting,No Results Available,Covid19|SARS-CoV-2|Corona Virus Infection,Drug: Iodine Complex|Drug: Placebo|Drug: Idoine Complex,All,"Adult, Older Adult",Phase 1|Phase 2,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 14, 2020","August 15, 2021"
1175,NCT04334928,Recruiting,No Results Available,Coronavirus Infection,Drug: Emtricitabine/tenofovir disoproxil|Drug: Hydroxychloroquine|Drug: Placebo: Emtricitabine/tenofovir disoproxil Placebo|Drug: Placebo: Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,4000.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","April 15, 2020","December 31, 2020"
1176,NCT04550403,Recruiting,No Results Available,Diabetes Mellitus|Covid19,,All,"Child, Adult, Older Adult",,700.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 30, 2020","December 31, 2021"
1177,NCT04349228,Withdrawn,No Results Available,COVID19|Sars-CoV2|Hydroxychloroquine|Prophylaxis|Healthcare Worker,Drug: Hydroxychloroquine (HCQ)|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"April 28, 2020","July 15, 2020"
1178,NCT04328272,Not yet recruiting,No Results Available,COVID19,Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 500Mg Oral Tablet|Dietary Supplement: Glucose tablets,All,Adult,Phase 3,75.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"March 28, 2020","June 28, 2020"
1179,NCT04429620,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: Immunfluorescence,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"May 30, 2020","December 31, 2020"
1180,NCT04640402,Recruiting,No Results Available,COVID-19,Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Two dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Three dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Two dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Three dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Two dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Three dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Two dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Three dose regimen|Biological: Low-dose placebo (18-59 years) & Two dose regimen|Biological: Low-dose placebo (18-59 years) & Three dose regimen|Biological: High-dose placebo (18-59 years) & Two dose regimen|Biological: High-dose placebo (18-59 years) & Three dose regimen|Biological: Low-dose placebo (60-85 years) & Two dose regimen|Biological: Low-dose placebo (60-85 years) & Three dose regimen|Biological: High-dose placebo (60-85 years) & Two dose regimen|Biological: High-dose placebo (60-85 years) & Three dose regimen,All,"Adult, Older Adult",Phase 2,960.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","November 17, 2020","November 18, 2021"
1181,NCT04459455,Completed,No Results Available,Anxiety,Behavioral: Contain COVID Anxiety SSI|Behavioral: Remain COVID Free SSI,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 19, 2020","October 15, 2020"
1182,NCT04426084,"Active, not recruiting",No Results Available,COVID-19,Other: Hypertension|Other: Diabetes type 2|Other: Obesity|Drug: Antihypertensive Agents|Drug: Statins (Cardiovascular Agents),All,"Adult, Older Adult",,22784.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"March 1, 2020","December 31, 2022"
1183,NCT04694716,Recruiting,No Results Available,Covid19,Other: No intervention,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 6, 2021",March 2021
1184,NCT04476602,Recruiting,No Results Available,Covid-19 (SARS-CoV-2),,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 27, 2020","December 31, 2020"
1185,NCT04366245,Recruiting,No Results Available,SARS-CoV 2,Biological: Hyperimmune plasma|Drug: Standard of care for SARS-CoV-2 infection,All,"Adult, Older Adult",Phase 1|Phase 2,72.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 23, 2020",December 2021
1186,NCT04508712,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,900.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"August 10, 2020","August 31, 2021"
1187,NCT04665193,Recruiting,No Results Available,Asymptomatic Condition|Healthy,Diagnostic Test: Rapid Antigen Test,All,"Adult, Older Adult",Not Applicable,900.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"November 23, 2020","April 30, 2021"
1188,NCT04407169,Completed,No Results Available,COVID,Other: no intervention,All,"Adult, Older Adult",,617.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020","November 17, 2020"
1189,NCT04770467,Not yet recruiting,No Results Available,COVID-19,Drug: BRII-196 and BRII-198|Drug: Placebo,All,"Adult, Older Adult",Phase 2,56.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,March 2021,October 2022
1190,NCT04677283,Recruiting,No Results Available,Symptoms Related to Covid-19,,All,"Adult, Older Adult",,2020.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 5, 2020",March 2021
1191,NCT04618861,Completed,No Results Available,Covid19|Pneumonia|Surfactant Protein Deficiency,,,"Adult, Older Adult",,127.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"October 13, 2020","November 2, 2020"
1192,NCT04344288,Terminated,No Results Available,Viral Pneumonia Human Coronavirus|COVID-19,Drug: Prednisone|Other: Control group,All,"Adult, Older Adult",Phase 2,11.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 21, 2020","August 18, 2020"
1193,NCT04403906,Not yet recruiting,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: PCL COV05 - COVID 19 Ag Rapid FIA test (Rapid Antigen Test),All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,June 2020,August 2021
1194,NCT04346355,Terminated,No Results Available,COVID-19 Pneumonia,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 2,126.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 31, 2020","June 6, 2020"
1195,NCT04644146,Recruiting,No Results Available,Covid19,Genetic: GENETIC,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"December 1, 2020","December 1, 2021"
1196,NCT04765254,Recruiting,No Results Available,Covid19|Diabete Type 2|Non Diabetic Patients|Chest CT Scan,Other: no intervention as it is an observational study,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"February 20, 2021","April 10, 2021"
1197,NCT04366778,Completed,No Results Available,Thrombosis|Covid-19|SARS-CoV 2,Diagnostic Test: TEM-tPA,All,"Adult, Older Adult",,341.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","January 1, 2021"
1198,NCT04353154,"Active, not recruiting",No Results Available,COVID-19,Diagnostic Test: Spartan Cube Point-of Care Covid-19 test,All,"Adult, Older Adult",,66.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","February 28, 2021"
1199,NCT04838093,Completed,No Results Available,Covid19,Diagnostic Test: PCR,All,"Child, Adult, Older Adult",,2243.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","January 1, 2021"
1200,NCT04340479,Recruiting,No Results Available,COVID|Trauma|Ultrasound,Diagnostic Test: Ultrasound lung imaging as part of FAST+ evaluation,All,"Child, Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 30, 2020",May 2022
1201,NCT04828460,Recruiting,No Results Available,Covid19|Kidney Transplantation,,All,"Child, Adult, Older Adult",,3500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 9, 2021",February 2023
1202,NCT04377672,Recruiting,No Results Available,Corona Virus Infection,Biological: Anti-SARS-CoV-2 Human Convalescent Plasma,All,"Child, Adult",Phase 1,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 28, 2020","May 28, 2022"
1203,NCT04399252,Recruiting,No Results Available,Microbiome,Dietary Supplement: Lactobaciltus rhamnosus GG|Dietary Supplement: Lactobaciltus rhamnosus GG Placebo,All,"Child, Adult, Older Adult",Not Applicable,1132.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science","June 24, 2020","May 25, 2022"
1204,NCT04587323,Recruiting,No Results Available,COVID-19 Disease,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 22, 2020","May 20, 2023"
1205,NCT04590274,Not yet recruiting,No Results Available,Covid19|SARS (Severe Acute Respiratory Syndrome),Drug: Hydroxychloroquine|Dietary Supplement: Vitamins and Minerals|Drug: Azithromycin,All,"Child, Adult, Older Adult",Phase 1,5000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,November 2020,December 2021
1206,NCT04534712,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: LYMPHOCYTE MONOCYTE RATIO,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","February 1, 2021"
1207,NCT04292327,"Active, not recruiting",No Results Available,Pneumonia Caused by Human Coronavirus,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 1, 2020","July 31, 2020"
1208,NCT04669938,Recruiting,No Results Available,Covid19,Other: oropharyngeal and intestinal microbiota|Other: host genotype|Other: host immune factors|Other: viral sequence,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 4, 2020","March 31, 2022"
1209,NCT04780321,Recruiting,No Results Available,COVID-19,Biological: Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg)|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 30, 2020","June 30, 2021"
1210,NCT04633980,Not yet recruiting,No Results Available,Covid-19,"Drug: Mixture 3,6% H2 in N2 (96.4%)",All,"Adult, Older Adult",Phase 1,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","September 30, 2021"
1211,NCT04422613,"Active, not recruiting",No Results Available,"Pneumonia, Viral",Diagnostic Test: pulmonary anomalies 4 months after documented COVID-19 pneumonia,All,"Adult, Older Adult",Not Applicable,73.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 28, 2020",May 2022
1212,NCT04354389,Withdrawn,No Results Available,COVID-19,Drug: DAS181|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 25, 2020","November 30, 2020"
1213,NCT04373824,Recruiting,No Results Available,COVID,Drug: Ivermectin,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 25, 2020","July 25, 2020"
1214,NCT04407156,Completed,No Results Available,COVID|AKI,Other: acute kidney injury,All,"Adult, Older Adult",,724.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"June 1, 2020","July 20, 2020"
1215,NCT04534803,Not yet recruiting,No Results Available,Covid19,Drug: BCG Vaccine|Other: Placebo,All,Older Adult,Phase 3,2100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 1, 2021","November 30, 2022"
1216,NCT04365231,Withdrawn,No Results Available,COVID19,Drug: Hydroxychloroquine and azithromycin treatment|Other: conventional management of patients,Female,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","April 1, 2021"
1217,NCT04806867,Completed,No Results Available,Covid19|Inflammatory Rheumatism|Rheumatoid Arthritis|Spondyloarthritis|Inflammatory Arthritis,Other: SePaRIC-Covid19 cohort,All,"Adult, Older Adult",,918.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 1, 2020","July 31, 2020"
1218,NCT04416464,Recruiting,No Results Available,Quality of Life|Long-term Outcomes|Coronavirus Infection|Morality|Rehospitalization,Other: COVID-19 Pneumonia,All,"Adult, Older Adult",,230.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2020","October 1, 2022"
1219,NCT04841707,Recruiting,No Results Available,Covid19,Device: uEXPLORER/mCT,All,"Adult, Older Adult",Not Applicable,15.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"April 22, 2021","February 22, 2023"
1220,NCT04710199,Recruiting,No Results Available,Virus Diseases,Drug: Maraviroc experimental group|Other: Standard treatment,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 8, 2021",October 2021
1221,NCT04416308,Completed,No Results Available,Coronavirus,Diagnostic Test: NG test|Diagnostic Test: Blood test|Behavioral: Self-questionnary,All,"Adult, Older Adult",Not Applicable,9453.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic,"May 29, 2020","October 12, 2020"
1222,NCT04542850,Recruiting,No Results Available,SARS-CoV 2|COVID-19,Dietary Supplement: 5-ALA-Phosphate + SFC (5-ALA + SFC),All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 15, 2020","September 15, 2021"
1223,NCT04381988,Recruiting,No Results Available,COVID-19|Cancer,Drug: Hydroxychloroquine|Other: Placebo|Radiation: Radiation therapy,All,"Adult, Older Adult",Phase 2,132.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","May 7, 2020",May 2021
1224,NCT04790994,"Active, not recruiting",No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,1145.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 24, 2020","April 16, 2021"
1225,NCT04585945,Recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,Diagnostic Test: Positive for SARS-CoV-2 infection,Female,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"August 4, 2020","September 30, 2021"
1226,NCT04681430,Recruiting,No Results Available,Corona Virus Infection|SARS-CoV-2 Infection|SARS-CoV-2 PCR Test Positive|SARS-CoV-2 Acute Respiratory Disease,Biological: Convalescent plasma|Drug: Camostat Mesilate|Drug: Placebo for Camostat Mesilate|Other: Standard of Care (SoC),All,"Adult, Older Adult",Phase 2,1094.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 8, 2021",November 2021
1227,NCT04446065,Not yet recruiting,No Results Available,COVID-19|SARS-CoV2,Drug: Previfenon®|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,524.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 30, 2020","October 30, 2021"
1228,NCT04667923,Recruiting,No Results Available,Covid19|ARDS,Diagnostic Test: Respiratory monitoring|Diagnostic Test: Respiratory muscles ultrasound|Diagnostic Test: Electro impedance tomography|Diagnostic Test: Capnography|Diagnostic Test: Arterial blood gas|Diagnostic Test: Quasistatic pressure-volume curve,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"October 1, 2020",August 2021
1229,NCT04483635,Recruiting,No Results Available,COVID-19,Dietary Supplement: Placebo|Dietary Supplement: Vitamin D,All,"Adult, Older Adult",Phase 3,2414.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 8, 2021","December 31, 2021"
1230,NCT04331106,Recruiting,No Results Available,Anxiety Related to the COVID-19 Pandemic,Diagnostic Test: Online Questionnaire,All,"Adult, Older Adult",,7500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 27, 2020",April 2022
1231,NCT04516811,Recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection|Severe Acute Respiratory Syndrome Coronavirus 2,Biological: COVID-19 convalescent plasma (CCP) plus standard of care (SOC)|Biological: Standard of care (SOC) plus placebo,All,"Adult, Older Adult",Phase 3,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 21, 2020","July 31, 2022"
1232,NCT04838834,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV-2|Inflammatory Bowel Diseases,,All,"Child, Adult",,472.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020","December 31, 2024"
1233,NCT04561063,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: Nitazoxanide|Drug: Sofosbuvir/Daclatasvir,All,"Adult, Older Adult",Phase 2,1950.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"December 8, 2020",July 2021
1234,NCT04463264,Recruiting,No Results Available,COVID-19,Drug: Nitazoxanide|Drug: Placebo,All,Adult,Phase 2|Phase 3,135.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 26, 2020","December 26, 2020"
1235,NCT04793984,Recruiting,No Results Available,Covid19,Device: Carragelose|Device: NaCl,All,"Adult, Older Adult",Not Applicable,228.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 8, 2021","October 30, 2021"
1236,NCT04576351,Recruiting,No Results Available,Covid19,Other: Observation,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","December 31, 2023"
1237,NCT04431856,Completed,No Results Available,Anxiety|Depression|Traumatic Stress Disorder,Behavioral: Unified Protocol for COVID-19 Parenting Stress (UP-COVID)|Behavioral: SHG,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 15, 2020","November 17, 2020"
1238,NCT04643860,Not yet recruiting,No Results Available,SARS-CoV-2 Infection Covid19,Diagnostic Test: Differential Leucocyte Count (CLDC) device and algorithm,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,December 2020,May 2021
1239,NCT04632615,"Active, not recruiting",No Results Available,"Sleep|Athlete|Training|Exercise|Covid19|Isolation, Social",,All,Adult,,84.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 22, 2020","March 31, 2021"
1240,NCT04584697,Withdrawn,No Results Available,Covid19,Biological: COVI-AMG|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",December 2020,April 2021
1241,NCT04337918,Completed,No Results Available,Corona Virus Infection,Drug: NORS (Nitric Oxide Releasing Solution),All,"Adult, Older Adult",Phase 2,143.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"May 8, 2020","February 2, 2021"
1242,NCT04715607,Recruiting,No Results Available,SARS-CoV Infection|Covid19|Coronavirus,Diagnostic Test: Sequence of testing.,All,"Child, Adult, Older Adult",Not Applicable,22000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic","January 22, 2021","May 30, 2021"
1243,NCT04331600,Completed,No Results Available,COVID-19,Drug: Chloroquine phosphate|Other: Telemedicine,All,"Adult, Older Adult",Phase 4,16.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","December 17, 2020"
1244,NCT04559100,Enrolling by invitation,No Results Available,Covid19,Radiation: chest radiography|Radiation: thoracic computed tomography scan|Diagnostic Test: spirometry|Diagnostic Test: Diffusing capacity of carbon monoxide|Diagnostic Test: 6 minute walk test|Diagnostic Test: saint george respiratory questionnaire,All,"Adult, Older Adult",,112.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"November 15, 2020","October 1, 2021"
1245,NCT04547127,Completed,No Results Available,COVID-19,Biological: Convalescent anti-SARS-CoV-2 MBT Plasma|Drug: Standard Medical Treatment,All,"Adult, Older Adult",Phase 2,200.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 29, 2020","February 4, 2021"
1246,NCT04582266,Recruiting,No Results Available,COVID-19,Drug: Remdesivir,Female,"Child, Adult, Older Adult",,40.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 12, 2021","January 15, 2022"
1247,NCT04552340,Recruiting,No Results Available,Covid19,Other: Patient with SAR-CoV-2 infection,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 16, 2020",July 2023
1248,NCT04324489,Completed,No Results Available,COVID-19,Drug: DAS181,All,"Adult, Older Adult",Not Applicable,4.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 6, 2020","April 30, 2020"
1249,NCT04691947,Recruiting,No Results Available,COVID-19 Vaccine,Biological: ERUCOV-VAC|Other: Placebo Vaccine,All,Adult,Phase 1,44.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","November 5, 2020","March 15, 2022"
1250,NCT04834739,Recruiting,No Results Available,Covid19|Functional Capacity,Other: 6 minute walk test|Other: 1 minute Sit to Stand Test|Other: Fatigue Severity Scale|Other: Medical Research Council (MRC) dyspnea scale|Other: SF-12|Other: Beck Depression Inventory|Other: Beck Anxiety Inventory|Other: 5 times sit to stand test|Other: 6 point Likert Scale,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"January 4, 2021","April 30, 2021"
1251,NCT04473053,Recruiting,No Results Available,COVID-19,Drug: Nafamostat Mesilate|Drug: TD139|Other: Standard care,All,"Child, Adult, Older Adult",Phase 2|Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 3, 2020","December 3, 2021"
1252,NCT04429724,"Active, not recruiting",No Results Available,COVID-19,Diagnostic Test: Diagnostic test Covid-19,All,"Adult, Older Adult",Not Applicable,2129.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 6, 2020",December 2021
1253,NCT04320017,Recruiting,No Results Available,COVID-19|Myocardial Injury|Myocarditis,"Diagnostic Test: Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care",All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020","May 20, 2020"
1254,NCT04498286,Recruiting,No Results Available,Multiple Sclerosis,Diagnostic Test: Testing of SARS-CoV-2 antibodies,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 6, 2020","December 1, 2021"
1255,NCT04558437,Recruiting,No Results Available,Post Traumatic Stress Disorder (PTSD)|Anxiety|Depression|Epidemic Disease|COVID19,Other: Questionnaire,All,"Adult, Older Adult",,20000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 12, 2020","December 31, 2020"
1256,NCT04544150,Completed,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,220.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 1, 2020","September 1, 2020"
1257,NCT04364984,Recruiting,No Results Available,Hypertension|COVID-19,Drug: Angiotensin converting enzyme inhibitor,All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","August 1, 2021"
1258,NCT04707534,Recruiting,No Results Available,Covid19,Drug: Dexamethasone,All,"Adult, Older Adult",Phase 4,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 21, 2021","June 21, 2021"
1259,NCT04813562,Recruiting,No Results Available,COVID-19,"Biological: a middle-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56|Biological: a high-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56|Biological: a middle-dose recombinant COVID-19 vaccine (CHO Cell) (60-85 years) at the schedule of day 0, 28, 56|Biological: a high-dose recombinant COVID-19 vaccine (CHO Cell) (60-85 years) at the schedule of day 0, 28, 56|Biological: a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56|Biological: a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56|Biological: a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56|Biological: a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",All,"Adult, Older Adult",Phase 2,480.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","March 23, 2021","June 30, 2022"
1260,NCT04433910,Completed,No Results Available,COVID-19,Drug: Convalesscent Plasma,All,"Adult, Older Adult",Phase 2,106.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 30, 2020","February 22, 2021"
1261,NCT04389710,Recruiting,No Results Available,COVID-19,Drug: Convalescent Plasma,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","April 14, 2021"
1262,NCT04362267,Recruiting,No Results Available,Sars-CoV2,Other: self-administered questionnaire|Diagnostic Test: SARS-Cov2 testing,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 15, 2020",September 2020
1263,NCT04587219,"Active, not recruiting",No Results Available,Coronavirus Infection,Biological: Gam-COVID-Vac,All,"Adult, Older Adult",Phase 2,110.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 22, 2020","April 30, 2021"
1264,NCT04480411,Not yet recruiting,No Results Available,Diagnoses Disease|Covid19,Behavioral: Doctorgram Patient Kit,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,March 2021,February 2022
1265,NCT04581746,Recruiting,No Results Available,Virus-HIV|Covid19,Other: questionnaire,All,"Adult, Older Adult",Not Applicable,1800.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 25, 2020",December 2021
1266,NCT04379336,Recruiting,No Results Available,COVID-19|Sars-CoV2,Biological: Bacille Calmette-Guérin (BCG)|Other: Placebo Comparator,All,"Adult, Older Adult",Phase 3,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 4, 2020","April 28, 2021"
1267,NCT04716985,Recruiting,No Results Available,SARS-CoV-2|Covid19|AMBULATORY CARE,Dietary Supplement: MOLECULAR HYDROGEN|Dietary Supplement: PLACEBO MAGNESIUM,All,"Adult, Older Adult",Not Applicable,450.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 22, 2021","December 22, 2022"
1268,NCT04542213,Completed,No Results Available,Hyperglycemia|Covid19,Drug: Linagliptin tablet|Drug: Insulin,All,"Adult, Older Adult",Phase 3,70.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 1, 2020","February 28, 2021"
1269,NCT04689399,Completed,No Results Available,Covid19|Rapid Antigen Test|SARS-CoV-2,"Diagnostic Test: Standard Q COVID-19 Ag - test, produced by SD Biosensor INC.",All,"Adult, Older Adult",Not Applicable,4697.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"December 26, 2020","March 25, 2021"
1270,NCT04780594,Completed,No Results Available,Covid19|Surgery--Complications|Nosocomial Infection,"Procedure: The study evaluates all surgical patients operated, both elective scheduled and emergent cases",All,"Adult, Older Adult",,2530.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Retrospective,"February 13, 2020","December 9, 2020"
1271,NCT04844541,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,December 2022
1272,NCT04469179,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV2,Biological: SAB-185|Other: Normal Saline,All,Adult,Phase 1,21.0,Industry|U.S. Fed|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 20, 2020",April 2021
1273,NCT04828148,Recruiting,No Results Available,"Covid19|Health Care Associated Infection|Infection, Coronavirus|Death",Behavioral: Survey,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 1, 2021","June 1, 2021"
1274,NCT04485130,Not yet recruiting,No Results Available,Covid19,Drug: Disulfiram|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 15, 2021","March 15, 2022"
1275,NCT04357574,Enrolling by invitation,No Results Available,COVID-19|Cancer,Other: Telehealth,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 14, 2020",April 2021
1276,NCT04581161,Recruiting,No Results Available,Acute Respiratory Failure|Covid19,Device: Life2000® Ventilator,All,"Adult, Older Adult",Not Applicable,10.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 28, 2020",October 2020
1277,NCT04600440,Recruiting,No Results Available,Covid-19|Respiratory Insufficiency,Biological: Convalescent plasma,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 25, 2020","February 28, 2022"
1278,NCT04715360,Recruiting,No Results Available,"Covid19|Sars-CoV-2 Infection|ARDS, Human|Severe covid19",Combination Product: autologous activated platelet-rich plasma|Drug: Avigan,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"December 29, 2020","December 27, 2021"
1279,NCT04608266,Recruiting,No Results Available,Covid19,Drug: Camostat Mesylate|Drug: Placebo,All,"Adult, Older Adult",Phase 3,596.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 3, 2020",March 2022
1280,NCT04630054,Recruiting,No Results Available,Covid19,Device: Face mask|Behavioral: Face mask awareness,All,"Adult, Older Adult",Not Applicable,450000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,"November 15, 2020","February 15, 2021"
1281,NCT04583969,Recruiting,No Results Available,COVID-19,Biological: Lenzilumab|Other: Placebo|Drug: Remdesivir,All,"Adult, Older Adult",Phase 2,200.0,NIH|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 19, 2020","December 31, 2021"
1282,NCT04476888,Completed,No Results Available,Covid19,Biological: Convalescent Plasma (CP)|Other: Drugs and supportive care,All,"Adult, Older Adult",Not Applicable,110.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 26, 2020","October 10, 2020"
1283,NCT04422509,Recruiting,No Results Available,COVID-19,Biological: lanadelumab|Other: regular care,All,"Child, Adult, Older Adult",Phase 1|Phase 2,80.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 3, 2020","August 3, 2021"
1284,NCT04626076,Recruiting,No Results Available,SARS-CoV Infection|Covid19,Other: Comparative Observational Cohort Study,All,"Adult, Older Adult",,10000.0,Industry|Other,Observational,Observational Model: Other|Time Perspective: Prospective,"August 13, 2020","October 31, 2021"
1285,NCT04328285,"Active, not recruiting",No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo of Hydroxychloroquine|Drug: Lopinavir and ritonavir|Drug: Placebo of LPV/r Tablets,All,"Adult, Older Adult",Phase 3,1200.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 14, 2020","March 30, 2021"
1286,NCT04536298,Recruiting,No Results Available,COVID-19,Dietary Supplement: vitamin D|Dietary Supplement: Placebo,All,"Adult, Older Adult",Phase 3,2700.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 28, 2020","June 30, 2021"
1287,NCT04478539,Recruiting,No Results Available,Covid19,Device: Extracorporeal blood purification using the oXiris® (AN69ST) hemofilter,All,"Adult, Older Adult",Not Applicable,35.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","July 1, 2021"
1288,NCT04599959,Completed,No Results Available,Covid-19,Diagnostic Test: Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisol,All,"Adult, Older Adult",Not Applicable,144.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"October 26, 2020","January 20, 2021"
1289,NCT04578509,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19,Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Saliva sample|Diagnostic Test: axillary sweat sample|Other: Data collection,All,"Child, Adult, Older Adult",,2750.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 19, 2020",June 2021
1290,NCT04681040,Recruiting,No Results Available,Covid19|Urine|Biomarker|Acute Respiratory Failure With Hypoxia,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 19, 2020","August 31, 2023"
1291,NCT04410263,Recruiting,No Results Available,Corona Virus Infection|ARDS|Coinfection,"Diagnostic Test: Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)",All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2020","December 31, 2023"
1292,NCT04703790,Not yet recruiting,No Results Available,Covid19|Vaccine Acceptability,,All,"Adult, Older Adult",,1200.0,Other|Industry,Observational,Observational Model: Other|Time Perspective: Prospective,February 2021,August 2022
1293,NCT04393558,Recruiting,No Results Available,COVID-19|Healthy Control,Device: ADAM Sensor,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","December 31, 2022"
1294,NCT04344015,Recruiting,No Results Available,COVID-19,Other: Plasma Donation,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 13, 2020","April 12, 2021"
1295,NCT04377763,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 15, 2020",March 2021
1296,NCT04456036,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","June 30, 2021"
1297,NCT04691609,Recruiting,No Results Available,ACS-COVID-19-Assiut,,All,"Child, Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 1, 2020",September 2023
1298,NCT04521296,Not yet recruiting,No Results Available,Mild to Moderate COVID-19,Drug: DWJ1248|Drug: Placebo,All,"Adult, Older Adult",Phase 2,90.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",August 2020,December 2020
1299,NCT04513210,Enrolling by invitation,No Results Available,Covid19,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 10, 2020","February 28, 2022"
1300,NCT04501796,Recruiting,No Results Available,COVID-19,Drug: Double-Blind NT-I7|Drug: Double-Blind Placebo,All,"Adult, Older Adult",Phase 1,30.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 27, 2020",December 2021
1301,NCT04607941,Recruiting,No Results Available,Covid19,Other: Questionnaires|Other: Phone interviews,All,"Adult, Older Adult",,57720.0,Industry|Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 27, 2020","June 30, 2021"
1302,NCT04318015,Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,400.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 14, 2020","March 31, 2021"
1303,NCT04392089,Recruiting,No Results Available,COVID-19|Respiratory Failure,"Device: Masimo, LidCO",All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","May 1, 2021"
1304,NCT04502667,Recruiting,No Results Available,"Covid19|Vitamin D|Children, Only",Drug: Cholecalciferol,All,Child,Phase 3,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 15, 2020",April 2021
1305,NCT04743349,Recruiting,No Results Available,Covid19|Coronavirus Infection|Coronavirus,Procedure: Steam inhalations,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 26, 2021","October 31, 2021"
1306,NCT04340544,Terminated,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 2,17.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 22, 2020","October 12, 2020"
1307,NCT04384380,Completed,No Results Available,Coronavirus Infection,Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil],All,"Adult, Older Adult",Not Applicable,33.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","May 31, 2020"
1308,NCT04487665,Not yet recruiting,No Results Available,Covid19,,All,Adult,,50.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"September 15, 2020","December 15, 2020"
1309,NCT04422626,Not yet recruiting,No Results Available,SARS-CoV-2|COVID-19,,All,"Adult, Older Adult",,42.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","December 1, 2022"
1310,NCT04389567,Completed,No Results Available,COVID-19,Drug: Famotidine,All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 12, 2020","May 25, 2020"
1311,NCT04659707,Recruiting,No Results Available,Covid19,Drug: Hyperpolarized Xe129,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"February 22, 2021","December 31, 2021"
1312,NCT04373200,Recruiting,No Results Available,SARS-CoV-2 Coronavirus|Acute Respiratory Distress Syndrome,Biological: Blood samples collection|Other: Saliva collection,All,"Adult, Older Adult",Not Applicable,75.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 25, 2020","September 25, 2021"
1313,NCT04595773,Recruiting,No Results Available,COVID-19,Other: Aerobic Exercise Training|Other: Education,All,"Adult, Older Adult",Phase 1|Phase 2,90.0,NIH,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"January 22, 2021","December 31, 2023"
1314,NCT04408391,Withdrawn,No Results Available,Covid-19|Anosmia,Other: Brain MRI scan,All,"Adult, Older Adult",,0.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 20, 2020","July 6, 2020"
1315,NCT04348396,Recruiting,No Results Available,COVID-19,,All,Older Adult,,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 3, 2020",December 2020
1316,NCT04670328,Completed,No Results Available,Covid19,Diagnostic Test: not required,All,"Child, Adult, Older Adult",,101.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 1, 2020","July 31, 2020"
1317,NCT04679272,Completed,No Results Available,Covid19|Rheumatoid Arthritis,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"December 1, 2020","February 1, 2021"
1318,NCT04481360,Not yet recruiting,No Results Available,Coronavirus,Device: CT of the chest,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,August 2020,September 2021
1319,NCT04357457,Recruiting,No Results Available,Covid 19|Hypoxemic Respiratory Failure,Drug: Almitrine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,212.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 3, 2020",July 2021
1320,NCT04668235,Not yet recruiting,No Results Available,COVID-19,Drug: AZVUDINE|Drug: AZVUDINE placebo,All,"Adult, Older Adult",Phase 3,342.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,October 2021
1321,NCT04581083,Completed,No Results Available,Covid19,Diagnostic Test: RT-PCR|Diagnostic Test: LAMP|Diagnostic Test: POOL RT-PCR|Diagnostic Test: POOL LAMP,All,Adult,,30.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"October 8, 2020","October 30, 2020"
1322,NCT04367870,Recruiting,No Results Available,Oncology,,All,"Adult, Older Adult",,450.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 23, 2020",October 2021
1323,NCT04365530,Recruiting,No Results Available,COVID,,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 1, 2020","December 31, 2022"
1324,NCT04460703,Completed,No Results Available,Vaccination|COVID-19,Other: Control message|Other: Baseline message|Other: Personal freedom message|Other: Economic freedom message|Other: Self-interest message|Other: Community interest message|Other: Economic benefit message|Other: Guilt message|Other: Embarrassment message|Other: Anger message|Other: Trust in science message|Other: Not bravery message,All,"Adult, Older Adult",Not Applicable,4000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 3, 2020","July 8, 2020"
1325,NCT04568031,"Active, not recruiting",No Results Available,COVID-19,Drug: AZD1222|Drug: 0.9% (w/v) saline,All,"Adult, Older Adult",Phase 1|Phase 2,256.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 23, 2020","November 15, 2021"
1326,NCT04354597,Not yet recruiting,No Results Available,COVID-19,Drug: HCQ & AZ,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 1, 2020","October 15, 2020"
1327,NCT04377711,Completed,No Results Available,COVID-19,Drug: Ciclesonide|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 3,400.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 8, 2020","January 5, 2021"
1328,NCT04537299,Not yet recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: Fisetin|Drug: Placebo,All,Older Adult,Phase 2,150.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,December 2023
1329,NCT04401046,Recruiting,No Results Available,Cancer,Other: Survey to assess Post traumatic stress and anxiety at inclusion and 6 months later,All,"Adult, Older Adult",Not Applicable,4000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 20, 2020","October 30, 2020"
1330,NCT04341922,"Active, not recruiting",No Results Available,Dysfunctional Worry,Behavioral: Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemic,All,"Child, Adult, Older Adult",Not Applicable,670.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 9, 2020","September 10, 2021"
1331,NCT04466462,Completed,No Results Available,SARS-CoV-2 Infection,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Other,"May 26, 2020","June 30, 2020"
1332,NCT04424134,Recruiting,No Results Available,COVID 19,Drug: Bromhexine and Spironolactone|Drug: Base therapy,All,"Adult, Older Adult",Phase 3,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 16, 2020","August 23, 2020"
1333,NCT04779021,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Other: Hospitalisation for SARS-COV2 infection,All,"Adult, Older Adult",,1300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 15, 2020","December 31, 2022"
1334,NCT04303507,Recruiting,No Results Available,COVID19|Coronavirus|Acute Respiratory Illnesses,Drug: Chloroquine or Hydroxychloroquine|Drug: Placebo,All,"Child, Adult, Older Adult",Not Applicable,40000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","April 29, 2020",April 2021
1335,NCT04756479,Completed,No Results Available,"Covid19|Old Age; Debility|Morbidity, Multiple",,All,Older Adult,,160.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 1, 2020","June 30, 2020"
1336,NCT04570202,Recruiting,No Results Available,"Depression|Burnout, Professional|Post Traumatic Stress Disorder",Behavioral: EMDR,All,"Adult, Older Adult",Not Applicable,900.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 20, 2020","August 20, 2022"
1337,NCT04407143,Recruiting,No Results Available,Lung Cancer|COVID|Corona Virus Infection,Diagnostic Test: IgG test,All,"Adult, Older Adult",,128.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","September 30, 2021"
1338,NCT04423770,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Other: No intervention,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"June 8, 2020","June 8, 2021"
1339,NCT04410562,Recruiting,No Results Available,Pregnancy Related|COVID|Covid-19,Drug: Hydroxychloroquine|Drug: Placebo,Female,"Child, Adult, Older Adult",Phase 3,714.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 13, 2020","August 1, 2021"
1340,NCT04727424,Recruiting,No Results Available,Covid19|SARS-Associated Coronavirus,Drug: Fluvoxamine Maleate 100 MG [Luvox]|Drug: Metformin Extended Release Oral Tablet|Drug: Ivermectin oral tablets or sublingual waffles|Drug: Placebo,All,"Adult, Older Adult",Phase 3,2724.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 19, 2021","March 1, 2022"
1341,NCT04504240,"Active, not recruiting",No Results Available,Covid19,Drug: Famotidine 20 MG,All,"Child, Adult, Older Adult",Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","April 10, 2021"
1342,NCT04389554,Completed,No Results Available,COVID-19|D-dimer,Other: Blood D-dimer assay,Female,Adult,,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 14, 2020","May 29, 2020"
1343,NCT04371640,Withdrawn,No Results Available,SARS-CoV-2|Covid-19,Drug: Sirolimus 1 MG/ML|Drug: Placebo,All,"Adult, Older Adult",Phase 1,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 6, 2020",August 2021
1344,NCT04384900,Recruiting,No Results Available,COVID-19,Procedure: Prone position ventilation,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 11, 2020",December 2020
1345,NCT04395664,Completed,No Results Available,COVID-19,Device: C3+ Holter Monitor,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","September 1, 2020"
1346,NCT04542954,Completed,No Results Available,"Covid19|Kidney Transplant Infection|Risk Factor, Cardiovascular|Immunosuppression|Outcome, Fatal|Graft Failure",Other: Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience from the Middle East,,"Child, Adult, Older Adult",,104.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 1, 2020","August 31, 2020"
1347,NCT04762680,"Active, not recruiting",No Results Available,COVID-19 (Healthy Volunteers),Biological: SARS-CoV-2 recombinant protein vaccine Formulation 1|Biological: SARS-CoV-2 recombinant protein vaccine Formulation 2|Biological: SARS-CoV-2 recombinant protein vaccine Formulation 3,All,"Adult, Older Adult",Phase 2,722.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 24, 2021",April 2022
1348,NCT04395976,Withdrawn,No Results Available,Covid-19,Other: Ayurveda,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 10, 2020","September 1, 2020"
1349,NCT04641806,Not yet recruiting,No Results Available,B-cell Lymphoma|Covid19,,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"December 15, 2020","September 16, 2021"
1350,NCT04583956,Recruiting,No Results Available,COVID-19,Other: Placebo|Drug: Remdesivir|Biological: Risankizumab,All,"Adult, Older Adult",Phase 2,200.0,NIH|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 14, 2020","December 31, 2021"
1351,NCT04414904,Withdrawn,No Results Available,"Infertility, Male|Testosterone Deficiency",Other: Exposure: Covid-19 infection,Male,Adult,,0.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 10, 2020","June 10, 2020"
1352,NCT04638842,Recruiting,No Results Available,Grief|Anxiety|Depression|Sleep Disturbance|Quality of Life,Behavioral: Online Intervention Grief COVID-19,All,Adult,Not Applicable,42.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"December 24, 2020","June 1, 2021"
1353,NCT04726137,Not yet recruiting,No Results Available,Sars-Cov2 Antibodies in Children and Adolescents Living With HIV,,All,"Child, Adult",,1150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2021","April 30, 2022"
1354,NCT04382495,Recruiting,No Results Available,Cancer,Other: survey,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 15, 2020","June 1, 2021"
1355,NCT04628143,Not yet recruiting,No Results Available,COVID-19,Drug: Nafamostat Mesilate,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 20, 2020","June 30, 2021"
1356,NCT04331665,Not yet recruiting,No Results Available,COVID-19|Pneumonia,Drug: Ruxolitinib,All,"Child, Adult, Older Adult",Not Applicable,64.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","January 31, 2021"
1357,NCT04428801,Not yet recruiting,No Results Available,COVID-19,Biological: autologous adipose-derived stem cells,All,"Adult, Older Adult",Phase 2,200.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2021","June 15, 2024"
1358,NCT04320732,Recruiting,No Results Available,Coronavirus,Behavioral: Observation of behavior and COVID-19 infection will be conducted.,All,"Adult, Older Adult",,250000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 27, 2020","March 20, 2030"
1359,NCT04728919,Recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 15, 2021","January 15, 2024"
1360,NCT04408235,Not yet recruiting,No Results Available,"COVID|Pneumonia, Viral|Coagulation Disorder",Drug: Enoxaparin,All,"Adult, Older Adult",Phase 3,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,June 2020,June 2021
1361,NCT04521010,Completed,No Results Available,COVID-19 Pandemic,Other: COVID-19 pandemic,All,"Child, Adult, Older Adult",,700.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 1, 2020","April 30, 2020"
1362,NCT04623047,Not yet recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,100000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"July 1, 2021","February 1, 2023"
1363,NCT04312997,Recruiting,No Results Available,COVID-19,Drug: PUL-042 Inhalation Solution|Drug: Placebo,All,"Adult, Older Adult",Phase 2,100.0,Industry|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 16, 2020",May 2021
1364,NCT04655612,Recruiting,No Results Available,COVID-19|SARS-CoV Infection|Rheumatoid Arthritis|Spondyloarthritis|Ankylosing Spondylitis|Psoriatic Arthritis,,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 1, 2020","July 30, 2021"
1365,NCT04346589,Recruiting,No Results Available,"Pneumonia, Ventilator-Associated|Coronavirus Infection",Biological: Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020",August 2020
1366,NCT04497987,Recruiting,No Results Available,COVID-19|SARS-CoV2,Drug: LY3819253|Drug: Placebo|Drug: LY3832479,All,"Adult, Older Adult",Phase 3,5000.0,Industry|NIH|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","August 2, 2020","June 29, 2021"
1367,NCT04481685,"Active, not recruiting",No Results Available,Covid19,Drug: ATI-450|Drug: Placebo,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","July 20, 2020",July 2022
1368,NCT04329832,"Active, not recruiting",No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Adult, Older Adult",Phase 2,85.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 30, 2020","December 31, 2021"
1369,NCT04757831,Not yet recruiting,No Results Available,Covid19; MIS-C,,All,"Child, Adult",,1000000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2021","February 15, 2026"
1370,NCT04703205,Recruiting,No Results Available,Covid19,Drug: Ivermectin 3 MG|Drug: Placebo,All,"Adult, Older Adult",Phase 2,240.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 16, 2020","September 30, 2021"
1371,NCT04498065,"Active, not recruiting",No Results Available,Covid19|Non Ischemic Myocardial Injury|Myocardial Infarction|Myocarditis|Troponin Elevation,Biological: Biological data|Other: Clinical data,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020",July 2021
1372,NCT04545060,"Active, not recruiting",No Results Available,Covid19,Biological: VIR-7831|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,1360.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 27, 2020",July 2021
1373,NCT04716088,Completed,No Results Available,SARS-CoV-2 Rapid Antigen Test,Diagnostic Test: Rapid antigen test for SARS CoV2,All,"Adult, Older Adult",,36.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"November 18, 2020","December 22, 2020"
1374,NCT04371107,Not yet recruiting,No Results Available,Covid19|Azithromycin|Ambulatory,Other: consultation|Drug: Azithromycin,All,"Adult, Older Adult",Phase 3,64.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 29, 2020",July 2020
1375,NCT04651374,Not yet recruiting,No Results Available,Covid19,Device: geko T3,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,December 2020,April 2021
1376,NCT04374487,"Active, not recruiting",No Results Available,COVID 19,Drug: Convalescent Plasma|Other: Standard Care Therapy,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 9, 2020","August 9, 2021"
1377,NCT04647305,"Active, not recruiting",No Results Available,SARS-CoV-2 Infection,Other: Closed face shield with Surgical face mask use|Other: Surgical face mask use only,All,"Adult, Older Adult",Not Applicable,233.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 16, 2021",March 2021
1378,NCT04770649,Recruiting,No Results Available,Vaccine Response Impaired|Vaccine Adverse Reaction,Biological: COVID-19 vaccine,All,"Adult, Older Adult",,10000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,December 2023
1379,NCT04350671,Enrolling by invitation,No Results Available,COVID-19,Drug: Interferon Beta-1A|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine,All,"Adult, Older Adult",Phase 4,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 15, 2020","April 24, 2020"
1380,NCT04567953,"Active, not recruiting",No Results Available,Covid19,Other: Saliva collection,All,"Adult, Older Adult",Not Applicable,2000.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"July 28, 2020","June 27, 2021"
1381,NCT04382391,Recruiting,No Results Available,"COVID|Corona Virus Infection|Respiratory Failure|Respiratory Distress Syndrome, Adult|ARDS, Human|SARS (Severe Acute Respiratory Syndrome)",Device: gammaCore® Sapphire (non-invasive vagus nerve stimulator)|Other: Standard of care therapies,All,"Adult, Older Adult",Not Applicable,60.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","June 30, 2022"
1382,NCT04382651,"Active, not recruiting",No Results Available,"COVID-19 Pneumonia, Impaired Respiratory Function",Drug: MAS825|Drug: Matching placebo,All,"Adult, Older Adult",Phase 2,140.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 7, 2020","April 14, 2021"
1383,NCT04566965,Recruiting,No Results Available,Covid19|Coronavirus|SARS-CoV Infection,Diagnostic Test: SARS-CoV-2,All,"Adult, Older Adult",,230.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"August 18, 2020","December 31, 2023"
1384,NCT04577105,Completed,No Results Available,"Covid19|ARDS|Pneumonia, Viral|Computed Tomography",Diagnostic Test: Simple chest tomography,All,"Child, Adult, Older Adult",,233.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","October 1, 2020"
1385,NCT04415086,Recruiting,No Results Available,COVID-19,Biological: convalescent plasma,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","May 22, 2022"
1386,NCT04631861,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,132069.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"January 1, 2014","July 31, 2020"
1387,NCT04426279,Recruiting,No Results Available,Sars-CoV2|Rheumatoid Arthritis|Rheumatic Diseases,Other: questionnaire assesment,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 18, 2020",February 2021
1388,NCT04691908,"Active, not recruiting",No Results Available,Covid19|SARS-CoV Infection|Vaccine Adverse Reaction,Biological: QazCovid-in®-vaccine against COVID-19|Other: Placebo,All,"Adult, Older Adult",Phase 3,3000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"December 25, 2020","July 30, 2021"
1389,NCT04718220,Recruiting,No Results Available,Covid19|Pregnancy Related|Maternal Complication of Pregnancy|Coronavirus|Neonatal Infection|Prenatal Stress|Preterm Birth,Diagnostic Test: Antibody testing for SARS-CoV-2 IgG|Diagnostic Test: Testing for SARS-CoV-2 RNA|Diagnostic Test: Testing for SARS-CoV-2 IgM/IgG,Female,"Child, Adult, Older Adult",Not Applicable,420.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 1, 2021",November 2022
1390,NCT04564287,Enrolling by invitation,No Results Available,COVID-19,,All,"Adult, Older Adult",,100.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 28, 2020","December 1, 2022"
1391,NCT04382586,"Active, not recruiting",No Results Available,COVID-19 Pulmonary Complications|COVID-19,Drug: Zanubrutinib|Drug: Supportive Care|Drug: Placebo,All,"Adult, Older Adult",Phase 2,93.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 6, 2020","April 30, 2021"
1392,NCT04365439,"Active, not recruiting",No Results Available,Blood Plasma Therapy|COVID,Biological: Blood plasma,All,"Adult, Older Adult",Not Applicable,11.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 20, 2020","June 30, 2021"
1393,NCT04444310,"Active, not recruiting",No Results Available,COVID-19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2020","September 30, 2020"
1394,NCT04724395,Not yet recruiting,No Results Available,COVID-19,Other: Hospitalization,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,January 2021,January 2023
1395,NCT04554264,Recruiting,No Results Available,Complicated Grief|Intensive Care|Covid19,Other: questionnaire,All,"Adult, Older Adult",Not Applicable,160.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"September 1, 2020",September 2022
1396,NCT04508985,Not yet recruiting,No Results Available,COVID-19|Cardiovascular Diseases,Other: Temporarily holding the RAAS inhibitor [intervention]|Other: RAAS inhibitor [continued standard of care],All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","September 1, 2021"
1397,NCT04629638,Completed,No Results Available,"Covid19|Depression, Anxiety|Pregnancy Related","Other: Maternal attachment, Edinburgh depression scoring and postpartum anxiety scale scores",Female,Adult,,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"August 1, 2020","November 20, 2020"
1398,NCT04509999,Recruiting,No Results Available,COVID-19,Drug: Bicalutamide 150 Mg Oral Tablet|Drug: Placebo,Male,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 26, 2020",September 2022
1399,NCT04563689,Completed,No Results Available,Covid19,Other: CHX0.12+CPC0.05 oral rinse (PerioAidActive Control)|Other: placebo rinse,All,"Adult, Older Adult",Not Applicable,23.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,"June 18, 2020","October 23, 2020"
1400,NCT04840459,Recruiting,No Results Available,Covid19,Biological: BAMLANIVIMAB|Biological: CASIRIVIMAB|Biological: IMDEVIMAB,All,"Child, Adult, Older Adult",Phase 2,1000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 20, 2020","January 31, 2022"
1401,NCT04331171,Completed,No Results Available,COVID-19,Device: Web application users,All,"Adult, Older Adult",,12000000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 17, 2020","November 15, 2020"
1402,NCT04559009,Recruiting,No Results Available,Covid19|Amyotrophic Lateral Sclerosis,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 15, 2020","April 30, 2024"
1403,NCT04445233,"Active, not recruiting",No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,315.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020",June 2021
1404,NCT04527614,Enrolling by invitation,No Results Available,"Influenza, Human|SARS Virus|COVID-19|Espiratory Tract Infections",Diagnostic Test: qRT-PCR and serology,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,"Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic","September 24, 2020","May 30, 2021"
1405,NCT04447144,Recruiting,No Results Available,Covid19|Chronic Inflammation|Non-Communicable Chronic Diseases,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","September 1, 2020"
1406,NCT04704388,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,478.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020","October 1, 2020"
1407,NCT04386083,Recruiting,No Results Available,Coronavirus Disease 2019,,All,"Adult, Older Adult",,1342.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 10, 2020",March 2021
1408,NCT04673162,Not yet recruiting,No Results Available,Covid19,"Drug: Methylprednisolone, Placebo",All,"Adult, Older Adult",Phase 3,260.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",December 2020,June 2021
1409,NCT04501783,"Active, not recruiting",No Results Available,COVID-19,Drug: Favipiravir|Drug: Standard of care (SOC)|Drug: standard concomitant therapy,All,Adult,Phase 3,168.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020",August 2020
1410,NCT04482621,Recruiting,No Results Available,COVID-19,Drug: Decitabine|Other: Placebo Saline,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 14, 2020",July 2021
1411,NCT04828135,Not yet recruiting,No Results Available,Covid19,Drug: Hyperpolarized 129Xenon gas,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 29, 2021","December 30, 2022"
1412,NCT04648709,Recruiting,No Results Available,Covid19,Diagnostic Test: ELISPOT|Diagnostic Test: QUANTIFERON,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 9, 2021",December 2022
1413,NCT04338672,Recruiting,No Results Available,"Emergency Service, Hospital|General Surgery",Other: COVID-19 Pandemic,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 5, 2020","April 1, 2022"
1414,NCT04836754,Not yet recruiting,No Results Available,Covid19|Human Milk,,Female,Adult,,30.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"May 1, 2021","September 1, 2021"
1415,NCT04343248,"Active, not recruiting",No Results Available,COVID-19|Viral Respiratory Illnesses,Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,All,"Adult, Older Adult",Phase 3,800.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","May 12, 2020","June 30, 2021"
1416,NCT04488562,Recruiting,No Results Available,COVID-19|Pulmonary Fibrosis,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 8, 2020","December 31, 2021"
1417,NCT04844242,Recruiting,No Results Available,SARS-CoV2 Infection|Multisystem Inflammatory Syndrome in Children,,All,Child,,180.0,Other|NIH,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"December 23, 2020","June 22, 2021"
1418,NCT04681001,Recruiting,No Results Available,Respiratory Viral Infection|Common Cold|Severe Acute Respiratory Syndrome (SARS) Pneumonia|COVID-19|Corona Virus Disease,Device: nasal spray,All,"Adult, Older Adult",Not Applicable,300.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 20, 2020","June 30, 2021"
1419,NCT04423692,Recruiting,No Results Available,Viral Infection,Other: labs,Female,Adult,,30.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 1, 2020","August 20, 2020"
1420,NCT04459312,Recruiting,No Results Available,Antibody COVID-19,Diagnostic Test: Antibody test (SARS-CoV2),All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","September 30, 2020"
1421,NCT04361500,Recruiting,No Results Available,COVID-19,Device: Seraph 100,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 15, 2020","October 1, 2021"
1422,NCT04326036,Recruiting,No Results Available,Pulmonary Alveolar Proteinosis|COPD|Idiopathic Pulmonary Fibrosis|Viral Pneumonia|Coronavirus Infection|Interstitial Lung Disease,Procedure: Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)|Device: Centricyte 1000|Procedure: IV Deployment Of cSVF In Sterile Normal Saline IV Solution|Drug: Liberase Enzyme (Roche)|Drug: Sterile Normal Saline for Intravenous Use,All,"Adult, Older Adult",Early Phase 1,10.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 25, 2020","December 31, 2021"
1423,NCT04332991,Completed,Has Results,Coronavirus|Acute Respiratory Infection|SARS-CoV Infection,Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,479.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 2, 2020","July 23, 2020"
1424,NCT04401475,Recruiting,No Results Available,COVID-19|ARDS,Biological: SOC plus 15mg/kg EB05 IV|Other: SOC plus Placebo IV,All,"Adult, Older Adult",Phase 2,396.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 25, 2020",April 2021
1425,NCT04581928,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"October 10, 2020","April 15, 2021"
1426,NCT04771351,Recruiting,No Results Available,Covid19,Biological: COVI-AMG|Drug: Placebo,All,"Adult, Older Adult",Phase 2,280.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,October 2021
1427,NCT04405102,Recruiting,No Results Available,COVID-19,Drug: Ozanimod|Other: Standard of care,All,"Adult, Older Adult",Phase 2,48.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 16, 2020","January 1, 2024"
1428,NCT04331509,Recruiting,No Results Available,COVID-19,Other: No Intervention,All,"Adult, Older Adult",,10000000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2020","March 23, 2022"
1429,NCT04742569,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,2352.0,Industry|Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 21, 2020",December 2021
1430,NCT04544605,Recruiting,No Results Available,Post COVID-19,Other: Individualized-Chinese herbal medicine,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"September 7, 2020","December 31, 2021"
1431,NCT04540484,Recruiting,No Results Available,Covid19|SARS-CoV Infection|Communicable Disease,,All,"Adult, Older Adult",,900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 26, 2020","September 24, 2021"
1432,NCT04534673,Recruiting,No Results Available,COVID-19,Drug: Lambda 180 mcg S.C,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 5, 2020","December 31, 2021"
1433,NCT04425317,Recruiting,No Results Available,Infertility|COVID|IVF,Diagnostic Test: Blood sample,Female,"Child, Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 24, 2020","June 15, 2021"
1434,NCT04614948,Recruiting,No Results Available,Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19,Biological: Ad26.COV2.S|Other: Placebo,All,"Adult, Older Adult",Phase 3,30000.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","November 16, 2020","May 23, 2023"
1435,NCT04473118,Recruiting,No Results Available,COVID-19,Other: Survey,All,"Adult, Older Adult",,25000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 11, 2020",June 2021
1436,NCT04756466,"Active, not recruiting",No Results Available,SARS CoV-2 Infection|Elderly,Dietary Supplement: Placebo|Dietary Supplement: Lactobacillus,All,"Adult, Older Adult",Not Applicable,201.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","January 1, 2021","December 31, 2021"
1437,NCT04510038,Suspended,No Results Available,Covid19|Myocardial Injury,Drug: Colchicine|Other: Covid-19 Standard of Care,All,"Adult, Older Adult",Phase 2|Phase 3,75.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 1, 2020","January 1, 2022"
1438,NCT04432350,"Active, not recruiting",No Results Available,COVID|Drug Effect|Drug Interaction|Risk Reduction,,All,"Child, Adult, Older Adult",,50000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 15, 2020","May 31, 2022"
1439,NCT04699851,Recruiting,No Results Available,COVID19|Tailored Recommendations|Citizen Self-reported Symptoms,Behavioral: Tailored recommendations|Behavioral: General recommendation,All,"Adult, Older Adult",Not Applicable,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"November 18, 2020","May 18, 2021"
1440,NCT04734860,Recruiting,No Results Available,Covid19,Biological: COVI-AMG|Drug: Placebo,All,"Adult, Older Adult",Phase 2,500.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",April 2021,November 2021
1441,NCT04391309,Recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19)|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Biological: anti-CD14|Other: Placebo|Drug: remdesivir,All,"Adult, Older Adult",Phase 2,300.0,NIH|Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 12, 2021",February 2022
1442,NCT04552366,"Active, not recruiting",No Results Available,COVID-19,Biological: Ad5-nCoV,All,"Adult, Older Adult",Phase 1,149.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 29, 2020","June 30, 2021"
1443,NCT04816682,Recruiting,No Results Available,Covid19|Liver Diseases,Drug: Silymarin,All,"Adult, Older Adult",Phase 4,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 17, 2021","December 30, 2021"
1444,NCT04361344,Terminated,No Results Available,COVID-19 Infection|Encephalitis,Biological: blood samples,All,"Adult, Older Adult",Not Applicable,2.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 19, 2020","October 25, 2020"
1445,NCT04747769,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,February 2021,October 2021
1446,NCT04689711,Enrolling by invitation,No Results Available,Covid19,,All,"Adult, Older Adult",,16.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 7, 2020","August 31, 2021"
1447,NCT04743388,Recruiting,No Results Available,COVID-19|Healthy Volunteers|Chronic Disease|Hematological Malignancies|Solid Tumor,Biological: BNT162b2|Biological: Other vaccine against SARS-Cov-2,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 4, 2021",April 2022
1448,NCT04439045,"Active, not recruiting",No Results Available,SARS-CoV-2 Infection,Biological: VPM1002|Other: Placebo,All,"Adult, Older Adult",Phase 3,122.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention","June 24, 2020","December 1, 2021"
1449,NCT04655638,Recruiting,No Results Available,Covid19|Acute Respiratory Failure,Device: High Flow Nasal Therapy|Device: Conventional Oxygen Therapy,All,"Adult, Older Adult",Not Applicable,364.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 10, 2021","March 1, 2022"
1450,NCT04414267,Recruiting,No Results Available,COVID-19|Virus Diseases|Corona Virus Infection|Coronary Heart Disease|Chronic Obstructive Pulmonary Disease,Biological: BCG vaccine|Biological: Placebo,All,"Adult, Older Adult",Phase 4,900.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 26, 2020","May 25, 2021"
1451,NCT04584710,"Active, not recruiting",No Results Available,Covid19,Drug: RTB101|Drug: Placebo,All,Older Adult,Phase 2,60.0,Industry|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 13, 2020",February 2021
1452,NCT04709068,Recruiting,No Results Available,Covid19,Device: Current Health,All,"Adult, Older Adult",,2050.0,Industry|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 8, 2021","July 1, 2021"
1453,NCT04314232,Recruiting,No Results Available,COVID|Coronavirus Infection,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 18, 2020","December 31, 2021"
1454,NCT04718480,Recruiting,No Results Available,Covid19,Drug: Placebo|Drug: Fluvoxamine,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 27, 2020",December 2021
1455,NCT04328129,Recruiting,No Results Available,Coronavirus Infections|Severe Acute Respiratory Syndrome|SARS-CoV Infection,Procedure: Human biological samples,All,"Child, Adult, Older Adult",Not Applicable,1300.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"March 23, 2020","March 23, 2022"
1456,NCT04383587,Completed,No Results Available,SARS-CoV 2|COVID-19,Other: Serologic testing,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 6, 2020","July 31, 2020"
1457,NCT04788459,Recruiting,No Results Available,COVID-19|Protection Against COVID-19 and Infections With SARS-CoV- 2|COVID-19 Immunisation,Biological: COVID-eVax|Device: Cliniporator® and EPSGun,All,"Adult, Older Adult",Phase 1|Phase 2,160.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 25, 2021",June 2022
1458,NCT04499300,Recruiting,No Results Available,Covid19,Other: Data collection from medical files,All,Older Adult,,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 9, 2020",December 2020
1459,NCT04311697,Completed,No Results Available,Critical COVID-19 With Respiratory Failure|Acute Respiratory Distress Syndrome (ARDS)|Corona Virus Infection|Acute Lung Injury,Drug: Aviptadil by intravenous infusion + standard of care|Drug: Normal Saline Infusion + standard of care,All,"Adult, Older Adult",Phase 2|Phase 3,196.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 15, 2020","February 22, 2021"
1460,NCT04510441,Recruiting,No Results Available,Coronavirus,Other: Nil intervention,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 26, 2020","May 1, 2022"
1461,NCT04406038,"Active, not recruiting",No Results Available,COVID19,,All,"Adult, Older Adult",,1038.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 27, 2020","October 28, 2021"
1462,NCT04824651,Not yet recruiting,No Results Available,Immune Deficiency,Biological: COVID-19 vaccine,All,"Adult, Older Adult",,10500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 25, 2021","September 25, 2024"
1463,NCT04448145,Recruiting,No Results Available,COVID-19|Corona Virus Infection|SARS-CoV 2,,All,"Child, Adult, Older Adult",,325.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 26, 2020","May 1, 2022"
1464,NCT04403243,Recruiting,No Results Available,COVID 19,Drug: Colchicine|Drug: Ruxolitinib 5 MG|Drug: Secukinumab 150 MG/ML Subcutaneous Solution [COSENTYX]|Other: standard therapy,All,"Adult, Older Adult",Phase 2,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","August 23, 2020"
1465,NCT04360707,Recruiting,No Results Available,SARS-CoV-2,,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 8, 2020","April 8, 2021"
1466,NCT04828161,Not yet recruiting,No Results Available,COVID-19,Drug: ensovibep|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,2100.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 15, 2021",June 2022
1467,NCT04621149,Recruiting,No Results Available,COVID-19,"Other: chlorine dioxide|Dietary Supplement: zinc acetate|Drug: Famotidine|Other: placebo|Dietary Supplement: lactoferrin, green tea extract",All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 15, 2020","March 31, 2021"
1468,NCT04394208,Recruiting,No Results Available,COVID-19|Viral Pneumonia Human Coronavirus,Drug: Silymarin|Drug: Placebo,All,"Adult, Older Adult",Phase 3,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","August 16, 2020","February 28, 2021"
1469,NCT04470609,Enrolling by invitation,No Results Available,COVID-19,Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Placebo on a 0- and 28-day schedule,All,"Adult, Older Adult",Phase 1|Phase 2,471.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 10, 2020",November 2021
1470,NCT04478019,Recruiting,No Results Available,COVID-19|SARS-CoV 2,Drug: 10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse,All,"Adult, Older Adult",Early Phase 1,250.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 7, 2020","April 30, 2022"
1471,NCT04313322,Recruiting,No Results Available,Use of Stem Cells for COVID-19 Treatment,Biological: WJ-MSCs,All,"Adult, Older Adult",Phase 1,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 16, 2020","September 30, 2020"
1472,NCT04411680,"Active, not recruiting",No Results Available,COVID-19|Sars-CoV2,Drug: Sargramostim|Drug: Standard of care,All,"Adult, Older Adult",Phase 2,122.0,Industry|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 18, 2020",May 2021
1473,NCT04348435,"Active, not recruiting",No Results Available,COVID-19,Drug: HB-adMSCs|Drug: Placebos,All,"Child, Adult, Older Adult",Phase 2,100.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 14, 2020","July 30, 2021"
1474,NCT04378777,"Active, not recruiting",No Results Available,Coronavirus Disease 2019 (COVID-19)|SARS-CoV-2,Procedure: Biological sample collection|Procedure: Data Collection: Clinical Care Assessments,All,"Adult, Older Adult",,1227.0,NIH|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020",March 2022
1475,NCT04351646,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","April 15, 2022"
1476,NCT04538469,Not yet recruiting,No Results Available,Cardiovascular Diseases|Delirium|Critical Illness|Intensive Care Unit Delirium|Thoracic Diseases|Respiratory Failure|Cardiac Disease|Cardiac Failure,Other: COVID visitation restrictions,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,September 2020,December 2021
1477,NCT04632043,Recruiting,No Results Available,COVID-19|Acute Hypoxemic Respiratory Failure,Other: Endotracheal intubation,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 18, 2020","June 1, 2021"
1478,NCT04370015,Not yet recruiting,No Results Available,SARS-CoV-2|Healthcare Workers,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,Adult,Not Applicable,374.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 15, 2020","October 15, 2020"
1479,NCT04703777,Recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 4, 2020","April 4, 2021"
1480,NCT04345315,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Other: serological test|Other: Rapid molecular test|Genetic: Next generation Sequencing (NGS) analysis|Other: serum chemistry analysis,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 27, 2020",March 2022
1481,NCT04452669,Recruiting,No Results Available,COVID-19,Drug: VentaProst (inhaled epoprostenol delivered via a dedicated delivery system),All,"Adult, Older Adult",Phase 2,20.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 15, 2020","September 1, 2021"
1482,NCT04357834,Recruiting,No Results Available,COVID|COVID 19|SARS-CoV 2,Other: Equipment with smartwatch throughout hospital stay on the general ward,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 1, 2020","December 31, 2021"
1483,NCT04410510,Recruiting,No Results Available,COVID|Coronavirus Infection|SARS-CoV 2|COVID19,Drug: P2Et (Caesalpinia spinosa extract)|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care","September 30, 2020",June 2021
1484,NCT04551378,Recruiting,No Results Available,COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Other: Quality-of-Life Assessment|Other: Survey Administration,All,Adult,,600.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 13, 2020","December 31, 2021"
1485,NCT04421612,Recruiting,No Results Available,Covid19|Anxiety,Behavioral: Co-mestring (co-coping),All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 2, 2020","December 31, 2021"
1486,NCT04366024,Recruiting,No Results Available,COVID-19 Disease|Nomogram Model,Other: other,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"January 17, 2020","December 31, 2021"
1487,NCT04534608,"Active, not recruiting",No Results Available,SARS-CoV-2|Covid19,,All,"Child, Adult",,6000.0,Other,Observational,Observational Model: Family-Based|Time Perspective: Prospective,"May 11, 2020","March 31, 2021"
1488,NCT04806529,Withdrawn,No Results Available,Influenza,Drug: Adjuvanted SARS-CoV-2 Subunit vaccine (aCoV2)|Drug: Comparator,All,"Adult, Older Adult",Phase 2|Phase 3,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","December 15, 2020","April 9, 2022"
1489,NCT04371835,Recruiting,No Results Available,HIV-infection/Aids|Coronavirus Infection,,All,"Adult, Older Adult",,1500.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 12, 2020","December 31, 2021"
1490,NCT04401033,Completed,No Results Available,SARS-CoV 2|COVID,Behavioral: Telephonic medical visit|Procedure: Gastrointestinal endoscopy|Procedure: Abdominal ultrasound,All,"Adult, Older Adult",,450.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","June 30, 2020"
1491,NCT04708327,Not yet recruiting,No Results Available,Covid19,Drug: Naltrexone Hydrochloride,All,"Adult, Older Adult",Phase 2,75.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,April 2022
1492,NCT04644341,Recruiting,No Results Available,COVID-19,Combination Product: cardiovascular and respiratory systems monitoring,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"January 15, 2021","November 1, 2021"
1493,NCT04344600,Recruiting,No Results Available,Sars-CoV2,Drug: Peginterferon lambda alfa-1a subcutaneous injection|Other: Saline,All,"Adult, Older Adult",Phase 2,164.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"May 29, 2020",December 2021
1494,NCT04500626,Not yet recruiting,No Results Available,Covid19,Drug: Oxygen,All,"Adult, Older Adult",Phase 2|Phase 3,234.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,April 2021,August 2022
1495,NCT04484545,"Active, not recruiting",No Results Available,COVID-19,Diagnostic Test: Prognostic score,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","June 1, 2021"
1496,NCT04659889,Recruiting,No Results Available,Long Covid|Covid19,Diagnostic Test: Blood sampling (venesection),All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,December 2020,June 2021
1497,NCT04632537,Withdrawn,No Results Available,COVID-19,Drug: Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine|Drug: Preservative-free saline,All,Adult,Phase 3,0.0,Other|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","December 7, 2020","March 23, 2021"
1498,NCT04388410,Recruiting,No Results Available,COVID-19,Biological: convalescent plasma,All,"Adult, Older Adult",Phase 2|Phase 3,410.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 25, 2020","December 31, 2020"
1499,NCT04598347,Recruiting,No Results Available,Covid19|Pregnancy Related,,Female,"Adult, Older Adult",,225.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"August 8, 2020","January 23, 2022"
1500,NCT04668170,Recruiting,No Results Available,COVID-19,Biological: Blood collection on admission and longitudinally|Biological: Blood collection on their first consultation and 10 to 14 days later,All,"Adult, Older Adult",,340.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 5, 2020","December 31, 2021"
1501,NCT04517136,Recruiting,No Results Available,"Covid19|SARS-CoV Infection|Burnout, Caregiver|Burnout, Professional",Behavioral: Assessment of work-related stress|Biological: Saliva sample collection|Device: Cardiac and electrodermal recordings|Behavioral: Assessment of behavioral response to emotional stimulation,All,Adult,,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 14, 2020","March 14, 2021"
1502,NCT04472585,Recruiting,No Results Available,Coronavirus Infection|COVID|Sars-CoV2,Drug: Ivermectin Injectable Solution|Other: Injectable Placebo|Drug: Zinc|Drug: Placebo empty capsule|Drug: Oral Ivermectin,All,Adult,Phase 1|Phase 2,180.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 14, 2020","October 30, 2021"
1503,NCT04472572,Available,No Results Available,COVID-19,Biological: Convalescent Plasma,All,"Adult, Older Adult",,,Other,Expanded Access:Treatment IND/Protocol,,,
1504,NCT04434131,Recruiting,No Results Available,COVID-19,Drug: Convalescent Plasma,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 28, 2020","April 28, 2025"
1505,NCT04629183,Recruiting,No Results Available,Covid19,Other: integrated clinical evaluation,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 1, 2020","July 31, 2021"
1506,NCT04686773,Not yet recruiting,No Results Available,COVID-19,Biological: AZD1222|Biological: rAd26-S,All,"Adult, Older Adult",Phase 2,100.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 10, 2021","September 20, 2021"
1507,NCT04596839,Recruiting,No Results Available,Covid19,Drug: Remdesivir|Other: Standard of Care,All,"Adult, Older Adult",Not Applicable,60.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 4, 2020","April 30, 2021"
1508,NCT04789512,Completed,No Results Available,Covid19,Other: Respiratory functions,Female,"Child, Adult",,42.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 1, 2021","March 29, 2021"
1509,NCT04685655,Recruiting,No Results Available,Therapeutic Plasma Exchange|Covid19,Other: Therapeutic plasma exchange,All,"Adult, Older Adult",Not Applicable,228.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 7, 2020","December 31, 2022"
1510,NCT04374591,"Active, not recruiting",No Results Available,Pneumonia|Covid19,Drug: Sodium Bicarbonate,All,"Adult, Older Adult",Not Applicable,180.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","November 1, 2020"
1511,NCT04803227,Recruiting,No Results Available,Covid19,Drug: Emricasan|Other: Placebo,All,"Adult, Older Adult",Phase 1,50.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","March 11, 2021",June 2021
1512,NCT04479124,Completed,No Results Available,Trauma|Covid19,Diagnostic Test: COVID-19 PCR,All,"Child, Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 10, 2020","July 14, 2020"
1513,NCT04836767,"Active, not recruiting",No Results Available,Corona Virus Infection|Covid19,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"February 16, 2021","February 1, 2022"
1514,NCT04560855,Recruiting,No Results Available,Covid19,Device: Connected devices measurements,All,"Adult, Older Adult",,400.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 14, 2020","September 14, 2021"
1515,NCT04705753,Completed,No Results Available,Covid19|Viral Infection|Respiratory Viral Infection,Dietary Supplement: Cretan IAMA,All,"Adult, Older Adult",Phase 2|Phase 3,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","October 15, 2020"
1516,NCT04386668,Terminated,No Results Available,COVID19,Other: Let It Out (LIO)-C|Other: Neutral writing control,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other","May 26, 2020","August 31, 2020"
1517,NCT04583761,"Active, not recruiting",No Results Available,COVID-19,Behavioral: questionnaire,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 12, 2020",March 2021
1518,NCT04706260,Recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"April 14, 2020","April 14, 2021"
1519,NCT04584437,Withdrawn,No Results Available,Covid19,Other: Infrared Energy and Dietary Supplement,All,"Child, Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 31, 2021","July 10, 2021"
1520,NCT04377815,Completed,No Results Available,COVID-19|Anosmia,Other: General Public cohort,All,"Adult, Older Adult",,569.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 23, 2020","June 24, 2020"
1521,NCT04386044,Not yet recruiting,No Results Available,COVID-19|Vitamin D Deficiency,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"June 1, 2020","June 1, 2021"
1522,NCT04560205,Recruiting,No Results Available,SARS-CoV Infection,Drug: Tocilizumab,All,"Child, Adult, Older Adult",Phase 1,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","December 30, 2020"
1523,NCT04375124,Recruiting,No Results Available,COVID-19,Biological: Biological/Vaccine: Angiotensin peptide (1-7) derived plasma,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 25, 2020","September 30, 2020"
1524,NCT04472078,Completed,No Results Available,SARS-CoV-2,Diagnostic Test: Serological Assay or IgG for SARS-CoV-2,All,"Child, Adult, Older Adult",,873.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 10, 2020","December 11, 2020"
1525,NCT04719182,"Active, not recruiting",No Results Available,"Covid19|Pneumonia|Thrombosis|Thromboembolism|Anticoagulants; Increased|ARDS, Human",Other: Adjunctive therapies,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"September 1, 2020","July 1, 2021"
1526,NCT04838795,Recruiting,No Results Available,SARS (Severe Acute Respiratory Syndrome),Biological: To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine,All,"Adult, Older Adult",Phase 3,500000.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 18, 2021","March 31, 2022"
1527,NCT04581031,Recruiting,No Results Available,COVID-19,Device: Continuous vital sign monitoring - Isansys Patient Status Engine|Other: Machine Learning/AI Algorithm,All,"Child, Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 11, 2020","February 1, 2021"
1528,NCT04701905,Recruiting,No Results Available,COVID-19 Pandemic,,All,"Adult, Older Adult",,450.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 30, 2020","April 30, 2021"
1529,NCT04350684,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,All,"Adult, Older Adult",Phase 4,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 15, 2020","April 24, 2020"
1530,NCT04473365,Recruiting,No Results Available,SARS-CoV-2|COVID-19,,All,"Child, Adult, Older Adult",,186.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 20, 2020","June 30, 2021"
1531,NCT04560231,Recruiting,No Results Available,SARS-CoV Infection,Drug: Remdesivir,All,"Child, Adult, Older Adult",Early Phase 1,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","November 30, 2020"
1532,NCT04841785,Not yet recruiting,No Results Available,Covid19|SARS-CoV Infection|Chronic Kidney Diseases,Diagnostic Test: mailer-based finger-prick,All,"Adult, Older Adult",,14300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 12, 2021","December 31, 2023"
1533,NCT04457570,Recruiting,No Results Available,"COVID, Cancer",Other: mortality,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"June 15, 2020","February 15, 2021"
1534,NCT04395807,Recruiting,No Results Available,COVID|Acute Hypoxemic Respiratory Failure,Device: Helmet CPAP|Device: HFNC,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 3, 2020",May 2021
1535,NCT04646525,Recruiting,No Results Available,Covid19|Immune Deficiency|Tonsillitis|Tonsil Hypertrophy|Adenoiditis|Adenoid Hypertrophy,Diagnostic Test: Physical examination,All,Child,,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"October 1, 2020","February 1, 2021"
1536,NCT04811339,Recruiting,No Results Available,Diarrhea|Covid-19,Drug: open label BSS (pepto Bismol),All,"Adult, Older Adult",Phase 4,35.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 2, 2020","August 31, 2023"
1537,NCT04753346,Not yet recruiting,No Results Available,COVID 19,Other: Physical Activity Level|Other: Anxiety and Depression Assessment|Diagnostic Test: Exercise Capacity|Diagnostic Test: Pulmonary Function Test|Diagnostic Test: Cardiopulmonary Fitness Level,All,"Adult, Older Adult",,240.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"February 15, 2021","January 1, 2023"
1538,NCT04347408,Completed,No Results Available,COVID|Corona Virus Infection,Diagnostic Test: Covid-19 Antibody testing (IgG and IgM),All,Child,,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 6, 2020","December 13, 2020"
1539,NCT04590586,Recruiting,No Results Available,COVID-19,Drug: Standard of care|Drug: Apremilast|Drug: Apremilast placebo|Drug: Lanadelumab|Drug: Lanadelumab placebo|Drug: Zilucoplan|Drug: Zilucoplan placebo,All,"Adult, Older Adult",Phase 3,1400.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 24, 2020","February 17, 2022"
1540,NCT04843917,Recruiting,No Results Available,Coronavirus 2019|Healthcare Workers|Vaccine,Diagnostic Test: Immunoglobulin G detection,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2021","August 9, 2022"
1541,NCT04535128,Recruiting,No Results Available,Covid19|Thrombosis Embolism|DVT|Pulmonary Embolism|Myocardial Infarction|Stroke,Other: No intervention,All,"Adult, Older Adult",,10000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 24, 2020","March 30, 2021"
1542,NCT04359914,Recruiting,No Results Available,Critical Illness|COVID-19|Central Nervous System Injury|Delirium|Encephalopathy,,All,"Child, Adult, Older Adult",,80.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 15, 2020","April 1, 2021"
1543,NCT04668222,Not yet recruiting,No Results Available,COVID19|Herbal Medicine,"Drug: Yu-Ping-Feng formula|Drug: Xiang-Sha-Liu-Jun formula|Drug: Liu-Wei-Di-Huang formula|Drug: Placebo for ""Deficiency of Qi and Yang""|Drug: Placebo for ""Deficiency of Qi and Yin""",All,"Adult, Older Adult",Phase 1|Phase 2,480.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 15, 2020","November 30, 2022"
1544,NCT04664010,"Active, not recruiting",No Results Available,COVID-19,"Drug: Alpha-interferon alpha, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste, fumigation/inhalation of vitamin C|Drug: Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and 5% glucose|Drug: Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and high-dose vitamin C treatment",All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 6, 2020","January 31, 2021"
1545,NCT04408014,Not yet recruiting,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: Serological test|Diagnostic Test: Nasopharyngeal Swab|Diagnostic Test: Oropharyngeal Swab,All,"Child, Adult, Older Adult",,18901.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 1, 2020","July 30, 2020"
1546,NCT04353284,Recruiting,No Results Available,COVID-19,Drug: Camostat Mesilate|Other: Placebo,All,"Adult, Older Adult",Phase 2,114.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 19, 2020","May 31, 2021"
1547,NCT04786808,Recruiting,No Results Available,COVID-19 Virus Infection|Population at Risk|Acute Respiratory Distress Syndrome,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 15, 2021","December 31, 2021"
1548,NCT04394429,Recruiting,No Results Available,Sars-CoV2,,All,"Adult, Older Adult",,184.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"April 24, 2020","June 24, 2021"
1549,NCT04707742,Completed,No Results Available,Covid19,Drug: Betadine© bucal 100 mg/ml|Drug: Oximen® 3%|Drug: Clorhexidine Dental PHB©|Drug: Vitis Xtra Forte©|Drug: Distilled Water,All,"Adult, Older Adult",Not Applicable,84.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 15, 2020","November 18, 2020"
1550,NCT04559113,Recruiting,No Results Available,SARS-CoV Infection|SARS (Severe Acute Respiratory Syndrome),Drug: Methylprednisolone Injectable Product,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","December 30, 2020"
1551,NCT04411459,Completed,No Results Available,COVID-19|Mechanical Ventilation|Quality of Life|Radiologic Increased Density of Lung|Sedation|Complication of Treatment,Other: Invasive mechanical ventilation,All,"Adult, Older Adult",,470.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2020","October 16, 2020"
1552,NCT04817397,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2021",August 2021
1553,NCT04524663,Recruiting,No Results Available,Covid19,Drug: Camostat Mesilate|Drug: Placebo|Other: Standard of Care Treatment,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 19, 2020",June 2021
1554,NCT04445610,Not yet recruiting,No Results Available,Coronavirus (COVID-19),,All,"Child, Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 1, 2020","November 1, 2020"
1555,NCT04474236,Recruiting,No Results Available,COVID-19|Acute Respiratory Failure|Triage|Lung Ultrasound|CT Scan,Other: thoracic lung ultrasound,All,"Child, Adult, Older Adult",,148.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 27, 2020","March 27, 2021"
1556,NCT04732637,Not yet recruiting,No Results Available,Covid19,"Diagnostic Test: Test At Home's Proprietary ""Lollipop"" Buccal Cavity Swab",All,"Adult, Older Adult",,300.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 31, 2021","August 31, 2021"
1557,NCT04629222,Completed,No Results Available,Ventilation Lung Scintigraphy During COVID-19 Infection,,All,"Child, Adult, Older Adult",,10.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 11, 2020","July 23, 2020"
1558,NCT04567979,"Active, not recruiting",No Results Available,Covid19|Cancer|Tumor,,All,"Child, Adult, Older Adult",,149.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 11, 2020","October 30, 2020"
1559,NCT04597034,Recruiting,No Results Available,Covid19|AKI,Procedure: AN69-Oxiris|Procedure: AN69-Standard,All,"Adult, Older Adult",Not Applicable,35.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"October 2, 2020","March 30, 2022"
1560,NCT04601012,Completed,No Results Available,Covid19,Diagnostic Test: Optical coherence tomography angiography,All,Adult,,40.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"September 20, 2020","October 22, 2020"
1561,NCT04429828,Not yet recruiting,No Results Available,Psychological Wellbeing,Other: COVID-19 e-package: Psychological wellbeing for healthcare workers,All,"Child, Adult, Older Adult",Not Applicable,45.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 13, 2020","December 30, 2020"
1562,NCT04651400,Recruiting,No Results Available,Covid19,Drug: Antithrombin III,All,"Child, Adult, Older Adult",,300.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 19, 2020",June 2021
1563,NCT04422873,Recruiting,No Results Available,End Stage Renal Disease|Sars-CoV2,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 3, 2020","January 1, 2021"
1564,NCT04377802,Not yet recruiting,No Results Available,COVID 19,Diagnostic Test: molecular testing for virus RNA using RT-PCR,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 17, 2020","December 30, 2020"
1565,NCT04343690,Withdrawn,No Results Available,COVID-19,Behavioral: Crisis management coaching,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 27, 2020","May 1, 2020"
1566,NCT04498936,Completed,No Results Available,COVID,Drug: Sofosbuvir and Ledipasvir|Drug: Nitazoxanide,All,"Child, Adult, Older Adult",Phase 4,240.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 15, 2020","October 30, 2020"
1567,NCT04568525,Completed,No Results Available,Covid19,Diagnostic Test: Passive Microwave Radiometry,All,"Adult, Older Adult",Not Applicable,195.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,"July 1, 2020","August 1, 2020"
1568,NCT04413955,Recruiting,No Results Available,COVID-19|SARS-CoV 2,Device: Seraph®-100 Microbind® Affinity Blood Filter,All,"Adult, Older Adult",,100.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","December 31, 2021"
1569,NCT04418284,Completed,No Results Available,COVID-19,Other: survey,All,"Child, Adult",,1517.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 5, 2020","November 5, 2020"
1570,NCT04843878,Completed,No Results Available,"Diagnostic Test, Routine|Coronavirus|Diagnoses Disease|Rapid Coronavirus Test",Diagnostic Test: COVID Detect,All,"Adult, Older Adult",,326.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"January 5, 2021","March 12, 2021"
1571,NCT04346264,Enrolling by invitation,No Results Available,Virus Diseases|COVID-19,Diagnostic Test: NO intervention planned due to the observational study design only a diagnostic testing,All,"Child, Adult, Older Adult",,5500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","September 30, 2020"
1572,NCT04346056,Recruiting,No Results Available,Coronavirus Disease (COVID-19)|COVID-19,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 14, 2020","December 1, 2020"
1573,NCT04354766,Recruiting,No Results Available,COVID,Other: Blood sample,All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020",July 2020
1574,NCT04335123,Completed,No Results Available,COVID-19,Drug: Losartan,All,"Adult, Older Adult",Phase 1,34.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 4, 2020","August 17, 2020"
1575,NCT04347538,"Active, not recruiting",No Results Available,COVID 19,Other: Saline Nasal Irrigation|Other: Saline with Baby Shampoo Nasal Irrigation,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020",June 2022
1576,NCT04442191,Recruiting,No Results Available,COVID-19,Biological: Convalescent plasma|Biological: Placebo,All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 5, 2020","May 5, 2021"
1577,NCT04387955,Recruiting,No Results Available,COVID-19|Chilblains,Diagnostic Test: Biological Sample Collection,All,"Child, Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 30, 2020",June 2021
1578,NCT04356417,Not yet recruiting,No Results Available,"AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection",Other: - Synthetic anti-malarial drugs,All,"Adult, Older Adult",,6000000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,April 2020,June 2020
1579,NCT04368065,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,100000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 2, 2020","June 1, 2023"
1580,NCT04362124,Withdrawn,No Results Available,COVID-19,Biological: vaccine BCG|Other: Placebo,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care",August 2020,November 2021
1581,NCT04511949,Completed,No Results Available,Coronavirus Infection,"Diagnostic Test: COVID-19 IgG / IgM rapid test (whole blood, serum, plasma)",All,"Child, Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 12, 2020","November 30, 2020"
1582,NCT04358380,Enrolling by invitation,No Results Available,Liver Injury,Other: Liver injury,All,"Child, Adult, Older Adult",,320.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","December 31, 2020"
1583,NCT04351919,Withdrawn,No Results Available,Patients With COVID19,Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Adult, Older Adult",Phase 4,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 5, 2020","July 15, 2020"
1584,NCT04624503,Recruiting,No Results Available,Covid19|Myocardial Injury|Cardiovascular Diseases|Heart Failure|Cardiovascular Morbidity,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","October 1, 2021"
1585,NCT04592510,Not yet recruiting,No Results Available,SARS-CoV2,,All,"Adult, Older Adult",,345.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,April 2021,January 2022
1586,NCT04735744,Not yet recruiting,No Results Available,Covid19|Allied Health Professionals|Primary Care|Retrospective Cohort|PROMs|Performance Measures|Prospective Cohort|National Dutch Program,Other: Patients recovering from COVID19 receive usual care by allied health professionals,All,"Adult, Older Adult",,1315.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 15, 2021","January 1, 2024"
1587,NCT04346212,Recruiting,No Results Available,Oropharyngeal Dysphagia|COVID-19|Sars-CoV2|Nutrition,Diagnostic Test: Swallowing evaluation with the EAT-10 and the volume-viscosity swallowing test (V-VST),All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 14, 2020",January 2021
1588,NCT04519411,Recruiting,No Results Available,COVID 19,Diagnostic Test: Transpulmonary pressure measurements,All,Child,Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 21, 2020","January 31, 2022"
1589,NCT04378595,Recruiting,No Results Available,Food Insecurity,Other: During COVID-19 Pandemic|Other: After COVID-19 Pandemic,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020","July 30, 2021"
1590,NCT04693026,Recruiting,No Results Available,Covid19|Covid-19 ARDS,Drug: Remdesivir|Drug: Baricitinib|Drug: Tocilizumab,All,"Child, Adult, Older Adult",Phase 3,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 10, 2020","March 5, 2021"
1591,NCT04553705,Recruiting,No Results Available,Covid19|Immunodeficiency,Drug: Omega 3/Nigella Sativa Oil|Drug: Omega 3/Nigella Sativa Oil/Indian Costus|Drug: Omega 3/Nigella Sativa Oil/Quinine pills|Drug: Omega 3/Nigella Sativa Oil/Anise seed capsule|Drug: Omega 3/Nigella Sativa Oil/Deglycyrrhizinated Licorice|Drug: Active Comparator,All,Adult,Phase 2|Phase 3,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","September 20, 2020","December 4, 2020"
1592,NCT04634409,Recruiting,No Results Available,COVID-19,Drug: LY3819253|Drug: LY3832479|Drug: Placebo|Drug: VIR-7831,All,Adult,Phase 2,700.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","January 29, 2020","June 29, 2021"
1593,NCT04561180,Not yet recruiting,No Results Available,Pneumonia as One of the Lung Complications Caused by SARS-CoV-2 Infection,Drug: EG-HPCP-03a|Drug: EG-HPCP-03a Placebo|Drug: Standard of Care|Drug: Dexamethasone,All,"Adult, Older Adult",Phase 2,96.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",June 2021,December 2021
1594,NCT04594356,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,126.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"November 19, 2020","June 30, 2021"
1595,NCT04686578,Recruiting,No Results Available,Fibromyalgia|Covid-19 Fear|Covid-19 Anxiety|Daily Life|Sleep Quality|Anxiety Depression,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"December 1, 2020","February 28, 2021"
1596,NCT04754113,Not yet recruiting,No Results Available,Covid19,Other: prone position,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 7, 2021","February 27, 2021"
1597,NCT04500418,Recruiting,No Results Available,Covid19,Drug: Cenicriviroc (CVC)|Drug: Placebo,All,"Adult, Older Adult",Phase 2,183.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","August 25, 2020","September 30, 2021"
1598,NCT04818801,Not yet recruiting,No Results Available,Covid19,Biological: Recombinant two-component COVID-19 vaccine (CHO cell)|Other: Placebo,All,"Adult, Older Adult",Early Phase 1,160.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",April 2021,June 2022
1599,NCT04487639,Recruiting,No Results Available,Sperm Preservation in Oncological Patients|Fertility|Cryopreservation,"Diagnostic Test: SARS-CoV-2 research in nasopharyngeal swab, sperm and serologics",Male,Adult,Not Applicable,250.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"July 10, 2020",July 2021
1600,NCT04256395,Completed,No Results Available,Susceptibility to Viral and Mycobacterial Infection,Other: mobile internet survey on self-test,All,"Child, Adult, Older Adult",,102456.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 1, 2020","July 1, 2020"
1601,NCT04497649,Recruiting,No Results Available,Covid19,Drug: Sofosbuvir|Drug: Daclatasvir,All,"Child, Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 1, 2020","April 10, 2021"
1602,NCT04568850,Recruiting,No Results Available,Covid19,Diagnostic Test: Plasma IgG levels,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 1, 2020","February 28, 2021"
1603,NCT04633915,"Active, not recruiting",No Results Available,Dialysis|Covid19,,All,"Adult, Older Adult",,51.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 26, 2020",August 2021
1604,NCT04721535,Not yet recruiting,No Results Available,Covid19|SARS-COV-2 Infection,Drug: DWJ1248|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1012.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",January 2021,July 2021
1605,NCT04623671,Recruiting,No Results Available,Covid19,Biological: CAP-1002|Biological: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 15, 2020","June 30, 2021"
1606,NCT04390191,Recruiting,No Results Available,COVID-19|COVID|Coronavirus,Device: Continuous Positive Airway Pressure,All,"Adult, Older Adult",Not Applicable,200.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 7, 2020",April 2022
1607,NCT04639440,Not yet recruiting,No Results Available,Covid19,Other: Adipose tissue,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"November 23, 2020","November 23, 2021"
1608,NCT04385251,Recruiting,No Results Available,COVID|COVID19|SARS-CoV 2|Dyspnea,Other: Data Collection,All,"Adult, Older Adult",,10000.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 18, 2020","June 30, 2021"
1609,NCT04370262,Completed,No Results Available,COVID-19,Drug: SOC + Intravenous Famotidine|Drug: SOC + Placebo,All,"Adult, Older Adult",Phase 3,233.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 7, 2020","September 7, 2020"
1610,NCT04405999,Completed,No Results Available,Increased Risk of SARS-CoV-2 Infection,Drug: Bromhexine Hydrochloride,All,"Adult, Older Adult",Phase 4,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 14, 2020","August 31, 2020"
1611,NCT04723459,Recruiting,No Results Available,Covid-19,Other: ivermectin impregnated mask,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 23, 2021","March 28, 2021"
1612,NCT04473157,Completed,No Results Available,Anosmia|Covid19|Dysgeusia,,All,"Adult, Older Adult",,58.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 1, 2020","December 30, 2020"
1613,NCT04800120,Recruiting,No Results Available,Covid19,Other: Hyperbaric Oxygen Therapy,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 15, 2021",December 2021
1614,NCT04784754,Not yet recruiting,No Results Available,COVID-19,Drug: Melatonin|Drug: Placebo,All,"Adult, Older Adult",Phase 2,50.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2021","December 31, 2021"
1615,NCT04328454,Recruiting,No Results Available,Coronavirus,Other: retrospective analysis,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 30, 2020","April 15, 2020"
1616,NCT04810689,Recruiting,No Results Available,Covid19,Drug: Xuanfei Baidu Granules|Other: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other","March 1, 2021","September 1, 2022"
1617,NCT04512079,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Enoxaparin|Drug: Apixaban,All,"Adult, Older Adult",Phase 4,3600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 8, 2020",March 2022
1618,NCT04709835,Recruiting,No Results Available,COVID-19,Drug: AT-527|Drug: Placebo,All,"Adult, Older Adult",Phase 2,220.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","February 3, 2021","June 3, 2021"
1619,NCT04729491,Completed,No Results Available,Covid19,Drug: Dutasteride 0.5 mg|Drug: Azithromycin|Drug: Nitazoxanide|Drug: Placebo,Male,"Adult, Older Adult",Phase 2|Phase 3,138.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 30, 2020","October 7, 2020"
1620,NCT04426253,"Active, not recruiting",No Results Available,COVID-19|Sars-CoV2,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 5, 2020","July 31, 2021"
1621,NCT04825093,Not yet recruiting,No Results Available,Pregnancy Complications|Covid19,Dietary Supplement: Vitamin D supplementation in pregnant women,Female,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 1, 2021","December 30, 2023"
1622,NCT04337190,Recruiting,No Results Available,COVID|Acute Respiratory Distress Syndrome,Biological: blood sampling,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 3, 2020","December 6, 2020"
1623,NCT04771624,Recruiting,No Results Available,Covid19|Cognitive Impairment,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 30, 2020","July 30, 2021"
1624,NCT04445272,Completed,No Results Available,COVID-19,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 2,495.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 22, 2020","December 23, 2020"
1625,NCT04832828,Completed,No Results Available,Covid19,Diagnostic Test: Roth´s Test,All,"Child, Adult, Older Adult",,114.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 1, 2020","November 28, 2020"
1626,NCT04449081,Completed,No Results Available,Acute Respiratory Distress Syndrome|Corona Virus Infection|Acute Lung Injury|Fever|Myalgia|Cough|Dyspnea|Septic Shock|Bleeding,"Behavioral: Knowledge, Attitude, Practice, Awareness, Preference",All,Adult,,215.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 25, 2020","June 20, 2020"
1627,NCT04505722,"Active, not recruiting",No Results Available,Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol,Biological: Ad26.COV2.S|Other: Placebo,All,"Adult, Older Adult",Phase 3,44325.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 7, 2020","January 2, 2023"
1628,NCT04801017,Not yet recruiting,No Results Available,COVID-19,Drug: OT-101|Drug: Artemisinin|Drug: Placebo,All,"Adult, Older Adult",Phase 2,18.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",April 2021,October 2021
1629,NCT04625296,Recruiting,No Results Available,Healthcare Worker Facing COVID-19,Behavioral: Semi-directive interview|Behavioral: Questionnaire : Preparedness for Caregiving Scale,All,"Adult, Older Adult",,75.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 17, 2020",January 2021
1630,NCT04460547,Not yet recruiting,No Results Available,COVID-19,Drug: Convalescent Plasma Transfusion|Drug: Hydroxychloroquine|Drug: DAS181|Drug: Ivermectin|Drug: Interferon Beta-1A,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 25, 2020","September 20, 2020"
1631,NCT04670094,"Active, not recruiting",No Results Available,Covid19,,All,"Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"December 30, 2020",December 2021
1632,NCT04385914,Not yet recruiting,No Results Available,Corona Virus Infection,Other: COVID positive via testing,Female,Adult,,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,May 2020,December 2020
1633,NCT04406389,Recruiting,No Results Available,COVID-19,Drug: Enoxaparin sodium|Drug: Unfractionated heparin|Drug: Fondapariniux|Drug: Argatroban,All,"Adult, Older Adult",Phase 4,186.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 13, 2020",December 2021
1634,NCT04757792,Completed,No Results Available,COVID-19 Disease,Other: File inquiry,All,"Child, Adult, Older Adult",,475.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"June 6, 2020","February 11, 2021"
1635,NCT04832945,Completed,No Results Available,Covid19,Drug: Ivermectin 6 Mg Oral Tablet,All,"Adult, Older Adult",,713.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 29, 2020","April 10, 2021"
1636,NCT04828538,Recruiting,No Results Available,Covid19,"Dietary Supplement: Vitamin D|Dietary Supplement: Omega DHA / EPA|Dietary Supplement: Vitamin C, Vitamin B complex and Zinc Acetate",All,"Adult, Older Adult",Not Applicable,3600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Other","March 1, 2021",July 2021
1637,NCT04427865,Not yet recruiting,No Results Available,COVID-19,Drug: prophylactic lactoferrin daily,All,"Adult, Older Adult",Phase 2|Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,July 2020,November 2020
1638,NCT04790786,Not yet recruiting,No Results Available,Covid19,Biological: Lilly Bamlanivimab|Biological: Regeneron Casirivimab + Imdevimab|Biological: Lilly Bamlanivimab + Etesevimab,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,March 2021,"December 30, 2022"
1639,NCT04808882,Not yet recruiting,No Results Available,Severe COVID-19 Pneumonia,"Drug: Tinzaparin, Low dose prophylactic anticoagulation|Drug: Tinzaparin, High dose prophylactic anticoagulation|Drug: Tinzaparin,Therapeutic anticoagulation",All,"Adult, Older Adult",Phase 2,353.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2021","February 1, 2022"
1640,NCT04542694,Completed,Has Results,COVID-19,Drug: Favipiravir|Drug: Standard of care,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 21, 2020","August 20, 2020"
1641,NCT04368260,Recruiting,No Results Available,COVID19,Device: Control swab|Device: Prototype swab,All,"Child, Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 24, 2020","July 31, 2020"
1642,NCT04740372,Recruiting,No Results Available,"Covid19, Patient Reported Outcome Measures, Quality of Life",Other: No intervention. Method study. Psychometric testing,All,"Adult, Older Adult",,350.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"November 20, 2020",November 2021
1643,NCT04573153,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine + Metabolic cofactor supplementation|Drug: Hydroxychloroquine + Sorbitol,All,"Adult, Older Adult",Phase 2|Phase 3,400.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 21, 2020","March 31, 2021"
1644,NCT04801030,Not yet recruiting,No Results Available,Covid19|Vaccine Refusal|Communication,Behavioral: CoVax Facts,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"June 1, 2021","May 30, 2023"
1645,NCT04613245,Recruiting,No Results Available,Asthma Chronic|Bronchial Asthma,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"May 1, 2020","March 1, 2021"
1646,NCT04779541,Recruiting,No Results Available,SARS-CoV-2|Covid19,Other: observation,All,Older Adult,,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 8, 2021","April 8, 2021"
1647,NCT04547114,Recruiting,No Results Available,SARS-CoV-2 Infection,Diagnostic Test: Multicapillary column coupled ion mobility spectrometry,All,"Adult, Older Adult",,200.0,Industry,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"September 14, 2020","April 30, 2021"
1648,NCT04802018,"Active, not recruiting",No Results Available,COVID-19,Device: Clinical decision support system based on non-invasive multimodal monitoring,All,"Child, Adult, Older Adult",Not Applicable,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","March 9, 2021",September 2021
1649,NCT04441710,Recruiting,No Results Available,COVID,Other: Questionnaire,All,"Child, Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 27, 2020",April 2024
1650,NCT04563650,Recruiting,No Results Available,Covid19|Geriatric Medicine|Seroconversion|Immunosenescence,Biological: blood sample,All,"Adult, Older Adult",Not Applicable,330.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"September 18, 2020",November 2021
1651,NCT04511819,"Active, not recruiting",No Results Available,COVID-19,Drug: Losmapimod oral tablet|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,410.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 28, 2020",June 2021
1652,NCT04475211,Recruiting,No Results Available,Sars-CoV2,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 10, 2020",August 2022
1653,NCT04809480,Completed,No Results Available,Covid19,Diagnostic Test: Fungal rhinosinusitis,All,"Child, Adult, Older Adult",,56.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2017","December 31, 2020"
1654,NCT04328493,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19,Drug: Chloroquine phosphate,All,"Adult, Older Adult",Phase 2,250.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 7, 2020","April 1, 2022"
1655,NCT04346186,Enrolling by invitation,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,All,"Child, Adult, Older Adult",,30000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","August 1, 2021"
1656,NCT04596085,Recruiting,No Results Available,Covid19,Dietary Supplement: Investigational Product - ViraCide|Other: Placebo - Starch Powder Soft gels,All,"Adult, Older Adult",Not Applicable,124.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care","September 16, 2020","January 30, 2021"
1657,NCT04328961,Completed,No Results Available,COVID-19|Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV-2,Drug: Hydroxychloroquine Sulfate|Drug: Ascorbic Acid,All,"Adult, Older Adult",Phase 2|Phase 3,829.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","March 31, 2020","October 8, 2020"
1658,NCT04397614,Recruiting,No Results Available,Sars-CoV2|Covid-19,Other: mHealth Assessments,All,"Adult, Older Adult",Phase 2,500.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"July 22, 2020",December 2021
1659,NCT04811885,"Active, not recruiting",No Results Available,Autism Spectrum Disorder|Cardiovascular Health,Other: The Effects of Covid 19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder,All,"Child, Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"October 14, 2019","October 14, 2021"
1660,NCT04646109,Completed,Has Results,COVID-19,Drug: Ivermectin,All,"Adult, Older Adult",Phase 3,66.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 11, 2020","September 2, 2020"
1661,NCT04757857,Recruiting,No Results Available,COVID-19,Drug: Rivaroxaban 10 mg,All,"Adult, Older Adult",Phase 4,1000.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 29, 2020","April 30, 2021"
1662,NCT04765449,Not yet recruiting,No Results Available,Covid19,Drug: Cytotoxic T Lymphocytes,All,Older Adult,Phase 1,24.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 30, 2021","February 29, 2024"
1663,NCT04615026,Recruiting,No Results Available,Covid19,Diagnostic Test: duplex sonography,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"November 4, 2020","June 30, 2021"
1664,NCT04429867,"Active, not recruiting",No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 4,700.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 7, 2020","December 7, 2020"
1665,NCT04460651,Recruiting,No Results Available,COVID19,Drug: Icosapent ethyl (IPE)|Drug: Placebo,All,"Adult, Older Adult",Phase 3,2000.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","August 14, 2020",January 2021
1666,NCT04779827,Not yet recruiting,No Results Available,Vaccination Refusal|Covid19|Contraception Behavior|Heart Diseases,Behavioral: Online Social Network and Collective Intelligence Intervention|Behavioral: Independent Control,All,"Adult, Older Adult",Not Applicable,1920.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"April 19, 2021","December 30, 2022"
1667,NCT04531319,Completed,No Results Available,Covid19,Diagnostic Test: Flow cytometric analysis,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"August 15, 2020","October 1, 2020"
1668,NCT04452643,Withdrawn,No Results Available,Covid19,Biological: BACMUNE (MV130)|Other: Placebo,All,"Adult, Older Adult",Phase 3,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",October 2020,December 2021
1669,NCT04348448,Not yet recruiting,No Results Available,COVID-19,Drug: Canakinumab 150 MG/ML [Ilaris],All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2020,September 2020
1670,NCT04357535,Completed,No Results Available,COVID-19,Drug: Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB),All,"Adult, Older Adult",,314.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 10, 2020","August 1, 2020"
1671,NCT04598256,Completed,No Results Available,Covid19,Procedure: Endoscopic procedure,All,"Child, Adult",,77.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 1, 2020","August 31, 2020"
1672,NCT04409522,Recruiting,No Results Available,COVID-19,Drug: Melatonin|Drug: The usual treatment,All,"Child, Adult, Older Adult",Not Applicable,55.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 12, 2020","September 25, 2020"
1673,NCT04466371,Not yet recruiting,No Results Available,Covid19,Other: Questionnaire,All,"Adult, Older Adult",,9209.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"July 15, 2021","March 1, 2022"
1674,NCT04485338,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 1, 2020","March 1, 2021"
1675,NCT04682912,Recruiting,No Results Available,COVID-19 Infection,,All,"Child, Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 30, 2021",February 2021
1676,NCT04425252,Completed,No Results Available,COVID-19,Drug: Brequinar|Other: Standard of Care,All,"Adult, Older Adult",Phase 1|Phase 2,23.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","December 29, 2020"
1677,NCT04336254,Recruiting,No Results Available,COVID-19,Biological: allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)|Other: Intravenous saline injection (Placebo),All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 6, 2020","December 31, 2021"
1678,NCT04539262,Completed,No Results Available,COVID-19,Drug: Remdesivir (RDV)|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,156.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 14, 2020","March 22, 2021"
1679,NCT04452487,Recruiting,No Results Available,Patient Hospitalized in Disease Infectious Unit|Patient Hospitalized in Intensive Reanimation Unit|Patient Hopsitalized in Internal Medicine Unit,Behavioral: decisions of limitations and stop processing,All,"Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 1, 2020",June 2021
1680,NCT04733729,Recruiting,No Results Available,COVID-19 Infection in Hematological Malignancies Patients,,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 1, 2020","December 31, 2021"
1681,NCT04636333,Recruiting,No Results Available,COVID-19,"Biological: Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14|Biological: Three doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28|Biological: Two doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14|Biological: Three doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28|Biological: Two doses of placebo at the schedule of day 0, 14 #middle-dose group#|Biological: Three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#|Biological: Two doses of placebo at the schedule of day 0, 14 #High-dose group#|Biological: Three doses of placebo at the schedule of day 0, 14, 28 #High-dose group#",All,"Adult, Older Adult",Phase 1,216.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","October 30, 2020","January 7, 2022"
1682,NCT04348305,"Active, not recruiting",No Results Available,Covid-19|Hypoxia,Drug: Hydrocortisone|Drug: Sodium Chloride 9mg/mL,All,"Adult, Older Adult",Phase 3,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 17, 2020","June 8, 2021"
1683,NCT04546841,Recruiting,No Results Available,COVID-19 Vaccine,Biological: multipeptide cocktail,All,"Adult, Older Adult",Phase 1,36.0,Other,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 27, 2020","December 20, 2021"
1684,NCT04372017,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV 2,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin D,All,"Adult, Older Adult",Phase 3,1.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","May 14, 2020","June 4, 2021"
1685,NCT04482205,Completed,No Results Available,Economic Burden,,All,"Child, Adult, Older Adult",,840.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 16, 2020","May 31, 2020"
1686,NCT04638634,Recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19),Biological: CSL760,All,"Adult, Older Adult",Phase 1,24.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Other,"February 2, 2021",May 2021
1687,NCT04439084,Enrolling by invitation,No Results Available,COVID-19|Chronic Liver Disease,Other: Prospective Chart Review,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 6, 2020",June 2021
1688,NCT04409834,Recruiting,No Results Available,COVID-19|Venous Thromboembolism|Arterial Thrombosis,Drug: Unfractionated Heparin IV|Drug: Enoxaparin 1 mg/kg|Drug: Clopidogrel|Drug: Unfractionated heparin SC|Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution,All,"Adult, Older Adult",Phase 4,750.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 5, 2020",May 2021
1689,NCT04323332,Not yet recruiting,No Results Available,COVID-19,Drug: Traditional Chinese Medicine Prescription,All,"Child, Adult, Older Adult",Phase 3,50.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2020,April 2020
1690,NCT04410328,Recruiting,No Results Available,Covid19,Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally AND Standard of care|Other: Standard of care,All,"Adult, Older Adult",Phase 3,132.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 21, 2020","December 15, 2021"
1691,NCT04569851,Enrolling by invitation,No Results Available,COVID-19 Infection,,All,"Child, Adult, Older Adult",,100000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 1, 2020","October 30, 2021"
1692,NCT04443270,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,All,Adult,Phase 1,200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"July 27, 2020","January 31, 2021"
1693,NCT04808921,Completed,No Results Available,SARS-CoV-2|Covid-19|Coronavirus,"Diagnostic Test: Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test",All,"Child, Adult, Older Adult",Not Applicable,151.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"January 9, 2021","January 28, 2021"
1694,NCT04745611,Recruiting,No Results Available,COVID-19 Infection,Diagnostic Test: MRI|Diagnostic Test: Neuropsychological assessment|Diagnostic Test: Questionnaires Patient|Diagnostic Test: Questionnaires Family,All,"Child, Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 12, 2020",September 2021
1695,NCT04843722,Recruiting,No Results Available,Covid19,Biological: hAd5-S-Fusion+N-ETSD vaccine,All,"Adult, Older Adult",Phase 1|Phase 2,540.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",April 2021,August 2022
1696,NCT04421534,Not yet recruiting,No Results Available,COVID-19,Drug: Lactoferrin,All,"Adult, Older Adult",Phase 2|Phase 3,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2020,November 2020
1697,NCT04344080,"Active, not recruiting",No Results Available,COVID-19,Device: CytoSorb-Therapy,All,"Adult, Older Adult",Not Applicable,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","May 1, 2021"
1698,NCT04449094,Completed,No Results Available,COVID,,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Retrospective,"February 28, 2020","April 4, 2020"
1699,NCT04492943,Completed,No Results Available,COVID-19,,All,"Adult, Older Adult",,35.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 20, 2020","June 30, 2020"
1700,NCT04339426,Recruiting,No Results Available,Covid19,Drug: Atovaquone/Azithromycin,All,"Adult, Older Adult",Phase 2,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020",December 2021
1701,NCT04824495,Recruiting,No Results Available,Covid19,Diagnostic Test: Blood sample,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 7, 2021","December 31, 2021"
1702,NCT04682548,Recruiting,No Results Available,Multiple Sclerosis|Covid19,,All,Adult,,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 5, 2021",December 2021
1703,NCT04342182,"Active, not recruiting",No Results Available,COVID-19,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 2|Phase 3,426.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 8, 2020","July 31, 2021"
1704,NCT04627194,"Active, not recruiting",No Results Available,"Covid19|Pneumonia, Viral",,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 20, 2020","December 1, 2020"
1705,NCT04384250,Recruiting,No Results Available,Genetic Basis of COVID-19 Infection,Diagnostic Test: Whole Exome Sequencing,All,"Child, Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 10, 2020","May 1, 2021"
1706,NCT04782427,"Active, not recruiting",No Results Available,"Covid19|Death|Infection Viral|Infections, Respiratory|Infection, Coronavirus|Elderly Infection|Old Age; Dementia|Epidemic Disease",Other: COVID-19 infection,All,"Child, Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2021","May 13, 2021"
1707,NCT04364763,Recruiting,No Results Available,COVID-19,Drug: RBT-9 (90 mg)|Drug: 0.9% sodium chloride (normal saline),All,"Adult, Older Adult",Phase 2,252.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 5, 2020","December 31, 2021"
1708,NCT04730323,Completed,No Results Available,Covid19,Drug: Tocilizumab,All,"Child, Adult, Older Adult",Phase 4,93.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 12, 2020","June 12, 2020"
1709,NCT04346446,Completed,No Results Available,COVID,Drug: Convalescent Plasma Transfusion|Other: Supportive Care|Drug: Random Donor Plasma,All,"Adult, Older Adult",Phase 2,29.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","May 30, 2020"
1710,NCT04395859,Recruiting,No Results Available,Age Related Macular Degeneration|Diabetic Macular Edema|Retinal Vein Occlusion,Procedure: Questionnaire|Other: Data collection up to 1 year,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 27, 2020",December 2021
1711,NCT04570501,Not yet recruiting,No Results Available,Covid19,Drug: Angiotensin-(1-7)|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,160.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",March 2021,August 2021
1712,NCT04488588,Completed,No Results Available,Covid19|Coronavirus Disease|SARS-CoV-2,Other: Kaplan Meier analysis,All,Adult,,1064.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 15, 2020","July 1, 2020"
1713,NCT04801888,Not yet recruiting,No Results Available,COVID-19|Influenza,"Biological: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.|Biological: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 14.",All,Adult,Phase 4,480.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,March 2021,July 2021
1714,NCT04412369,Not yet recruiting,No Results Available,COVID19|Cardiovascular Diseases,Diagnostic Test: Non-invasive cardiac imaging,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,June 2020,June 2021
1715,NCT04834856,Recruiting,No Results Available,Covid19,Drug: ensovibep,All,"Adult, Older Adult",Phase 2,40.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2021","October 31, 2021"
1716,NCT04746443,Recruiting,No Results Available,Covid19,Other: NOT APPLICABLE (NA),All,Adult,,40.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"December 8, 2020","March 8, 2021"
1717,NCT04838119,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,300000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Retrospective,April 2021,July 2021
1718,NCT04762056,Not yet recruiting,No Results Available,Post Intensive Care Unit Syndrome|Covid19,Other: Chelsea Critical Care Physical Assessment Tool,All,"Adult, Older Adult",,26.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 20, 2021","May 30, 2021"
1719,NCT04665258,Recruiting,No Results Available,"Infertility, Male",,Male,Adult,,60.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 14, 2020","June 14, 2021"
1720,NCT04826770,Recruiting,No Results Available,SARS-CoV-2,Other: anti-SARS-CoV-2 antibody testing,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 6, 2021","December 31, 2022"
1721,NCT04363385,Recruiting,No Results Available,Covid-19,Biological: Biological test,All,"Child, Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 31, 2020","May 31, 2021"
1722,NCT04418609,Recruiting,No Results Available,Neurologic Complication,Other: further processing of health data,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"May 1, 2020","May 30, 2022"
1723,NCT04468139,Recruiting,No Results Available,Covid-19,Drug: Quercetin|Dietary Supplement: bromelain|Drug: Zinc|Drug: Vitamin C,All,"Adult, Older Adult",Phase 4,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 20, 2020","July 30, 2020"
1724,NCT04845191,Not yet recruiting,No Results Available,Covid19,Biological: hAd5-S-Fusion+N-ETSD vaccine,All,"Adult, Older Adult",Phase 1|Phase 2,540.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",April 2021,August 2022
1725,NCT04779775,Not yet recruiting,No Results Available,Perinatal Mental Health Care Practices During the COVID-19 Pandemic,,All,"Child, Adult, Older Adult",,70.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 15, 2021","June 30, 2021"
1726,NCT04433039,Completed,No Results Available,COVID,,All,"Child, Adult, Older Adult",,130.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Retrospective,"May 22, 2020","June 14, 2020"
1727,NCT04544176,Completed,No Results Available,Covid19,Other: Observational,All,"Child, Adult, Older Adult",,48000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2020","January 1, 2021"
1728,NCT04373759,Completed,No Results Available,Sars-CoV2|Covid-19,Other: Cardiopulmonary resuscitation|Other: Modified Rankin score,All,"Adult, Older Adult",,186.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 2, 2020","September 30, 2020"
1729,NCT04330495,Not yet recruiting,No Results Available,COVID 19|Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors,Drug: Hidroxicloroquina|Drug: Control group,All,"Adult, Older Adult",Phase 4,800.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","April 6, 2020","November 6, 2020"
1730,NCT04623385,Not yet recruiting,No Results Available,Covid19,Combination Product: Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone|Drug: The standard therapy,All,"Adult, Older Adult",Phase 4,1000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,November 2020,December 2021
1731,NCT04509713,Recruiting,No Results Available,Covid19,Behavioral: Collection of odour samples,All,"Child, Adult, Older Adult",,16250.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 2, 2020","October 31, 2020"
1732,NCT04337541,Completed,No Results Available,COVID-19,Other: Surgical facial mask,All,"Adult, Older Adult",Not Applicable,6000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 2, 2020","June 2, 2020"
1733,NCT04330599,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,12000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","April 1, 2025"
1734,NCT04487119,Completed,No Results Available,Covid19,,All,"Child, Adult",,29.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 12, 2020","August 23, 2020"
1735,NCT04729075,Completed,No Results Available,"ARDS, Human|Covid19",Other: ARDS and COVID19 treatments,All,"Child, Adult, Older Adult",,1800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 19, 2021","January 19, 2021"
1736,NCT04477668,Recruiting,No Results Available,COVID-19|Acute Hypoxemic Respiratory Failure,Device: Helmet non-invasive ventilation,All,"Child, Adult, Older Adult",Not Applicable,320.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 8, 2021",January 2022
1737,NCT04552483,Completed,No Results Available,Covid19|Coronavirus,Drug: Nitazoxanide|Drug: Placebo,All,"Adult, Older Adult",Phase 2,392.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","June 8, 2020","September 5, 2020"
1738,NCT04424771,Completed,No Results Available,COVID|Post Traumatic Stress Disorder,Behavioral: Maslach Burnout Inventory (MBI),All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","July 1, 2020"
1739,NCT04709146,Not yet recruiting,No Results Available,Covid19,Diagnostic Test: Audio-Vestibular evaluation,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 1, 2021","June 30, 2022"
1740,NCT04372602,Recruiting,No Results Available,COVID-19,Drug: Duvelisib|Procedure: Peripheral blood draw|Drug: Placebo,All,"Adult, Older Adult",Phase 2,28.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","October 12, 2020","April 30, 2022"
1741,NCT04555005,Completed,No Results Available,Mindfulness|COVID-19|Healthcare Worker,Other: Mindfulness based intervention,All,"Child, Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 10, 2020","April 26, 2020"
1742,NCT04623255,Recruiting,No Results Available,COVID19,Drug: OCTAPLAS,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 16, 2020","November 1, 2021"
1743,NCT04716569,Recruiting,No Results Available,Covid19,Drug: intranasal ivermectin spray,All,"Adult, Older Adult",Phase 2|Phase 3,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 20, 2021","March 20, 2021"
1744,NCT04329923,Terminated,Has Results,COVID-19,Drug: Hydroxychloroquine Sulfate 400 mg twice a day|Drug: Hydroxychloroquine Sulfate 600 mg twice a day|Drug: Hydroxychloroquine Sulfate 600 mg once a day|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,173.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 9, 2020","November 13, 2020"
1745,NCT04526405,Completed,No Results Available,Thalassemia Major|Covid19,Diagnostic Test: SARS-CoV-2 S1/S2 IgG,All,"Adult, Older Adult",,63.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 14, 2020","November 3, 2020"
1746,NCT04392531,Recruiting,No Results Available,COVID19 Infection,Drug: Cyclosporine|Drug: Standard treatment,All,"Adult, Older Adult",Phase 4,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020",March 2021
1747,NCT04510467,Not yet recruiting,No Results Available,Covid19|Systemic Autoimmune Disease|Inflammatory Rheumatism|Auto Inflammatory Diseases,,All,"Adult, Older Adult",,1313.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,January 2021,August 2021
1748,NCT04509752,Recruiting,No Results Available,Dysphagia|Covid19,Other: Survey,All,Adult,,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 8, 2020","February 28, 2021"
1749,NCT04527562,Completed,No Results Available,Covid19,Drug: Colchicine|Drug: Placebo,All,"Adult, Older Adult",Not Applicable,299.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 14, 2020","December 10, 2020"
1750,NCT04695379,Recruiting,No Results Available,Myasthenia Gravis,,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 26, 2020","November 26, 2022"
1751,NCT04663906,Not yet recruiting,No Results Available,Isotretinoin Adverse Reaction|Covid19,,All,"Child, Adult",,300.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 15, 2021","May 31, 2021"
1752,NCT04628000,Recruiting,No Results Available,Vitamin D Deficiency|Covid19,Other: Vitamin D,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 27, 2020","April 14, 2022"
1753,NCT04715815,Not yet recruiting,No Results Available,Chronic Pain,Other: No intervention (only interview),All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,February 2021,June 2022
1754,NCT04540393,Suspended,No Results Available,COVID-19,Biological: AZD1222,All,"Adult, Older Adult",Phase 3,100.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 2, 2020","May 11, 2021"
1755,NCT04675281,Recruiting,No Results Available,SARS-CoV-2|Covid19|Pathology|Intensive Care Units|Respiratory Distress Syndrome,Other: 2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 24, 2020","April 24, 2021"
1756,NCT04377477,Recruiting,No Results Available,COVID-19,Radiation: Single fraction whole lung radiotherapy,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 10, 2020","August 30, 2022"
1757,NCT04636203,Not yet recruiting,No Results Available,SARS-CoV-2 Infection|Covid19,,All,"Adult, Older Adult",,3500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"December 15, 2020","June 15, 2022"
1758,NCT04375670,Recruiting,No Results Available,Liver Diseases|COVID19,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"May 11, 2020","December 31, 2020"
1759,NCT04745442,Completed,No Results Available,Covid19|Severe Acute Respiratory Syndrome|Distress Respiratory Syndrome,Drug: Antithrombin + best available treatment|Drug: Best available treatment,All,"Adult, Older Adult",Phase 2,48.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 27, 2020","January 15, 2021"
1760,NCT04315298,Completed,No Results Available,COVID-19,Drug: Sarilumab|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,1912.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 18, 2020","September 2, 2020"
1761,NCT04694612,Recruiting,No Results Available,Covid19,Drug: Favipiravir|Drug: Placebo|Drug: Remdesivir,All,"Adult, Older Adult",Phase 3,676.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 1, 2021","May 31, 2021"
1762,NCT04434144,Completed,No Results Available,Ivermectin|Hydroxychloroquine|COVID19,Drug: Ivermectin + Doxycycline|Drug: Hydroxychloroquine + Azithromycin,All,"Child, Adult, Older Adult",,116.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 2, 2020","June 5, 2020"
1763,NCT04492267,Recruiting,No Results Available,Inflammatory Bowel Disease,,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"July 7, 2020","January 7, 2021"
1764,NCT04498325,Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2,"Drug: NT-I7|Drug: Placebo|Procedure: Blood for research purposes|Procedure: Blood for pharmacokinetic samples|Procedure: Nasopharyngeal, oropharyngeal, or saliva swab|Procedure: Blood for anti-drug antibody (ADA)",All,"Adult, Older Adult",Phase 1,42.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 30, 2021","January 31, 2022"
1765,NCT04350593,"Active, not recruiting",No Results Available,COVID-19,Drug: Dapagliflozin 10 MG|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1250.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 22, 2020",June 2021
1766,NCT04377308,Recruiting,No Results Available,COVID-19|Cytokine Storm,Drug: Fluoxetine,All,"Adult, Older Adult",Phase 4,2000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","October 20, 2021"
1767,NCT04501952,"Active, not recruiting",No Results Available,COVID-19,Drug: RDV|Drug: Placebo to Match RDV,All,"Child, Adult, Older Adult",Phase 3,585.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 18, 2020",May 2021
1768,NCT04595240,Completed,No Results Available,Covid19,Diagnostic Test: semen analysis,Male,Adult,,100.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 1, 2020","October 15, 2020"
1769,NCT04714515,Completed,No Results Available,Covid19|SARS-CoV-2 Infection,Drug: Montelukast|Drug: Hydroxychloroquine|Drug: Ivermectin,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 20, 2020","April 20, 2020"
1770,NCT04380519,Completed,No Results Available,COVID-19,Biological: RPH-104 80 mg|Drug: Olokizumab 64 mg|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,372.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 23, 2020","July 24, 2020"
1771,NCT04561089,Enrolling by invitation,No Results Available,SARS-CoV-2,Diagnostic Test: COVIDSeq Test,All,"Adult, Older Adult",,2000.0,Industry|Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 13, 2020","April 30, 2021"
1772,NCT04425538,Completed,No Results Available,COVID-19,Drug: Infliximab,All,"Adult, Older Adult",Phase 2,17.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","January 22, 2021"
1773,NCT04413747,Not yet recruiting,No Results Available,Coronavirus Infection|Cytokine Storm|Mental Disorder,Behavioral: morning Yoga-based breathing support|Behavioral: pre_lunch Yoga-based breathing support|Behavioral: pre_dinner Yoga-based breathing support,All,"Adult, Older Adult",Not Applicable,1000.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 15, 2020","September 30, 2021"
1774,NCT04333407,Recruiting,No Results Available,COVID-19,Drug: Aspirin 75mg|Drug: Clopidogrel 75mg|Drug: Rivaroxaban 2.5 MG|Drug: Atorvastatin 40mg|Drug: Omeprazole 20mg,All,"Adult, Older Adult",Not Applicable,3170.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020","March 30, 2021"
1775,NCT04352946,Not yet recruiting,No Results Available,Prophylaxis|COVID-19|Health Care Worker|Hydroxychloroquine,Drug: Hydroxychloroquine Pre-Exposure Prophylaxis|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,374.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 24, 2020","August 24, 2020"
1776,NCT04327570,Recruiting,No Results Available,Coronavirus Infections,Other: Patient sampling,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"March 27, 2020","September 30, 2020"
1777,NCT04516915,Recruiting,No Results Available,Covid 19,Drug: IMU-838|Drug: Oseltamivir,All,"Adult, Older Adult",Phase 2,120.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 15, 2020",July 2021
1778,NCT04363541,Recruiting,No Results Available,COVID-19|Thermotherapy,Device: Electric pad for human external pain therapy,All,"Adult, Older Adult",Not Applicable,274.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 27, 2020",June 2022
1779,NCT04385121,Recruiting,No Results Available,"Covid-19|Stress Disorders, Post-Traumatic|Anxiety|Depression",Other: Questionnary,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020",March 2021
1780,NCT04528667,Recruiting,No Results Available,Covid19,Drug: STI-5656|Drug: Placebo,All,"Adult, Older Adult",Phase 2,400.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","January 6, 2021",May 2021
1781,NCT04344327,Completed,No Results Available,"Infection Viral|Infection, Hospital|COVID",,All,"Adult, Older Adult",,2878.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 10, 2020","April 21, 2020"
1782,NCT04345848,Recruiting,No Results Available,COVID|Sars-CoV2,Drug: Enoxaparin,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 28, 2020","March 31, 2021"
1783,NCT04344197,Completed,No Results Available,Surgery|COVID|Asymptomatic Patient|Covid-19|Preventive Measures,Other: global survey,All,"Child, Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 2, 2020","April 15, 2020"
1784,NCT04657497,Recruiting,No Results Available,SARS-CoV-2 Infection (COVID-19),Drug: FOY-305|Drug: Placebo,All,"Adult, Older Adult",Phase 3,110.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 9, 2020","May 31, 2021"
1785,NCT04365699,Completed,No Results Available,COVID-19,Drug: AT-001,All,"Adult, Older Adult",Phase 2,10.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 8, 2020","January 31, 2021"
1786,NCT04363060,Not yet recruiting,No Results Available,COVID-19 Pneumonia,Combination Product: Azithromycin with amoxicillin/clavulanate|Drug: amoxicillin/clavulanate,All,"Adult, Older Adult",Phase 3,104.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","July 30, 2020"
1787,NCT04354441,Withdrawn,No Results Available,COVID-19|SARS-CoV-2|Pregnant Women|Hydroxychloroquine,Drug: hydroxychloroquine sulfate 200 MG|Drug: Placebo oral tablet,Female,Adult,Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",May 2020,May 2020
1788,NCT04365634,Completed,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,306.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"February 2, 2020","April 1, 2020"
1789,NCT04613310,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Diagnostic Test: Rapid Diagnostic Test vs PCR,All,"Adult, Older Adult",Not Applicable,1250.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 25, 2020","December 31, 2020"
1790,NCT04551690,Completed,No Results Available,Pregnancy|Covid19|Labor (Obstetrics)--Complications|Demography,,Female,Adult,,720.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"April 15, 2020","July 15, 2020"
1791,NCT04805970,Recruiting,No Results Available,Covid19|Diabetes,,All,"Adult, Older Adult",,66.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,April 2021,January 2022
1792,NCT04454372,Not yet recruiting,No Results Available,COVID-19,Other: demographic and clinical data obtained from hospital's electronic medical record.,All,"Child, Adult, Older Adult",,187.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 15, 2020","November 30, 2020"
1793,NCT04456556,Completed,No Results Available,Endophthalmitis and Orbital Cellulitis,,All,"Child, Adult, Older Adult",,5.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 27, 2020","June 30, 2020"
1794,NCT04782700,Recruiting,No Results Available,Covid19|Lung Inflammation|Hypoxemic Respiratory Failure,Other: Steroid Taper (Prednisone),All,"Adult, Older Adult",Not Applicable,522.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","March 15, 2021","March 3, 2025"
1795,NCT04418544,Recruiting,No Results Available,COVID-19,Device: Device used to record voice for screening,All,"Adult, Older Adult",,400.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 1, 2020",December 2020
1796,NCT04632602,Recruiting,No Results Available,Respiratory Failure,Other: physiological effects of awake prone position in COVID 19 patients,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Other,"April 4, 2020","January 31, 2021"
1797,NCT04729452,Recruiting,No Results Available,Covid19,Other: blood test,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 1, 2020","December 1, 2023"
1798,NCT04384926,Recruiting,No Results Available,COVID-19|Coronavirus|Cancer|Surgery,Procedure: Elective Cancer Surgery,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 30, 2020","December 31, 2020"
1799,NCT04715932,Recruiting,No Results Available,"Covid19|Anosmia|Fever|Cough|Shortness of Breath|Sore Throat|Nausea|Vomiting|Headache|Muscle Weakness|Pain, Muscle|Pain, Chest|Pain, Joint|Pain, Abdominal|Pain|Irritable Mood|Confusion",Drug: Hesperidin|Drug: Placebo,All,"Adult, Older Adult",Phase 2,216.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 18, 2021",May 2021
1800,NCT04734886,Recruiting,No Results Available,Covid19,Dietary Supplement: L. reuteri DSM 17938 + vitamin D|Dietary Supplement: Placebo + vitamin D,All,Adult,Not Applicable,400.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","November 27, 2020","December 31, 2021"
1801,NCT04346628,"Active, not recruiting",No Results Available,Sars-CoV2|COVID-19,Drug: Favipiravir|Drug: Placebo|Other: Standard of care treatment,All,"Adult, Older Adult",Phase 2,149.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 12, 2020",April 2021
1802,NCT04786041,Completed,No Results Available,Covid19|Appendicitis,Procedure: laparoscopic appendectomy,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","May 30, 2020"
1803,NCT04470739,Recruiting,No Results Available,Covid19|Thymic Hypoplasia,Diagnostic Test: chest x-ray,All,Child,Not Applicable,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 30, 2020","October 30, 2020"
1804,NCT04411511,Recruiting,No Results Available,"Covid-19|Obesity, Childhood|Lifestyle|Lifestyle, Healthy|Overweight, Childhood|Children, Only|Family",Other: Exposure to the Dutch measures due to the Covid-19 pandemic.,All,Child,,4000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 6, 2020","May 6, 2022"
1805,NCT04432922,Completed,No Results Available,COVID19,Other: Hospitalized Patients for COVID-19 Infection,All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"November 1, 2020","November 15, 2020"
1806,NCT04442087,Recruiting,No Results Available,SARS-CoV2,Biological: Serology SARS-CoV2|Behavioral: Data collection,All,"Child, Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"June 19, 2020",September 2021
1807,NCT04794088,Recruiting,No Results Available,ARDS|Acute Respiratory Distress Syndrome|Covid19|Endothelial Dysfunction|Pulmonary Edema,Drug: Imatinib Mesylate intravenous solution|Drug: Placebo,All,"Adult, Older Adult",Phase 2,90.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 14, 2021",February 2022
1808,NCT04347382,Completed,No Results Available,Coronavirus Infection|Sars-CoV2,Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos,All,"Adult, Older Adult",Phase 3,313.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 30, 2020","August 30, 2020"
1809,NCT04661839,Recruiting,No Results Available,SARS-CoV-2,Biological: COVID-HIGIV|Other: Placebo (saline),All,Adult,Phase 1,56.0,Industry|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 24, 2020",September 2021
1810,NCT04584424,Not yet recruiting,No Results Available,Epidemiology|Clinical|Nutritional-status|Immunologic Defect,Other: The study does not required,All,"Child, Adult, Older Adult",,6390.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 30, 2020","November 14, 2021"
1811,NCT04422678,Not yet recruiting,No Results Available,COVID-19,Drug: Imatinib Mesylate|Drug: Standard of Care,All,"Adult, Older Adult",Phase 3,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2020,October 2020
1812,NCT04619407,Completed,No Results Available,SARS-CoV-2,Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Serum testing,All,"Child, Adult, Older Adult",,142.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 4, 2020","March 26, 2021"
1813,NCT04385108,Recruiting,No Results Available,COVID-19,Biological: Blood collection on admission and longitudinally|Biological: Blood collection on their first consultation and 10 to 14 days later,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"March 4, 2020","December 31, 2021"
1814,NCT04336904,"Active, not recruiting",No Results Available,COVID-19,Drug: Favipiravir|Other: Placebo,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","March 25, 2020",July 2020
1815,NCT04475991,Not yet recruiting,No Results Available,COVID-19,Drug: Maraviroc + Currently used therapy|Procedure: Curently used therapy for COVID-19 non-critical patients|Drug: Favipiravir + Currently used therapy|Drug: Maraviroc+Favipiravir+CT,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,May 2021,September 2021
1816,NCT04668625,Completed,No Results Available,COVID-19 (SARS-CoV-2),Behavioral: Participate in a massive musical event,All,Adult,Not Applicable,1000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 30, 2020","January 8, 2021"
1817,NCT04452422,Recruiting,No Results Available,Deep Venous Thrombosis,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"June 23, 2020","September 23, 2020"
1818,NCT04512300,Completed,No Results Available,Dental Treatment During Covid -19,,All,"Child, Adult, Older Adult",,267.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 15, 2020","June 25, 2020"
1819,NCT04547257,Not yet recruiting,No Results Available,COVID-19,Device: Seraph 100,All,"Adult, Older Adult",Not Applicable,42.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021","October 15, 2021"
1820,NCT04324866,Not yet recruiting,No Results Available,Coronavirus Infection,Diagnostic Test: Nasopharyngeal swab,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020",December 2020
1821,NCT04446169,"Active, not recruiting",No Results Available,SARS-CoV 2|Sexual Function and Fertility Disorders|Urinary Function Disorders|Urine|Semen,Diagnostic Test: SARS-CoV 2 RNA PCR Urine|Diagnostic Test: SARS-CoV 2 RNA PCR Semen|Diagnostic Test: Semen Qualitative Analysis|Diagnostic Test: IIEF-5 questionnaire|Diagnostic Test: Male Sexual Health Questionnaire (MSHQ)|Diagnostic Test: IPSS questionnaire|Diagnostic Test: SECRET questionnaire|Diagnostic Test: Interleukin assessment in semen,Male,"Adult, Older Adult",,43.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 27, 2020","May 2, 2021"
1822,NCT04391400,Not yet recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: nasal pharyngeal (NP) swab samples|Diagnostic Test: peripheral blood draw,All,"Child, Adult, Older Adult",,500.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 1, 2020","June 30, 2021"
1823,NCT04414410,Enrolling by invitation,No Results Available,COVID|Sars-CoV2,,All,"Child, Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 12, 2020","September 30, 2020"
1824,NCT04462120,"Active, not recruiting",No Results Available,Covid-19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 16, 2020","July 30, 2020"
1825,NCT04561024,"Active, not recruiting",No Results Available,Covid19,Diagnostic Test: AI model,All,"Adult, Older Adult",,4000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","December 31, 2020"
1826,NCT04581044,Completed,No Results Available,Psoriasis|Covid19,,All,"Adult, Older Adult",,197.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"September 17, 2020","October 23, 2020"
1827,NCT04397328,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,336.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 19, 2020","April 30, 2021"
1828,NCT04325412,Recruiting,No Results Available,COVID-19; Cardiovascular Diseases,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2020","June 23, 2021"
1829,NCT04665752,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,150.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 2, 2021","June 30, 2023"
1830,NCT04387253,Recruiting,No Results Available,Identification of the Mother or Fetus Contamination by SARS Cov-2|Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father|The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes|Analysis Laboratories of the Poitiers CHU,Diagnostic Test: Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus,All,"Child, Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,"May 23, 2020","July 23, 2021"
1831,NCT04723524,Recruiting,No Results Available,COVID-19,"Combination Product: Jinhua Qinggan (JHQG) Granules, Traditional Chinese Medicine|Other: Placebo Comparator",All,"Adult, Older Adult",Phase 2,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","September 22, 2020",August 2021
1832,NCT04379544,"Active, not recruiting",No Results Available,Coronavirus|Respiratory Failure,Other: Observation only,All,"Adult, Older Adult",,125.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020",December 2021
1833,NCT04316884,Recruiting,No Results Available,"COVID-19|Organ Dysfunction Syndrome Sepsis|Organ Dysfunction Syndrome, Multiple|Septic Shock|Acute Kidney Injury|Acute Respiratory Distress Syndrome",,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 12, 2020","December 31, 2021"
1834,NCT04527211,Not yet recruiting,No Results Available,Covid19|Healthcare Worker Patient Transmission,Drug: Ivermectin,All,"Adult, Older Adult",Phase 3,550.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 7, 2020","December 16, 2020"
1835,NCT04567810,Completed,No Results Available,Covid19,Drug: anti-SARS-CoV-2 IgY|Drug: Placebo,All,Adult,Phase 1,48.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","September 18, 2020","December 14, 2020"
1836,NCT04353323,Not yet recruiting,No Results Available,"Infection, COVID-19",Other: Blood sampling,All,"Adult, Older Adult",,130.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 25, 2020","December 25, 2020"
1837,NCT04448418,"Active, not recruiting",No Results Available,Transgender Persons|Coronavirus|Coronavirus Infection|COVID|COVID-19,Other: web based survey,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 20, 2020","November 20, 2020"
1838,NCT04840966,Completed,No Results Available,Covid19,Diagnostic Test: Flavor test|Other: Self-assesment questionnaire,All,"Adult, Older Adult",,111.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 5, 2020","January 15, 2021"
1839,NCT04343768,Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 9, 2020","April 27, 2020"
1840,NCT04412252,Withdrawn,No Results Available,COVID-19,Drug: Tofacitinib|Other: Placebo,All,"Adult, Older Adult",Phase 2,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 6, 2020","October 18, 2020"
1841,NCT04732949,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19,Drug: SNG001|Drug: Placebo,All,"Adult, Older Adult",Phase 3,610.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","January 12, 2021","September 1, 2021"
1842,NCT04476927,Not yet recruiting,No Results Available,COVID-19,Device: DiaNose,All,"Adult, Older Adult",Not Applicable,300.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"August 1, 2020","June 30, 2021"
1843,NCT04750629,Not yet recruiting,No Results Available,SARS-CoV-2|Covid19,Device: POC CoviDx™ Rapid Antigen Test,All,"Child, Adult, Older Adult",,100.0,Industry,Observational,Observational Model: Other|Time Perspective: Prospective,"February 8, 2021","March 26, 2021"
1844,NCT04456010,Completed,No Results Available,COVID19|Fertility Issues|ART,Other: Questionnaire,All,Adult,,600.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 1, 2020","July 30, 2020"
1845,NCT04382417,Completed,No Results Available,Covid-19|Critical Illness,Other: Observational study,All,"Adult, Older Adult",,57.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 26, 2020","November 12, 2020"
1846,NCT04582903,Recruiting,No Results Available,COVID-19 Infection,,All,"Child, Adult, Older Adult",,500.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 19, 2021","August 31, 2025"
1847,NCT04371354,"Active, not recruiting",No Results Available,Covid-19 Disease|Endoscopy Unit,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 27, 2020","July 27, 2021"
1848,NCT04360759,Withdrawn,No Results Available,Covid-19|HIV,Drug: Chloroquine or hydroxychloroquine,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","June 30, 2021"
1849,NCT04456426,Not yet recruiting,No Results Available,COVID|SARS-CoV 2|SARS Pneumonia|SARS (Disease)|SARS (Severe Acute Respiratory Syndrome),,All,"Child, Adult, Older Adult",,250.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Retrospective,July 2020,August 2020
1850,NCT04335188,Recruiting,No Results Available,COVID,Other: Prospective oberservational registry,All,"Child, Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 6, 2020","September 30, 2021"
1851,NCT04327206,"Active, not recruiting",No Results Available,Coronavirus Disease 2019 (COVID-19)|Respiratory Illness|Corona Virus Infection|COVID-19,Drug: BCG Vaccine|Drug: 0.9%NaCl,All,"Adult, Older Adult",Phase 3,10078.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","March 30, 2020","March 30, 2022"
1852,NCT04641481,"Active, not recruiting",No Results Available,Covid19|SARS-CoV Infection,Biological: BBV152|Biological: Placebo,All,"Adult, Older Adult",Phase 3,25800.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","November 16, 2020",December 2022
1853,NCT04568096,Not yet recruiting,No Results Available,the Lung Complication of COVID-19,Combination Product: Aerosolized All-Trans Retinoic acid plus oral Tamoxifen|Other: Standard treatment,All,"Adult, Older Adult",Phase 2,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,November 2020,December 2020
1854,NCT04834869,Not yet recruiting,No Results Available,Adverse Reaction to Vaccine|COVID19 Vaccine,Biological: BNT162b2|Biological: mRNA-1273|Biological: AZD1222|Biological: CoronaVac|Biological: Sinopharm|Biological: Gam-COVID-Vac|Biological: JNJ-78436735|Biological: CVnCoV|Biological: NVX-CoV2373|Biological: BBV152,All,"Adult, Older Adult",,30000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 1, 2021","January 31, 2022"
1855,NCT04332016,Recruiting,No Results Available,Infection Viral,Other: biological samples collection,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 2, 2020",March 2023
1856,NCT04499391,Recruiting,No Results Available,Covid19,Other: Project ECHO,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"December 4, 2020",July 2022
1857,NCT04497948,Terminated,No Results Available,COVID-19,Drug: Acalabrutinib,All,"Adult, Older Adult",Phase 1,8.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 21, 2020","November 18, 2020"
1858,NCT04409327,Terminated,No Results Available,COVID19,Drug: RTB101|Drug: Placebo,All,Older Adult,Phase 2,36.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 11, 2020","January 24, 2021"
1859,NCT04347954,Completed,No Results Available,COVID-19,Drug: Povidone-Iodine 2%|Drug: Povidone-Iodine 0.5%|Drug: Isotonic saline 0.9%,All,"Adult, Older Adult",Phase 1|Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 15, 2020","December 13, 2020"
1860,NCT04409574,Not yet recruiting,No Results Available,"Infection, Coronavirus",,All,Adult,,31.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,June 2020,June 2021
1861,NCT04642638,"Active, not recruiting",No Results Available,Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|COVID-19 Disease,Drug: INO-4800|Device: CELLECTRA® 2000|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,401.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","November 30, 2020",September 2022
1862,NCT04364009,Terminated,No Results Available,COVID-19 Infection|ANAKINRA Treatment|Optimized Standard of Care (oSOC),Drug: Anakinra plus oSOC|Drug: oSOC,All,"Adult, Older Adult",Phase 3,71.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 27, 2020","November 3, 2020"
1863,NCT04442165,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,15393.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 15, 2020","July 14, 2021"
1864,NCT04661462,Recruiting,No Results Available,COVID-19,Other: online survey,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"September 30, 2020","December 31, 2021"
1865,NCT04799743,Not yet recruiting,No Results Available,Covid-19,Drug: Resveratrol|Drug: Placebo capsules,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,May 2022
1866,NCT04795557,Not yet recruiting,No Results Available,Covid19,Dietary Supplement: ADAPT-232 oral solution|Other: Placebo oral solution,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,January 2022
1867,NCT04627584,Recruiting,No Results Available,Covid19,Combination Product: MW33 injection|Combination Product: MW33 injection placebo,All,"Adult, Older Adult",Phase 2,150.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 29, 2020",September 2021
1868,NCT04382196,"Active, not recruiting",No Results Available,Mental Health|Quality of Life,Other: Online survey,All,"Child, Adult, Older Adult",,497.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 17, 2020","December 31, 2022"
1869,NCT04355767,"Active, not recruiting",No Results Available,Covid19,Biological: Convalescent Plasma|Biological: Saline,All,"Adult, Older Adult",Phase 3,511.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","August 11, 2020",April 2021
1870,NCT04560257,Recruiting,No Results Available,SARS-CoV Infection|SARS (Severe Acute Respiratory Syndrome),Device: High flow nasal cannula HFNC,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","December 30, 2020"
1871,NCT04684433,Completed,No Results Available,Covid19,Other: Data extraction from medical files,All,"Child, Adult, Older Adult",,707.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 14, 2020","March 15, 2021"
1872,NCT04468009,Recruiting,No Results Available,SARS-Associated Coronavirus|Covid19|SARS-CoV Infection,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 2,36.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 25, 2020",February 2021
1873,NCT04326075,Recruiting,No Results Available,CPAP Ventilation|COVID-19|Emergency Departments,Device: CPAP treatment,All,"Adult, Older Adult",Not Applicable,900.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","May 31, 2021"
1874,NCT04764747,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"November 1, 2020",April 2021
1875,NCT04818853,Recruiting,No Results Available,Covid19|Aspergillosis|Fungal Infection,Other: Observation to monitor patients for these infections,All,"Adult, Older Adult",,400.0,Other|U.S. Fed|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 9, 2021","March 1, 2024"
1876,NCT04446104,Completed,No Results Available,Covid-19,Drug: Hydroxychloroquine Sulfate Tablets|Drug: Ivermectin 3mg Tab|Drug: Zinc|Drug: Povidone-Iodine|Dietary Supplement: Vitamin C,Male,Adult,Phase 3,4257.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 13, 2020","August 31, 2020"
1877,NCT04363346,"Active, not recruiting",No Results Available,COVID-19,Drug: FT516,All,"Adult, Older Adult",Phase 1,5.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 14, 2020",January 2022
1878,NCT04430062,Completed,No Results Available,General Surgery|Disease Outbreaks,Procedure: Surgical procedures performed under general anesthesia,All,"Child, Adult, Older Adult",,14.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 1, 2020","May 30, 2020"
1879,NCT04330144,Not yet recruiting,No Results Available,Contact Person From COVID-19 Confirmed Patient,Drug: Hydroxychloroquine as post exposure prophylaxis|Other: Others(No intervention),All,"Adult, Older Adult",Phase 3,2486.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"April 1, 2020","March 30, 2022"
1880,NCT04712357,Recruiting,No Results Available,Covid19,Drug: Vitamin C 500 MG Oral Tablet|Drug: Tenofovir disoproxyl fumarate 300 MG Oral Tablet|Drug: Tenofovir disoproxyl fumarate 300 MG plus emtricitabine 200 MG Oral Tablet,All,"Adult, Older Adult",Not Applicable,219.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 9, 2020",January 2023
1881,NCT04797975,Not yet recruiting,No Results Available,Covid19,Biological: KDS-1000|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,54.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,November 2021
1882,NCT04517188,Not yet recruiting,No Results Available,SARS-CoV-2 Infection,Drug: Povidone-Iodine Solution 1.25% w/w [0.125% available iodine] USP,All,"Adult, Older Adult",Phase 4,40.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2021","July 1, 2021"
1883,NCT04410939,Completed,No Results Available,COVID-19|Asymptomatic Pregnant,Diagnostic Test: Reverse transcription polymerase chain reaction,Female,"Child, Adult, Older Adult",,179.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Retrospective,"April 10, 2020","May 21, 2020"
1884,NCT04494204,Completed,No Results Available,Treatment of Covid-19 Virus Infection,Combination Product: Immunofree tablets and Reginmune capsule,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 7, 2020","December 20, 2020"
1885,NCT04360122,Not yet recruiting,No Results Available,Coronavirus Disease (COVID-19),Drug: Levamisole|Drug: Isoprinosine|Drug: Levamisole and Isoprinosine,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 20, 2020","December 1, 2020"
1886,NCT04732858,"Active, not recruiting",No Results Available,COVID-19,Other: Cross sectional e-Survey on surgeons exposed to any educational intervention,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"March 1, 2020","June 1, 2021"
1887,NCT04405310,Completed,No Results Available,SARS Pneumonia,Biological: Convalescent Plasma of patients with COVID-19|Other: placebo (hartmann plus albumine),All,"Adult, Older Adult",Phase 2,42.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","May 20, 2020","December 10, 2020"
1888,NCT04407689,Recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: Interleukin-7|Drug: Placebo,All,"Adult, Older Adult",Phase 2,48.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 8, 2020","December 30, 2021"
1889,NCT04379076,Recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: Interleukin-7|Drug: Placebos,All,"Adult, Older Adult",Phase 2,48.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 14, 2020","December 30, 2021"
1890,NCT04340232,Withdrawn,No Results Available,COVID-19,Drug: Baricitinib,All,"Adult, Older Adult",Phase 2|Phase 3,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,October 2021
1891,NCT04348071,Withdrawn,No Results Available,COVID-19,Drug: Ruxolitinib,All,"Adult, Older Adult",Phase 2|Phase 3,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,July 2021,October 2021
1892,NCT04487873,Recruiting,No Results Available,Covid19|Bronchiectasis,,All,Adult,,28.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 23, 2020","December 31, 2020"
1893,NCT04443140,Completed,No Results Available,Covid-19|Preeclampsia|Pregnancy Related,"Diagnostic Test: PCR, lung ultrasound",Female,Adult,,131.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2020","July 10, 2020"
1894,NCT04344379,Suspended,No Results Available,SARS-CoV-2 Infection,Drug: hydroxychloroquine|Drug: azithromycin|Drug: hydroxychloroquine placebo,All,"Adult, Older Adult",Phase 3,122.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","April 17, 2020","July 15, 2020"
1895,NCT04561154,Recruiting,No Results Available,SARS-COV2|COVID19,Other: questionnaire,All,"Adult, Older Adult",Not Applicable,134.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"June 11, 2020","June 11, 2022"
1896,NCT04775784,Recruiting,No Results Available,COVID-19 Testing|CNS Disease|CNS Infection,Diagnostic Test: Determination of SARS-CoV2 presence in CNS,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 17, 2020","December 20, 2022"
1897,NCT04416399,Terminated,No Results Available,Coronavirus Infection,Drug: Budesonide dry powder inhaler,All,"Adult, Older Adult",Phase 2,146.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 16, 2020","January 12, 2021"
1898,NCT04487197,Completed,No Results Available,Kidney Transplant|Pancreatic Transplat|Pancreatic Islets Langerhans,Procedure: blood sample for seroepidemiological investigation,All,"Adult, Older Adult",,282.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 15, 2020","January 15, 2021"
1899,NCT04407273,Completed,No Results Available,COVID|Statin|Cardiovascular Diseases,Drug: observational,All,"Adult, Older Adult",,2159.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 14, 2020","December 30, 2020"
1900,NCT04443803,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,9.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 1, 2020","August 31, 2020"
1901,NCT04784897,Recruiting,No Results Available,COVID-19,Drug: Brilacidin|Drug: Placebo|Drug: Standard of Care (SoC),All,"Adult, Older Adult",Phase 2,120.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 22, 2021",July 2021
1902,NCT04699578,Recruiting,No Results Available,Covid19|Obstetric Complication|SARS-CoV Infection|Preterm Birth|Miscarriage|Placenta Diseases,Diagnostic Test: Covid-19 positive,Female,"Adult, Older Adult",,230.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 28, 2020","May 1, 2022"
1903,NCT04664309,Recruiting,No Results Available,COVID-19|Immunity|Vaccine,Other: No intervention,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 26, 2021",January 2023
1904,NCT04570449,Withdrawn,No Results Available,Covid19,Drug: Fluoxetine|Drug: Placebo,All,"Adult, Older Adult",Early Phase 1,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",November 2020,December 2021
1905,NCT04393311,Not yet recruiting,No Results Available,COVID-19,Drug: Ulinastatin|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,160.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",March 2021,September 2021
1906,NCT04379297,"Active, not recruiting",No Results Available,COVID19,,All,"Adult, Older Adult",,1800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020","December 31, 2021"
1907,NCT04353271,Terminated,No Results Available,Covid 19|Corona Virus Infection,Drug: Hydroxychloroquine|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,58.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 17, 2020","July 8, 2020"
1908,NCT04831866,Not yet recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,1000000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 30, 2021","April 15, 2023"
1909,NCT04419571,Completed,No Results Available,COVID-19|Emergency General Surgery,Procedure: Emergency Laparotomy,All,"Adult, Older Adult",,94.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 23, 2020","June 16, 2020"
1910,NCT04432987,Recruiting,No Results Available,COVID-19,Drug: Pulmozyme,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 25, 2020","September 25, 2020"
1911,NCT04699227,Recruiting,No Results Available,Covid19|Ischemia,Procedure: Cuff application with inflation|Other: Sham inflation,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"April 23, 2020","April 30, 2021"
1912,NCT04649658,Completed,No Results Available,Covid19,Behavioral: Prone position,All,"Adult, Older Adult",,93.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","November 30, 2020"
1913,NCT04519125,Not yet recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19,Drug: Tenofovir/ Emtricitabine ( 300 mg / 200 mg daily during 60 days) + Personal Protective Equipment (PPE)|Other: Placebo (1 tablet daily during 60 days) + Personal Protective Equipment (PPE),All,"Adult, Older Adult",Phase 2|Phase 3,950.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","August 30, 2020","April 1, 2021"
1914,NCT04813939,Recruiting,No Results Available,Covid19,"Device: IB10 sphingotest® bio-ADM® apparatus (Sphingotec GmbH, Hennigsdorf, Germany)",All,"Adult, Older Adult",,65.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 22, 2021","January 31, 2022"
1915,NCT04480632,Not yet recruiting,No Results Available,COVID-19,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 2,44.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020",August 2022
1916,NCT04523181,Recruiting,No Results Available,Covid-19,Drug: Antroquinonol|Drug: Placebo,All,"Adult, Older Adult",Phase 2,174.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 8, 2020","May 31, 2021"
1917,NCT04304053,Completed,No Results Available,COVID-19,Drug: Treatment and prophylaxis|Other: Standard Public Health measures,All,"Adult, Older Adult",Phase 3,2300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 18, 2020","June 15, 2020"
1918,NCT04418505,Recruiting,No Results Available,COVID-19,Device: Vielight RX Plus,All,"Adult, Older Adult",Not Applicable,280.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 2, 2020","August 1, 2021"
1919,NCT04396067,Not yet recruiting,No Results Available,COVID-19,Drug: Aerosolized 13 cis retinoic acid|Drug: Aerosolized All trans retinoic acid|Other: Placebo,All,"Adult, Older Adult",Phase 2,360.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,October 2020,December 2020
1920,NCT04796402,Recruiting,No Results Available,Covid19,Biological: Bamlanivimab|Other: Standard of Care,All,"Adult, Older Adult",Phase 4,576.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 17, 2021","December 31, 2021"
1921,NCT04472611,Recruiting,No Results Available,SARS-CoV-2,Drug: Standard of Care (SOC) and Colchicine+Rosuvastatin,All,"Adult, Older Adult",Phase 3,466.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 30, 2020","August 1, 2022"
1922,NCT04572412,Recruiting,No Results Available,Covid19,Radiation: Low dose Radiotherapy,All,"Adult, Older Adult",Not Applicable,13.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"November 25, 2020",April 2021
1923,NCT04352959,Completed,No Results Available,COVID19|Mouthwash|Saliva,Device: mouthrinse with bêta-cyclodextrin and citrox|Device: mouthrinse without bêta-cyclodextrin and citrox,All,"Adult, Older Adult",Not Applicable,176.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","April 27, 2020","December 11, 2020"
1924,NCT04510662,Recruiting,No Results Available,"COVID-19|Respiratory Insufficiency|Telmisartan|Respiratory Distress Syndrome, Adult",Drug: Telmisartan,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,August 2020,April 2021
1925,NCT04355793,Available,No Results Available,COVID-19,Drug: Ruxolitinib,All,"Child, Adult, Older Adult",,,Industry,Expanded Access:Treatment IND/Protocol,,,
1926,NCT04357327,Completed,No Results Available,COVID-19|SARS-CoV 2|Corona Virus Infection,Diagnostic Test: rapid salivary test,All,"Child, Adult, Older Adult",Not Applicable,122.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic,"April 16, 2020","July 31, 2020"
1927,NCT04546191,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,1580.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"July 1, 2020","September 1, 2020"
1928,NCT04764981,Enrolling by invitation,No Results Available,Covid19|SARS-CoV Infection|Olfactory Disorder|Anosmia,Other: Essence oils,All,"Adult, Older Adult",Not Applicable,350.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",May 2021,"May 1, 2024"
1929,NCT04739449,Not yet recruiting,No Results Available,SARS-CoV Infection|Covid19,"Behavioral: Coaching, Cleaning, Communication, Collaboration",All,"Adult, Older Adult",Not Applicable,100.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 7, 2021",January 2022
1930,NCT04507282,Completed,No Results Available,COVID-19,Drug: LMWH,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020","July 15, 2020"
1931,NCT04367883,Recruiting,No Results Available,COVID19|Influenza Vaccination|ACE Inhibitors|ARB,Drug: ACE inhibitor|Drug: ARB,All,"Child, Adult, Older Adult",,2574.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"March 1, 2020","August 31, 2023"
1932,NCT04728802,"Active, not recruiting",No Results Available,Covid19|SARS (Severe Acute Respiratory Syndrome),Drug: Proxalutamide|Drug: Standard of Care,All,"Adult, Older Adult",Phase 3,590.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 2, 2021","April 22, 2021"
1933,NCT04340349,Enrolling by invitation,No Results Available,Hydroxychloroquine|Antimalarials|Enzyme Inhibitors|Antirheumatic Agents,Drug: Hydroxychloroquine Sulfate|Drug: Bromhexine 8 MG,All,Adult,Early Phase 1,214.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","February 1, 2021","June 30, 2021"
1934,NCT04495907,Recruiting,No Results Available,SARS-CoV-2 Infection (Asymptomatic)|SARS-CoV-2 Infection (Symptomatic),,All,"Adult, Older Adult",,1000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Other,"August 6, 2020",June 2021
1935,NCT04609501,"Active, not recruiting",No Results Available,Delivery; Trauma|Covid19,,Female,Adult,,440.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","June 30, 2024"
1936,NCT04416334,Recruiting,No Results Available,SARS-CoV-2 Infection (COVID-19),Drug: Colchicine plus symptomatic treatment (paracetamol)|Drug: Symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations),All,"Adult, Older Adult",Phase 3,954.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 19, 2020","December 31, 2021"
1937,NCT04371471,Completed,No Results Available,Sars-CoV2|Covid19,Diagnostic Test: STC-19 score,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","April 30, 2020"
1938,NCT04820803,Recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,Other: ORAL INTERVENTION WITH CETYLPYRIDINIUM CHLORIDE|Other: PLACEBO,All,"Adult, Older Adult",Not Applicable,80.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","February 3, 2021","May 5, 2021"
1939,NCT04369794,Recruiting,No Results Available,COVID-19|Therapeutic Vaccine|BCG|SARS-CoV 2|Transmission,Biological: BCG|Biological: Placebo,All,"Adult, Older Adult",Phase 4,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 10, 2020",August 2023
1940,NCT04391881,Recruiting,No Results Available,Oral Health and COVID 19,,All,Adult,,500.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 30, 2020","August 30, 2020"
1941,NCT04426201,Recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: CYT107|Drug: Placebo,All,"Adult, Older Adult",Phase 2,48.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 20, 2020","December 31, 2021"
1942,NCT04809389,Recruiting,No Results Available,Covid19,Biological: DelNS1-nCoV-RBD LAIV|Biological: Matching placebo,All,Adult,Phase 1,115.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 29, 2021",September 2022
1943,NCT04522466,Terminated,No Results Available,Sars-CoV2,Drug: Hydroxychloroquine (HCQ),All,"Adult, Older Adult",Phase 3,7.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020","May 28, 2020"
1944,NCT04479150,Completed,No Results Available,Covid19|Surgery--Complications,,All,"Adult, Older Adult",,5307.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 1, 2020","August 31, 2020"
1945,NCT04421391,Recruiting,No Results Available,Covid19|Coronavirus|SARS-CoV 2,Dietary Supplement: QuadraMune(TM),All,"Adult, Older Adult",Not Applicable,500.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 8, 2020","November 8, 2020"
1946,NCT04442178,Recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: CYT107|Drug: Placebo,All,"Adult, Older Adult",Phase 2,48.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 15, 2020","December 31, 2021"
1947,NCT04738175,Not yet recruiting,No Results Available,Covid19,Biological: COVI-AMG|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,209.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",April 2021,November 2021
1948,NCT04723706,Recruiting,No Results Available,"Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)",Diagnostic Test: COVID-19 serology IgG,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 19, 2021","April 1, 2022"
1949,NCT04588909,"Active, not recruiting",No Results Available,Colo-rectal Cancer,Procedure: Colorectal resections,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 23, 2020","October 22, 2020"
1950,NCT04318444,Recruiting,No Results Available,COVID-19|Corona Virus Infection,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2|Phase 3,1600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 29, 2020",March 2022
1951,NCT04775134,Recruiting,No Results Available,Covid19,Diagnostic Test: Lung biopsy,All,"Adult, Older Adult",,75.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 31, 2021","January 31, 2022"
1952,NCT04824638,Recruiting,No Results Available,Healthy|Immunization; Infection,Biological: two doses of BNT162b2 vaccine|Biological: one dose of BNT162b2 vaccine,All,"Adult, Older Adult",Phase 2,300.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 8, 2021","December 8, 2023"
1953,NCT04542200,Enrolling by invitation,No Results Available,Covid19,Biological: Antibody testing,All,"Adult, Older Adult",,70812.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2021","December 31, 2022"
1954,NCT04530357,Completed,No Results Available,Covid19|SARS-CoV Infection|Vaccine Adverse Reaction,Biological: QazCovid-in® - COVID-19 inactivated vaccine|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,244.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"September 19, 2020","November 30, 2020"
1955,NCT04371029,Recruiting,No Results Available,ARDS|COVID-19,Other: PSG,All,"Adult, Older Adult",Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 28, 2020","December 28, 2020"
1956,NCT04824625,Not yet recruiting,No Results Available,Covid-19 (SARS-CoV-2),,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,March 2021,"April 10, 2021"
1957,NCT04342884,Recruiting,No Results Available,Coronavirus|COVID,,All,"Child, Adult, Older Adult",,150000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 8, 2020",December 2021
1958,NCT04684550,Not yet recruiting,No Results Available,SARS-CoV Infection|Covid19|Infection Viral,Drug: Stabilized hypochlorous acid|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,556.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","February 15, 2021","August 15, 2021"
1959,NCT04403438,Enrolling by invitation,No Results Available,Behcet Disease|COVID|FMF,"Other: ıt will be compared pain, sleep, fatigue, physical activity level and quality of life and questioning exercise habits before and after the covid-19 outbreak in patients with Behçet and FMF.",All,"Adult, Older Adult",,45.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","June 15, 2020"
1960,NCT04573270,Completed,No Results Available,Covid19|Prophylaxis,Biological: PrimePro|Other: Placebo,All,"Adult, Older Adult",Phase 1,40.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 24, 2020","September 1, 2020"
1961,NCT04333550,Recruiting,No Results Available,COVID-19,Drug: Deferoxamine,All,"Child, Adult, Older Adult",Phase 1|Phase 2,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2020,March 2021
1962,NCT04542122,Not yet recruiting,No Results Available,Morals,Behavioral: Choices and judgements,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other","September 3, 2020","August 2, 2021"
1963,NCT04347928,Completed,No Results Available,COVID-19|ARDS|Sars-CoV2,,All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","November 6, 2020"
1964,NCT04523090,Recruiting,No Results Available,Covid19,Drug: Nitazoxanide|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,960.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","August 27, 2020",February 2022
1965,NCT04814914,Recruiting,No Results Available,COVID-19,Other: KB109 + Self Supportive Care|Other: Self Supportive Care (SSC) Alone,All,"Adult, Older Adult",,300.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,March 2021,August 2021
1966,NCT04639375,Recruiting,No Results Available,SARS-CoV-2,Biological: Vaccinated with polio vaccine (IPV),All,"Adult, Older Adult",Phase 4,300.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 15, 2020","April 18, 2021"
1967,NCT04587375,Completed,No Results Available,Covid 19,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","May 30, 2020"
1968,NCT04327674,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,375.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 14, 2020","May 15, 2020"
1969,NCT04452435,Completed,No Results Available,COVID-19,Drug: C21|Drug: Placebo,All,"Adult, Older Adult",Phase 2,106.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 21, 2020","October 13, 2020"
1970,NCT04324606,"Active, not recruiting",No Results Available,Coronavirus,Biological: ChAdOx1 nCoV-19|Biological: MenACWY|Biological: ChAdOx1 nCoV-19 full boost|Biological: ChAdOx1 nCoV-19 half boost|Biological: MenACWY boost|Drug: Paracetamol|Biological: ChAdOx1 nCoV-19 0.5mL boost|Biological: ChAdOx1 nCoV-19 0.5mL (3.5-6.5x10^10vp) late vaccine (LV)|Biological: ChAdOx1 nCoV-19 0.5mL (3.5-6.5x10^10vp) late vaccine two (LVT),All,Adult,Phase 1|Phase 2,1090.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"April 23, 2020",October 2021
1971,NCT04840940,Recruiting,No Results Available,Ventilator Associated Pneumonia|Covid19,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 21, 2020","December 21, 2021"
1972,NCT04490772,Not yet recruiting,No Results Available,Infectious,Diagnostic Test: Laboratory tests,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,July 2020,September 2020
1973,NCT04400890,"Active, not recruiting",No Results Available,COVID-19,Drug: Resveratrol|Dietary Supplement: Vitamin D3,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 12, 2020",March 2021
1974,NCT04336761,Completed,No Results Available,Coronavirus|COVID|Infection Viral,Diagnostic Test: nasopharyngeal swab,All,"Child, Adult",,901.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","January 1, 2021"
1975,NCT04459689,Recruiting,No Results Available,Primary Immune Deficiency|COVID,,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 15, 2020","March 31, 2022"
1976,NCT04649957,Not yet recruiting,No Results Available,"Infections, Respiratory|Respiratory Physiology|Respiratory Muscle|Symptoms and General Pathology",,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 4, 2021","December 17, 2021"
1977,NCT04628104,Not yet recruiting,No Results Available,Myocardial Infarction,Radiation: cardiac magnetic resonance,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"January 1, 2021",October 2023
1978,NCT04444401,Recruiting,No Results Available,Neuroendocrine Tumors|COVID-19,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"June 15, 2020","December 15, 2021"
1979,NCT04762771,Suspended,No Results Available,Covid19,Drug: Colchicine,All,"Adult, Older Adult",Phase 1|Phase 2,75.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","November 1, 2021"
1980,NCT04366167,Recruiting,No Results Available,Cardiac Surgery|COVID,Other: Cardiac surgery,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 18, 2020","December 31, 2021"
1981,NCT04444271,Recruiting,No Results Available,COVID-19,Drug: Mesenchymal stem cells|Other: Placebo,All,"Child, Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","September 30, 2020"
1982,NCT04622891,Completed,No Results Available,Covid19,Drug: Clarithromycin 500mg|Drug: Azithromycin|Drug: Placebo,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2020","July 30, 2020"
1983,NCT04537663,Recruiting,No Results Available,Respiratory Tract Infections|Covid19,Drug: Bacille Calmette-Guérin (BCG)|Drug: Placebo,All,"Adult, Older Adult",Phase 4,5200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 25, 2020",April 2021
1984,NCT04738136,Not yet recruiting,No Results Available,Covid19|SARS-CoV-2 Infection,Drug: S-1226,All,"Adult, Older Adult",Phase 2,30.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 15, 2021","December 31, 2021"
1985,NCT04806113,Recruiting,No Results Available,Covid19|Rheumatic Diseases|Rheumatoid Arthritis|SLE,Biological: Moderna COVID-19 vaccine,All,"Adult, Older Adult",Phase 3,220.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 11, 2021","March 15, 2022"
1986,NCT04333472,Recruiting,No Results Available,COVID-19|Coronavirus Infection,Drug: Piclidenoson|Drug: Placebo,All,"Adult, Older Adult",Phase 2,40.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 6, 2021","July 6, 2022"
1987,NCT04437706,Enrolling by invitation,No Results Available,COVID-19|SARS-CoV 2,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"December 11, 2020","June 30, 2022"
1988,NCT04390594,Recruiting,No Results Available,COVID-19,Drug: Nafamostat Mesilate,All,"Adult, Older Adult",Phase 3,186.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 13, 2020","August 12, 2021"
1989,NCT04445285,Recruiting,No Results Available,Covid19,Drug: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase)|Drug: 0.9%sodium chloride,All,"Adult, Older Adult",Phase 2,44.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 28, 2020","February 28, 2021"
1990,NCT04383002,Recruiting,No Results Available,COVID-19,Drug: Nitric Oxide,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 2, 2020",August 2021
1991,NCT04403100,Recruiting,No Results Available,COVID-19|Coronavirus Infection|Virus Disease|Acute Respiratory Infection|SARS-CoV Infection,Drug: Hydroxychloroquine Sulfate Tablets|Drug: Lopinavir/ Ritonavir Oral Tablet|Drug: Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1968.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 3, 2020","February 1, 2021"
1992,NCT04700163,"Active, not recruiting",No Results Available,Covid19,Biological: C144-LS and C-135-LS,All,"Adult, Older Adult",Phase 1,23.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 11, 2021","April 15, 2022"
1993,NCT04619706,Recruiting,No Results Available,COVID-19,Drug: FSD201|Drug: Placebo,All,"Adult, Older Adult",Phase 2,350.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 14, 2020","December 5, 2021"
1994,NCT04359680,"Active, not recruiting",No Results Available,COVID-19|Viral Respiratory Illnesses,Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,All,"Adult, Older Adult",Phase 3,1407.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","May 13, 2020","March 29, 2021"
1995,NCT04386265,Enrolling by invitation,No Results Available,COVID-19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 15, 2020","May 11, 2022"
1996,NCT04381351,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","July 31, 2021"
1997,NCT04348370,Recruiting,No Results Available,Coronavirus|Coronavirus Infection|Coronavirus as the Cause of Diseases Classified Elsewhere,Biological: BCG Vaccine|Biological: Placebo Vaccine,All,"Adult, Older Adult",Phase 4,1800.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","April 20, 2020",November 2021
1998,NCT04377035,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 31, 2020","March 1, 2021"
1999,NCT04834401,Recruiting,No Results Available,Multiple Sclerosis|Covid19,,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 22, 2021","April 15, 2023"
2000,NCT04779996,Recruiting,No Results Available,Covid19|Cancer|HIV Infections,Diagnostic Test: Laboratory Samples,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"February 16, 2021","February 28, 2022"
2001,NCT04368728,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19,Biological: BNT162b1|Biological: BNT162b2|Other: Placebo|Biological: BNT162b2SA,All,"Child, Adult, Older Adult",Phase 2|Phase 3,43998.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","April 29, 2020","April 6, 2023"
2002,NCT04477993,Terminated,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|SARS-CoV2,Drug: Janus Kinase Inhibitor (ruxolitinib)|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,5.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 14, 2020","March 29, 2021"
2003,NCT04757285,Completed,No Results Available,Psychological Stress|Hemostatic Disorder,,All,Adult,,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 10, 2020","October 30, 2020"
2004,NCT04354428,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV-2,Drug: Ascorbic Acid|Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Folic Acid|Drug: Lopinavir 200 MG / Ritonavir 50 MG [Kaletra],All,"Adult, Older Adult",Phase 2|Phase 3,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 16, 2020",January 2021
2005,NCT04444609,Recruiting,No Results Available,"COVID-19|SARS-CoV 2|ARDS, Human|Immune System Disorder","Other: Blood tests sputum, nasal lavage and brushing",All,"Child, Adult, Older Adult",,230.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 18, 2020",June 2022
2006,NCT04756323,"Active, not recruiting",No Results Available,COVID-19,Biological: medium dosage inactivated SARS-CoV-2 vaccine|Biological: high dosage inactivated SARS-CoV-2 vaccine|Biological: Placebo,All,"Adult, Older Adult",Phase 2,1000.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 27, 2020","February 28, 2022"
2007,NCT04712279,Not yet recruiting,No Results Available,Covid19,Drug: Ivermectin 0.6mg/kg/day|Drug: Ivermectin 1.0mg/kg/day|Drug: Placebo|Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 2|Phase 3,294.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","January 25, 2021","April 20, 2021"
2008,NCT04746092,Recruiting,No Results Available,CLL|Multiple Myeloma|Lymphoma,,All,"Adult, Older Adult",,550.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 6, 2021","May 24, 2022"
2009,NCT04344145,Completed,No Results Available,COVID-19,,All,"Adult, Older Adult",,693.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"April 16, 2020","May 29, 2020"
2010,NCT04549337,Recruiting,No Results Available,COVID-19,Behavioral: Exercise training,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","September 25, 2020","May 1, 2021"
2011,NCT04819802,Recruiting,No Results Available,Covid-19|Critical Illness|Hemodynamics|SARS-CoV Infection,Other: Measurement of sublingual microcirculation|Other: Plasma sampling,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 28, 2021",October 2022
2012,NCT04371328,"Active, not recruiting",No Results Available,Emergencies,Other: RECOP unit patient,All,"Child, Adult, Older Adult",,1860.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 13, 2020",March 2021
2013,NCT04435314,Not yet recruiting,No Results Available,covid19,Drug: Nitazoxanide|Drug: Placebo,All,"Adult, Older Adult",Phase 2,200.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",June 2020,August 2020
2014,NCT04522986,Completed,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Biological: Mesenchymal stem cell,All,"Adult, Older Adult",Phase 1,6.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 21, 2020","February 2, 2021"
2015,NCT04464408,Recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,576.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 23, 2020",December 2021
2016,NCT04546776,Enrolling by invitation,No Results Available,SARS-CoV Infection,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 8, 2020",June 2022
2017,NCT04567836,Recruiting,No Results Available,Covid19,Other: Investigation of the prevalence of test positivity,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","December 1, 2020"
2018,NCT04844515,Not yet recruiting,No Results Available,Healthcare Workers|COVID-19,,All,"Adult, Older Adult",,15000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2021","April 23, 2021"
2019,NCT04643691,Recruiting,No Results Available,COVID-19|ARDS,Drug: Losartan 50 mg and Spironolactone 25 mg pillules oral use,All,"Adult, Older Adult",Phase 2,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 11, 2020","October 30, 2022"
2020,NCT04448782,Completed,No Results Available,Mechanical Ventilation Complication,Diagnostic Test: Asynchronies detection,All,"Adult, Older Adult",,32.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 9, 2020","June 30, 2020"
2021,NCT04374461,Recruiting,No Results Available,Covid-19,Drug: N-acetylcysteine|Other: Peripheral Blood,All,"Adult, Older Adult",Phase 2,84.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020",May 2023
2022,NCT04671017,"Active, not recruiting",No Results Available,Sars-Cov-2 Virus Infection,Biological: VLA2001,All,Adult,Phase 1|Phase 2,153.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 16, 2020","August 28, 2021"
2023,NCT04784546,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021",January 2022
2024,NCT04802278,Recruiting,No Results Available,Covid19|Breastfeeding|Vaccine Exposure Via Breast Milk,Biological: COVID-19 vaccine,All,"Child, Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","December 1, 2021"
2025,NCT04486313,Completed,No Results Available,COVID-19,Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,All,"Child, Adult, Older Adult",Phase 3,1092.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","August 13, 2020","February 8, 2021"
2026,NCT04344548,Not yet recruiting,No Results Available,COVID,Biological: Allogeneic NK transfer,All,"Adult, Older Adult",Phase 1|Phase 2,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 13, 2020","November 10, 2020"
2027,NCT04335084,Recruiting,No Results Available,COVID-19|Coronavirus Infection|Sars-CoV2|Corona Virus Infection|COVID|Coronavirus|Coronavirus-19|Coronavirus 19,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc,All,"Adult, Older Adult",Phase 2,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","June 22, 2020",December 2021
2028,NCT04377503,Not yet recruiting,No Results Available,Cytokine Release Syndrome|Covid-19,Drug: Tocilizumab 180 MG/ML|Drug: Methylprednisolone Sodium Succinate,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,May 2020,November 2020
2029,NCT04497623,Completed,No Results Available,Covid19,Device: Invasive mechanical ventilation using the Unisabana-Herons Ventilator during 24 hours,All,"Adult, Older Adult",Not Applicable,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,"July 28, 2020","September 20, 2020"
2030,NCT04526977,Recruiting,No Results Available,Covid19|Immune Suppression|HIV-1-infection,Diagnostic Test: Immune response study,All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"January 10, 2021","September 30, 2021"
2031,NCT04408040,Recruiting,No Results Available,COVID,Biological: Convalescent Plasma,All,"Adult, Older Adult",Phase 2,700.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 14, 2020","July 31, 2024"
2032,NCT04745923,Recruiting,No Results Available,Covid19|Chronic Kidney Diseases,,All,"Adult, Older Adult",,28.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 20, 2021","March 30, 2021"
2033,NCT04530656,"Active, not recruiting",No Results Available,COVID-19,"Biological: Two doses of middle-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28|Biological: Two doses of high-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28|Biological: Three doses of high-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 14, 28|Biological: Two doses of placebo at the schedule of day 0, 28（middle-dose group）|Biological: Two doses of placebo at the schedule of day 0, 28（high-dose group）|Biological: Three doses of placebo at the schedule of day 0, 14, 28（high-dose group）",All,"Adult, Older Adult",Phase 1,168.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","August 28, 2020","August 28, 2021"
2034,NCT04331886,Recruiting,No Results Available,COVID-19|Coronavirus,,All,"Adult, Older Adult",,5000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Other,"April 13, 2020",March 2022
2035,NCT04762628,"Active, not recruiting",No Results Available,Covid19,Dietary Supplement: MAF capsules 148 mg|Dietary Supplement: M capsules 148 mg|Other: Standard of care,All,"Adult, Older Adult",Not Applicable,600.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 27, 2020","January 10, 2022"
2036,NCT04408365,Recruiting,No Results Available,COVID|Shock,,All,"Adult, Older Adult",,82.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 5, 2020","May 31, 2021"
2037,NCT04622748,Recruiting,No Results Available,Cognition|Covid-19,Behavioral: Trier Social Stress Test,All,"Adult, Older Adult",,160.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"July 10, 2020","December 10, 2020"
2038,NCT04470323,Recruiting,No Results Available,T Cell Deficiency,Diagnostic Test: Flow cytometry,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 22, 2020",November 2020
2039,NCT04824391,Recruiting,No Results Available,COVID-19,Biological: ERUCOV-VAC 3 µg/0.5 ml Vaccine|Biological: ERUCOV-VAC 6 µg/0.5 ml Vaccine|Other: Placebo,All,Adult,Phase 2,250.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","February 10, 2021","April 30, 2022"
2040,NCT04494984,Completed,No Results Available,Covid19,Drug: INM005|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,242.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 27, 2020","December 30, 2020"
2041,NCT04661631,Recruiting,No Results Available,Ultrasonography|Lung Diseases|Surgical Procedure|Covid19|Severe Acute Respiratory Syndrome Coronavirus 2,Diagnostic Test: Lung ultrasound,All,"Adult, Older Adult",,451.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 8, 2020","November 30, 2021"
2042,NCT04615390,Recruiting,No Results Available,Covid19_rehabilitation,Behavioral: Early rehabilitation|Behavioral: Subacute rehabilitation|Behavioral: Mindfulness training|Behavioral: Personalized ambulatory training,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2020","June 3, 2021"
2043,NCT04275947,Recruiting,No Results Available,COVID-19,"Other: nCapp, a cell phone-based auto-diagnosis system",All,"Adult, Older Adult",,450.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 14, 2020","May 31, 2020"
2044,NCT04445389,Recruiting,No Results Available,SARS-CoV-2,Drug: GX-19|Drug: Saline,All,Adult,Phase 1|Phase 2,210.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","June 17, 2020","June 17, 2022"
2045,NCT04619719,Recruiting,No Results Available,Covid19,Device: Hyperbaric Oxygen Therapy (HBOT),All,"Adult, Older Adult",Not Applicable,360.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 15, 2021","February 15, 2022"
2046,NCT04830046,Not yet recruiting,No Results Available,Multiple Myeloma|Waldenstrom Macroglobulinemia|Immune System Disorder|Covid19,,All,"Adult, Older Adult",,160.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,September 2021,"August 1, 2022"
2047,NCT04395768,Recruiting,No Results Available,COVID19,Dietary Supplement: Vitamin C|Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Zinc Citrate|Dietary Supplement: Vitamin D3|Dietary Supplement: Vitamin B12,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 9, 2020","December 31, 2021"
2048,NCT04832841,Recruiting,No Results Available,Kidney Transplantation,Diagnostic Test: anti-spike SARS-CoV-2 IgG,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 18, 2021","September 30, 2021"
2049,NCT04394117,Recruiting,No Results Available,SARS-Cov-2|COVID-19,Drug: Angiotensin Receptor Blockers|Other: Placebo,All,"Adult, Older Adult",Phase 4,1500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 19, 2020","August 30, 2021"
2050,NCT04280913,Withdrawn,No Results Available,Coronavirus Disease 2019,Other: retrospective analysis,All,"Child, Adult, Older Adult",,0.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 22, 2020","March 31, 2020"
2051,NCT04724850,Not yet recruiting,No Results Available,Coronavirus Disease 2019,,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"February 1, 2021","July 1, 2023"
2052,NCT04431869,Recruiting,No Results Available,Pregnancy Related|COVID|Intestinal Atresia|Limb Anomaly,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 18, 2020",July 2022
2053,NCT04668950,Recruiting,No Results Available,Covid19|Coronavirus,Drug: Fluvoxamine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 22, 2020",September 2021
2054,NCT04805931,Recruiting,No Results Available,Covid19|Vaccine Refusal,Behavioral: Behavioral economics,All,"Adult, Older Adult",Not Applicable,4311.0,U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,"March 15, 2021","November 1, 2021"
2055,NCT04467918,"Active, not recruiting",No Results Available,SARS-CoV2,Drug: Cannabidiol|Other: PLACEBO,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 6, 2020","December 16, 2020"
2056,NCT04555148,Recruiting,No Results Available,Covid19,Biological: GC5131|Other: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 20, 2020",August 2021
2057,NCT04352582,Completed,No Results Available,COVID-19,Other: Survey,All,"Child, Adult, Older Adult",,1194.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 14, 2020","April 30, 2020"
2058,NCT04716647,Completed,No Results Available,Covid19,Other: Ayurveda,All,"Adult, Older Adult",Not Applicable,28.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"October 9, 2020","December 18, 2020"
2059,NCT04409509,Completed,No Results Available,Coronavirus Disease 2019 (COVID-19),"Biological: Garadacimab, Factor XIIa Antagonist Monoclonal Antibody|Drug: Placebo",All,"Adult, Older Adult",Phase 2,124.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 1, 2020","January 12, 2021"
2060,NCT04416113,Not yet recruiting,No Results Available,Photodynamic Therapy& Low Level Laser in Management of COVID 19,Procedure: photobiomodulation and photodynamic therapy,All,"Child, Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,August 2020,February 2021
2061,NCT04521400,Not yet recruiting,No Results Available,Covid19,Drug: High dose Interferon-beta 1a|Drug: Lopinavir/Ritonavir|Drug: Low dose Interferon-beta 1a,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 20, 2020","September 11, 2020"
2062,NCT04785144,Recruiting,No Results Available,COVID-19|COVID-19 Immunisation,Biological: mRNA-1273|Biological: mRNA-1273.351,All,"Adult, Older Adult",Phase 1,210.0,NIH|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 29, 2021","August 31, 2022"
2063,NCT04326920,Completed,No Results Available,COVID-19,Drug: Sargramostim|Other: Control,All,"Adult, Older Adult",Phase 4,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 24, 2020","February 26, 2021"
2064,NCT04760704,Recruiting,No Results Available,Covid19 Vaccine,Biological: Specific antibody and cellular immune response after anti-SARS-CoV-2 vaccine administration,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"February 19, 2021",May 2023
2065,NCT04383678,Recruiting,No Results Available,COVID-19|Extracorporeal Membrane Oxygenation Complication|Acute Respiratory Distress Syndrome,Device: Extracorporeal membrane oxygenation,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","April 1, 2021"
2066,NCT04402905,Completed,No Results Available,Coronavirus Infection,,All,"Adult, Older Adult",,450.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 15, 2020","August 15, 2020"
2067,NCT04354701,Recruiting,No Results Available,COVID-19|Invasive Malignancy (Any Type),Other: Web-based REDCap survey,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 17, 2020",December 2022
2068,NCT04376944,Recruiting,No Results Available,Caregivers|COVID-19,Other: Survey,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"April 1, 2020","December 30, 2020"
2069,NCT04383613,Recruiting,No Results Available,Covid-19|ARDS,Other: Prone positioning,All,"Adult, Older Adult",Not Applicable,340.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 15, 2020","June 1, 2021"
2070,NCT04546737,Recruiting,No Results Available,Covid19|Neurological Manifestations|Brain Damage,Other: Magnetic Resonance Spectroscopy (MRS).,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 8, 2020",May 2022
2071,NCT04446377,Recruiting,No Results Available,COVID-19 Disease,Drug: Apilimod Dimesylate Capsule|Other: Placebo,All,"Adult, Older Adult",Phase 2,142.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 15, 2020","April 30, 2021"
2072,NCT04700462,Recruiting,No Results Available,Covid19|Health Behavior,Behavioral: Sm-EMA,All,"Adult, Older Adult",Not Applicable,250.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 5, 2021","October 30, 2021"
2073,NCT04350931,Not yet recruiting,No Results Available,Coronavirus Disease (COVID-19),Biological: intradermal injection of BCG Vaccine|Other: placebo,All,"Adult, Older Adult",Phase 3,900.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"April 20, 2020","December 1, 2020"
2074,NCT04821674,Recruiting,No Results Available,Covid19,Biological: DS-5670a|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,152.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","March 15, 2021","December 31, 2022"
2075,NCT04603079,Not yet recruiting,No Results Available,Nurse's Role|Infection,Behavioral: Intervention for COVID-19 preventive protocols,Female,"Child, Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"April 1, 2021","September 1, 2021"
2076,NCT04715295,Recruiting,No Results Available,COVID-19,Drug: Doxycycline Tablets|Drug: Rivaroxaban 15Mg Tab|Combination Product: Hydroxychloroquine and Azithromycin,All,"Adult, Older Adult",Phase 4,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 5, 2020","September 5, 2021"
2077,NCT04445402,Recruiting,No Results Available,Pediatric Cancer|Immune System Disorder|COVID-19|Hemoglobinopathies,,All,"Child, Adult",,1500.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 30, 2020","May 1, 2022"
2078,NCT04542993,"Active, not recruiting",No Results Available,Covid19|SARS-CoV Infection,Dietary Supplement: Zinc Picolinate|Dietary Supplement: Resveratrol|Dietary Supplement: Zinc Picolinate Placebo|Dietary Supplement: Resveratrol Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"September 8, 2020",June 2022
2079,NCT04434157,Completed,No Results Available,Covid-19,,All,"Child, Adult, Older Adult",,221.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 28, 2020","May 5, 2020"
2080,NCT04409951,Not yet recruiting,No Results Available,"Event, Life Change",,All,"Child, Adult",,100.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,November 2020,September 2021
2081,NCT04756674,Not yet recruiting,No Results Available,Covid19|Muscle Loss|Mitochondrial Alteration,Other: No intervetion will be used,All,"Adult, Older Adult",,36.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 9, 2021","April 30, 2023"
2082,NCT04726111,Recruiting,No Results Available,Covid19,Other: Specimens specific for the study,Female,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"December 30, 2020","August 30, 2021"
2083,NCT04721236,Recruiting,No Results Available,Covid19,Other: hyperimmune plasma,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 19, 2020","May 19, 2022"
2084,NCT04541979,Recruiting,No Results Available,COVID-19,Drug: aerosolized DNase|Drug: NaCl,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 4, 2020","June 1, 2021"
2085,NCT04555096,Recruiting,No Results Available,Covid19|SARS-CoV-2 Infection,Drug: GC4419|Drug: Placebo,All,"Adult, Older Adult",Phase 2,50.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 9, 2020",December 2021
2086,NCT04401371,Completed,No Results Available,Distance Education Learning Environment During COVID 19 Pandemic,,All,"Child, Adult, Older Adult",,418.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 1, 2020","May 10, 2020"
2087,NCT04413435,Completed,No Results Available,Coronavirus Infection|Critical Illness|Characteristics Disease,Other: File Scanning,All,"Adult, Older Adult",,105.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"October 30, 2020","December 25, 2020"
2088,NCT04590170,Recruiting,No Results Available,Covid19,Behavioral: Post-intensive Care unit syndrome,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 30, 2020","April 30, 2023"
2089,NCT04669990,Recruiting,No Results Available,Covid19,Drug: Remdesivir,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"November 19, 2020","November 19, 2021"
2090,NCT04391920,Recruiting,No Results Available,COVID-19,Device: CytoSorb 300 mL device,All,"Adult, Older Adult",,500.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Other,"August 28, 2020",October 2022
2091,NCT04374032,Completed,No Results Available,COVID-19 Infection,Drug: metenkefalin + tridecactide|Drug: The standard of care,All,"Adult, Older Adult",Phase 2|Phase 3,120.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","November 3, 2020"
2092,NCT04793269,Recruiting,No Results Available,Long COVID Syndrome,Other: No intervention,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 23, 2021","April 30, 2024"
2093,NCT04445961,Completed,No Results Available,SARS Pneumonia,Diagnostic Test: Respiratory mechanics measurement|Diagnostic Test: Gas exchange measurement,All,"Adult, Older Adult",,117.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 1, 2020","August 14, 2020"
2094,NCT04777981,Not yet recruiting,No Results Available,COVID-19|SAR,Dietary Supplement: CBDRA60 supplement|Dietary Supplement: Placebo,All,"Adult, Older Adult",Not Applicable,60.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 1, 2021","May 28, 2021"
2095,NCT04724720,Recruiting,No Results Available,Covid-19,Drug: Famotidine|Drug: Placebo,All,"Adult, Older Adult",Phase 2,84.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","January 19, 2021",December 2021
2096,NCT04320277,Not yet recruiting,No Results Available,Pharmacological Action,Drug: Baricitinib,All,"Adult, Older Adult",Phase 2|Phase 3,200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 16, 2020","July 30, 2020"
2097,NCT04453553,Not yet recruiting,No Results Available,COVID,Diagnostic Test: Q16 testing|Diagnostic Test: Nasopharyngeal swab and main laboratory,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"July 2, 2020","September 28, 2020"
2098,NCT04341480,"Active, not recruiting",No Results Available,Gynecological Cancer,Drug: Chemotherapy,Female,"Adult, Older Adult",,305.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","January 10, 2021"
2099,NCT04362969,Not yet recruiting,No Results Available,COVID,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,May 2020,May 2020
2100,NCT04401540,Recruiting,No Results Available,COVID-19|Neonatal Disease|Healthy,,All,Child,,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","December 30, 2020"
2101,NCT04466540,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 4,1300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 12, 2020","March 30, 2021"
2102,NCT04689490,Recruiting,No Results Available,Covid19|Dyspnea,Diagnostic Test: Cardiopulmonary exercise test,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 1, 2020","December 31, 2020"
2103,NCT04689464,Recruiting,No Results Available,Covid19|Anxiety|Depression,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"December 1, 2020","June 1, 2021"
2104,NCT04385186,Not yet recruiting,No Results Available,"Infections, Coronavirus",Drug: Inactivated convalescent plasma|Drug: Support treatment,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"June 20, 2020","December 30, 2020"
2105,NCT04732663,Recruiting,No Results Available,Covid19|Dyspnea,Other: No Intervention,All,"Adult, Older Adult",,225.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"March 4, 2021",December 2023
2106,NCT04794985,Not yet recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,125.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 1, 2021","April 3, 2021"
2107,NCT04706416,"Active, not recruiting",No Results Available,Coronavirus|Covid19,Dietary Supplement: N-acetyl glucosamine (NAG),All,"Adult, Older Adult",Phase 1,50.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 14, 2020","January 15, 2021"
2108,NCT04400448,Not yet recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"June 1, 2020","October 31, 2020"
2109,NCT04460183,Recruiting,No Results Available,COVID-19,"Drug: RESP301, a Nitric Oxide generating solution|Other: Standard of Care",All,"Adult, Older Adult",Phase 2|Phase 3,300.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 29, 2020","April 23, 2021"
2110,NCT04787588,Recruiting,No Results Available,Asthma|Covid19,,All,"Adult, Older Adult",,235.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 14, 2021","February 1, 2022"
2111,NCT04573335,Completed,No Results Available,"Diabetes|Covid19|Isolation, Social",,All,"Adult, Older Adult",,1282.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 1, 2020","July 30, 2020"
2112,NCT04460534,Recruiting,No Results Available,COVID,Diagnostic Test: diagnostic,Male,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 7, 2020","August 31, 2021"
2113,NCT04713150,Recruiting,No Results Available,Child Development|Prenatal Infection|Prenatal Stress|Covid19,Other: No Intervention,All,"Adult, Older Adult",,75.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"October 5, 2020",November 2021
2114,NCT04466670,Recruiting,No Results Available,COVID-19,Drug: unfractionated Heparin|Drug: Unfractionated heparin nebulized|Drug: acetylsalicylic acid|Drug: Enoxaparin,All,"Adult, Older Adult",Phase 3,310.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 8, 2020","April 30, 2021"
2115,NCT04425629,Recruiting,No Results Available,COVID-19,Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 2|Phase 3,6420.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 16, 2020","August 28, 2021"
2116,NCT04824443,Recruiting,No Results Available,Covid19|Coronavirus|Cancer,Other: Aerobic Exercise Therapy,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 29, 2021","March 29, 2023"
2117,NCT04503057,Recruiting,No Results Available,"Covid19|ARDS, Human|ALI",,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 1, 2020","May 1, 2024"
2118,NCT04532931,Recruiting,No Results Available,COVID-19,Other: Standard of care (Paracetamol)|Drug: Artesunate-amodiaquine|Drug: Pyronaridine-artesunate|Drug: Favipiravir plus Nitazoxanide|Drug: Sofosbuvir/daclatasvir,All,"Adult, Older Adult",Phase 2,250.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 3, 2020",October 2021
2119,NCT04628039,Not yet recruiting,No Results Available,COVID-19,Other: Rehabilitation-focused program,All,"Adult, Older Adult",Not Applicable,506.0,U.S. Fed,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"April 15, 2021","October 31, 2024"
2120,NCT04487964,Recruiting,No Results Available,COVID-19,Dietary Supplement: Licorice extract,All,"Child, Adult, Older Adult",Not Applicable,70.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 1, 2020",January 2021
2121,NCT04324996,Recruiting,No Results Available,COVID-19,"Biological: NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells",All,"Adult, Older Adult",Phase 1|Phase 2,90.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 21, 2020","August 31, 2022"
2122,NCT04481620,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,1315.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 31, 2020","May 31, 2021"
2123,NCT04558749,Recruiting,No Results Available,Covid19,Other: State-trait anxiety inventory scale|Other: Edinburgh Postnatal Depression Scale (EDPS),Female,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"October 1, 2020",June 2021
2124,NCT04472013,Recruiting,No Results Available,COVID-19 Disease,Other: Data collection from lumbar puncture|Other: Data collection from blood draw|Other: CNS magnetic resonance imaging (MRI) imaging|Other: Microscopy of defined brain regions on autopsy specimens,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 12, 2020",December 2022
2125,NCT04528901,Recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,1080.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 4, 2020",December 2022
2126,NCT04425850,Completed,Has Results,Covid19,Combination Product: Iota carrageenan nasal spray and Ivermectin oral drops (used as buccal drops),All,"Adult, Older Adult",,229.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","August 10, 2020"
2127,NCT04609423,Recruiting,No Results Available,Covid-19|Respiratory Tract Infections,Dietary Supplement: Cod liver oil|Dietary Supplement: Corn oil (placebo),All,"Adult, Older Adult",Phase 4,80000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","November 10, 2020",May 2023
2128,NCT04346342,Completed,No Results Available,COVID|Mechanical Ventilation|Acute Respiratory Failure,,All,"Adult, Older Adult",,1122.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 6, 2020","September 1, 2020"
2129,NCT04361786,Completed,No Results Available,COVID 19,,All,"Child, Adult, Older Adult",,10.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 1, 2020","October 30, 2020"
2130,NCT04715919,Recruiting,No Results Available,Covid19,Diagnostic Test: Chest Computed Tomography|Diagnostic Test: Pulmonary Function Tests|Other: Six Minutes Walk Test|Other: Quality of Life,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 15, 2021","June 1, 2021"
2131,NCT04653844,"Active, not recruiting",No Results Available,Covid-19|SARS-CoV Infection,,All,"Child, Adult, Older Adult",,7000000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"February 1, 2020","March 30, 2021"
2132,NCT04567576,Not yet recruiting,No Results Available,Rheumatic Diseases|Covid19,Drug: Disease-modifying antirheumatic drugs (DMARDs),All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,October 2020,"October 31, 2021"
2133,NCT04805645,Not yet recruiting,No Results Available,Covid19|Critically Ill,Other: No intervention (Retrospective Cohort Observational),All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,April 2021,May 2021
2134,NCT04530474,Not yet recruiting,No Results Available,Covid19,Drug: Ivermectin Pill|Drug: Placebo,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","October 1, 2020","December 31, 2021"
2135,NCT04600895,Recruiting,No Results Available,Covid19,Drug: Favipiravir|Drug: Placebo,All,"Adult, Older Adult",Phase 3,826.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 30, 2020",October 2021
2136,NCT04378881,"Active, not recruiting",No Results Available,COVID|Drug Effect|Drug Interaction|Adverse Drug Event,,All,"Adult, Older Adult",,100.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020","April 30, 2021"
2137,NCT04372628,Recruiting,No Results Available,COVID-19,Drug: Lopinavir/Ritonavir 400 mg/100 mg|Other: Placebo,All,"Adult, Older Adult",Phase 2,600.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 1, 2020","May 1, 2021"
2138,NCT04634370,Not yet recruiting,No Results Available,Covid19|Sars-cov 2,Biological: Natural Killer Cells infusion,All,"Adult, Older Adult",Phase 1,24.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 2, 2021","March 30, 2021"
2139,NCT04760639,Recruiting,No Results Available,Covid19,Diagnostic Test: Breath test,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 16, 2020","April 16, 2021"
2140,NCT04352842,Completed,No Results Available,Covid19|Echocardiography,Other: Echocardiography,All,"Adult, Older Adult",,51.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 21, 2020","April 8, 2020"
2141,NCT04810065,Recruiting,No Results Available,Long Covid,Other: SingStrong: Strong lungs through Song,All,"Adult, Older Adult",Not Applicable,35.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 29, 2021","September 30, 2021"
2142,NCT04331795,Completed,No Results Available,COVID-19,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 2,32.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 4, 2020","June 5, 2020"
2143,NCT04446429,Completed,Has Results,COVID-19|SARS-CoV2|Androgenetic Alopecia|Prostate Cancer|Benign Prostatic Hyperplasia|SARS (Severe Acute Respiratory Syndrome),Drug: Proxalutamide|Other: Standard of Care,Male,"Adult, Older Adult",Not Applicable,262.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 15, 2020","January 21, 2021"
2144,NCT04411433,"Active, not recruiting",No Results Available,Sars-CoV2|COVID-19,Drug: Favipiravir (3200 mg + 1200 mg)|Drug: Favipiravir (3600 mg + 1600 mg)|Drug: Favipiravir (3200 mg + 1200 mg) combined with Hydroxychloroquine|Drug: Favipiravir (3200 mg + 1200 mg) combined with Azithromycin|Drug: Hydroxychloroquine|Drug: Hydroxychloroquine combined with Azithromycin,All,"Adult, Older Adult",Phase 3,1008.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","June 1, 2021"
2145,NCT04348656,"Active, not recruiting",No Results Available,COVID-19,Biological: Convalescent plasma,All,"Child, Adult, Older Adult",Phase 3,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 14, 2020","March 31, 2021"
2146,NCT04321421,Completed,No Results Available,COVID-19,Other: hyperimmune plasma,All,"Adult, Older Adult",Not Applicable,49.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 17, 2020","May 7, 2020"
2147,NCT04608305,Recruiting,No Results Available,Covid19,"Biological: IIBR-100, low dose (prime)|Biological: IIBR-100 medium dose (prime)|Biological: IIBR-100 high-dose (prime)|Biological: IIBR-100 low-dose (prime-boost)|Other: Saline Placebo",All,"Adult, Older Adult",Phase 1|Phase 2,1040.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 28, 2020","June 1, 2022"
2148,NCT04383886,Recruiting,No Results Available,Emergency Department Staff During the COVID-19 Pandemic|Emergency Department Staff's Level of Stress,Other: stress and anxiety questionnaire,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 18, 2020","August 18, 2020"
2149,NCT04407299,Completed,No Results Available,COVID,Behavioral: self-administered structured questionnaire,All,"Child, Adult, Older Adult",,360.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 20, 2020","May 20, 2020"
2150,NCT04636086,Recruiting,No Results Available,Covid19,Drug: Cholecalciferol|Other: Placebo,All,"Adult, Older Adult",Phase 4,100.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 12, 2020","February 28, 2021"
2151,NCT04352556,Recruiting,No Results Available,SARS-CoV-2 Infection|Hematological Malignancies,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 7, 2020","April 30, 2021"
2152,NCT04738760,Recruiting,No Results Available,Covid19|Corona Virus Infection|Cytokine Storm|Vitamin D Deficiency,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"December 1, 2020","June 1, 2021"
2153,NCT04497779,Recruiting,No Results Available,Asymptomatic COVID-19 Infection Laboratory-Confirmed|Symptomatic COVID-19 Infection Laboratory-Confirmed,Procedure: Biospecimen Collection|Other: Diagnostic Laboratory Biomarker Analysis|Other: Electronic Health Record Review|Other: Questionnaire Administration,All,"Adult, Older Adult",,800.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 13, 2020","August 21, 2022"
2154,NCT04830943,Completed,No Results Available,Covid19 Related Anosmia and Aguesia,Drug: Cerebrolysin,All,Adult,Phase 4,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","March 30, 2021"
2155,NCT04701515,Recruiting,No Results Available,COVID-19,Other: Chart review,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 10, 2020","December 31, 2022"
2156,NCT04397718,Recruiting,No Results Available,COVID-19,Drug: Degarelix|Other: Saline,Male,"Adult, Older Adult",Phase 2,198.0,U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 6, 2020","July 6, 2021"
2157,NCT04681053,Recruiting,No Results Available,COVID-19,Drug: Ivermectin Powder,All,"Adult, Older Adult",Phase 3,80.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 25, 2021","December 31, 2021"
2158,NCT04578236,Not yet recruiting,No Results Available,Covid19,Combination Product: Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg|Drug: Drug: Standard treatment Standard treatment,All,"Adult, Older Adult",Phase 2,360.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,November 2020,January 2021
2159,NCT04363866,Withdrawn,No Results Available,COVID-19|SARS-CoV-2,Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",August 2020,September 2021
2160,NCT04510012,Recruiting,No Results Available,SARS-CoV Infection|Covid-19,"Other: Analysis of cytokine response, innate and adaptive immune response, complement activation, and serum neurofilaments as a marker of neurological damage.",All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 5, 2020","March 5, 2021"
2161,NCT04432805,Recruiting,No Results Available,Pregnant Women Suspected of COVID-19,Device: Performing of lung ultrasound,Female,"Adult, Older Adult",Not Applicable,160.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 15, 2020","June 15, 2021"
2162,NCT04358042,Recruiting,No Results Available,Psychiatric Disorder|Covid19,"Other: Brief Psychiatric Rating Scale|Other: Depression, Anxiety and Stress Scale|Other: Impact of Event Scale-Revised|Other: Connor-Davidson Resilience Scale 10 items (CD-RISC 10)",All,"Child, Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 24, 2020","January 1, 2023"
2163,NCT04368156,"Active, not recruiting",No Results Available,Covid-19,Device: gammaCore® (Vagus nerve stimulation),All,"Adult, Older Adult",Not Applicable,110.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","February 23, 2021"
2164,NCT04508959,Recruiting,No Results Available,Coronavirus Infection|Coronavirus|SARS-CoV-2 Infection|Covid19,,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020",July 2021
2165,NCT04322513,Recruiting,No Results Available,Coronavirus,Diagnostic Test: Biomarkers expression,All,"Child, Adult, Older Adult",,110.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 24, 2020","December 30, 2020"
2166,NCT04386447,Withdrawn,No Results Available,Covid-19|Corona Virus Infection|SARS-CoV 2,Drug: Oxytocin|Drug: Standard of Care,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","December 31, 2020"
2167,NCT04665960,Enrolling by invitation,No Results Available,Covid19|SARS-CoV Infection|SARS Pneumonia|Coronavirus Infection|Infection,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 29, 2021","May 15, 2021"
2168,NCT04403386,Recruiting,No Results Available,COVID-19,,All,Adult,,200.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","May 31, 2022"
2169,NCT04821934,Recruiting,No Results Available,COVID-19 Pneumonia,Other: TR|Other: TSu,All,"Adult, Older Adult",Not Applicable,74.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"March 26, 2021",December 2021
2170,NCT04425044,Completed,No Results Available,Covid19,Other: Other,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 12, 2020","May 28, 2020"
2171,NCT04435795,Recruiting,No Results Available,COVID 19,Drug: Normal Saline intranasal,All,"Adult, Older Adult",Phase 2|Phase 3,454.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 14, 2020","March 25, 2021"
2172,NCT04353180,Not yet recruiting,No Results Available,COVID19,Drug: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment|Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment|Drug: Isotretinoin (13 cis retinoic acid ) capsules|Drug: Aerosolized 13 cis retinoic acid|Drug: Standard treatment,All,"Adult, Older Adult",Phase 3,100000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,July 2021
2173,NCT04386070,Not yet recruiting,No Results Available,Pulmonary Complications in Surgical Patients|COVID|Severe Acute Respiratory Syndrome,Drug: Lopinavir-Ritonavir|Drug: Hydroxychloroquine,All,"Child, Adult, Older Adult",Phase 3,6400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 15, 2020","May 14, 2026"
2174,NCT04468087,Not yet recruiting,No Results Available,COVID-19,Drug: Atazanavir|Drug: Daclatasvir 60 mg|Drug: Sofusbuvir + Daclastavir 60 mg|Drug: Placebo Atazanavir|Drug: Placebo Daclatasvir 60 mg|Drug: Placebo Sofusbuvir + Daclatasvir 60 mg,All,"Adult, Older Adult",Phase 2|Phase 3,1005.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 1, 2020","April 30, 2021"
2175,NCT04531501,Recruiting,No Results Available,Covid19,Diagnostic Test: Saliva and NPS test,All,"Adult, Older Adult",,400.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 29, 2020","September 29, 2020"
2176,NCT04342221,Recruiting,No Results Available,"COVID-19, Hydroxychloroquine Sulfate",Drug: Hydroxychloroquine Sulfate|Drug: Placebo,All,"Adult, Older Adult",Phase 3,220.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 29, 2020",February 2022
2177,NCT04625257,Recruiting,No Results Available,Coronavirus Infectious Disease 2019 (COVID-19),Other: Saliva based assay: crude RNA extraction|Other: Validation of the NGS method|Other: Validation of the LAMP assays|Other: Validation of the POCT Antigen and Antibody tests,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 24, 2020",March 2021
2178,NCT04606498,Recruiting,No Results Available,Covid19,Other: Observational,All,"Adult, Older Adult",,200.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Other,"December 18, 2020","February 1, 2022"
2179,NCT04479358,Recruiting,No Results Available,COVID-19,Drug: Tocilizumab|Other: Standard of Care,All,"Adult, Older Adult",Phase 2,332.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 10, 2020","March 1, 2021"
2180,NCT04355611,Recruiting,No Results Available,Multiple Sclerosis|NMO Spectrum Disorder|COVID-19,Other: Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2),All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 20, 2020","April 20, 2022"
2181,NCT04751617,Enrolling by invitation,No Results Available,Covid19,Procedure: Pulmonary rehabilitation,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 1, 2021","March 31, 2021"
2182,NCT04438993,Recruiting,No Results Available,COVID|Coronavirus,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 29, 2020",November 2020
2183,NCT04470622,Recruiting,No Results Available,COVID-19,Drug: Aprepitant injectable emulsion|Drug: Saline Placebo,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 20, 2020",July 2021
2184,NCT04750278,Not yet recruiting,No Results Available,Severe to Critical Coronavirus (CoV) Disease 2019 (COVID 19) With Associated Acute Respiratory Distress Syndrome (ARDS),Drug: FP-025 100 mg|Drug: FP-025 300 mg|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,403.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",February 2021,August 2022
2185,NCT04397237,"Active, not recruiting",No Results Available,COVID-19|Systemic Lupus Erythematosus|Sjogren's Syndrome|Axial Spondyloarthritis|Rheumatoid Arthritis|Giant Cell Arteritis,,All,"Adult, Older Adult",,3100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 10, 2020",January 2021
2186,NCT04551547,Recruiting,No Results Available,COVID-19,"Biological: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Other: Two doses of placebo at the schedule of day 0,28",All,Child,Phase 1|Phase 2,552.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","October 31, 2020",September 2021
2187,NCT04358510,Completed,No Results Available,COVID-19|Pneumonia|Mechanical Ventilation,Device: COViage,All,"Adult, Older Adult",,114.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","April 17, 2020"
2188,NCT04351854,Recruiting,No Results Available,Corona Virus Infection|SARS-CoV 2,Other: Retrospective data collection,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"April 20, 2020","August 31, 2026"
2189,NCT04646031,Available,No Results Available,Covid19,Drug: T89 capsule,All,"Child, Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population,,,
2190,NCT04758299,Recruiting,No Results Available,COVID-19 Testing|Decision Making,Other: decision science-based design,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Other,"March 13, 2021","March 31, 2021"
2191,NCT04464486,Enrolling by invitation,No Results Available,Oncology,Other: SCH Intervention,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 21, 2020","May 31, 2021"
2192,NCT04608214,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Alisporivir|Other: Standard of care (SOC),All,"Adult, Older Adult",Phase 2,100.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 1, 2020","August 4, 2021"
2193,NCT04724629,Recruiting,No Results Available,Covid19,Biological: Ixekizumab|Biological: Aldesleukin|Drug: Colchicine|Drug: Standard of care (SOC),All,"Adult, Older Adult",Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 5, 2021","July 30, 2021"
2194,NCT04285801,Completed,No Results Available,COVID-19,,All,"Adult, Older Adult",,8.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"February 14, 2020","February 25, 2020"
2195,NCT04844710,Completed,No Results Available,Acupuncture|Covid19,Combination Product: acupuncture and standard care|Drug: standard care,All,"Adult, Older Adult",Not Applicable,22.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 1, 2020","November 20, 2020"
2196,NCT04306497,Completed,No Results Available,COVID-19,Drug: TCM prescriptions,All,"Adult, Older Adult",,340.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Other,"January 22, 2020","May 30, 2020"
2197,NCT04714125,Recruiting,No Results Available,Covid19|SARS-CoV Infection,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 19, 2020","June 1, 2022"
2198,NCT04377776,Completed,No Results Available,Kidney Transplant|Pancreas Tranplant|Pancreatic Islet Transplantation,Other: Practice details,All,"Adult, Older Adult",,644.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 4, 2020","May 18, 2020"
2199,NCT04338828,"Active, not recruiting",No Results Available,COVID19,Drug: Nitric Oxide Gas|Other: Inhaled Supplemental Oxygen,All,"Adult, Older Adult",Phase 2,47.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 18, 2020",April 2022
2200,NCT04377620,Terminated,No Results Available,COVID-19,Drug: Placebo|Drug: Ruxolitinib,All,"Child, Adult, Older Adult",Phase 3,211.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 24, 2020","February 26, 2021"
2201,NCT04739345,Recruiting,No Results Available,Covid19|Corona Virus Infection|Cytokine Storm,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"December 1, 2020","July 1, 2021"
2202,NCT04726098,Recruiting,No Results Available,Covid19|Corticosteroids,Drug: Dexamethasone high dose|Drug: Dexamethasone low dose,All,"Adult, Older Adult",Phase 4,198.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 15, 2021","December 31, 2022"
2203,NCT04634318,Recruiting,No Results Available,Covid19,Other: Respiratory rehabilitation program (RR).|Other: Respiratory tele-rehabilitation program (TRR).,All,"Adult, Older Adult",Not Applicable,118.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"December 10, 2020",December 2022
2204,NCT04734717,Enrolling by invitation,No Results Available,Covid19|Motility Disorder|Balance,Diagnostic Test: Neurology test,All,"Adult, Older Adult",Not Applicable,2.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"January 12, 2021","April 12, 2021"
2205,NCT04348500,"Active, not recruiting",No Results Available,COVID19,Drug: Clazakizumab,All,"Adult, Older Adult",Phase 2,17.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 24, 2020","March 31, 2021"
2206,NCT04823351,Not yet recruiting,No Results Available,Covid19,Behavioral: Surgical Mask,All,"Adult, Older Adult",Not Applicable,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 8, 2021","November 1, 2021"
2207,NCT04686734,Recruiting,No Results Available,Covid19,Other: No active intervention (observational only),All,"Child, Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 6, 2021",December 2021
2208,NCT04376775,"Active, not recruiting",No Results Available,Transplantation,Other: Transplant patient,All,"Adult, Older Adult",,3602.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","December 11, 2020"
2209,NCT04497389,Recruiting,No Results Available,SARS CoV-2,Biological: Human Amniotic Fluid,All,"Adult, Older Adult",Phase 1|Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 28, 2020","September 15, 2021"
2210,NCT04792021,Recruiting,No Results Available,Corona Virus Disease 19 (Covid19)|Corona Virus Infection|Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2),Drug: N-acetylcysteine,All,"Adult, Older Adult",Phase 3,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","March 9, 2021",November 2021
2211,NCT04362995,Recruiting,No Results Available,COVID-19|Coronavirus Infection|Coronavirus|SARS-CoV-2,,All,"Adult, Older Adult",,1517.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020",March 2025
2212,NCT04635605,Recruiting,No Results Available,SARS-CoV2,Drug: Methylene Blue|Drug: Control Test,All,"Adult, Older Adult",Phase 2,64.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 5, 2020","December 31, 2022"
2213,NCT04748614,Not yet recruiting,No Results Available,Cost of ICU,Other: Cost,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 15, 2021","March 30, 2021"
2214,NCT04502056,"Active, not recruiting",No Results Available,Covid19,Behavioral: Acknowledgement Racial Injustice AMA|Behavioral: African American Sender Acknowledgement|Behavioral: African American Sender in Informational Videos.|Behavioral: Racial Inequality Highlighted|Behavioral: AMA Acknowledgement Drug Pricing|Behavioral: White Sender in Acknowledgement|Behavioral: White Sender in Informational Videos|Behavioral: No Racial Inequality Highlighting|Behavioral: Placebo videos,All,"Adult, Older Adult",Not Applicable,20000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 31, 2020",September 2021
2215,NCT04603105,Not yet recruiting,No Results Available,Cancer|Covid19,,All,"Child, Adult, Older Adult",,9000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 28, 2021","October 31, 2022"
2216,NCT04505761,Completed,No Results Available,Coronavirus|Post Intensive Care Unit Syndrome,Device: Virtual Reality,All,"Child, Adult, Older Adult",Not Applicable,48.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","March 31, 2021"
2217,NCT04841746,Not yet recruiting,No Results Available,Person With a Severe Form of COVID-19 That Caused an Acute Distress Respiratory Syndrome Treated by Mechanical Ventilation in Intensive Care Unit,Behavioral: Physical therapy that include a standardized cycling training with functional electrical stimulation|Behavioral: Physical therapy that include a standardized cycling training with no additional functional electrical stimulation,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 1, 2021","September 16, 2022"
2218,NCT04351763,Recruiting,No Results Available,COVID-19,Drug: Amiodarone|Drug: Verapamil,All,"Adult, Older Adult",Phase 2|Phase 3,804.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 27, 2020","April 10, 2021"
2219,NCT04732767,Not yet recruiting,No Results Available,Covid19|Pregnancy Related|Antibody Response,,Female,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 20, 2021","June 30, 2021"
2220,NCT04291053,Not yet recruiting,No Results Available,COVID-19,Drug: Huaier Granule,All,"Adult, Older Adult",Phase 2|Phase 3,550.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","September 1, 2020"
2221,NCT04519255,"Active, not recruiting",No Results Available,PET/CT|COVID-19|Respiratory Function|Inflammatory Lesions,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"July 1, 2020","July 31, 2023"
2222,NCT04489446,Recruiting,No Results Available,Covid19|SARS-COV2 Infection,Drug: Sildenafil|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 19, 2020",March 2021
2223,NCT04551781,Completed,No Results Available,Covid19,Drug: 20 Mg Prednisone for 14 days|Drug: control,All,"Adult, Older Adult",Not Applicable,450.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 1, 2020","July 30, 2020"
2224,NCT04383652,Recruiting,No Results Available,COVID,Other: Biological sample and clinical data collection,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 6, 2020","June 30, 2021"
2225,NCT04387214,Completed,No Results Available,COVID-19,Other: survey,All,Adult,,1426.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 13, 2020","August 10, 2020"
2226,NCT04530578,Recruiting,No Results Available,Covid19|Pneumonia,Drug: Heparin sodium|Drug: Enoxaparin,All,"Adult, Older Adult",Phase 4,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","June 1, 2021"
2227,NCT04540120,Recruiting,No Results Available,Covid19|Cytokine Release Syndrome,Drug: dapansutrile capsules|Drug: placebo capsules,All,"Adult, Older Adult",Phase 2,80.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 25, 2020",July 2021
2228,NCT04527432,Recruiting,No Results Available,Coronavirus Infection|Severe Acute Respiratory Syndrome,Other: Survey|Diagnostic Test: SARS-CoV-2 antibody test,All,"Child, Adult, Older Adult",Not Applicable,3000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"December 16, 2020","March 31, 2022"
2229,NCT04695301,Recruiting,No Results Available,COVID-19|Coronavirus Infections|Exercise Therapy,Other: Rehabilitation protocol through a digital platform,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Other,"July 1, 2020",August 2021
2230,NCT04631536,Recruiting,No Results Available,Covid19,Drug: Atorvastatin + L-arginine + Folic acid + Nicorandil + Nebivolol|Drug: Placebo,All,"Adult, Older Adult",Phase 3,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","January 10, 2021","June 1, 2021"
2231,NCT04740125,Completed,No Results Available,HEALTH CARE WORKERS,,All,"Adult, Older Adult",,368.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 1, 2020","November 30, 2020"
2232,NCT04445935,Recruiting,No Results Available,Anticoagulation in COVID-19 ARDS,Drug: Bivalirudin Injection|Drug: Standard treatment,All,"Adult, Older Adult",Phase 4,100.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","June 28, 2020","March 28, 2021"
2233,NCT04771611,Not yet recruiting,No Results Available,Covid19|Coronavirus Infection,Drug: Fisetin,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",March 2021,June 2023
2234,NCT04401150,Recruiting,No Results Available,Vitamin C|COVID-19|Hospitalized Patients,Drug: Vitamin C|Drug: Control,All,"Adult, Older Adult",Phase 3,800.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 14, 2020",January 2022
2235,NCT04530422,Completed,No Results Available,Covid19,Drug: Sofosbuvir plus Ledipasvir,All,"Adult, Older Adult",Phase 3,250.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"April 15, 2020","July 23, 2020"
2236,NCT04682873,Recruiting,No Results Available,Covid-19 Disease,Drug: Enisamium Iodide|Drug: Placebo,All,"Adult, Older Adult",Phase 3,700.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 15, 2020","July 1, 2021"
2237,NCT04405466,Recruiting,No Results Available,COVID-19,Procedure: Blood sampling|Procedure: Throat swab,All,"Adult, Older Adult",,500.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 22, 2020","January 31, 2021"
2238,NCT04446286,Recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"June 18, 2020","August 18, 2020"
2239,NCT04805632,Recruiting,No Results Available,Covid19|Chronic Kidney Disease 5D,,All,"Adult, Older Adult",,42.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2021",October 2021
2240,NCT04400812,Enrolling by invitation,No Results Available,COVID-19,Other: questionnaire,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 19, 2020",October 2020
2241,NCT04529525,Recruiting,No Results Available,Covid19,Drug: Ivermectin|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 19, 2020","March 15, 2021"
2242,NCT04586140,Recruiting,No Results Available,Covid19|Ethics,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"November 9, 2020","April 30, 2022"
2243,NCT04618042,Recruiting,No Results Available,Ards|Covid19|Pneumonia,Drug: FX06|Drug: Placebo of FX06,All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 13, 2020",July 2021
2244,NCT04381962,Recruiting,No Results Available,COVID-19,Drug: Azithromycin Capsule,All,"Adult, Older Adult",Phase 3,800.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 29, 2020","October 13, 2020"
2245,NCT04666207,Recruiting,No Results Available,Covid19,Diagnostic Test: PCR,All,Child,,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 25, 2020","June 30, 2021"
2246,NCT04382066,Completed,No Results Available,COVID-19,Drug: Plitidepsin 1.5 mg/day|Drug: Plitidepsin 2.0 mg/day|Drug: Plitidepsin 2.5 mg/day,All,"Adult, Older Adult",Phase 1,46.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 12, 2020","December 23, 2020"
2247,NCT04742946,Not yet recruiting,No Results Available,Covid19,Other: Standard Physiotherapy program|Other: Telerehabilitation,All,"Adult, Older Adult",Not Applicable,237.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"February 15, 2021","September 30, 2021"
2248,NCT04422691,Recruiting,No Results Available,"COVID-19|Pneumonia, Viral|Pulmonary Infection",Diagnostic Test: Lung ultrasound,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"July 1, 2020",December 2025
2249,NCT04356937,Completed,No Results Available,SARS-CoV 2,Drug: Tocilizumab|Drug: Placebos,All,"Adult, Older Adult",Phase 3,243.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 20, 2020","August 27, 2020"
2250,NCT04494893,"Active, not recruiting",No Results Available,Covid19,,All,"Adult, Older Adult",,808.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 24, 2020","June 30, 2021"
2251,NCT04321993,Recruiting,No Results Available,COVID-19,Drug: Baricitinib (janus kinase inhibitor),All,"Adult, Older Adult",Phase 2,800.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 17, 2020",March 2022
2252,NCT04697927,Recruiting,No Results Available,COVID-19 Infections in Cancer Patients,Other: Questionnaires,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 30, 2020",December 2022
2253,NCT04418518,Recruiting,No Results Available,COVID-19,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 3,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 24, 2020",December 2021
2254,NCT04334980,"Active, not recruiting",No Results Available,COVID-19,Biological: bacTRL-Spike,All,"Adult, Older Adult",Phase 1,24.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 2, 2020","February 28, 2022"
2255,NCT04733833,Recruiting,No Results Available,Severe COVID-19,Drug: VB-201 + Standard of care|Drug: Standard of care,All,"Adult, Older Adult",Phase 2,30.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 26, 2021","June 30, 2022"
2256,NCT04492410,"Active, not recruiting",No Results Available,Cancer,Other: rapid serological test,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"July 21, 2020",May 2021
2257,NCT04351516,Withdrawn,No Results Available,SARS-CoV 2|COVID-19,Drug: Hydroxychloroquine|Other: Placebo,All,Older Adult,Phase 2|Phase 3,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 21, 2020","May 1, 2021"
2258,NCT04577534,Recruiting,No Results Available,Covid19,Drug: iv Tocillizumab (TCZ),All,"Adult, Older Adult",Phase 3,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 14, 2020","December 31, 2021"
2259,NCT04684615,Enrolling by invitation,No Results Available,Depression|Anxiety|Bipolar Disorder,,All,"Adult, Older Adult",,1000.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 19, 2021","July 31, 2022"
2260,NCT04344509,Not yet recruiting,No Results Available,Ventilator Associated Pneumonia,Other: Bacterial species isolated,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,June 2020,December 2020
2261,NCT04400877,Completed,No Results Available,COVID-19|Venous Thromboembolism|Pulmonary Embolism|Deep Vein Thrombosis|SARS-CoV 2,Diagnostic Test: Diagnostic examination for venous thromboembolism,All,"Adult, Older Adult",,7795.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 8, 2020","September 30, 2020"
2262,NCT04732819,Recruiting,No Results Available,COVID-19 Vaccines,Behavioral: High touch multi-pronged behavioral intervention,All,"Child, Adult, Older Adult",Not Applicable,22500.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research,"January 4, 2021","April 19, 2021"
2263,NCT04358939,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Other: Prone decubitus,All,"Adult, Older Adult",Not Applicable,404.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 27, 2020","November 24, 2021"
2264,NCT04587258,Recruiting,No Results Available,Breast Cancer|Colorectal Cancer|Covid19,Behavioral: Informational videos and social media campaigns encouraging cancer screening.,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"August 28, 2020","September 1, 2022"
2265,NCT04361643,Not yet recruiting,No Results Available,COVID-19,"Drug: Lenalidomide as a 5 mg capsule PO daily, days 1, 3, and 5.|Drug: Placebo",All,"Adult, Older Adult",Phase 4,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 27, 2020","December 31, 2021"
2266,NCT04408183,Recruiting,No Results Available,SARS-CoV 2|Infection,Drug: GLS-1200|Drug: Placebo,All,"Adult, Older Adult",Phase 2,225.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","June 1, 2020",September 2021
2267,NCT04328012,Recruiting,No Results Available,SARS-CoV-2 Infection,Drug: Losartan|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 6, 2020","August 1, 2021"
2268,NCT04348214,Recruiting,No Results Available,Coronavirus Disease (COVID-19),,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 22, 2020","December 1, 2020"
2269,NCT04609462,Completed,No Results Available,Covid19|Acute Hypoxemic Respiratory Failure,Procedure: Conventional oxygen therapy|Procedure: High flow nasal cannula,All,"Adult, Older Adult",Not Applicable,199.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 11, 2020","February 10, 2021"
2270,NCT04709172,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Cefditoren pivoxil 400mg,All,"Adult, Older Adult",Phase 4,30.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 5, 2021","September 30, 2021"
2271,NCT04354870,Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine (HCQ),All,"Adult, Older Adult",Phase 2,130.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020","October 1, 2020"
2272,NCT04304690,"Active, not recruiting",No Results Available,Sars-CoV2,Other: blood sample,All,"Child, Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 16, 2020","October 16, 2021"
2273,NCT04495803,Recruiting,No Results Available,Perinatal Anxiety|Covid19,Other: Cognitive Behavioural Group Therapy for Perinatal Anxiety,Female,Adult,Not Applicable,120.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","August 1, 2022"
2274,NCT04365725,Recruiting,No Results Available,COVID-19,Drug: Remdesivir,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 5, 2020",June 2020
2275,NCT04703114,Not yet recruiting,No Results Available,Covid19|SARS-CoV-2,Diagnostic Test: Blood count|Diagnostic Test: Blood collection|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Saliva samples|Diagnostic Test: Faeces samples|Genetic: Genetic blood collection|Other: Data collection,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,February 2021,December 2021
2276,NCT04435119,Completed,No Results Available,Coronavirus,,All,Older Adult,,96.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 15, 2020","May 15, 2020"
2277,NCT04383470,Recruiting,No Results Available,Mental Health Wellness 1|Pandemic,,All,"Child, Adult, Older Adult",,100000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"April 26, 2020",June 2022
2278,NCT04346615,Recruiting,No Results Available,COVID-19 Infection,Drug: Zavegepant (BHV-3500)|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,120.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 25, 2020",July 2021
2279,NCT04569188,Completed,No Results Available,COVID-19,Biological: Convalescent plasma,All,Older Adult,Phase 2,21.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 15, 2020","September 3, 2020"
2280,NCT04499313,Recruiting,No Results Available,Covid19|ARDS,Drug: Dexamethasone|Drug: Methylprednisolone,All,"Adult, Older Adult",Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 2, 2020","November 30, 2020"
2281,NCT04688372,Completed,No Results Available,Volume Outcome Relationship Among COVID-19 Inpatients in US Hospitals,Other: Surge Index,All,"Adult, Older Adult",,144116.0,NIH|Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 1, 2020","February 15, 2021"
2282,NCT04339660,Recruiting,No Results Available,COVID-19,Biological: UC-MSCs|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","February 1, 2020","June 30, 2020"
2283,NCT04681092,Recruiting,No Results Available,Covid19,Biological: AKS-452,All,"Adult, Older Adult",Phase 1|Phase 2,130.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 12, 2021","June 30, 2021"
2284,NCT04650035,Completed,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,60.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"November 1, 2020","November 10, 2020"
2285,NCT04367545,Completed,No Results Available,COVID|RT-ddPCR Multiplex,Diagnostic Test: Saliva collection,All,"Adult, Older Adult",Not Applicable,130.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 16, 2020","May 17, 2020"
2286,NCT04775069,Not yet recruiting,No Results Available,Chronic Liver Disease,Biological: BNT162b2|Biological: CoronaVac|Biological: AZD1222,All,"Adult, Older Adult",Phase 4,900.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 15, 2021","March 31, 2022"
2287,NCT04373798,Recruiting,No Results Available,Coronavirus Infection,Diagnostic Test: C-reactive protein,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 4, 2020","November 30, 2020"
2288,NCT04735588,Not yet recruiting,No Results Available,Immune Thrombocytopenia|ITP|Covid19|ITP Secondary to Infection,,All,"Adult, Older Adult",,140.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,April 2021,October 2023
2289,NCT04761718,Not yet recruiting,No Results Available,Covid19 Epidemic Lockdown Impact,,All,"Child, Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 1, 2021","May 30, 2021"
2290,NCT04385004,Recruiting,No Results Available,Acute Respiratory Distress Syndrome,,All,"Adult, Older Adult",,320.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"April 27, 2020",July 2020
2291,NCT04411563,Recruiting,No Results Available,Prognosis,Other: Taking biological samples,All,"Adult, Older Adult",,105.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 21, 2020",December 2020
2292,NCT04798001,Recruiting,No Results Available,Covid19,"Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 2, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Two Doses, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Spray",All,"Adult, Older Adult",Phase 1,130.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 12, 2021","October 31, 2022"
2293,NCT04625218,Not yet recruiting,No Results Available,COVID-19 Pneumonia,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,January 2021,May 2021
2294,NCT04745416,Completed,No Results Available,"Leukemia, Acute|Covid19|Leukemia, Lymphoblastic",,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2020","January 25, 2021"
2295,NCT04409847,Recruiting,No Results Available,COVID|Hypertension,Diagnostic Test: ABPM|Diagnostic Test: ECG|Diagnostic Test: FMD|Diagnostic Test: PWV|Diagnostic Test: Rarefaction,All,Adult,,70.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","May 31, 2021"
2296,NCT04520880,Not yet recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection)|Hospitalized Patients|Laboratory-confirmed SARS-CoV 2 Infection,Diagnostic Test: Testing procedure for Binding antibodies|Diagnostic Test: Neutralizing antibodies,All,"Adult, Older Adult",,158.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,August 2020,February 2021
2297,NCT04357431,Completed,No Results Available,COVID,Other: self-administered questionnaire,All,"Child, Adult, Older Adult",,565.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 22, 2020","May 30, 2020"
2298,NCT04387292,Recruiting,No Results Available,COVID19|Ophthalmopathy,Procedure: Ophthalmologic exam,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 7, 2020",May 2021
2299,NCT04734678,Recruiting,No Results Available,Covid19|Cytokine Storm|Corona Virus Infection,Drug: Tocilizumab|Drug: Infliximab,All,"Adult, Older Adult",,84.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"December 1, 2020","June 1, 2021"
2300,NCT04494867,Recruiting,No Results Available,Covid19,Device: Core Warming|Other: Standard of Care,All,"Adult, Older Adult",Not Applicable,20.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 19, 2020",December 2020
2301,NCT04793243,Completed,No Results Available,Covid19,Dietary Supplement: Vitamin D3,All,"Adult, Older Adult",Not Applicable,42.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 17, 2020","October 24, 2020"
2302,NCT04540029,Recruiting,No Results Available,Prenatal Stress,Other: Maternal stress,All,Child,,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 6, 2020","May 31, 2023"
2303,NCT04400305,Recruiting,No Results Available,"Physical Activity, Healthy Promotion",Behavioral: Digital Health Online Platform,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"May 20, 2020","July 31, 2021"
2304,NCT04410692,Completed,No Results Available,"Health Knowledge, Attitudes, Practice",Other: Prediction Market,All,"Adult, Older Adult",Not Applicable,560.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 15, 2020","May 17, 2020"
2305,NCT04393324,Recruiting,No Results Available,"COVID-19|ARDS, Human",,All,"Child, Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 24, 2020","June 30, 2020"
2306,NCT04666285,Not yet recruiting,No Results Available,Mental Health Wellness 1,Other: Experience of pandemic,All,"Child, Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,December 2020,December 2020
2307,NCT04519424,Withdrawn,No Results Available,Coronavirus Disease 2019 (COVID-19),Biological: CSL324|Drug: Placebo,All,"Adult, Older Adult",Phase 2,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",September 2020,May 2021
2308,NCT04798027,Recruiting,No Results Available,COVID-19,Biological: SARS-CoV-2 mRNA vaccine formulation 1|Biological: SARS-CoV-2 mRNA vaccine formulation 2|Biological: SARS-CoV-2 mRNA vaccine formulation 3|Biological: Placebo (0.9% normal saline),All,"Adult, Older Adult",Phase 1|Phase 2,415.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 12, 2021",May 2022
2309,NCT04815109,Not yet recruiting,No Results Available,Conscious Sedation|Pathologic Processes|Electroencephalogram|Acute Respiratory Distress Syndrome|Corona Virus Infection,Other: Encephalography measurement,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2021","August 30, 2021"
2310,NCT04394104,Terminated,No Results Available,Health Behavior,Other: Survey,All,"Adult, Older Adult",,593.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"May 27, 2020","May 31, 2020"
2311,NCT04537585,Not yet recruiting,No Results Available,Covid19,"Combination Product: Tomeka®|Drug: ""Vernonia amygdalina""",All,"Child, Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,November 2020,December 2022
2312,NCT04547218,Completed,No Results Available,"Age Problem|Surgery|Depression, Anxiety",,All,Older Adult,,150.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"June 22, 2020","December 31, 2020"
2313,NCT04350476,Withdrawn,No Results Available,COVID-19|Cardiac Arrhythmias,Diagnostic Test: VitalConnect Vital Sign Patch,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"April 17, 2020","May 1, 2020"
2314,NCT04337346,Completed,No Results Available,Endometriosis|Covid19,,Female,Adult,,80.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 5, 2020","April 25, 2020"
2315,NCT04514016,Completed,No Results Available,SARS-CoV Infection|Covid19,,All,"Child, Adult",,64.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"August 12, 2020","March 17, 2021"
2316,NCT04701528,Recruiting,No Results Available,Covid19|Kidney Transplant Infection,Drug: Voclosporin|Drug: Tacrolimus,All,"Adult, Older Adult",Phase 2,20.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 15, 2020","October 25, 2022"
2317,NCT04441996,Completed,No Results Available,COVID-19,Biological: Therapeutic plasma exchange (TPE)|Other: Standard of care,All,"Adult, Older Adult",Phase 4,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 17, 2020","March 18, 2021"
2318,NCT04385199,Recruiting,No Results Available,Coronavirus Infection|Coronavirus|COVID,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 4, 2020","August 1, 2020"
2319,NCT04805216,Recruiting,No Results Available,Covid19|Haematological Disorders|Immune Suppression,Procedure: Blood test,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"March 15, 2021","November 15, 2021"
2320,NCT04640233,Recruiting,No Results Available,COVID-19 Prevention,Biological: Gam-COVID-Vac|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,1600.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","November 30, 2020",September 2021
2321,NCT04341610,Withdrawn,No Results Available,Respiratory Tract Diseases,Drug: Stem Cell Product,All,"Adult, Older Adult",Phase 1|Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 20, 2020","April 30, 2021"
2322,NCT04799652,Recruiting,No Results Available,Covid19,Other: Survey,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 15, 2021","April 30, 2021"
2323,NCT04558021,Recruiting,No Results Available,Covid19,Drug: Niclosamide suspension|Other: Placebo,All,"Adult, Older Adult",Phase 3,200.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","October 8, 2020","February 14, 2021"
2324,NCT04402983,Completed,No Results Available,Covid19|Telerehabilitation|Physical Therapy,Other: Physiotherapy,All,"Adult, Older Adult",Not Applicable,34.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 27, 2020","December 1, 2020"
2325,NCT04619628,Recruiting,No Results Available,COVID-19,Biological: COVI-VAC|Other: Placebo,All,Adult,Phase 1,48.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 11, 2020",May 2022
2326,NCT04359511,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,All,"Adult, Older Adult",Phase 3,210.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,June 2020,December 2020
2327,NCT04542031,Not yet recruiting,No Results Available,Covid19|Rheumatic Diseases,Other: Questionnaire,All,"Adult, Older Adult",Not Applicable,7911.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,October 2020,October 2021
2328,NCT04445454,Recruiting,No Results Available,Coronavirus Infection,Biological: Mesenchymal stromal cells,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 12, 2020","September 30, 2022"
2329,NCT04779047,Recruiting,No Results Available,Covid19|Pneumonia,Drug: Remdesivir|Drug: Hydroxychloroquine|Drug: Tocilizumab|Drug: Lopinavir/ Ritonavir|Drug: Ivermectin,All,"Adult, Older Adult",Phase 4,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2020","April 5, 2021"
2330,NCT04516486,"Active, not recruiting",No Results Available,"Respiratory Distress Syndrome, Adult|COVID-19",Other: retrospective metagenomics on clinical samples collected during hospitalization,All,"Adult, Older Adult",,180.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 9, 2020","December 31, 2020"
2331,NCT04389645,Completed,No Results Available,COVID-19,Diagnostic Test: IP-10 in CDS protocol,All,"Adult, Older Adult",,52.0,Industry,Observational,,"April 7, 2020","May 12, 2020"
2332,NCT04366232,Terminated,No Results Available,Covid-19,Drug: Anakinra alone (stages 2b/3)|Drug: Anakinra and Ruxolitinib (overcome stage 3)|Other: Standard of care,All,"Adult, Older Adult",Phase 2,2.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 19, 2020","October 2, 2020"
2333,NCT04392232,Recruiting,No Results Available,Coronavirus|COVID-19|Convalescent Plasma,Drug: Convalescent Plasma,All,"Child, Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 5, 2020","December 31, 2020"
2334,NCT04438980,Recruiting,No Results Available,Covid-19 Pneumonia,Drug: Methylprednisolone|Other: Placebo,All,"Adult, Older Adult",Phase 3,72.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 15, 2020",February 2021
2335,NCT04363593,Completed,No Results Available,Corona Virus Infection,Biological: Serological test|Biological: Serum test,All,"Adult, Older Adult",Not Applicable,2587.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 4, 2020","November 16, 2020"
2336,NCT04377568,Recruiting,No Results Available,Hospitalized Children|Covid-19 Infection,Biological: Convalescent plasma (CP),All,"Child, Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 7, 2020","May 1, 2022"
2337,NCT04643444,Enrolling by invitation,No Results Available,SARS-CoV-2 Infection|Volunteers|Healthy,Diagnostic Test: Blood sampling|Other: Online Questionnaire,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 9, 2021",June 2022
2338,NCT04652765,Recruiting,No Results Available,Covid19|SARS-CoV Infection|Coronavirus Infection,Drug: Camostat Mesilate|Drug: Bicalutamide 150 mg,All,"Adult, Older Adult",Phase 1,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 3, 2021",January 2023
2339,NCT04382547,Enrolling by invitation,No Results Available,"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2",Biological: Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Other: Standard treatment according to the Clinical protocols,All,"Adult, Older Adult",Phase 1|Phase 2,40.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 11, 2020","June 30, 2021"
2340,NCT04787211,Not yet recruiting,No Results Available,COVID-19,Drug: BRII-196 and BRII-198|Drug: Placebo,All,"Adult, Older Adult",Phase 2,24.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,March 2021,December 2021
2341,NCT04348513,Recruiting,No Results Available,Pulmonary Infection|Covid-19,Drug: T3 solution for injection|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 29, 2020","May 31, 2021"
2342,NCT04346043,Not yet recruiting,No Results Available,Coronavirus Disease (COVID-19),,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"April 20, 2020","December 1, 2020"
2343,NCT04706533,Recruiting,No Results Available,Covid19|Kidney Diseases|Inflammation|SARS-CoV Infection,Diagnostic Test: Biomarkers of inflammation,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2020",June 2021
2344,NCT04344535,Enrolling by invitation,No Results Available,COVID,Biological: Convalescent Plasma|Biological: Standard Donor Plasma,All,"Adult, Older Adult",Phase 1|Phase 2,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 8, 2020","August 31, 2021"
2345,NCT04842721,Not yet recruiting,No Results Available,Covid19,Drug: Hypertonic Saturated Saline Mouth Rinse Active Arm|Other: Placebo Plain Water Mouth Rinse Arm,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,July 2021,December 2021
2346,NCT04427735,Recruiting,No Results Available,STEMI,,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"January 24, 2019","July 24, 2021"
2347,NCT04481646,Recruiting,No Results Available,Covid19,Diagnostic Test: Face mask sampling,All,"Child, Adult, Older Adult",,630.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 12, 2020",June 2025
2348,NCT04449978,Recruiting,No Results Available,Coronavirus|COVID-19|Virus|Family and Household|Infection Viral,,All,Child,,1082.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2020","December 31, 2022"
2349,NCT04460443,Recruiting,No Results Available,COVID,Drug: sofosbuvir|Drug: Sofosbuvir ledipsavir|Drug: Daclatasvir,All,"Child, Adult, Older Adult",Phase 2|Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","August 31, 2021"
2350,NCT04401449,Recruiting,No Results Available,Acute and Long Term Effects of COVID-19:on Systemic Inflammation|Acute and Long Term Effects of COVID-19 on Lung Function|Acute and Long Term Effects of COVID-19 on Mrain Function|Acute and Long Term Effects of COVID-19 on Cardiac Function|Acute and Long Term Effects of COVID-19 on Kidney Function,,All,"Adult, Older Adult",,180.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 8, 2020","May 1, 2024"
2351,NCT04382625,Withdrawn,No Results Available,SARS-CoV-2 Pneumonia|COVID-19,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 4,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,October 2020,"June 1, 2022"
2352,NCT04695197,Recruiting,No Results Available,Covid-19|Malaria,Drug: Artemether-lumefantrine (AL)|Drug: Pyronaridine-artesunate (PA),All,"Child, Adult, Older Adult",Phase 3,142.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 8, 2021","July 31, 2023"
2353,NCT04327349,Enrolling by invitation,No Results Available,Coronavirus Infections,Biological: Convalescent Plasma,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 28, 2020","September 30, 2020"
2354,NCT04497311,Recruiting,No Results Available,SARS-CoV-2|Covid19|H1N1 Influenza|Computed Tomography,Diagnostic Test: Thoraxic computed tomography,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2020","April 30, 2022"
2355,NCT04343092,Completed,Has Results,COVID 19,Drug: Ivermectin (IVM),All,"Adult, Older Adult",Phase 1,16.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 18, 2020","June 1, 2020"
2356,NCT04368988,"Active, not recruiting",No Results Available,COVID-19,"Biological: SARS-CoV-2 rS - Phase 1|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1|Other: Normal saline solution (NSS), Placebo - Phase 1|Other: Normal saline solution (NSS), Placebo - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1|Other: Normal saline solution (NSS), Placebo, Day 21 - Phase 1|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Days 0 and 21 - Phase 2|Other: Normal saline solution (NSS), Placebo, Day 189 - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 2|Other: Normal saline solution (NSS), Placebo, Day 21 - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant - Day 189 - Phase 2",All,"Adult, Older Adult",Phase 1|Phase 2,1419.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 25, 2020","November 18, 2021"
2357,NCT04421664,Terminated,No Results Available,Corona Virus Infection|SARS-CoV Infection|Coronavirus,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,70.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 25, 2020","August 17, 2020"
2358,NCT04623697,Recruiting,No Results Available,Covid19|type1diabetes,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"November 1, 2020","October 30, 2023"
2359,NCT04678739,Completed,No Results Available,Covid19|Covid-19 ARDS,Drug: Remdesivir|Drug: Tocilizumab,All,"Child, Adult, Older Adult",Phase 3,205.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 15, 2020","February 10, 2021"
2360,NCT04353674,Recruiting,No Results Available,COVID-19|SARS,Device: Control group|Device: SLEDD with a L-MOD,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 28, 2020",December 2021
2361,NCT04333420,Recruiting,No Results Available,Severe COVID-19 Pneumonia,Drug: SOC + IFX-1|Drug: SOC + Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,390.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 31, 2020","August 31, 2021"
2362,NCT04529408,Recruiting,No Results Available,Covid19|Pulmonary Disease,Device: EarSats Pulse Oximeter Probe,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 26, 2020","August 26, 2020"
2363,NCT04691934,Completed,No Results Available,Covid19|Obstetric Anesthesia,Procedure: Anesthesia management,Female,"Adult, Older Adult",,61.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 11, 2020","December 25, 2020"
2364,NCT04434417,Recruiting,No Results Available,COVID,Device: 2019-nCoV IgG/IgM Rapid Test Cassette,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","December 31, 2021"
2365,NCT04556318,Recruiting,No Results Available,Covid19,Device: Ion Mobility Spectrometry (IMS),All,"Adult, Older Adult",,392.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 23, 2020",April 2021
2366,NCT04487769,Recruiting,No Results Available,Covid19|Ultrasound|ARDS,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020",October 2021
2367,NCT04273581,Not yet recruiting,No Results Available,COVID-19 Thalidomide,Drug: placebo|Drug: Thalidomide,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 18, 2020","May 30, 2020"
2368,NCT04779359,Not yet recruiting,No Results Available,COVID-19 Disease,,All,"Adult, Older Adult",,1.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,April 2021,December 2021
2369,NCT04620798,"Active, not recruiting",No Results Available,SARS-CoV-2|Serology|Students,Behavioral: Immediate vs. delayed provision of antibody test results,All,"Adult, Older Adult",Not Applicable,1700.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Screening","September 14, 2020",December 2020
2370,NCT04445493,Not yet recruiting,No Results Available,"Stroke, Acute|COVID-19",Device: MindRhythm Harmony,All,"Adult, Older Adult",,250.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021",September 2021
2371,NCT04365738,Completed,No Results Available,COVID-19,Other: Rehabilitation,All,Adult,Not Applicable,270.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"March 11, 2020","April 26, 2020"
2372,NCT04568018,Recruiting,No Results Available,ARDS Due to COVID-19,Drug: Surfactant,All,"Adult, Older Adult",,120.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 3, 2020",December 2021
2373,NCT04551898,Completed,No Results Available,Covid19,Drug: BGB-DXP593|Drug: Placebo,All,"Adult, Older Adult",Phase 2,181.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 2, 2020","January 25, 2021"
2374,NCT04452942,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,30.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,July 2020,April 2021
2375,NCT04323839,Enrolling by invitation,No Results Available,Pregnancy|Coronavirus|COVID-19,Other: Pregnant women under investigation for Coronavirus or diagnosed with COVID-19|Other: Postpartum women under investigation for Coronavirus or diagnosed with COVID-19,Female,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020","March 31, 2024"
2376,NCT04540185,Enrolling by invitation,No Results Available,Covid19|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV Infection|SARS-CoV-2,Biological: Biological: oral polio vaccine|Biological: Comparable Placebo|Drug: NA-831|Drug: Comparable Placebo of drug|Combination Product: Combination of oral polio vaccine and NA-831|Combination Product: Comparable Placebo of Oral Polio Vaccine and Placebo of drug,All,"Adult, Older Adult",Phase 3,3600.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","November 1, 2020","December 31, 2022"
2377,NCT04844346,Not yet recruiting,No Results Available,Overweight and Obesity,Dietary Supplement: Plant stanol mini drinks|Dietary Supplement: Placebo mini drinks|Biological: COVID-19 vaccine,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 1, 2021","August 31, 2021"
2378,NCT04362137,Completed,No Results Available,Cytokine Storm (Covid-19),Drug: Ruxolitinib|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 3,432.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 2, 2020","October 17, 2020"
2379,NCT04341038,Recruiting,No Results Available,COVID-19|Lung Injury,Drug: Tacrolimus|Drug: Methylprednisolone,All,"Adult, Older Adult",Phase 3,84.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 1, 2020","July 1, 2020"
2380,NCT04394793,"Active, not recruiting",No Results Available,COVID-19|Pneumonia,Radiation: Low dose radiation therapy,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 13, 2020",September 2020
2381,NCT04363034,Temporarily not available,No Results Available,COVID-19,Biological: Convalescent Plasma,All,"Adult, Older Adult",,,Other,Expanded Access:Intermediate-size Population,,,
2382,NCT04680949,"Active, not recruiting",No Results Available,Covid19,Drug: Anakinra|Drug: Placebo,All,"Adult, Older Adult",Phase 3,606.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 23, 2020","December 20, 2021"
2383,NCT04388605,Recruiting,No Results Available,Corona Virus Infection|COVID|Pregnancy Related|Early Pregnancy,,Female,"Adult, Older Adult",,11000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 21, 2020",September 2022
2384,NCT04600141,Recruiting,No Results Available,Covid19,Drug: Tocilizumab|Drug: Heparin - Therapeutic dosage|Drug: Heparin - Prophylactic dosage,All,"Adult, Older Adult",Phase 3,308.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 10, 2020","December 31, 2021"
2385,NCT04497324,Recruiting,No Results Available,COVID-19,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 21, 2020","May 15, 2021"
2386,NCT04650191,Recruiting,No Results Available,Coronavirus Infection,Other: Identification of genetic variants,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 1, 2020",December 2021
2387,NCT04375644,Completed,No Results Available,"Covid 19|Stress, Psychological",Other: Questionnaires on psychological quality of life,All,"Adult, Older Adult",,1565.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 7, 2020","July 15, 2020"
2388,NCT04397796,Recruiting,No Results Available,COVID,Biological: BM-Allo.MSC|Biological: Placebo,All,"Adult, Older Adult",Phase 1,45.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 3, 2020",June 2021
2389,NCT04417335,"Active, not recruiting",No Results Available,COVID-19,Biological: BCG vaccine|Biological: Placebo,All,"Adult, Older Adult",Phase 4,2014.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"April 16, 2020",May 2021
2390,NCT04403880,"Active, not recruiting",No Results Available,SARS-CoV-2|COVID-19,Other: Sample collection,All,"Adult, Older Adult",,727.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Other,"May 13, 2020",August 2021
2391,NCT04754633,Completed,No Results Available,Covid19|Infection Viral|CT Scan,,All,"Adult, Older Adult",,764.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"July 1, 2020","July 20, 2020"
2392,NCT04383717,Not yet recruiting,No Results Available,Respiratory Tract Infections,Drug: Levamisole and isoprinosine|Drug: Azithromycin and hydroxychloroquine,All,"Child, Adult, Older Adult",Phase 3,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 5, 2020","October 30, 2020"
2393,NCT04826718,Not yet recruiting,No Results Available,SARS-CoV Infection|BCG|Health Care Worker,Diagnostic Test: SARS-CoV-2 Serology,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"April 19, 2021","November 30, 2021"
2394,NCT04611269,Completed,No Results Available,Respiratory Failure|Covid-19|Mechanical Ventilation,,All,"Adult, Older Adult",,950.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020","October 31, 2020"
2395,NCT04746066,"Active, not recruiting",No Results Available,Haemoglobinopathies,,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 31, 2020",December 2030
2396,NCT04358068,Terminated,Has Results,COVID-19|SARS-CoV 2,Drug: Hydroxychloroquine (HCQ)|Drug: Azithromycin (Azithro)|Drug: Placebo for Hydroxychloroquine|Drug: Placebo for Azithromycin,All,"Adult, Older Adult",Phase 2,20.0,NIH|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 13, 2020","July 7, 2020"
2397,NCT04374279,Withdrawn,No Results Available,COVID-19|SARS-CoV 2,Drug: Bicalutamide 150 Mg Oral Tablet,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,January 2022
2398,NCT04787614,Enrolling by invitation,No Results Available,Child Care,Other: No intervention,All,"Child, Adult, Older Adult",,15200.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"November 1, 2020","June 30, 2021"
2399,NCT04742725,Not yet recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19),Drug: Placebo|Drug: Prothione™ (6g),All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 15, 2021","March 26, 2021"
2400,NCT04635813,Completed,No Results Available,Thyroid Disease,Procedure: Thyroidectomy,All,"Child, Adult, Older Adult",,3800.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 10, 2020","November 12, 2020"
2401,NCT04603794,Recruiting,No Results Available,COVID-19,Drug: 0.5% Povidone Iodine|Drug: 0.12% Chlorhexidine Gluconate Mouth Rinse|Drug: 1% Hydrogen Peroxide|Drug: 0.9% Normal Saline,All,"Adult, Older Adult",Phase 4,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","October 1, 2020",November 2020
2402,NCT04834128,Not yet recruiting,No Results Available,Covid19,Drug: TCB008,All,"Adult, Older Adult",Phase 2,12.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2021","August 1, 2022"
2403,NCT04511429,Recruiting,No Results Available,"Infections, Coronavirus|Kidney Transplantation|Liver Transplantation|Cancer|Covid19",,All,"Child, Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 30, 2020",April 2021
2404,NCT04818463,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2021","December 31, 2021"
2405,NCT04646239,Recruiting,No Results Available,Covid19,Diagnostic Test: Heterologous stimuli|Diagnostic Test: Neutralization assay,All,"Adult, Older Adult",,140.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 17, 2020",June 2021
2406,NCT04527133,"Active, not recruiting",No Results Available,COVID-19,Drug: Aprotinin,All,"Adult, Older Adult",Not Applicable,30.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 11, 2020","August 31, 2020"
2407,NCT04308668,Completed,No Results Available,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection|Coronavirus|Coronavirus Infections,Drug: Hydroxychloroquine|Other: Placebo,All,"Adult, Older Adult",Phase 3,1309.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 17, 2020","May 20, 2020"
2408,NCT04378842,Recruiting,No Results Available,Sars-CoV2|Critical Illness,,All,"Adult, Older Adult",,690.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 18, 2020",May 2021
2409,NCT04780685,Recruiting,No Results Available,Covid19,Biological: hMSC,All,"Adult, Older Adult",Phase 2,40.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 20, 2021","December 31, 2021"
2410,NCT04524715,Not yet recruiting,No Results Available,Covid19,Device: Non-invasive red LLLT treatment to chest of patient.|Device: Sham Device Treatment,All,"Adult, Older Adult",Not Applicable,64.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"March 31, 2021","March 31, 2022"
2411,NCT04379037,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Device: Transcutaneous Auricular Vagus Nerve Stimulation,All,"Adult, Older Adult",Not Applicable,50.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 27, 2020","November 1, 2020"
2412,NCT04597047,Recruiting,No Results Available,Covid19,Diagnostic Test: Capillary Collection & Testing|Diagnostic Test: Venous Draw & Testing,All,"Child, Adult, Older Adult",Not Applicable,200.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"August 20, 2020","December 31, 2022"
2413,NCT04427501,Recruiting,No Results Available,COVID-19,Drug: LY3819253|Drug: LY3832479|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 2|Phase 3,3160.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 17, 2020","May 31, 2021"
2414,NCT04591717,Recruiting,No Results Available,COVID-19,Biological: hAd5-S-Fusion+N-ETSD vaccine,All,Adult,Phase 1,60.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 19, 2020","November 19, 2021"
2415,NCT04429763,Not yet recruiting,No Results Available,COVID-19,Biological: Umbilical cord derived mesenchymal stem cells|Biological: Placebo,All,"Adult, Older Adult",Phase 2,30.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",July 2020,November 2020
2416,NCT04400032,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|Covid19,Biological: Mesenchymal Stromal Cells,All,"Adult, Older Adult",Phase 1|Phase 2,21.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 15, 2020",June 2021
2417,NCT04348942,"Active, not recruiting",No Results Available,COVID-19,,All,"Adult, Older Adult",,10000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 29, 2020","May 1, 2021"
2418,NCT04844580,Recruiting,No Results Available,Covid19,Drug: Inhaled Aviptadil|Drug: Placebo,All,"Adult, Older Adult",Phase 2,80.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 10, 2021",December 2022
2419,NCT04666025,Recruiting,No Results Available,"Accelerated Phase CML, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Chronic Lymphocytic Leukemia|Chronic Phase CML, BCR-ABL1 Positive|COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Hodgkin Lymphoma|Lymphoblastic Lymphoma|Myelodysplastic Syndrome|Myelofibrosis|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma",Procedure: Biospecimen Collection|Other: Diagnostic Laboratory Biomarker Analysis|Other: Electronic Health Record Review|Other: Questionnaire Administration,All,"Adult, Older Adult",,36.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 23, 2020","September 23, 2022"
2420,NCT04362150,"Active, not recruiting",No Results Available,COVID,,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 21, 2020","December 21, 2024"
2421,NCT04396353,Completed,No Results Available,COVID-19|SARS-CoV 2|Corona Virus Infection|Sedentary Behavior,Other: Electronic questionnaire,All,"Child, Adult, Older Adult",,1574.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 4, 2020","October 1, 2020"
2422,NCT04527315,Recruiting,No Results Available,Covid19,Other: Questionnaires,All,"Adult, Older Adult",,350.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 17, 2020",August 2023
2423,NCT04373148,Recruiting,No Results Available,Coronavirus,Other: There is no intervention,All,"Child, Adult, Older Adult",,1000.0,Other|NIH,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 8, 2020","April 30, 2022"
2424,NCT04347993,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 27, 2020",April 2021
2425,NCT04348240,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,90.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","February 28, 2022"
2426,NCT04648800,Recruiting,No Results Available,Covid19|BCG Vaccination Reaction|SARS-CoV Infection,Drug: BCG-10 vaccine|Drug: 0.9% saline,All,"Adult, Older Adult",Phase 3,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 7, 2020",April 2021
2427,NCT04343053,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Other: SARS-Cov-2 infection,All,"Adult, Older Adult",Not Applicable,54.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 8, 2020","June 9, 2021"
2428,NCT04393948,Recruiting,No Results Available,SARS-CoV 2,Radiation: Phase 1|Radiation: Phase 2,All,"Adult, Older Adult",Not Applicable,48.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2020,November 2020
2429,NCT04698382,"Active, not recruiting",No Results Available,Sepsis|Septic Shock,,All,"Child, Adult, Older Adult",,5000.0,NIH|Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 1, 2020","May 1, 2021"
2430,NCT04426292,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: Serological testing,All,"Adult, Older Adult",Not Applicable,3500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 12, 2020","May 12, 2021"
2431,NCT04373889,"Active, not recruiting",No Results Available,SARS-CoV-2|COVID-19,,All,"Adult, Older Adult",,850.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 22, 2020","April 30, 2021"
2432,NCT04323644,Recruiting,No Results Available,COVID-19|Coronavirus|Surgery,Procedure: Surgery,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 1, 2020","September 30, 2020"
2433,NCT04769258,Not yet recruiting,No Results Available,Inflammatory Bowel Diseases,Biological: Pfizer Comirnaty vaccine,All,"Adult, Older Adult",,1380.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 1, 2021","June 1, 2022"
2434,NCT04441385,Recruiting,No Results Available,COVID-19,Drug: Maraviroc 300 mg|Other: Standard care therapy,All,"Adult, Older Adult",Phase 2,200.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 26, 2020","December 20, 2020"
2435,NCT04367363,Completed,No Results Available,Coronavirus|Depression|Anxiety|Stress,Behavioral: Social media & news consumption,All,"Adult, Older Adult",,151.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 17, 2020","May 31, 2020"
2436,NCT04411667,"Active, not recruiting",No Results Available,Sars-CoV2,Drug: Octagam,All,"Adult, Older Adult",Phase 4,34.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 28, 2020","November 30, 2020"
2437,NCT04779749,Recruiting,No Results Available,Covid19,Other: Data extraction from medical files,Female,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"December 8, 2020",December 2021
2438,NCT04823182,Recruiting,No Results Available,SARS-CoV Infection|Covid19|Cardiomyopathies,Diagnostic Test: Cardiovascular Magnetic Resonance Imaging,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 16, 2021","June 16, 2022"
2439,NCT04548557,Not yet recruiting,No Results Available,Covid19,Biological: intravenous immunoglobulin therapy,All,"Adult, Older Adult",Phase 3,60.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 15, 2020","November 15, 2020"
2440,NCT04565392,Not yet recruiting,No Results Available,Covid19,Drug: Famotidine 20 milligram tablet,All,"Adult, Older Adult",Phase 4,150.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 1, 2021","January 31, 2022"
2441,NCT04802382,Not yet recruiting,No Results Available,Corona Virus Infection|Covid19|SARS-CoV Infection,Drug: Placebo administration|Diagnostic Test: Confirm SARS-CoV-2 infection|Procedure: Physical Examination|Procedure: Vital Signs|Diagnostic Test: Hematology blood test|Diagnostic Test: Biochemistry blood test|Other: NEWS score|Diagnostic Test: PK test|Diagnostic Test: blood test for inflammatory markers|Diagnostic Test: D-dimer test|Other: VAS scale|Diagnostic Test: Urine pregnancy test for women of childbearing potential|Procedure: ECG|Other: COVID-19-Impact on Quality of Life Questionnaire|Drug: CimetrA-1|Drug: CimetrA-2,All,"Adult, Older Adult",Phase 3,252.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,December 2021
2442,NCT04370236,Recruiting,No Results Available,COVID-19,Drug: INB03|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,366.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 21, 2020",February 2021
2443,NCT04657445,Recruiting,No Results Available,Olfactory and Taste Dysfunction in SARS-CoV2 Infection,Diagnostic Test: visual analogue scale,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 17, 2020",June 2021
2444,NCT04361214,Recruiting,No Results Available,COVID-19,Drug: Leflunomide,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 5, 2020",February 2021
2445,NCT04394416,Recruiting,No Results Available,COVID-19,Drug: Imatinib|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,204.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 2, 2020","June 1, 2023"
2446,NCT04766931,Recruiting,No Results Available,Covid19,Drug: FB2001|Drug: FB2001 Placebo,All,Adult,Phase 1,32.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 27, 2021",December 2021
2447,NCT04369807,Recruiting,No Results Available,COVID-19,Diagnostic Test: Outpatient MRI,All,"Adult, Older Adult",,507.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 21, 2020","May 31, 2023"
2448,NCT04539275,Recruiting,No Results Available,COVID-19,Drug: Convalescent Plasma|Other: Masked Saline Placebo,All,"Adult, Older Adult",Phase 3,702.0,U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 16, 2020","July 18, 2022"
2449,NCT04597775,Not yet recruiting,No Results Available,SARS-CoV Infection,Drug: hydroxychloroquine,All,"Adult, Older Adult",Phase 2|Phase 3,93.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 27, 2020","January 31, 2021"
2450,NCT04261517,Completed,No Results Available,"Pneumonia, Pneumocystis|Coronavirus|COVID-19",Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 6, 2020","February 25, 2020"
2451,NCT04611230,Recruiting,No Results Available,Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2),,All,"Adult, Older Adult",,1250.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 5, 2020","September 24, 2021"
2452,NCT04770740,Recruiting,No Results Available,Covid19,Dietary Supplement: Vitamin K2 in the form of Menaquinone-7 (MK-7)|Dietary Supplement: Placebo,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","February 22, 2021","October 1, 2021"
2453,NCT04418531,Not yet recruiting,No Results Available,"Pneumonia, Viral|Corona Virus Infection",Biological: Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2020,September 2020
2454,NCT04412785,Recruiting,No Results Available,COVID-19,Drug: Cyclosporine,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 30, 2020",December 2021
2455,NCT04548895,Recruiting,No Results Available,Covid19|Community-Acquired Respiratory Tract Infection,Device: Observational measurement of biometric data. No change to health care provided.,All,"Child, Adult, Older Adult",,30.0,Industry,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"December 30, 2020","October 26, 2021"
2456,NCT04352465,Not yet recruiting,No Results Available,COVID-19,Drug: Methotrexate,All,"Adult, Older Adult",Phase 1|Phase 2,42.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","November 30, 2020"
2457,NCT04724681,Recruiting,No Results Available,Clinical Deterioration,Device: WARD CSS,All,"Adult, Older Adult",Not Applicable,800.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 1, 2021","December 31, 2021"
2458,NCT04409483,Withdrawn,No Results Available,Covid-19,Drug: Lopinavir-Ritonavir Drug Combination|Combination Product: Standard Care,All,"Child, Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","December 31, 2020"
2459,NCT04844489,Not yet recruiting,No Results Available,Autoimmune or Autoinflammatory Diseases|HIV|Multiple Sclerosis|Solid Tumors or Cancers|Solid Organ Transplant,Other: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19,All,"Adult, Older Adult",Not Applicable,485.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 15, 2021","December 31, 2022"
2460,NCT04711954,Recruiting,No Results Available,Hiv|Covid19,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"November 1, 2020","November 1, 2022"
2461,NCT04377724,"Active, not recruiting",No Results Available,Covid-19|Virus Disease,,All,Adult,,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","June 30, 2021"
2462,NCT04752085,"Active, not recruiting",No Results Available,Covid19|SARS-CoV Infection,Diagnostic Test: Chitotriosidase activity,All,"Adult, Older Adult",,345.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 1, 2020","September 30, 2021"
2463,NCT04821973,Recruiting,No Results Available,Covid19,Device: Radius PPG Tetherless Pulse Oximetry (Masimo)|Device: usual monitoring,All,"Child, Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"September 22, 2020","November 15, 2021"
2464,NCT04468217,Recruiting,No Results Available,COVID|SARS-CoV2|Corona Virus Infection,"Diagnostic Test: Obtainment of nasopharyngeal, oropharyngeal, buccal, nasal and saliva samples",All,"Adult, Older Adult",,150.0,Industry,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 2, 2020","September 25, 2020"
2465,NCT04393038,Recruiting,No Results Available,COVID-19,Drug: ABX464|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,1034.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 1, 2020","April 30, 2021"
2466,NCT04449718,Completed,No Results Available,COVID-19,Dietary Supplement: Vitamin D|Dietary Supplement: Placebo,All,"Adult, Older Adult",Not Applicable,240.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2020","October 7, 2020"
2467,NCT04451291,Not yet recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome,Biological: Decidual Stromal Cells (DSC),All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 24, 2020","February 24, 2021"
2468,NCT04385849,Not yet recruiting,No Results Available,COVID-19,Biological: N-803|Other: Saline,All,"Adult, Older Adult",Phase 1,30.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 1, 2020","July 11, 2020"
2469,NCT04529499,"Active, not recruiting",No Results Available,Covid19,Drug: AVIGAN|Drug: Placebo Comparator,All,"Adult, Older Adult",Phase 3,780.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 20, 2020","March 31, 2021"
2470,NCT04568148,Recruiting,No Results Available,Covid-19|SARS-CoV 2|Coronavirus|COVID,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"April 15, 2020","December 31, 2021"
2471,NCT04360278,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,1500.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 21, 2020","April 6, 2030"
2472,NCT04449380,Recruiting,No Results Available,COVID-19 Virus Infection,Drug: Interferon-ß-1a|Combination Product: Standard of Care (SOC),All,"Adult, Older Adult",Phase 2,126.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 2, 2020",June 2021
2473,NCT04492449,Not yet recruiting,No Results Available,Exposure During Pregnancy|Corona Virus Infection,Other: congenital malformation,Female,"Child, Adult",,260.0,Other,Observational,Observational Model: Other|Time Perspective: Other,January 2021,December 2022
2474,NCT04400838,Recruiting,No Results Available,Coronavirus,Biological: ChAdOx1 nCoV-19 (Abs 260)|Biological: MenACWY vaccine|Biological: ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR) boost|Biological: Two dose MenACWY vaccine|Biological: ChAdOx1 nCoV-19 (qPCR)|Biological: ChAdOx1 nCoV-19 0.5mL prime plus boost|Biological: Two dose MenACWY vaccine min. 4 weeks apart|Biological: Two dose ChAdOx1 nCoV-19/Covishield 0.5mL|Biological: Two dose ChAdOx1 nCoV-19/Covishield 0.25mL & 0.5mL,All,"Adult, Older Adult",Phase 2|Phase 3,12390.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"May 28, 2020",September 2021
2475,NCT04324684,Completed,No Results Available,"Pneumonia, Viral|Hypertension|Diabetes Mellitus|Obesity|Cardiovascular Diseases|Obstructive Lung Disease",,All,"Adult, Older Adult",,198.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 31, 2020","May 7, 2020"
2476,NCT04463433,Recruiting,No Results Available,Parent-child Relationship and Couple Relationship Under COVID-19 in China,Behavioral: Cognitive and behavioral intervention.|Behavioral: Problem-solving and relationship improvement intervention.,All,Adult,Not Applicable,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","February 1, 2020","January 31, 2022"
2477,NCT04659876,Completed,No Results Available,Covid19 and Mortality,Diagnostic Test: clinical features and laboratory values,All,"Adult, Older Adult",,445.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 22, 2020","December 8, 2020"
2478,NCT04784481,Completed,No Results Available,Covid19|SARS (Severe Acute Respiratory Syndrome),Drug: Ivermectin,All,"Adult, Older Adult",Phase 1|Phase 2,240.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 20, 2020","January 18, 2021"
2479,NCT04366206,Recruiting,No Results Available,COVID|SARS-CoV 2,,All,"Child, Adult, Older Adult",,143.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 14, 2020","July 31, 2020"
2480,NCT04662086,Enrolling by invitation,No Results Available,Covid19,Drug: Acebilustat|Drug: Camostat,All,"Adult, Older Adult",Phase 2,240.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,March 2022
2481,NCT04412538,Recruiting,No Results Available,COVID-19,Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Placebo on a 0- and 28-day schedule|Biological: Placebo on a 0- and 14-day schedule,All,Adult,Phase 1|Phase 2,942.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 15, 2020",September 2021
2482,NCT04453501,Completed,No Results Available,"COVID|Pneumonia, Viral",Drug: favorable outcome,All,"Adult, Older Adult",,132.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 2, 2020","April 25, 2020"
2483,NCT04662073,Enrolling by invitation,No Results Available,Covid19,Drug: Camostat|Drug: Placebo,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,March 2022
2484,NCT04708236,Recruiting,No Results Available,COVID-19,Drug: ORTD-1 low dose|Drug: ORTD-1 mid dose|Drug: ORTD-1 high dose|Other: Vehicle control,All,"Adult, Older Adult",Phase 1|Phase 2,18.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,July 2021
2485,NCT04794829,Recruiting,No Results Available,Influenza|COVID-19,,All,"Adult, Older Adult",,150.0,NIH,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 19, 2021","December 31, 2026"
2486,NCT04467931,"Active, not recruiting",No Results Available,Hypertension|COVID,Drug: ACEI/ARB|Drug: Non-ACEI/ARB|Drug: ACEI|Drug: ARB,All,"Adult, Older Adult",,10000.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 19, 2020","December 31, 2020"
2487,NCT04659473,Not yet recruiting,No Results Available,Covid19,Other: Online survey,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"December 9, 2020","December 20, 2020"
2488,NCT04701710,Completed,No Results Available,Covid19|SARS (Severe Acute Respiratory Syndrome),Drug: Ivermectin / Iota-Carrageenan,All,Adult,Phase 1|Phase 2,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 15, 2020","December 31, 2020"
2489,NCT04338347,No longer available,No Results Available,COVID-19,Biological: CAP-1002 Allogeneic Cardiosphere-Derived Cells,All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,
2490,NCT04324190,Recruiting,No Results Available,COVID-19|Psychosocial Stress|Mental Health,Behavioral: Guided online support program|Behavioral: WHO recommendations (waiting condition),All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,"April 8, 2020",December 2021
2491,NCT04646616,Not yet recruiting,No Results Available,Covid19|Mental Health Issue|Violence,Other: Community popular opinion leader (POL) based intervention,All,"Adult, Older Adult",Not Applicable,800.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 6, 2021","October 31, 2021"
2492,NCT04377490,Recruiting,No Results Available,COVID-19|Hemostasis|Coagulation,Other: venous ultrasound|Biological: blood sample,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 4, 2020",November 2020
2493,NCT04345640,Recruiting,No Results Available,Liver Cirrhoses,Other: no intervention,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020","December 31, 2020"
2494,NCT04497636,Recruiting,No Results Available,"Anxiety|Depression|Stress, Psychological|Loneliness|Social Isolation",,All,"Adult, Older Adult",,1092.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 3, 2020","May 31, 2021"
2495,NCT04437901,Not yet recruiting,No Results Available,"COVID|Arrhythmia|Torsades de Pointe Caused by Drug|Qt Interval, Variation in|Atrioventricular Block|Atrial Fibrillation|Bradyarrhythmia|Ventricular Arrythmia",,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,June 2020,December 2021
2496,NCT04518410,Recruiting,No Results Available,Coronavirus|Covid19,Biological: bamlanivimab|Drug: Placebo (IV)|Biological: BRII-196/BRII-198|Biological: AZD7442 (IV)|Biological: AZD7442 (IM)|Drug: SNG001|Drug: Camostat|Drug: Placebo (IM)|Drug: Placebo (Inhaled solution)|Drug: Placebo (oral tablet)|Biological: C135-LS + C144-LS|Drug: Placebo (SC injections),All,"Adult, Older Adult",Phase 2|Phase 3,2000.0,NIH|Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","August 19, 2020",May 2023
2497,NCT04630015,Recruiting,No Results Available,COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Other: Survey Administration,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 31, 2020","December 31, 2023"
2498,NCT04392778,Recruiting,No Results Available,Covid19|Pneumonia|Multiple Organ Failure|Corona Virus Infection,Biological: MSC Treatment|Biological: Saline Control,All,Adult,Phase 1|Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2020",September 2020
2499,NCT04659200,Completed,No Results Available,COVID-19 Infection|Thyroid Function Tests|Inflammation; Thyroid|Inflammatory Markers,Diagnostic Test: Venous blood was collected for biochemistry testing.,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"September 1, 2020","December 7, 2020"
2500,NCT04758273,"Active, not recruiting",No Results Available,COVID-19,Biological: medium dosage inactivated SARS-CoV-2 vaccine|Biological: high dosage inactivated SARS-CoV-2 vaccine|Biological: Placebo,All,"Adult, Older Adult",Phase 1,180.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 7, 2020","February 28, 2022"
2501,NCT04420299,Recruiting,No Results Available,Covid-19,Drug: Bemiparin,All,"Adult, Older Adult",Phase 2,120.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 4, 2020","March 31, 2021"
2502,NCT04525287,Recruiting,No Results Available,Coronavirus Infection|COVID19,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"February 20, 2020","August 20, 2020"
2503,NCT04588441,Not yet recruiting,No Results Available,Acute Respiratory Distress,Drug: Adenosine,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,December 2022
2504,NCT04568135,Not yet recruiting,No Results Available,Covid19,Other: survey,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"October 31, 2020","December 31, 2021"
2505,NCT04448743,Not yet recruiting,No Results Available,COVID-19,Other: Blood sample,All,"Adult, Older Adult",,175.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,June 2020,November 2021
2506,NCT04346017,Recruiting,No Results Available,COVID-19,Diagnostic Test: Cytokines dosage|Diagnostic Test: Complement dosage,All,"Child, Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"March 20, 2020",December 2020
2507,NCT04681755,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,55.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 19, 2020","May 19, 2021"
2508,NCT04397666,Recruiting,No Results Available,SARS-CoV Infection|Pinkeye,Diagnostic Test: conjunctival RT PCR,All,"Adult, Older Adult",Not Applicable,68.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 15, 2020","November 15, 2020"
2509,NCT04789226,Not yet recruiting,No Results Available,Psychological Impact of Covid-19,,All,"Adult, Older Adult",,239.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"March 1, 2021","March 1, 2022"
2510,NCT04447638,Completed,No Results Available,Tracheostomy,Procedure: Tracheostomy with aerosol box in COVID-19 positive patients,All,"Adult, Older Adult",,24.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 20, 2020","June 1, 2020"
2511,NCT04414293,Recruiting,No Results Available,"COVID|Pneumonia, Viral",Radiation: Lung Low Dose Radiation,All,Older Adult,Not Applicable,41.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2020","December 31, 2021"
2512,NCT04797871,Enrolling by invitation,No Results Available,"Covid19|SARS-CoV2|Fatigue Syndrome, Chronic|Stress, Psychological|Pain, Chronic",Behavioral: Resistance training|Behavioral: Standard care,All,Adult,Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research,"March 8, 2021","March 15, 2022"
2513,NCT04479488,"Active, not recruiting",No Results Available,Covid19|SARS-CoV Infection,Other: Hospital admission|Other: Non-hospitalization procedures,All,"Adult, Older Adult",,1587.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 27, 2020",April 2021
2514,NCT04329546,Recruiting,No Results Available,SARS-CoV-2 Viral Kinetics and Host Immune Responses,Other: NA (no intervention),All,"Child, Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 27, 2020","March 31, 2022"
2515,NCT04361396,Recruiting,No Results Available,Coronavirus Infection,Other: Collection of samples,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"June 16, 2020",June 2021
2516,NCT04597736,Not yet recruiting,No Results Available,Covid19|Contact Case,"Biological: Biological collection with nasopharyngeal samples, saliva, blood, stool and urine",All,"Child, Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,November 2020,February 2022
2517,NCT04355481,Recruiting,No Results Available,Covid-19|Viral Infection,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 17, 2020","December 17, 2020"
2518,NCT04362111,Recruiting,No Results Available,Cytokine Storm|COVID-19,Drug: Anakinra|Drug: Normal saline,All,"Adult, Older Adult",Phase 3,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 29, 2020",March 2021
2519,NCT04549636,Recruiting,No Results Available,Covid-19|Asthma|Healthy,Other: V/Q SPECT-CT|Other: St. George's Respiratory Questionnaire (SGRQ)|Other: mMRC (Modified Medical Research Council) Dyspnea Scale|Other: Six-minute walk test (6MWT)|Other: Spirometry|Other: Plethysmography & DLCO|Other: Airwave Oscillometry,All,"Adult, Older Adult",,92.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 18, 2020",December 2021
2520,NCT04669925,"Active, not recruiting",No Results Available,Covid19,,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"September 1, 2020",July 2021
2521,NCT04637893,Not yet recruiting,No Results Available,Colorectal Cancer,Other: Colonoscopy,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"December 16, 2020","March 31, 2021"
2522,NCT04510194,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: Metformin|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,750.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 1, 2021",August 2021
2523,NCT04652102,Recruiting,No Results Available,Covid19|SARS-CoV-2,Biological: CVnCoV|Biological: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,36500.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","December 14, 2020","March 4, 2023"
2524,NCT04419610,Recruiting,No Results Available,COVID,Biological: TRV027|Other: sodium chloride 0.9%,All,"Adult, Older Adult",Early Phase 1,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research","October 9, 2020",June 2021
2525,NCT04354805,Not yet recruiting,No Results Available,COVID-19,Drug: Chlorpromazine,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"August 1, 2020",November 2020
2526,NCT04799691,Recruiting,No Results Available,COVID-19,Procedure: Invasive ventilation strategy|Procedure: Non-invasive ventilation strategies,All,"Adult, Older Adult",,140.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"February 1, 2021",December 2021
2527,NCT04689542,Recruiting,No Results Available,Covid19,Other: Sit-To-Stand test,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care","January 1, 2021","August 1, 2021"
2528,NCT04329650,Recruiting,No Results Available,COVID-19,Drug: Siltuximab|Drug: Methylprednisolone,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","May 20, 2020"
2529,NCT04385901,Completed,No Results Available,SARS-CoV 2|SARS Pneumonia,Behavioral: Therapy Intervention,All,"Adult, Older Adult",Not Applicable,26.0,Other,Interventional,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 19, 2020","September 19, 2020"
2530,NCT04727294,Recruiting,No Results Available,Multiple Myeloma|Smoldering Multiple Myeloma|Monoclonal Gammopathy of Undetermined Significance|Coronavirus,Behavioral: Questionnaire,All,"Adult, Older Adult",,1500.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 22, 2021",December 2021
2531,NCT04244591,Completed,No Results Available,COVID-19 Infections,Drug: methylprednisolone therapy|Other: Standard care,All,"Adult, Older Adult",Phase 2|Phase 3,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 26, 2020","April 13, 2020"
2532,NCT04450277,Completed,No Results Available,COVID-19|Emergency Surgery,Procedure: Emergency surgery,All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","May 31, 2020"
2533,NCT04487574,Completed,No Results Available,SARS-CoV-2 Infection,Drug: XC221|Drug: Placebo,All,"Adult, Older Adult",Phase 3,118.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 25, 2020","October 29, 2020"
2534,NCT04447222,Recruiting,No Results Available,COVID-19 Infection|Malignant Solid Neoplasm,Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Other: Survey Administration,All,"Child, Adult, Older Adult",,1242.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 12, 2020","July 21, 2021"
2535,NCT04820751,Not yet recruiting,No Results Available,Viral Pneumonia|Serotonin Syndrome|Platelet Dysfunction,Drug: Cyproheptadine Hydrochloride 4 MG,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 10, 2021","January 1, 2022"
2536,NCT04362085,Recruiting,No Results Available,COVID-19,Drug: Therapeutic Anticoagulation,All,"Adult, Older Adult",Phase 3,462.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 11, 2020",April 2022
2537,NCT04609085,Enrolling by invitation,No Results Available,SARS-COV2 Virus,,All,"Child, Adult, Older Adult",,5000.0,NIH,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 19, 2021","April 30, 2023"
2538,NCT04273529,Not yet recruiting,No Results Available,COVID-19 Thalidomide,Drug: thalidomide|Drug: placebo,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 20, 2020","June 30, 2020"
2539,NCT04344730,"Active, not recruiting",No Results Available,Acute Hypoxemic Respiratory Failure|COVID-19,Drug: Dexamethasone injection|Drug: placebo|Procedure: conventional oxygen|Procedure: CPAP|Procedure: HFNO|Procedure: mechanical ventilation,All,"Adult, Older Adult",Not Applicable,550.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 10, 2020","December 31, 2021"
2540,NCT04518969,Recruiting,No Results Available,Covid19,Device: CytoSorb,All,"Adult, Older Adult",Not Applicable,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 3, 2020","December 1, 2020"
2541,NCT04360980,Recruiting,No Results Available,COVID-19,Drug: Colchicine Tablets,All,"Adult, Older Adult",Phase 2,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 20, 2020","November 30, 2021"
2542,NCT04470999,Recruiting,No Results Available,Covid19|SARS-CoV-2,Other: Leukapheresis,All,Adult,Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"April 15, 2020","December 31, 2021"
2543,NCT04746183,Recruiting,No Results Available,Covid19,Drug: CST-2: EIDD-2801|Drug: CST-2: Placebo|Drug: Nitazoxanide|Drug: VIR-7832|Drug: VIR-7831|Drug: CST-5: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 3, 2020","April 30, 2022"
2544,NCT04366934,Completed,No Results Available,Coronavirus Infection|Severe Acute Respiratory Syndrome|Sars-CoV2,Other: Nasal swab|Other: Taste and olfactory function evaluation,All,"Adult, Older Adult",,26.0,Industry|Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"May 4, 2020","October 29, 2020"
2545,NCT04358549,"Active, not recruiting",No Results Available,COVID-19,Drug: Favipiravir + Standard of Care|Drug: Standard of Care,All,"Adult, Older Adult",Phase 2,50.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 17, 2020","May 1, 2021"
2546,NCT04553055,Completed,No Results Available,Covid19,Other: online questionnaires,All,"Adult, Older Adult",,413.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"July 20, 2020","September 15, 2020"
2547,NCT04685629,Recruiting,No Results Available,Covid19,Diagnostic Test: 25 post ICU-patients|Other: 25 post non-ICU patients,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 7, 2020",December 2022
2548,NCT04395742,Not yet recruiting,No Results Available,Coronavirus Disease 2019,Other: Data collection,All,"Adult, Older Adult",,93.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,May 2020,December 2020
2549,NCT04475601,Recruiting,No Results Available,COVID-19|Corona Virus Infection,Drug: Enzalutamide Pill,All,"Adult, Older Adult",Phase 2,500.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 15, 2020","May 8, 2022"
2550,NCT04347369,Recruiting,No Results Available,COVID-19 Disease,Other: other,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"January 17, 2020","December 31, 2020"
2551,NCT04591613,Recruiting,No Results Available,Covid19,Other: Questionnaire|Other: Biocollection|Other: Follow-up visit,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"December 31, 2020",August 2022
2552,NCT04379440,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 25, 2020","November 30, 2020"
2553,NCT04780295,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 15, 2020",December 2021
2554,NCT04710771,Completed,No Results Available,Covid19,Other: Prone Lying Position|Other: alternate nostril breathing,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 23, 2020","January 29, 2021"
2555,NCT04355936,Completed,No Results Available,COVID-19 Drug Treatment,Drug: Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care.,All,"Adult, Older Adult",Phase 4,400.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 19, 2020","November 30, 2020"
2556,NCT04747405,Not yet recruiting,No Results Available,Intensive Care Unit Syndrome|Covid19|Anxiety|Depression,Other: therapy group,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"February 22, 2021","August 22, 2022"
2557,NCT04401423,Recruiting,No Results Available,COVID-19,Drug: TXA127|Drug: Placebo,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","February 10, 2021",December 2021
2558,NCT04735757,Recruiting,No Results Available,Diaphragm Disease|Covid19,Other: Contrast-enhanced MRI|Other: Measurement of respiratory muscle force,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"February 3, 2021","January 19, 2023"
2559,NCT04391712,Completed,No Results Available,COVID-19,Device: MLS Laser|Other: Regular Inpatient Medical Care,All,"Adult, Older Adult",Phase 2,10.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","July 16, 2020"
2560,NCT04470297,Not yet recruiting,No Results Available,Covid19|Lung Injury,Drug: Ramelteon 8mg,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",September 2020,March 2021
2561,NCT04708912,Recruiting,No Results Available,Covid19,Other: Observation,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"December 15, 2020","April 1, 2021"
2562,NCT04661527,Recruiting,No Results Available,COVID-19 Drug Treatment,Drug: Sarilumab,All,"Adult, Older Adult",Phase 2,60.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 22, 2020","December 30, 2020"
2563,NCT04681157,Recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 3, 2020","April 3, 2021"
2564,NCT04475068,Recruiting,No Results Available,Sars-CoV2|ARDS,Procedure: Lateral Position (left and right lateral decubitus),All,"Adult, Older Adult",,12.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 17, 2020",October 2020
2565,NCT04466241,Recruiting,No Results Available,COVID-19|COVID-19 Drug Treatment|Severe Acute Respiratory Syndrome Coronavirus 2,Drug: Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet|Drug: Telmisartan 40Mg Oral Tablet|Drug: Atorvastatin 20 Mg Oral Tablet,All,"Adult, Older Adult",Phase 2|Phase 3,294.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 27, 2020","March 26, 2021"
2566,NCT04335201,Recruiting,No Results Available,Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure,Drug: Defibrotide Injection,All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020","August 31, 2021"
2567,NCT04530682,Recruiting,No Results Available,Rheumatoid Arthritis,,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 5, 2021",July 2024
2568,NCT04589949,Recruiting,No Results Available,Covid19,Biological: ConvP|Biological: FFP,All,"Adult, Older Adult",Phase 3,690.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 12, 2020","November 1, 2023"
2569,NCT04315896,"Active, not recruiting",No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,500.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 14, 2020","August 15, 2020"
2570,NCT04480398,Completed,No Results Available,Covid19|Asymptomatic Condition,Drug: Guduchi Ghan Vati,All,"Adult, Older Adult",,91.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 12, 2020","July 3, 2020"
2571,NCT04279899,Recruiting,No Results Available,Neonatal Infection|Perinatal Problems|Infectious Disease,,All,Child,,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 1, 2020","December 31, 2023"
2572,NCT04784559,Not yet recruiting,No Results Available,COVID-19 Infection,Drug: Plitidepsin|Drug: Dexamethasone|Drug: Remdesivir,All,"Adult, Older Adult",Phase 3,609.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,August 2021
2573,NCT04368208,Completed,No Results Available,Postnatal Depression,Other: Assessment of postnatal depression using the the Edinburgh questionnaire between 4 and 6 weeks after delivery,Female,Adult,,501.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020","November 27, 2020"
2574,NCT04751721,Not yet recruiting,No Results Available,Covid-19 Vaccine,Biological: CoronoVac Vaccine,Female,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,February 2021,April 2021
2575,NCT04342104,Recruiting,No Results Available,Respiratory Failure|Covid-19,Other: Monitoring for aggravation|Other: Evaluate HACOR score effectivity in this patients,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","November 15, 2021"
2576,NCT04354753,Completed,No Results Available,COVID 19,Other: No Intervention,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 28, 2020","April 17, 2020"
2577,NCT04617483,Recruiting,No Results Available,Covid19,"Biological: Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14|Biological: Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14|Biological: Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14 in elderly",All,"Adult, Older Adult",Phase 3,1040.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","October 31, 2020","May 31, 2021"
2578,NCT04459975,Recruiting,No Results Available,on Occurrence of Acurate Kidney Injury During Intensive Care Unit|Abnormalities of Urinary Analysis,Other: Non interventional study,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020",November 2020
2579,NCT04352803,Not yet recruiting,No Results Available,Covid-19 Pneumonia|Cyotokine Storm,Biological: Autologous Adipose MSC's,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2020,April 2026
2580,NCT04358614,Completed,No Results Available,COVID|Pneumonia,Drug: Baricitinib 4 MG Oral Tablet,All,"Adult, Older Adult",Phase 2|Phase 3,12.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 16, 2020","April 7, 2020"
2581,NCT04425382,Recruiting,No Results Available,Coronavirus|COVID|Pneumonia,Drug: Darunavir/Cobicistat|Drug: Lopinavir/Ritonavir,All,"Adult, Older Adult",,200.0,Industry,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 1, 2020",September 2020
2582,NCT04686747,Enrolling by invitation,No Results Available,Pancreatic Cancer|Gastric Cancer|Esophagus Cancer|Colorectal Cancer,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,January 2021,"June 30, 2021"
2583,NCT04726371,Recruiting,No Results Available,Intellectual Disability|Developmental Disability|Axis I Diagnosis|Mental Illness|Covid19|Coronavirus,Behavioral: Generic Best Practices|Behavioral: Tailored Best Practices,All,"Adult, Older Adult",Not Applicable,5350.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"January 8, 2021",October 2022
2584,NCT04380727,Completed,No Results Available,COVID-19|Hypoxic Respiratory Failure,,All,"Adult, Older Adult",,17.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 20, 2020","April 25, 2020"
2585,NCT04359329,Recruiting,No Results Available,COVID,Drug: Estradiol patch,All,"Adult, Older Adult",Phase 2,110.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","November 15, 2020"
2586,NCT04371822,Not yet recruiting,No Results Available,COVID-19,Drug: SnPP Protoporphyrin plus Sunlight exposure|Drug: Sulfonatoporphyrin(TPPS) plus Sunlight exposure.|Other: placebo,All,"Adult, Older Adult",Phase 1,56.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,August 2020,November 2020
2587,NCT04729374,Recruiting,No Results Available,SARS-CoV-2|Vaccine|COVID-19,,All,Adult,,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 27, 2021","December 31, 2023"
2588,NCT04517695,Recruiting,No Results Available,Covid19|Acute Respiratory Distress Syndrome,Device: BVA-100,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 1, 2020","February 1, 2021"
2589,NCT04338074,Recruiting,No Results Available,COVID-19,Drug: Tranexamic acid tablets|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2020","December 31, 2021"
2590,NCT04454398,Withdrawn,No Results Available,Covid-19,Biological: COVI-GUARD|Other: Standard of Care|Drug: Placebo,All,"Adult, Older Adult",Phase 1,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",September 2020,January 2021
2591,NCT04375046,Not yet recruiting,No Results Available,COVID-19,Drug: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2),All,"Adult, Older Adult",Phase 1,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,September 2020,October 2020
2592,NCT04805671,Recruiting,No Results Available,COVID-19,Drug: ADG20|Drug: Normal saline,All,"Adult, Older Adult",Phase 2|Phase 3,1728.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",March 2021,January 2023
2593,NCT04830852,Not yet recruiting,No Results Available,SARS-CoV-2,,All,"Child, Adult",,5000.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2021","May 1, 2027"
2594,NCT04537572,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: comparison of sample collection methods,All,"Adult, Older Adult",Not Applicable,300.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,September 2020,September 2022
2595,NCT04497610,Not yet recruiting,No Results Available,COVID19,Diagnostic Test: Breath sample,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 4, 2020","August 15, 2020"
2596,NCT04594330,Recruiting,No Results Available,Coronavirus Infections,Drug: virgin coconut oil (VCO)|Other: placebo,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","June 1, 2020","December 31, 2020"
2597,NCT04359706,Recruiting,No Results Available,Sars-CoV2,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 8, 2020",September 2020
2598,NCT04741061,Recruiting,No Results Available,COVID-19 Prevention,Biological: Sputnik Light|Other: Placebo,All,"Adult, Older Adult",Phase 3,6000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","February 19, 2021","January 31, 2022"
2599,NCT04335552,Terminated,No Results Available,SARS-CoV-2,Other: Standard of care|Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Child, Adult, Older Adult",Phase 2,11.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 17, 2020","June 26, 2020"
2600,NCT04446338,Recruiting,No Results Available,"History of Covid-19, Seroprevalence",Diagnostic Test: Antibody Test,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 13, 2020",August 2020
2601,NCT04428268,Withdrawn,No Results Available,COVID-19 Pneumonia,Drug: Chloroquine Phosphate Tablets,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 10, 2020","February 16, 2021"
2602,NCT04355884,Not yet recruiting,No Results Available,COVID-19,"Diagnostic Test: Standard 12-lead ECG, NT-proBNP, echocardiography",All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","May 1, 2020"
2603,NCT04575038,"Active, not recruiting",No Results Available,COVID-19 Infection,Drug: Brequinar|Drug: Placebo,All,"Adult, Older Adult",Phase 2,115.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 19, 2020","April 28, 2021"
2604,NCT04751604,Recruiting,No Results Available,COVID-19,Dietary Supplement: Nicotinamide|Dietary Supplement: Placebo,All,"Adult, Older Adult",Not Applicable,840.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","February 1, 2021",December 2021
2605,NCT04374656,Recruiting,No Results Available,"Conjunctivitis|SARS-CoV-2|COVID-19|Ocular Infection, Viral|Ocular Inflammation",,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 18, 2020",May 2021
2606,NCT04369365,Recruiting,No Results Available,COVID,Drug: Azithromycin 500 milligram (mg) oral Tablet|Drug: Placebo,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"April 27, 2020","December 27, 2020"
2607,NCT04345289,Recruiting,No Results Available,COVID|Corona Virus Infection|Viral Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Other: Infusion placebo,All,"Adult, Older Adult",Phase 3,1100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 1, 2020","June 15, 2021"
2608,NCT04547660,Completed,No Results Available,Covid19,Biological: Convalescent Plasma|Other: Best Supportive Care,All,"Adult, Older Adult",Phase 3,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 16, 2020","January 7, 2021"
2609,NCT04449783,Recruiting,No Results Available,Covid19|Cancer,Other: pre-operative screening|Other: telephone consult,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 25, 2020","September 25, 2020"
2610,NCT04830033,Not yet recruiting,No Results Available,COVID-19 Recovery,Other: ENO Breathe group,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,December 2021
2611,NCT04443868,Not yet recruiting,No Results Available,SARS-CoV Infection,Drug: Nitric Oxide-Releasing Drug,All,"Adult, Older Adult",Phase 2,50.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",January 2021,July 2021
2612,NCT04787510,Recruiting,No Results Available,SARS-COV2 Infection|COVID-19 Disease|Hospitalized Patients,Drug: low molecular weight Heparin as standard of care treatment,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 23, 2020","June 23, 2021"
2613,NCT04476823,Completed,No Results Available,Clinical Practice During the COVID-19 Crisis,Other: Activity,All,"Child, Adult, Older Adult",,71.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"March 15, 2020","May 31, 2020"
2614,NCT04345653,"Active, not recruiting",No Results Available,COVID19,Drug: Hydroxychloroquine Sulfate (HCQ),All,"Adult, Older Adult",Phase 2,44.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 14, 2020","June 8, 2021"
2615,NCT04510025,Recruiting,No Results Available,Coronavirus Infection|Multi-Organ Disorder,Diagnostic Test: Magnetic Resonance Imaging,All,"Adult, Older Adult",,616.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 13, 2020","May 1, 2023"
2616,NCT04751643,Not yet recruiting,No Results Available,"Intensive Care Units|ARDS, Human|Covid19",Other: Therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3)|Other: Usual treatments in intensive care unit according to the current state of knowledge,All,"Adult, Older Adult",Not Applicable,132.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,February 2021,November 2022
2617,NCT04758286,Completed,No Results Available,COVID-19,Procedure: Emergency surgical procedures,All,"Child, Adult, Older Adult",Not Applicable,209.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 1, 2020","February 11, 2021"
2618,NCT04287686,Withdrawn,No Results Available,COVID-19,Drug: Recombinant human angiotensin-converting enzyme 2 (rhACE2),All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,February 2020,April 2020
2619,NCT04545541,Recruiting,No Results Available,Covid19|Respiratory Failure,Drug: Nebulised unfractionated heparin (UFH),All,"Adult, Older Adult",Phase 2|Phase 3,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 1, 2020",June 2022
2620,NCT04472793,Recruiting,No Results Available,COVID-19,Diagnostic Test: SARS-CoV-2,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 11, 2020",December 2023
2621,NCT04351620,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2020,June 2020
2622,NCT04383574,"Active, not recruiting",No Results Available,COVID-19,"Biological: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Other: Two doses of placebo at the schedule of day 0,28",All,"Adult, Older Adult",Phase 1|Phase 2,422.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","May 22, 2020","May 30, 2021"
2623,NCT04390464,Recruiting,No Results Available,COVID19,Drug: Ravulizumab|Drug: Baricitinib|Other: Standard of care,All,"Adult, Older Adult",Phase 4,1167.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","May 1, 2022"
2624,NCT04789447,Recruiting,No Results Available,"Covid19|SARS-CoV Infection|Pneumonia, Viral",,All,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 4, 2021","March 28, 2021"
2625,NCT04393805,Completed,No Results Available,COVID-19|Hypercoagulability,Drug: Low Molecular Weight Heparin,All,"Adult, Older Adult",,744.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020","February 26, 2021"
2626,NCT04409925,Recruiting,No Results Available,COVID-19 Infection,Drug: rhDNase I,All,"Adult, Older Adult",Phase 1,25.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 25, 2020",August 2021
2627,NCT04462757,Suspended,No Results Available,COVID-19,Drug: Anakinra 100Mg/0.67Ml Inj Syringe,All,"Adult, Older Adult",Phase 2,5.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 28, 2020","December 31, 2020"
2628,NCT04433000,Recruiting,No Results Available,Covid-19 Pneumonia,Diagnostic Test: Butterfly,All,"Child, Adult, Older Adult",,34.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 15, 2020","June 10, 2020"
2629,NCT04669015,Not yet recruiting,No Results Available,Covid19,Biological: Novaferon|Biological: Placebo,All,"Adult, Older Adult",Phase 3,914.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,August 2021
2630,NCT04705597,Recruiting,No Results Available,Covid19,Drug: BGE-175|Other: Placebo,All,"Adult, Older Adult",Phase 2,132.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 18, 2021",September 2021
2631,NCT04338932,Completed,No Results Available,COVID-19|Deep Vein Thrombosis (DVT)/Thrombophlebitis,,All,"Adult, Older Adult",,12.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 17, 2020","May 15, 2020"
2632,NCT04743401,Not yet recruiting,No Results Available,COVID 19|Rehabilitation,Other: Tele-exergaming Tablet,All,"Adult, Older Adult",Phase 1|Phase 2,60.0,U.S. Fed|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 30, 2021","March 31, 2023"
2633,NCT04390022,Completed,Has Results,Covid-19|Coronavirus Infection|SARS-CoV-2 Infection,Drug: Ivermectin|Drug: Placebo,All,Adult,Phase 2,24.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 31, 2020","October 9, 2020"
2634,NCT04450004,"Active, not recruiting",No Results Available,SARS-CoV 2,Biological: Intramuscular Vaccine,All,Adult,Phase 1,180.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 10, 2020","December 31, 2021"
2635,NCT04610541,"Active, not recruiting",No Results Available,SARS-CoV-2 Infection,Drug: Remdesivir-HU,All,"Child, Adult, Older Adult",Phase 3,2000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 12, 2020","November 30, 2021"
2636,NCT04332094,Recruiting,No Results Available,COVID-19,Drug: Tocilizumab|Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Adult, Older Adult",Phase 2,276.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 2, 2020",October 2020
2637,NCT04326114,Not yet recruiting,No Results Available,"Disease, Infectious|Respiratory Disease|Safety Issues|Effectiveness",Device: Inspiratory training device|Device: Expiratory training device,All,"Adult, Older Adult",Not Applicable,240.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"July 26, 2020","December 20, 2020"
2638,NCT04344171,Recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2020","June 30, 2023"
2639,NCT04666753,Completed,No Results Available,Covid19,Dietary Supplement: ImmunoFormulation,All,"Adult, Older Adult",,40.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 2, 2020","September 29, 2020"
2640,NCT04736901,Recruiting,No Results Available,Covid19|Corona Virus Infection|Hypercoagulability,Drug: Enoxaparin|Drug: Rivaroxaban|Drug: Apixaban,All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"December 1, 2020","June 1, 2021"
2641,NCT04349371,Terminated,No Results Available,COVID|Coronavirus Infection,Drug: Chloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,8.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 21, 2020","January 7, 2021"
2642,NCT04647682,Recruiting,No Results Available,COVID-19 Infection,Other: physical activity program,All,Older Adult,,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"November 1, 2020","December 31, 2021"
2643,NCT04652648,Completed,No Results Available,Covid19|Hydroxychloroquine|Coronavirus Infection|Transmission|Prophylaxis,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 4,54.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 27, 2020","November 15, 2020"
2644,NCT04523051,Recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","May 1, 2021"
2645,NCT04341103,Not yet recruiting,No Results Available,Solid Organ Transplant Rejection|COVID-19,,All,"Child, Adult, Older Adult",,500.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 1, 2020","March 1, 2021"
2646,NCT04497246,Recruiting,No Results Available,Covid19,Other: Questionnaire,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 29, 2020",December 2020
2647,NCT04720612,Not yet recruiting,No Results Available,Covid19,Biological: Omalizumab|Other: Placebo,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",February 2021,January 2022
2648,NCT04495764,Completed,No Results Available,SARS-CoV-2 Infection|Anti-SARS-CoV-2 Infection,,All,"Adult, Older Adult",,2504.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 20, 2020","February 12, 2021"
2649,NCT04724434,Enrolling by invitation,No Results Available,SARS-CoV-2 Positive Patients,,All,"Adult, Older Adult",,400.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 4, 2020",June 2026
2650,NCT04455243,Not yet recruiting,No Results Available,COVID-19,Drug: N-Acetyl cysteine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1180.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 1, 2020","August 30, 2021"
2651,NCT04382053,Completed,No Results Available,"COVID 19 Pneumonia, Impaired Respiratory Function",Drug: DFV890|Drug: Standard of Care (SoC),All,"Adult, Older Adult",Phase 2,143.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 27, 2020","December 24, 2020"
2652,NCT04369456,Recruiting,No Results Available,Kidney Transplant; Complications|Coronavirus Infection,Other: blood sample,All,"Adult, Older Adult",Not Applicable,115.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 22, 2020","October 22, 2020"
2653,NCT04714008,Recruiting,No Results Available,Gambling|Covid19,,All,"Adult, Older Adult",,180000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Retrospective,"December 1, 2020","December 31, 2022"
2654,NCT04475471,Recruiting,No Results Available,COVID-19|Cardiovascular Diseases,,All,"Adult, Older Adult",,5200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 11, 2020","December 30, 2021"
2655,NCT04394182,Recruiting,No Results Available,"Pneumonia, Viral|Cytokine Storm",Radiation: Ultra-Low-dose radiotherapy|Device: ventilatory support with oxygen therapy|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Piperacillin/tazobactam|Drug: Low molecular weight heparin|Drug: Corticosteroid injection|Drug: Tocilizumab,All,"Adult, Older Adult",Not Applicable,15.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 21, 2020","April 21, 2021"
2656,NCT04465474,Recruiting,No Results Available,COVID-19,Other: Non Intervention,Female,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"May 1, 2020","December 31, 2022"
2657,NCT04360486,Available,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Biological: Anti-Sars-CoV-2 Convalescent Plasma,All,"Child, Adult, Older Adult",,,U.S. Fed,Expanded Access:Treatment IND/Protocol,,,
2658,NCT04357847,Recruiting,No Results Available,Covid-19|Endothelial Dysfunction|Thrombosis|Critically Ill,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2020","August 31, 2021"
2659,NCT04374045,Completed,No Results Available,SARS-CoV 2,Other: ECG-Holter,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 30, 2020","June 18, 2020"
2660,NCT04492891,Recruiting,No Results Available,SARS (Disease),Drug: Cyclosporine|Other: Standard of Care Treatment,All,"Adult, Older Adult",Phase 2,75.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 23, 2020","November 23, 2025"
2661,NCT04453488,Not yet recruiting,No Results Available,Covid-19|Sars-CoV2,Biological: RUTI® vaccine|Biological: Placebo,All,"Adult, Older Adult",Phase 3,315.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 30, 2020",December 2020
2662,NCT04378582,Completed,No Results Available,"SARS-CoV 2|Respiratory Distress Syndrome, Adult|Corona Virus Infection|Critical Illness",Other: risk factors,All,"Child, Adult, Older Adult",,1589.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"May 7, 2020","August 5, 2020"
2663,NCT04305457,"Active, not recruiting",No Results Available,"Coronavirus Infections|Pneumonia, Viral|Acute Respiratory Distress Syndrome",Drug: Nitric Oxide,All,"Adult, Older Adult",Phase 2,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 21, 2020","April 1, 2022"
2664,NCT04805125,Not yet recruiting,No Results Available,Immunocompromised Patients,"Biological: Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)|Biological: Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)",All,"Adult, Older Adult",Phase 3,380.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,April 2021,July 2022
2665,NCT04732468,Recruiting,No Results Available,Covid19,Biological: hAd5-S-Fusion+N-ETSD (Suspension for injection)|Drug: hAd5-SFusion+ N-ETSD (Oral capsule),All,Adult,Phase 1,65.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 24, 2021",April 2022
2666,NCT04840082,Completed,No Results Available,Covid19,Diagnostic Test: Nasopharyngeal swab for COVID-19 testing,All,"Child, Adult, Older Adult",Not Applicable,109.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 7, 2021","March 8, 2021"
2667,NCT04405986,Completed,No Results Available,SARS-CoV 2,Procedure: Auditory Evoked Potentials (AEP)|Procedure: Blink and Masseter Inhibitory Reflex,All,"Adult, Older Adult",Not Applicable,38.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 19, 2020","March 10, 2021"
2668,NCT04469114,"Active, not recruiting",No Results Available,Covid19,Drug: Tofacitinib 10 mg|Drug: Placebo,All,"Adult, Older Adult",Phase 2,260.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 16, 2020","March 1, 2021"
2669,NCT04650178,Recruiting,No Results Available,COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Neuropathy,Other: Quality-of-Life Assessment|Other: Questionnaire Administration,All,"Child, Adult, Older Adult",,274.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Other,"May 26, 2020","July 1, 2021"
2670,NCT04709328,Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: SCTA01|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,690.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","March 28, 2021","March 1, 2022"
2671,NCT04454333,Completed,No Results Available,Infection|COVID|Pain,,All,"Adult, Older Adult",,466.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 3, 2020","June 20, 2020"
2672,NCT04393246,Recruiting,No Results Available,COVID-19,Drug: EDP1815|Drug: Dapagliflozin|Drug: Ambrisentan|Other: Standard of care,All,"Adult, Older Adult",Phase 2|Phase 3,1407.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 3, 2020","June 15, 2022"
2673,NCT04463758,Recruiting,No Results Available,covid19 Infection|Pregnancy Complications|Neonatal Complications,Other: An auto-questionnaire comprising three psychometric scales,Female,"Child, Adult, Older Adult",,3060.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020",October 2022
2674,NCT04495101,Recruiting,No Results Available,COVID-19,Biological: Prolastin|Drug: Standard Medical Treatment,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 29, 2020",May 2021
2675,NCT04270383,Not yet recruiting,No Results Available,2019-nCoV,,All,"Child, Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 15, 2020","December 31, 2020"
2676,NCT04360954,Completed,No Results Available,COVID|Coronavirus,Diagnostic Test: Diagnostic test,All,"Adult, Older Adult",,461.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 23, 2020","July 8, 2020"
2677,NCT04412473,Recruiting,No Results Available,Sars-CoV2,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 30, 2020",June 2021
2678,NCT04444336,Not yet recruiting,No Results Available,Depression|Anxiety,Behavioral: Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 22, 2020","July 13, 2020"
2679,NCT04432298,Terminated,No Results Available,COVID-19,Drug: Pamrevlumab|Drug: Placebo,All,"Adult, Older Adult",Phase 2,22.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 20, 2020","March 22, 2021"
2680,NCT04542876,Completed,No Results Available,Covid19,Drug: Guduchi Ghan Vati,All,"Adult, Older Adult",Not Applicable,46.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","August 18, 2020"
2681,NCT04423003,Completed,No Results Available,"Change; Endoscopy, COVID-19",Procedure: Endoscopic intervention,All,"Child, Adult, Older Adult",,10.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","May 15, 2020"
2682,NCT04357808,Completed,No Results Available,Covid-19,Drug: Sarilumab|Other: Standar of care,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 13, 2020","December 4, 2020"
2683,NCT04576728,Recruiting,No Results Available,Covid19,Drug: Trimodulin|Other: Placebo (human albumin 1%),All,"Adult, Older Adult",Phase 2,164.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 6, 2020",May 2021
2684,NCT04457609,Recruiting,No Results Available,COVID|Pulmonary Infection|Sars-CoV2,Drug: Oseltamivir|Drug: Azithromycin|Biological: Umbilical Cord Mesenchymal Stem Cells,All,"Adult, Older Adult",Phase 1,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",July 2020,September 2020
2685,NCT04358081,Completed,Has Results,Covid-19,Drug: HCQ|Drug: HCQ+AZT|Drug: Placebo,All,"Adult, Older Adult",Phase 3,20.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 1, 2020","July 27, 2020"
2686,NCT04723537,Recruiting,No Results Available,Covid19,Drug: Part A: Upamostat 200 mg|Drug: Part A: Upamostat 400 mg|Drug: Part A and B: Placebo|Drug: Part B: Upamostat 200 or 400 mg,All,"Adult, Older Adult",Phase 2|Phase 3,310.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 16, 2021",September 2021
2687,NCT04384471,Completed,No Results Available,Type1diabetes|Covid19,Other: Online survey,All,"Child, Adult, Older Adult",,384.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"April 29, 2020","July 1, 2020"
2688,NCT04723563,Enrolling by invitation,No Results Available,"Covid19|Pneumonia, Viral",Drug: Heparin|Drug: 0.9%sodium chloride,All,"Adult, Older Adult",Phase 4,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 22, 2021","May 29, 2021"
2689,NCT04542512,Recruiting,No Results Available,"Cholecystitis, Acute|Cholecystitis; Gangrenous|Cholecystitis Suppurative|Covid19",,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"October 1, 2020",December 2021
2690,NCT04479280,Completed,No Results Available,Coagulation Disorder,"Device: Sonclot Coagulation and platelet function Analyzer SCP1, Sienco, USA",All,"Child, Adult, Older Adult",,70.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 20, 2020","August 16, 2020"
2691,NCT04508972,Recruiting,No Results Available,Covid19,Device: Alexa Amazon,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","November 1, 2020"
2692,NCT04327804,Recruiting,No Results Available,SARS-CoV Infection,Diagnostic Test: Odd/Even birth year intervention groups,All,"Child, Adult, Older Adult",,120.0,Industry|Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 25, 2020","April 10, 2020"
2693,NCT04393415,Recruiting,No Results Available,Virus,Combination Product: stem cells,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","May 25, 2020","September 1, 2020"
2694,NCT04456049,Not yet recruiting,No Results Available,COVID-19 Infection,Drug: Enzalutamide,Male,"Adult, Older Adult",Phase 2,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,July 2020,December 2021
2695,NCT04339998,Recruiting,No Results Available,Coronavirus Infection|COVID|Covid-19|SARS-CoV-2,Diagnostic Test: Point-of-Care Ultrasonography (POCUS),All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020",October 2020
2696,NCT04460469,Recruiting,No Results Available,Anxiety|Covid19|Oral Hygiene,,All,"Child, Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"July 1, 2020",September 2020
2697,NCT04360824,Recruiting,No Results Available,COVID 19 Associated Coagulopathy,Drug: Intermediate dose thromboprophylaxis|Drug: Standard of Care thromboprophylaxis,All,"Adult, Older Adult",Phase 4,170.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 6, 2020","April 16, 2021"
2698,NCT04816760,Recruiting,No Results Available,Sars-CoV2|Innate Immunity|Immunization; Infection|Alveolar Lung Disease|Endothelial Dysfunction,Biological: Peripheral blood samples,All,"Adult, Older Adult",,100.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 25, 2020",December 2021
2699,NCT04456361,"Active, not recruiting",No Results Available,"ARDS, Human|Covid-19",Biological: Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords,All,"Adult, Older Adult",Early Phase 1,9.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","December 15, 2020"
2700,NCT04368000,Terminated,No Results Available,Respiratory Failure|COVID-19,Behavioral: Intermittent prone positioning instructions|Behavioral: Usual care positioning with no instructions,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 29, 2020","August 6, 2020"
2701,NCT04373044,Recruiting,No Results Available,Symptomatic COVID-19 Infection Laboratory-Confirmed,Drug: Baricitinib|Drug: Hydroxychloroquine|Drug: Placebo Administration,All,"Adult, Older Adult",Phase 2,144.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 1, 2020","May 1, 2022"
2702,NCT04701606,Recruiting,No Results Available,Covid19,Drug: Artecom® (pyronaridine-artesunate)|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,402.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","March 29, 2021","October 15, 2021"
2703,NCT04335097,Recruiting,No Results Available,COVID 19,Device: Biosensors,All,"Adult, Older Adult",Not Applicable,214.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 22, 2020","December 20, 2025"
2704,NCT04641858,Recruiting,No Results Available,Covid19|Morbidity|Absenteeism,Biological: BCG-Denmark|Biological: Saline,All,"Adult, Older Adult",Phase 4,1050.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","December 3, 2020",March 2022
2705,NCT04684446,Not yet recruiting,No Results Available,COVID-19,Biological: AZD1222|Biological: rAd26-S,All,"Adult, Older Adult",Phase 1|Phase 2,100.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 30, 2021","October 12, 2021"
2706,NCT04508933,Not yet recruiting,No Results Available,"Respiratory Distress Syndrome, Adult|Ventilation Perfusion Mismatch|Pulmonary Edema|Covid19",Device: Extravascular Lung Water Index|Device: Pulmonary Vascular Permeability Index,All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"September 1, 2020","December 31, 2020"
2707,NCT04591600,Completed,No Results Available,Covid19,Drug: Ivermectin and Doxycyline|Drug: Standard of care,All,"Child, Adult, Older Adult",Phase 1|Phase 2,140.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 1, 2020","October 14, 2020"
2708,NCT04517682,Enrolling by invitation,No Results Available,RNA Virus Infections,Diagnostic Test: RT-PCR,All,"Adult, Older Adult",,300.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 21, 2020","December 30, 2020"
2709,NCT04366765,Recruiting,No Results Available,COVID-19|SARS-CoV 2,,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 19, 2020","June 30, 2021"
2710,NCT04728698,Not yet recruiting,No Results Available,Covid19|ARDS,Drug: COVI-MSC|Drug: Placebo,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",March 2021,September 2021
2711,NCT04344938,Not yet recruiting,No Results Available,Covid 19 Pandemic From Ethical View,Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality,All,Adult,,874.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,April 2020,July 2020
2712,NCT04357886,Completed,No Results Available,Healthy,,All,"Child, Adult, Older Adult",,2605.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020","June 1, 2020"
2713,NCT04410016,Recruiting,No Results Available,Mental Health Wellness 1,Other: Staff Wellbeing Centres,All,"Child, Adult, Older Adult",Not Applicable,45.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 25, 2020","November 30, 2020"
2714,NCT04327180,Recruiting,No Results Available,Infection Viral|Coronavirus|ARDS|Pneumonia,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2020",September 2021
2715,NCT04753619,Recruiting,No Results Available,Covid-19|SARS Pneumonia,Drug: Niclosamide Oral Tablet,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 3, 2021","May 3, 2021"
2716,NCT04715438,Recruiting,No Results Available,Cancer,,All,"Adult, Older Adult",,873.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 8, 2021",April 2023
2717,NCT04432324,Completed,No Results Available,COVID-19,Biological: Intravenous Immune Globulin|Drug: Standard Medical Treatment,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 2, 2020","March 3, 2021"
2718,NCT04369742,Suspended,No Results Available,COVID-19,Drug: Hydroxychloroquine (HCQ)|Other: Pacebo: Calcium citrate,All,"Adult, Older Adult",Phase 2,626.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","April 15, 2020",June 2021
2719,NCT04581915,Recruiting,No Results Available,Covid19,Drug: Triazavirin (Riamilovir)|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,420.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 8, 2020","December 31, 2021"
2720,NCT04779879,Recruiting,No Results Available,Covid19,Biological: VIR-7831 (Gen1)|Biological: VIR-7831 (Gen2),All,"Adult, Older Adult",Phase 2,40.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 18, 2021",September 2021
2721,NCT04359602,Recruiting,No Results Available,Recovered From COVID-19,,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 8, 2020","April 20, 2042"
2722,NCT04730427,Recruiting,No Results Available,Covid19,Drug: GX-I7|Drug: GX-I7 vehicle,All,"Adult, Older Adult",Phase 1,40.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,January 2021,April 2022
2723,NCT04441424,Completed,No Results Available,IMMUNOTHERAPY,Biological: Convalescent plasma|Drug: Hydroxychloroquin with Azithromycin,All,"Adult, Older Adult",Not Applicable,49.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020","June 1, 2020"
2724,NCT04404361,Recruiting,No Results Available,COVID19|COVID-19|COVID,Drug: Pacritinib|Drug: Placebo,All,"Adult, Older Adult",Phase 3,364.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 22, 2020","October 31, 2021"
2725,NCT04808284,Not yet recruiting,No Results Available,COVID-19,Device: Transcranial direct-current stimulation|Device: Sham Transcranial direct-current stimulation,All,"Adult, Older Adult",Phase 1|Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2021","April 1, 2022"
2726,NCT04449588,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: BDB-001 Injection|Other: Conventional treatment,All,"Adult, Older Adult",Phase 2|Phase 3,368.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 23, 2020","August 7, 2022"
2727,NCT04793464,Recruiting,No Results Available,Health Behavior|Health Care Utilization,Behavioral: Promotores de Salud|Behavioral: Services as usual,All,"Child, Adult, Older Adult",Not Applicable,3600.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"February 4, 2021","August 31, 2022"
2728,NCT04500067,Completed,No Results Available,Covid19|Pneumonia,Drug: IVIG,All,"Adult, Older Adult",Phase 3,76.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 7, 2020","September 15, 2020"
2729,NCT04491201,Recruiting,No Results Available,COVID-19 Pandemics|Obstetrics and Gynecology|Workload|Questionnaire|National Survey|China,Other: Customized questionnaire,All,"Adult, Older Adult",,6000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"July 27, 2020","September 27, 2020"
2730,NCT04410354,Terminated,No Results Available,COVID-19,Drug: Merimepodib|Drug: Matching Placebo|Drug: Remdesivir,All,"Adult, Older Adult",Phase 2,44.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 16, 2020","December 1, 2020"
2731,NCT04672395,Not yet recruiting,No Results Available,COVID-19,Biological: CpG 1018/Alum-adjuvanted SCB-2019 vaccine|Biological: Placebo; 0.9% saline,All,"Adult, Older Adult",Phase 2|Phase 3,22000.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",March 2021,July 2022
2732,NCT04318431,Completed,No Results Available,Covid19,Diagnostic Test: Data collection and rhinopharyngeal swab,All,Child,Not Applicable,605.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 14, 2020","June 1, 2020"
2733,NCT04579549,Enrolling by invitation,No Results Available,COVID-19|Sars-CoV-2,Device: Saliva Assay,All,"Child, Adult, Older Adult",Not Applicable,10000.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 29, 2020",September 2021
2734,NCT04385095,"Active, not recruiting",No Results Available,SARS-CoV-2,Drug: SNG001|Drug: Placebo,All,"Adult, Older Adult",Phase 2,820.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 16, 2020","May 31, 2021"
2735,NCT04743011,Not yet recruiting,No Results Available,Covid19,Drug: Heparin sodium|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 15, 2021","December 31, 2021"
2736,NCT04317092,"Active, not recruiting",No Results Available,COVID-19 Pneumonia,Drug: Tocilizumab Injection,All,"Child, Adult, Older Adult",Phase 2,402.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 19, 2020","December 19, 2022"
2737,NCT04547140,Recruiting,No Results Available,COVID-19,Biological: Liquid Alpha1-Proteinase Inhibitor (Human)|Drug: Placebo|Drug: Standard Medical Treatment,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","January 29, 2021",September 2021
2738,NCT04351581,Recruiting,No Results Available,Covid-19,Other: Discontinuation of ACEi/ARB|Other: Continuation of ACEi/ARB,All,"Adult, Older Adult",Not Applicable,215.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 18, 2020",December 2020
2739,NCT04541485,Not yet recruiting,No Results Available,COVID-19 Patients,Drug: DWRX2003|Drug: Placebo,All,"Adult, Older Adult",Phase 1,40.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 6, 2020","January 29, 2021"
2740,NCT04369066,Recruiting,No Results Available,Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection,Diagnostic Test: Blood samples (collection of 5 mL of blood in a dry tube)|Diagnostic Test: Nasopharyngeal swabs,All,"Adult, Older Adult",Not Applicable,2800.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"April 28, 2020","April 28, 2022"
2741,NCT04381052,Not yet recruiting,No Results Available,COVID-19,Drug: Clazakizumab|Other: Placebo,All,"Adult, Older Adult",Phase 2,30.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",May 2020,"August 1, 2020"
2742,NCT04561141,Not yet recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,85.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"December 1, 2020","January 1, 2022"
2743,NCT04802642,Completed,No Results Available,Covid19|Anxiety and Fear,Other: Survey,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"January 1, 2021","March 1, 2021"
2744,NCT04744415,Recruiting,No Results Available,Management and Epidemiology of Patients Admitted in ICU,Other: Epidemiology of admissions,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"November 9, 2020","February 9, 2021"
2745,NCT04584606,Recruiting,No Results Available,Coronavirus Disease (COVID-19),Diagnostic Test: Lab workup (on admission and regularly during follow up).,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"June 27, 2020","December 30, 2020"
2746,NCT04325633,Terminated,No Results Available,COVID-19,Drug: 1: Naproxen|Drug: 2: Standard of care,All,"Adult, Older Adult",Phase 3,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 24, 2020","December 15, 2020"
2747,NCT04355962,Recruiting,No Results Available,"ARDS, Human|Coronavirus",Drug: Sevoflurane|Drug: Intravenous drug,All,"Adult, Older Adult",Phase 3,64.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","April 23, 2020","March 31, 2022"
2748,NCT04839094,Completed,No Results Available,SARS-CoV-2,Diagnostic Test: rapid antigen testing versus RT-PCR,All,"Adult, Older Adult",,58.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 10, 2020","February 1, 2021"
2749,NCT04399356,Recruiting,No Results Available,COVID-19,Drug: Niclosamide|Drug: Placebo|Other: Telehealth monitoring,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","October 1, 2020","June 30, 2021"
2750,NCT03891420,Recruiting,No Results Available,COVID-19|Yellow Fever,Drug: Galidesivir|Drug: Placebo,All,"Adult, Older Adult",Phase 1,132.0,Industry|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 9, 2020","May 31, 2021"
2751,NCT04477083,"Active, not recruiting",No Results Available,Covid19|Hydroxychloroquine Adverse Reaction,Drug: inhalable hydroxychloroquine (HCQ)|Drug: supportive and symptomatic treatment,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 15, 2020","August 15, 2020"
2752,NCT04498091,"Active, not recruiting",No Results Available,Acute Myocardial Infarction,Biological: Biological data|Other: Clinical data,All,"Adult, Older Adult",,35.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2020",July 2021
2753,NCT04410718,Recruiting,No Results Available,"Diabetes Mellitus|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|COVID",Other: Glycaemic levels,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","November 30, 2021"
2754,NCT04440007,"Active, not recruiting",No Results Available,Covid-19,Drug: Abivertinib|Other: Standard of Care,All,"Adult, Older Adult",Phase 2,80.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 9, 2020",July 2021
2755,NCT04477954,Terminated,No Results Available,Covid19,Combination Product: Hyperbaric Oxygen,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 6, 2020","December 30, 2020"
2756,NCT04351191,Terminated,No Results Available,Sars-CoV2|Symptomatic Condition|Covid-19,Drug: Hydroxychloroquine Sulfate Regular dose|Drug: Hydroxychloroquine Sulfate Loading Dose|Drug: Chloroquine|Drug: Placebo,All,Adult,Phase 4,137.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 15, 2020","August 30, 2020"
2757,NCT04387643,Completed,No Results Available,Covid-19,Dietary Supplement: Ayurvedic Kadha,All,Adult,,52.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"March 1, 2020","April 2, 2020"
2758,NCT04344444,"Active, not recruiting",No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Adult, Older Adult",Phase 3,600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 13, 2020","December 10, 2021"
2759,NCT04443712,Recruiting,No Results Available,Coronavirus Disease 2019 (COVID19),,All,"Child, Adult, Older Adult",,1900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 29, 2020","December 1, 2021"
2760,NCT04363814,Recruiting,No Results Available,COVID-19,Biological: Bactek-R,All,"Adult, Older Adult",Phase 3,100.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 10, 2020","July 31, 2021"
2761,NCT04349592,Completed,No Results Available,Covid19,Drug: Hydroxychloroquine|Drug: Azithromycin|Other: Placebo Tablet|Other: Placebo capsules,All,"Adult, Older Adult",Not Applicable,456.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 14, 2020","August 30, 2020"
2762,NCT04305574,Completed,No Results Available,Coronavirus|Depression|Anxiety|Stress,Behavioral: Use of social media during COVID-19,All,"Adult, Older Adult",,1145.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 7, 2020","April 21, 2020"
2763,NCT04843761,Not yet recruiting,No Results Available,Covid19,Biological: Remdesivir|Drug: Remdesivir placebo|Biological: VIP|Drug: VIP Placebo|Drug: Corticosteroid,All,"Adult, Older Adult",Phase 3,640.0,NIH|Other|U.S. Fed|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",April 2021,April 2023
2764,NCT04276896,Recruiting,No Results Available,Pathogen Infection Covid-19 Infection,Biological: Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs,All,"Child, Adult, Older Adult",Phase 1|Phase 2,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 24, 2020","December 31, 2024"
2765,NCT04501965,Enrolling by invitation,No Results Available,Covid19,Combination Product: Hydroxychloroquine/Azithromycine|Combination Product: Quinquina-Stevia/Azythromycin|Combination Product: 4Plants/Azythromycin,All,"Adult, Older Adult",Phase 2,231.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","September 30, 2020"
2766,NCT04374019,Recruiting,No Results Available,COVID|Sars-CoV2,Drug: Ivermectin|Drug: Camostat Mesilate|Dietary Supplement: Artemesia annua|Drug: Artesunate,All,"Adult, Older Adult",Phase 2,240.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020",May 2021
2767,NCT04623021,Completed,No Results Available,COVID-19,Drug: Nafamostat Mesilate,All,"Adult, Older Adult",Phase 2,104.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 25, 2020","December 12, 2020"
2768,NCT04802083,Available,No Results Available,Covid19,Biological: Eculizumab,All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population,,,
2769,NCT04416438,Recruiting,No Results Available,Myeloproliferative Neoplasm|COVID-19 Infection,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 18, 2020","December 31, 2020"
2770,NCT04352985,Available,No Results Available,"Septic Shock|Endotoxemia|COVID|Corona Virus Infection|Sepsis, Severe",Device: Toraymyxin PMX-20R (PMX Cartridge),All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population,,,
2771,NCT04398004,Completed,No Results Available,COVID-19|Virus Diseases|Corona Virus Infection,Drug: Clarithromycin,All,"Adult, Older Adult",Phase 2,90.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 6, 2020","November 30, 2020"
2772,NCT04388579,Completed,No Results Available,Respiratory Disease,Other: Pulmonary Rehabilitation,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 20, 2020","March 27, 2020"
2773,NCT04493268,Completed,No Results Available,Hyponatremia|Covid19|Corona Virus Infection,,All,"Child, Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 7, 2020","July 21, 2020"
2774,NCT04590261,Not yet recruiting,No Results Available,Covid-19; SARS-Cov2,Other: Blood sampling|Other: Nasal Brushing,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"November 1, 2020","November 1, 2023"
2775,NCT04644185,Recruiting,No Results Available,Covid19,Drug: SCTA01|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,795.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 27, 2021","December 27, 2021"
2776,NCT04402827,Recruiting,No Results Available,"Health Care Worker Patient Transmission|Receptor Site Alteration|Susceptibility, Disease|Immune Response",Diagnostic Test: Susceptibility to infection,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"August 1, 2020","January 30, 2021"
2777,NCT04280705,Completed,Has Results,COVID-19,Other: Placebo|Drug: Remdesivir,All,"Adult, Older Adult",Phase 3,1062.0,NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","February 21, 2020","May 21, 2020"
2778,NCT04486001,Recruiting,No Results Available,Covid19,Biological: PSC-04,All,"Adult, Older Adult",Phase 1,20.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 15, 2020","January 15, 2022"
2779,NCT04779424,"Active, not recruiting",No Results Available,SARS-CoV-2|COVID-19,Other: POCT,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 15, 2020","June 30, 2022"
2780,NCT04528641,"Active, not recruiting",No Results Available,COVID-19,Biological: GRAd-COV2,All,"Adult, Older Adult",Phase 1,90.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 10, 2020","July 31, 2021"
2781,NCT04492228,Recruiting,No Results Available,Covid19|Ketogenic Dieting,Other: Ketogenic diet,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","May 30, 2021"
2782,NCT04773665,Not yet recruiting,No Results Available,Covid19,Biological: VBI-2902a|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,780.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",March 2021,June 2022
2783,NCT04801056,Not yet recruiting,No Results Available,Covid19,Drug: TB006|Other: Placebo,All,"Adult, Older Adult",Phase 1,27.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",March 2021,September 2021
2784,NCT04438863,Recruiting,No Results Available,COVID 19,Diagnostic Test: home spirometry,All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 8, 2020","September 1, 2021"
2785,NCT04751669,Not yet recruiting,No Results Available,Covid19,Dietary Supplement: Vitamin and trace elements|Dietary Supplement: Placebo,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2021","December 31, 2021"
2786,NCT04798677,Recruiting,No Results Available,Immunity|Vaccine Reaction|Influenza|Covid19|Cytokine Storm|Immunologic Deficiency Syndromes,Dietary Supplement: ABBC1 Immunoessential|Dietary Supplement: Placebo,All,"Adult, Older Adult",Not Applicable,90.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Other","October 29, 2020",April 2021
2787,NCT04747366,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,750.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 6, 2020","November 30, 2025"
2788,NCT04385771,Suspended,No Results Available,Coronavirus Infection|COVID|SARS-CoV 2|Respiratory Failure|Cytokine Storm|Extracorporeal Membrane Oxygenation,Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption),All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","October 31, 2021"
2789,NCT04611256,Recruiting,No Results Available,Covid19,Biological: MSC|Drug: Control,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","December 30, 2020"
2790,NCT04557241,Completed,No Results Available,COVID19 Behavioral Prophylaxis,Behavioral: Brief informational infographic|Behavioral: Placebo control (non-behavioral infographic),All,"Adult, Older Adult",Not Applicable,1017.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","January 14, 2020","January 31, 2021"
2791,NCT04602507,Recruiting,No Results Available,Covid19|Severe Acute Respiratory Syndrome,Drug: Ivermectin|Other: Placebo,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 7, 2020",March 2021
2792,NCT04361565,Enrolling by invitation,No Results Available,COVID-19 by SARS-CoV-2 Infection,,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 20, 2020","May 31, 2020"
2793,NCT04517422,Completed,No Results Available,SARS-CoV Infection,Dietary Supplement: Probiotics|Other: Placebo,All,Adult,Not Applicable,300.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","August 19, 2020","February 2, 2021"
2794,NCT04836260,Recruiting,No Results Available,Covid19|Immuno-Deficiency|Old Age; Debility,Drug: SARS-CoV-2 convalescent plasma,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 8, 2021","December 31, 2021"
2795,NCT04662437,Completed,No Results Available,COVID-19 Infection|Parathyroid Gland|Parathyroid Hormone|Calcium|Phosphorus|Alkaline Phosphatase,Diagnostic Test: Venous blood was collected for biochemistry testing,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"September 10, 2020","December 9, 2020"
2796,NCT04791072,Not yet recruiting,No Results Available,Covid19|Rehabilitation,Other: Exercise,All,"Adult, Older Adult",Not Applicable,36.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 1, 2021","March 1, 2021"
2797,NCT04747522,Recruiting,No Results Available,Kidney Transplant Infection|SARS-CoV Infection,Drug: SARS-CoV-2 vaccine,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 22, 2021","June 30, 2021"
2798,NCT04568876,Recruiting,No Results Available,Covid19,"Dietary Supplement: Micronized and ultra-micronized Palmitoylethanolamide (mPEA and umPEA, 300mg + 600mg) oral suspension|Combination Product: Standard Therapy",All,"Adult, Older Adult",Phase 4,40.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"October 23, 2020",November 2021
2799,NCT04361123,Enrolling by invitation,No Results Available,Coronavirus|COVID,Other: daily syndromic surveillance|Diagnostic Test: monthly serologic IgM/G test,All,"Adult, Older Adult",,450000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 6, 2020",December 2021
2800,NCT04661657,Recruiting,No Results Available,Covid19|Cardiac Disease|Cardiac Arrhythmia|Myocarditis|Left Ventricular Dysfunction,Other: Transthoracic echocardiogram (TTE)|Other: Cardiovascular Magnetic Resonance (CMR) Imaging,All,"Adult, Older Adult",,70.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 28, 2020","September 30, 2022"
2801,NCT04347941,Recruiting,No Results Available,"ARDS, Human|Mechanical Ventilation Complication|COVID19",Procedure: Prone Positioning|Procedure: Standard of care.,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 11, 2020","September 11, 2021"
2802,NCT04659122,Not yet recruiting,No Results Available,Covid19,Biological: AT-100,All,"Adult, Older Adult",Phase 1,9.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,July 2021
2803,NCT04487886,Recruiting,No Results Available,COVID-19,Drug: Duvelisib|Drug: Placebo,All,"Adult, Older Adult",Phase 2,80.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","November 18, 2020",February 2022
2804,NCT04362345,Recruiting,No Results Available,Covid-19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"April 9, 2020","January 9, 2021"
2805,NCT04662060,Enrolling by invitation,No Results Available,Covid19,Drug: Acebilustat|Drug: Placebo,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,March 2022
2806,NCT04634799,Recruiting,No Results Available,Covid19,Drug: TM5614|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","January 8, 2021","June 30, 2022"
2807,NCT04359251,Completed,No Results Available,COVID-19|Mechanical Ventilation Pressure High|Acute Respiratory Distress Syndrome,Other: Gas exchanges at different PEEP|Other: lung mechanics at different PEEP|Other: Hemodynamics changes at different PEEP,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 5, 2020","March 25, 2020"
2808,NCT04359654,Recruiting,No Results Available,COVID19|Hypoxia,Drug: Dornase Alfa Inhalation Solution [Pulmozyme],All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 16, 2020","November 1, 2021"
2809,NCT04559035,Enrolling by invitation,No Results Available,Covid19,Other: Nasal lavage,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 24, 2020","December 31, 2020"
2810,NCT04335773,Recruiting,No Results Available,Pediatric Respiratory Diseases|COVID|Fatigue Post Viral,,All,"Child, Adult",,350.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 3, 2020","December 31, 2030"
2811,NCT04536441,Completed,No Results Available,Mental Health Wellness|Psychological Security|Psychological Distress,Behavioral: Ultra Brief Online Mindfulness-based Intervention|Behavioral: Control,All,"Adult, Older Adult",Not Applicable,161.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","April 1, 2020","June 30, 2020"
2812,NCT04505605,"Active, not recruiting",No Results Available,Community-acquired Pneumonia|Covid19,Other: Blood samples,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 14, 2020","November 30, 2020"
2813,NCT04745351,Recruiting,No Results Available,COVID-19,Drug: Remdesivir|Drug: RDV Placebo|Drug: Standard of Care,All,"Child, Adult, Older Adult",Phase 3,1116.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",March 2021,September 2021
2814,NCT04556565,Recruiting,No Results Available,Covid19|Mental Health Disorder|Mental Health Conditions,,All,"Adult, Older Adult",,16000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 8, 2020",May 2021
2815,NCT04834115,Recruiting,No Results Available,Covid19|Coronavirus Infection,Drug: Ivermectin Tablets|Other: Placebo,All,"Adult, Older Adult",Phase 3,400.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 17, 2020","May 30, 2021"
2816,NCT04460664,Enrolling by invitation,No Results Available,COVID|Disseminated Intravascular Coagulation|Coagulation Disorder,Diagnostic Test: Quantra System,All,"Adult, Older Adult",,50.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 14, 2020","February 15, 2021"
2817,NCT04756141,Recruiting,No Results Available,Diabetes Mellitus|Covid19,Device: Continuous Glucose Monitor (CGM),All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 3, 2021","January 28, 2022"
2818,NCT04361253,Recruiting,No Results Available,COVID|Infectious Disease,Biological: High-Titer COVID-19 Convalescent Plasma (HT-CCP)|Biological: Standard Plasma (FFP),All,"Child, Adult, Older Adult",Phase 3,220.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 30, 2020",December 2021
2819,NCT04375748,Recruiting,No Results Available,Acute Myocarditis,Diagnostic Test: Performing routine care (clinical and paraclinical tests)|Diagnostic Test: Examinations for the research:,All,"Child, Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","October 15, 2021"
2820,NCT04343183,Not yet recruiting,No Results Available,COVID-19,Device: Hyperbaric Oxygen Therapy,All,"Adult, Older Adult",Not Applicable,48.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,April 2020,June 2020
2821,NCT04716023,Recruiting,No Results Available,Copd|COVID-19|Asthma|Small Airways Disease,,All,"Child, Adult, Older Adult",,42.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"August 23, 2019","February 2, 2022"
2822,NCT04374084,Recruiting,No Results Available,COVID-19|Convalescence,Other: Moxibustion plus Cupping,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 10, 2020",December 2021
2823,NCT04843787,Not yet recruiting,No Results Available,Covid19,Drug: SLV213|Drug: Placebo,All,"Adult, Older Adult",Phase 2,81.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 1, 2021","October 1, 2021"
2824,NCT04465695,Recruiting,No Results Available,COVID-19,Drug: Interferon beta-1b|Drug: Clofazimine,All,"Adult, Older Adult",Phase 2,81.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 14, 2020","September 30, 2021"
2825,NCT04344925,Terminated,No Results Available,COVID-19,Device: Aerosol-reducing Mask|Device: Standard Mask,All,"Adult, Older Adult",,21.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 18, 2020","November 27, 2020"
2826,NCT04537130,Not yet recruiting,No Results Available,Pulmonary Fibrosis|Covid19,Biological: IN01 vaccine,All,"Adult, Older Adult",Phase 1,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020",June 2022
2827,NCT04452773,Recruiting,No Results Available,COVID19,Dietary Supplement: Manremyc|Dietary Supplement: Placebo,All,"Adult, Older Adult",Not Applicable,315.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 14, 2020",December 2021
2828,NCT04730895,Not yet recruiting,No Results Available,Covid19 Vaccine,Drug: Oral 13 cis retinoic acid|Drug: Aerosolized 13 cis retinoic acid|Combination Product: 13 cis retinoic acid doses orally in combination with spike protein based vaccine|Combination Product: Aerosolized 13 cis retinoic acid in combination with spike protein based vaccine|Biological: Biological: spike protein based vaccine such as ChAdOx1 nCoV-19 vaccine,Male,Adult,Phase 1|Phase 2,360.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,February 2021,December 2023
2829,NCT04806061,Not yet recruiting,No Results Available,Covid19|Acute Kidney Injury,Drug: Sodium bicarbonate|Drug: standard care,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 15, 2021","December 31, 2022"
2830,NCT04647695,Recruiting,No Results Available,Covid19,Drug: Interferon beta-1b|Drug: Remdesivir,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 20, 2020","September 30, 2021"
2831,NCT04694651,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 15, 2020","February 15, 2021"
2832,NCT04644198,Recruiting,No Results Available,"COVID-19, Convalescent Plasma Treatment",Biological: Convalescent Plasma Infusion,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2021","December 1, 2021"
2833,NCT04367714,Recruiting,No Results Available,COVID|Terminal Renal Insufficiency,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2020","December 1, 2021"
2834,NCT04359407,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|Electric Impedance|Prone Positioning,Other: Prone positioning,All,"Adult, Older Adult",,16.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 27, 2020","January 31, 2021"
2835,NCT04565197,"Active, not recruiting",No Results Available,SARS-CoV Infection,Biological: convalescent plasma,All,"Child, Adult, Older Adult",Early Phase 1,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","December 30, 2020"
2836,NCT04642196,Completed,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,155.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 2, 2020","October 10, 2020"
2837,NCT04435808,Terminated,Has Results,COVID-19,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 1|Phase 2,1.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 14, 2020","July 15, 2020"
2838,NCT04719208,Recruiting,No Results Available,Covid19,Other: Water (E) Mouth rinse with the solution provided|Other: Chlorhexidine gluconate (A) Mouth rinse with the solution provided|Other: Hydrogen peroxide (B) Mouth rinse with the solution provided|Other: Betadine (C) Mouth rinse with the solution provided|Other: Alcohol mouthwash (Listerine) (D) Mouth rinse with the solution provided,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","October 6, 2020",June 2021
2839,NCT04690114,Recruiting,No Results Available,SARS-CoV-2 Infection,,All,"Child, Adult",,2000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"October 1, 2020","July 31, 2021"
2840,NCT04836780,Not yet recruiting,No Results Available,"COVID-19|Acute Respiratory Distress Syndrome|Pneumonia, Viral",Drug: Dexamethasone,All,"Adult, Older Adult",Phase 3,126.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2021","June 30, 2021"
2841,NCT04616001,Not yet recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: IVIG,All,"Adult, Older Adult",Phase 4,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 1, 2020","June 30, 2021"
2842,NCT04498442,Completed,No Results Available,Covid19|Stress|Anxiety Depression,Behavioral: Simha Kriya|Behavioral: Reading a Book,All,"Adult, Older Adult",Not Applicable,8519.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 22, 2020","October 22, 2020"
2843,NCT04386551,Completed,No Results Available,Sars-CoV2|RT-PCR|Saliva Collection|Nasopharyngeal Sample,,All,"Adult, Older Adult",,501.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 6, 2020","August 5, 2020"
2844,NCT04377581,Completed,No Results Available,Public Health|Demography|Pandemics|Corona Virus Infection|News|Global Health|Perception,,All,"Adult, Older Adult",,18251.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"April 9, 2020","July 10, 2020"
2845,NCT04363333,"Active, not recruiting",No Results Available,COVID|Obstructive Sleep Apnea|Pneumonia,Diagnostic Test: Home Sleep Apnea Testing or In-hospital Polysomnography,All,"Adult, Older Adult",,320.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","July 31, 2021"
2846,NCT04723576,Recruiting,No Results Available,Healthy,Behavioral: Stress First Aid,All,"Child, Adult, Older Adult",Not Applicable,2132.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"December 3, 2020","November 30, 2023"
2847,NCT04635241,Recruiting,No Results Available,Covid19,Drug: Unfractionated heparin,All,"Adult, Older Adult",Phase 2|Phase 3,712.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2020","June 1, 2021"
2848,NCT04793997,Recruiting,No Results Available,SARS-CoV Infection|Corona Virus Infection,Biological: Microbiome spray|Biological: Placebo spray,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 1, 2021","February 1, 2022"
2849,NCT04823234,Recruiting,No Results Available,Pregnancy Complications|Covid19,Diagnostic Test: Lung ultrasound,Female,Adult,,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 10, 2021","September 30, 2021"
2850,NCT04409249,Completed,No Results Available,COVID-19|Prognostic Factors|Pregnancy,"Diagnostic Test: imaging, blood tests",Female,Adult,,155.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 15, 2020","May 28, 2020"
2851,NCT04324736,Completed,No Results Available,Coronavirus|Diabetes,Other: no interventional study,All,"Child, Adult, Older Adult",,5309.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 10, 2020","December 31, 2020"
2852,NCT04387786,Completed,No Results Available,COVID-19|Mechanical Ventilation,Drug: Dornase Alfa,All,"Adult, Older Adult",,5.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 31, 2020","September 4, 2020"
2853,NCT04713553,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19,Biological: BNT162b2,All,"Child, Adult",Phase 3,1530.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","February 15, 2021","May 11, 2021"
2854,NCT04737161,Not yet recruiting,No Results Available,Acute Respiratory Distress Syndrome|Covid19,Biological: T regulatory cells,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,September 2022
2855,NCT04798716,Not yet recruiting,No Results Available,Covid19|Novel Coronavirus Pneumonia|Acute Respiratory Distress Syndrome,Drug: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)|Drug: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8)|Drug: MSC-exosomes delivered intravenously every other day (8:8:8),All,"Adult, Older Adult",Phase 1|Phase 2,55.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",April 2021,December 2021
2856,NCT04734873,Recruiting,No Results Available,Covid-19,Drug: CPI-006 2 mg/kg + SOC|Drug: CPI-006 1 mg/kg + SOC|Drug: Placebo + SOC,All,"Adult, Older Adult",Phase 3,1000.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 25, 2021","January 30, 2022"
2857,NCT04486144,Completed,No Results Available,Covid19 Positive Patient|Covid19 Close Contact|Immune Function,Other: Proprietary extract of Nerium oleander,All,"Adult, Older Adult",Not Applicable,82.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020","July 23, 2020"
2858,NCT04713878,Completed,No Results Available,Coronavirus Disease 2019 (COVID-19) Pneumonia,Other: Mesenchymal stem cells,All,"Adult, Older Adult",Not Applicable,21.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","July 15, 2020"
2859,NCT04801836,Recruiting,No Results Available,Covid19,Drug: Estetrol monohydrate 15 mg|Drug: Placebo,All,"Adult, Older Adult",Phase 2,300.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 19, 2020","June 30, 2021"
2860,NCT04368897,Recruiting,No Results Available,SARS-CoV 2|COVID|COVID-19|Androgenetic Alopecia|Androgen Receptor Abnormal|Androgen Deficiency,Diagnostic Test: CAG length <22|Diagnostic Test: CAG length >=22,Male,"Adult, Older Adult",,200.0,Industry|Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 1, 2020","June 1, 2021"
2861,NCT04832061,Not yet recruiting,No Results Available,COVID-19,Other: Respiratory supports,All,"Adult, Older Adult",,2100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2021","August 31, 2021"
2862,NCT04402840,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Procedure: Stellate Ganglion Block,All,"Adult, Older Adult",Not Applicable,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 24, 2020",December 2021
2863,NCT04773899,Not yet recruiting,No Results Available,Covid19|Microcirculation,Diagnostic Test: Procedure : Multimodal microvascular assessment at study inclusion,All,"Adult, Older Adult",Not Applicable,75.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 9, 2021","June 9, 2022"
2864,NCT04641988,Completed,No Results Available,COVID-19,,All,"Adult, Older Adult",,111.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 1, 2020","June 30, 2020"
2865,NCT04380402,Recruiting,No Results Available,COVID-19,Drug: Atorvastatin,All,"Adult, Older Adult",Phase 2,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 25, 2020","May 8, 2022"
2866,NCT04380688,Completed,No Results Available,COVID-19,Drug: Acalabrutinib,All,"Adult, Older Adult",Phase 2,62.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 13, 2020","November 16, 2020"
2867,NCT04346199,Completed,No Results Available,COVID-19,Drug: Acalabrutinib,All,"Adult, Older Adult",Phase 2,177.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 12, 2020","November 17, 2020"
2868,NCT04516759,Recruiting,No Results Available,Covid19,Drug: AZD1656|Other: Placebo,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 12, 2020",April 2021
2869,NCT04788407,Recruiting,No Results Available,Covid19|SARS-CoV-2 Infection|Households Contacts,Drug: Nitazoxanide|Drug: Placebo,All,"Adult, Older Adult",Phase 4,456.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","December 1, 2020","April 30, 2021"
2870,NCT04422353,Recruiting,No Results Available,Parkinson Disease|Parkinson Disease 10,Other: Video Dance classes|Other: Unsupervised physical activities,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 1, 2020","December 30, 2024"
2871,NCT04377750,Recruiting,No Results Available,Covid19 Pneumonia,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 4,500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 8, 2020","May 8, 2021"
2872,NCT04420247,Completed,No Results Available,COVID|COVID-19|SARS-CoV 2|Coronavirus|Corona Virus Infection,Drug: Chloroquine|Drug: Hydroxychloroquine|Other: standard care,All,"Adult, Older Adult",Phase 3,142.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","September 3, 2020"
2873,NCT04349631,"Active, not recruiting",No Results Available,COVID-19,Drug: HB-adMSCs,All,"Child, Adult, Older Adult",Phase 2,56.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 22, 2020","May 1, 2021"
2874,NCT04432870,Enrolling by invitation,No Results Available,Colon Cancer,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 9, 2020","June 30, 2021"
2875,NCT04558463,Recruiting,No Results Available,Covid19,Drug: Favipiravir|Drug: Oseltamivir 75mg,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","October 30, 2020"
2876,NCT04501978,Recruiting,No Results Available,Covid19,Biological: LY3819253|Drug: Placebo|Biological: Remdesivir|Biological: VIR-7831|Biological: BRII-196/BRII-198|Biological: AZD7442,All,"Adult, Older Adult",Phase 3,10000.0,NIH|Other|U.S. Fed|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","August 4, 2020",July 2022
2877,NCT04360551,Recruiting,No Results Available,COVID-19,Drug: Telmisartan 40mg|Drug: Placebo,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 1, 2020","June 30, 2021"
2878,NCT04346667,Terminated,No Results Available,SARS-CoV-2|Coronavirus Infection|Asymptomatic Condition|COVID-19,Drug: Hydroxychloroquine Sulfate Regular dose|Drug: Hydroxychloroquine Sulfate Loading Dose|Drug: Chloroquine|Drug: Placebo,All,Adult,Phase 4,125.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","April 14, 2020","August 30, 2020"
2879,NCT04703036,Recruiting,No Results Available,Covid19,Dietary Supplement: Glycine|Dietary Supplement: N-acetylcysteine|Dietary Supplement: Alanine,All,"Adult, Older Adult",Early Phase 1,64.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","January 11, 2021","December 31, 2021"
2880,NCT04376593,Enrolling by invitation,No Results Available,COVID-19|SARS-CoV-2 Infection,Drug: 18F-αvβ6-BP,All,"Adult, Older Adult",Early Phase 1,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 1, 2020",May 2022
2881,NCT04397562,Completed,No Results Available,COVID-19,Drug: Levilimab|Drug: Placebo,All,"Adult, Older Adult",Phase 3,206.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 29, 2020","August 3, 2020"
2882,NCT04603742,Not yet recruiting,No Results Available,Covid19|Cytokine Storm|Mechanical Ventilation Complication,Drug: Anakinra|Drug: 0.9% Saline,All,"Adult, Older Adult",Phase 2,170.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",July 2021,February 2022
2883,NCT04375709,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2020","August 31, 2021"
2884,NCT04639427,Not yet recruiting,No Results Available,Oral-Linguo-Facial Praxies|Covid19,,All,"Adult, Older Adult",,4.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,November 2020,February 2021
2885,NCT04437121,Completed,No Results Available,Eating Behavior|COVID-19,Other: Online Survey about Dietary and Lifestyle Habits,All,"Child, Adult",,397.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"April 30, 2020","May 24, 2020"
2886,NCT04373135,"Active, not recruiting",No Results Available,Covid-19|Critical Illness|Attitude of Health Personnel|Attitude to Health|Health Behavior|Health Care Utilization,Behavioral: Brief educational video,All,"Adult, Older Adult",Not Applicable,2500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 8, 2020",March 2021
2887,NCT04647604,Recruiting,No Results Available,COVID-19,Drug: Omegaven®|Drug: Sodium chloride,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 23, 2020","April 30, 2021"
2888,NCT04352400,Not yet recruiting,No Results Available,COVID19,Drug: Nafamostat Mesilate|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,256.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2020,December 2021
2889,NCT04322487,Recruiting,No Results Available,"Coronavirus|Epidemic Disease|Pneumonia, Viral",Diagnostic Test: Lung ultrasound,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 8, 2020","January 15, 2021"
2890,NCT04673149,Recruiting,No Results Available,SARS-CoV-2,Biological: GLS-5310|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,345.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","December 23, 2020","December 31, 2022"
2891,NCT04375202,Recruiting,No Results Available,COVID-19,Drug: Colchicine 1 MG Oral Tablet,All,"Adult, Older Adult",Phase 2,308.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 18, 2020","October 31, 2021"
2892,NCT04655521,Recruiting,No Results Available,COVID-19|SARS-CoV-2|Viral Infection,,All,"Child, Adult, Older Adult",,300.0,Other|Industry,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"December 2, 2020",November 2021
2893,NCT04399889,Recruiting,No Results Available,COVID|Corona Virus Infection|COVID19,Biological: human cord tissue mesenchymal stromal cells,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 18, 2020","July 31, 2021"
2894,NCT04354779,Completed,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|SARS-CoV 2|Coronavirus Infection|Covid19,Diagnostic Test: a specifically designed self-administered questionnaire,All,"Child, Adult, Older Adult",,3301.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 11, 2020","September 28, 2020"
2895,NCT04325646,Recruiting,No Results Available,SARS (Severe Acute Respiratory Syndrome)|COVID-19,Other: Human Biological samples,All,"Child, Adult, Older Adult",,2000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 13, 2020","February 28, 2023"
2896,NCT04290858,Withdrawn,No Results Available,"Coronavirus Infections|Pneumonia, Viral|Dyspnea",Drug: Nitric Oxide,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 1, 2020","February 1, 2022"
2897,NCT04405921,Not yet recruiting,No Results Available,SARS-CoV-2 Pneumonia|COVID-19,Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 250 MG,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",July 2020,March 2021
2898,NCT04326387,Recruiting,No Results Available,Acute Disease|Coronavirus|Respiratory Viral Infection,Diagnostic Test: SAMBA II (Diagnostic for the Real World)|Diagnostic Test: Public Health England Gold Standard|Diagnostic Test: Cambridge Validated Viral Detection Method|Diagnostic Test: Radiological Detection,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 6, 2020","October 7, 2021"
2899,NCT04351711,Recruiting,No Results Available,SARS-CoV-2|Covid-19,Other: Immunological profiling,All,"Adult, Older Adult",,130.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 9, 2020",April 2023
2900,NCT04500600,Recruiting,No Results Available,COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Other: Quality-of-Life Assessment|Other: Questionnaire Administration,All,"Adult, Older Adult",,50000.0,Other|NIH,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"June 11, 2020","July 1, 2021"
2901,NCT04724707,Recruiting,No Results Available,Covid19|Acute Cardiovascular Disease|Cardiovascular Diseases,,All,"Adult, Older Adult",,900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 11, 2020",December 2022
2902,NCT04537351,Recruiting,No Results Available,Covid19|Acute Respiratory Distress Syndrome,Biological: CYP-001,All,"Adult, Older Adult",Phase 1|Phase 2,24.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 24, 2020","March 31, 2021"
2903,NCT04413071,Completed,No Results Available,SARS-CoV 2|COVID-19|Coronavirus|Cardiac Magnetic Resonance|Myocarditis|Cardiac Anomaly,Other: Passed infection of SARS-CoV-2,All,"Adult, Older Adult",,142.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 25, 2020","June 12, 2020"
2904,NCT04392388,Recruiting,No Results Available,SARS-CoV 2,Biological: Non applicable,All,"Child, Adult, Older Adult",,110000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","December 31, 2020"
2905,NCT04356950,"Active, not recruiting",No Results Available,Sepsis|Blood Coagulation Disorders|Thrombin|Disseminated Intravascular Coagulation|COVID-19,Other: Thrombin generation test assay|Other: Fibrin generation markers assays,All,"Adult, Older Adult",,175.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 28, 2020",July 2022
2906,NCT04718506,Recruiting,No Results Available,Covid19|Post-COVID-19 Syndrome,Behavioral: Exercise|Behavioral: Controls,All,"Adult, Older Adult",Not Applicable,56.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 12, 2021","December 12, 2021"
2907,NCT04371289,"Active, not recruiting",No Results Available,COVID-19|Cardiovascular Risk Factor,,All,"Adult, Older Adult",,5500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 8, 2020","September 10, 2021"
2908,NCT04422587,Completed,No Results Available,Emergencies,Other: RECOP unit patient,All,"Child, Adult, Older Adult",,1860.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 13, 2020","June 7, 2020"
2909,NCT04596579,Enrolling by invitation,No Results Available,Coronavirus Infection,Diagnostic Test: SARS-CoV-2 Antibody Analysis|Diagnostic Test: Weck-cel Swab Collection|Behavioral: Web Based Questionnaire,All,"Adult, Older Adult",,1200.0,Other|Industry,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"October 9, 2020","October 9, 2022"
2910,NCT04462848,Not yet recruiting,No Results Available,Corona Virus Infection,Biological: anti-SARS-CoV-2 human convalescent plasma,All,Child,Phase 1,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,August 2020,December 2024
2911,NCT04590469,Not yet recruiting,No Results Available,Dementia,Other: COVID WHELD,All,"Adult, Older Adult",Not Applicable,2880.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"November 20, 2020","January 1, 2022"
2912,NCT04479202,Completed,No Results Available,Berberine|COVID-19,Drug: Berberine|Drug: Montmorrillonite,All,"Adult, Older Adult",Phase 4,76.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","February 8, 2020","April 23, 2020"
2913,NCT04802408,Not yet recruiting,No Results Available,Covid19|SARS-CoV Infection,Combination Product: Shampoo and saline|Combination Product: Saline and Listerine|Combination Product: Shampoo and Listerine|Combination Product: Saline and Saline,All,"Adult, Older Adult",Phase 2|Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 1, 2021","April 30, 2022"
2914,NCT04551339,"Active, not recruiting",No Results Available,Healthy|Health Care Worker Patient Transmission|Aging,Dietary Supplement: PreserVision AREDS formulation soft gels or tablets|Dietary Supplement: Multivitamin with 11mg of zinc,All,"Adult, Older Adult",Not Applicable,4500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 28, 2020","September 14, 2021"
2915,NCT04346329,Not yet recruiting,No Results Available,COVID,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,86.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention","April 20, 2020","October 1, 2020"
2916,NCT04740320,Recruiting,No Results Available,Covid19,,All,Adult,,250.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 15, 2020",May 2021
2917,NCT04649931,Recruiting,No Results Available,SARS (Severe Acute Respiratory Syndrome)|Covid19,Device: Ion Mobility Spectrometry (IMS),All,"Adult, Older Adult",,400.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 14, 2020",May 2021
2918,NCT04453982,Recruiting,No Results Available,Sars-CoV2|Breastmilk,Other: Human milk donors,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 21, 2020",February 2021
2919,NCT04484493,Completed,No Results Available,Covid19|Anosmia,Drug: mometasone furoate nasal spray,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 8, 2020","November 3, 2020"
2920,NCT04445428,Enrolling by invitation,No Results Available,"Poliovirus Vaccine, Oral|COVID|Mortality|Morbidity|Non-Specific Effects of Vaccines",Biological: oral polio vaccine + information|Behavioral: Information,All,"Adult, Older Adult",Phase 4,3400.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","July 15, 2020",December 2021
2921,NCT04834882,Recruiting,No Results Available,"Covid19|Burnout, Professional",Other: Data collection (,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"January 20, 2021","May 20, 2022"
2922,NCT04610489,Not yet recruiting,No Results Available,Covid-19,Diagnostic Test: Quidel Sofia SARS Antigen FIA,All,"Adult, Older Adult",Not Applicable,800.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"November 1, 2020","January 31, 2021"
2923,NCT04503434,Completed,No Results Available,Patient Preference|COVID-19,,All,"Child, Adult, Older Adult",,517.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 15, 2020","June 6, 2020"
2924,NCT04401111,Recruiting,No Results Available,COVID|ARDS|Quality of Life,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 16, 2020","June 15, 2021"
2925,NCT04336332,"Active, not recruiting",No Results Available,SARS-CoV-2|COVID-19,Combination Product: Hydroxychloroquine Sulfate + Azithromycin|Drug: Hydroxychloroquine Sulfate,All,"Adult, Older Adult",Phase 2,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","April 30, 2021"
2926,NCT04747782,Recruiting,No Results Available,Covid19|Respiratory Disease|Critical Illness,"Other: no interventions performed. Just collecting data, blood samples and post-mortem biopsies.",All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2020","December 31, 2021"
2927,NCT04399317,Recruiting,No Results Available,ARDS Associated With COVID-19,Device: Flow controlled ventilation (Evone-ventilator),All,"Adult, Older Adult",Not Applicable,20.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","May 28, 2020",August 2020
2928,NCT04403477,Recruiting,No Results Available,Covid19|Convalescence,Biological: Convalescent plasma,All,"Child, Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020","October 30, 2020"
2929,NCT04472494,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Biological: Abatacept|Other: Placebo,All,"Adult, Older Adult",Phase 2,129.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 24, 2020","January 14, 2021"
2930,NCT04420637,Enrolling by invitation,No Results Available,COVID,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 15, 2020",December 2021
2931,NCT04299152,Not yet recruiting,No Results Available,Severe Acute Respiratory Syndrome (SARS) Pneumonia,Combination Product: Stem Cell Educator-Treated Mononuclear Cells Apheresis,All,Adult,Phase 2,20.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,"November 10, 2020","November 10, 2021"
2932,NCT04502342,Enrolling by invitation,No Results Available,Covid19,Combination Product: Hydroxycloroquine and Azythromycine|Combination Product: Cospherunate/Azythromycine|Combination Product: Cospherunate/Phytomedicine/Azythromycien,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","September 30, 2020"
2933,NCT04540406,Recruiting,No Results Available,Suspected or Confirmed COVID-19,Drug: NBT-NM108|Other: Usual Care Only,All,"Adult, Older Adult",Phase 2,100.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 8, 2021","June 1, 2021"
2934,NCT04538586,Recruiting,No Results Available,COVID-19 Screening,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 1, 2020","December 1, 2025"
2935,NCT04603924,Recruiting,No Results Available,COVID-19,Drug: Niclosamide|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,436.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 7, 2020",June 2022
2936,NCT04476667,Recruiting,No Results Available,Mental Health Issue|Covid19|Anxiety Disorders|Depression,Behavioral: e-Psychotherapy,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 15, 2020",May 2021
2937,NCT04560530,Completed,No Results Available,Covid19,Radiation: Non-enhanced CT scan of the chest,All,"Adult, Older Adult",,76.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","September 1, 2020"
2938,NCT04334382,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Adult, Older Adult",Phase 3,1550.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 2, 2020","December 31, 2021"
2939,NCT04371952,Not yet recruiting,No Results Available,COVID19,Drug: Doxycycline|Drug: Placebo,All,"Adult, Older Adult",Phase 3,330.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 1, 2020","December 1, 2020"
2940,NCT04438967,Recruiting,No Results Available,Brain Health,,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 16, 2020","December 31, 2021"
2941,NCT04613050,Recruiting,No Results Available,Covid 19 Infection,Other: Respiratory Training|Other: Aerobic training,All,Adult,Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 2, 2020","February 20, 2022"
2942,NCT04390477,Recruiting,No Results Available,COVID-19|Coronavirus Infection,Dietary Supplement: Probiotic,All,"Adult, Older Adult",Not Applicable,40.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 4, 2020",September 2021
2943,NCT04355351,Recruiting,No Results Available,"New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2",Other: blood sampling|Other: additional blood tubes,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"May 5, 2020","October 22, 2020"
2944,NCT04474301,Recruiting,No Results Available,COVID-19 Infection|Melanoma,Other: Survey Administration,All,"Child, Adult, Older Adult",,1152.0,Other|NIH,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"June 11, 2020","July 1, 2021"
2945,NCT04414124,"Active, not recruiting",No Results Available,Mild-to-moderate COVID-19,Other: KB109 + Self Supportive Care (SSC)|Other: Self Supportive Care (SSC) Alone,All,"Adult, Older Adult",Not Applicable,350.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"August 2, 2020",February 2021
2946,NCT04530435,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV-2,Device: PEP flute,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"October 6, 2020","April 30, 2021"
2947,NCT04466800,Recruiting,No Results Available,COVID,Other: Intervention group_rehabilitation program,All,"Adult, Older Adult",Not Applicable,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"July 30, 2020","July 30, 2022"
2948,NCT04568122,Recruiting,No Results Available,Covid19,Device: Saliva test kit,All,"Child, Adult, Older Adult",Not Applicable,3015.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"November 20, 2020",August 2021
2949,NCT04366986,Recruiting,No Results Available,Covid-19,Other: Tested for SARS-CoV-2 (regardless of the result)|Other: Clinical diagnosis of COVID-19 by a health care professional,Female,"Adult, Older Adult",,25000.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 23, 2020","April 30, 2024"
2950,NCT04415151,Recruiting,No Results Available,COVID-19,Drug: Tofacitinib 10 mg|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 29, 2020","March 31, 2021"
2951,NCT04557046,Recruiting,No Results Available,Covid19,Diagnostic Test: Nasal Swab|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Throat swab|Diagnostic Test: Fingerstick|Diagnostic Test: Saliva specimen,All,"Child, Adult, Older Adult",Not Applicable,400.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 26, 2020","December 31, 2021"
2952,NCT04414059,Not yet recruiting,No Results Available,SARS-CoV 2|Hospitalisation-Associated Infection,,All,"Adult, Older Adult",,155.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,March 2021,August 2021
2953,NCT04435184,Completed,No Results Available,COVID-19,Drug: Crizanlizumab|Other: 0.9% saline,All,"Adult, Older Adult",Phase 2,50.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 9, 2020","January 4, 2021"
2954,NCT04389840,Recruiting,No Results Available,COVID-19|Acute Lung Injury|SARS-CoV-2,Drug: Dociparstat sodium|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,525.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 3, 2020",June 2021
2955,NCT04410159,Completed,Has Results,COVID-19,Drug: Povidone-Iodine|Drug: Essential oils|Other: Tap water,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 22, 2020","July 6, 2020"
2956,NCT04252118,Recruiting,No Results Available,COVID-19,Biological: MSCs,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 27, 2020",December 2021
2957,NCT04646044,Recruiting,No Results Available,Covid-19|Coronavirus Disease 2019,Drug: Bempegaldesleukin|Drug: Standard of Care|Other: Placebo,All,"Adult, Older Adult",Phase 1,30.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 13, 2020","March 27, 2021"
2958,NCT04696562,Not yet recruiting,No Results Available,COVID-19,Behavioral: Deep Breathing Exercise with Triflo,All,"Adult, Older Adult",Not Applicable,44.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"January 1, 2021","March 31, 2021"
2959,NCT04377997,Not yet recruiting,No Results Available,Cardiovascular Diseases|COVID-19,Drug: Enoxaparin,All,"Adult, Older Adult",Phase 2,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 15, 2020","January 1, 2022"
2960,NCT04652518,Recruiting,No Results Available,Covid19,Drug: LYT-100|Other: Placebo,All,"Adult, Older Adult",Phase 2,168.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 11, 2020",December 2021
2961,NCT04356508,Not yet recruiting,No Results Available,"COVID-19|SARS-CoV-2|2019-nCoV|Pneumonia, Viral",Drug: Nivolumab,All,"Adult, Older Adult",Phase 2,15.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 14, 2020","August 31, 2021"
2962,NCT04707703,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|Aspergillosis Invasive,Drug: Isavuconazonium Injection [Cresemba]|Drug: Placebo,All,"Adult, Older Adult",Phase 3,162.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","March 16, 2021",March 2022
2963,NCT04330690,Recruiting,No Results Available,COVID-19,Drug: Interferon beta-1a|Drug: Remdesivir,All,"Adult, Older Adult",Phase 2,2900.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 18, 2020","May 18, 2022"
2964,NCT04593654,Completed,No Results Available,Covid19|Thromboembolism,Drug: Dose of tinzaparin or dalteparin,All,"Child, Adult, Older Adult",,257.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","October 15, 2020"
2965,NCT04598581,"Active, not recruiting",No Results Available,Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2),Radiation: Low Dose Radiation Therapy (LD-RT)|Other: Sham irradiation,All,"Adult, Older Adult",Not Applicable,22.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","November 2, 2020",November 2021
2966,NCT04409535,"Active, not recruiting",No Results Available,Activities|Mental Health Issue|Life Style,Other: WHOQOL-BREF survey,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Other,"May 7, 2020","March 31, 2021"
2967,NCT04452097,Not yet recruiting,No Results Available,COVID-19|ARDS|Acute Respiratory Distress Syndrome,Biological: Human umbilical cord mesenchymal stem cells + best supportive care|Other: Placebo control + best supportive care,All,"Adult, Older Adult",Phase 1|Phase 2,39.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 1, 2021","March 31, 2022"
2968,NCT04532411,Completed,No Results Available,SARS-CoV Infection|Respiratory Viral Infection|Personal Protective Equipment|Covid19,Other: Personal Protective Testing Booth,All,"Child, Adult, Older Adult",,28948.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"March 1, 2020","September 30, 2020"
2969,NCT04375735,Not yet recruiting,No Results Available,"ARDS, Human|COVID-19",Drug: Bovine Lipid Extract Surfactant,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 1, 2020","July 1, 2021"
2970,NCT04443257,Enrolling by invitation,No Results Available,Sars-CoV2,Other: assessment of the sequelae after hospitalization for Sars-COV-2,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 8, 2020","July 25, 2021"
2971,NCT04490811,Recruiting,No Results Available,COVID-19,Other: no intervention. observational cohort study,All,"Child, Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 9, 2020","December 31, 2021"
2972,NCT04806880,Recruiting,No Results Available,Covid19,Device: Web-application,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2021","August 1, 2021"
2973,NCT04797091,Recruiting,No Results Available,Corona Virus Infection|SARS-CoV 2,Other: Retrospective data collection,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"April 20, 2020","August 31, 2026"
2974,NCT04551755,Not yet recruiting,No Results Available,Covid19,Drug: Ivermectin and Doxycycline|Other: Placebo,All,"Adult, Older Adult",Phase 2,188.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",September 2020,December 2020
2975,NCT04775017,Recruiting,No Results Available,Intensive Care Unit Delirium|Covid19|Post Intensive Care Unit Syndrome,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2021",December 2021
2976,NCT04459351,Recruiting,No Results Available,Coronavirus|Corona Virus Infection|COVID-19|2019nCoV|2019 Novel Coronavirus Infection,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 19, 2020",June 2023
2977,NCT04412291,Recruiting,No Results Available,Covid-19,Drug: Anakinra Prefilled Syringe|Drug: Tocilizumab Prefilled Syringe|Drug: Standard-of-care treatment,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 11, 2020",June 2021
2978,NCT04813328,Not yet recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,600.0,NIH,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,April 2021,April 2022
2979,NCT04756817,Recruiting,No Results Available,"Immunogenicity, Vaccine",,All,Older Adult,,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 13, 2021","September 30, 2021"
2980,NCT04616950,Recruiting,No Results Available,Covid19|Cancer,,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"December 1, 2020","December 31, 2021"
2981,NCT04799977,Recruiting,No Results Available,Olfaction Disorders,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 1, 2020","December 31, 2022"
2982,NCT04352608,"Active, not recruiting",No Results Available,COVID-19,Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of placebo at the emergency vaccination schedule|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of placebo at the routine vaccination schedule,All,Adult,Phase 1|Phase 2,744.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 16, 2020","December 13, 2020"
2983,NCT04392128,Withdrawn,No Results Available,COVID19|Hematologic Malignancy,Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil]|Drug: Azithromycin 250 MG Oral Capsule|Drug: Placebo oral tablet|Drug: Placebo oral capsule,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 2, 2020","September 2, 2020"
2984,NCT04535700,Recruiting,No Results Available,Type 2 Diabetes,Drug: Pioglitazone 30 mg|Other: standard of care,All,"Adult, Older Adult",Phase 4,76.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 18, 2020","April 10, 2021"
2985,NCT04665115,Not yet recruiting,No Results Available,Asymptomatic COVID-19 Infection Laboratory-Confirmed|B-Cell Neoplasm|Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Small Lymphocytic Lymphoma|Symptomatic COVID-19 Infection Laboratory-Confirmed|Waldenstrom Macroglobulinemia,Drug: Ibrutinib|Other: Quality-of-Life Assessment,All,"Adult, Older Adult",Phase 2,134.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 30, 2021","May 1, 2025"
2986,NCT04479163,Completed,No Results Available,COVID,Biological: Convalescent Plasma|Other: Placebo,All,Older Adult,Not Applicable,165.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 4, 2020","October 25, 2020"
2987,NCT04399603,Recruiting,No Results Available,COVID,Other: no intervention-mechanistic study,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 1, 2020","November 17, 2021"
2988,NCT04779944,Completed,No Results Available,SARS-CoV-2,Other: other,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 7, 2020","August 15, 2020"
2989,NCT04374942,Enrolling by invitation,No Results Available,Pre-Exposure Prophylaxis|Coronavirus|SARS-CoV 2,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,988.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 30, 2020","January 30, 2022"
2990,NCT04435223,Completed,No Results Available,COVID-19 Severe Pneumonia|Severe Pneumonia Due to Other Pathogene,Biological: biological assays in particular on the lipid metabolism,All,"Adult, Older Adult",,62.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 7, 2020","May 7, 2020"
2991,NCT04403035,Recruiting,No Results Available,Covid-19,Diagnostic Test: ID NOW vs. Accula,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 10, 2020","May 9, 2021"
2992,NCT04408339,Recruiting,No Results Available,Cancer|COVID,Other: No Intervention,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","April 14, 2022"
2993,NCT04530409,Recruiting,No Results Available,Covid19|Corticosteroids,Drug: Early-Dexamethasone|Drug: Late-Dexamethasone,All,"Adult, Older Adult",Phase 4,450.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 26, 2020","May 1, 2021"
2994,NCT04683328,Not yet recruiting,No Results Available,Covid19,Biological: SCTA01|Biological: SCTA01 Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,560.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 25, 2021","November 25, 2021"
2995,NCT04445376,Completed,No Results Available,Covid19,Other: Physical Exercises,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 3, 2020","October 3, 2020"
2996,NCT04739410,Completed,No Results Available,Covid19,Drug: Ivermectin,All,"Adult, Older Adult",Phase 4,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","June 30, 2020"
2997,NCT04641195,Not yet recruiting,No Results Available,COVID-19,Dietary Supplement: Vitamin D3 (cholecalciferol)|Dietary Supplement: Zinc (zinc gluconate)|Dietary Supplement: Zinc (zinc gluconate) & Vitamin D (cholecalciferol)|Other: Placebo,All,"Adult, Older Adult",Phase 3,700.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 1, 2021","March 31, 2022"
2998,NCT04389411,Not yet recruiting,No Results Available,COVID-19,Drug: Montelukast 10mg,All,"Adult, Older Adult",Phase 3,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 1, 2020",December 2021
2999,NCT04292899,Completed,Has Results,COVID-19,Drug: Remdesivir|Drug: Standard of Care,All,"Child, Adult, Older Adult",Phase 3,4891.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 6, 2020","June 30, 2020"
3000,NCT04653831,Recruiting,No Results Available,Covid19|ARDS,Drug: Pirfenidone|Other: Standard of care,All,"Adult, Older Adult",Not Applicable,100.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 8, 2020",December 2021
3001,NCT04475120,Completed,No Results Available,Covid19,Drug: liposomal lactoferrin,All,"Adult, Older Adult",Phase 2|Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","July 2, 2020"
3002,NCT04426695,Recruiting,No Results Available,COVID-19,Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,6900.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 11, 2020","April 16, 2021"
3003,NCT04771013,Recruiting,No Results Available,COVID-19,Biological: Thymic peptides,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 10, 2021",May 2021
3004,NCT04416100,Recruiting,No Results Available,Covid-19|Pulmonary Fibrosis,Diagnostic Test: Pulmonary function tests|Diagnostic Test: Imaging|Biological: Blood sampling,All,"Adult, Older Adult",,130.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020","April 28, 2022"
3005,NCT04769245,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"February 18, 2021","June 1, 2021"
3006,NCT04371965,Completed,No Results Available,COVID-19,Drug: Povidone-Iodine,All,"Adult, Older Adult",Phase 2,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","October 23, 2020"
3007,NCT04637295,Recruiting,No Results Available,Neoplasms Malignant,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"January 27, 2021","June 30, 2021"
3008,NCT04452474,Not yet recruiting,No Results Available,COVID-19,Drug: Olokizumab 64 mg|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,376.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 30, 2020","January 29, 2021"
3009,NCT04340466,Completed,No Results Available,"Pneumonia, Viral|Critically Ill|Corona Virus Infection",Other: No intervention,All,"Adult, Older Adult",,1003.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 3, 2020","July 3, 2020"
3010,NCT04332107,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV-2,Drug: Azithromycin|Drug: Placebos,All,"Adult, Older Adult",Phase 3,2271.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 22, 2020","December 30, 2021"
3011,NCT04542915,"Active, not recruiting",No Results Available,SARS-CoV Infection|Anxiety|Depression|Occupational Problems|Severe Acute Respiratory Syndrome|Coronavirus Infection,Other: No intervention,All,"Adult, Older Adult",,4776.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"September 29, 2020",October 2021
3012,NCT04527354,Completed,No Results Available,SARS-CoV-2 Infection|Fibrosis Lung,Drug: Treamid|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 1, 2020","February 10, 2021"
3013,NCT04639466,Recruiting,No Results Available,COVID-19,Drug: Placebo Administration|Biological: Vaccine Therapy,All,Adult,Phase 1,129.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 11, 2020","November 10, 2022"
3014,NCT04640428,Recruiting,No Results Available,"Covid19|Stroke, Acute|Stroke, Ischemic|Stroke Hemorrhagic",,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 10, 2020","October 31, 2021"
3015,NCT04654416,Completed,No Results Available,Covid-19,Drug: Corticosteroid with or without colchicine,All,"Adult, Older Adult",,301.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"March 20, 2020","August 20, 2020"
3016,NCT04730661,Recruiting,No Results Available,SARS-CoV Infection,Diagnostic Test: Sit to stand test,All,"Adult, Older Adult",Not Applicable,146.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"December 21, 2020","December 28, 2021"
3017,NCT04810637,Recruiting,No Results Available,Covid19,Drug: GX-I7,All,"Adult, Older Adult",Phase 2,210.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 1, 2020",September 2021
3018,NCT04491292,Recruiting,No Results Available,COVID-19 Infection,Other: Questionnaire Administration,All,"Adult, Older Adult",,20000.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 18, 2020","April 30, 2021"
3019,NCT04398303,Not yet recruiting,No Results Available,COVID-19 Pneumonia,Biological: ACT-20-MSC|Biological: ACT-20-CM|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,70.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",May 2020,October 2020
3020,NCT04786249,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,2400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 24, 2021","April 30, 2021"
3021,NCT04834089,Not yet recruiting,No Results Available,Immunosuppression|Cancer|COVID-19|Other Complication of Kidney Transplant|Chemotherapy|Renal Disease|Diabetes Mellitus|Cardiovascular Diseases|Chronic Obstructive Pulmonary Disease,Biological: AntiSARS-CoV-2 Serum|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,618.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",May 2021,May 2022
3022,NCT04807699,Enrolling by invitation,No Results Available,Covid19|Hospitalization,Other: Data collection,All,"Adult, Older Adult",,3500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 25, 2020","March 25, 2022"
3023,NCT04537858,"Active, not recruiting",No Results Available,COVID-19|Inpatient,Device: Virtual reality therapy first|Device: Conventional therapy first,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 18, 2020","December 1, 2020"
3024,NCT04365257,Recruiting,No Results Available,COVID-19,Drug: Prazosin|Other: Standard of care,All,"Adult, Older Adult",Phase 2,220.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 13, 2020","June 30, 2021"
3025,NCT04485429,Recruiting,No Results Available,COVID-19,Drug: Methylprednisolone|Drug: Heparin,All,"Adult, Older Adult",Phase 3,268.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 20, 2020","December 31, 2020"
3026,NCT04395300,Completed,No Results Available,COVID-19|Sleep Quality|General Health,Other: Web Based Survey,All,"Adult, Older Adult",,143.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"March 30, 2020","May 16, 2020"
3027,NCT04372199,Recruiting,No Results Available,COVID|Pneumonia,,All,"Adult, Older Adult",,248.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020","May 27, 2020"
3028,NCT04349241,Completed,No Results Available,Coronavirus Disease (COVID-19),Drug: favipiravir|Drug: Standard of care therapy,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 18, 2020","June 20, 2020"
3029,NCT04436458,Not yet recruiting,No Results Available,COVID,Drug: Niclosamide Oral Tablet|Drug: Placebo,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",June 2021,December 2021
3030,NCT04354259,Recruiting,No Results Available,Sars-CoV2|Covid-19,Drug: Peginterferon Lambda-1A|Other: placebo,All,"Adult, Older Adult",Phase 2,140.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 13, 2020","November 30, 2020"
3031,NCT04351295,Recruiting,No Results Available,COVID,Drug: Favipiravir|Drug: Placebos,All,"Child, Adult, Older Adult",Phase 2|Phase 3,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","December 1, 2020"
3032,NCT04615429,"Active, not recruiting",No Results Available,Acute Respiratory Distress Syndrome|COVID-19 Pneumonia,Biological: Mesenchymal stromal cells|Other: Placebo,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 15, 2020",January 2022
3033,NCT04834726,Not yet recruiting,No Results Available,Covid19,Behavioral: Opt-In|Behavioral: Preference|Behavioral: Standard Message|Behavioral: Clinician Endorsement|Behavioral: Scarcity|Behavioral: Opt-Out Framing|Behavioral: Phone Call,All,"Child, Adult, Older Adult",Not Applicable,21000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research",April 2021,June 2021
3034,NCT04347239,Recruiting,No Results Available,Coronavirus Disease 2019,Drug: Placebos|Drug: Leronlimab (700mg),All,"Adult, Older Adult",Phase 2,394.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 15, 2020","October 15, 2021"
3035,NCT04806620,Recruiting,No Results Available,ME/CFS|Covid19,,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","May 1, 2025"
3036,NCT04844554,Not yet recruiting,No Results Available,Covid19|High-definition Transcranial Direct Current Stimulation,Other: HD-tDCS 4mA|Other: HD-tDCS 2mA,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 19, 2021","October 12, 2022"
3037,NCT04351490,Withdrawn,No Results Available,SARS-CoV 2,Dietary Supplement: Zinc gluconate|Dietary Supplement: 25-OH cholecalciferol,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2020,July 2020
3038,NCT04522817,Withdrawn,No Results Available,Covid-19,Biological: CLBS119,All,"Adult, Older Adult",Phase 1,0.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 5, 2020",May 2021
3039,NCT04325048,Recruiting,No Results Available,Coronavirus Infection,Device: Cordio App,All,"Adult, Older Adult",,5000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020",September 2021
3040,NCT04343664,Not yet recruiting,No Results Available,Mental Stress|Mental Health Wellness 1|Depression|Anxiety|Behavior Problem|Emotional Problem,,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"February 1, 2021","December 31, 2021"
3041,NCT04794062,Recruiting,No Results Available,COVID-19|Myocardial Injury|Myocarditis Post Infection,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 16, 2020","December 31, 2021"
3042,NCT04456075,Recruiting,No Results Available,SARS-CoV2|COVID,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020",April 2022
3043,NCT04644120,Recruiting,No Results Available,CoronaVirus Disease-2019 (COVID-19),Drug: ABBV-47D11|Drug: Placebo for ABBV-47D11|Drug: ABBV-2B04|Drug: Placebo for ABBV-2B04,All,"Adult, Older Adult",Phase 1,54.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","December 10, 2020","September 5, 2021"
3044,NCT04525404,Recruiting,No Results Available,Covid19|Coronavirus Infection|SARS-CoV Infection,"Diagnostic Test: MRI (heart, brain, lungs, liver)|Diagnostic Test: Bloodwork|Other: Cognitive testing|Other: Olfaction testing|Diagnostic Test: Spirometry|Other: Walk Test",All,"Adult, Older Adult",,228.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 12, 2020","September 1, 2021"
3045,NCT04773067,Recruiting,No Results Available,COVID-19,Biological: UB-612|Biological: Placebo,All,"Child, Adult, Older Adult",Phase 2,3850.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","January 30, 2021","June 30, 2022"
3046,NCT04292730,Completed,Has Results,COVID-19,Drug: Remdesivir|Drug: Standard of Care,All,"Child, Adult, Older Adult",Phase 3,1113.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 15, 2020","June 26, 2020"
3047,NCT04591158,Recruiting,No Results Available,Covid19|Lung Infection,Device: Butterfly iQ,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 15, 2020",September 2021
3048,NCT04604184,Recruiting,No Results Available,COVID-19,Drug: BI 764198|Drug: Placebo,All,"Adult, Older Adult",Phase 2,130.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 3, 2020","May 26, 2021"
3049,NCT04365322,Recruiting,No Results Available,SARS-CoV-2 Infection,Other: Additional biological samples,All,"Adult, Older Adult",,160.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","April 20, 2025"
3050,NCT04363203,Suspended,No Results Available,SARS-CoV-2|COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,300.0,U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 30, 2020",August 2021
3051,NCT04713488,"Active, not recruiting",No Results Available,COVID-19 Prevention,Biological: Sputnik Light,All,"Adult, Older Adult",Phase 1|Phase 2,110.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 15, 2021","July 31, 2021"
3052,NCT04686565,Recruiting,No Results Available,"Cerebral Palsy|Covid19|Telemedicine|Caregiver Quality of Life|Disability, Developmental",,All,"Child, Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"February 15, 2020","February 28, 2021"
3053,NCT04578197,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 18, 2020",November 2022
3054,NCT04563208,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: Placebo|Drug: DuACT,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","December 9, 2020",March 2021
3055,NCT04441918,Recruiting,No Results Available,COVID-19; and High Infection Risk of SARS-CoV-2,Combination Product: JS016 (anti-SARS-CoV-2 monoclonal antibody),All,"Child, Adult",Phase 1,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 5, 2020","December 11, 2020"
3056,NCT04575571,Recruiting,No Results Available,Psychosocial Impacts of the COVID-19 Pandemic,"Other: No intervention, this is an observational study that uses validated questionnaires and qualitative interviews..",All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020","April 29, 2025"
3057,NCT04829552,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,704.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 10, 2020","April 15, 2020"
3058,NCT04682093,Enrolling by invitation,No Results Available,Covid19,,All,"Adult, Older Adult",,8000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 9, 2020","February 28, 2021"
3059,NCT04494724,Recruiting,No Results Available,COVID-19 Infection,Drug: Clazakizumab|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 13, 2020","July 31, 2021"
3060,NCT04811859,Recruiting,No Results Available,Covid19|Infective Pneumonia,Other: Inspiratory Muscle Training,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 10, 2021","March 10, 2022"
3061,NCT04431453,Recruiting,No Results Available,COVID-19,Drug: Remdesivir,All,"Child, Adult",Phase 2|Phase 3,52.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 21, 2020",February 2022
3062,NCT04353336,Recruiting,No Results Available,COVID-19|Coronavirus Infection,Drug: Chloroquine or Hydroxychloroquine,All,"Child, Adult, Older Adult",Phase 2|Phase 3,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 23, 2020","December 23, 2030"
3063,NCT04617119,Not yet recruiting,No Results Available,Covid19|Severe Systemic Illness Respiratory Muscle Fatigue,Device: Threshold IMT device|Other: Conventional physical therapy,All,Adult,Not Applicable,38.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","November 1, 2020","April 6, 2021"
3064,NCT04451902,Not yet recruiting,No Results Available,Rare Diseases,,All,"Child, Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 30, 2020","June 30, 2021"
3065,NCT04334954,"Active, not recruiting",No Results Available,SARS-COV2 Virus,,All,"Adult, Older Adult",,11363.0,NIH,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"August 26, 2020","March 31, 2022"
3066,NCT04322279,Recruiting,No Results Available,Coronavirus,Diagnostic Test: Serology|Genetic: Sequencing,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 9, 2020","June 1, 2021"
3067,NCT04813718,Not yet recruiting,No Results Available,Covid19,Dietary Supplement: Omni-Biotic Pro Vi 5|Dietary Supplement: Placebo,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other","May 1, 2021","December 31, 2022"
3068,NCT04694742,Recruiting,No Results Available,ARDS,Other: data collecting,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","April 15, 2021"
3069,NCT04328441,"Active, not recruiting",No Results Available,COVID-19,Drug: BCG Vaccine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 25, 2020","April 30, 2021"
3070,NCT04608201,Recruiting,No Results Available,SARS-COV2,Drug: Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour|Drug: Placebo of NICOTINE Transdermal patch,All,"Adult, Older Adult",Phase 3,220.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 9, 2020",December 2021
3071,NCT04811456,Recruiting,No Results Available,Covid19,Other: multisystem inflammatory syndrome in children (MIS-C),All,"Child, Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"May 25, 2020","August 25, 2025"
3072,NCT04712292,Recruiting,No Results Available,Colorectal Neoplasms Malignant,Procedure: Surgical procedure for cancer,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"September 8, 2020","February 28, 2021"
3073,NCT04778033,Recruiting,No Results Available,Covid19|Fertility Issues,Other: Sperm collection,Male,Adult,,75.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 9, 2021","May 1, 2021"
3074,NCT04443725,Not yet recruiting,No Results Available,COVID-19,"Drug: Hydroxychloroquine , Sofosbuvir, daclatasvir|Drug: Standard of care treatment",All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,July 2020,December 2020
3075,NCT04699097,Completed,No Results Available,Azithromycin Adverse Reaction|Covid19|Long QT Syndrome,Drug: Azithromycin,All,"Child, Adult",,105.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 1, 2020","November 1, 2020"
3076,NCT04397380,Not yet recruiting,No Results Available,Pyrexia|COVID,Device: Thermography|Device: Tympanic Temperature,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 20, 2020","July 1, 2020"
3077,NCT04389671,Recruiting,No Results Available,COVID-19|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS),Drug: Lucinactant,All,"Adult, Older Adult",Phase 2,20.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 2, 2020",July 2021
3078,NCT04373733,Recruiting,No Results Available,Coronavirus Infection,Drug: Favipiravir|Other: Standard of care management,All,"Adult, Older Adult",Phase 3,500.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","March 31, 2021"
3079,NCT04746430,Recruiting,No Results Available,Covid19|Corona Virus Infection,Drug: Dexamethasone,All,"Adult, Older Adult",Phase 4,2000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 16, 2021",March 2022
3080,NCT04537208,"Active, not recruiting",No Results Available,COVID-19 (Healthy Volunteers),Biological: SARS-CoV-2 vaccine formulation 1 with adjuvant 1|Biological: SARS-CoV-2 vaccine formulation 1 with adjuvant 2|Biological: SARS-CoV-2 vaccine formulation 2 with adjuvant 1|Biological: SARS-CoV-2 vaccine formulation 2 with adjuvant 2|Biological: SARS-CoV-2 vaccine formulation 2 without adjuvant|Biological: Placebo (0.9% normal saline),All,"Adult, Older Adult",Phase 1|Phase 2,440.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 3, 2020",November 2021
3081,NCT04373005,"Active, not recruiting",No Results Available,Covid-19|Cancer,Diagnostic Test: Nasopharyngeal (NP) swab,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","June 30, 2021"
3082,NCT04363372,Recruiting,No Results Available,COVID-19,Drug: MRx-4DP0004|Drug: Placebo,All,"Adult, Older Adult",Phase 2,90.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",June 2020,September 2020
3083,NCT04468308,Recruiting,No Results Available,Senile Cataract,Other: Questionnaire,All,"Adult, Older Adult",,116.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 8, 2020",March 2021
3084,NCT04337788,Not yet recruiting,No Results Available,Coronavirus Infection,Other: telehealth applications,All,Older Adult,Not Applicable,200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,May 2020,September 2020
3085,NCT04408248,Recruiting,No Results Available,COVID|Acute Respiratory Failure|Acute Kidney Injury,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 20, 2020","June 30, 2021"
3086,NCT04667247,Recruiting,No Results Available,COVID-19,Drug: FoTv,All,"Adult, Older Adult",Phase 1|Phase 2,66.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","December 3, 2020","August 1, 2021"
3087,NCT04388813,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,,All,"Adult, Older Adult",,1500.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 28, 2020",October 2021
3088,NCT04347226,Recruiting,No Results Available,Solid Tumor|Sars-CoV2|Hematological Malignancy,Drug: BMS-986253,All,"Adult, Older Adult",Phase 2,138.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020",September 2022
3089,NCT04635943,Recruiting,No Results Available,Covid19|Coronavirus Infection|SARS-CoV Infection,Drug: Ivermectin|Drug: Placebo,All,"Adult, Older Adult",Phase 2,186.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 29, 2020","April 30, 2021"
3090,NCT04452812,Not yet recruiting,No Results Available,COVID-19 Pneumonia|Convalescent Plasma,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 1|Phase 2,15.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","July 6, 2020","April 1, 2021"
3091,NCT04649151,"Active, not recruiting",No Results Available,SARS-CoV-2,Biological: mRNA-1273|Biological: Placebo,All,Child,Phase 2|Phase 3,3000.0,Industry|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 9, 2020","June 30, 2022"
3092,NCT04778020,Not yet recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,March 2021,January 2022
3093,NCT04482647,Recruiting,No Results Available,COVID-19 Infection,Other: Media Intervention|Procedure: Meditation Therapy|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Procedure: Yoga,All,"Child, Adult, Older Adult",Phase 1,50.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 17, 2020","July 1, 2021"
3094,NCT04542434,Not yet recruiting,No Results Available,Covid19,Drug: Niclosamide Oral Tablet|Drug: Placebo,All,"Adult, Older Adult",Phase 2,148.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",June 2021,December 2021
3095,NCT04403555,Recruiting,No Results Available,COVID,Drug: Ivermectin,All,"Child, Adult, Older Adult",Phase 2|Phase 3,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","December 3, 2030"
3096,NCT04649021,"Active, not recruiting",No Results Available,SARS-CoV-2,Biological: BNT162b2|Other: Placebo,All,"Adult, Older Adult",Phase 2,950.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 4, 2020",December 2021
3097,NCT04513990,Recruiting,No Results Available,COVID-19 Infection,Procedure: Biospecimen Collection|Other: Questionnaire Administration,All,"Child, Adult, Older Adult",Not Applicable,1500.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 9, 2020","April 30, 2021"
3098,NCT04812496,Completed,No Results Available,Covid19|SARS-CoV Infection|Tenofovir,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","January 15, 2021"
3099,NCT04456153,Completed,No Results Available,COVID-19,Drug: Experimental Group|Drug: Placebo Group,All,"Adult, Older Adult",Phase 2,61.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 22, 2020","January 31, 2021"
3100,NCT04517123,Recruiting,No Results Available,"Covid19|Pneumonia, Viral",Other: Prone Positioning,All,"Adult, Older Adult",Not Applicable,100.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","December 31, 2021"
3101,NCT04666246,Recruiting,No Results Available,Acute Respiratory Failure|Covid19,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","February 1, 2022"
3102,NCT04321096,"Active, not recruiting",No Results Available,Corona Virus Infection,Drug: Camostat Mesilate|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 1|Phase 2,580.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 4, 2020","May 1, 2021"
3103,NCT04513184,Recruiting,No Results Available,Covid19,Drug: IV Dexamethasone|Drug: Nasal Dexamethasone,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","July 14, 2020","July 31, 2021"
3104,NCT04756271,Recruiting,No Results Available,Vaccine Adverse Reaction|Seroconversion,Biological: SARS-Cov-2 neutralizing antibody titer,All,"Adult, Older Adult",Phase 3,140.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 11, 2021",August 2021
3105,NCT04387240,Not yet recruiting,No Results Available,Covid 19 Positive|Corona Virus Infection,Drug: Artemisinin / Artesunate|Other: placebo,All,Adult,Phase 2,22.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",January 2022,December 2022
3106,NCT04485351,Recruiting,No Results Available,Diabetes Mellitus|Coronavirus Infection|Metabolic Disease|Glucose Metabolism Disorders,Other: no intervention,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,July 2020,September 2020
3107,NCT04705766,Recruiting,No Results Available,SARS-CoV Infection|Covid19|Corona Virus Infection|Acute Kidney Injury|Kidney Injury,Other: Urine Collection,All,"Adult, Older Adult",,2000.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021",March 2022
3108,NCT04508439,Recruiting,No Results Available,Covid19|Pneumonia|Coagulation Disorder|Pulmonary Embolism,Drug: Enoxaparin,All,"Adult, Older Adult",Not Applicable,130.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","June 20, 2020","December 30, 2020"
3109,NCT04794920,"Active, not recruiting",No Results Available,Covid19,,All,"Adult, Older Adult",,780.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 10, 2020","May 31, 2021"
3110,NCT04433871,Recruiting,No Results Available,Covid-19|Cancer,"Other: No intervention, observational",All,"Child, Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","April 27, 2023"
3111,NCT04557358,Enrolling by invitation,No Results Available,Rheumatoid Arthritis|Quality of Life,Other: COVID-19 survey|Other: RAPID-3|Other: WHOQOL-BREF|Other: DASS-21 instrument (depression and anxiety)|Other: IER-R (posttraumatic stress),All,"Adult, Older Adult",,346.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","December 31, 2022"
3112,NCT04370821,Recruiting,No Results Available,Occupational Exposure to SARS-CoV-2|COVID-19,,All,"Adult, Older Adult",,20000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 9, 2020","April 27, 2040"
3113,NCT04477473,Recruiting,No Results Available,COVID-19 Pandemic|Vulnerable Subjects|Long-term Non-invasive Ventilation,Other: Questionnaire-based observational study,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 30, 2020","August 31, 2020"
3114,NCT04385147,Completed,No Results Available,"Cholangitis, Secondary Biliary|Cholangiocarcinoma|Obstructive Jaundice|Pancreas Cancer|COVID-19|SARS-CoV-2",Other: Endoscopic management according to standard of care,All,"Child, Adult, Older Adult",,670.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 18, 2020","July 5, 2020"
3115,NCT04379232,Completed,No Results Available,Digestive Cancer|Gynaecological Cancer|Head and Neck Cancer,Biological: Screening test for covid ( RT PCR and CT Chest),All,"Adult, Older Adult",,112.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 19, 2020","April 25, 2020"
3116,NCT04482712,Not yet recruiting,No Results Available,Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Respiratory Failure|Sars-CoV2,Drug: Rapamycin|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,January 2023
3117,NCT04357613,Not yet recruiting,No Results Available,SARS Virus,Drug: Experimental drug,All,Older Adult,Phase 2,99.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","December 1, 2021"
3118,NCT04635787,Enrolling by invitation,No Results Available,Covid19,Device: ANNE One,All,"Adult, Older Adult",,300.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 5, 2020","October 30, 2022"
3119,NCT04803409,Recruiting,No Results Available,Covid19,Device: Splenic Ultrasound,All,"Adult, Older Adult",Not Applicable,40.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 22, 2021","October 1, 2021"
3120,NCT04816669,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19,Biological: BNT162b2,All,Adult,Phase 3,550.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","April 1, 2021","May 30, 2021"
3121,NCT04511650,Recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome,Drug: Razuprotafib Subcutaneous Solution|Drug: Placebo Subcutaneous Solution,All,"Adult, Older Adult",Phase 2,180.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 21, 2020",February 2021
3122,NCT04821570,Recruiting,No Results Available,Breast Cancer|Lung Cancer|Melanoma (Skin),Biological: COVID-19 Vaccine,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 23, 2021","March 28, 2023"
3123,NCT04333953,Recruiting,No Results Available,HIV/AIDS|COVID-19|SARS-CoV-2,Other: No intervention,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 1, 2020","October 1, 2020"
3124,NCT04841681,Completed,No Results Available,"Covid19|Distress, Emotional",Behavioral: Video-based Psychotherapy,All,"Adult, Older Adult",Not Applicable,42.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 7, 2020","August 26, 2020"
3125,NCT04407429,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Diagnostic Test: Laboratory Analyses,All,"Child, Adult, Older Adult",,12000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 27, 2020","June 27, 2021"
3126,NCT04385940,Not yet recruiting,No Results Available,COVID-19,"Dietary Supplement: Ddrops® products, 50,000 IU, Oral|Dietary Supplement: Vitamin D3",All,"Child, Adult, Older Adult",Phase 3,64.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",June 2020,December 2020
3127,NCT04338100,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 6, 2020","January 29, 2021"
3128,NCT04425759,Recruiting,No Results Available,Covid19|Corona Virus Infection|SARS-CoV 2|COVID,Diagnostic Test: Blood sample,All,"Adult, Older Adult",,2400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 8, 2020","June 30, 2021"
3129,NCT04469491,Recruiting,No Results Available,COVID-19|INTERFERON|NEBULIZATION,Drug: inhaled type I interferon|Drug: WFI water nebulization,All,"Adult, Older Adult",Phase 2,146.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 20, 2020",September 2021
3130,NCT04362189,"Active, not recruiting",No Results Available,COVID-19,Drug: HB-adMSC|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 2,100.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 30, 2020","October 31, 2021"
3131,NCT04365582,Suspended,No Results Available,COVID,Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Lopinavir 200Mg/Ritonavir 50Mg Tab,All,"Adult, Older Adult",Phase 3,640.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 7, 2020","February 7, 2021"
3132,NCT04341688,Not yet recruiting,No Results Available,Covid-19,Drug: Gargle/Mouthwash,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","February 1, 2021","July 31, 2021"
3133,NCT04353401,Enrolling by invitation,No Results Available,Coronavirus Infection|COVID-19,,All,"Adult, Older Adult",,5000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 3, 2020",May 2021
3134,NCT04487444,Recruiting,No Results Available,Covid19,Drug: Thymalfasin,All,"Adult, Older Adult",Phase 2,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 10, 2020",June 2021
3135,NCT04561219,Completed,No Results Available,"Covid19|Corona Virus Infection|Pneumonia, Viral",Drug: Nitazoxanide|Drug: Placebo,All,"Adult, Older Adult",Phase 2,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","April 19, 2020","October 2, 2020"
3136,NCT04351789,Recruiting,No Results Available,COVID-19|Mental Health|Psychoeducation|Anxiety,Other: Psychoeducational intervention,All,"Adult, Older Adult",Not Applicable,66.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"May 1, 2020",April 2023
3137,NCT04319445,Completed,No Results Available,Migraine Disorders|Stress|Anxiety,Behavioral: Mindfulness session(s),All,"Child, Adult, Older Adult",Not Applicable,233.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 22, 2020","March 30, 2021"
3138,NCT04460170,Recruiting,No Results Available,Quality of Life|COVID-19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","February 1, 2022"
3139,NCT04341142,Recruiting,No Results Available,CoV2 Positive Caregivers,Diagnostic Test: Serological tests will be applied on patients blood sampling,All,"Adult, Older Adult",Not Applicable,550.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 9, 2020","April 9, 2024"
3140,NCT04336774,Withdrawn,No Results Available,COVID-19,Device: Caption AI,All,"Adult, Older Adult",Not Applicable,0.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,July 2020,"November 9, 2020"
3141,NCT04843930,Not yet recruiting,No Results Available,Cognitive Dysfunction|Covid19,Device: AKL-T01,All,"Adult, Older Adult",Phase 2,125.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,October 2022
3142,NCT04836052,Recruiting,No Results Available,COVID-19,Drug: Omega 3 fatty acid,All,"Adult, Older Adult",Phase 3,372.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 24, 2020","December 24, 2021"
3143,NCT04780672,Recruiting,No Results Available,COVID-19,Drug: Molixan|Drug: Placebo,All,"Adult, Older Adult",Phase 3,330.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","March 9, 2021","October 19, 2021"
3144,NCT04361448,Terminated,No Results Available,Covid-19|SARS-CoV-2|Diagnosis|Polymerase Chain Reaction,Other: samling of oropharynx and nasopharynx,All,"Child, Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 20, 2020","June 30, 2020"
3145,NCT04368923,"Active, not recruiting",No Results Available,Covid 19,Device: Oxygen Therapy|Procedure: Physical Therapy,All,Adult,Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 15, 2020","June 23, 2020"
3146,NCT04527198,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: Brainstem Responses Assessment Sedation Score (BRASS)|Diagnostic Test: Electroencephalogram with EKG lead,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,September 2020,June 2021
3147,NCT04351633,Completed,No Results Available,Sars-CoV2|Osteoporosis,Other: questionnaire assesment,All,"Adult, Older Adult",,52.0,Other,Observational,Observational Model: Family-Based|Time Perspective: Cross-Sectional,"April 23, 2020","April 30, 2020"
3148,NCT04325919,Recruiting,No Results Available,Coronavirus Infections,Other: No intervention,All,"Adult, Older Adult",,170.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"February 24, 2020","June 17, 2021"
3149,NCT04752839,Not yet recruiting,No Results Available,Psychological Stress|Psychosocial Impairment|Anxiety|Depression|Post Traumatic Stress Disorder|Coronavirus Infection|COVID,,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,February 2021,May 2021
3150,NCT04374110,Recruiting,No Results Available,COVID|Hypertension|Cardiovascular Diseases|Cardiovascular Risk Factor,Other: Clinical data,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 5, 2020","August 24, 2021"
3151,NCT04431414,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Other: Sample collection,All,"Adult, Older Adult",,800.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 20, 2020",September 2021
3152,NCT04451239,Not yet recruiting,No Results Available,Keratonjunctivitis,Drug: topical steroids and cyclosporin-A,All,"Child, Adult, Older Adult",Not Applicable,12.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 30, 2020",July 2020
3153,NCT04324528,Completed,No Results Available,Coronavirus|COVID-19|SARS-CoV Infection|Respiratory Failure|Cytokine Storm,Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption),All,"Adult, Older Adult",Not Applicable,34.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 27, 2020","January 27, 2021"
3154,NCT04673292,Enrolling by invitation,No Results Available,Coronavirus Infection,"Behavioral: Fixed site standard of care testing|Behavioral: Community-based, mobile van testing|Behavioral: Self-collected, home-based testing",All,"Child, Adult, Older Adult",Not Applicable,3000.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"February 8, 2021",August 2021
3155,NCT04423978,Completed,No Results Available,COVID-19,,All,"Adult, Older Adult",,1826.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"May 4, 2020","June 15, 2020"
3156,NCT04377165,Terminated,No Results Available,COVID|Influenza|Gastroenteritis,Behavioral: Gamification|Behavioral: Newsfeed function,All,"Adult, Older Adult",Not Applicable,34.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 6, 2020","August 26, 2020"
3157,NCT04426006,"Active, not recruiting",No Results Available,Sars-CoV2|Serum; Disease,Other: PRO-SERO-COV,All,"Adult, Older Adult",Not Applicable,550.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 1, 2020",December 2021
3158,NCT04354714,Withdrawn,No Results Available,COVID-19,Drug: Ruxolitinib|Procedure: Peripheral blood draw,All,"Adult, Older Adult",Phase 2,0.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 30, 2020","December 31, 2021"
3159,NCT04422561,Completed,Has Results,COVID,Drug: Ivermectin Tablets,All,"Child, Adult, Older Adult",Phase 2|Phase 3,340.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 31, 2020","July 27, 2020"
3160,NCT04455347,Recruiting,No Results Available,COVID-19 Infection,,All,"Child, Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2020",June 2022
3161,NCT04491214,Completed,No Results Available,Covid19|Follow up|Rehabilitation,Other: quality of live assessment,All,"Adult, Older Adult",,112.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 24, 2020","January 21, 2021"
3162,NCT04746521,Recruiting,No Results Available,Covid19,Diagnostic Test: Multitest 6 color TBNK and BD Lyotubes,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,March 2021,December 2022
3163,NCT04529421,Enrolling by invitation,No Results Available,Infection|Infection Control,Behavioral: Online instruction|Behavioral: In-person instruction,All,"Adult, Older Adult",,70000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 4, 2020",August 2021
3164,NCT04629105,Recruiting,No Results Available,"ARDS, Human|Covid19",Biological: Longeveron Mesenchymal Stem Cells (LMSCs)|Other: Placebo,All,"Adult, Older Adult",Phase 1,70.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 24, 2020",July 2025
3165,NCT04711863,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|Coronavirus Infection|Mild to Moderate COVID-19,Drug: Fluvoxamine|Drug: Placebo,All,"Adult, Older Adult",Phase 2,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"January 16, 2021","July 31, 2021"
3166,NCT04750369,Recruiting,No Results Available,COVID-19|SARS-CoV 2,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 1, 2020","March 31, 2021"
3167,NCT04681079,Recruiting,No Results Available,COVID-19,Drug: albuterol sulfate (MDI)|Drug: albuterol sulfate (nebulizer),All,"Adult, Older Adult",,10.0,Industry,Observational,Observational Model: Other|Time Perspective: Other,February 2021,April 2021
3168,NCT04330638,"Active, not recruiting",No Results Available,COVID-19,Other: Usual Care|Drug: Anakinra|Drug: Siltuximab|Drug: Tocilizumab,All,"Adult, Older Adult",Phase 3,342.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020","April 12, 2021"
3169,NCT04441372,Recruiting,No Results Available,SARS-CoV2|COVID,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","May 1, 2021"
3170,NCT04425031,Recruiting,No Results Available,Hypoxemic Respiratory Failure|Oxygen Toxicity,Drug: Oxygen,All,"Adult, Older Adult",Phase 4,780.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"August 25, 2020","March 1, 2024"
3171,NCT04619693,Recruiting,No Results Available,"Pneumonia, Viral|SARS-Cov-2",,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 18, 2020","September 18, 2021"
3172,NCT04363736,Completed,No Results Available,COVID-19 Pneumonia,Drug: Tociliuzumab,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 5, 2020","August 12, 2020"
3173,NCT04731116,Recruiting,No Results Available,COVID-19,Drug: Cannabidiol,All,"Adult, Older Adult",Phase 1|Phase 2,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 10, 2021","April 30, 2022"
3174,NCT04407468,Completed,No Results Available,COVID|ARDS|Pneumonia,Procedure: Prone position,All,"Adult, Older Adult",,827.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 1, 2020","July 13, 2020"
3175,NCT04588480,"Active, not recruiting",No Results Available,SARS-CoV-2 Infection|COVID-19,Biological: BNT162b2|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,160.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","October 21, 2020","November 30, 2021"
3176,NCT04826822,Recruiting,No Results Available,"Coronavirus Infection|Pneumonia, Viral",Drug: Spironolactone + Dexamethasone|Drug: Standard-of-care SARS-CoV-2 treatment,All,"Adult, Older Adult",Phase 3,440.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 24, 2021","September 2, 2021"
3177,NCT04394442,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 21, 2020",August 2020
3178,NCT04517630,Recruiting,No Results Available,Coronavirus Infection|Covid19|SARS (Severe Acute Respiratory Syndrome)|AKI,"Diagnostic Test: urinary NGAL, TIMP-2, IGFBP7, IL-6, viral load and metabolomic",All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","September 30, 2022"
3179,NCT04324463,Recruiting,No Results Available,Coronavirus|Severe Acute Respiratory Syndrome,Drug: Colchicine|Drug: Interferon-Beta|Drug: Aspirin|Drug: Rivaroxaban,All,"Adult, Older Adult",Phase 3,4000.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 21, 2020","June 30, 2021"
3180,NCT04818320,Recruiting,No Results Available,Covid19,Drug: Favipiravir,All,"Adult, Older Adult",Phase 3,500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 16, 2021","December 31, 2021"
3181,NCT04359277,Terminated,No Results Available,COVID-19,Drug: Enoxaparin Higher Dose|Drug: Lower-dose prophylactic anticoagulation,All,"Adult, Older Adult",Phase 3,77.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 21, 2020","September 20, 2020"
3182,NCT04649333,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,1336.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 15, 2020","August 31, 2020"
3183,NCT04334460,"Active, not recruiting",No Results Available,Sars-CoV-2|Covid19,Drug: BLD-2660,All,"Adult, Older Adult",Phase 2,120.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 4, 2020",November 2021
3184,NCT04406532,Not yet recruiting,No Results Available,Covid-19,Behavioral: PT-Pal|Behavioral: Self-guided exercises,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,May 2021,March 2022
3185,NCT04534790,Completed,No Results Available,COVID-19 Pneumonia,Radiation: Low Dose Radiotherapy,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","July 24, 2020","January 8, 2021"
3186,NCT04427566,Recruiting,No Results Available,COVID-19,Radiation: Radiation therapy,All,"Adult, Older Adult",Phase 2,24.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 23, 2020","December 31, 2021"
3187,NCT04351347,Recruiting,No Results Available,COVID,Drug: Ivermectin,All,"Child, Adult, Older Adult",Phase 2|Phase 3,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 16, 2020","December 1, 2030"
3188,NCT04693052,Enrolling by invitation,No Results Available,Psychiatric Disorder|Mental Health Disorder|Stress|Adjustment Disorders,Other: No interventions,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"December 10, 2020","June 30, 2021"
3189,NCT04485364,"Active, not recruiting",No Results Available,Coronavirus|Covid19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 14, 2020","October 31, 2020"
3190,NCT04380376,Recruiting,No Results Available,COVID-19|Viral Pneumonia,Drug: Melphalan|Other: Standard of care,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 30, 2020","October 30, 2020"
3191,NCT04477642,Withdrawn,No Results Available,COVID-19,Drug: Abatacept,All,"Adult, Older Adult",Phase 1|Phase 2,0.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,August 2020,December 2020
3192,NCT04746339,Recruiting,No Results Available,Covid19|Thrombosis,Drug: Apixaban 2.5 MG|Drug: Placebo,All,"Adult, Older Adult",Phase 4,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 4, 2021",December 2021
3193,NCT04355247,Recruiting,No Results Available,Covid-19,Drug: MethylPREDNISolone 80 Mg/mL Injectable Suspension,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 14, 2020","April 30, 2021"
3194,NCT04390217,Not yet recruiting,No Results Available,COVID-19|Coronavirus Disease 2019|Covid19|COVID-19 Pneumonia,Drug: LB1148|Drug: Placebo,All,"Adult, Older Adult",Phase 2,120.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 31, 2021","March 31, 2022"
3195,NCT04420390,Recruiting,No Results Available,Covid19,Radiation: Radiotherapy,All,"Adult, Older Adult",Not Applicable,41.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","September 8, 2020"
3196,NCT04370782,Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Zinc Sulfate|Drug: Doxycycline,All,"Adult, Older Adult",Phase 4,18.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 28, 2020","September 30, 2020"
3197,NCT04330521,Recruiting,No Results Available,Cancer|COVID-19,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 8, 2020",May 2022
3198,NCT04407923,Recruiting,No Results Available,Juvenile Idiopathic Arthritis|COVID 19|Treatment,,All,Child,,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 25, 2020","November 25, 2020"
3199,NCT04376840,Recruiting,No Results Available,Severe SARS-CoV2 Pneumonia,Other: Blood sample and data record,All,"Adult, Older Adult",Not Applicable,270.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 28, 2020","October 28, 2022"
3200,NCT04615871,Not yet recruiting,No Results Available,Covid19|Myocardial Injury,Drug: semaglutide,All,"Adult, Older Adult",Phase 2,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"November 30, 2020","March 31, 2022"
3201,NCT04366323,"Active, not recruiting",No Results Available,Sars-CoV2,Drug: ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS,All,"Adult, Older Adult",Phase 1|Phase 2,26.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 27, 2020",October 2021
3202,NCT04355507,Completed,No Results Available,COVID-19,Diagnostic Test: Chest computed tomography (CT)|Diagnostic Test: Reverse-transcription polymerase chain reaction (RT-PCR),All,"Adult, Older Adult",,10735.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","October 16, 2020"
3203,NCT04335071,Terminated,No Results Available,SARS-CoV-2 Infection,Drug: Tocilizumab (TCZ)|Drug: Placebo,All,"Adult, Older Adult",Phase 2,5.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 26, 2020","September 27, 2020"
3204,NCT04532554,Withdrawn,No Results Available,Covid19,Drug: Growth Hormone|Drug: Placebo,All,"Adult, Older Adult",Phase 4,0.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 26, 2020","December 20, 2020"
3205,NCT04403607,Recruiting,No Results Available,COVID,,All,"Adult, Older Adult",,180.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 22, 2020",August 2021
3206,NCT04364893,Recruiting,No Results Available,Corona Virus Infection|COVID-19,Other: Suspension or Maintenance of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors,All,"Adult, Older Adult",Not Applicable,700.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 9, 2020","December 1, 2020"
3207,NCT04621461,Completed,No Results Available,Corona Virus Infection,Dietary Supplement: Zinc Sulfate 220 MG|Drug: Placebo,All,"Adult, Older Adult",Phase 4,3.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 20, 2020","February 8, 2021"
3208,NCT04782336,Recruiting,No Results Available,Covid19|RSV Infection|Influenza Type A|Influenza Type B,Other: Group A (Sample Collection)|Other: Group B (Sample Collection)|Diagnostic Test: On-Site Testing (LumiraDx),All,"Child, Adult, Older Adult",Not Applicable,3500.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"December 12, 2020","May 31, 2022"
3209,NCT04813471,Recruiting,No Results Available,Covid19|Endothelial Dysfunction,Drug: Endothelial Protocol,All,"Adult, Older Adult",Phase 3,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 20, 2021","April 30, 2021"
3210,NCT04465604,Recruiting,No Results Available,COVID-19,Other: Wearing surgical face mask sprayed with hypertonic saline,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021",May 2022
3211,NCT04347824,Recruiting,No Results Available,Covid-19,,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"April 27, 2020","December 31, 2021"
3212,NCT04613817,Recruiting,No Results Available,SARS-CoV-2|SARS-CoV Infection|Covid19,,All,Child,,1640.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 3, 2020","August 31, 2021"
3213,NCT04380961,Recruiting,No Results Available,Critical Confirmed Coronavirus Disease (COVID)-19,Drug: Sirukumab|Drug: Placebo|Other: Standard of Care (SOC),All,"Adult, Older Adult",Phase 2,111.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 24, 2020","July 2, 2021"
3214,NCT04357938,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Device: CT-imaging,All,"Adult, Older Adult",,145.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","April 30, 2021"
3215,NCT04427280,Recruiting,No Results Available,Infectious Disease|Cancer|Coronavirus Infection,,All,"Adult, Older Adult",,60.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 26, 2020",April 2021
3216,NCT04544891,Not yet recruiting,No Results Available,Covid19,Other: blood sampling,All,"Adult, Older Adult",,1000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","April 1, 2023"
3217,NCT04686539,Not yet recruiting,No Results Available,Covid19|CBD,Drug: CBD|Drug: Placebo,All,"Adult, Older Adult",Phase 1,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","December 20, 2020",January 2022
3218,NCT04463823,Recruiting,No Results Available,COVID,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 6, 2020","May 31, 2025"
3219,NCT04650087,Recruiting,No Results Available,Covid19,Drug: Apixaban 2.5 MG|Drug: Placebo,All,"Adult, Older Adult",Phase 3,5320.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 15, 2021",September 2021
3220,NCT04839107,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,20000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 14, 2020","December 31, 2021"
3221,NCT04445623,Not yet recruiting,No Results Available,COVID19|Thrombosis,Drug: Prasugrel Hydrochloride 10 MG Oral Tablet|Drug: Placebo,All,"Adult, Older Adult",Phase 3,128.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",July 2020,January 2021
3222,NCT04575610,Recruiting,No Results Available,COVID-19,Drug: PF-06650833|Drug: Placebo,All,"Adult, Older Adult",Phase 2,68.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 30, 2020","March 31, 2021"
3223,NCT04655716,Not yet recruiting,No Results Available,Covid19,Drug: Sodium Bicarbonate 150Meq/L/D5W Inj,All,"Adult, Older Adult",Phase 3,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021","March 30, 2022"
3224,NCT04771598,Not yet recruiting,No Results Available,Covid19,Other: Breathing exercise with the phone application|Other: Breathing exercise,All,"Adult, Older Adult",Not Applicable,52.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"February 25, 2021","July 30, 2021"
3225,NCT04509973,Recruiting,No Results Available,Covid19|Hypoxia,Drug: Dexamethasone,All,"Adult, Older Adult",Phase 3,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 27, 2020","February 17, 2022"
3226,NCT04604145,Recruiting,No Results Available,SARS-CoV Infection|Polymerase Chain Reaction|Laboratory Testing,Diagnostic Test: SARS-CoV-2 testing on the Eppendorf Thermal Cycler PCR system using self-collected saliva as the specimen,All,"Adult, Older Adult",Not Applicable,65.0,U.S. Fed,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"February 3, 2021",June 2021
3227,NCT04360863,Recruiting,No Results Available,Smoking Cessation,Other: Telephone survey,All,"Child, Adult",,150.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 24, 2020","December 30, 2021"
3228,NCT04757272,Recruiting,No Results Available,Corona Virus Infection|Hepatitis,,All,"Adult, Older Adult",,1150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 1, 2020","April 30, 2021"
3229,NCT04278963,Suspended,No Results Available,CoVID-19|Chinese Medicine,Drug: YinHu QingWen Decoction|Drug: YinHu QingWen Decoction(low dose)|Other: Chinese medicine treatment|Other: standard western medicine treatment,All,"Adult, Older Adult",Phase 2|Phase 3,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","February 27, 2020",January 2021
3230,NCT04421027,Recruiting,No Results Available,COVID-19,Drug: Baricitinib|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1400.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 12, 2020","June 20, 2021"
3231,NCT04512118,Completed,No Results Available,Presence of COVID-19 Compatible CT Abnormalities,Diagnostic Test: PET-CT of 18F-FDG,All,"Adult, Older Adult",,22.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 15, 2020","July 30, 2020"
3232,NCT04470427,"Active, not recruiting",No Results Available,SARS-CoV-2,Biological: mRNA-1273|Biological: Placebo,All,"Adult, Older Adult",Phase 3,30420.0,Industry|U.S. Fed|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 27, 2020","October 27, 2022"
3233,NCT04487691,"Active, not recruiting",No Results Available,Covid19,Biological: Nebulized Platelet Lysate|Other: Nebulized Sterile Saline,All,"Adult, Older Adult",Not Applicable,1.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","December 8, 2020","December 30, 2021"
3234,NCT04768153,Recruiting,No Results Available,Cancer,Biological: Serology,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 29, 2020","December 29, 2021"
3235,NCT04365309,Enrolling by invitation,No Results Available,Novel Coronavirus Pneumonia|Aspirin|Treatment,Drug: Aspirin 100mg,All,"Adult, Older Adult",Phase 2|Phase 3,128.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 10, 2020",June 2020
3236,NCT04353011,Completed,No Results Available,Sars-CoV2|Chronic Pain,Other: questionnaire assesment,All,"Adult, Older Adult",,312.0,Other,Observational,Observational Model: Family-Based|Time Perspective: Cross-Sectional,"April 20, 2020","April 27, 2020"
3237,NCT04558203,Recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,450.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"September 22, 2020","May 30, 2021"
3238,NCT04316299,Completed,No Results Available,COVID-19|Acute Kidney Injury|Kidney Function,,All,"Adult, Older Adult",,287.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"February 26, 2020","March 8, 2020"
3239,NCT04716972,Not yet recruiting,No Results Available,Covid19,Other: survey|Other: Interview,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2021","December 1, 2021"
3240,NCT04647747,Recruiting,No Results Available,Covid19|Hypoxemia,Other: Self measurement with pulse oximeter,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 30, 2020","December 31, 2021"
3241,NCT04338568,Recruiting,No Results Available,COVID-19 Pneumonia|Lung Ultrasound,Diagnostic Test: Lung ultrasound,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 16, 2020","December 30, 2020"
3242,NCT04442230,Recruiting,No Results Available,Coronavirus Infection,Biological: NasoVAX|Other: Placebo,All,"Adult, Older Adult",Phase 2,96.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 10, 2020",February 2021
3243,NCT04603690,Withdrawn,No Results Available,Covid-19,Drug: Colchicine,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 15, 2020","June 14, 2021"
3244,NCT04359121,Recruiting,No Results Available,COVID19,Other: Questionnaires for specific phobia,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","April 15, 2024"
3245,NCT04542408,Recruiting,No Results Available,Covid19,Drug: Anticoagulation Agents (Edoxaban and/or high dose LMWH)|Drug: Low dose Low molecular weight heparin or Placebo,All,"Adult, Older Adult",Phase 3,172.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 12, 2020","September 30, 2021"
3246,NCT04799873,Completed,No Results Available,Covid19,Drug: AAT( Alpha 1 Antitrypsin),All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 8, 2020","December 1, 2020"
3247,NCT04382755,"Active, not recruiting",No Results Available,COVID-19,Drug: Zilucoplan®|Drug: Placebo,All,"Adult, Older Adult",Phase 2,81.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 22, 2020","April 30, 2021"
3248,NCT04417257,Recruiting,No Results Available,COVID-19 Disease,Drug: LAU-7b|Drug: Placebo oral capsule,All,"Adult, Older Adult",Phase 2,240.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 29, 2020","May 30, 2021"
3249,NCT04372472,"Active, not recruiting",No Results Available,Sepsis|COVID-19,,All,"Adult, Older Adult",,300.0,Industry|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 7, 2020","May 29, 2020"
3250,NCT04483960,Recruiting,No Results Available,SARS-CoV-2 Infection (COVID-19),Drug: Nafamostat Mesilate|Biological: Convalescent plasma|Drug: Enoxaparin|Drug: Dalteparin|Drug: Tinzaparin|Drug: Aspirin,All,"Adult, Older Adult",Phase 3,2400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 28, 2020","December 31, 2022"
3251,NCT04822701,Not yet recruiting,No Results Available,COVID-19,Drug: BI 767551 intravenous|Drug: BI 767551 inhaled|Drug: Placebo intravenous|Drug: Placebo inhaled,All,"Adult, Older Adult",Phase 2|Phase 3,1440.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 16, 2021","March 3, 2022"
3252,NCT04351243,Completed,No Results Available,COVID-19,Drug: Gimsilumab|Drug: Placebo,All,"Adult, Older Adult",Phase 2,227.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 12, 2020","April 1, 2021"
3253,NCT04445337,Not yet recruiting,No Results Available,COVID 19|ARDS,Procedure: Stellate Ganglion Block,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,July 2020,July 2021
3254,NCT04344587,"Active, not recruiting",No Results Available,COVID-19,Other: Self-prone position recommendation|Other: Usual care,All,"Adult, Older Adult",Not Applicable,305.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 23, 2020",May 2021
3255,NCT04363671,Not yet recruiting,No Results Available,Remote Consultation|Covid-19,,All,"Child, Adult, Older Adult",,30.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,May 2020,December 2020
3256,NCT04405076,"Active, not recruiting",No Results Available,SARS-CoV-2,Biological: Biological: mRNA-1273|Biological: Placebo|Biological: mRNA-1273.351,All,"Adult, Older Adult",Phase 2,660.0,Industry|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","May 29, 2020","October 6, 2021"
3257,NCT04436484,Recruiting,No Results Available,COVID-19,Diagnostic Test: Peripheral blood sampling,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020","February 19, 2021"
3258,NCT04304313,Recruiting,No Results Available,COVID-19,Drug: Sildenafil citrate tablets,All,"Adult, Older Adult",Phase 3,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 9, 2020","November 9, 2020"
3259,NCT04598594,"Active, not recruiting",No Results Available,Covid19|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,"Drug: Patch, Nicotine|Drug: Patch, Placebo",All,"Adult, Older Adult",Phase 3,220.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 6, 2020",November 2021
3260,NCT04453475,Recruiting,No Results Available,"Psychosomatic Disorder|Parkinson|Psychological Distress|Psychological Stress|Psychological Disease|Psychological Disorder|Psychological Impairment|Psychological Disability|Psychological Adjustment|Psychological Adaptation|Communication|Health Care Seeking Behavior|Anxiety|Behavior, Health|Health Risk Behaviors|Healthy Lifestyle",Behavioral: Training session adressing information and health literacy,All,"Adult, Older Adult",Not Applicable,1230.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"July 1, 2020","December 31, 2021"
3261,NCT04458298,"Active, not recruiting",No Results Available,COVID-19,Drug: OP-101|Drug: Placebo,All,"Adult, Older Adult",Phase 2,24.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 11, 2020","May 14, 2021"
3262,NCT04816786,Recruiting,No Results Available,Covid19,"Other: no intervention will be administered, this is a retrospective observational study.",All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2021","July 1, 2021"
3263,NCT04616846,Recruiting,No Results Available,Neoplasms Malignant|Covid19|Thromboembolism,Diagnostic Test: Peripheral venous ultrasound,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"August 4, 2020","September 15, 2021"
3264,NCT04410107,Recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,"Diagnostic Test: Lung Function tests|Diagnostic Test: Exercise capacity|Diagnostic Test: Exercise physiology|Diagnostic Test: Health-related quality of life|Diagnostic Test: Respiratory symptoms, symptoms of anxiety and depression, and post-traumatic stress screening",All,"Child, Adult, Older Adult",,134.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020","August 2, 2022"
3265,NCT04692129,Recruiting,No Results Available,"Covid19|ARDS, Human",,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 29, 2020","December 31, 2021"
3266,NCT04527497,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 1, 2020","August 31, 2021"
3267,NCT04498273,Recruiting,No Results Available,COVID-19,Drug: Apixaban 2.5 MG|Drug: Apixaban 5MG|Drug: Aspirin|Drug: Placebo,All,"Adult, Older Adult",Phase 3,7000.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 7, 2020",September 2021
3268,NCT04447781,Recruiting,No Results Available,Coronavirus Infection|SARS-CoV 2,Biological: INO-4800|Device: CELLECTRA® 2000|Other: Saline-sodium citrate (SSC) buffer,All,Adult,Phase 1|Phase 2,160.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 15, 2020","February 22, 2022"
3269,NCT04780061,Not yet recruiting,No Results Available,Covid19,"Drug: Vitamin D3 50,000 IU|Dietary Supplement: Vitamin C/Zinc|Dietary Supplement: Vitamin K2/D|Other: Microcrystalline Cellulose Capsule|Other: Medium Chain Triglyceride Oil",All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,December 2021
3270,NCT04504032,"Active, not recruiting",No Results Available,COVID-19,Drug: Rivaroxaban|Drug: Placebo,All,"Adult, Older Adult",Phase 2,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 2, 2020",April 2021
3271,NCT04432961,Not yet recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,July 2020,July 2021
3272,NCT04528771,Not yet recruiting,No Results Available,SARS-CoV2 Infection|Covid19,Drug: SNO|Drug: Nitrogen gas,All,"Adult, Older Adult",Phase 1,21.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 31, 2020","April 30, 2021"
3273,NCT04726150,Not yet recruiting,No Results Available,Covid19|Athletes Heart|Myocarditis Viral|Ventricular Arrythmia,Other: ILR implantation,All,"Adult, Older Adult",,250.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,April 2026
3274,NCT04494399,Recruiting,No Results Available,Covid19,Drug: Interferon beta-1b|Drug: Ribavirin,All,"Adult, Older Adult",Phase 2,96.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 29, 2020","August 1, 2022"
3275,NCT04424940,Not yet recruiting,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","September 1, 2021"
3276,NCT04794400,Recruiting,No Results Available,Covid19,Other: oxygen mask,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"February 4, 2021","December 31, 2021"
3277,NCT04425863,Completed,Has Results,Severe Acute Respiratory Syndrome|Ventilation Pneumonitis,"Drug: Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets|Other: Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tablets|Other: Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU.",All,"Child, Adult, Older Adult",,167.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","August 30, 2020"
3278,NCT04581096,Recruiting,No Results Available,Covid19|Spatial Visualization|Neural Network|Respiratory Disease|Pandemic|Disease Spread,Other: no intervention,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 2, 2020","June 15, 2021"
3279,NCT04344834,Recruiting,No Results Available,Mental Health Issue,Diagnostic Test: A questionnaire or scales,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"June 15, 2020","June 30, 2021"
3280,NCT04647669,Not yet recruiting,No Results Available,Covid19,Drug: Remdesivir|Drug: Acalabrutinib|Drug: Interferon beta-1a|Other: Standard of Care,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021","December 31, 2021"
3281,NCT04779346,Recruiting,No Results Available,Cancer|Covid19|Immunity,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 21, 2020","December 31, 2022"
3282,NCT04409873,Recruiting,No Results Available,COVID-19|SARS-CoV 2|Severe Acute Respiratory Syndrome Coronavirus 2|Virus Disease|Coronavirus Infections|Pharyngeal Diseases,Drug: Oral-B Mouth Sore mouthwash|Drug: Crest Pro-Health Multi-Protection mouthwash|Drug: CloSYS Ultra Sensitive Rinse mouthwash|Drug: Distilled water|Drug: Listerine Zero Mouthwash Product,All,"Adult, Older Adult",Phase 2,150.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","March 31, 2021","September 30, 2021"
3283,NCT04409821,Recruiting,No Results Available,Posttraumatic Stress Disorder|Prolonged Grief Disorder|COVID,Behavioral: Tele-delivered psychological intervention,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 29, 2020",February 2022
3284,NCT04560413,Completed,No Results Available,SARS-CoV-2|Post-stroke Depression|Anxiety and Fear,,All,"Adult, Older Adult",,77.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 1, 2020","August 10, 2020"
3285,NCT04694664,Completed,No Results Available,Pregnancy Related|Mothers,Other: This is an online survey with no intervention.,Female,"Adult, Older Adult",,18000.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"October 1, 2020","December 1, 2020"
3286,NCT04396197,Completed,No Results Available,COVID-19|Critical Illness|Ards|ICU Acquired Weakness,Other: Physiotherapy,All,"Adult, Older Adult",,92.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020","May 8, 2020"
3287,NCT04343898,"Active, not recruiting",No Results Available,Coronavirus Infection,Other: No intervention,All,"Adult, Older Adult",,5154.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 1, 2020","August 1, 2022"
3288,NCT04363268,Recruiting,No Results Available,Coronavirus|COVID|COVID-19|COVID19|Corona Virus Infection|Coronavirus Infection,,All,"Adult, Older Adult",,1000000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","October 1, 2031"
3289,NCT04435717,Recruiting,No Results Available,Covid19,Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]_#1|Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]_#1 (2 doses),All,"Adult, Older Adult",Phase 2,78.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 4, 2020","August 4, 2020"
3290,NCT04480424,Recruiting,No Results Available,COVID-19,Biological: GAMUNEX-C|Drug: Standard Medical Treatment,All,"Adult, Older Adult",Phase 2,100.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 17, 2020",May 2021
3291,NCT04748172,Recruiting,No Results Available,Fertility Issues|Vaccine Adverse Reaction,Biological: SARS-CoV-2 virus vaccines|Diagnostic Test: AMH sampling,Female,Adult,,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"February 1, 2021",February 2022
3292,NCT04412317,Recruiting,No Results Available,Covid-19,,All,Child,,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 3, 2020","May 31, 2021"
3293,NCT04761692,Not yet recruiting,No Results Available,Covid19|Influenza|Pneumonia|Vaccine Refusal,Behavioral: Full VEPMP Intervention|Behavioral: Partial VEPMP Intervention|Behavioral: Delayed VEPMP Intervention,All,Older Adult,Not Applicable,570.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"October 1, 2021","December 31, 2026"
3294,NCT04615728,Completed,No Results Available,Acute Appendicitis,Procedure: laparoscopic or open appendicectomy,All,"Child, Adult, Older Adult",,207.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 1, 2019","October 6, 2020"
3295,NCT04798066,No longer available,No Results Available,Post COVID-19 Syndrome,Biological: Autologous HB-adMSC's,All,"Adult, Older Adult",,,Other,Expanded Access:Intermediate-size Population,,,
3296,NCT04397575,"Active, not recruiting",No Results Available,Cancer|COVID|Solid Tumor|Social Inequality|French National Cohort|Chemotherapy|Immunotherapy|Surgery|Radiotherapy,,All,"Adult, Older Adult",,1509.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 3, 2020",December 2021
3297,NCT04358627,Not yet recruiting,No Results Available,"Acute Respiratory Distress Syndrome|Inflammation|Dexmedetomidine|Cytokine Storm|Delirium, Emergence",Drug: Dexmedetomidine Injectable Product,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 15, 2020","June 30, 2020"
3298,NCT04527471,"Active, not recruiting",No Results Available,Coronavirus Infection|Covid-19|SARS-CoV-2,Drug: Ensifentrine Dose 1|Drug: Placebo pMDI,All,"Adult, Older Adult",Phase 2,45.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 4, 2020",March 2021
3299,NCT04549922,"Active, not recruiting",No Results Available,Covid19,Drug: ISIS 721744|Drug: Normal Saline,All,"Adult, Older Adult",Phase 2,111.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 22, 2020",December 2021
3300,NCT04339790,"Active, not recruiting",No Results Available,Healthy Volunteer|Mood Disorder|Anxiety Disorder|Preexisting Medical Condition,,All,"Adult, Older Adult",,10000.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 7, 2020","April 1, 2022"
3301,NCT04459247,"Active, not recruiting",No Results Available,COVID,Drug: Vit D,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","June 15, 2020","September 10, 2021"
3302,NCT04346160,Not yet recruiting,No Results Available,COVID|Conjunctivitis,Diagnostic Test: Schirmer Test I,All,"Adult, Older Adult",,25.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 14, 2020","April 30, 2020"
3303,NCT03376854,Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult|Sars-CoV2",Device: Hypothermia|Drug: Neuromuscular Blocking Agents|Device: Standard of Care,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2018","December 31, 2020"
3304,NCT04592354,Recruiting,No Results Available,Treatment of Fatigue After Resolution of COVID-19 Infection,Dietary Supplement: Oxaloacetate Medical Food/Dietary Supplement,Female,"Adult, Older Adult",Not Applicable,40.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 15, 2020","June 15, 2021"
3305,NCT04355026,Recruiting,No Results Available,Covid-19,Drug: Bromhexine Oral Tablet and/or hydroxychloroquine tablet,All,"Adult, Older Adult",Phase 4,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 10, 2020","July 31, 2020"
3306,NCT04424797,Recruiting,No Results Available,COVID-19,Other: Prone Positioning|Other: Supine Positioning,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 13, 2020",December 2020
3307,NCT04662684,Recruiting,No Results Available,Covid19|Venous Thromboembolism,Drug: Rivaroxaban 10 MG,All,"Adult, Older Adult",Phase 3,320.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 16, 2020","June 30, 2021"
3308,NCT04359797,"Active, not recruiting",No Results Available,COVID-19,Other: Prone|Other: Usual Care,All,"Adult, Older Adult",Not Applicable,503.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"April 27, 2020",June 2021
3309,NCT04842292,Recruiting,No Results Available,Covid19,Drug: Heparin|Drug: Placebo,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 12, 2021","March 31, 2022"
3310,NCT04750317,Completed,No Results Available,COVID-19,Drug: Tofacitinib,All,"Adult, Older Adult",Phase 2,414.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 11, 2020","September 1, 2020"
3311,NCT04756856,Not yet recruiting,No Results Available,Sarcopenia,Other: Muscle-target oral nutritional supplementation,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 1, 2021","December 1, 2021"
3312,NCT04527224,Not yet recruiting,No Results Available,Covid19 Pneumonia,Drug: AstroStem-V,All,"Adult, Older Adult",Phase 1|Phase 2,10.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2021","April 1, 2023"
3313,NCT04520191,Not yet recruiting,No Results Available,COVID-19 Realted Disruption in Patient With Diabetes and CKD,,All,"Adult, Older Adult",,529.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","September 30, 2021"
3314,NCT04714138,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,190.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 5, 2021","March 15, 2021"
3315,NCT04757870,Not yet recruiting,No Results Available,COVID19,Other: frequency,All,"Child, Adult, Older Adult",,1790.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"March 1, 2021","December 31, 2021"
3316,NCT04591210,Recruiting,No Results Available,COVID-19|Cardiovascular Diseases,Drug: Angiotensin converting enzyme inhibitor|Drug: Angiotensin II Receptor Blockers,All,Older Adult,Phase 3,1155.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 27, 2021",August 2022
3317,NCT04495816,Recruiting,No Results Available,Anosmia|Covid19,Drug: Omega-3 Fatty Acid Supplement|Drug: Placebo/Control,All,"Adult, Older Adult",Phase 2,126.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 15, 2020",August 2021
3318,NCT04470531,Recruiting,No Results Available,Covid19|Severe COVID-19 Patients,Drug: oral co-trimoxazole,All,"Adult, Older Adult",Phase 2,94.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 12, 2020","January 30, 2021"
3319,NCT04356690,Recruiting,No Results Available,COVID-19,Drug: Etoposide,All,"Adult, Older Adult",Phase 2,64.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 8, 2020",June 2022
3320,NCT04838106,"Active, not recruiting",No Results Available,Covid19|Myocardial Infarction|Stroke|Critical Illness|Heart Failure|Deep Vein Thrombosis|Pulmonary Embolism|Renal Failure,Other: Not applicable as observational study,All,"Child, Adult, Older Adult",,319600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 1, 2020","November 1, 2021"
3321,NCT04746365,Completed,No Results Available,Covid19,Drug: ivermectin|Drug: hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 4,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","December 6, 2020","February 6, 2021"
3322,NCT04338958,Recruiting,No Results Available,Covid-19,Drug: Ruxolitinib,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 22, 2020","July 31, 2021"
3323,NCT04473105,Recruiting,No Results Available,COVID19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 1, 2020","January 31, 2021"
3324,NCT04643054,Not yet recruiting,No Results Available,Covid19,Dietary Supplement: Ovotransferrin,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","March 30, 2021"
3325,NCT04430374,Recruiting,No Results Available,Cardiovascular Diseases,Other: No interverntion,All,"Child, Adult, Older Adult",,100.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Other,"June 2, 2020","December 31, 2020"
3326,NCT04342897,Terminated,No Results Available,COVID-19|Pneumonia,Drug: LY3127804|Drug: Placebo,All,"Adult, Older Adult",Phase 2,95.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 20, 2020","October 12, 2020"
3327,NCT04352517,Completed,No Results Available,Sedentary Behavior|Mental Health Wellness 1,Other: Online Survey,All,"Adult, Older Adult",,3500.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"March 16, 2020","September 30, 2020"
3328,NCT04341792,Recruiting,No Results Available,Infection Viral|Coronavirus|COVID-19,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 11, 2020",April 2021
3329,NCT04666233,Completed,No Results Available,Neonates Needing Resuscitation at Birth,Procedure: Neonatal resuscitation with PPE for the prevention of SARS-Cov-2 infection|Procedure: Neonatal resuscitation without PPE for the prevention of SARS-Cov-2 infection,All,"Child, Adult, Older Adult",Not Applicable,48.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 16, 2021","March 23, 2021"
3330,NCT04756193,Recruiting,No Results Available,Covid19|Echocardiography|Ultrasound,"Diagnostic Test: Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2021","December 31, 2022"
3331,NCT04333628,Terminated,No Results Available,COVID-19,Drug: chloroquine|Other: standard care,All,"Adult, Older Adult",Phase 2|Phase 3,5.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","September 1, 2020"
3332,NCT04366921,Recruiting,No Results Available,"COVID|SARS-CoV-2|ARDS, Human|Refractory Hypoxemia|Cardiogenic Shock|Septic Shock|Extracorporeal Membrane Oxygenation",,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020",April 2021
3333,NCT04500132,Recruiting,No Results Available,COVID-19,Drug: EC-18|Drug: Placebo EC-18,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 28, 2020",May 2022
3334,NCT04536090,Not yet recruiting,No Results Available,COVID-19,Drug: Isoquercetin (IQC-950AN),All,"Adult, Older Adult",Phase 2,150.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,November 2020,May 2021
3335,NCT04476680,Recruiting,No Results Available,SARS-CoV Infection|Vitamin D Deficiency|Covid19|Acute Respiratory Tract Infection,Dietary Supplement: Vitamin D,All,Adult,Not Applicable,900.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 1, 2020","April 28, 2021"
3336,NCT04491227,Enrolling by invitation,No Results Available,"Covid19|AKI|CKD|ESRD|Transplant;Failure,Kidney",,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 5, 2020","March 31, 2023"
3337,NCT04593069,Recruiting,No Results Available,Covid19|Cognitive Impairment,Behavioral: Neurocognitive assessment,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"October 7, 2020","February 28, 2021"
3338,NCT04615052,Recruiting,No Results Available,Covid19|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV Infection,Other: Exercise training,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 26, 2020","December 21, 2021"
3339,NCT04800224,Recruiting,No Results Available,Covid19|Inflammation,Drug: Standardized Brazilian Green Propolis Extract|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 12, 2021","July 30, 2021"
3340,NCT04358406,"Active, not recruiting",No Results Available,Sars-CoV2,Drug: Recombinant human plasma gelsolin (Rhu-pGSN)|Other: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 30, 2020","June 1, 2021"
3341,NCT04537949,"Active, not recruiting",No Results Available,Covid-19|Protection Against COVID-19,Biological: BNT162b3,All,"Adult, Older Adult",Phase 1|Phase 2,96.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 9, 2020",February 2022
3342,NCT04602351,Enrolling by invitation,No Results Available,COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Severe Acute Respiratory Syndrome,Behavioral: Communication,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"March 22, 2021","April 15, 2021"
3343,NCT04365816,Completed,No Results Available,COVID-19,Other: Interview,All,"Adult, Older Adult",,403.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 30, 2020","July 10, 2020"
3344,NCT04537650,Enrolling by invitation,No Results Available,Covid19,Diagnostic Test: Videofluoroscopic Swallowing Study (VFSS),All,"Adult, Older Adult",,75.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2021","December 31, 2021"
3345,NCT04611841,Enrolling by invitation,No Results Available,Covid19,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"July 21, 2020",December 2022
3346,NCT04613271,Suspended,No Results Available,Infectious Disease|SARS-CoV Infection|Covid19,Drug: Favipiravir|Drug: Azithromycin,All,Adult,Phase 3,210.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 15, 2020","June 30, 2021"
3347,NCT04674189,Recruiting,No Results Available,Coronavirus|Covid19|SARS-CoV-2|Severe Acute Respiratory Syndrome,Biological: CVnCoV Vaccine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,2520.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","December 23, 2020","April 30, 2022"
3348,NCT04743947,Recruiting,No Results Available,Chronic Kidney Disease Stage 5 on Dialysis|Chronic Kidney Disease Stage 5 With Transplant|Vaccine Response Impaired,Other: No intervention; observational study,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 21, 2020","December 31, 2025"
3349,NCT04328480,Recruiting,No Results Available,COVID-19,Drug: Colchicine|Other: Local standard of care,All,"Adult, Older Adult",Phase 3,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 17, 2020","March 30, 2021"
3350,NCT04738331,Recruiting,No Results Available,Covid-19|SARS-CoV Infection,,All,"Child, Adult, Older Adult",,10000000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"February 1, 2021","June 30, 2022"
3351,NCT04498377,Recruiting,No Results Available,Covid19,Biological: F-652|Biological: Placebo,All,"Adult, Older Adult",Phase 2,38.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 26, 2021","December 31, 2021"
3352,NCT04573764,Recruiting,No Results Available,COVID-19,"Dietary Supplement: D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester|Dietary Supplement: Placebo",All,"Adult, Older Adult",Not Applicable,12.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","February 1, 2021","January 1, 2022"
3353,NCT04791423,"Active, not recruiting",No Results Available,Covid19,Biological: GRAd-COV2|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,10300.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 15, 2021","April 30, 2022"
3354,NCT04355728,Completed,No Results Available,"Corona Virus Infection|ARDS|ARDS, Human|Acute Respiratory Distress Syndrome|COVID-19",Biological: Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.|Other: Vehicle + Heparin along with best supportive care,All,"Adult, Older Adult",Phase 1|Phase 2,24.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 25, 2020","October 31, 2020"
3355,NCT04539795,Recruiting,No Results Available,Covid19,Drug: Alvelestat|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,15.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 1, 2020","September 30, 2021"
3356,NCT04404218,Recruiting,No Results Available,COVID,Dietary Supplement: Açaí palm berry extract - natural product|Other: Placebo,All,"Adult, Older Adult",Phase 2,480.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 4, 2020",May 2021
3357,NCT04360876,Withdrawn,No Results Available,COVID-19|ARDS,Drug: Dexamethasone injection|Drug: Placebos,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","September 1, 2020","January 30, 2021"
3358,NCT04631666,Recruiting,No Results Available,SARS-CoV-2 Infection,Biological: DZIF-10c|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,57.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","December 8, 2020","July 31, 2021"
3359,NCT04715997,Recruiting,No Results Available,SARS-CoV-2,Drug: GX-19N,All,Adult,Phase 1|Phase 2,170.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","December 30, 2020","March 30, 2022"
3360,NCT04594343,Recruiting,No Results Available,Covid19,Drug: Disulfiram|Drug: Placebo,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 20, 2020",September 2021
3361,NCT04444115,Not yet recruiting,No Results Available,Loneliness During COVID-19,,All,"Adult, Older Adult",,10084.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
3362,NCT04656444,Not yet recruiting,No Results Available,Covid19,,All,Child,,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,June 2021
3363,NCT04358952,Recruiting,No Results Available,Cardiomyopathies,Diagnostic Test: Global Longitudinal Strain,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 4, 2020","April 4, 2021"
3364,NCT04643561,"Active, not recruiting",No Results Available,Covid19,Other: Travelan OTC,Male,"Adult, Older Adult",Phase 1|Phase 2,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"November 1, 2020","December 31, 2020"
3365,NCT04336748,Not yet recruiting,No Results Available,Sars-CoV2|Infection Viral|Healthcare Worker|Prophylaxis,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,440.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention",April 2020,August 2020
3366,NCT04579562,Not yet recruiting,No Results Available,Acute Kidney Injury,Other: No intervention,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"November 1, 2020","October 31, 2021"
3367,NCT04343001,Withdrawn,No Results Available,Covid-19,Drug: Aspirin|Drug: Losartan|Drug: Simvastatin,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,October 2020,August 2021
3368,NCT04307693,Terminated,No Results Available,COVID-19,Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine sulfate,All,"Child, Adult, Older Adult",Phase 2,65.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 11, 2020","April 30, 2020"
3369,NCT04259892,Recruiting,No Results Available,Coronavirus,Biological: 2019-nCoV PCR,All,"Child, Adult, Older Adult",,345.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 4, 2020","February 4, 2021"
3370,NCT04382729,Recruiting,No Results Available,COVID-19 Pneumonia,Other: Neuromuscular Electrical Stimulation|Other: Physical Therapy Exercise,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"April 17, 2020",July 2020
3371,NCT04554251,Enrolling by invitation,No Results Available,Covid19|Global Impact|Pulmonology,Other: Survey,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","December 30, 2020"
3372,NCT04392245,Completed,No Results Available,Proctologic Practice During COVID-19,,All,"Child, Adult, Older Adult",,1050.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 15, 2020","April 26, 2020"
3373,NCT04400461,Completed,No Results Available,COVID-19,Other: Data collection and clinical testing of subjects,All,"Adult, Older Adult",,71.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 15, 2020","March 1, 2021"
3374,NCT04653727,Recruiting,No Results Available,Covid19|Influenza A|Respiratory Disease,Other: Cross-sectional survey,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"January 6, 2021",December 2021
3375,NCT04385264,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Mannitol,All,"Adult, Older Adult",Phase 2|Phase 3,800.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 12, 2020",October 2020
3376,NCT04675086,Withdrawn,No Results Available,"Covid19|Pneumonia, Viral",Drug: alpha1-proteinase inhibitor|Drug: Antiviral Agents,All,"Adult, Older Adult",Phase 3,0.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,December 2021
3377,NCT04481529,"Active, not recruiting",No Results Available,Infection Viral,Other: Health Questionnaire,All,"Adult, Older Adult",,1576.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 29, 2020","January 15, 2021"
3378,NCT04463602,"Active, not recruiting",No Results Available,COVID-19,Drug: Desidustat|Other: Standard of Care,All,"Adult, Older Adult",Phase 2,24.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 25, 2020","February 28, 2021"
3379,NCT04800770,Recruiting,No Results Available,Phosphate Deficiency|Covid19|Mortality,Diagnostic Test: 4C mortality score,All,"Child, Adult, Older Adult",,160.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 3, 2021","July 31, 2021"
3380,NCT04535674,Recruiting,No Results Available,COVID-19 Induced Pneumonia|Covid19,Biological: Asunercept,All,"Adult, Older Adult",Phase 2,400.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 9, 2020",May 2021
3381,NCT04496128,"Active, not recruiting",No Results Available,SARS-CoV 2|Neurologic Manifestations,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 13, 2020","April 30, 2021"
3382,NCT04519320,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: Pulmonary function testing,All,"Adult, Older Adult",Not Applicable,140.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 18, 2020","August 18, 2025"
3383,NCT04655586,Recruiting,No Results Available,Covid19,Drug: rNAPc2|Drug: Heparin,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","December 10, 2020","May 31, 2021"
3384,NCT04338906,Withdrawn,No Results Available,COVID,Drug: Camostat Mesilate|Drug: Placebo|Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 4,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",May 2020,December 2021
3385,NCT04522037,Recruiting,No Results Available,Patients Hospitalized in the Hospices Civils of Lyon|COVID-19 Disease|Moderate to Severe Dyspnea|Without Resuscitation Objective Management,Other: No intervention / Compare the difference in respiratory rate between H0 and H12 of the initiation of morphine between the control and interventional groups,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 1, 2020",February 2021
3386,NCT04445207,Available,No Results Available,COVID|Sars-CoV2|Corona Virus Infection,Biological: Convalescent Plasma,All,"Child, Adult, Older Adult",,,Other,Expanded Access:Treatment IND/Protocol,,,
3387,NCT04604327,Recruiting,No Results Available,COVID-19,Drug: Bemiparin sodium,All,"Adult, Older Adult",Phase 3,164.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 26, 2020","July 31, 2021"
3388,NCT04374149,Completed,No Results Available,Cytokine Release Syndrome|COVID19,Procedure: Therapeutic Plasma Exchange|Drug: Ruxolitinib,All,"Child, Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","December 1, 2020"
3389,NCT04492254,Not yet recruiting,No Results Available,COVID-19,Drug: Enoxaparin,All,"Adult, Older Adult",Phase 3,1370.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,July 2020,July 2021
3390,NCT04368221,Completed,No Results Available,Covid-19,,All,"Adult, Older Adult",,576.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"May 4, 2020","February 23, 2021"
3391,NCT04555213,Recruiting,No Results Available,Covid19,Drug: NOX66,All,"Adult, Older Adult",Phase 1,40.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 30, 2020",December 2021
3392,NCT04319315,Recruiting,No Results Available,COVID-19,Other: survey,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"March 11, 2020","April 16, 2020"
3393,NCT04363216,Not yet recruiting,No Results Available,COVID-19,Drug: Ascorbic Acid,All,"Adult, Older Adult",Phase 2,66.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,May 2020,May 2021
3394,NCT04406181,Recruiting,No Results Available,Anxiety and Fear|Anxiety Depression|Anxiety Postoperative|Psychological Stress,Behavioral: HADS|Behavioral: a survey,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 18, 2020","January 1, 2021"
3395,NCT04468893,Recruiting,No Results Available,Anxiety|Depression|Sleep Disturbance,Behavioral: Online Intervention Mental Health COVID-19,All,"Adult, Older Adult",Not Applicable,128.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"May 20, 2020","January 15, 2021"
3396,NCT04602481,Recruiting,No Results Available,Primary Ciliary Dyskinesia,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 31, 2020","May 31, 2025"
3397,NCT04296643,Recruiting,No Results Available,Coronavirus|N95|Medical Mask,Device: Medical Mask|Device: N95 respirator,All,"Adult, Older Adult",Not Applicable,576.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"April 1, 2020","April 1, 2021"
3398,NCT04568889,"Active, not recruiting",No Results Available,Covid19|Infectious Disease,Behavioral: A $10 Survey Incentive|Behavioral: A $20 Survey Incentive|Behavioral: Emphasis of Government Involvement|Behavioral: Emphasis of Academic Researchers Involvement|Behavioral: Cost-Benefit Frame|Behavioral: Duty Frame|Behavioral: Racial/Ethnic Frame|Behavioral: No Messaging,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research","September 28, 2020","June 30, 2021"
3399,NCT04386395,"Active, not recruiting",No Results Available,SARS-CoV-2|Immune System Disorder,,All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2020","May 30, 2020"
3400,NCT04374071,Completed,No Results Available,"COVID|Pneumonia, Viral",Drug: Methylprednisolone,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 12, 2020","April 30, 2020"
3401,NCT04806815,Enrolling by invitation,No Results Available,Menstrual Problem|Covid19|Fatigue,Other: A survey of 60 questions was created through the internet-based 'Google Forms surveys' site.,Female,Adult,,180.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 25, 2021","April 30, 2021"
3402,NCT04613739,Recruiting,No Results Available,Asthma,Behavioral: insurance navigation,All,"Child, Adult",Not Applicable,430.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"December 8, 2020","January 31, 2023"
3403,NCT04397900,Completed,No Results Available,Identify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection|Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA Types,,All,"Child, Adult, Older Adult",,80.0,Industry,Observational,Observational Model: Other|Time Perspective: Retrospective,"April 9, 2020","April 12, 2021"
3404,NCT04399967,Recruiting,No Results Available,Smoking Cessation,Behavioral: Chat-based support|Behavioral: AWARD plus COVID-specific advice|Behavioral: AWARD advice|Behavioral: COVID-19 related health warning leaflet|Behavioral: Health warning leaflet|Behavioral: SMS-based support|Behavioral: Referral card|Behavioral: COSH Self-help smoking cessation booklet,All,"Adult, Older Adult",Not Applicable,842.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"June 13, 2020","June 30, 2022"
3405,NCT04813731,Recruiting,No Results Available,Covid19|Symptoms and Signs,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 12, 2020","December 31, 2021"
3406,NCT04407533,"Active, not recruiting",No Results Available,COVID-19,Other: Diet tracking and survey,All,"Adult, Older Adult",,2020.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"May 25, 2020","August 31, 2022"
3407,NCT04425772,Not yet recruiting,No Results Available,COVID-19,Drug: FNC+Standard of Care|Drug: FNC dummy tablet+Standard of Care,All,"Adult, Older Adult",Not Applicable,342.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 12, 2020","August 12, 2020"
3408,NCT04583592,Completed,No Results Available,COVID-19,Drug: Camostat Mesilate|Drug: Placebo,All,"Adult, Older Adult",Phase 2,295.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 9, 2020","March 31, 2021"
3409,NCT04350580,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Drug: Human immunoglobulin|Drug: Placebo,All,"Adult, Older Adult",Phase 3,138.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","April 11, 2020",June 2021
3410,NCT04385069,Recruiting,No Results Available,COV-HI|COVID-19|COVID-19 (COV) Hyperinflammatory (HI) Syndrome,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 16, 2020","July 5, 2020"
3411,NCT04391686,Recruiting,No Results Available,COVID-19|Obesity,Diagnostic Test: indirect calorimetry,All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 3, 2020","November 2, 2021"
3412,NCT04319731,Recruiting,No Results Available,SARS CoV-2 Infection,Biological: Human Amniotic Fluid,All,"Adult, Older Adult",Early Phase 1,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 20, 2020","March 20, 2021"
3413,NCT04425460,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Other: Placebo,All,"Adult, Older Adult",Phase 3,256.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",June 2020,September 2020
3414,NCT04498299,Recruiting,No Results Available,"Echocardiography, Stress|COVID-19|Hypertension, Pulmonary",Diagnostic Test: echocardiogram 2D,All,Adult,,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","November 30, 2020"
3415,NCT04447495,Not yet recruiting,No Results Available,Coronavirus,Diagnostic Test: iAMP test,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 1, 2020","December 31, 2020"
3416,NCT04505774,Recruiting,No Results Available,Covid19,Drug: theraputic heparin|Drug: prophylactic heparin|Drug: P2Y12,All,"Adult, Older Adult",Phase 4,2000.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 4, 2020",December 2021
3417,NCT04407221,Enrolling by invitation,No Results Available,Transplant Recipients,,All,"Adult, Older Adult",,1100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 16, 2020","May 1, 2024"
3418,NCT04453891,Not yet recruiting,No Results Available,COVID-19,Device: Monitoring physiological data with the Hexoskin smart shirt,All,"Adult, Older Adult",,16.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 15, 2021","December 15, 2021"
3419,NCT04320615,Completed,No Results Available,COVID-19 Pneumonia,Drug: Tocilizumab (TCZ)|Drug: Placebo,All,"Adult, Older Adult",Phase 3,450.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 3, 2020","July 28, 2020"
3420,NCT04716998,Recruiting,No Results Available,Covid19,Biological: MesenCure,All,"Adult, Older Adult",Phase 1|Phase 2,35.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,January 2022
3421,NCT04452604,Not yet recruiting,No Results Available,Acute Myeloblastic Leukemia|Acute Lymphoblastic Leukemia|SARS-CoV-2,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 1, 2020","December 1, 2023"
3422,NCT04344236,Recruiting,No Results Available,COVID-19,Drug: Saline oral/nasal rinse|Drug: 0.5% Povidone/Iodine oral/nasal rinse|Drug: 0.12% Chlorhexidine oral/nasal rinse,All,"Adult, Older Adult",Phase 2,48.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 9, 2020","May 9, 2020"
3423,NCT04647734,Not yet recruiting,No Results Available,"COVID-19, SARS-CoV2",Behavioral: High intensity interval training|Behavioral: Standard care,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research,"January 1, 2021","December 31, 2021"
3424,NCT04563702,"Active, not recruiting",No Results Available,Covid19,Biological: VXA-CoV2-1,All,Adult,Phase 1,35.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 21, 2020",October 2021
3425,NCT04341389,"Active, not recruiting",No Results Available,COVID-19,Biological: Recombinant novel coronavirus vaccine (Adenovirus type 5 vector)|Other: Placebo,All,"Adult, Older Adult",Phase 2,508.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","April 12, 2020","January 31, 2021"
3426,NCT04480138,Recruiting,No Results Available,Covid19,Drug: Pegylated Interferon-α2b|Other: Standard of Care,All,"Adult, Older Adult",Phase 2,40.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 11, 2020","May 30, 2021"
3427,NCT04344431,Recruiting,No Results Available,Covid-19,Combination Product: Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device),All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 14, 2020",April 2022
3428,NCT04676971,Recruiting,No Results Available,COVID-19,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),All,"Adult, Older Adult",Phase 2,105.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 11, 2020","October 18, 2021"
3429,NCT04371978,Recruiting,No Results Available,"COVID 19|Coronavirus|Diabetes Mellitus, Type 2|Diabetes Mellitus|Glucose Metabolism Disorders|Metabolic Disease|Endocrine System Diseases|Dipeptidyl-Peptidase IV Inhibitors|Linagliptin|Severe Acute Respiratory Syndrome Coronavirus 2|Sars-CoV2|Hypoglycemic Agents|Respiratory Tract Diseases|Incretins|Hormones",Drug: Linagliptin 5 MG,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2020","September 30, 2021"
3430,NCT04647656,Not yet recruiting,No Results Available,Covid19|Neurocognitive Dysfunction,Device: Hyperbaric oxygen|Device: Sham,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 1, 2021","January 1, 2023"
3431,NCT04429711,Recruiting,No Results Available,COVID-19,Drug: Ivermectin Oral Product,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 12, 2020","October 31, 2020"
3432,NCT04471701,Recruiting,No Results Available,"Covid19|SARS-CoV Infection|Survey, Family Life|Epidemic Disease|Self-Assessment",Behavioral: Environmental exposure and clinical features,All,"Adult, Older Adult",,200000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 13, 2020","August 31, 2020"
3433,NCT04783311,Recruiting,No Results Available,Covid19,Biological: EuCorVac-19|Other: Normal Saline,All,"Adult, Older Adult",Phase 1|Phase 2,280.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 23, 2021",January 2023
3434,NCT04332081,Terminated,No Results Available,COVID-19,Device: hyperbaric oxygen therapy (HBOT),All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 6, 2020","May 29, 2020"
3435,NCT04338126,Not yet recruiting,No Results Available,COVID19,Drug: Tranexamic acid|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 30, 2021","December 31, 2021"
3436,NCT04468646,Recruiting,No Results Available,"Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus",Drug: NK-1R antagonist,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 15, 2020","August 30, 2020"
3437,NCT04776005,Not yet recruiting,No Results Available,"Solid Tumor|Hematologic Malignancy|Thoracic Cancer|Cancer, Treatment-Related|Vaccine Response Impaired",Other: Data collection,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,March 2021,December 2022
3438,NCT04377659,"Active, not recruiting",No Results Available,COVID-19,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 2,9.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","May 1, 2022"
3439,NCT04839965,Recruiting,No Results Available,COVID-19,Biological: Ampion|Other: Saline,All,"Adult, Older Adult",Phase 2,200.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,November 2021
3440,NCT04452617,Completed,No Results Available,COVID-19,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 19, 2020","July 1, 2020"
3441,NCT04738045,Recruiting,No Results Available,Covid19,Drug: Remdesivir|Drug: Lopinavir/ Ritonavir and Remdesivir combination,All,"Adult, Older Adult",Phase 4,90.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 1, 2020","April 1, 2021"
3442,NCT04816071,Not yet recruiting,No Results Available,Covid19,Drug: Essential amino acids|Dietary Supplement: Maltodextrin,All,"Adult, Older Adult",Phase 2|Phase 3,104.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",May 2021,March 2022
3443,NCT04334005,Not yet recruiting,No Results Available,Patients Infected With COVID-19,Dietary Supplement: Vitamin D,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 10, 2020","June 30, 2020"
3444,NCT04362332,Terminated,No Results Available,COVID-19,Drug: Chloroquine Sulfate|Drug: Hydroxychloroquine|Other: Standard supportive care,All,"Adult, Older Adult",Phase 4,25.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 14, 2020","June 8, 2020"
3445,NCT04391101,Not yet recruiting,No Results Available,SARS-Cov-2,Drug: Convalescent plasma,All,"Adult, Older Adult",Phase 3,231.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2020,December 2021
3446,NCT04699058,"Active, not recruiting",No Results Available,SARS-CoV Infection|Seroprevalence,Diagnostic Test: COVID-antibody test,All,"Child, Adult, Older Adult",,1650.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"July 17, 2020","April 30, 2021"
3447,NCT04713852,Completed,No Results Available,Covid19,,All,"Adult, Older Adult",,116.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 13, 2020","December 31, 2020"
3448,NCT04729595,Not yet recruiting,No Results Available,Covid19,Drug: Tempol|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,310.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 1, 2021","January 30, 2022"
3449,NCT04522310,Recruiting,No Results Available,Covid19,Other: MR-Pro-ADM,All,"Adult, Older Adult",,183.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 20, 2020","June 28, 2021"
3450,NCT04776044,Recruiting,No Results Available,COVID-19,Drug: ATR-002|Drug: Placebo,All,"Adult, Older Adult",Phase 2,220.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",March 2021,March 2022
3451,NCT04380935,Recruiting,No Results Available,COVID|Acute Respiratory Distress Syndrome,Biological: Convalescent plasma|Drug: Standard of care,All,"Adult, Older Adult",Phase 2|Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 18, 2020","October 31, 2020"
3452,NCT04573348,Recruiting,No Results Available,Covid19|Corona Virus Infection,Diagnostic Test: Savicell's ImmunoBiopsy™,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"October 14, 2020","October 10, 2021"
3453,NCT04662671,Completed,No Results Available,COVID19,Device: RD-X19,All,"Adult, Older Adult",Phase 1|Phase 2,31.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 18, 2020","January 30, 2021"
3454,NCT04569227,Not yet recruiting,No Results Available,Covid19 Pneumonia,Drug: EC-18|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 16, 2020",November 2021
3455,NCT04451174,Recruiting,No Results Available,COVID-19,Drug: Prednisone,All,"Adult, Older Adult",Phase 3,184.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 23, 2020","December 30, 2020"
3456,NCT04679350,Not yet recruiting,No Results Available,COVID-19,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),All,"Adult, Older Adult",Phase 2,48.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",March 2021,July 2021
3457,NCT04406246,Completed,No Results Available,Coronavirus Infection,Drug: Nitazoxanide 500Mg Oral Tablet,All,"Adult, Older Adult",Phase 4,150.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 21, 2020","December 31, 2020"
3458,NCT04337359,No longer available,No Results Available,Severe/Very Severe COVID-19 Illness,Drug: Ruxolitinib,All,"Child, Adult, Older Adult",,,Industry|Other,Expanded Access:Intermediate-size Population,,,
3459,NCT04372186,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Placebo|Drug: Tocilizumab,All,"Adult, Older Adult",Phase 3,379.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 14, 2020","December 1, 2021"
3460,NCT04344951,Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,All,"Adult, Older Adult",Phase 2,60.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 6, 2020","April 30, 2021"
3461,NCT04322565,Recruiting,No Results Available,"Coronavirus Infections|Pneumonia, Viral",Drug: Colchicine,All,"Adult, Older Adult",Phase 2,310.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","December 21, 2020"
3462,NCT04405544,Completed,No Results Available,Encephalopathy|COVID,Diagnostic Test: CT-scan|Diagnostic Test: EEG|Diagnostic Test: EP|Diagnostic Test: Pulse oximetry|Diagnostic Test: Blood tests,All,Adult,Not Applicable,51.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 22, 2020","October 29, 2020"
3463,NCT04659304,Not yet recruiting,No Results Available,Covid19,Drug: Allocetra-OTS|Other: Ringer's lactate,All,"Adult, Older Adult",Phase 1,50.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,March 2021,March 2022
3464,NCT04384458,Recruiting,No Results Available,Coronavirus Infections,Drug: Hydroxychloroquine|Drug: Ivermectin,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 20, 2020",April 2021
3465,NCT04379375,Terminated,No Results Available,Health Behavior|COVID-19,Behavioral: Nudge,All,"Adult, Older Adult",Not Applicable,45.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 27, 2020","September 30, 2020"
3466,NCT04637828,Recruiting,No Results Available,COVID-19,Drug: GNS561,All,"Adult, Older Adult",Phase 2,178.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 18, 2020","October 30, 2021"
3467,NCT04606784,"Active, not recruiting",No Results Available,Covid19,Biological: Ampion|Other: Standard of Care,All,"Adult, Older Adult",Phase 1,40.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"October 28, 2020","June 18, 2021"
3468,NCT04716556,"Active, not recruiting",No Results Available,"Covid19|Coronavirus Infection|Pneumonia, Viral",Biological: Convalescent plasma,All,"Adult, Older Adult",Not Applicable,474.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 16, 2020",May 2021
3469,NCT04615975,Recruiting,No Results Available,Covid19,Dietary Supplement: Ketogenic diet with phytoextracts,All,"Adult, Older Adult",Not Applicable,28.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 1, 2020","August 30, 2021"
3470,NCT04359875,Completed,No Results Available,Cardiovascular Diseases|Mental Disorder,Behavioral: Phone-call screening and management by a medical student/general practitioner tandem,All,"Adult, Older Adult",Not Applicable,22000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"April 30, 2020","December 31, 2020"
3471,NCT04601077,Recruiting,No Results Available,COVID-19,"Drug: Nitric Oxide lozenges, 30 mg|Drug: Placebo",All,"Adult, Older Adult",Phase 1|Phase 2,100.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 1, 2020","July 31, 2021"
3472,NCT04807075,Not yet recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 1, 2021","June 30, 2021"
3473,NCT04741282,Not yet recruiting,No Results Available,Covid19,Other: Pulmonary telerehabilitation|Other: progressive muscle relaxation training,All,"Adult, Older Adult",Not Applicable,52.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","September 15, 2021","August 15, 2022"
3474,NCT04455815,Recruiting,No Results Available,COVID-19 Infection,Drug: Camostat,All,"Adult, Older Adult",Phase 2|Phase 3,389.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 25, 2020","August 31, 2021"
3475,NCT04659486,Enrolling by invitation,No Results Available,Covid19|Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV Infection,Behavioral: Home-based exercise training,All,"Child, Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 24, 2020","April 30, 2021"
3476,NCT04456452,Completed,No Results Available,COVID-19,Biological: Ampion|Other: Standard of Care,All,"Adult, Older Adult",Phase 1,10.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 27, 2020","November 30, 2020"
3477,NCT04331366,Completed,Has Results,COVID-19,Device: GO2 PEEP MOUTHPIECE,All,"Adult, Older Adult",Not Applicable,2.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 8, 2020","August 31, 2020"
3478,NCT04372693,Enrolling by invitation,No Results Available,Distance Learning-Online Learning|Traditional Classroom-Based Learning|Coronavirus Disease Social Distancing Measures|Nursing Students' Perception and Achievement,Other: impliminting Online Distance Learning,All,"Adult, Older Adult",Not Applicable,180.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 1, 2020","February 28, 2021"
3479,NCT04354155,Recruiting,No Results Available,"Infection Viral|Thromboses, Venous|COVID-19",Drug: Enoxaparin Prefilled Syringe [Lovenox],All,"Child, Adult",Phase 2,38.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 2, 2020","October 15, 2022"
3480,NCT04366752,Recruiting,No Results Available,COVID-19|Pneumonia|ARDS|Hemostasis|Coagulation,Other: venous ultrasound|Other: blood sample,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 22, 2020","September 22, 2020"
3481,NCT04629157,Recruiting,No Results Available,This is a Pilot Study Which Aims to Assess the Validity and Applicability of Lateral Flow Assays (LFAs) Which Can be Used as a Point of Care Test for COVID-19|Covid19,Device: Innova Lateral Flow Device,All,Child,Not Applicable,400.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"November 5, 2020","November 19, 2020"
3482,NCT04589104,Completed,No Results Available,Distress Due to COVID-19,Behavioral: Expressive writing,All,"Adult, Older Adult",Not Applicable,63.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 26, 2020","August 17, 2020"
3483,NCT04634422,Recruiting,No Results Available,"Respiratory Failure|Renal Failure, Acute",Procedure: Plasma exchange and convalescent plasma,All,"Adult, Older Adult",Not Applicable,220.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 16, 2020","June 30, 2022"
3484,NCT04679415,Recruiting,No Results Available,COVID-19,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),All,"Adult, Older Adult",Phase 2,63.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 17, 2020",May 2021
3485,NCT04275245,Completed,No Results Available,Coronavirus Disease 2019 (COVID-19),Drug: Meplazumab for Injection,All,"Adult, Older Adult",Phase 1|Phase 2,17.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 3, 2020","March 9, 2020"
3486,NCT04570462,Recruiting,No Results Available,COVID19 ARDS,Other: Hypothermia Via Cooling Machine- Arctic Sun 5000,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 18, 2020","December 31, 2020"
3487,NCT04558424,Not yet recruiting,No Results Available,Covid19,Dietary Supplement: zinc gluconate and ascorbic acid,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","October 1, 2020","September 1, 2021"
3488,NCT04738435,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 5, 2021","March 1, 2021"
3489,NCT04344756,Not yet recruiting,No Results Available,COVID19 Pneumonia,Drug: Tinzaparin or unfractionated heparin,All,"Adult, Older Adult",Phase 2,808.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","September 30, 2020"
3490,NCT04394169,Recruiting,No Results Available,Post ICU Syndrome|Chronic Pain|Covid-19,Behavioral: Intervention program,All,"Adult, Older Adult",Not Applicable,102.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention,"May 25, 2020","March 25, 2021"
3491,NCT04583293,Recruiting,No Results Available,Acute Kidney Injury,Other: No intervention,All,"Adult, Older Adult",,220.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 8, 2020",October 2022
3492,NCT04667286,Not yet recruiting,No Results Available,Covid-19 Infection,Procedure: Prone Position (PP),All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 30, 2020","July 1, 2021"
3493,NCT04405843,Completed,No Results Available,COVID-19,Drug: Ivermectin Oral Product|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,476.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 14, 2020","December 21, 2020"
3494,NCT04355143,Recruiting,No Results Available,COVID-19,Drug: Colchicine Tablets|Other: Current care per UCLA treating physicians,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","April 25, 2021"
3495,NCT04280588,Withdrawn,No Results Available,Coronavirus Disease (COVID-19),Drug: Fingolimod 0.5 mg,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 22, 2020","July 1, 2020"
3496,NCT04394195,Completed,No Results Available,CORONAVIRUS INFECTIONS,Other: measurement of circulating sFlt1 concentration,All,"Adult, Older Adult",,72.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 3, 2020","September 1, 2020"
3497,NCT04482634,Recruiting,No Results Available,Pulmonary Rehabilitation|COVID-19,Other: Remote controlled exercise|Other: Home exercise,All,"Adult, Older Adult",Not Applicable,122.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 1, 2020",August 2022
3498,NCT04283461,"Active, not recruiting",No Results Available,COVID-19|COVID-19 Immunisation,Biological: mRNA-1273,All,"Adult, Older Adult",Phase 1,120.0,NIH|Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 16, 2020","November 22, 2022"
3499,NCT04473183,Recruiting,No Results Available,Covid19|SARS-CoV Infection|SARS-CoV-2|Corona Virus Infection,Diagnostic Test: Specimen Collection|Diagnostic Test: Surveys,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 21, 2020",January 2022
3500,NCT04632381,Not yet recruiting,No Results Available,Corona Virus Infection,Drug: Zotatifin|Drug: Placebo,All,Adult,Phase 1,36.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 16, 2021","December 31, 2021"
3501,NCT04468035,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 1, 2020","December 31, 2021"
3502,NCT04252664,Suspended,No Results Available,COVID-19|SARS-CoV-2,Drug: Remdesivir|Drug: Remdesivir placebo,All,"Adult, Older Adult",Phase 3,308.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 12, 2020","April 27, 2020"
3503,NCT04483752,Recruiting,No Results Available,CoV2 SARS Pneumonia,Other: CHEST CT SCAN,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 8, 2020","November 8, 2021"
3504,NCT04407546,Recruiting,No Results Available,Immunosuppression,,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 27, 2020","May 28, 2023"
3505,NCT04784767,Recruiting,No Results Available,SARS-CoV-2 Infection,"Biological: 25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)|Drug: Sodium chloride, USP, for injection (0.9% NaCl)|Biological: 50 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)",All,Adult,Phase 1,72.0,U.S. Fed|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 5, 2021","October 30, 2023"
3506,NCT04649424,Recruiting,No Results Available,Covid19,Device: CanSwab,All,"Adult, Older Adult",Not Applicable,72.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,"December 22, 2020","May 30, 2021"
3507,NCT04483375,Completed,No Results Available,Coronavirus Disease 2019(COVID-19),Biological: SCTA01|Other: Placebo,All,"Adult, Older Adult",Phase 1,33.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 24, 2020","November 17, 2020"
3508,NCT04320472,"Active, not recruiting",No Results Available,COVID-19|Encephalopathy|Critically Ill,Other: Follow up,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2020","December 31, 2020"
3509,NCT04780581,Recruiting,No Results Available,Corona Virus Infection,Drug: Dexamethasone|Drug: Methylprednisolone,All,"Adult, Older Adult",Phase 4,290.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021","December 31, 2021"
3510,NCT04368845,Recruiting,No Results Available,COVID-19|Comorbidities and Coexisting Conditions,Device: Telerehabilitation,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 11, 2020","March 31, 2021"
3511,NCT04640181,Recruiting,No Results Available,Covid19,Drug: Enoxaparin|Drug: Rivaroxaban,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020","July 31, 2021"
3512,NCT04305106,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Bevacizumab,All,"Adult, Older Adult",Not Applicable,140.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","March 17, 2020","July 31, 2020"
3513,NCT04424056,Not yet recruiting,No Results Available,Covid19,Drug: Anakinra +/- Ruxolitinib (stages 2b/3)|Drug: Anakinra and Ruxolitinib (Advanced stage 3)|Drug: Tocilizumab +/- ruxolitinib (stages 2b/3)|Drug: Tocilizumab and Ruxolitinib (Advanced stage 3)|Other: Standard of care,All,"Adult, Older Adult",Phase 3,216.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","November 1, 2022"
3514,NCT04584684,Recruiting,No Results Available,Covid19|Coronavirus Infection|SARS-CoV-2 Infection,Drug: 1.5-2% w/v Hydrogen Peroxide|Drug: 0.12% Chlorhexidine Gluconate|Drug: 21% Ethanol plus essential oils|Drug: 1% w/v Povidone-iodide|Drug: 0.075% Cetylpyridinium Chloride|Other: Saline,All,"Adult, Older Adult",Phase 2,480.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","December 18, 2020",September 2023
3515,NCT04402866,Recruiting,No Results Available,Acute Lung Injury (ALI) Associated With COVID-19|Lung Inflammation Associated With COVID-19,Drug: TD-0903|Drug: Placebo,All,"Adult, Older Adult",Phase 2,222.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 24, 2020",April 2021
3516,NCT04375501,Completed,No Results Available,Femoral Neck Fractures|SARS-CoV 2,"Other: Surgery: Dynamic Hip Screw, hemiarthroplasty, hip replacement, intramedullary nail",All,"Adult, Older Adult",,442.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2020","April 15, 2020"
3517,NCT04351568,Recruiting,No Results Available,Evaluating the Effect of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics,Other: quesionnair,All,Adult,,874.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"April 1, 2020",August 2020
3518,NCT04389320,Completed,No Results Available,Rheumatoid Arthritis,Drug: Hydroxychloroquine,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 15, 2020","May 1, 2020"
3519,NCT04337424,Completed,No Results Available,SARS-CoV-2,Diagnostic Test: Sampling salivary,All,"Adult, Older Adult",,627.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 13, 2020","October 7, 2020"
3520,NCT04695821,Not yet recruiting,No Results Available,Covid19,Device: Senti V1.0 Device,All,"Adult, Older Adult",Not Applicable,10.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,January 2021,March 2021
3521,NCT04348409,Recruiting,No Results Available,COVID-19,Drug: Nitazoxanide Tablets|Drug: Placebo,All,"Adult, Older Adult",Not Applicable,50.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 25, 2020","July 31, 2020"
3522,NCT04577378,Not yet recruiting,No Results Available,Covid19,Drug: Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) plus Aerosolized Itraconazole|Drug: Drug: Isotretinoin(Aerosolized 13 cis retinoic acid),All,"Child, Adult, Older Adult",Phase 2,45.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"October 20, 2020","November 20, 2020"
3523,NCT04798053,Recruiting,No Results Available,Covid19|Rheumatic Fever|Mental Disorder,Behavioral: Questionnaire|Biological: blood sample and salivary sample,All,"Adult, Older Adult",Not Applicable,318.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 8, 2021",October 2022
3524,NCT04706325,Recruiting,No Results Available,Acute Kidney Injury,Other: ACUTE KIDNEY INJURY,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 1, 2021","May 15, 2021"
3525,NCT04401163,Not yet recruiting,No Results Available,Sars-CoV2|Covid19,Diagnostic Test: Imaging of the lungs,All,"Adult, Older Adult",,180.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,May 2020,December 2022
3526,NCT04713176,Recruiting,No Results Available,Severe COVID-19,Drug: DWJ1248 with Remdesivir|Drug: Placebo with Remdesivir,All,"Adult, Older Adult",Phase 3,1022.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","February 2, 2021","June 30, 2021"
3527,NCT04815850,Recruiting,No Results Available,End Stage Kidney Disease,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","December 31, 2021"
3528,NCT04551768,Recruiting,No Results Available,COVID19,Drug: 50 mg/mL Virazole|Drug: 100 mg/mL Virazole,All,"Adult, Older Adult",Phase 1,50.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 10, 2021",July 2021
3529,NCT04334044,Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2,Drug: Ruxolitinib Oral Tablet,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","May 1, 2021"
3530,NCT04423861,Not yet recruiting,No Results Available,covid19,Drug: Nitazoxanide|Drug: Placebo,All,"Adult, Older Adult",Phase 3,380.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",December 2020,May 2021
3531,NCT04751695,Not yet recruiting,No Results Available,Covid-19 Vaccine,Biological: CoronoVac Vaccine,Male,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,February 2021,April 2021
3532,NCT04441489,Completed,No Results Available,COVID-19|FDG PET/CT|Inflammation,,All,"Adult, Older Adult",,13.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 27, 2020","May 27, 2020"
3533,NCT04700254,Completed,No Results Available,Diabetes Mellitus|SARS-CoV-2,Other: DASS questionnaire|Other: EAT-26 questionnaire,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"December 28, 2020","January 11, 2021"
3534,NCT04589117,Completed,No Results Available,Parents During COVID-19,Behavioral: Expressive writing,All,"Adult, Older Adult",Not Applicable,11.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 27, 2020","August 2, 2020"
3535,NCT04435041,"Active, not recruiting",No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,1.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"June 1, 2020","November 30, 2021"
3536,NCT04408222,"Active, not recruiting",No Results Available,Oxygen Deficiency|Coronavirus Infection,Other: Awake proning,All,"Adult, Older Adult",,29.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 16, 2020",May 2021
3537,NCT04468971,Recruiting,No Results Available,COVID19|ARDS,Biological: CK0802|Drug: Placebo,All,"Adult, Older Adult",Phase 1,45.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 29, 2020","September 30, 2021"
3538,NCT04579627,Completed,No Results Available,COVID|Safety Issues,Behavioral: Questionnaire,All,"Child, Adult, Older Adult",,358.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 14, 2020","June 8, 2020"
3539,NCT04686721,Recruiting,No Results Available,Tracheal Stenosis,Diagnostic Test: Chest CT scan + baseline spirometry,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"December 20, 2020",October 2021
3540,NCT04334148,Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 3,1363.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","April 22, 2020","January 9, 2021"
3541,NCT04350450,Withdrawn,No Results Available,COVID|Coronavirus|COVID-19,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2020,August 2020
3542,NCT04499378,Not yet recruiting,No Results Available,"Covid19|Influenza A H1N1|Intubation Complication|Morality|Lung Injury, Acute",Diagnostic Test: Lung CT,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 15, 2020","April 30, 2022"
3543,NCT04441398,Not yet recruiting,No Results Available,covid19,Drug: Nitazoxanide|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,300.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",July 2020,September 2020
3544,NCT04822025,Not yet recruiting,No Results Available,Covid19 Vaccine,Biological: MVC-COV1901 (High-Dose)|Biological: MVC-COV1901(Mid-Dose),All,Older Adult,Phase 2,400.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",May 2021,January 2022
3545,NCT04380792,Completed,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,2497.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"April 13, 2020","October 13, 2020"
3546,NCT04356677,Not yet recruiting,No Results Available,COVID19,Drug: 50 mg/mL Virazole|Drug: 100 mg/mL Virazole,All,"Adult, Older Adult",Phase 1,50.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,August 2021
3547,NCT04576312,"Active, not recruiting",No Results Available,COVID-19,Drug: UNI911 INHALATION,All,"Adult, Older Adult",Phase 1,64.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","June 29, 2020","April 30, 2021"
3548,NCT04476706,No longer available,No Results Available,Cytokine Release Syndrome in COVID-19-induced Pneumonia,Drug: canakinumab,All,"Adult, Older Adult",,,Industry,Expanded Access,,,
3549,NCT04526717,Not yet recruiting,No Results Available,Covid19,Drug: MPT0B640,All,"Adult, Older Adult",Phase 1,15.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,December 2021,December 2022
3550,NCT04347980,Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult|COVID-19",Drug: Dexamethasone and Hydroxychloroquine|Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,122.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,April 2020,August 2020
3551,NCT04368143,Recruiting,No Results Available,COVID|SARS-CoV 2|Corona Virus Infection|RDT|B Cell,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","December 31, 2021"
3552,NCT04545008,Recruiting,No Results Available,Covid19,Drug: Famotidine|Drug: N-Acetyl cysteine,All,"Adult, Older Adult",Phase 1,42.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 20, 2020","October 31, 2021"
3553,NCT04568863,Completed,No Results Available,COVID-19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin intravenous|Drug: Placebo intravenous,All,"Adult, Older Adult",Phase 2,18.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 20, 2020","November 30, 2020"
3554,NCT04348474,Suspended,No Results Available,Covid-19,Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin Tablets,All,"Adult, Older Adult",Early Phase 1,200.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","July 31, 2020"
3555,NCT04383899,Withdrawn,No Results Available,Coronavirus Infection,Other: Questionnaire,All,"Child, Adult, Older Adult",,0.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"September 30, 2020","November 30, 2020"
3556,NCT04504734,Enrolling by invitation,No Results Available,Covid19,Drug: Bucillamine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1000.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 27, 2020","June 1, 2021"
3557,NCT04365517,Not yet recruiting,No Results Available,"Covid19|Diabetes Mellitus, Type 2|CKD",Drug: Sitagliptin,All,"Adult, Older Adult",Phase 3,170.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 29, 2020","December 30, 2021"
3558,NCT04360837,Recruiting,No Results Available,COVID-19|Virus; Pneumonia|Atelectasis,Procedure: alveolar recruitment,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 6, 2020","June 1, 2021"
3559,NCT04552379,Recruiting,No Results Available,SARS-CoV Infection|Interferon|Covid19,Biological: Peginterferon beta-1a,All,"Adult, Older Adult",Phase 3,1240.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020",December 2021
3560,NCT04505631,Recruiting,No Results Available,Covid19|Dyspnea,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 10, 2020",June 2021
3561,NCT04661930,Recruiting,No Results Available,Corona Virus Disease (COVID-19)|Respiratory Distress Syndrome|SARS-CoV-2 Infection,Drug: TriCor® 145mg tablets|Other: Usual Care|Other: Placebo,All,"Adult, Older Adult",Phase 3,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 13, 2020","December 1, 2021"
3562,NCT04528927,Withdrawn,No Results Available,COVID 19|Patients Hospitalized,Drug: HCQ|Drug: Azithromycin|Drug: Doxycycline|Dietary Supplement: Zinc,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 15, 2020","July 15, 2020"
3563,NCT04374552,Withdrawn,No Results Available,SARS-CoV-2 Infection,Drug: Hydroxychloroquine sulfate &Azithromycin|Drug: Placebo,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 5, 2020",April 2021
3564,NCT04412668,Completed,No Results Available,SARS-CoV-2 (COVID-19) Severe Pneumonia,Drug: ATYR1923 1 mg/kg|Drug: ATYR1923 3 mg/kg|Drug: Placebo,All,"Adult, Older Adult",Phase 2,32.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 12, 2020","December 21, 2020"
3565,NCT04315987,Not yet recruiting,No Results Available,COVID-19 Pneumonia,Biological: NestaCell®|Biological: Placebo,All,"Adult, Older Adult",Phase 2,90.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",June 2020,August 2020
3566,NCT04329572,Suspended,No Results Available,COVID-19,Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin Tablets,All,"Adult, Older Adult",Early Phase 1,400.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 23, 2020","June 30, 2020"
3567,NCT04416009,Recruiting,No Results Available,Extracellular Fluid Alteration|Corona Virus Infection,Device: NİCaS,All,"Adult, Older Adult",,52.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 5, 2020","February 20, 2021"
3568,NCT04371367,"Active, not recruiting",No Results Available,COVID,Biological: avdoralimab|Other: Placebo,All,"Adult, Older Adult",Phase 2,208.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 27, 2020","March 1, 2021"
3569,NCT04412772,Recruiting,No Results Available,COVID-19,Drug: Tocilizumab|Drug: Placebo,All,"Adult, Older Adult",Phase 3,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 12, 2020","December 31, 2021"
3570,NCT04486482,Recruiting,No Results Available,Mild-to-Moderate COVID-19,Other: KB109 + Self Supportive Care (SSC)|Other: Self Supportive Care (SSC) Alone,All,"Adult, Older Adult",Not Applicable,50.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 12, 2021",March 2021
3571,NCT04586153,Not yet recruiting,No Results Available,COVID-19,Drug: Meplazumab for Injection|Drug: Sterile normal saline (0.9%),All,"Adult, Older Adult",Phase 2|Phase 3,456.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 30, 2020","September 30, 2021"
3572,NCT04341675,Recruiting,No Results Available,COVID-19,Drug: Sirolimus|Drug: Placebo,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 24, 2020",September 2020
3573,NCT04698083,Completed,No Results Available,Covid19,"Diagnostic Test: Electrocardiography ,Tomographic imaging",All,"Child, Adult, Older Adult",,160.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"July 22, 2020","November 5, 2020"
3574,NCT04453579,Completed,No Results Available,Obese|Morbid Obesity,Behavioral: Telephonic interview during the Italian lockdown.,All,"Adult, Older Adult",,116.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 9, 2020","May 30, 2020"
3575,NCT04345601,Recruiting,No Results Available,Sars-CoV2|Acute Respiratory Distress Syndrome|COVID-19,Biological: Mesenchymal Stromal Cells|Other: Supportive Care,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 12, 2021",October 2022
3576,NCT04461925,Recruiting,No Results Available,COVID-19 Pneumonia,Procedure: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|Drug: Antibiotics|Drug: Hormones|Drug: Anticoagulant Therapy|Device: Оxygen therapy,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 2, 2020",December 2021
3577,NCT04812041,Recruiting,No Results Available,Delirium|Covid19|Intensive Care Unit Delirium,Other: CAM-ICU 7 score|Other: 4C Mortality Score,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"January 21, 2021","May 25, 2021"
3578,NCT04364737,"Active, not recruiting",No Results Available,COVID-19|Coronavirus|Coronavirus Infection,Biological: Convalescent Plasma|Other: Saline solution,All,"Adult, Older Adult",Phase 2,384.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 17, 2020","June 14, 2021"
3579,NCT04672564,Recruiting,No Results Available,Coronavirus Disease 2019,Drug: Carrimycin|Drug: Placebo,All,"Adult, Older Adult",Phase 3,300.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","March 30, 2021","June 30, 2021"
3580,NCT04366050,Recruiting,No Results Available,COVID-19,Drug: Ramipril 2.5 MG Oral Capsule|Drug: Placebo oral capsule,All,"Adult, Older Adult",Phase 2,560.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 11, 2020",May 2021
3581,NCT04355494,No longer available,No Results Available,"COVID-19|Pneumonia, Viral|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)",Biological: eculizumab,All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population,,,
3582,NCT04363502,Recruiting,No Results Available,Covid19,Drug: Clazakizumab|Drug: Placebo,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 7, 2020",June 2021
3583,NCT04666012,Recruiting,No Results Available,COVID-19,Biological: AdCLD-CoV19,All,Adult,Phase 1|Phase 2,150.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"December 29, 2020",April 2022
3584,NCT04581291,Completed,No Results Available,Covid19,Other: Moderate Intensity Aerobic Exercises,All,Adult,Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"January 1, 2020","October 1, 2020"
3585,NCT04365127,Completed,No Results Available,COVID-19|Sars-CoV2,Drug: Progesterone 100 MG,Male,"Adult, Older Adult",Phase 1,40.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 27, 2020","August 20, 2020"
3586,NCT04565379,Recruiting,No Results Available,COVID19 Pneumonia,Drug: NuSepin® 0.1 mg|Drug: NuSepin® 0.2 mg|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 25, 2020","April 30, 2021"
3587,NCT04455308,Completed,No Results Available,Chilblains|COVID-19,Diagnostic Test: Biological sample collection,All,"Child, Adult, Older Adult",Not Applicable,269.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 21, 2020","October 19, 2020"
3588,NCT04359992,Not yet recruiting,No Results Available,COVID-19 Infection,Other: Extra blood sample,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 17, 2020","May 1, 2021"
3589,NCT04486508,Recruiting,No Results Available,Covid19,Drug: intermediate dose Enoxaparin/ unfractionated heparin|Drug: standard prophylactic dose Enoxaparin/ unfractionated heparin|Drug: Atorvastatin 20mg|Drug: Matched placebo,All,"Adult, Older Adult",Phase 3,600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 30, 2020","May 7, 2021"
3590,NCT04308317,Enrolling by invitation,No Results Available,"Corona Virus Disease 2019,COVID-19",Drug: Tetrandrine,All,"Adult, Older Adult",Phase 4,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 5, 2020","May 1, 2021"
3591,NCT04375137,Recruiting,No Results Available,Oxidative Stress,Diagnostic Test: Oxidative Stress ELISA Kit,All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"April 20, 2020","May 30, 2021"
3592,NCT04809974,Not yet recruiting,No Results Available,Covid19|Sequelae of; Infection|Cognitive Symptom,Dietary Supplement: Niagen,All,"Adult, Older Adult",Phase 4,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2021","December 31, 2022"
3593,NCT04421508,"Active, not recruiting",No Results Available,COVID-19|Coronavirus|Coronavirus Infection,Combination Product: INOpulse|Combination Product: Placebo,All,"Adult, Older Adult",Phase 3,500.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 12, 2020",June 2021
3594,NCT04390061,Not yet recruiting,No Results Available,"Pneumonitis, Interstitial|COVID-19",Drug: Tofacitinib|Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 2,116.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2020,October 2020
3595,NCT04412304,Completed,No Results Available,Covid-19|Thromboembolic Events|Bleeding,Drug: Dose of Tinzaparin or Dalteparin,All,"Child, Adult, Older Adult",,166.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 6, 2020","May 28, 2020"
3596,NCT04637867,Recruiting,No Results Available,Infection Viral,"Other: Collection of blood, salivary and nasopharyngeal samples.",All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"November 23, 2020","November 1, 2021"
3597,NCT04325672,Withdrawn,No Results Available,Coronavirus,Biological: Convalescent Plasma,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"April 1, 2020","December 31, 2022"
3598,NCT04561193,Recruiting,No Results Available,COVID-19,Other: Observational,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 30, 2020",May 2021
3599,NCT04623619,Not yet recruiting,No Results Available,Covid19,Dietary Supplement: Acetyl L-Carnitine,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 15, 2020","July 31, 2021"
3600,NCT04398290,Withdrawn,No Results Available,COVID-19|Hypoxemia|Hypoxemic Respiratory Failure,Drug: Inhaled nitric oxide (iNO)|Drug: Nitrogen gas|Drug: Oxygen gas,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 1, 2020","July 15, 2021"
3601,NCT04590222,Not yet recruiting,No Results Available,SARS-CoV2 Infection,Other: blood sample,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,November 2020,November 2021
3602,NCT04460105,Withdrawn,No Results Available,COVID-19 Pneumonia,Drug: Lanadelumab|Other: Placebo,All,"Adult, Older Adult",Phase 1,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 31, 2020","January 27, 2021"
3603,NCT04696601,Not yet recruiting,No Results Available,Olfaction Disorders|COVID-19 Testing,Diagnostic Test: Olfactory test,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"January 10, 2021","February 10, 2022"
3604,NCT04703478,Not yet recruiting,No Results Available,Covid19,Other: Breathing exercise,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"January 20, 2021","April 20, 2021"
3605,NCT04355052,Recruiting,No Results Available,COVID - 19,Drug: hydroxychloroquine in combination with camostat mesylate|Drug: Hydroxychloroquine in combination of Azithromycin,All,"Adult, Older Adult",Phase 3,250.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 11, 2020","December 11, 2020"
3606,NCT04477902,Suspended,No Results Available,Covid19|Corona Virus Infection|Quality of Life|Risk Reduction,Other: none - observational,All,"Adult, Older Adult",,50000.0,Industry,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"July 1, 2020","July 1, 2022"
3607,NCT04802044,Recruiting,No Results Available,Covid19|Obesity|Diabetes Mellitus|Aging|Cardiometabolic Syndrome|Immune System Disorder,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 8, 2020","December 31, 2022"
3608,NCT04731870,Not yet recruiting,No Results Available,Coronavirus,Other: Survey research,All,"Adult, Older Adult",,632.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,February 2021,January 2023
3609,NCT04488575,Recruiting,No Results Available,Covid19,Drug: EDP1815|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 26, 2020","July 6, 2021"
3610,NCT04703140,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Diagnostic Test: Rapid Diagnostic Test vs PCR,All,"Adult, Older Adult",Not Applicable,350.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"February 11, 2021","September 11, 2022"
3611,NCT04407130,Completed,No Results Available,COVID-19 Patients,Drug: Ivermectin + Doxycycline + Placebo|Drug: Ivermectin + Placebo|Drug: Placebo,All,"Adult, Older Adult",Phase 2,72.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 16, 2020","November 20, 2020"
3612,NCT04412226,Completed,No Results Available,"Intubation, Intratracheal|COVID-19",Device: aerosol box|Device: transparent sheet,All,"Child, Adult, Older Adult",,13.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 10, 2020","June 30, 2020"
3613,NCT04794803,Terminated,No Results Available,Severe Pneumonia,Drug: Reparixin|Drug: Standard of care,All,"Adult, Older Adult",Phase 2|Phase 3,55.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 5, 2020","February 2, 2021"
3614,NCT04365101,Recruiting,No Results Available,"Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2|Pneumonia|Pneumonia, Viral|Lung Diseases|Respiratory Tract Disease|Respiratory Tract Infections|Coronaviridae Infections|Nidovirales Infections|RNA Virus Infections|Virus Disease|Immunologic Disease|ARDS|Immunologic Factors|Physiological Effects of Drugs|Antiviral Agents|Anti-infective Agents|Analgesics|Antimetabolites, Antineoplastic",Biological: CYNK-001,All,"Adult, Older Adult",Phase 1|Phase 2,86.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 13, 2020","June 30, 2022"
3615,NCT04358926,Completed,No Results Available,COVID-19|Desaturation of Blood,Device: Hyperbaric oxygen therapy,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 30, 2020","November 1, 2020"
3616,NCT04481516,Recruiting,No Results Available,Stress,Other: Yoga,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","February 1, 2021"
3617,NCT04435353,Recruiting,No Results Available,Respiratory Distress Syndrome|Hypoxemia,Device: VibroLUNG,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 22, 2020","February 1, 2021"
3618,NCT04686409,Not yet recruiting,No Results Available,Adverse Events in COVID-19 Vaccination,Biological: COVID-19 vaccines,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"January 11, 2021","August 31, 2022"
3619,NCT04340219,Completed,No Results Available,Cancer,Other: Survey administration,All,"Adult, Older Adult",,394.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2020","September 18, 2020"
3620,NCT04393233,Recruiting,No Results Available,Rheumatoid Arthritis|COVID,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020","May 23, 2020"
3621,NCT04625114,Recruiting,No Results Available,Covid19,Drug: Camostat|Drug: Placebo,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 4, 2020","January 1, 2023"
3622,NCT04307459,Recruiting,No Results Available,Coronavirus Infections|Respiratory Failure|Ventilator Lung,Other: standard operating procedures,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 19, 2020","December 31, 2020"
3623,NCT04411628,Completed,No Results Available,COVID-19,Drug: LY3819253|Drug: Placebo,All,"Adult, Older Adult",Phase 1,24.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","May 28, 2020","August 26, 2020"
3624,NCT04396106,Recruiting,No Results Available,COVID-19,Drug: AT-527|Other: Placebo,All,"Adult, Older Adult",Phase 2,190.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 26, 2020",May 2021
3625,NCT04830735,Not yet recruiting,No Results Available,Symptomatic COVID-19 Infection Laboratory-Confirmed,Drug: Dasatinib Anhydrous|Drug: Placebo Administration,All,"Adult, Older Adult",Phase 2,144.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 15, 2021","April 15, 2024"
3626,NCT04273646,Not yet recruiting,No Results Available,2019 Novel Coronavirus Pneumonia|COVID-19,Biological: UC-MSCs|Drug: Placebo,All,"Adult, Older Adult",Not Applicable,48.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","February 15, 2022"
3627,NCT04697030,Completed,No Results Available,"Burnout, Psychological|Covid-19 Pandemic",,All,"Child, Adult",,443.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"September 15, 2020","December 22, 2020"
3628,NCT04315870,Recruiting,No Results Available,Infection Viral,Other: pregnant women with laboratory-confirmed 2019-n-CoV,Female,Adult,,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 1, 2020","April 30, 2020"
3629,NCT04480515,Completed,No Results Available,Covid19|In-hospital Cardiac Arrest,Other: in-hospital mortality rate,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 11, 2020","June 30, 2020"
3630,NCT04322396,Completed,No Results Available,Virus Diseases|Infection Viral|Corona Virus Infection,Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Child, Adult, Older Adult",Phase 2,117.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 6, 2020","February 2, 2021"
3631,NCT04445467,Recruiting,No Results Available,COVID,Drug: Favipiravir,All,"Adult, Older Adult",Phase 2,190.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 1, 2020",November 2020
3632,NCT04694014,Enrolling by invitation,No Results Available,Emotional Intelligence|Leadership|Health Personnel Attitude|Covid-19,Behavioral: EI Open ended Pre-Survey and Semi Structured Interview|Behavioral: Behavioral and Cognitive Assessment|Behavioral: Geneva Emotional Competence Test (GECO),All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 15, 2020","June 30, 2021"
3633,NCT04432766,Not yet recruiting,No Results Available,COVID-19,Drug: BAT2020,All,"Adult, Older Adult",Phase 1|Phase 2,174.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 20, 2020","August 18, 2021"
3634,NCT04832880,Not yet recruiting,No Results Available,Covid19,Drug: Baricitinib Oral Tablet [Olumiant]|Drug: Remdesivir|Drug: Dexamethasone,All,"Adult, Older Adult",Phase 3,4000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 6, 2021",December 2022
3635,NCT04344782,Not yet recruiting,No Results Available,COVID19 Pneumonia,Drug: Bevacizumab Injection,All,"Adult, Older Adult",Phase 2,130.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","November 30, 2020"
3636,NCT04632173,Not yet recruiting,No Results Available,Head and Neck Cancer|Covid19,Other: non interventional study,All,"Adult, Older Adult",,750.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"December 1, 2020","June 30, 2021"
3637,NCT04558320,Recruiting,No Results Available,Coronavirus Infection,,All,"Child, Adult, Older Adult",,100.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 2, 2020","April 1, 2021"
3638,NCT04379661,Completed,No Results Available,MS (Multiple Sclerosis)|COVID-19|Support Groups,Behavioral: Online support Group,All,"Adult, Older Adult",Not Applicable,32.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 7, 2020","August 31, 2020"
3639,NCT04341870,Suspended,No Results Available,COVID19|SARS-CoV-2 Infection,Drug: Sarilumab|Drug: Azithromycin|Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 2|Phase 3,27.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 11, 2020",August 2020
3640,NCT04414241,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,320.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,June 2020,October 2020
3641,NCT04319016,Recruiting,No Results Available,Infection Viral,Other: pregnant women with laboratory-confirmed 2019-n-CoV,Female,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 1, 2020","May 1, 2020"
3642,NCT04323631,Withdrawn,No Results Available,COVID-19,Drug: Hydroxychloroquine|Other: The control group will not receive hydroxychloroquine,All,"Adult, Older Adult",Early Phase 1,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","April 30, 2020"
3643,NCT04363853,"Active, not recruiting",No Results Available,Sars-CoV2,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 2,200.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","August 1, 2021"
3644,NCT04492501,Completed,No Results Available,Covid19|Cytokine Release Syndrome|Critical Illness|ARDS,Procedure: Therapeutic Plasma exchange|Biological: Convalescent Plasma|Drug: Tocilizumab|Drug: Remdesivir|Biological: Mesenchymal stem cell therapy,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","July 20, 2020"
3645,NCT04581018,Recruiting,No Results Available,Covid19|Microbiota,Other: Health supplements,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 13, 2020","April 30, 2022"
3646,NCT04351724,Recruiting,No Results Available,COVID-19,Drug: Chloroquine or Hydroxychloroquine|Drug: Lopinavir/Ritonavir|Other: Best standard of care|Drug: Rivaroxaban|Drug: Thromboprophylaxis|Drug: Candesartan|Drug: non-RAS blocking antihypertensives|Drug: Remdesivir|Drug: Asunercept 400mg|Drug: Asunercept 100mg|Drug: Asunercept 25mg|Drug: Pentaglobin,All,"Adult, Older Adult",Phase 2|Phase 3,500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","March 31, 2022"
3647,NCT04600999,Recruiting,No Results Available,SARS-CoV-2 Infection,Drug: Favipiravir,All,"Adult, Older Adult",Phase 3,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 7, 2020",June 2021
3648,NCT04694638,Recruiting,No Results Available,Prone Positioning|Covid19|Hypoxemic Respiratory Failure|ARDS|Non Invasive Ventilation|High Flow Nasal Cannulla,Other: Body position change,All,"Adult, Older Adult",Not Applicable,24.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 21, 2020",May 2021
3649,NCT04330300,Suspended,No Results Available,Hypertension|COVID-19,Drug: Thiazide or Thiazide-like diuretics|Drug: Calcium Channel Blockers|Drug: ACE inhibitor|Drug: Angiotensin receptor blocker,All,"Adult, Older Adult",Phase 4,2414.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 30, 2020","December 1, 2021"
3650,NCT04747574,Recruiting,No Results Available,SARS-CoV-2,Drug: EXO-CD24,All,"Adult, Older Adult",Phase 1,35.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 25, 2020","March 25, 2021"
3651,NCT04771000,Recruiting,No Results Available,Covid19|Hypoxemia,Drug: Ambrisentan|Drug: Placebo,All,"Adult, Older Adult",Phase 2,150.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","February 8, 2021","October 31, 2021"
3652,NCT04595084,Not yet recruiting,No Results Available,"Depression|Anxiety|Substance Use|Stress, Psychological|Stress, Emotional|Alcohol Use, Unspecified|Drug Use|Covid19",Behavioral: Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell|Behavioral: Internet Cognitive Behavioral Therapy plus CHAMindWell|Behavioral: CHAMindWell,All,"Adult, Older Adult",Not Applicable,240.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 15, 2021","November 1, 2022"
3653,NCT04371302,Not yet recruiting,No Results Available,"Burnout, Professional|Medical Errors|Depression",Diagnostic Test: Questionnaire,All,"Adult, Older Adult",,145.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 1, 2020","June 30, 2020"
3654,NCT04459403,Completed,No Results Available,Corona Virus Infection,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"June 8, 2020","December 30, 2020"
3655,NCT04354272,Completed,No Results Available,Orofacial Pain|Orofacial Edema|Dental Trauma|Oral Infection,Other: Questionnaire,All,"Adult, Older Adult",,503.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 21, 2020","June 29, 2020"
3656,NCT04339816,Terminated,No Results Available,COVID-19|Respiratory Failure,Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,3.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","May 13, 2020","November 4, 2020"
3657,NCT04526990,Recruiting,No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,All,"Adult, Older Adult",Phase 3,40000.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 15, 2020","January 30, 2022"
3658,NCT04354584,Recruiting,No Results Available,COVID-19|Respiratory Failure,,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 6, 2020","April 6, 2021"
3659,NCT04359693,Completed,No Results Available,SARS-CoV 2,,All,"Adult, Older Adult",,1576.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 22, 2020","July 1, 2020"
3660,NCT04570488,Recruiting,No Results Available,COVID|Corona Virus Infection|Adverse Event,Other: EPIC risk score display,All,"Adult, Older Adult",Not Applicable,1200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Health Services Research","May 15, 2020","May 15, 2021"
3661,NCT04695704,Not yet recruiting,No Results Available,Covid19|SARS (Disease),Drug: Montelukast|Other: placebo,All,"Adult, Older Adult",Phase 3,284.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2021","December 31, 2022"
3662,NCT04565106,Completed,No Results Available,Covid19|Hypoxemic Respiratory Failure|Hypoxemia,Device: Closed-loop control of oxygen supplementation by O2matic,All,"Adult, Older Adult",,16.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","May 31, 2020"
3663,NCT04565509,Recruiting,No Results Available,Covid19|Intellectual Disability|Developmental Disability|Child Development Disorder,Behavioral: General Communication Message|Behavioral: Focused/Targeted Message|Behavioral: Best Message Alone|Behavioral: Best Message + Augmented Message or Implementation Strategy,All,"Child, Adult, Older Adult",Not Applicable,2500.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"November 20, 2020","September 21, 2022"
3664,NCT04386616,Completed,No Results Available,COVID-19 Pneumonia,Drug: MSTT1041A|Drug: MSTT1041A-matched Placebo|Drug: UTTR1147A|Drug: UTTR1147A-matched Placebo,All,"Adult, Older Adult",Phase 2,410.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 2, 2020","February 12, 2021"
3665,NCT04457817,Enrolling by invitation,No Results Available,COVID,Device: CRI management,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2020",July 2021
3666,NCT04700137,Enrolling by invitation,No Results Available,Covid19|Mental Health,Other: Caring Contacts Plus Introductory Phone Call (CC+)|Other: Caring Contacts without an introductory phone call (CC),All,"Child, Adult, Older Adult",Not Applicable,660.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 18, 2021","January 17, 2022"
3667,NCT04542447,Recruiting,No Results Available,Covid19,Drug: Nuvastatic,All,"Adult, Older Adult",Phase 1,10.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","September 30, 2020"
3668,NCT04834102,Recruiting,No Results Available,Covid19|Telogen Effluvium|SARS-CoV Infection|Alopecia,Diagnostic Test: Blood Tests,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 27, 2021","April 27, 2021"
3669,NCT04337008,Recruiting,No Results Available,COVID 19,Other: blood draw,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 3, 2020","July 31, 2020"
3670,NCT04373213,Not yet recruiting,No Results Available,Pleth Variability Index,Diagnostic Test: Pleth variability index,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"May 5, 2020","June 15, 2020"
3671,NCT04524520,Recruiting,No Results Available,Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 5, 2020","May 8, 2022"
3672,NCT04673279,Recruiting,No Results Available,Coronavirus Disease 2019,Diagnostic Test: serology,All,"Child, Adult, Older Adult",,189.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"December 2, 2020","July 1, 2021"
3673,NCT04754594,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19|Maternal Immunization,Biological: BNT162b2|Other: Placebo,All,"Child, Adult, Older Adult",Phase 2|Phase 3,4000.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","February 16, 2021","June 27, 2022"
3674,NCT04337489,Not yet recruiting,No Results Available,Coronavirus,Device: SensiumVitals wearable sensor,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 28, 2020","April 1, 2021"
3675,NCT04677660,"Active, not recruiting",No Results Available,Prevention of Infectious Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2),Biological: TAK-919|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,200.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 21, 2021","March 3, 2022"
3676,NCT04331470,Recruiting,No Results Available,COVID-19,Drug: Levamisole Pill + Budesonide+Formoterol inhaler|Drug: Lopinavir/Ritonavir + hydoxychloroquine,All,"Child, Adult, Older Adult",Phase 2|Phase 3,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","April 4, 2020","May 20, 2020"
3677,NCT04581954,Recruiting,No Results Available,Coronavirus|Covid19|Pneumonia,Drug: Ruxolitinib|Drug: Fostamatinib|Other: Standard of care,All,"Adult, Older Adult",Phase 1|Phase 2,456.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 2, 2020","July 31, 2021"
3678,NCT04409262,Completed,No Results Available,COVID-19 Pneumonia,Drug: Remdesivir|Drug: Tocilizumab|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 3,649.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 16, 2020","March 8, 2021"
3679,NCT04371744,Completed,No Results Available,COVID-19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 17, 2020","June 5, 2020"
3680,NCT04815135,Completed,No Results Available,Emergencies,Other: Observational study,All,"Child, Adult, Older Adult",,344.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"March 1, 2019","January 18, 2021"
3681,NCT04395781,Recruiting,No Results Available,COVID|Pediatric Disorder,,All,"Child, Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"May 18, 2020","December 31, 2023"
3682,NCT04386694,Completed,No Results Available,COVID-19|Respiratory Failure,Device: Active PBMT/sMF|Device: Placebo PBMT/sMF,All,"Child, Adult, Older Adult",Not Applicable,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 18, 2020","September 17, 2020"
3683,NCT04411446,Recruiting,No Results Available,COVID,Drug: Vitamin D|Drug: Placebo,All,"Adult, Older Adult",Phase 4,1264.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 11, 2020","October 28, 2021"
3684,NCT04573322,Recruiting,No Results Available,SARS-CoV-2 (Covid19),Drug: Trans Sodium Crocetinate|Drug: Normal saline,All,"Adult, Older Adult",Phase 1|Phase 2,224.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 10, 2020","December 14, 2021"
3685,NCT04667936,Recruiting,No Results Available,Prone Position|Severe Acute Respiratory Syndrome Coronavirus 2|Hypnotics and Sedatives|Pulmonary Ventilation,Other: Treatment group,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 1, 2020","January 1, 2021"
3686,NCT04708158,Not yet recruiting,No Results Available,Covid19,Biological: Novaferon|Biological: Placebo,All,"Adult, Older Adult",Phase 3,385.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",January 2021,June 2021
3687,NCT04438850,Recruiting,No Results Available,Covid19,Drug: Ivermectin|Other: Placebo,All,"Adult, Older Adult",Phase 2,102.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 31, 2020",May 2021
3688,NCT04397939,Recruiting,No Results Available,COVID-19|Myocardial Reperfusion Injury|Cardiovascular Diseases,,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 8, 2020",March 2023
3689,NCT04652674,Recruiting,No Results Available,"Covid19|Satisfaction, Patient|Telemedicine",Behavioral: Telemedicine visit|Behavioral: In-person postoperative visit,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"September 28, 2020","June 30, 2021"
3690,NCT04349410,Completed,No Results Available,CoVid 19 Positive,"Drug: Hydroxychloroquine, Azithromycin|Drug: Hydroxychloroquine, Doxycycline|Drug: Hydroxychloroquine, Clindamycin|Drug: Hydroxychloroquine, Clindamycin, Primaquine - low dose.|Drug: Hydroxychloroquine, Clindamycin, Primaquine - high dose.|Drug: Remdesivir|Drug: Tocilizumab|Drug: Methylprednisolone|Drug: Interferon-Alpha2B|Drug: Losartan|Drug: Convalescent Serum",All,"Child, Adult, Older Adult",Phase 2|Phase 3,1800.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"April 11, 2020","September 14, 2020"
3691,NCT04738032,Completed,No Results Available,Type2 Diabetes,Other: Digital Storytelling Intervention,All,"Adult, Older Adult",,76.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"August 26, 2020","January 7, 2021"
3692,NCT04569825,Recruiting,No Results Available,Clinical Trial,Drug: Ophtamesone,All,"Adult, Older Adult",Early Phase 1,250.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 1, 2020","October 15, 2020"
3693,NCT04789499,Recruiting,No Results Available,Covid19|Anosmia|Olfactory Disorder|Covid-19 Pandemic|SARS-CoV-2 Infection|Hyposmia|Ageusia|Hypogeusia,Drug: Theophylline Powder,All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 15, 2021",December 2021
3694,NCT04596943,Recruiting,No Results Available,Covid19|Endothelial Dysfunction|PET Imaging,Diagnostic Test: [68Ga]Ga-DOTA-(RGD)2 PET/CT,All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 15, 2020","January 30, 2021"
3695,NCT04606563,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: Losartan,All,"Adult, Older Adult",Phase 3,1372.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 9, 2020","June 30, 2021"
3696,NCT04463420,Recruiting,No Results Available,COVID-19,Drug: PHR160 Spray|Drug: Placebo|Drug: Standard treatment,All,"Adult, Older Adult",Not Applicable,224.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 15, 2020","December 15, 2020"
3697,NCT04357275,Recruiting,No Results Available,Critical Illness|ARDS|Inflammatory Response|COVID-19|Circulatory Shock,Other: ICU treatment,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 13, 2020",March 2022
3698,NCT04351152,"Active, not recruiting",No Results Available,Coronavirus Disease 2019 (COVID-19) Pneumonia,Biological: Lenzilumab|Drug: Standard of Care,All,"Adult, Older Adult",Phase 3,520.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 5, 2020",March 2021
3699,NCT04646590,Recruiting,No Results Available,Prevention of COVID-19|Safety and Efficacy,Biological: Recombinant new coronavirus vaccine (CHO cell) group|Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group,All,"Adult, Older Adult",Phase 3,29000.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 16, 2020",April 2022
3700,NCT04748783,Terminated,No Results Available,COVID19|Coronavirus Infection|SARS CoV-2 Infection,Other: Water|Other: Peroxyl|Drug: Periogard|Other: Colgate Total Zero,All,"Adult, Older Adult",Phase 2,2.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","March 26, 2021","April 7, 2021"
3701,NCT04542226,Completed,Has Results,"Infections, Coronavirus",Drug: Polyoxidonium,All,"Adult, Older Adult",,81.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 31, 2020","October 30, 2020"
3702,NCT04743232,Recruiting,No Results Available,Covid19|Cardiac Arrest,Other: Decision tool for clinicians,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"March 1, 2021","January 31, 2022"
3703,NCT04402918,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: biological samples day of delivery,Female,"Adult, Older Adult",Not Applicable,160.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 17, 2020","February 28, 2021"
3704,NCT04380818,Recruiting,No Results Available,"Pneumonia, Viral",Radiation: Low-dose radiotherapy|Drug: Hydroxychloroquine Sulfate|Drug: Ritonavir/lopinavir|Drug: Tocilizumab Injection [Actemra]|Drug: Azithromycin|Drug: Corticosteroid|Drug: Low molecular weight heparin|Device: Oxygen supply,All,"Adult, Older Adult",Not Applicable,106.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 5, 2020","July 1, 2021"
3705,NCT04374539,Recruiting,No Results Available,Coronavirus,Biological: Plasma exchange|Drug: Standar medical treatmen,All,"Adult, Older Adult",Phase 2,116.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 29, 2020","August 29, 2021"
3706,NCT04279197,Recruiting,No Results Available,Pulmonary Fibrosis Due to COVID-19,Drug: Fuzheng Huayu Tablet|Drug: Vitamin C tablets|Other: Placebo|Other: respiratory function rehabilitation training,All,"Adult, Older Adult",Phase 2,160.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 23, 2020",December 2021
3707,NCT04343989,"Active, not recruiting",No Results Available,COVID-19,Drug: Clazakizumab 25 mg|Drug: Clazakizumab 12.5 mg|Other: Placebo,All,"Adult, Older Adult",Phase 2,90.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 31, 2020","January 30, 2021"
3708,NCT04393142,Completed,No Results Available,Coronavirus Infection,,All,"Child, Adult, Older Adult",,96.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 5, 2020","February 16, 2021"
3709,NCT04459325,Completed,No Results Available,COVID-19|Coronavirus Disease 2019,Biological: Tigerase® and best available care|Other: Best available care,All,"Adult, Older Adult",Phase 3,100.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","July 20, 2020"
3710,NCT04459676,Recruiting,No Results Available,COVID-19|Pneumonia,Drug: Standard of Care (SOC) + ANG-3777|Drug: Standard Of Care (SOC) + Placebo,All,"Adult, Older Adult",Phase 2,100.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 31, 2020",October 2020
3711,NCT04418128,Not yet recruiting,No Results Available,Corona Virus Infection|COVID-19,Drug: Nafamostat Mesylate,All,"Adult, Older Adult",Phase 2|Phase 3,84.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 10, 2020","April 30, 2021"
3712,NCT04606069,Not yet recruiting,No Results Available,COVID-19|Lung Inflammation,Drug: Regadenoson|Other: Placebo Control,All,"Adult, Older Adult",Phase 1|Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 1, 2020","January 31, 2022"
3713,NCT04627233,Not yet recruiting,No Results Available,Covid19|Treatment|Corona Virus Infection,Drug: Human Ezrin Peptide 1 (HEP1)|Drug: Placebo,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 20, 2020","April 1, 2021"
3714,NCT04360733,Recruiting,No Results Available,SARS-CoV 2|COVID,Other: Blood draw,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 20, 2020",September 2022
3715,NCT04316377,"Active, not recruiting",No Results Available,Corona Virus Infection,Drug: Hydroxychloroquine Sulfate,All,"Adult, Older Adult",Phase 4,53.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 25, 2020","March 3, 2025"
3716,NCT04502108,Recruiting,No Results Available,Exercise|Nutritional Status|Sleep,Behavioral: Covid19,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","December 31, 2022"
3717,NCT04550390,Completed,No Results Available,SARS-CoV Infection,Diagnostic Test: Saliva collection,All,"Adult, Older Adult",,329.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 15, 2020","October 19, 2020"
3718,NCT04642703,Recruiting,No Results Available,Mechanical Ventilation|Covid19|Tracheostomy,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 3, 2020","November 30, 2021"
3719,NCT04420676,Recruiting,No Results Available,COVID,Dietary Supplement: Omnibiotic AAD|Dietary Supplement: Placebo,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 24, 2020",December 2022
3720,NCT04352699,Completed,No Results Available,Surgery|Complication of Surgical Procedure|COVID,,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 15, 2020","May 1, 2020"
3721,NCT04748588,Not yet recruiting,No Results Available,Covid19|Nosocomial Infection,Drug: Bamlanivimab,All,"Adult, Older Adult",Phase 4,648.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021","March 31, 2023"
3722,NCT04429334,Not yet recruiting,No Results Available,COVID19,Drug: nangibotide|Drug: placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",August 2020,March 2021
3723,NCT04456101,Recruiting,No Results Available,COVID-19,,All,"Adult, Older Adult",,240.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 19, 2020","June 1, 2022"
3724,NCT04579640,"Active, not recruiting",No Results Available,Covid19|Acute Respiratory Tract Infection,Dietary Supplement: Vitamin D,All,"Child, Adult, Older Adult",Phase 3,6200.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 27, 2020","June 30, 2021"
3725,NCT04414618,Completed,No Results Available,Coronavirus Infections,Drug: Opaganib|Drug: Placebo,All,"Adult, Older Adult",Phase 2,42.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 2, 2020","December 23, 2020"
3726,NCT04487990,Recruiting,No Results Available,Acute Kidney Injury|Covid19,Drug: unfractionated Heparin,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 29, 2020",July 2021
3727,NCT04429854,"Active, not recruiting",No Results Available,COVID-19,Biological: Convalescent Plasma|Drug: Standard of care,All,"Adult, Older Adult",Phase 2,483.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 2, 2020","November 2, 2021"
3728,NCT04321616,Recruiting,No Results Available,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,All,"Adult, Older Adult",Phase 2|Phase 3,700.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 28, 2020",November 2020
3729,NCT04413058,Completed,No Results Available,Menstrual Irregularity|Covid 19,,Female,Adult,,260.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Prospective,"April 10, 2020","September 10, 2020"
3730,NCT04644302,Recruiting,No Results Available,Viral Pneumonia|Sepsis,Diagnostic Test: microcirculation recording,All,"Adult, Older Adult",,25.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2020",December 2021
3731,NCT04407572,Completed,No Results Available,COVID|Zinc Deficiency|Vitamin D Deficiency,"Other: Serum zinc, vitamin d vitamin b12 levels .",Female,Adult,,44.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 20, 2020","June 14, 2020"
3732,NCT04368351,"Active, not recruiting",No Results Available,COVID|Pneumonia|Diarrhea,Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine,All,"Adult, Older Adult",,70.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 1, 2020","July 31, 2020"
3733,NCT04576299,"Active, not recruiting",No Results Available,Patient Safety,Other: Group 1,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"September 1, 2020","December 15, 2020"
3734,NCT04342195,Recruiting,No Results Available,COVID-19|Coronavirus Infection|Corona Virus Infection,Procedure: Blood draw,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"March 25, 2020",March 2021
3735,NCT04534478,Not yet recruiting,No Results Available,COVID-19 Pneumonia,Drug: Prednisone,All,"Adult, Older Adult",Phase 4,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 7, 2020","December 15, 2021"
3736,NCT04430608,Recruiting,No Results Available,Diabetes|Covid-19|Infection,Device: Dexcom G6,All,"Adult, Older Adult",Not Applicable,72.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 25, 2020","May 25, 2021"
3737,NCT04366830,No longer available,No Results Available,Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19,Drug: Remestemcel-L,All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,
3738,NCT04784624,Not yet recruiting,No Results Available,Cardiometabolic Syndrome|Weight Loss,Behavioral: Lifestyle program,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","March 31, 2022"
3739,NCT04710303,Recruiting,No Results Available,Covid19,Biological: hAd5-S-Fusion+N-ETSD vaccine,All,Adult,Phase 1,35.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 2, 2021",April 2022
3740,NCT04510402,Not yet recruiting,No Results Available,Covid19|Povidone Iodine Adverse Reaction,Drug: Povidine iodine nasal swabs,All,"Adult, Older Adult",Phase 1|Phase 2,50.0,Other|Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,August 2020,April 2021
3741,NCT04551911,Recruiting,No Results Available,Covid19|Coronavirus|SARS-CoV-2 Infection,Drug: Rayaldee 30Mcg Extended-Release (ER) Capsule|Drug: Placebo,All,"Adult, Older Adult",Phase 2,160.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 26, 2020",May 2021
3742,NCT04438057,Recruiting,No Results Available,COVID-19,Biological: CCP,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 12, 2020","August 12, 2021"
3743,NCT04405362,Not yet recruiting,No Results Available,SARS-CoV 2|Traumatic Stress Disorder,,All,"Adult, Older Adult",,753.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,May 2020,May 2021
3744,NCT04657484,Recruiting,No Results Available,Post COVID-19 Diffuse Lung Disease,Drug: Medium dose prednisolone|Drug: Low dose prednisolone,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 8, 2020","December 7, 2021"
3745,NCT04382040,Completed,No Results Available,COVID-19|Corona Virus Infection|SARS-CoV 2|Coronavirus|Coronavirus Infection,Drug: ArtemiC|Drug: Placebo,All,"Adult, Older Adult",Phase 2,50.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 8, 2020","December 21, 2020"
3746,NCT04791436,Not yet recruiting,No Results Available,Oral Complication|Dysgeusia|Olfactory Disorder,Diagnostic Test: Gustatory and olfactory function test|Diagnostic Test: Molecular assessment of saliva,All,"Adult, Older Adult",,402.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","February 28, 2022"
3747,NCT04326790,Terminated,No Results Available,Corona Virus Disease 19 (Covid 19),Drug: Colchicine|Drug: Standard treatment,All,"Adult, Older Adult",Phase 2,105.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 3, 2020","April 27, 2020"
3748,NCT04573868,Recruiting,No Results Available,Mortality,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 1, 2020","September 30, 2020"
3749,NCT04535856,Completed,No Results Available,Covid19|Corona Virus Infection|SAR,Drug: allogeneic mesenchymal stem cell|Other: Placebo,All,"Adult, Older Adult",Phase 1,9.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 14, 2020","January 14, 2021"
3750,NCT04394000,Completed,No Results Available,COVID19|Thromboembolism,Other: thromboprofylaxis protocol|Other: standard protocol,All,"Adult, Older Adult",,72.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"May 4, 2020","May 15, 2020"
3751,NCT04334850,Recruiting,No Results Available,Covid19|Pneumonia,Procedure: Combined use of a respiratory broad panel multiplex PCR and procalcitonin|Other: Usual antibiotic treatment,All,"Adult, Older Adult",Not Applicable,194.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020",August 2020
3752,NCT04311177,Completed,No Results Available,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection,Drug: Losartan|Other: Placebo,All,"Adult, Older Adult",Phase 2,580.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 9, 2020","February 1, 2021"
3753,NCT04367337,"Active, not recruiting",No Results Available,Health Behavior,Other: No intervention,All,"Adult, Older Adult",,6079.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"March 25, 2020","March 24, 2021"
3754,NCT04390269,Recruiting,No Results Available,Genetic Predisposition to Disease,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"September 10, 2020","May 9, 2022"
3755,NCT04445259,Recruiting,No Results Available,COVID|Acute Kidney Injury|Critical Illness,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 20, 2020","May 31, 2021"
3756,NCT04801134,Not yet recruiting,No Results Available,"Food Insecurity|Children, Only|Covid19",Other: Education,All,Child,Not Applicable,50.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 22, 2021","May 30, 2022"
3757,NCT04360096,Recruiting,No Results Available,SARS-CoV 2|COVID|ARDS|ALI|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Dyspnea,Drug: ZYESAMI™ (aviptadil acetate)|Drug: Placebo|Device: Nebulized administration of ZYESAMI™ or Placebo,All,"Child, Adult, Older Adult",Phase 2|Phase 3,288.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 15, 2021","September 1, 2021"
3758,NCT04397510,Enrolling by invitation,No Results Available,"Covid-19|ARDS, Human|Acute Lung Injury",Drug: Heparin|Drug: 0.9% Sodium-chloride,All,"Adult, Older Adult",Phase 4,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2020","December 31, 2021"
3759,NCT04605692,Completed,No Results Available,Burnout|COVID-19|Dentistry|Filiation|Pandemic,,All,"Child, Adult, Older Adult",,706.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 9, 2020","May 20, 2020"
3760,NCT04505592,Recruiting,No Results Available,COVID-19|Respiratory Failure|ARDS,Drug: Tenecteplase|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 25, 2020",December 2021
3761,NCT04367831,Recruiting,No Results Available,COVID-19|Venous Thromboses|Arterial Thrombosis,Drug: Enoxaparin Prophylactic Dose|Drug: Heparin Infusion|Drug: Heparin SC|Drug: Enoxaparin/Lovenox Intermediate Dose,All,"Adult, Older Adult",Phase 4,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 2, 2020",April 2021
3762,NCT04828668,Recruiting,No Results Available,Covid 19,Dietary Supplement: Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C),All,"Adult, Older Adult",Not Applicable,60.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Other,"April 2, 2021","November 30, 2021"
3763,NCT04511780,Not yet recruiting,No Results Available,"Critical Illness|Covid19|Stress Disorders, Post-Traumatic",Other: questionnaire filling,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,January 2021,September 2022
3764,NCT04603963,Terminated,No Results Available,Covid19|Respiratory Disease,Device: power breathe,All,"Adult, Older Adult",Not Applicable,55.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"June 1, 2020","October 23, 2020"
3765,NCT04366219,Not yet recruiting,No Results Available,COVID|SARS-CoV 2|Lung Cancer,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Other|Time Perspective: Other,June 2020,"August 28, 2022"
3766,NCT04392401,Recruiting,No Results Available,Intensive Care Unit|SARS-Cov-2,Biological: Collection of blood samples in order to create a biocollection,All,"Adult, Older Adult",,200.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020",February 2021
3767,NCT04466280,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Mucodentol|Device: Personal protective equipment,All,"Adult, Older Adult",Not Applicable,180.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 15, 2020","December 15, 2020"
3768,NCT04456439,Available,No Results Available,Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19),Biological: Remestemcel-L|Drug: Hydrocortisone|Drug: Diphenhydramine,All,Child,,,Industry,Expanded Access:Intermediate-size Population,,,
3769,NCT04382846,Recruiting,No Results Available,COVID|Corona Virus Infection,Drug: Nitazoxanide,All,"Adult, Older Adult",Phase 3,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","December 1, 2030"
3770,NCT04433260,Recruiting,No Results Available,Mental Health,"Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index|Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.|Other: Informed consent",All,"Adult, Older Adult",,1050.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"July 25, 2020",September 2021
3771,NCT04343144,Not yet recruiting,No Results Available,COVID19- Infection With SARS-CoV-2 Virus,Drug: Nivolumab Injection,All,"Adult, Older Adult",Phase 2,92.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","September 30, 2020"
3772,NCT04312100,Recruiting,No Results Available,Coronavirus Disease-2019,Other: oxygen treatment,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2020",February 2021
3773,NCT04594668,Recruiting,No Results Available,"ARDS, Human|COVID",Drug: Senicapoc,All,"Adult, Older Adult",Phase 2,46.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 24, 2020","December 31, 2021"
3774,NCT04582214,Recruiting,No Results Available,COVID-19|Oscillation and Lung Expansion|Ventilation,Device: MetaNeb® System,All,"Adult, Older Adult",Not Applicable,30.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 28, 2020","January 1, 2021"
3775,NCT04707820,Recruiting,No Results Available,Corona Virus Infection,Diagnostic Test: ELISPOT,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 16, 2020","June 10, 2021"
3776,NCT04321928,Recruiting,No Results Available,SARS-CoV-2|Coronavirus|COVID-19|2019-nCoV|2019nCoV,Behavioral: Personalized health education|Behavioral: General health education,All,"Adult, Older Adult",Not Applicable,7576.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","April 1, 2020","August 21, 2021"
3777,NCT04836793,Not yet recruiting,No Results Available,Cancer|Elderly Without Cancer|Healthy Aging,Other: Additional biological samples,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2021","March 25, 2023"
3778,NCT04365595,Completed,No Results Available,SARS-CoV 2|COVID,"Other: Questionnaires, spirometry",All,"Adult, Older Adult",,58.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 3, 2020","February 17, 2021"
3779,NCT04335019,Not yet recruiting,No Results Available,2019-nCoV (COVID-19)|Interstitial Pneumonia,Other: Pulmonary ultrasound,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,April 2020,May 2020
3780,NCT04736524,Recruiting,No Results Available,IgM and IgG in Blood,Other: Rapid antibody test,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 15, 2021",March 2022
3781,NCT04369989,Enrolling by invitation,No Results Available,Coronavirus|Coronavirus Infection|Corona Virus Infection|COVID|Sars-CoV2|Coronavirus as the Cause of Diseases Classified Elsewhere|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|COVID-19|Coronavirus Disease|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere,Other: No intervention,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 14, 2020","April 14, 2021"
3782,NCT04631380,Recruiting,No Results Available,Covid19,Other: PRAYER,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,"August 1, 2020",January 2021
3783,NCT04379492,Withdrawn,No Results Available,COVID-19|COVID19|Sars-CoV2|SARS-Cov-2,Drug: Hydroxychloroquine|Other: Placebo,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 5, 2020","September 25, 2020"
3784,NCT04368013,Not yet recruiting,No Results Available,COVID-19,Procedure: Extended sampling and procedures,All,"Child, Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"April 28, 2020","April 14, 2026"
3785,NCT04565665,Recruiting,No Results Available,COVID-19 Infection|COVID-19-Associated Acute Respiratory Distress Syndrome,Other: Best Practice|Biological: Mesenchymal Stem Cell,All,"Adult, Older Adult",Phase 1,70.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 29, 2020","April 30, 2021"
3786,NCT04751630,Not yet recruiting,No Results Available,Covid19|Physical Disability,Other: Therapeutic Exercise,All,"Adult, Older Adult",Not Applicable,78.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 1, 2021","February 1, 2022"
3787,NCT04708340,Recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|SARS-CoV-2|Hypoxemia,Drug: Rejuveinix (RJX) Active Comparator|Drug: Placebo Comparator,All,"Adult, Older Adult",Phase 1|Phase 2,237.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 25, 2021",February 2023
3788,NCT04441814,Enrolling by invitation,No Results Available,COVID 19|Inflammatory Status,,All,"Adult, Older Adult",,960.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 23, 2019",July 2021
3789,NCT04390139,Recruiting,No Results Available,COVID-19|SARS-CoV 2|Adult Respiratory Distress Syndrome,Drug: XCEL-UMC-BETA|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 13, 2020",December 2021
3790,NCT04478071,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|Coronavirus Infection,Drug: vadadustat|Drug: placebo,All,"Adult, Older Adult",Phase 2,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 22, 2020","August 1, 2022"
3791,NCT04640038,Recruiting,No Results Available,Covid19|MIS-C,Drug: Sulfur hexafluoride lipid-type A microspheres,All,Child,Phase 3,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"December 18, 2020",December 2022
3792,NCT04378686,Recruiting,No Results Available,SARS-CoV 2|End Stage Renal Failure on Dialysis,Other: dialysis,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 23, 2020","May 1, 2022"
3793,NCT04286503,Not yet recruiting,No Results Available,Novel Coronavirus Infectious Disease (COVID-19),Drug: Carrimycin|Drug: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate|Drug: basic treatment,All,"Adult, Older Adult",Phase 4,520.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 23, 2020","February 28, 2021"
3794,NCT04376710,Completed,No Results Available,COVID|Surgery,Other: Completion of pre-pandemic survey|Other: Completion of survey after peak of pandemic|Other: Completion of post telemedicine encounter survey,All,"Child, Adult",,180.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"July 1, 2020","October 1, 2020"
3795,NCT04461379,"Active, not recruiting",No Results Available,BCG|COVID-19|SARS-CoV2|Corona Virus Infection,Biological: BCG vaccine|Other: Placebo,All,"Adult, Older Adult",Phase 3,908.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","July 21, 2020","January 1, 2021"
3796,NCT03944447,Recruiting,No Results Available,Chronic Pain|Chronic Pain Syndrome|Chronic Pain Due to Injury|Chronic Pain Due to Trauma|Fibromyalgia|Seizures|Hepatitis C|Cancer|Crohn Disease|HIV/AIDS|Multiple Sclerosis|Traumatic Brain Injury|Sickle Cell Disease|Post Traumatic Stress Disorder|Tourette Syndrome|Ulcerative Colitis|Glaucoma|Epilepsy|Inflammatory Bowel Diseases|Parkinson Disease|Amyotrophic Lateral Sclerosis|Chronic Traumatic Encephalopathy|Anxiety|Depression|Insomnia|Autism|Opioid-use Disorder|Bipolar Disorder|Covid19|SARS-CoV Infection|COVID-19|Corona Virus Infection|Coronavirus,"Drug: Cannabis, Medical",All,"Child, Adult, Older Adult",Phase 2,200000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2018","December 31, 2025"
3797,NCT04321265,Recruiting,No Results Available,COVID-19|Elderly Patients|Critical Illness|Survival|Old Age,,All,Older Adult,,4000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 19, 2020",December 2021
3798,NCT04465513,Not yet recruiting,No Results Available,Asthma; Eosinophilic|COVID|Covid-19,Dietary Supplement: Best Standard of Care + CARDIO|Dietary Supplement: Best Standard of Care,All,"Adult, Older Adult",Not Applicable,100.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 31, 2020","August 31, 2021"
3799,NCT04349982,Recruiting,No Results Available,"Risk Factor, Cardiovascular|Covid19|Critical Illness|Course Illness","Diagnostic Test: Biomarker (TropT, Myoglobin, CK, CK-MB, LDH, D-dimer, CRP, PCT)",All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 8, 2020","July 31, 2022"
3800,NCT04768998,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Other: Observational of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings,All,"Adult, Older Adult",,6550.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 4, 2020",September 2023
3801,NCT04831853,Not yet recruiting,No Results Available,Covid19,Other: nasopharyngeal swabbing procedure (self swabbing first)|Other: nasopharyngeal swabbing procedure (conventionnal swabbing first),All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,April 2021,December 2021
3802,NCT04343339,Completed,No Results Available,"Addiction, Substance|COVID-19",,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 8, 2020","September 30, 2020"
3803,NCT04524234,Completed,No Results Available,Covid19|Left Ventricular Dysfunction|Right Ventricular Dysfunction|Pulmonary Hypertension,Diagnostic Test: Echocardiography,All,"Adult, Older Adult",,132.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","September 30, 2020"
3804,NCT04366817,Not yet recruiting,No Results Available,Post Partum Depression,Behavioral: psychological assessment,Female,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,April 2020,June 2020
3805,NCT04356378,Recruiting,No Results Available,Infection With Coronavirus SARS-CoV2,Other: Data record,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 2, 2020","March 2, 2022"
3806,NCT04386512,Completed,No Results Available,COVID|Lymphoma,,All,"Adult, Older Adult",,89.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 15, 2020","July 15, 2020"
3807,NCT04393051,Not yet recruiting,No Results Available,Covid-19|SARS-CoV 2|SARS Pneumonia,Drug: Baricitinib Oral Tablet,All,"Adult, Older Adult",Phase 2,126.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020","July 30, 2020"
3808,NCT04395755,Completed,No Results Available,"Infertility, Female|ART|IVF|COVID-19",Behavioral: Generalized Anxiety Disorder-7 (GAD-7)|Behavioral: Patient Health Questionnaire-9 (PHQ-9),Female,"Adult, Older Adult",,503.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","May 15, 2020"
3809,NCT04444531,Completed,No Results Available,COVID-19 Pneumonia,,,"Child, Adult, Older Adult",,18.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020","May 26, 2020"
3810,NCT04389463,Recruiting,No Results Available,Patients Undergoing Cardiac or Thoracic Surgery,Other: No intervention,All,"Adult, Older Adult",,350.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","June 30, 2022"
3811,NCT04530539,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Dietary Supplement: Vitamin C|Dietary Supplement: melatonin|Dietary Supplement: Placebo|Other: Symptom Survey,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care","October 5, 2020","December 1, 2021"
3812,NCT04346927,Completed,No Results Available,Telerehabilitation|Coronavirus,Other: Telerehabilitation|Other: exercise brochure,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"August 10, 2020","November 30, 2020"
3813,NCT03808922,Recruiting,No Results Available,Lower Respiratory Tract Infection|Parainfluenza|Immunocompromised|COVID-19,Drug: DAS181|Drug: Placebo|Drug: DAS181 COVID-19|Drug: DAS181 OL,All,"Child, Adult, Older Adult",Phase 3,274.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 23, 2019","December 31, 2023"
3814,NCT04823988,Not yet recruiting,No Results Available,Healthy Volunteer,,All,"Adult, Older Adult",,3000.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 19, 2021","January 27, 2022"
3815,NCT04368637,Recruiting,No Results Available,"Acute Myocardial Infarction|Ventricular Tachycardia|Sudden Cardiac Death|Stroke, Acute",,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 3, 2020","August 30, 2020"
3816,NCT04636034,Recruiting,No Results Available,Headache|Covid19|Sphenopalatine Ganglion Block|Persistent Headache Following COVID-19,"Procedure: Sphenopalatine Ganglion Block with Local Anesthetic|Procedure: Sphenopalatine Ganglion Block with Placebo (Isotone NaCl)|Procedure: ""Sham""-block with Placebo (Isotone NaCl)",All,"Adult, Older Adult",Phase 3,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 12, 2021",November 2021
3817,NCT04405570,Completed,No Results Available,SARS-CoV 2,Drug: EIDD-2801|Drug: Placebo (PBO),All,"Adult, Older Adult",Phase 2,204.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 16, 2020","February 21, 2021"
3818,NCT04604223,Recruiting,No Results Available,Covid19|Type 2 Diabetes,Drug: Pioglitazone 45 mg,All,"Adult, Older Adult",Phase 4,1506.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 18, 2021","June 29, 2021"
3819,NCT04477655,Completed,No Results Available,Covid19,Procedure: Awake prone positioning|Procedure: Standard oxygen therapy,All,"Adult, Older Adult",Not Applicable,430.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 3, 2020","January 26, 2021"
3820,NCT04710329,Completed,No Results Available,"Respiratory Distress Syndrome, Adult|Covid19",Drug: Ascorbic acid,All,"Adult, Older Adult",,78.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 16, 2021","February 10, 2021"
3821,NCT04336657,Recruiting,No Results Available,COVID-19,Other: Questionnaire|Diagnostic Test: IgG,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,April 2020,May 2020
3822,NCT04322188,Completed,No Results Available,Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection,,All,"Adult, Older Adult",,220.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 19, 2020","May 8, 2020"
3823,NCT04542083,Not yet recruiting,No Results Available,COVID-19|Acute Cardiovascular Condition|Acute Neurovascular Condition|Stroke|Acute Myocardial Infarction,,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 20, 2021","June 30, 2021"
3824,NCT04458337,Recruiting,No Results Available,"Covid-19|SARS-CoV2|Surgery|Surgical Procedure; Complications, Late Effect of Complications|Postoperative Complications",,All,"Child, Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 13, 2020","April 13, 2022"
3825,NCT04667962,Recruiting,No Results Available,"Burnout, Caregiver",Other: Online questionnaire,All,"Adult, Older Adult",,302.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 23, 2020",September 2021
3826,NCT04348383,Recruiting,No Results Available,COVID19,Drug: Defibrotide 25 mg/kg 24 hours continuous infusion for 15 days|Drug: Placebo 250 cc 24 hours continuous infusion for 15 days,All,"Adult, Older Adult",Phase 2,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 8, 2020","May 15, 2021"
3827,NCT04556513,Recruiting,No Results Available,Covid19|ARDS|Functional Recovery,Other: Paraclinical examination|Other: Clinical Examination|Other: Semi-directive interview|Other: quality of life questionnaires,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 18, 2020",November 2022
3828,NCT04494646,Completed,No Results Available,Covid19,Drug: Bardoxolone Methyl|Drug: Placebo,All,"Adult, Older Adult",Phase 2,40.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 8, 2020","January 8, 2021"
3829,NCT04310865,Suspended,No Results Available,COVID-19|Severe Pneumonia|Chinese Medicine,Drug: Yinhu Qingwen Granula|Drug: Yin Hu Qing Wen Granula(low does)|Other: standard medical treatment,All,"Adult, Older Adult",Phase 2|Phase 3,116.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",November 2020,"June 30, 2021"
3830,NCT04389996,"Active, not recruiting",No Results Available,Cancer,Other: No intervention,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 14, 2020","May 1, 2023"
3831,NCT04361435,Not yet recruiting,No Results Available,COVID-19|Physiotherapy,Procedure: Chest physiotherapy using a non-invasive oscillating device,All,"Child, Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 1, 2020","December 31, 2020"
3832,NCT04341116,Recruiting,No Results Available,Coronavirus Disease 2019 COVID-19,Drug: TJ003234|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,384.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 11, 2020",December 2021
3833,NCT04663555,Recruiting,No Results Available,Covid19|ARDS,Drug: Dexamethasone,All,"Adult, Older Adult",Phase 4,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 2, 2021","March 31, 2023"
3834,NCT04718285,Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Montelukast Oral Tablet|Drug: Montelukast plus Favicovir (Favipiravir)|Drug: Favicovir (Standard Treatment),All,"Adult, Older Adult",Phase 2,380.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 30, 2021","May 30, 2021"
3835,NCT04437823,Recruiting,No Results Available,Corona Virus Infection,Biological: Intravenous Infusions of Stem Cells,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","June 30, 2021"
3836,NCT04433325,Not yet recruiting,No Results Available,COVID-19|Intensive Care Unit Syndrome,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,June 2020,September 2020
3837,NCT04818866,Recruiting,No Results Available,"Covid19|Outcome, Fatal|Respiratory Failure|Acute Kidney Injury|Inflammation","Diagnostic Test: SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase",All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2020","December 30, 2021"
3838,NCT04541680,Recruiting,No Results Available,SARS-Cov-2 Induced Pulmonary Fibrosis,Drug: Nintedanib 150 MG [Ofev]|Other: Placebo,All,"Adult, Older Adult",Phase 3,250.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","October 29, 2020",December 2021
3839,NCT04646642,Completed,No Results Available,Coping Skills|Healthcare Workers|Covid19,,All,"Child, Adult, Older Adult",,21.0,U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 14, 2020","February 1, 2021"
3840,NCT04408326,Recruiting,No Results Available,COVID|Acute Respiratory Distress Syndrome,Drug: Angiotensin II|Drug: Interleukin-1 receptor antagonist,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"June 1, 2020","May 1, 2021"
3841,NCT04476953,Enrolling by invitation,No Results Available,Covid19,Drug: Placebo|Drug: Fisetin,All,"Adult, Older Adult",Phase 2,70.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 3, 2020",July 2021
3842,NCT04359290,"Active, not recruiting",No Results Available,"ARDS, Human|COVID",Drug: Ruxolitinib administration,All,"Adult, Older Adult",Phase 2,15.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 1, 2020",July 2021
3843,NCT04345159,Completed,No Results Available,SARS-CoV-2|Systemic Lupus Erythematosus|Rheumatoid Arthritis|Sjogren's Syndrome|Psoriatic Arthritis,Other: Questionnaire by phone call,All,"Adult, Older Adult",,572.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 17, 2020","November 30, 2020"
3844,NCT04815031,Not yet recruiting,No Results Available,COVID-19,Biological: BNT162b2,All,"Child, Adult, Older Adult",,20000.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 7, 2021","December 12, 2022"
3845,NCT04366115,Not yet recruiting,No Results Available,"ARDS|Covid19|Influenza, Human",Drug: AVM0703|Drug: Placebo,All,"Adult, Older Adult",Phase 1,16.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",January 2021,June 2023
3846,NCT04468802,Completed,No Results Available,Covid19|Measles Vaccine|Mortality,Other: Case fatality rate,All,"Child, Adult, Older Adult",,32.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 1, 2020","July 1, 2020"
3847,NCT04288102,Completed,No Results Available,Corona Virus Disease 2019(COVID-19),Biological: UC-MSCs|Biological: Saline containing 1% Human serum albumin（solution without UC-MSCs）,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 5, 2020","July 9, 2020"
3848,NCT04420338,Recruiting,No Results Available,Chronic Hemodialysis Patients|Caregivers of Chronic Hemodialysis Patients,Biological: Blood sample|Biological: Serum tube collection,All,"Adult, Older Adult",Not Applicable,800.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 5, 2020","December 15, 2020"
3849,NCT04402944,Recruiting,No Results Available,COVID,Drug: Pulmozyme|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 5, 2020","December 31, 2021"
3850,NCT04323592,Completed,Has Results,"Severe Acute Respiratory Syndrome (SARS) Pneumonia|Coronavirus Infections|ARDS, Human",Drug: Methylprednisolone|Other: standard care,All,"Adult, Older Adult",,173.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2020","May 10, 2020"
3851,NCT04374370,Available,No Results Available,COVID|SARSCoV2 Convalescent Plasma,Biological: SARSCoV2 Convalescent Plasma,All,"Child, Adult, Older Adult",,,Other,Expanded Access:Intermediate-size Population,,,
3852,NCT04346368,Not yet recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19),Biological: BM-MSCs|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,April 2020,December 2020
3853,NCT04631705,Recruiting,No Results Available,SARS-CoV-2 Infection,Biological: DZIF-10c|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,78.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","December 14, 2020","July 31, 2021"
3854,NCT04680858,Enrolling by invitation,No Results Available,Endoscopy|Communication,Other: DECT,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"July 1, 2020","February 15, 2021"
3855,NCT04412031,Completed,No Results Available,to Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of Patients,Other: non applicable,All,"Adult, Older Adult",,802.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"November 11, 2019","May 15, 2020"
3856,NCT04548505,Recruiting,No Results Available,SARS-CoV Infection,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 5, 2020","April 5, 2023"
3857,NCT04574869,Not yet recruiting,No Results Available,Acute Lung Injury|ALI|COVID-19,Drug: RLS-0071|Drug: Placebo,All,"Adult, Older Adult",Phase 1,42.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",October 2020,July 2021
3858,NCT04409886,Not yet recruiting,No Results Available,"COVID, Coronavirus",Device: Hyperbaric Chamber,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 1, 2020","March 30, 2021"
3859,NCT04346797,Recruiting,No Results Available,SARS-CoV-2|COVID19,Drug: Eculizumab,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","December 31, 2020"
3860,NCT04345419,Recruiting,No Results Available,COVID,Drug: Remdesivir|Other: Standard of care treatment,All,"Child, Adult, Older Adult",Phase 2|Phase 3,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 16, 2020",December 2029
3861,NCT04497194,Recruiting,No Results Available,Coronavirus Disease 2019,Other: not applicable (observational study),All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 1, 2020","September 30, 2020"
3862,NCT04492514,Recruiting,No Results Available,COVID 19|SARS-CoV 2|Pneumonia,Drug: Mavrilimumab|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 20, 2020","May 31, 2021"
3863,NCT04712110,"Active, not recruiting",No Results Available,Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2),Biological: TAK-019|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,200.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 24, 2021","April 4, 2022"
3864,NCT04404426,Recruiting,No Results Available,ARDS Secondary to COVID-19 Pneumonia,Dietary Supplement: L-citrulline|Other: Placebo,All,"Adult, Older Adult",Not Applicable,32.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 2, 2020","September 15, 2021"
3865,NCT04543760,Recruiting,No Results Available,Covid19,Other: Prone position|Other: Supine position,All,"Adult, Older Adult",Not Applicable,18.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"October 1, 2020",May 2021
3866,NCT04356482,Recruiting,No Results Available,COVID-19|SARS-CoV 2|Convalescence|Plasma|Doses,Biological: convalescent plasma,All,"Child, Adult, Older Adult",Phase 1|Phase 2,90.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020",December 2020
3867,NCT04435457,Recruiting,No Results Available,SARS-CoV 2|SARS Pneumonia|COVID-19|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|Cardiac Complication,,All,"Adult, Older Adult",,70.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"September 1, 2020","June 30, 2021"
3868,NCT04320511,Recruiting,No Results Available,SARS-COV2|Severe Acute Respiratory Syndrome|COVID-19,Device: CT-V,All,"Adult, Older Adult",,25.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 24, 2020",June 2022
3869,NCT04519307,"Active, not recruiting",No Results Available,Viral Infection,,All,Child,,72.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 1, 2020","August 31, 2020"
3870,NCT04492384,Completed,No Results Available,Covid19|SARS-CoV-2 Infection|Pneumonia|Copd|CKD|Cardiac Event|Overweight and Obesity|Cardiovascular Diseases|Diabetes|Hypertension|Coronary Heart Disease,Other: non-interventional,All,"Adult, Older Adult",,3500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 11, 2020","January 14, 2021"
3871,NCT04429555,Recruiting,No Results Available,"Pneumonia, Viral",Drug: Ibudilast|Drug: Placebo,All,"Adult, Older Adult",Phase 2,40.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","January 11, 2021","December 1, 2021"
3872,NCT04462367,Recruiting,No Results Available,COVID19|Coronavirus Infection|Pregnancy Disease|Severe Acute Respiratory Syndrome,,Female,"Child, Adult, Older Adult",,180.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 1, 2020","December 20, 2022"
3873,NCT04776317,Recruiting,No Results Available,COVID-19,"Biological: ChAdV68-S|Biological: ChAdV68-S-TCE|Biological: SAM-LNP-S|Biological: SAM-LNP-S-TCE|Other: Sodium Chloride, 0.9%",All,"Adult, Older Adult",Phase 1,130.0,NIH|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 25, 2021","September 19, 2022"
3874,NCT04605887,Recruiting,No Results Available,COVID-19,Drug: Angiotensin 1-7,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","January 18, 2021",April 2024
3875,NCT04621214,Completed,No Results Available,Audio-Visual Triage System|Anxiety Levels|COVID-19 Spread|GAD-7 Score|Healthcare Professionals|Screening Strategy,Device: Audio-Visual Triage System (AVT),All,Adult,,60.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"March 21, 2020","April 28, 2020"
3876,NCT04649736,Recruiting,No Results Available,Covid19|Respiratory Disease|Mental Health Disorder,Other: Respiratory and psychological rehabilitation,All,"Adult, Older Adult",Not Applicable,108.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"October 26, 2020","March 30, 2021"
3877,NCT04332913,Recruiting,No Results Available,COVID-19 Pneumonia,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","March 31, 2021"
3878,NCT04492475,Completed,No Results Available,COVID-19,Drug: Interferon beta-1a|Other: Placebo|Drug: Remdesivir,All,"Adult, Older Adult",Phase 3,969.0,NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 5, 2020","December 21, 2020"
3879,NCT04353141,Recruiting,No Results Available,"COVID|Pregnancy Complications, Infectious|Pregnancy Related|Pregnancy, High Risk|Pregnancy Disease|Pneumonia|Pneumonia, Viral|Diagnoses Disease",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,Female,"Child, Adult, Older Adult",,1850.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 28, 2020","December 31, 2020"
3880,NCT04395105,Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult|Covid-19",Drug: Dexamethasone (high dose),All,"Adult, Older Adult",Phase 3,284.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 21, 2020","January 31, 2021"
3881,NCT04399980,"Active, not recruiting",No Results Available,COVID 19|SARS-CoV 2|Pneumonia,Drug: Mavrilimumab|Drug: Placebos,All,"Adult, Older Adult",Phase 2,30.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 20, 2020","May 31, 2021"
3882,NCT04403646,Terminated,No Results Available,COVID-19|SARS-CoV 2|Coronavirus Infection,Dietary Supplement: ARBOX|Other: PLACEBO,All,"Adult, Older Adult",Not Applicable,124.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 12, 2020","November 1, 2020"
3883,NCT04377100,Recruiting,No Results Available,Anxiety|Healthy Volunteers,Behavioral: Computer task questionnaires,All,"Adult, Older Adult",Not Applicable,6000.0,NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"April 19, 2021","February 28, 2022"
3884,NCT04449627,Not yet recruiting,No Results Available,Anxiety Disorders|Post Traumatic Stress Disorder|Depressive Disorder|Covid19,Other: Feeling Good Digital App,All,"Adult, Older Adult",,125.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 31, 2020","January 31, 2021"
3885,NCT04401579,Completed,No Results Available,COVID-19,Other: Placebo|Drug: Remdesivir|Drug: Baricitinib,All,"Adult, Older Adult",Phase 3,1034.0,NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 8, 2020","July 31, 2020"
3886,NCT04412278,Completed,No Results Available,"COVID|Isolation, Social",Other: Online Survey,All,"Child, Adult, Older Adult",,392.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"June 1, 2020","June 8, 2020"
3887,NCT04761107,Recruiting,No Results Available,COVID-19 Infection|Genitourinary Cancer|Benign Urologic Conditions,,All,"Adult, Older Adult",,15240.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 18, 2021",February 2026
3888,NCT04570982,Recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Prospective,"July 30, 2020","December 30, 2020"
3889,NCT04502069,Withdrawn,No Results Available,COVID-19|Lung Infection,Drug: Opaganib,All,"Adult, Older Adult",Phase 1|Phase 2,0.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,August 2020,June 2021
3890,NCT04597853,Not yet recruiting,No Results Available,Covid19|ARDS,Diagnostic Test: Assessment of lung mechanics and heart-lung interactions,All,"Adult, Older Adult",,25.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 20, 2020","December 31, 2021"
3891,NCT04445311,Recruiting,No Results Available,COVID,Drug: Ivermectin,All,"Adult, Older Adult",Phase 2|Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 31, 2020","August 15, 2020"
3892,NCT04372082,Withdrawn,No Results Available,Sars-CoV2,Other: Standard of care (SOC)|Drug: Hydroxychloroquine|Drug: Association of diltiazem and niclosamide,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,May 2020,May 2023
3893,NCT04713111,Completed,No Results Available,Covid19|Stress|Wearables,Behavioral: Lifestyle (Meditation)|Behavioral: Lifestyle (Exercise),All,"Adult, Older Adult",Not Applicable,383.0,Other|Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"May 4, 2020","November 30, 2020"
3894,NCT04772703,Recruiting,No Results Available,"Covid19|Organ Failure, Multiple|DNA Damage",Diagnostic Test: COMET ASSAY,All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 23, 2020","July 30, 2021"
3895,NCT04387409,"Active, not recruiting",No Results Available,"Infection, Respiratory Tract",Biological: VPM1002|Biological: Placebo,All,"Adult, Older Adult",Phase 3,59.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 25, 2020","May 1, 2021"
3896,NCT04379245,Completed,No Results Available,HIV|Pre-exposure Prophylaxis,"Other: Data research, database analysis",All,"Adult, Older Adult",,4200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 30, 2020","May 4, 2020"
3897,NCT04725084,Completed,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Other: Use of High Flow Nasal Cannula alone|Other: Use of Non-invasive Ventilation|Other: Use of Continuous Positive Airway Pressure,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 1, 2020","December 15, 2020"
3898,NCT04530617,Recruiting,No Results Available,Covid19|Diabetes|Hypertension|Obesity,Drug: Camostat Mesilate|Drug: Artemisia Annua Leaf,All,"Adult, Older Adult",Phase 2,360.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","October 5, 2020","April 30, 2021"
3899,NCT04412551,Recruiting,No Results Available,Corona Virus Infection|Virus Diseases|Coronaviridae Infections,,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 20, 2020","December 31, 2020"
3900,NCT04442048,Recruiting,No Results Available,Cancer|Covid-19,Biological: IMM-101|Other: Observation,All,"Adult, Older Adult",Phase 3,1500.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 25, 2020","March 31, 2022"
3901,NCT04388709,Withdrawn,No Results Available,SARS-CoV-2,Drug: Peginterferon Lambda-1A,All,"Adult, Older Adult",Phase 2,0.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,September 2020,"February 5, 2021"
3902,NCT04357769,Completed,No Results Available,Psychological Distress|COVID|Severe Mental Disorder,Other: PSS (Perceived Stress Scale)|Other: GAD-7 (7-item Generalized Anxiety Disorder)|Other: PHQ-9 (9-item Patient Health Questionnaire)|Other: SPEQ (Specific Psychotic Experiences Questionnaire) - Paranoia and Grandiosity Subscales|Other: Zaritt Burden Interview,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"April 10, 2020","April 25, 2020"
3903,NCT04588792,Recruiting,No Results Available,Covid19|Respiratory Failure,Drug: Nebulized Furosemide|Drug: Nebulized Saline,All,"Adult, Older Adult",Phase 2|Phase 3,640.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 1, 2021","October 1, 2021"
3904,NCT04590352,Completed,No Results Available,SARS-CoV-2 Infection,Procedure: nasopharyngeal and throat swab|Procedure: collection of mucosal lining fluid|Procedure: blood collection via fingerprick,All,"Child, Adult, Older Adult",,187.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 26, 2020","May 13, 2020"
3905,NCT04403932,Completed,No Results Available,Coronavirus Disease 2019 (COVID-19),,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 17, 2020","August 1, 2020"
3906,NCT04730206,Not yet recruiting,No Results Available,Covid19|SARS-CoV Infection,Drug: Camostat|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1306.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",March 2021,May 2023
3907,NCT04401293,Recruiting,No Results Available,Sars-CoV2|COVID,Drug: Enoxaparin|Drug: Prophylactic/Intermediate Dose Enoxaparin,All,"Adult, Older Adult",Phase 3,308.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 26, 2020","April 26, 2021"
3908,NCT04649086,Recruiting,No Results Available,Covid19|Sarcopenia|Muscle Weakness,Other: Rehabilitation by Eccentric exercises|Other: Rehabilitation by Concentric exercises,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 5, 2020","December 5, 2021"
3909,NCT04535154,"Active, not recruiting",No Results Available,Covid19|Lung Function Decreased,Other: No interventions,All,"Adult, Older Adult",,264.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 31, 2020","June 1, 2022"
3910,NCT04405908,"Active, not recruiting",No Results Available,COVID-19,Biological: SCB-2019|Biological: SCB-2019 with AS03 adjuvant|Biological: SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant,All,"Adult, Older Adult",Phase 1,150.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 19, 2020","May 25, 2021"
3911,NCT04657458,Available,No Results Available,Covid19|ARDS|Hypoxia|Cytokine Storm,Biological: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment,All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population,,,
3912,NCT04355364,Recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome,Drug: Dornase Alfa Inhalation Solution [Pulmozyme]|Procedure: standard procedure,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"April 21, 2020","April 21, 2021"
3913,NCT04353037,Terminated,No Results Available,Coronavirus|Corona Virus Infection,Drug: Group A HCQ|Drug: Group B Control,All,"Adult, Older Adult",Phase 2,21.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","April 7, 2020","July 11, 2020"
3914,NCT04640168,Recruiting,No Results Available,COVID-19,Drug: Baricitinib|Drug: Dexamethasone|Other: Placebo|Drug: Remdesivir,All,"Adult, Older Adult",Phase 3,1500.0,NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 24, 2020","June 30, 2021"
3915,NCT04636554,Available,No Results Available,Covid19|Bacteremia|Septicemia|Acinetobacter Baumannii Infection|Pseudomonas Aeruginosa Infection|Staph Aureus Infection,Other: Phage Therapy,All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,
3916,NCT04724642,Recruiting,No Results Available,Allogenic Hematopoietic Cell Transplant|CAR-T Therapy|Primary Immunodeficiency,,All,"Adult, Older Adult",,110.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 28, 2020","December 28, 2021"
3917,NCT04409184,Withdrawn,No Results Available,COVID|Sars-CoV2,,All,"Adult, Older Adult",,0.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 14, 2020","August 14, 2020"
3918,NCT04537806,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Drug: Brexanolone|Drug: Placebo,All,"Adult, Older Adult",Phase 3,100.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","December 18, 2020",October 2021
3919,NCT04844567,Recruiting,No Results Available,Covid19|Dyspnea,Device: COVVR,All,"Adult, Older Adult",Not Applicable,35.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"November 26, 2020","December 31, 2021"
3920,NCT04321369,Completed,No Results Available,"Infections, Respiratory|Fever|Cough",Diagnostic Test: Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals,All,"Child, Adult, Older Adult",,533.0,Industry|Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 9, 2020","March 23, 2020"
3921,NCT04356586,Completed,No Results Available,COVID-19|Serology,,All,"Adult, Older Adult",,287.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 4, 2020","August 21, 2020"
3922,NCT04582201,Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult",Drug: agenT-797,All,"Adult, Older Adult",Phase 1,55.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 21, 2020","October 15, 2021"
3923,NCT04595123,Recruiting,No Results Available,Post Traumatic Stress Disorder|Depression|Anxiety|Psychological Distress,,Female,"Adult, Older Adult",,3900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2020","June 15, 2021"
3924,NCT04395456,Not yet recruiting,No Results Available,Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19),Drug: AMY-101|Other: WFI 5% glucose,All,"Adult, Older Adult",Phase 2,144.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,September 2021,December 2022
3925,NCT04379258,Completed,No Results Available,"COVID-19|Critical Illness|Effectiveness|Outcome, Fatal",,All,"Adult, Older Adult",,868.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 8, 2021","February 8, 2021"
3926,NCT04692779,Recruiting,No Results Available,Covid19|ARDS,Other: Lung Ultrasound (LUS),All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 31, 2021","October 30, 2021"
3927,NCT04344210,Completed,No Results Available,"COVID|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1",Behavioral: Tele-interventions related to diabetes management and mental well-being,All,"Adult, Older Adult",Not Applicable,149.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 17, 2020","September 20, 2020"
3928,NCT04412057,Completed,No Results Available,COVID-19 Pneumonia|Acute Lung Injury|ARDS,Drug: CERC-002|Drug: Placebo,All,"Adult, Older Adult",Phase 2,83.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 9, 2020","January 19, 2021"
3929,NCT04681950,Recruiting,No Results Available,Subjects Possibly Exposed to COVID-19,,All,"Child, Adult, Older Adult",,500.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Other,"November 24, 2020","December 31, 2020"
3930,NCT04586114,"Active, not recruiting",No Results Available,Acute Respiratory Distress Syndrome Secondary to Covid-19,Drug: Corticosteroids and Derivatives,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","December 31, 2020"
3931,NCT04321174,Recruiting,No Results Available,Coronavirus Infections|Post-exposure Prophylaxis,Drug: Lopinavir/ritonavir,All,"Child, Adult, Older Adult",Phase 3,1220.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"April 17, 2020","March 31, 2022"
3932,NCT04467840,Recruiting,No Results Available,COVID-19|Lung Infection,Drug: Opaganib|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,464.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 21, 2020",June 2021
3933,NCT04712045,Completed,No Results Available,Covid19|Personal Protective Equipment,Other: New PPE|Other: Old PPE,All,"Child, Adult, Older Adult",Not Applicable,67.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 1, 2020","December 12, 2020"
3934,NCT04720378,Recruiting,No Results Available,Cytokine Release Syndrome,Biological: ST266,All,"Adult, Older Adult",Phase 1,12.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,August 2021
3935,NCT04418193,Withdrawn,No Results Available,Coronavirus,,All,"Adult, Older Adult",,0.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 6, 2020","February 4, 2021"
3936,NCT04815304,Recruiting,No Results Available,Covid19|Acute Respiratory Distress Syndrome|Ventilatory Failure,Diagnostic Test: peripheral lymphocytes subsets,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 13, 2020","March 13, 2022"
3937,NCT04583319,Recruiting,No Results Available,SARS-CoV,Diagnostic Test: EasyCov POC,All,"Adult, Older Adult",,160.0,Industry|Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,October 2020,March 2021
3938,NCT04558645,Completed,No Results Available,Type 1 Diabetes Mellitus|Covid19,Other: Online Survey,All,"Adult, Older Adult",,118.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"September 18, 2020","December 26, 2020"
3939,NCT04525378,Recruiting,No Results Available,"Covid19|ARDS, Human",Other: Mesenchymal stromal cell-based therapy,All,"Adult, Older Adult",Phase 1,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 1, 2020","October 31, 2020"
3940,NCT04402203,Recruiting,No Results Available,COVID-19|Favipiravir (Favipira),Drug: Favipiravir|Drug: Only Standard Treatment,All,"Adult, Older Adult",Phase 2|Phase 3,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment",May 2020,July 2020
3941,NCT04636671,Not yet recruiting,No Results Available,Covid19|Viral Pneumonia Human Coronavirus|Severe Acute Respiratory Syndrome,Drug: Methylprednisolone|Drug: Dexamethasone,All,"Adult, Older Adult",Phase 3,680.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 25, 2020","April 30, 2021"
3942,NCT04273321,Completed,No Results Available,COVID-19|Novel Coronavirus Pneumonia,Drug: Methylprednisolone,All,"Adult, Older Adult",Not Applicable,86.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 14, 2020","April 15, 2020"
3943,NCT04595097,Not yet recruiting,No Results Available,Covid19|Exercise,Device: inspiratory muscle traiing,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","February 1, 2021","September 30, 2021"
3944,NCT04677478,Not yet recruiting,No Results Available,Tuberculosis|Covid19,Other: Impact of respiratory isolation on quality of life,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,December 2020,January 2022
3945,NCT04372589,"Active, not recruiting",No Results Available,COVID-19|Pneumonia,Drug: Heparin,All,"Adult, Older Adult",Phase 2|Phase 3,1203.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020",January 2021
3946,NCT04385810,Completed,No Results Available,Covid19|Sars-CoV2,Procedure: Ophthalmologic exam,All,"Adult, Older Adult",Not Applicable,23.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 27, 2020","July 29, 2020"
3947,NCT04672291,Not yet recruiting,No Results Available,COVID - 19,Drug: Poly-ICLC (Hiltonol®),All,Adult,Phase 1,43.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2021","January 16, 2024"
3948,NCT04816643,Recruiting,No Results Available,"SARS-CoV-2 Infection, COVID-19",Biological: Biological/Vaccine: BNT162b2 10mcg|Biological: BNT162b2 20mcg|Biological: BNT162b2 30mcg,All,Child,Phase 1,4644.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 24, 2021","August 29, 2023"
3949,NCT04354558,Recruiting,No Results Available,Epidemiology|Sars-CoV2|COVID 19|Critical Care|Prognostic|Survival,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020",August 2021
3950,NCT04761913,Not yet recruiting,No Results Available,Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-Cov-2,,All,Child,,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,April 2021,December 2021
3951,NCT04361526,Recruiting,No Results Available,Coronavirus Infection|Acute Respiratory Distress Syndrome|COVID,Device: Cytokine Adsorption,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 17, 2020",July 2020
3952,NCT04381364,Recruiting,No Results Available,"Covid-19|Pneumonia, Viral|Sars-CoV2",Drug: Ciclesonide Inhalation Aerosol,All,"Adult, Older Adult",Phase 2,446.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 29, 2020","May 1, 2022"
3953,NCT04463628,Recruiting,No Results Available,Cystic Fibrosis in Children|Cystic Fibrosis,Behavioral: Questionnaire|Behavioral: Interview,All,"Child, Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020","June 30, 2021"
3954,NCT04721457,Recruiting,No Results Available,SARS-CoV-2|COVID-19|Mouthwashes|Viral Load|Polymerase Chain Reaction,Drug: Distilled Water|Drug: 1% Povidone Iodine (PVP-I)|Drug: 1.5% Hydrogen Peroxide (H2O2)|Drug: 0.075% Cetylpyridinium Chloride (CPC)|Drug: 0.1% Sodium Hypochlorite,All,"Adult, Older Adult",Phase 4,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 3, 2021","June 30, 2021"
3955,NCT04480034,Recruiting,No Results Available,"Bariatric Surgery Candidate|Covid19|Complication of Surgical Procedure|Pneumonia, Viral|Viral Infection|Obesity, Morbid|Safety Issues|Readmission",Procedure: Bariatric procedures,All,Adult,,1600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 15, 2020","May 30, 2021"
3956,NCT04393727,Terminated,No Results Available,COVID|SARS-CoV 2,Biological: CONVALESCENT PLASMA,All,"Adult, Older Adult",Phase 2,1.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","September 30, 2020"
3957,NCT04358588,No longer available,No Results Available,"Coronavirus Infection|COVID-19|Pneumonia, Viral",Drug: iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System,All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population,,,
3958,NCT04623177,"Active, not recruiting",No Results Available,Covid19|Anticoagulant Therapy|Thrombosis,,All,"Adult, Older Adult",,950.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2020",November 2020
3959,NCT04531202,Recruiting,No Results Available,Coronavirus Infection (COVID-19),,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 2, 2020","September 30, 2021"
3960,NCT04673318,Not yet recruiting,No Results Available,Covid19|Physical Disability,Behavioral: heat therapy|Behavioral: exercise training,All,"Adult, Older Adult",Not Applicable,87.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,January 2021,December 2023
3961,NCT04400929,Recruiting,No Results Available,"COVID|Sars-CoV2|ARDS, Human",Drug: Sargramostim|Other: Normal Saline 0.9%,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 2, 2020",June 2022
3962,NCT04453566,Recruiting,No Results Available,COVID-19|Life Satisfaction|Anxiety|Mental Health Wellness 1|Athlete|Stress,Other: Online Survey,All,Adult,,120.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"May 27, 2020",December 2020
3963,NCT04508023,Recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19),Drug: Rivaroxaban|Other: Placebo|Other: Standard of Care (SOC),All,"Adult, Older Adult",Phase 3,4000.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 13, 2020","January 31, 2022"
3964,NCT04348695,Recruiting,No Results Available,Coronavirus Infection,Drug: Ruxolitinib plus simvastatin|Other: Standard of Care,All,"Adult, Older Adult",Phase 2,94.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 12, 2020","May 13, 2020"
3965,NCT04730856,Not yet recruiting,No Results Available,Covid19|Thrombosis,Drug: Tinzaparin,All,"Adult, Older Adult",Phase 3,600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 29, 2021","July 31, 2021"
3966,NCT04581577,Recruiting,No Results Available,Neuromuscular Diseases|Neurological Diseases or Conditions,Other: Semi-structured telephone questionnaire,All,"Child, Adult, Older Adult",,75.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"September 11, 2020","April 30, 2021"
3967,NCT04826731,Recruiting,No Results Available,"Covid19|Respiratory Function Loss|Coronavirus Infection|Pneumonia, Viral",Other: Incentive Spirometer/Respiratory Exerciser,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 1, 2021",July 2021
3968,NCT04547283,Recruiting,No Results Available,Covid19|Respiratory Failure,Other: Usual Care|Other: APPS,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 14, 2020","September 30, 2020"
3969,NCT04646603,Recruiting,No Results Available,COVID-19,Drug: MRG-001|Drug: Placebo,All,Adult,Phase 1|Phase 2,18.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","January 28, 2021","June 5, 2021"
3970,NCT04319211,Not yet recruiting,No Results Available,Healthy People,"Other: Determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus.",All,Adult,,200.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"March 25, 2020","July 20, 2020"
3971,NCT04392713,Recruiting,No Results Available,COVID,Drug: Ivermectin 6 MG Oral Tablet (2 tablets),All,"Child, Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020",July 2020
3972,NCT04666441,"Active, not recruiting",No Results Available,COVID-19,Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,All,"Adult, Older Adult",Phase 2,1164.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 15, 2020","August 13, 2021"
3973,NCT04257656,Terminated,No Results Available,COVID-19|Remdesivir|SARS-CoV-2,Drug: Remdesivir|Drug: Remdesivir placebo,All,"Adult, Older Adult",Phase 3,237.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 6, 2020","April 10, 2020"
3974,NCT04799808,Recruiting,No Results Available,SARS-CoV-2 Infection|Active Immunization|Immune Response|Immunosuppression,,All,"Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 15, 2021","December 31, 2022"
3975,NCT04397172,Recruiting,No Results Available,COVID|Corona Virus Infection|Sars-CoV2,Procedure: Study Arm,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2020",December 2021
3976,NCT04371523,Not yet recruiting,No Results Available,Corona Virus Infection,Drug: Apo-Hydroxychloroquine|Drug: Matched Placebo,All,"Adult, Older Adult",Phase 3,1100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 1, 2020","August 30, 2020"
3977,NCT04459364,Completed,No Results Available,"Hypertension, Pulmonary|Right Ventricular Overload|COVID",,All,"Adult, Older Adult",,67.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Other,"June 1, 2020","July 15, 2020"
3978,NCT04769284,Completed,No Results Available,"Stress, Psychological|Anxiety|Depression|Covid19",Other: Mental health student,All,"Child, Adult, Older Adult",,332.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 12, 2021","February 21, 2021"
3979,NCT04629989,Completed,No Results Available,Covid19|Hypoxemia,Other: Standard Oxygen Delivery System|Other: Double-Trunk Mask|Other: Surgical Mask,All,"Adult, Older Adult",Not Applicable,27.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"November 13, 2020","March 5, 2021"
3980,NCT04442152,Enrolling by invitation,No Results Available,Gender Relations|Partner Communication|Division of Carework|Couple Conflict|Stress,Behavioral: MenCare+/Bandebereho fathers'/couples' group education,All,Adult,Not Applicable,1000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,June 2020,August 2020
3981,NCT04412330,Recruiting,No Results Available,Covid-19|Critical Illness|Post Intensive Care Unit Syndrome|Muscle Weakness,Other: ICU Recovery + Physical Therapy,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","May 1, 2021"
3982,NCT04368793,Recruiting,No Results Available,COVID-2019 Pneumonia|Pulmonary Rehabilitation,Behavioral: Remote pulmonary rehabilitation,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 6, 2020","December 31, 2021"
3983,NCT04372680,Recruiting,No Results Available,"COVID-19|ARDS, Human|Mechanical Ventilation",Diagnostic Test: CTUS examination,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 22, 2020","October 22, 2021"
3984,NCT04791462,Not yet recruiting,No Results Available,Osteoarthritis,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 10, 2021","December 30, 2021"
3985,NCT04285190,Withdrawn,No Results Available,Coronavirus Disease 2019|Novel Coronavirus Pneumonia,Drug: T89,All,"Adult, Older Adult",Not Applicable,0.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 26, 2020","April 20, 2020"
3986,NCT04616989,Not yet recruiting,No Results Available,Community Mental Health,Behavioral: Psycho-education|Behavioral: Comparator,All,"Adult, Older Adult",Not Applicable,840.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"January 1, 2021","July 30, 2021"
3987,NCT04842448,Not yet recruiting,No Results Available,COVID-19,Drug: Hyperbaric oxygen|Procedure: Sham treatment,All,Adult,Phase 2,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment",June 2021,December 2023
3988,NCT04447534,Recruiting,No Results Available,COVID,Drug: Chloroquine|Drug: zinc,All,"Adult, Older Adult",Phase 3,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","June 23, 2020","October 1, 2030"
3989,NCT04430322,Recruiting,No Results Available,COVID,,All,"Child, Adult, Older Adult",,330.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 1, 2020","June 30, 2021"
3990,NCT04370678,Completed,No Results Available,Arthroscopy,Behavioral: Change in preference to surgery under COVID-19 pandemic.,All,"Adult, Older Adult",,79.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 17, 2020","April 24, 2020"
3991,NCT04406571,Recruiting,No Results Available,Pancreatic Adenocarcinoma,Other: Data record,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020",April 2022
3992,NCT04359901,"Active, not recruiting",No Results Available,COVID,Biological: SARILUMAB,All,"Adult, Older Adult",Phase 2,50.0,U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 10, 2020",April 2023
3993,NCT04507230,Completed,No Results Available,Coagulopathy,,All,"Child, Adult, Older Adult",,106.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"August 7, 2020","October 31, 2020"
3994,NCT04522089,Recruiting,No Results Available,COVID-19,Biological: AdimrSC-2f,All,Adult,Phase 1,70.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 24, 2020","March 20, 2021"
3995,NCT04447469,Recruiting,No Results Available,COVID,Drug: mavrilimumab|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,588.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 27, 2020",February 2022
3996,NCT04412239,Recruiting,No Results Available,TB - Tuberculosis|Patient Satisfaction,Behavioral: Patient-centred advice on Telephone Consultation in TB Patients:,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 20, 2020","December 20, 2020"
3997,NCT04604119,Completed,No Results Available,Sars-CoV2|Anxiety|Burnout,,All,"Adult, Older Adult",,104.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 1, 2020","June 1, 2020"
3998,NCT04838847,Not yet recruiting,No Results Available,Coronavirus|Covid19|SARS-CoV-2|Severe Acute Respiratory Syndrome,Biological: CVnCoV Vaccine,All,"Adult, Older Adult",Phase 3,180.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 14, 2021",June 2022
3999,NCT04432051,Recruiting,No Results Available,Ultrasonography,Behavioral: mechanical ventilator settings and position,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Other","May 26, 2020","August 10, 2020"
4000,NCT04394390,Enrolling by invitation,No Results Available,COVID,Dietary Supplement: vitamin d,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 1, 2020","June 30, 2020"
4001,NCT04336787,Not yet recruiting,No Results Available,Covid-19|Coronavirus Infection|Pregnancy Related,Other: Survey,Female,Adult,,100.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"April 12, 2020","June 10, 2020"
4002,NCT04424901,Recruiting,No Results Available,COVID-19 Pneumonia|Vascular Complications,Drug: Dipyridamole,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 3, 2020","May 30, 2021"
4003,NCT04579393,"Active, not recruiting",No Results Available,Coronavirus Disease 2019,Drug: Placebo|Drug: fostamatinib,All,"Adult, Older Adult",Phase 2,80.0,NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","January 27, 2020","June 30, 2021"
4004,NCT04558450,Not yet recruiting,No Results Available,Covid19|Arterial Stiffness|Endothelial Dysfunction|Diastolic Dysfunction,Diagnostic Test: carotid-femoral pulse-wave velocity,All,"Adult, Older Adult",Not Applicable,360.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,September 2020,June 2032
4005,NCT04515147,"Active, not recruiting",No Results Available,Coronavirus|Covid19|SARS-CoV-2|Severe Acute Respiratory Syndrome,Biological: CVnCoV 6 μg|Biological: CVnCoV 12 μg|Biological: Hepatitis A vaccine|Biological: Pneumococcal vaccine|Biological: CVnCoV 12μg,All,"Adult, Older Adult",Phase 2,674.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 28, 2020","November 9, 2021"
4006,NCT04511962,Not yet recruiting,No Results Available,Pulmonary Disease,Other: Tele-Pulmonary rehabilitation,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"August 12, 2020","January 20, 2022"
4007,NCT04356495,Recruiting,No Results Available,Corona Virus Infection|Sars-CoV2,Dietary Supplement: Vitamins|Drug: Telmisartan|Drug: Ciclesonide|Drug: interferon β-1b,All,"Adult, Older Adult",Phase 2|Phase 3,820.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 29, 2020","August 31, 2021"
4008,NCT04473898,Completed,No Results Available,COVID,Other: Aerobic Exercise Training|Behavioral: Patient Education|Other: Respiratory Exercise Training,All,"Adult, Older Adult",Not Applicable,35.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"June 19, 2020","February 17, 2021"
4009,NCT04625985,Completed,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Drug: Metformin Glycinate|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,20.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 14, 2020","March 18, 2021"
4010,NCT04343651,"Active, not recruiting",No Results Available,Coronavirus Disease 2019,Drug: Placebos|Drug: Leronlimab (700mg),All,"Adult, Older Adult",Phase 2,86.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2020","August 31, 2020"
4011,NCT04542330,Recruiting,No Results Available,Covid19|Non-specific Effects of Vaccines|Heterologous Immunity|Morbidity|Immunosenescence|Vaccine Preventable Disease,Biological: BCG-Denmark|Biological: Saline,All,Older Adult,Phase 3,1900.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","September 15, 2020",March 2022
4012,NCT04373811,"Active, not recruiting",No Results Available,COVID-19|ICU Acquired Weakness|Weaning Failure,Diagnostic Test: Lung ultrasound|Diagnostic Test: Muscle ultrasound,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","July 13, 2021"
4013,NCT04558476,Recruiting,No Results Available,Covid19|Mechanical Ventilation Complication|Corona Virus Infection|Respiratory Failure|SARS (Severe Acute Respiratory Syndrome),Biological: Convalescent Plasma|Other: Standard of Care,All,"Adult, Older Adult",Phase 2,500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","September 1, 2022"
4014,NCT04658433,Recruiting,No Results Available,Cardiovascular Risk Factor|Covid19,Dietary Supplement: 300 mg of omega3-FA,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"December 5, 2020","March 30, 2021"
4015,NCT04373291,"Active, not recruiting",No Results Available,COVID-19|Non-specific Effects of Vaccines|Morbidity|Absenteeism|Heterologous Immunity,Biological: BCG-Denmark|Biological: Saline,All,"Adult, Older Adult",Phase 3,1293.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","May 18, 2020","December 31, 2021"
4016,NCT04472728,Recruiting,No Results Available,Covid-19|SARS-CoV2,Drug: BIO101|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,310.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 16, 2020",September 2021
4017,NCT04377412,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,Female,"Adult, Older Adult",,8500.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"May 1, 2020","October 31, 2020"
4018,NCT04405869,Recruiting,No Results Available,Pulmonary Thromboembolism,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 29, 2020",April 2021
4019,NCT04605926,Withdrawn,No Results Available,Coronavirus,Biological: EQ001|Biological: EQ001 Placebo,All,"Adult, Older Adult",Phase 3,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",November 2020,June 2021
4020,NCT04370210,Completed,No Results Available,Sleep Disturbance,Behavioral: Questionnaires,All,Child,,247.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 4, 2020","June 4, 2020"
4021,NCT04840953,Completed,No Results Available,Subcutaneous Emphysema|Covid19,Device: Vçac,All,"Child, Adult, Older Adult",,2.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 1, 2020","February 1, 2021"
4022,NCT04575597,Recruiting,No Results Available,Coronavirus Disease (COVID-19),Drug: Molnupiravir|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,1450.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 19, 2020","December 26, 2021"
4023,NCT04494386,Recruiting,No Results Available,Covid19|Corona Virus Infection|SARS-CoV Infection|ARDS|Coronavirus,Biological: Umbilical Cord Lining Stem Cells (ULSC)|Other: Placebo (carrier control),All,"Adult, Older Adult",Phase 1|Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 23, 2020","December 30, 2021"
4024,NCT04371562,Completed,No Results Available,COVID,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","April 15, 2020"
4025,NCT04382924,"Active, not recruiting",No Results Available,COVID,Drug: NP-120 (Ifenprodil),All,"Adult, Older Adult",Phase 2|Phase 3,682.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 5, 2020",February 2022
4026,NCT04306055,Completed,No Results Available,Blood Donation,Other: Questionnaire with precaution information|Other: Experimental: Questionnaire without precaution information,All,Adult,Not Applicable,19491.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"March 13, 2020","April 3, 2020"
4027,NCT04678024,Enrolling by invitation,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,410.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"November 18, 2020",November 2021
4028,NCT04701502,Completed,No Results Available,Covid19|Respiratory Disease|Immune System|Immunomodulator|Antiseptic|Supportive Care,Dietary Supplement: Viusid|Dietary Supplement: Asbrip|Drug: Standard Care,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"November 9, 2020","February 15, 2021"
4029,NCT04362956,Completed,No Results Available,Covid19|Pregnancy Related|Neonatal Infection,,Female,"Child, Adult, Older Adult",,114.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 10, 2020","October 1, 2020"
4030,NCT04350086,Withdrawn,No Results Available,COVID-19 Infection|Sars-cov-2|Respiratory Failure|Palliative Situation,Drug: Treatment with Dexmedetomidine,All,"Adult, Older Adult",Phase 4,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 20, 2020","November 20, 2020"
4031,NCT04400019,Not yet recruiting,No Results Available,Sars-CoV2|Coronavirus Infection|Prevention & Control|Nursing Home|Hydroxychloroquine,Drug: Hydroxychloroquine Only Product in Oral Dose Form,All,"Adult, Older Adult",Phase 2|Phase 3,1930.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention",September 2020,"April 1, 2021"
4032,NCT04466982,Recruiting,No Results Available,Olfactory Disorder|COVID19|SARS-CoV-2|Anosmia|Microsomia|Smell Disorder|Quality of Life,,All,"Adult, Older Adult",,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 2, 2020",January 2022
4033,NCT04681859,Not yet recruiting,No Results Available,Covid19|Hypoxemia,Device: High Flow Nasal Oxygen (HFNO) treatment|Device: Continuous Positive Airway Pressure (CPAP) therapy using OxyJet,All,Adult,Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,July 2021
4034,NCT04433949,Recruiting,No Results Available,Pneumonia|Severe Acute Respiratory Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed,Other: Best Practice|Radiation: Low Dose Radiation Therapy,All,"Adult, Older Adult",Phase 3,52.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 12, 2020","May 30, 2022"
4035,NCT04469634,"Active, not recruiting",No Results Available,SARS-CoV2|COVID-19,"Diagnostic Test: Assessing antibody responses, neutralizing capacity and memory B-cell function",All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"July 31, 2020",July 2021
4036,NCT04371419,Completed,No Results Available,Coronavirus,Behavioral: Messaging,All,"Adult, Older Adult",Not Applicable,15475.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 13, 2020","May 24, 2020"
4037,NCT04773756,Completed,No Results Available,Covid19,Drug: Sofosbuvir 400 MG/ Daclatasvir 60mg,All,"Child, Adult, Older Adult",Phase 4,54.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 1, 2020","December 12, 2020"
4038,NCT04355429,Not yet recruiting,No Results Available,Pneumonia|Coronavirus Infection|COVID-19,Drug: captopril 25mg,All,"Adult, Older Adult",Phase 2,230.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 5, 2020",August 2020
4039,NCT04750343,Recruiting,No Results Available,COVID-19 (Healthy Volunteers),Biological: GBP510 adjuvanted with AS03 (RBD 10μg/dose) - Stage 1|Biological: GBP510 (RBD 10μg/dose) - Stage 1|Other: Normal saline (0.9% sodium chloride solution) - Stage 1|Biological: GBP510 adjuvanted with AS03 (RBD 25μg/dose) - Stage 1|Biological: GBP510 (RBD 25μg/dose) - Stage 1|Biological: GBP510 adjuvanted with AS03 (RBD 10μg/dose) - Stage 2|Biological: GBP510 adjuvanted with AS03 (RBD 25μg/dose)- Stage 2|Biological: GBP510 (RBD 25μg/dose)- Stage 2|Other: Normal saline (0.9% sodium chloride solution)- Stage 2,All,"Adult, Older Adult",Phase 1|Phase 2,320.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 3, 2021",June 2022
4040,NCT04742738,Recruiting,No Results Available,COVID-19 (Healthy Volunteers),Biological: GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 1|Other: Normal saline (0.9% sodium chloride solution) - Stage 1|Biological: GBP510 adjuvanted with Alum (RBD 25μg/dose) - Stage 1|Biological: GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 2|Biological: GBP510 adjuvanted with Alum (RBD 25μg/dose)- Stage 2|Other: Normal saline (0.9% sodium chloride solution)- Stage 2,All,"Adult, Older Adult",Phase 1|Phase 2,260.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 20, 2021",April 2022
4041,NCT04602637,"Active, not recruiting",No Results Available,Monitor Training Load,Other: Training load,Male,"Child, Adult, Older Adult",,3.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"December 15, 2019","January 15, 2021"
4042,NCT04336215,Recruiting,No Results Available,Coronavirus|SARS-CoV-2,Other: Non-Interventional,All,"Adult, Older Adult",,750.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 7, 2020","October 21, 2021"
4043,NCT04544072,Recruiting,No Results Available,SARS-CoV Infection|Antimicrobial Stewardship|Respiratory Tract Infections|Antibiotic Resistance,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","March 1, 2021"
4044,NCT04669054,"Active, not recruiting",No Results Available,"COVID 19|Depression|Stress Disorders, Post-Traumatic",,All,"Adult, Older Adult",,102.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 1, 2020","July 30, 2021"
4045,NCT04357860,Not yet recruiting,No Results Available,SARS-CoV 2|SARS,Drug: Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]|Drug: Sarilumab 400 MG/2.28 ML Subcutaneous Solution [KEVZARA]|Drug: Best available treatment,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 27, 2020","July 27, 2020"
4046,NCT04347512,Withdrawn,No Results Available,"Sars-CoV-2, Community-Acquired Pneumonia,COVID-19",Drug: Hydroxychloroquine and azithromycin treatment arm.|Drug: Hydroxychloroquine|Drug: Control arm,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 2, 2020","June 2, 2020"
4047,NCT04572438,Recruiting,No Results Available,Tracheostomy Complication|Covid19|Ventilator Lung,Procedure: Tracheostomy,All,"Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 1, 2020","August 1, 2021"
4048,NCT04351399,Completed,No Results Available,Sars-CoV2|Rheumatic Diseases|Rheumatoid Arthritis|Chronic Pain,Other: questionnaire assesment,All,"Adult, Older Adult",,318.0,Other,Observational,Observational Model: Family-Based|Time Perspective: Cross-Sectional,"April 27, 2020","May 4, 2020"
4049,NCT04273763,"Active, not recruiting",No Results Available,Novel Coronavirus Pneumonia|2019-nCoV,Drug: Bromhexine Hydrochloride Tablets|Drug: Arbidol Hydrochloride Granules|Drug: Recombinant Human Interferon α2b Spray,All,"Adult, Older Adult",Not Applicable,18.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 16, 2020","June 1, 2020"
4050,NCT04538456,Recruiting,No Results Available,Lung Cancer|PROM|Covid19|Psychological,Other: questionnaire and optional interview,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 15, 2020",April 2021
4051,NCT04720404,Recruiting,No Results Available,Mindfulness|Randomized Controlled Trial|Psychopathology|Health Personnel,Behavioral: Mindfulness-Based Stress Reduction|Other: Self-help mindfulness/compassion exercises|Other: Support as usual,All,"Adult, Older Adult",Not Applicable,220.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"June 23, 2020",February 2022
4052,NCT04381377,"Active, not recruiting",No Results Available,"Infections, Coronavirus",Drug: azoximer bromide|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,394.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 29, 2020",April 2021
4053,NCT04448756,Recruiting,No Results Available,Coronavirus Disease 2019,Drug: M5049|Drug: Placebo,All,"Adult, Older Adult",Phase 2,150.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 29, 2020","June 6, 2021"
4054,NCT04362319,Completed,No Results Available,"Burnout, Professional|Depression|Medical Errors|Covid-19",Diagnostic Test: Questionnaire forms,All,"Adult, Older Adult",,85.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 15, 2020","May 31, 2020"
4055,NCT04451317,Recruiting,No Results Available,Physical Activity|COVID-19,"Other: Questionnaire, phone call",All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 12, 2020",August 2021
4056,NCT04399746,Recruiting,No Results Available,COVID,Drug: Ivermectin|Drug: Azithromycin|Drug: Cholecalciferol,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 15, 2020","June 10, 2020"
4057,NCT04583449,Recruiting,No Results Available,Viral Infection|Covid19,Behavioral: Mental imagery,All,"Adult, Older Adult",Not Applicable,250.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"August 19, 2020","December 1, 2020"
4058,NCT04379453,Recruiting,No Results Available,Coronary Artery Disease,Procedure: Robot Assisted Percutaneous Cardiovascular Intervention,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 27, 2020","April 27, 2020"
4059,NCT04357977,Not yet recruiting,No Results Available,Coronavirus|COVID,Diagnostic Test: RBA-2,All,"Adult, Older Adult",,300.0,Industry|Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,April 2020,December 2020
4060,NCT04476992,"Active, not recruiting",No Results Available,"Hypoxemia|Pneumonia, Viral|Coronavirus Infection",Drug: Nitric Oxide-Sessions|Drug: Nitric Oxide-Continuous and Sessions,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 24, 2020","September 17, 2021"
4061,NCT04785807,Not yet recruiting,No Results Available,Covid19|Post Traumatic Stress Disorder|Anxiety,"Other: Post traumatic, Anxiety and depression evaluation",All,"Adult, Older Adult",Not Applicable,140.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,March 2021,January 2022
4062,NCT04415060,Recruiting,No Results Available,Covid19|Hypoxic Respiratory Failure,Drug: Isoflurane Inhalant Product|Drug: Sevoflurane inhalant product,All,"Adult, Older Adult",Phase 3,752.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 15, 2020","June 15, 2023"
4063,NCT04769349,Recruiting,No Results Available,Housing|Covid19|Mental Health|Physical Health|Social Interaction|Healthcare,,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 29, 2021","December 15, 2022"
4064,NCT04498507,Completed,No Results Available,Critical Illness|Family|Psychological Stress|Covid19,Diagnostic Test: HADS questionnaire,All,"Adult, Older Adult",,39.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","October 30, 2020"
4065,NCT04445220,Recruiting,No Results Available,COVID-19|Acute Kidney Injury,Biological: SBI-101,All,"Adult, Older Adult",Phase 1|Phase 2,22.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 19, 2020",December 2021
4066,NCT04703270,Recruiting,No Results Available,Corona Virus Infection|Pregnancy Related|Neonatal Infection|Breastfeeding,,Female,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 4, 2021","January 3, 2023"
4067,NCT04487171,Recruiting,No Results Available,Postpartum Depression|Covid19|Prevalence|Social Distance,Other: Questionnaire,Female,"Adult, Older Adult",Not Applicable,248.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 21, 2020",August 2021
4068,NCT04334512,Recruiting,No Results Available,COVID-19|Corona Virus Infection|Coronavirus-19|Sars-CoV2,Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc,All,"Adult, Older Adult",Phase 2,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 22, 2020",September 2021
4069,NCT04471831,Not yet recruiting,No Results Available,Corona Virus Infection|Stroke,Other: Rehabilitation exercise protocol,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 13, 2020","December 31, 2021"
4070,NCT04736004,Not yet recruiting,No Results Available,Cardiac Involvement With COVID-19,,All,Adult,,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"May 15, 2021","April 30, 2022"
4071,NCT04349098,Completed,No Results Available,Coronavirus Infection,Drug: Selinexor|Other: Placebo,All,"Adult, Older Adult",Phase 2,202.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"April 17, 2020","October 5, 2020"
4072,NCT04581889,Recruiting,No Results Available,Severe Acute Respiratory Syndrome,Other: Diagnostic test,All,"Child, Adult",,2380.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 2, 2020",December 2021
4073,NCT04462783,Not yet recruiting,No Results Available,COVID|Covid-19|SARS-CoV 2,Other: Symptoms entered into the CovidX application,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,April 2021,September 2021
4074,NCT04748471,Not yet recruiting,No Results Available,Prevention of COVID19,Biological: mRNA-1273,All,"Adult, Older Adult",Phase 2,180.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 10, 2021","January 25, 2023"
4075,NCT04501991,Completed,No Results Available,Type 2 Diabetes|Metabolic Control,Other: antidiabetic treatment,All,"Adult, Older Adult",,114.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 11, 2020","June 30, 2020"
4076,NCT04371393,"Active, not recruiting",No Results Available,Mesenchymal Stromal Cells|Remestemcel-L|Acute Respiratory Distress Syndrome|COVID,Biological: Remestemcel-L|Drug: Placebo,All,"Adult, Older Adult",Phase 3,223.0,Other|Industry|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 30, 2020",February 2022
4077,NCT04355676,Withdrawn,No Results Available,Coronavirus Infection,Drug: Selinexor,All,"Adult, Older Adult",Phase 2,0.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","August 30, 2020"
4078,NCT04401527,Withdrawn,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Acute Respiratory Failure,Drug: Sodium Nitrite|Drug: Normal Saline,All,"Adult, Older Adult",Phase 2,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 22, 2020","August 15, 2020"
4079,NCT04384731,Recruiting,No Results Available,"COVID-19|ARDS, Human",Drug: poractant alfa,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"May 29, 2020","July 31, 2021"
4080,NCT04324047,Recruiting,No Results Available,Corona Virus Infection,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 27, 2020","December 31, 2021"
4081,NCT04288713,Available,No Results Available,Coronavirus,Drug: Eculizumab,All,"Adult, Older Adult",,,Other,Expanded Access:Individual Patients|Treatment IND/Protocol,,,
4082,NCT04701489,Enrolling by invitation,No Results Available,Covid19|Cytokine Storm|Inflammation,Device: Splenic ultrasound,All,"Adult, Older Adult",Not Applicable,30.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 14, 2021",June 2021
4083,NCT04292964,Completed,No Results Available,"SARS-CoV-2|Outcome, Fatal",,All,"Adult, Older Adult",,201.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","March 13, 2020"
4084,NCT04433988,Not yet recruiting,No Results Available,COVID,Drug: Pentoxifylline|Drug: Placebo,All,Adult,Phase 1|Phase 2,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 13, 2021","December 30, 2021"
4085,NCT04796064,Completed,No Results Available,Sarcopenia,Other: low-intensity aerobic training,Male,"Adult, Older Adult",Not Applicable,76.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","March 30, 2020","December 15, 2020"
4086,NCT04766983,Recruiting,No Results Available,Ventilator Associated Pneumonia|Covid19,Diagnostic Test: bronchoalveolar lavage,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 22, 2021","April 30, 2022"
4087,NCT04361032,Not yet recruiting,No Results Available,COVID19|Intensive Care Unit,Drug: Tocilizumab Injection|Drug: Deferoxamine,All,"Adult, Older Adult",Phase 3,260.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 4, 2020","October 4, 2020"
4088,NCT04400058,Completed,No Results Available,Covid-19,Biological: Octagam 10%|Other: Placebo,All,"Adult, Older Adult",Phase 3,208.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 1, 2020","January 31, 2021"
4089,NCT04808895,Not yet recruiting,No Results Available,COVID-19|Thrombosis Pulmonary,Drug: Acetylsalicylic acid|Drug: Placebo,All,"Adult, Older Adult",Phase 3,204.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2021","August 31, 2021"
4090,NCT04613986,Not yet recruiting,No Results Available,Severe Covid-19,Device: therapeutic plasmaexchnage,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,December 2020,December 2021
4091,NCT04463004,"Active, not recruiting",No Results Available,COVID-19|Sars-CoV2|Pneumonia,Drug: Mavrilimumab|Drug: Placebos,All,"Adult, Older Adult",Phase 2,2.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 2, 2020",August 2021
4092,NCT04622865,Recruiting,No Results Available,SARS-CoV 2|COVID-19|Coronavirus Disease 2019,Drug: Masitinib|Drug: Isoquercetin|Drug: Best Supportive Care,All,"Adult, Older Adult",Phase 2,200.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 1, 2020",June 2021
4093,NCT04398277,Recruiting,No Results Available,Psychological Stress,Behavioral: Daily Coping Toolkit,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care","May 1, 2020",April 2021
4094,NCT04516941,Not yet recruiting,No Results Available,SARS-CoV Infection|COVID-19,Drug: Edoxaban Tablets|Drug: Colchicine Tablets,All,"Adult, Older Adult",Phase 3,420.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2020","December 31, 2021"
4095,NCT04594395,Not yet recruiting,No Results Available,Healthy Volunteers,,All,"Adult, Older Adult",,2700.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 19, 2021","December 31, 2023"
4096,NCT04388657,Recruiting,No Results Available,"COVID|Embolism and Thrombosis|Pneumonia, Viral",Diagnostic Test: Echo-Doppler,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","September 1, 2020"
4097,NCT04760743,"Active, not recruiting",No Results Available,COVID-19 (Healthy Volunteers),Biological: NBP2001 adjuvanted with alum (RBD 30μg/dose)|Biological: NBP2001 adjuvanted with alum (RBD 50μg/dose)|Other: Normal Saline,All,Adult,Phase 1,50.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","December 17, 2020",April 2022
4098,NCT04394078,Completed,No Results Available,Depression|Quality of Life|Covid 19|Social Isolation,Other: Online survey,All,"Child, Adult, Older Adult",,543.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"May 6, 2020","May 18, 2020"
4099,NCT04570384,Recruiting,No Results Available,Acute Hypoxemic Respiratory Failure,Drug: L-Citrulline|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 15, 2020","October 28, 2021"
4100,NCT04564274,Recruiting,No Results Available,Chronic Health Conditions|Older Age is Associated With Increased Pathogenicity,,All,"Child, Adult, Older Adult",,5000.0,NIH,Observational,Observational Model: Other|Time Perspective: Other,"April 19, 2021","September 1, 2021"
4101,NCT04347694,Recruiting,No Results Available,SARS-CoV 2|Immunization; Infection,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 11, 2020","April 11, 2021"
4102,NCT04575558,Withdrawn,No Results Available,Sars-CoV2,Drug: Hydroxychloroquine and Azithromycin,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 30, 2020","October 30, 2020"
4103,NCT04788355,Completed,No Results Available,Complication,Drug: Control group (standard hospital treatment)|Drug: Group Hydroxychloroquine|Drug: Group Hydroxychloroquine and apixaban|Drug: Group Apixaban,All,"Adult, Older Adult",Phase 3,176.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","July 1, 2020","December 23, 2020"
4104,NCT04605965,Recruiting,No Results Available,Covid19|Cardiovascular Complication|Behavioral Changes,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"June 9, 2020",June 2022
4105,NCT04329195,Terminated,No Results Available,History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection,Drug: 1: discontinuation of RAS blocker therapy|Drug: 2: continuation of RAS blocker therapy,All,"Adult, Older Adult",Phase 3,44.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 9, 2020","January 9, 2021"
4106,NCT04654481,Recruiting,No Results Available,Chronic Obstructive Pulmonary Disease|Chronic Cough|Covid19,Device: HCFWO|Other: Standard Care Plus Monitoring,All,"Adult, Older Adult",Not Applicable,30.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,December 2020,November 2021
4107,NCT04694768,Recruiting,No Results Available,Post COVID-19 Syndrome|Rehabilitation,Behavioral: Rehabilitation,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","January 31, 2021"
4108,NCT04357366,Recruiting,No Results Available,COVID-19|Virus Diseases|Corona Virus Infection|Lower Respiratory Tract Infection Viral,Drug: Anakinra,All,"Adult, Older Adult",Phase 2,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 15, 2020","April 15, 2022"
4109,NCT04794036,Recruiting,No Results Available,Coronavirus|Fatigue|Musculoskeletal Complication,Other: Asynchronous telerehabilitation programme|Other: Rehabilitation programme,All,"Adult, Older Adult",Not Applicable,32.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 5, 2021","September 30, 2021"
4110,NCT04414657,Recruiting,No Results Available,COVID19,Other: blood sampling for biobank,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2020","April 30, 2022"
4111,NCT04519385,Completed,No Results Available,"Pneumonia, Viral",Drug: Tocilizumab|Drug: Dexamethasone,All,"Adult, Older Adult",Not Applicable,69.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","March 1, 2020","August 5, 2020"
4112,NCT04750356,Recruiting,No Results Available,SARS-CoV Infection,,All,"Adult, Older Adult",,6000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 27, 2021","December 31, 2024"
4113,NCT04536350,Not yet recruiting,No Results Available,Covid19|Corona Virus Infection|ARDS|Aviptadil,Drug: Aviptadil 67μg|Drug: Placebo 0.9% NaCl solution,All,"Adult, Older Adult",Phase 1,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",January 2021,March 2022
4114,NCT04382950,Not yet recruiting,No Results Available,COVID,Combination Product: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid,All,Adult,Phase 1,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,July 2020,December 2020
4115,NCT04546581,"Active, not recruiting",No Results Available,COVID|COVID-19|SARS-CoV-2|SARS (Severe Acute Respiratory Syndrome),Drug: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)|Other: Placebo|Drug: Remdesivir,All,"Adult, Older Adult",Phase 3,593.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 8, 2020",July 2021
4116,NCT04351503,Recruiting,No Results Available,SARS Coronavirus (SARS-CoV-2) Infection,Other: Study A|Other: Study B|Other: Study C|Other: Study D,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"April 9, 2020",April 2022
4117,NCT04445246,Recruiting,No Results Available,"COVID-19|ARDS, Human|Hypoxemic Respiratory Failure",Drug: Inhaled ILOPROST,All,"Adult, Older Adult",Phase 2,40.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 23, 2020","May 31, 2021"
4118,NCT04344119,Recruiting,No Results Available,Skin Manifestations|COVID|Chilblains,,All,"Child, Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 9, 2020","April 30, 2021"
4119,NCT04390152,Recruiting,No Results Available,Acute Respiratory Distress Syndrome,"Drug: Wharton's jelly derived Mesenchymal stem cells.|Drug: Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)",All,"Adult, Older Adult",Phase 1|Phase 2,40.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 13, 2020",April 2022
4120,NCT04401202,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Dietary Supplement: Nigella sativa,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 21, 2020","December 31, 2020"
4121,NCT04772586,Recruiting,No Results Available,Sarcopenia,,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"September 1, 2020","March 1, 2022"
4122,NCT04794946,Recruiting,No Results Available,Liver Cirrhosis,Biological: Covishield,All,Adult,Not Applicable,2200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 19, 2021","March 19, 2022"
4123,NCT04587921,Recruiting,No Results Available,Oximetry|Covid19,Device: Digital oximeter monitoring,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 22, 2020","June 22, 2021"
4124,NCT04584580,Recruiting,No Results Available,Coronavirus Disease (COVID)19,Drug: low-molecular-weight heparin,All,"Adult, Older Adult",Phase 4,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"August 1, 2020","December 31, 2020"
4125,NCT04366856,Recruiting,No Results Available,COVID|ARDS,Behavioral: 1: Prone positioning|Behavioral: 2: No instruction regarding positioning,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 26, 2020",January 2021
4126,NCT04792086,Recruiting,No Results Available,"Dementia|Cognitive Impairment|Depression, Anxiety|Loneliness",,All,Older Adult,,12000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 18, 2021","December 31, 2024"
4127,NCT04341493,Terminated,No Results Available,Coronavirus Infection,Drug: Nitazoxanide 500 MG|Drug: Hydroxychloroquine,All,"Child, Adult, Older Adult",Phase 4,44.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"April 6, 2020","December 30, 2020"
4128,NCT04569383,Recruiting,No Results Available,Covid19,Biological: MVA-SARS-2-S vaccinations (days 0 & 28),All,Adult,Phase 1,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 5, 2020",May 2021
4129,NCT04381936,Recruiting,No Results Available,Severe Acute Respiratory Syndrome,Drug: Lopinavir-Ritonavir|Drug: Corticosteroid|Drug: Hydroxychloroquine|Drug: Azithromycin|Biological: Convalescent plasma|Drug: Tocilizumab|Biological: Immunoglobulin|Drug: Synthetic neutralising antibodies|Drug: Aspirin|Drug: Colchicine|Drug: Baricitinib|Drug: Anakinra|Drug: Dimethyl fumarate,All,"Child, Adult, Older Adult",Phase 2|Phase 3,40000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 19, 2020",December 2031
4130,NCT04333654,Terminated,No Results Available,Coronavirus Infection,Drug: Hydroxychloroquine SAR321068|Drug: Placebo,All,"Adult, Older Adult",Phase 1,8.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 12, 2020","May 26, 2020"
4131,NCT04378257,Not yet recruiting,No Results Available,Depressive Symptoms|Generalized Anxiety,Behavioral: Therapist Guided E-Therapy|Behavioral: Self-Help Therapy,All,"Adult, Older Adult",Phase 3,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","October 20, 2020"
4132,NCT04367129,Recruiting,No Results Available,SARS-CoV Infection,Diagnostic Test: ECG,All,"Adult, Older Adult",,1014.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 14, 2020","April 1, 2021"
4133,NCT04488510,"Active, not recruiting",No Results Available,Covid19|Ventilator Associated Pneumonia|Nosocomial Pneumonia,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 6, 2020","November 30, 2020"
4134,NCT04512027,Completed,No Results Available,COVID-19,Other: Prolectin-M; a (1-6)-alpha-D-Mannopyranose class|Other: Standard of Care,All,Adult,Not Applicable,10.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 15, 2020","October 16, 2020"
4135,NCT04403685,Terminated,No Results Available,COVID|SARS Pneumonia|Cytokine Release Syndrome,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 3,129.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","July 21, 2020"
4136,NCT04342169,Recruiting,No Results Available,Coronavirus Infection|Coronavirus|Infectious Disease,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 4, 2020",April 2022
4137,NCT04468412,"Active, not recruiting",No Results Available,COVID|Vascular; Damage,Diagnostic Test: Carotid Artery Reactivity Testing,All,"Child, Adult, Older Adult",,203.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 14, 2020","September 30, 2021"
4138,NCT04668313,Recruiting,No Results Available,Respiratory Failure|Covid19|Biosensor,,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 29, 2020","September 29, 2021"
4139,NCT04832867,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2021","May 1, 2021"
4140,NCT04395885,Completed,No Results Available,Sexual Dysfunction,Other: Electronic questionnaire,All,Adult,,306.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 1, 2020","September 15, 2020"
4141,NCT04366154,"Active, not recruiting",No Results Available,COVID-19|Cancer,Other: Questionnaire,All,"Adult, Older Adult",,809.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020",May 2021
4142,NCT04378920,Recruiting,No Results Available,"COVID19, Sepsis or Other Causes|Acute Respiratory Distress Syndrome",Drug: LEAF-4L6715,All,"Adult, Older Adult",Phase 1|Phase 2,90.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 14, 2020","June 30, 2021"
4143,NCT04789395,Recruiting,No Results Available,Ozone Therapy for Covid 19 Pneumonia Patients,,All,"Adult, Older Adult",,25.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 2, 2020","December 20, 2021"
4144,NCT04733625,Completed,No Results Available,Covid19|SARS-CoV Infection,Drug: Cholecalciferol|Drug: Placebo,All,"Adult, Older Adult",Not Applicable,56.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 15, 2020","December 17, 2020"
4145,NCT04397848,Completed,No Results Available,Mental Health Wellness 1|PTSD|Anxiety|Stress|Depression|COVID-19|Healthcare Workers,,All,"Adult, Older Adult",,3852.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 14, 2020","July 3, 2020"
4146,NCT04532372,Recruiting,No Results Available,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed,Other: Best Practice|Drug: Leflunomide|Drug: Placebo Administration,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","January 7, 2021","September 18, 2022"
4147,NCT04344561,Recruiting,No Results Available,COVID|Hypoxic Respiratory Failure,Other: Postural Positioning,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 25, 2020","May 1, 2021"
4148,NCT04558125,Recruiting,No Results Available,Pulmonary Embolism|COVID,Drug: TNKase,All,"Adult, Older Adult",Phase 4,45.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 8, 2020","June 30, 2022"
4149,NCT04575064,"Active, not recruiting",No Results Available,SARS-CoV-2 Infection|COVID-19|Moderate and Severe COVID-19,Other: Standard of Care (SoC)|Drug: Remdesivir,All,"Adult, Older Adult",Phase 2|Phase 3,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 29, 2020",November 2022
4150,NCT04495842,Recruiting,No Results Available,Stress|Covid19|Anxiety,Other: Essential Oil Blend|Other: Control Blend,All,"Adult, Older Adult",Not Applicable,65.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"October 1, 2020","June 30, 2021"
4151,NCT04315948,"Active, not recruiting",No Results Available,Corona Virus Infection,Drug: Remdesivir|Drug: Lopinavir/ritonavir|Drug: Interferon Beta-1A|Drug: Hydroxychloroquine|Other: Standard of care,All,"Adult, Older Adult",Phase 3,3100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 22, 2020",March 2023
4152,NCT04494776,Recruiting,No Results Available,SARS-CoV-2 Infection|Kidney Transplant Infection,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 21, 2020","April 2, 2022"
4153,NCT04609865,Recruiting,No Results Available,Acute Respiratory Distress Syndrome (ARDS)|COVID-19|Corona Virus Infection,Drug: Lidocaine 2%|Drug: Control,All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 4, 2020","February 4, 2024"
4154,NCT04412460,Recruiting,No Results Available,"COVID|ARDS, Human",,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020","December 31, 2021"
4155,NCT04455451,Recruiting,No Results Available,COVID|ARDS,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"August 6, 2020",June 2023
4156,NCT04579588,Enrolling by invitation,No Results Available,Corona Virus Infection|Flu Vaccine|Immunity,Biological: Flu shot,All,Adult,,100.0,Other|NIH,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 29, 2020","December 1, 2022"
4157,NCT04663659,Completed,No Results Available,Covid19|Diabetes Mellitus,Other: no intervention,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 15, 2020","May 15, 2020"
4158,NCT04279795,Recruiting,No Results Available,Coronavirus,,All,"Child, Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 20, 2020","February 28, 2021"
4159,NCT04792567,Not yet recruiting,No Results Available,Secondary Progressive Multiple Sclerosis,Drug: BAF312|Drug: Baseline disease modifying therapies (DMTs),All,"Adult, Older Adult",Phase 4,60.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 19, 2021","April 2, 2022"
4160,NCT04302688,Completed,No Results Available,Pneumonitis,,All,"Child, Adult, Older Adult",,669.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"December 10, 2019","March 4, 2020"
4161,NCT04365881,Completed,No Results Available,"Loneliness, Worry, Rumination, Health Anxiety, Depression, Anxiety",Other: Cross-sectional observational study,All,"Adult, Older Adult",,10084.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 31, 2020","April 7, 2020"
4162,NCT04326725,"Active, not recruiting",No Results Available,Pneumonitis|Coronavirus Infection,Drug: Plaquenil 200Mg Tablet,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 20, 2020","September 1, 2020"
4163,NCT04339712,Completed,No Results Available,COVID-19|Virus Diseases|Macrophage Activation Syndrome|Corona Virus Infection,Drug: Anakinra|Drug: Tocilizumab,All,"Adult, Older Adult",Phase 2,102.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 2, 2020","January 8, 2021"
4164,NCT04629703,Recruiting,No Results Available,"Covid19|SARS (Severe Acute Respiratory Syndrome)|SARS Pneumonia|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|Pneumonia|Pneumonia, Viral",Drug: Fostamatinib|Drug: Placebo,All,"Adult, Older Adult",Phase 3,308.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","February 22, 2021",October 2021
4165,NCT04501432,Completed,No Results Available,Cardiac Rehabilitation,Other: No intervention,All,"Adult, Older Adult",,27.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"July 14, 2020","October 24, 2020"
4166,NCT04402229,Completed,No Results Available,Nurse|Student|Post Traumatic Stress Disorder|COVID-19,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 12, 2020","July 31, 2020"
4167,NCT04637906,Recruiting,No Results Available,Covid19,Dietary Supplement: Bioarginina®,All,"Adult, Older Adult",Not Applicable,290.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","November 18, 2020","September 18, 2021"
4168,NCT04406233,Recruiting,No Results Available,SARS-CoV 2,,All,"Adult, Older Adult",,176.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 23, 2020","May 23, 2022"
4169,NCT04760821,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|Covid19|Myocardial Injury,Drug: Trimetazidine,All,"Adult, Older Adult",Phase 2,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 10, 2020","April 30, 2021"
4170,NCT04245631,Recruiting,No Results Available,New Coronavirus,Diagnostic Test: Recombinase aided amplification (RAA) assay,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2020","December 31, 2020"
4171,NCT03183570,Recruiting,No Results Available,Idiopathic Pulmonary Fibrosis|Primary Sclerosing Cholangitis|Covid19 Pneumonia,Drug: [18F]FP-R01-MG-F2,All,"Adult, Older Adult",Early Phase 1,30.0,Other|Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"November 8, 2017","April 14, 2023"
4172,NCT04760561,Not yet recruiting,No Results Available,Prone Position|Coronavirus Disease 2019|Oxygenation,Procedure: prone position group,All,"Adult, Older Adult",Not Applicable,82.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","February 20, 2021","April 20, 2021"
4173,NCT04672590,Not yet recruiting,No Results Available,Diseases of the Nervous System|Other Specified Viral Diseases,Other: Primary exposure is hypoxia (no intervention),All,"Adult, Older Adult",,681.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,January 2021,December 2021
4174,NCT04517162,Recruiting,No Results Available,Covid19|Cytokine Storm|Regulation of Inflammatory Response|Pulmonary Fibrosis,Drug: Collagen-Polyvinylpyrrolidone,All,"Adult, Older Adult",Phase 1|Phase 2,90.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 19, 2020","June 19, 2021"
4175,NCT04821908,Not yet recruiting,No Results Available,Asthma in Children,,All,Child,,577.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,July 2021,July 2025
4176,NCT04398043,Not yet recruiting,No Results Available,rt PCR|COVID|Personal Protective Equipment PPE|SARS-CoV 2|Health Personnel Attitude|Virus Diseases,,All,"Child, Adult, Older Adult",,16.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020","July 30, 2020"
4177,NCT04568551,Recruiting,No Results Available,Anxiety State,,Female,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","July 31, 2021"
4178,NCT04397497,Not yet recruiting,No Results Available,"Covid-19|Acute Respiratory Failure|ARDS, Human|Sars-CoV2|Viral Pneumonia",Drug: Mavrilimumab|Drug: Placebo,All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 22, 2020","November 22, 2020"
4179,NCT04412356,Recruiting,No Results Available,Covid-19|ARDS|Tracheostomy Complication|Respiratory Insufficiency|Corona Virus Infection,Procedure: Tracheotomy,All,"Adult, Older Adult",Not Applicable,180.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 4, 2020","September 1, 2021"
4180,NCT04361019,Recruiting,No Results Available,Physical Activity,Other: On-Line Survey,All,"Child, Adult, Older Adult",,25000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","October 20, 2020"
4181,NCT04425720,Recruiting,No Results Available,COVID,Device: LifeSignals Biosensor 1AX*|Other: Standard of Care,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"September 1, 2020","June 1, 2021"
4182,NCT04720118,Recruiting,No Results Available,"Parkinson Disease|Covid19|Satisfaction, Patient|Quality of Life",Other: No Intervention,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 1, 2021",May 2021
4183,NCT04452565,Recruiting,No Results Available,Coronavirus Infection|Severe Acute Respiratory Infection|Severe Acute Respiratory Syndrome Coronavirus 2,Drug: Drug: NA-831|Combination Product: NA-831 and Atazanavir|Combination Product: NA-831and Dexamethasone|Combination Product: Atazanavir and Dexamethasone,All,"Adult, Older Adult",Phase 2|Phase 3,525.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 15, 2020","February 15, 2021"
4184,NCT04329533,Completed,No Results Available,Perceived Stress|Anxiety|Sleep Disturbance,"Other: ""Calm"" is a mindfulness meditation mobile app",Female,"Adult, Older Adult",Not Applicable,101.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 13, 2020","November 1, 2020"
4185,NCT04748757,Not yet recruiting,No Results Available,Coronavirus Infection|Sepsis,Drug: recombinant human annexin A5|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",March 2021,December 2022
4186,NCT04292340,Recruiting,No Results Available,Coronavirus,,All,"Child, Adult, Older Adult",,15.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 1, 2020","December 31, 2020"
4187,NCT04602260,Recruiting,No Results Available,Covid19|Corona Virus Infection|Mobility Limitation|Frailty,,All,"Adult, Older Adult",,211.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 9, 2020",September 2021
4188,NCT04483973,Not yet recruiting,No Results Available,Covid19|Coronavirus|Coronavirus Infection|Corona Virus Infection,Drug: Ebselen|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",May 2021,June 2022
4189,NCT04511923,Recruiting,No Results Available,"Covid19|ARDS, Human|Lung Injury, Acute|Ventilation Perfusion Mismatch",Drug: Nebulised heparin,All,"Adult, Older Adult",Phase 1|Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 23, 2020",January 2022
4190,NCT04766788,"Active, not recruiting",No Results Available,Covid19,"Other: Wearable devices, saliva samples, survey measures",All,"Adult, Older Adult",,2494.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 3, 2020",August 2021
4191,NCT04368975,Recruiting,No Results Available,Acute Respiratory Failure With Hypoxia,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 12, 2020","December 31, 2020"
4192,NCT04484025,Not yet recruiting,No Results Available,Covid19|Corona Virus Infection|Coronavirus|Coronavirus Infection,Drug: Ebselen|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",May 2021,June 2022
4193,NCT04381286,Recruiting,No Results Available,Mechanical Ventilation|SARS-CoV-2|COVID-19,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2019","December 31, 2021"
4194,NCT04628195,Completed,No Results Available,Covid19|Acute Cor Pulmonale|Cardiac Failure,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","August 1, 2020"
4195,NCT04339881,Completed,No Results Available,Sars-CoV2,,All,"Child, Adult, Older Adult",,2523.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 17, 2020","July 12, 2020"
4196,NCT04350281,Completed,No Results Available,COVID,Drug: Interferon Beta-1B|Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 9, 2020","July 7, 2020"
4197,NCT04392973,Recruiting,No Results Available,COVID19,Combination Product: Favipiravir and Hydroxychloroquine,All,"Adult, Older Adult",Not Applicable,520.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 21, 2020",November 2021
4198,NCT04844658,Recruiting,No Results Available,Coronavirus Infection,Drug: NASAFYTOL®|Drug: FULTIUM® -D3 800,All,"Adult, Older Adult",Not Applicable,50.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 17, 2021","September 1, 2021"
4199,NCT04642326,"Active, not recruiting",No Results Available,Covid19,Device: Test Group: experimental - UVC Therapy applied,All,"Adult, Older Adult",Not Applicable,50.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 26, 2020","May 4, 2021"
4200,NCT04670003,Completed,No Results Available,Covid19,Other: users,All,"Adult, Older Adult",,4975.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 2, 2021","March 30, 2021"
4201,NCT04427176,Completed,No Results Available,Nurse,Device: ARFC mask,All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 29, 2020","May 28, 2020"
4202,NCT04412018,Recruiting,No Results Available,COVID-19|Inflammatory Response,Drug: Icosapent ethyl,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 4, 2020",December 2020
4203,NCT04366063,Recruiting,No Results Available,Covid-19,Biological: Cell therapy protocol 1|Biological: Cell therapy protocol 2,All,"Adult, Older Adult",Phase 2|Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 5, 2020","December 10, 2020"
4204,NCT04590209,Not yet recruiting,No Results Available,Adult Patients With Lesions on Fingers or Toes,Other: Blood sampling|Other: Skin biopsy,All,"Adult, Older Adult",Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,October 2020,December 2020
4205,NCT04439071,Recruiting,No Results Available,Pneumonia|COVID-19|Coronavirus,Drug: PTC299|Other: SOC|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,380.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 9, 2020","July 31, 2021"
4206,NCT04365764,Recruiting,No Results Available,Covid-19|ARDS|Pneumonia,,All,"Child, Adult, Older Adult",,400.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"March 14, 2020","December 31, 2022"
4207,NCT04544878,Recruiting,No Results Available,Covid19|Pediatric ALL|Infection|Critical Illness|SARS-CoV Infection,,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 26, 2020","June 1, 2021"
4208,NCT04528888,Not yet recruiting,No Results Available,"Covid19|SARS-CoV Infection|Pneumonia, Viral|Coagulopathy",Drug: Enoxaparin|Drug: Methylprednisolone|Drug: unfractionated heparin,All,"Adult, Older Adult",Phase 3,210.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020","July 30, 2021"
4209,NCT04422470,Recruiting,No Results Available,Coronavirus Infection and Hematologic Diseases,Other: Non-interventional study,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 22, 2020","July 22, 2021"
4210,NCT04355442,Completed,No Results Available,Maxillofacial Injuries|Skull Fractures|COVID-19,Procedure: Facial fractures reduction or osteosynthesis,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","May 30, 2020"
4211,NCT04336345,Completed,No Results Available,Coronavirus Infections|COVID-19|Viral Pneumonia Human Coronavirus,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 1, 2020","June 4, 2020"
4212,NCT04517396,Enrolling by invitation,No Results Available,Covid19,Other: Fenofibrate/fenofibric acid|Other: Placebo|Other: Usual care,All,"Adult, Older Adult",Phase 2,700.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 18, 2020","October 31, 2021"
4213,NCT04641182,Completed,No Results Available,Covid19|Ards|Respiratory Failure,Other: Prone position,All,"Adult, Older Adult",,66.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 6, 2020","September 16, 2020"
4214,NCT04374422,Completed,No Results Available,Sexual Behavior|COVID,Behavioral: fsfi survey,Female,"Adult, Older Adult",,58.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020","April 12, 2020"
4215,NCT04786483,"Active, not recruiting",No Results Available,Laughter Yoga|Anxiety|Life Satisfaction|Psychological Well-being|COVID-19,Other: Laughter Theraphy,All,"Child, Adult, Older Adult",Not Applicable,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research","November 1, 2020","May 10, 2021"
4216,NCT04805086,Recruiting,No Results Available,Pulmonary Fibrosis|Interstitial Lung Disease|Covid19,Biological: MON002,All,"Adult, Older Adult",Phase 1|Phase 2,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 8, 2021","March 5, 2023"
4217,NCT04515225,Not yet recruiting,No Results Available,HIV Infections,Other: Blood Sample,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 15, 2020","September 15, 2020"
4218,NCT04380714,Completed,No Results Available,People Incarcerated|COVID-19,,All,"Adult, Older Adult",,700.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"May 1, 2020","August 1, 2020"
4219,NCT04660422,Recruiting,No Results Available,Advanced Care Planning|Shared Decision Making|Video Decision Aids|Communication Skills|Advance Directives|Natural Language Processing|Covid19,Other: VitalTalk communication skills training|Other: ACP Decisions Video Program|Other: Intervention training:|Other: Medical Record Review,All,Older Adult,,13150.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Other,"December 15, 2020","May 14, 2021"
4220,NCT04780113,Recruiting,No Results Available,Stress,,All,"Adult, Older Adult",,285.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 25, 2021","October 25, 2021"
4221,NCT04419025,Recruiting,No Results Available,COVID|Sars-CoV2|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|Oxidative Stress,Drug: N-acetylcysteine,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 23, 2020","June 30, 2021"
4222,NCT04556864,Not yet recruiting,No Results Available,"Covid19|Hemodynamic Instability|ARDS, Human",,All,"Adult, Older Adult",,67.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","April 1, 2021"
4223,NCT04435522,Completed,No Results Available,COVID,Drug: Maraviroc,All,"Adult, Older Adult",Phase 1,9.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2020","December 31, 2020"
4224,NCT04401124,Not yet recruiting,No Results Available,Gastric Cancer|Colorectal Cancer|Gastrointestinal Disease,Other: no intervention,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 25, 2020","June 7, 2020"
4225,NCT04534569,Completed,No Results Available,Covid19|Acute Respiratory Failure|Acute Respiratory Distress Syndrome,Other: Experts consensus,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"September 4, 2020","October 6, 2020"
4226,NCT04780555,Not yet recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","June 1, 2021"
4227,NCT04476914,Recruiting,No Results Available,Respiratory Failure|SARS-CoV 2|Corona Virus Infection|Post Intensive Care Unit Syndrome|Family Members|Post Traumatic Stress Disorder|Anxiety|Depression,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 29, 2020","December 31, 2021"
4228,NCT04358640,Completed,No Results Available,"Critical Illness|Sars-CoV2|SARS Pneumonia|Coronavirus Infection|Stress Disorders, Post-Traumatic",,All,"Adult, Older Adult",,1784.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 9, 2020","April 27, 2020"
4229,NCT04322123,"Active, not recruiting",No Results Available,Coronavirus Infections,Drug: Hydroxychloroquine Oral Product|Drug: Hydroxychloroquine + azithromycin,All,"Adult, Older Adult",Phase 3,630.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","August 30, 2020"
4230,NCT04615949,Not yet recruiting,No Results Available,COVID-19|Cardiovascular Diseases|Cardiovascular Risk Factor,"Drug: Cannabidiol, pharmaceutically produced with < 5 ppm THC|Drug: Placebo",All,"Adult, Older Adult",Phase 2|Phase 3,422.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",December 2020,September 2021
4231,NCT04312009,Completed,No Results Available,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection,Drug: Losartan|Other: Placebo,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 13, 2020","February 1, 2021"
4232,NCT04325906,Recruiting,No Results Available,Prone Positioning|High Flow Nasal Cannula|Acute Respiratory Distress Syndrome|Corona Virus Infection,Device: high flow nasal cannula (HFNC)|Procedure: Prone positioning (PP),All,"Adult, Older Adult",Not Applicable,346.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 2, 2020","June 30, 2021"
4233,NCT04468958,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV2,Biological: SAB-185|Other: Normal saline,All,Adult,Phase 1,28.0,Industry|U.S. Fed|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 5, 2020",April 2021
4234,NCT04380870,Recruiting,No Results Available,Coronavirus Infection,Dietary Supplement: Chinese Herbal Medicine,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"April 11, 2020","April 11, 2025"
4235,NCT04397471,Not yet recruiting,No Results Available,Healthy Volunteers for Bone Marrow Donation,Procedure: Bone Marrow Harvest,All,Adult,,10.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,May 2020,December 2021
4236,NCT04361838,Recruiting,No Results Available,Coronavirus Infection,Behavioral: prayer,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care","May 21, 2020","August 31, 2021"
4237,NCT04413968,Completed,No Results Available,Coronavirus|Coronavirus Infection|Covid19|Sars-CoV2,Diagnostic Test: Rapid detection test|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Stool collection,All,"Child, Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 2, 2020","October 2, 2020"
4238,NCT04668196,Completed,No Results Available,Covid19|Acute Respiratory Failure|Corona Virus Infection,Device: High-flow nasal cannula treatment|Device: Continuous positive airway pressure (CPAP) treatment|Device: Noninvasive ventilation treatment,All,"Adult, Older Adult",,367.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 22, 2020","January 25, 2021"
4239,NCT04406688,Recruiting,No Results Available,Acute Kidney Injury|COVID-19|ARDS,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 22, 2020",March 2021
4240,NCT04663945,Recruiting,No Results Available,Covid-19|Deconditioning,Behavioral: Biobehavioral Tele-rehabilitation Sessions,All,"Adult, Older Adult",Not Applicable,45.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"December 11, 2020","August 1, 2021"
4241,NCT04719234,Completed,No Results Available,Lung Ultrasound|Pneumonia|Covid19,Device: lung ultrasonography,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 15, 2020","December 1, 2020"
4242,NCT04815759,Recruiting,No Results Available,Dental Anxiety,Other: routine dental restorative procedures,All,Child,,82.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 1, 2021","April 30, 2021"
4243,NCT04391179,Completed,No Results Available,COVID|Corona Virus Infection|Covid-19|SARS-CoV-2 Infection,Drug: Dipyridamole 100 Milligram(mg)|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"May 31, 2020","February 22, 2021"
4244,NCT04375397,Recruiting,No Results Available,CoronaVirus Induced Disease-2019 (COVID-19),Drug: Ibrutinib|Drug: Placebo,All,"Adult, Older Adult",Phase 2,46.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 6, 2020","August 25, 2021"
4245,NCT04363528,Recruiting,No Results Available,Deep Vein Thrombosis,Other: Doppler Echo,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 24, 2020","October 30, 2020"
4246,NCT04747249,Not yet recruiting,No Results Available,Solid Carcinoma|Post Traumatic Stress Disorder|Covid19,Other: Psychological support,All,"Adult, Older Adult",Not Applicable,115.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,March 2022
4247,NCT04537975,Withdrawn,No Results Available,Continuous Renal Replacement Therapy|Pulmonary Edema|COVID-19,Device: C2Rx|Other: Standard of Care (SOC),All,"Adult, Older Adult",Not Applicable,0.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 15, 2020","January 15, 2021"
4248,NCT04427267,Completed,No Results Available,Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients,Other: Personal protective equipment from biological hazard,All,Adult,,6.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 3, 2020","June 27, 2020"
4249,NCT04698044,Completed,No Results Available,Anxiety|Depression|Covid19|Cancer|Chronic Disease,Diagnostic Test: Hospital Anxiety Depression Scale,All,"Adult, Older Adult",,1107.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 8, 2020","June 25, 2020"
4250,NCT04775966,Completed,No Results Available,Sleep Apnea Syndromes,,All,"Adult, Older Adult",,8477.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 15, 2021","February 15, 2021"
4251,NCT04696679,Completed,No Results Available,Very Preterm Children With Dysexecutive Disorders,Other: Patient Quality of life assessment|Other: Control group Quality of life assessment,All,Child,,170.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 19, 2020","December 31, 2020"
4252,NCT04316949,Recruiting,No Results Available,SARS-CoV-2 Pneumonia,,All,"Adult, Older Adult",,350.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 20, 2020","May 31, 2020"
4253,NCT04614025,Recruiting,No Results Available,COVID|ARDS,Biological: PLX-PAD,All,"Adult, Older Adult",Phase 2,40.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,November 2020,March 2022
4254,NCT04636697,Recruiting,No Results Available,SARS-CoV-2 Infection,Drug: Intramuscular injection|Biological: Intramuscular vaccine,All,"Adult, Older Adult",Phase 2|Phase 3,30918.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","November 19, 2020","April 30, 2022"
4255,NCT04406844,Recruiting,No Results Available,Oncology Patients,,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 9, 2020","June 30, 2021"
4256,NCT04429529,Completed,No Results Available,Coronavirus Disease-2019 (COVID-19),Biological: TY027|Other: 0.9% Saline,All,Adult,Phase 1,32.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 9, 2020","January 20, 2021"
4257,NCT04320238,Recruiting,No Results Available,2019 Novel Coronavirus Infection,Drug: recombinant human interferon Alpha-1b|Drug: thymosin alpha 1,All,"Adult, Older Adult",Phase 3,2944.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 21, 2020",June 2020
4258,NCT04335279,Completed,No Results Available,"Scleroderma|Scleroderma, Systemic|Systemic Sclerosis",Other: SPIN-CHAT Program,All,"Adult, Older Adult",Not Applicable,172.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 9, 2020","July 24, 2020"
4259,NCT04609722,Recruiting,No Results Available,Anxiety|Parents|Covid19,Other: Solution-Focused Support Program,All,Adult,Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"July 1, 2020","February 15, 2021"
4260,NCT04348461,Suspended,No Results Available,COVID|Respiratory Distress Syndrome,Drug: Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells,All,"Adult, Older Adult",Phase 2,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 6, 2020","September 30, 2021"
4261,NCT04705831,Recruiting,No Results Available,Post-Viral Fatigue Syndrome|Post-Viral Disorder (Disorder)|Covid19,Drug: Ruconest,All,"Adult, Older Adult",Phase 4,40.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","December 30, 2020",January 2022
4262,NCT04373096,Recruiting,No Results Available,Covid19,Device: current IPAC-UHN PPE|Device: modified IPAC-UHN PPE,All,"Adult, Older Adult",Not Applicable,42.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"December 7, 2020","October 31, 2021"
4263,NCT04750265,Recruiting,No Results Available,Covid19|Critical Illness|Critical Illness Polyneuromyopathy|Early Mobilization|Rehabilitation|Robotics,Device: Robotic assisted early mobilization,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 21, 2021",December 2021
4264,NCT04699916,Not yet recruiting,No Results Available,Sedation Complication|Covid19,Other: EEG based protocol for deep sedation,All,"Adult, Older Adult",Not Applicable,44.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","January 4, 2021","December 31, 2021"
4265,NCT04389450,Recruiting,No Results Available,COVID|ARDS,Biological: PLX-PAD|Biological: Placebo,All,"Adult, Older Adult",Phase 2,140.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 1, 2020",March 2022
4266,NCT04504877,"Active, not recruiting",No Results Available,Covid19|Burn Out|Post Traumatic Stress Disorder,Drug: Cannabidiol,All,Adult,Phase 2|Phase 3,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 16, 2020","December 16, 2020"
4267,NCT04728880,Recruiting,No Results Available,"Pneumonia, Viral",Drug: Remdesivir,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 26, 2021","May 30, 2021"
4268,NCT04469660,Recruiting,No Results Available,Psychological Stress,,All,"Adult, Older Adult",,1300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 18, 2020","September 30, 2020"
4269,NCT04380779,Completed,No Results Available,COVID-19,,All,"Child, Adult, Older Adult",,2430.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"April 13, 2020","October 13, 2020"
4270,NCT04322344,Recruiting,No Results Available,Coronavirus Infections,Drug: Escin|Drug: standard therapy,All,"Adult, Older Adult",Phase 2|Phase 3,120.0,Other,Interventional,"Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care","March 23, 2020","December 30, 2020"
4271,NCT04408131,Recruiting,No Results Available,Homeless,Biological: Blood sample,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 28, 2020","January 27, 2021"
4272,NCT04389801,Not yet recruiting,No Results Available,Covid 19,Drug: Desferal 500 MG Injection,All,"Child, Adult, Older Adult",Phase 4,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 1, 2020","December 31, 2020"
4273,NCT04373109,Completed,No Results Available,Stroke|Rehabilitation|COVID-19|Cohort Studies,Behavioral: Observation,All,"Adult, Older Adult",,36.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","October 12, 2020"
4274,NCT04668209,Recruiting,No Results Available,Coronavirus,Drug: Silmitasertib,All,"Adult, Older Adult",Phase 2,40.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 1, 2021","September 30, 2021"
4275,NCT04496869,Not yet recruiting,No Results Available,Infertility Treatment|Women,Other: Online questionnaire,Female,Adult,,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,July 2020,December 2020
4276,NCT04440098,Completed,No Results Available,Loneliness|Depression|Anxiety|Alcohol Abuse|Drug Abuse,,All,Adult,,1008.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"April 22, 2020","May 11, 2020"
4277,NCT04374786,Enrolling by invitation,No Results Available,Perceived Stress|Anxiety|Sleep Disturbance|Burnout|PTSD,Device: Calm Meditation App,All,"Adult, Older Adult",Not Applicable,328.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 15, 2020","October 1, 2020"
4278,NCT04435080,Completed,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Rehabilitation|Intensive Care Unit Acquired Weakness|Critical Illness Polyneuromyopathy,,All,"Adult, Older Adult",,35.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 15, 2020","June 11, 2020"
4279,NCT04390412,"Active, not recruiting",No Results Available,COVID|SARS (Severe Acute Respiratory Syndrome),Radiation: Low Dose Radiotherapy,All,"Adult, Older Adult",Phase 1|Phase 2,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 4, 2020",December 2020
4280,NCT04420364,Not yet recruiting,No Results Available,COVID|Kidney Transplant; Complications|Immunosuppression,Other: Maintenance or reduction of immunosuppression,All,"Adult, Older Adult",Phase 2|Phase 3,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 1, 2021","December 31, 2021"
4281,NCT04359836,Recruiting,No Results Available,Gut Microbiome|Gastrointestinal Microbiome|COVID|COVID-19|Corona Virus Infection|Coronavirus|Coronaviridae Infections|Coronavirus 19|Coronavirus-19|COVID 19,Other: There is no intervention in this study,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"April 16, 2020","July 31, 2021"
4282,NCT04410835,Recruiting,No Results Available,Corona Virus Infection|Psychiatric Disorder|Psychological Distress,Diagnostic Test: Online Survey,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 28, 2020","April 28, 2021"
4283,NCT04395716,Withdrawn,No Results Available,COVID|Covid-19|Corona Virus Infection|Sars-CoV2|Coronavirus-19|SARS Pneumonia|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,Biological: ResCure™,All,"Adult, Older Adult",Phase 1,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2020,November 2021
4284,NCT04525820,Recruiting,No Results Available,Covid19|Vitamin D Deficiency|Corona Virus Infection|ARDS|Coronavirus|SARS-CoV Infection,Drug: Single high dose vitamin D|Drug: Placebo|Drug: Treatment as usual vitamin D,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 15, 2020","June 30, 2021"
4285,NCT04425733,Withdrawn,No Results Available,Coronavirus Disease 2019 (COVID-19)|Pneumonia|Hypoxemia,Drug: MK-5475|Drug: Placebo,All,"Adult, Older Adult",Phase 1,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","July 7, 2020","November 10, 2020"
4286,NCT04433546,Terminated,No Results Available,Acute Respiratory Distress Syndrome|Coronavirus|Hypoxic Respiratory Failure|Hypoxemic Respiratory Failure|Respiratory Complication|Respiratory Insufficiency|Cardiac Dysfunction|Pneumonia|Pulmonary Edema|Pulmonary Inflammation|Respiratory Failure|Cytokine Storm|COVID 19|SARS-CoV-2|Cardiac Event|Cardiac Complication|Cardiac Failure|Cardiac Infarct,Drug: Pemziviptadil (PB1046)|Drug: Low Dose (10 mg) Control,All,"Adult, Older Adult",Phase 2,54.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 15, 2020","December 2, 2020"
4287,NCT04775056,Not yet recruiting,No Results Available,Chronic Liver Disease|Hepatic Carcinoma,,All,"Adult, Older Adult",,30000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2021","March 31, 2022"
4288,NCT04615676,Completed,No Results Available,SARS-CoV2,Other: Follow-up phone call,All,"Child, Adult, Older Adult",,4734.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","July 17, 2020"
4289,NCT04595903,Not yet recruiting,No Results Available,SARS (Severe Acute Respiratory Syndrome),Device: Hemopurifier,All,"Adult, Older Adult",Not Applicable,40.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,August 2021
4290,NCT04331613,Recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Virus; Pneumonia|Acute Lung Injury,Biological: CAStem,All,"Adult, Older Adult",Phase 1|Phase 2,9.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 27, 2020",December 2020
4291,NCT04403269,Recruiting,No Results Available,Sars-CoV2,Drug: IgIV,All,Older Adult,Phase 2,35.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 5, 2020","May 5, 2021"
4292,NCT04331054,Recruiting,No Results Available,Covid-19 Infection|Hospitalization in Respiratory Disease Department,Drug: 2: Usual practice + SYMBICORT RAPIHALER|Other: 1: Usual practice,All,"Adult, Older Adult",Phase 3,436.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 13, 2020","January 13, 2022"
4293,NCT04374474,Withdrawn,No Results Available,Olfactory Disorder,Other: Olfactory retraining|Drug: corticosteroid nasal irrigation|Other: smell household Items|Other: Nasal Irrigation,All,"Adult, Older Adult",Phase 4,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 10, 2021","March 10, 2022"
4294,NCT04337502,Completed,No Results Available,Coronavirus|Machine Learning,Diagnostic Test: Machine learning model,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"December 23, 2019","March 3, 2020"
4295,NCT04535167,Recruiting,No Results Available,Viral Disease,Drug: PF-07304814|Drug: Placebo,All,"Adult, Older Adult",Phase 1,72.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 9, 2020","May 19, 2021"
4296,NCT04378244,Not yet recruiting,No Results Available,COVID-19|Cytokine Storm|Acute Respiratory Distress Syndrome,Drug: DeltaRex-G,All,"Adult, Older Adult",Phase 1|Phase 2,18.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 12, 2021","March 12, 2022"
4297,NCT04487210,"Active, not recruiting",No Results Available,COVID-19,Biological: MVC-COV1901,All,Adult,Phase 1,45.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 7, 2020","June 30, 2021"
4298,NCT04581070,Terminated,No Results Available,Cancer|COVID-19,,All,"Adult, Older Adult",,4.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 29, 2020","October 9, 2020"
4299,NCT04530461,Recruiting,No Results Available,SARS-CoV Infection|Systemic Disease|Systemic Lupus Erythematosus|Sjogren's Syndrome|Sarcoidosis|Inflammatory Myopathy|Behçet Disease|Rheumatoid Arthritis|Spondyloarthritis,Diagnostic Test: Serological test,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","January 31, 2021"
4300,NCT04726865,Completed,No Results Available,the Effect of COVID-19 Pandemic,Other: Naser Al-Husban,All,Adult,,415.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"October 1, 2020","December 31, 2020"
4301,NCT04313127,"Active, not recruiting",No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),All,Adult,Phase 1,108.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 16, 2020","December 20, 2022"
4302,NCT04343963,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Pyridostigmine Bromide|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,436.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 4, 2020","April 30, 2021"
4303,NCT04431284,Completed,No Results Available,Feeding and Eating Disorders,Other: Questionnaires,All,"Adult, Older Adult",,37.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"June 16, 2020","December 16, 2020"
4304,NCT04791241,Recruiting,No Results Available,Acute Respiratory Failure,Other: check-list including lung ultrasound,All,"Adult, Older Adult",Not Applicable,105.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 3, 2021","May 4, 2021"
4305,NCT04455958,Not yet recruiting,No Results Available,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed,Drug: Lopinavir/Ritonavir|Drug: Placebo Administration|Other: Questionnaire Administration,All,"Adult, Older Adult",Phase 2,75.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 1, 2020","November 1, 2021"
4306,NCT04321278,Completed,No Results Available,"Coronavirus Infections|Pneumonia, Viral",Drug: Hydroxychloroquine + azithromycin|Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 3,440.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 28, 2020","June 14, 2020"
4307,NCT04500652,Recruiting,No Results Available,Anxiety|Depression|Insomnia|Covid19|Coronavirus,,All,"Adult, Older Adult",,310.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 27, 2020","October 1, 2020"
4308,NCT04423289,Completed,No Results Available,Face-to-face Reconsultation to Emergency Room,Other: Farmalarm,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 31, 2020","May 18, 2020"
4309,NCT04363463,Recruiting,No Results Available,COVID19|Oxygen Therapy|Prone Position|Spontaneous Ventilation|Respiratory Distress Syndrome,Other: prone position,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 28, 2020","August 28, 2022"
4310,NCT04422340,Recruiting,No Results Available,"COVID-19 Disease, Severe Form",Other: Group1,All,"Adult, Older Adult",,185.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 1, 2020","August 15, 2020"
4311,NCT04709120,Recruiting,No Results Available,"Covid19|Comorbidities and Coexisting Conditions|Risk Factor, Cardiovascular|Death|Diabetes|COPD|Atrial Fibrillation|DVT|CKD",,All,"Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 11, 2021","December 31, 2021"
4312,NCT04375410,Completed,No Results Available,Hand Eczema|Hand Dermatitis|Covid19,,All,Child,,6273.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 22, 2020","May 10, 2020"
4313,NCT04619290,Recruiting,No Results Available,Sars Cov 2,Drug: Sublingual Methylene blue|Other: Control patients,All,"Adult, Older Adult",Phase 1,46.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 12, 2020","December 30, 2020"
4314,NCT04604769,Completed,No Results Available,Coronavirus|Nurse's Role|Professional Stress,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 26, 2019","September 1, 2020"
4315,NCT04275414,Completed,No Results Available,Coronavirus Infections,Drug: Bevacizumab Injection,All,"Adult, Older Adult",Phase 2,27.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 15, 2020","May 2, 2020"
4316,NCT04466683,Recruiting,No Results Available,Covid-19|Sars-CoV2|Pneumonia,Radiation: Low dose radiation 35 cGy|Radiation: High dose radiation 100 cGy,All,"Adult, Older Adult",Phase 2,100.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 28, 2020","December 31, 2022"
4317,NCT04357730,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome|Respiratory Failure|Acute Respiratory Distress Syndrome,Drug: Alteplase 50 MG [Activase],All,"Adult, Older Adult",Phase 2,50.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 14, 2020",November 2021
4318,NCT04556604,Completed,No Results Available,Consent,Behavioral: Educational meetings and visual prompts,All,"Adult, Older Adult",,45.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"April 10, 2020","August 14, 2020"
4319,NCT04565249,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|SARS-CoV-2,Drug: PLN-74809|Drug: Placebo,All,"Adult, Older Adult",Phase 2,36.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 22, 2020","October 31, 2021"
4320,NCT04353583,Recruiting,No Results Available,Acute Kidney Injury|Corona Virus Infection,,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 21, 2020","June 30, 2021"
4321,NCT04367350,Recruiting,No Results Available,COVID|Sars-CoV2|Corona Virus Infection|Myositis|Myocarditis,Diagnostic Test: laboratory biomarkers|Diagnostic Test: muscle ultrasound,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020","March 31, 2022"
4322,NCT04366791,Suspended,No Results Available,Pneumonia|Coronavirus Infection in 2019 (COVID-19)|Severe Acute Respiratory Syndrome (SARS) Pneumonia,Radiation: Low Dose Radiation Therapy,All,"Adult, Older Adult",Phase 1|Phase 2,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 23, 2020","April 15, 2021"
4323,NCT04500366,Recruiting,No Results Available,Frailty,Behavioral: Socialization|Behavioral: Virtual Group Exercise|Combination Product: Nutrition Consult and Protein Supplementation|Behavioral: Medication Review,All,Older Adult,Not Applicable,70.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 26, 2020",May 2021
4324,NCT04384445,Recruiting,No Results Available,Corona Virus Infection|COVID-19|SARS|Acute Respiratory Distress Syndrome,Biological: Zofin|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 8, 2020","July 31, 2021"
4325,NCT04535297,Completed,No Results Available,Parkinson Disease|Stroke,Other: exposure,All,"Adult, Older Adult",,198.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"May 10, 2020","June 30, 2020"
4326,NCT04378712,Completed,No Results Available,Covid-19|Hydrogen/Oxygen Mixed Gas|Dyspnea,Device: Hydrogen Oxygen Generator with Nebulizer|Other: Standard-of-care,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 21, 2020","March 23, 2020"
4327,NCT04425213,Completed,No Results Available,COVID|Severe Acute Respiratory Syndrome|Obesity|Comorbidities and Coexisting Conditions,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 12, 2020","May 26, 2020"
4328,NCT04353128,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2|Phase 3,450.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 20, 2020",December 2020
4329,NCT04444674,"Active, not recruiting",No Results Available,Coronavirus,Biological: ChAdOx1 nCoV-19|Biological: Normal saline 0.9%,All,"Adult, Older Adult",Phase 1|Phase 2,2130.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 24, 2020",December 2021
4330,NCT04818216,Not yet recruiting,No Results Available,SARS-CoV-2 Infection|Acute Kidney Injury,Drug: Placebo|Drug: Nicotinamide riboside,All,"Adult, Older Adult",Phase 2,100.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",April 2021,June 2023
4331,NCT04710836,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"December 3, 2020","August 31, 2032"
4332,NCT04791085,Recruiting,No Results Available,"Stress, Psychological|Stress, Emotional|Life Style Induced Illness|Anxiety Depression|Covid19",,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"February 8, 2021","May 8, 2021"
4333,NCT04377334,Not yet recruiting,No Results Available,ARDS|COVID-19,Biological: MSC,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,October 2020,July 2021
4334,NCT04472052,Completed,No Results Available,Perforated Appendicitis|Covid19,Other: appendectomy,All,"Child, Adult, Older Adult",,143.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 16, 2020","May 31, 2020"
4335,NCT04326452,Recruiting,No Results Available,Coronavirus Infection,Device: bidirectional oxygenation mouthpiece,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 27, 2020","March 27, 2021"
4336,NCT04610515,Recruiting,No Results Available,Covid19|ME/CFS|SARS COV2|Novel Coronavirus Infection|Neurocognitive Disorders|Cardiovascular Diseases,,All,"Adult, Older Adult",,4800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 15, 2020","November 14, 2022"
4337,NCT04733105,Recruiting,No Results Available,Acute Respiratory Failure,,All,"Adult, Older Adult",,530.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"November 19, 2020","February 20, 2022"
4338,NCT04382469,Completed,No Results Available,COVID,,All,"Child, Adult, Older Adult",,48.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Retrospective,"February 1, 2020","May 1, 2020"
4339,NCT04385823,Completed,No Results Available,"Respiratory Syndrome, Acute, Severe|Hypoxic Respiratory Failure|Viral Pneumonia",Device: patients receiving nasal high flow,All,"Adult, Older Adult",,62.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","May 4, 2020"
4340,NCT04328467,"Active, not recruiting",No Results Available,COVID-19|Corona Virus Infection|ARDS|Acute Respiratory Distress Syndrome,Drug: Hydroxychloroquine|Other: Placebo,All,"Adult, Older Adult",Phase 3,1500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 6, 2020",August 2020
4341,NCT04397588,Recruiting,No Results Available,ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2|Acute Refractory Heart Failure Related to SARS-CoV 2,,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 21, 2020","October 21, 2020"
4342,NCT04594460,Not yet recruiting,No Results Available,Covid19|Hydrogen-oxygen Gas|AMS-H-03,"Device: Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03|Device: OLO-1 Medical Molecular Sieve Oxygen Generator",All,"Adult, Older Adult",Not Applicable,198.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 31, 2020","December 31, 2021"
4343,NCT04370938,Withdrawn,No Results Available,"Perceived Organizational Support, Anxiety, Burnout",Behavioral: Coping strategies video,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"April 29, 2020","October 29, 2020"
4344,NCT04734561,Recruiting,No Results Available,Covid19|Respiratory Muscle Training|Respiratory Function Test|Quality of Life|Psychosocial Factor,Other: Inspiratory muscle training group|Other: Inspiratory muscle training placebo group|Other: Inspiratory + expiratory muscle training group|Other: Inspiratory + expiratory muscle training placebo group,All,"Adult, Older Adult",Not Applicable,88.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","February 8, 2021","July 30, 2022"
4345,NCT04327401,Terminated,No Results Available,"Coronavirus Infection|Pneumonia, Viral|Acute Respiratory Distress Syndrome",Drug: Dexamethasone,All,"Adult, Older Adult",Phase 3,299.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 13, 2020","July 22, 2020"
4346,NCT04839042,Not yet recruiting,No Results Available,Covid19,Biological: SC-Ad6-1,All,Adult,Phase 1,40.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 1, 2021","September 30, 2021"
4347,NCT04769154,Not yet recruiting,No Results Available,Airway Management|Intensive Care Unit|Covid19,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,February 2021,February 2023
4348,NCT04769297,"Active, not recruiting",No Results Available,Acute Stress Disorder,Drug: Sublingual Micro-Dose Ketamine,All,"Adult, Older Adult",Phase 4,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020",April 2021
4349,NCT04513314,Not yet recruiting,No Results Available,"Covid19|Hyperactive Delirium|Pneumonia, Viral",Drug: Valproate|Drug: Quetiapine|Other: Standard of Care,All,"Adult, Older Adult",Phase 4,20.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","November 1, 2021","November 1, 2022"
4350,NCT04836299,Not yet recruiting,No Results Available,Covid19,Drug: Ivermectin|Drug: Placebo,All,"Adult, Older Adult",Phase 2,90.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","May 8, 2021","December 5, 2021"
4351,NCT04350736,Completed,No Results Available,Acute Lung Injury (ALI) Associated With COVID-19|Inflammatory Lung Conditions Associated With COVID-19,Drug: TD-0903|Drug: Placebo,All,Adult,Phase 1,54.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 23, 2020","June 24, 2020"
4352,NCT04268537,Not yet recruiting,No Results Available,"2019 nCoV, PD-1",Drug: PD-1 blocking antibody+standard treatment|Drug: Thymosin+standard treatment|Other: standard treatment,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 10, 2020","October 31, 2020"
4353,NCT04603755,Recruiting,No Results Available,SARS-CoV Infection|Acute Respiratory Distress Syndrome,Device: Electrical Impedance tomography,All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 26, 2020",April 2022
4354,NCT04397705,Recruiting,No Results Available,COVID|Oncology|Haematological Malignancy,Device: Patient Status Engine,All,"Adult, Older Adult",Phase 1,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"October 12, 2020",April 2021
4355,NCT04497415,Recruiting,No Results Available,Brief Video-based Intervention|Non Intervention Control,Other: Video-Based intervention,All,"Adult, Older Adult",Not Applicable,1200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,"October 21, 2020","January 30, 2021"
4356,NCT04290871,Withdrawn,No Results Available,Coronavirus|SARS (Severe Acute Respiratory Syndrome),Drug: Nitric Oxide Gas,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","March 23, 2020","March 1, 2022"
4357,NCT04484207,Recruiting,No Results Available,Brief Video-based Intervention|Vignette Based Intervention|Non Intervention Control Arm,Other: A short video intervention|Other: A vignette intervention,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,"July 6, 2020","October 26, 2020"
4358,NCT04251767,Withdrawn,No Results Available,COVID-19 Complicated With Refractory Intestinal Infections,Other: washed microbiota transplantation|Other: placebo,All,"Child, Adult, Older Adult",Not Applicable,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 5, 2020","April 30, 2020"
4359,NCT04411784,"Active, not recruiting",No Results Available,Inflammatory Bowel Diseases|COVID,,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"May 20, 2020",July 2020
4360,NCT04451993,Completed,No Results Available,Obstructive Sleep Apnea-hypopnea Syndrome,,All,"Adult, Older Adult",,63.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 25, 2020","September 30, 2020"
4361,NCT04805684,Completed,No Results Available,Lung Ultrasound|Pneumonia|Covid19,Device: LUS Twelve area|Device: LUS Fourteen area,All,"Adult, Older Adult",Not Applicable,59.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Diagnostic,"January 1, 2021","March 5, 2021"
4362,NCT04380909,"Active, not recruiting",No Results Available,"Psychological Distress|Adjustment, Psychological|Coronavirus",Behavioral: Internet-based self-help|Behavioral: Internet-based self-help after 3 weeks,All,"Adult, Older Adult",Not Applicable,107.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 6, 2020",April 2021
4363,NCT04572399,Completed,No Results Available,Coronavirus,Device: UV Light Treatment,All,"Adult, Older Adult",Not Applicable,5.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 30, 2020","December 28, 2020"
4364,NCT04608097,Recruiting,No Results Available,Healthy Participants|Intrusive Memories,Behavioral: Simple cognitive task intervention|Behavioral: Attention Placebo,All,"Adult, Older Adult",Not Applicable,66.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","October 28, 2020","January 15, 2021"
4365,NCT04400006,Completed,No Results Available,Corona Virus Infection,,All,"Adult, Older Adult",,71.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 6, 2020","May 17, 2020"
4366,NCT04368026,Completed,No Results Available,"Surgical Procedure, Unspecified",Other: No intervention (survey study for medical doctors).,All,"Adult, Older Adult",,70.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 30, 2020","December 1, 2020"
4367,NCT04609488,Not yet recruiting,No Results Available,To Assess Surfactant Levels in Lung Fluid,Diagnostic Test: Surfactant assessment,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"November 1, 2020","October 1, 2022"
4368,NCT04350099,Recruiting,No Results Available,Emotionnal Distress; COVID-19,Other: quetionnary,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","June 15, 2021"
4369,NCT04429477,Completed,No Results Available,Intracranial Hypertension|Cerebral Circulatory Failure,Device: Cerebral compliance and hemodynamics monitoring,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","July 31, 2020"
4370,NCT04435015,Not yet recruiting,No Results Available,Coagulopathy|Cardiovascular Complication|COVID-19,"Drug: Camostat Mesylate|Drug: Microcrystalline Cellulose, NF",All,"Adult, Older Adult",Phase 1|Phase 2,200.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 1, 2021","July 30, 2021"
4371,NCT04367077,Recruiting,No Results Available,ARDS,Biological: MultiStem|Biological: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,400.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 28, 2020",December 2023
4372,NCT04326400,Recruiting,No Results Available,Coronavirus Infection,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 23, 2020","September 20, 2020"
4373,NCT04341935,Not yet recruiting,No Results Available,Coronavirus Infection|Type 2 Diabetes,Drug: Linagliptin|Drug: Insulin regimen,All,"Adult, Older Adult",Phase 4,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 30, 2021","December 30, 2021"
4374,NCT04369469,"Active, not recruiting",No Results Available,"COVID-19 Severe Pneumonia|Acute Lung Injury|Acute Respiratory Distress Syndrome|Pneumonia, Viral",Biological: Ravulizumab|Other: Best Supportive Care,All,"Adult, Older Adult",Phase 3,270.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 11, 2020",July 2021
4375,NCT04363827,"Active, not recruiting",No Results Available,COVID19|Hydroxychloroquine|Prophylaxis|Treatment|SARS-CoV-2,Drug: Hydroxychloroquine,All,"Adult, Older Adult",Phase 2,2300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 14, 2020",September 2021
4376,NCT04762173,"Active, not recruiting",No Results Available,Stress,Device: Online self-help intervention,All,"Adult, Older Adult",Not Applicable,585.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 6, 2020","June 3, 2021"
4377,NCT04407208,Completed,No Results Available,Convalescence|Corona Virus Infection|Plaque,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 1,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 1, 2020","June 22, 2020"
4378,NCT04406064,Withdrawn,No Results Available,Viral Infection,Biological: Viral Specific T-cells (VSTs),All,"Child, Adult, Older Adult",Phase 2,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,June 2025
4379,NCT04611243,Recruiting,No Results Available,Lung Function|Exercise Capacity|Quality of Life|Covid19,Drug: Kaletra and beta interferon,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 22, 2020","May 21, 2022"
4380,NCT04750018,Recruiting,No Results Available,COVID-19|Breast Cancer,Other: surgery,Female,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"July 3, 2020","June 1, 2021"
4381,NCT04619576,Recruiting,No Results Available,Occupational Health,Behavioral: Occupational health workers,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 1, 2020","December 21, 2025"
4382,NCT04169542,Recruiting,No Results Available,Breast Ductal Carcinoma In Situ|COVID-19 Infection|Hereditary Breast Carcinoma|Invasive Breast Carcinoma,Other: Questionnaire Administration,Female,"Adult, Older Adult",,600.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 21, 2019","March 31, 2022"
4383,NCT04602000,Recruiting,No Results Available,SARS-CoV-2 Infection,Biological: CT-P59/Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,1020.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 25, 2020",September 2021
4384,NCT04507256,"Active, not recruiting",No Results Available,COVID-19,Combination Product: AZD7442|Other: Placebo,All,Adult,Phase 1,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 18, 2020","October 25, 2021"
4385,NCT04818970,Not yet recruiting,No Results Available,"Covid19|Corona Virus Infection|Autoimmune Diseases|Coagulation Disorder, Blood",Device: Narrow Band ultraviolet B-Band Light|Device: non Narrow Band ultraviolet B-Band Light,All,"Adult, Older Adult",Not Applicable,30.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 10, 2021","August 31, 2021"
4386,NCT04390516,Completed,No Results Available,COVID-19|Coronavirus|Mortality|Mechanical Ventilation,Device: COViage,All,"Adult, Older Adult",Not Applicable,197.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 24, 2020","May 30, 2020"
4387,NCT04335786,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|SARS-CoV-2|COVID|COVID-19|Severe Acute Respiratory Syndrome,Drug: Valsartan (Diovan)|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 4,651.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 17, 2020",December 2021
4388,NCT04442789,Recruiting,No Results Available,Lung Diseases|Cardiac Disease|Inflammatory Reaction,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 20, 2020","December 31, 2023"
4389,NCT04354792,Completed,No Results Available,Immunologic Activity Alteration,Diagnostic Test: Serum SARs COV 2 IGg screening in health care workers,All,Adult,,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 1, 2020","June 10, 2020"
4390,NCT04393818,Completed,No Results Available,Mental Health Disorder|Depression|Posttraumatic Stress Disorder|Burnout|Anxiety Disorders,Behavioral: Intervention App,All,"Adult, Older Adult",Phase 3,560.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care","May 5, 2020","August 24, 2020"
4391,NCT04363437,Recruiting,No Results Available,Coronavirus Infection,Drug: Colchicine|Drug: Usual Care,All,"Adult, Older Adult",Phase 2,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 26, 2020","June 14, 2020"
4392,NCT04335032,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Eicosapentaenoic acid gastro-resistant capsules|Drug: Placebo,All,"Adult, Older Adult",Phase 3,284.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 9, 2020","July 31, 2021"
4393,NCT04160975,Completed,No Results Available,"Flu, Human|Influenza, Human|Covid19",Behavioral: Video about safety and effectiveness of adult seasonal flu vaccination|Behavioral: Message directing subjects to information on COVID-19 vaccine safety and efficacy,Male,Adult,Not Applicable,2902.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research","December 20, 2019","February 19, 2021"
4394,NCT04541472,Recruiting,No Results Available,Dental Surgeon,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 1, 2020","December 1, 2020"
4395,NCT04539873,Not yet recruiting,No Results Available,Corona Virus Infection,Drug: Colchicine 0.5 MG|Combination Product: CONTROL GROUP,All,"Adult, Older Adult",Phase 3,128.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"March 15, 2021","September 15, 2021"
4396,NCT04407117,Completed,No Results Available,Appendicitis,Behavioral: Lock-down and social distancing,All,"Child, Adult, Older Adult",,6000000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 23, 2017","April 19, 2020"
4397,NCT04772404,Recruiting,No Results Available,Healthy,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 7, 2021","June 15, 2021"
4398,NCT04397692,Recruiting,No Results Available,"Corona Virus Infection|COVID-19|SARS-CoV 2|Nitric Oxide|Respiratory Disease|Pneumonia, Viral|Inhaled Nitric Oxide",Device: Nitric Oxide delivered via LungFit™ system,All,"Adult, Older Adult",Not Applicable,20.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,"June 13, 2020","September 30, 2020"
4399,NCT04357418,Completed,No Results Available,"Anxiety State|COVID-19|Isolation, Social|Health Personnel Attitude",Other: it is a survey,All,"Adult, Older Adult",,187.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"April 1, 2020","June 30, 2020"
4400,NCT04649775,Not yet recruiting,No Results Available,Corona Virus Infection|Respiratory Rate|Hypoxia|Covid19,Device: AirFLO2,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 30, 2021",June 2021
4401,NCT04583345,Recruiting,No Results Available,Hypertension|Social Isolation|COVID,Behavioral: Questionnaires,All,"Adult, Older Adult",,32.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"June 1, 2020","September 1, 2021"
4402,NCT04325867,Recruiting,No Results Available,"Angina Pectoris|Acute Coronary Syndrome|Coronary Syndrome|Coronary Artery Disease|Angioplasty|Stent Restenosis|Hypertension|Heart Failure, Systolic|Depression, Anxiety|Covid-19|Isolation, Social",Other: Tele-medicine platform,All,"Child, Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"March 31, 2020","October 1, 2020"
4403,NCT04530604,Recruiting,No Results Available,COVID|Sars-CoV2|COVID-19|Acute Respiratory Distress Syndrome,Drug: Defibrotide,All,"Adult, Older Adult",Phase 1,12.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2020","October 1, 2021"
4404,NCT04338698,Recruiting,No Results Available,COVID 19,Drug: Hydroxychloroquine|Drug: Oseltamivir|Drug: Azithromycin,All,"Adult, Older Adult",Phase 3,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 22, 2020","November 30, 2020"
4405,NCT04490200,Recruiting,No Results Available,"Covid19|SARS-CoV Infection|Worker-Patient Transmission, Healthcare",Device: VESTA respirator|Device: Conventional N95 respirator,All,Adult,Not Applicable,1000.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","March 1, 2021","February 15, 2022"
4406,NCT04710394,"Active, not recruiting",No Results Available,Anosmia|Covid19|Ageusia|Hyposmia|Hypogeusia|SARS-CoV-2 Infection|COVID-19 Pandemic,Behavioral: Smell Training,All,"Adult, Older Adult",Not Applicable,240.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","January 11, 2021","March 11, 2022"
4407,NCT04507867,Not yet recruiting,No Results Available,Covid19|Diabetes Mellitus|Hypertension|Obesity,Dietary Supplement: Nutritional support system (NSS)|Other: Control,All,"Adult, Older Adult",Not Applicable,240.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Investigator)|Primary Purpose: Supportive Care,August 2020,December 2020
4408,NCT04590547,Recruiting,No Results Available,Pneumonitis|SARS-CoV Infection,Drug: GLS-1027|Drug: Placebo,All,"Adult, Older Adult",Phase 2,132.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",April 2021,November 2021
4409,NCT04581187,Not yet recruiting,No Results Available,Hematologic Malignancies,Other: Quality of life assessment,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,October 2020,October 2024
4410,NCT04748185,Recruiting,No Results Available,Monoclonal B-Cell Lymphocytosis|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|B-cell Non Hodgkin Lymphoma|Hodgkin Lymphoma,,All,"Adult, Older Adult",,650.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 18, 2021","January 30, 2023"
4411,NCT04475081,Not yet recruiting,No Results Available,Sepsis Syndrome,Biological: MMR vaccine,All,"Adult, Older Adult",Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"August 17, 2020","December 1, 2021"
4412,NCT04626089,Withdrawn,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|Metabolic Syndrome|Type 2 Diabetes,Drug: metformin glycinate|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",February 2021,February 2021
4413,NCT04668339,"Active, not recruiting",No Results Available,Covid19|SARS-CoV Infection|Corona Virus Infection,"Biological: ARCT-021 single dose priming|Biological: ARCT-021 two lower dose priming|Biological: ARCT-021 two higher dose priming|Biological: Placebo (two doses), priming|Biological: Randomized booster|Biological: Placebo booster",All,"Adult, Older Adult",Phase 2,600.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 7, 2021","April 30, 2022"
4414,NCT04366089,Recruiting,No Results Available,"COVID|SARS-CoV 2|Pneumonia, Viral|Coronavirus Infection","Other: Oxygen-ozone therapy, probiotic supplementation and Standard of care|Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine",All,"Adult, Older Adult",Phase 2,152.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 26, 2020","December 31, 2020"
4415,NCT04666311,Recruiting,No Results Available,Pulmonary Tuberculosis|Tuberculosis Diagnosis|Covid-19|HIV,Diagnostic Test: Accuracy of CAD4TB and Afinion CRP assay for pulmonary TB|Diagnostic Test: CAD4COVID+WBC and COVID-19 RDT for SARS-CoV-2 infection,All,"Adult, Older Adult",,1400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,March 2021,May 2022
4416,NCT04403009,Recruiting,No Results Available,Coronavirus Disease 2019|Character of the Severe Patients,Other: no intervention,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"February 1, 2020","June 20, 2020"
4417,NCT04486404,Enrolling by invitation,No Results Available,Acute Stress Disorder,Other: Online survey,All,"Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","November 30, 2020"
4418,NCT04456088,Withdrawn,No Results Available,"COVID-19|SARS-CoV 2|Respiratory Disease|Pneumonia, Viral|Corona Virus Infection",Combination Product: 150 ppm Nitric Oxide delivered through LungFit Delivery System|Combination Product: 80 ppm Nitric Oxide delivered through LungFit Delivery System,All,"Adult, Older Adult",Phase 2,0.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 15, 2020","December 15, 2020"
4419,NCT04536051,Recruiting,No Results Available,Coronavirus,Biological: ChAdOx1 nCoV-19 single dose + paracetamol|Biological: MenACWY single dose + paracetamol|Biological: ChAdOx1 nCoV-19 two dose + paracetamol|Biological: MenACWY prime & saline placebo boost + paracetamol,All,"Adult, Older Adult",Phase 3,10300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"June 2, 2020",September 2021
4420,NCT04346277,Available,No Results Available,"COVID|ARDS, Human|Ards|SARS-CoV2","Biological: IC14, a monoclonal antibody against CD14",All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population,,,
4421,NCT04443673,Recruiting,No Results Available,"COVID-19|SARS-CoV Infection|SARS (Severe Acute Respiratory Syndrome)|SARS Pneumonia|ARDS, Human|Pneumonia, Viral",Dietary Supplement: Glycine,All,"Child, Adult, Older Adult",Not Applicable,82.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 20, 2020","June 30, 2021"
4422,NCT04291729,Completed,No Results Available,COVID-19,Drug: Ganovo+ritonavir+/-Interferon nebulization,All,"Adult, Older Adult",Phase 4,11.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 17, 2020","March 19, 2020"
4423,NCT04677270,Completed,No Results Available,Problem Solving,Behavioral: Digital problem solving tool,All,"Child, Adult, Older Adult",Not Applicable,397.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"August 31, 2020","November 30, 2020"
4424,NCT04334967,Suspended,No Results Available,COVID-19|Corona Virus Infection|SARS-CoV-2|2019-nCoV|2019 Novel Coronavirus,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C,All,"Adult, Older Adult",Phase 4,13.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 30, 2020","May 27, 2022"
4425,NCT04466306,Enrolling by invitation,No Results Available,Acute Kidney Injury|COVID,,All,"Child, Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","July 1, 2021"
4426,NCT04448704,Completed,No Results Available,Mental Health Issue,,All,"Adult, Older Adult",,1011.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 22, 2020","October 11, 2020"
4427,NCT04345276,Completed,No Results Available,COVID-19,Drug: Danoprevir+Ritonavir,All,"Adult, Older Adult",Phase 4,10.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 18, 2020","April 15, 2020"
4428,NCT04657406,Available,No Results Available,Covid19|Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|Acute Respiratory Distress Syndrome,Drug: ZofinTM,All,"Adult, Older Adult",,,Industry,Expanded Access:Treatment IND/Protocol,,,
4429,NCT04633941,Completed,No Results Available,"Diabetes Mellitus, Type 2|Obesity, Morbid|Bariatric Surgery Candidate",Other: Standard Care,All,"Adult, Older Adult",,272.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 1, 2020","July 30, 2020"
4430,NCT04718519,Completed,No Results Available,Coronavirus|Trust|Misinformation,,Male,Adult,,1011.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"June 22, 2020","October 11, 2020"
4431,NCT04382534,Recruiting,No Results Available,Covid19|Respiratory Rehabilitation|Cross-sectional Study|Cohort Study,Combination Product: Respiratory rehabilitation,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 10, 2020","December 31, 2020"
4432,NCT04334434,Completed,No Results Available,Telerehabilitation,Other: Telerehabilitation,All,Older Adult,Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"July 30, 2020","December 15, 2020"
4433,NCT04306705,Recruiting,No Results Available,Covid-19|SARS|Cytokine Storm|Cytokine Release Syndrome|Tocilizumab,Drug: Tocilizumab|Other: Standard of care|Procedure: Continuous renal replacement therapy,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 20, 2020","June 20, 2020"
4434,NCT04765371,Not yet recruiting,No Results Available,Coronavirus Infection,Drug: DEXAMETHASONE|Drug: PREDNISOLONE,All,"Adult, Older Adult",Phase 3,220.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,October 2021
4435,NCT04335305,Recruiting,No Results Available,"COVID-19|Pneumonia, Viral",Drug: Tocilizumab|Biological: Pembrolizumab (MK-3475),All,"Adult, Older Adult",Phase 2,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 9, 2020","June 30, 2021"
4436,NCT04356443,Recruiting,No Results Available,"Respiratory Failure|Ventilatory Failure|COVID-19|Pneumonia|ARDS, Human",Device: AirGo Respiratory Monitor,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","December 31, 2020"
4437,NCT04717089,Recruiting,No Results Available,Overnight Intensive Recovery|Postoperative Care,Other: overnight intensive recovery / extended post anaesthetic care in PACU,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"February 10, 2020","June 30, 2021"
4438,NCT04272710,Withdrawn,No Results Available,2019-nCoV,,All,"Adult, Older Adult",,0.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 25, 2020","April 30, 2020"
4439,NCT04460677,Recruiting,No Results Available,"Psychological Distress|Stress, Psychological|Autism Spectrum Disorder",Behavioral: Emotional Support Plan|Behavioral: Daily Monitoring,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 12, 2020","March 31, 2021"
4440,NCT04522128,Recruiting,No Results Available,COVID|Quality of Life|Behavior|Social Isolation,Behavioral: Behaviour Change Technique Intervention to Improve Quality of Life,All,"Adult, Older Adult",Not Applicable,969.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","May 22, 2020","December 31, 2022"
4441,NCT04333914,Recruiting,No Results Available,SARS-CoV-2 (COVID-19) Infection|Advanced or Metastatic Hematological or Solid Tumor,Drug: Autophagy inhibitor (GNS651)|Other: Standard of care|Drug: Avdoralimab|Drug: Monalizumab,All,"Adult, Older Adult",Phase 2,219.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020",August 2021
4442,NCT04581811,Recruiting,No Results Available,ARDS|Covid19|Acute Hypoxemic Respiratory Failure,Other: Prolonged Proned Positioning|Other: Traditional Proning Arm,All,"Adult, Older Adult",Not Applicable,52.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 10, 2020",June 2021
4443,NCT04645433,Completed,No Results Available,Mortality|Intensive Care Unit,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 15, 2020","May 15, 2020"
4444,NCT04395911,Recruiting,No Results Available,AKI|ARDS|COVID,Device: SCD,All,"Adult, Older Adult",Not Applicable,30.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 10, 2020",December 2021
4445,NCT04601090,Recruiting,No Results Available,Covid19|Acute Respiratory Failure|Acute Respiratory Distress Syndrome|Post Intensive Care Unit Syndrome|Survivorship,Other: ICU treatment,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 16, 2020",September 2022
4446,NCT04798625,Recruiting,No Results Available,Rheumatoid Arthritis|Psoriatic Arthritis|Spondyloarthritis|Crohn Disease|Ulcerative Colitis|Autoimmune Hepatitis|Liver Transplant; Complications,,All,"Adult, Older Adult",,1600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 15, 2021","February 15, 2027"
4447,NCT04381923,Not yet recruiting,No Results Available,"Severe Acute Respiratory Syndrome Coronavirus 2|Hypoxemic Respiratory Failure|Pneumonia, Viral|COVID",Device: Helmet Continuous Positive Airway Pressure (CPAP)|Device: High Flow Nasal Oxygen (HFNO),All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"February 15, 2021","May 15, 2022"
4448,NCT04395833,Completed,No Results Available,Identify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic,,All,"Child, Adult",,2500.0,Other,Observational,Observational Model: Family-Based|Time Perspective: Cross-Sectional,"April 7, 2020","May 11, 2020"
4449,NCT04723407,Not yet recruiting,No Results Available,Rheumatism,Other: questionnaires,All,"Adult, Older Adult",,950.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"February 1, 2021","March 1, 2022"
4450,NCT04659135,Recruiting,No Results Available,Neoplasms|Coronavirus,,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 19, 2020",December 2022
4451,NCT04355637,Recruiting,No Results Available,Coronavirus Infection,Drug: Inhaled budesonide,All,"Adult, Older Adult",Phase 4,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 21, 2020","August 31, 2021"
4452,NCT04445506,Completed,No Results Available,Corticosteroids|Covid19|SARS-CoV 2|Steroids|Dexamethasone,Drug: Dexamethasone,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"April 1, 2020","May 31, 2020"
4453,NCT04611425,Recruiting,No Results Available,Acute Respiratory Failure|COVID-19|Trauma|Stroke|Sepsis|Shock,Drug: Remimazolam,All,"Adult, Older Adult",Phase 2,30.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"November 30, 2020","May 1, 2021"
4454,NCT04402879,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19|Acute Respiratory Distress Syndrome|ARDS|Hypoxemic Respiratory Failure,Procedure: Prone Positioning (PP),All,"Adult, Older Adult",Not Applicable,596.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 10, 2020","June 1, 2022"
4455,NCT04452695,Completed,No Results Available,COVID-19|Telemedicine|Robotics|Emergencies|Emerging Infectious Disease,Device: Doctor Spot,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 10, 2020","August 10, 2020"
4456,NCT04351542,Completed,No Results Available,Flu Like Illness,Dietary Supplement: Ayurveda|Other: Usual Care,All,Adult,Not Applicable,32.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care,"March 6, 2020","April 12, 2020"
4457,NCT04293692,Withdrawn,No Results Available,COVID-19,Biological: UC-MSCs|Other: Placebo,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","February 24, 2020","February 25, 2020"
4458,NCT04753632,Recruiting,No Results Available,Cerebral Palsy,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 9, 2021","June 15, 2021"
4459,NCT04593641,"Active, not recruiting",No Results Available,SARS-CoV-2 Infection,Biological: CT-P59,All,Adult,Phase 1,18.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 4, 2020","December 23, 2020"
4460,NCT04615936,Recruiting,No Results Available,COVID-19|Corona Virus Infection|SARS-CoV 2,Other: Methylene-Blue Photodisinfection,All,"Child, Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 10, 2020","May 31, 2021"
4461,NCT04403061,Completed,No Results Available,"Disease, Viral|Cytokine Release Syndrome|TLRs",Diagnostic Test: Cytokines measurement|Diagnostic Test: Cellular response|Diagnostic Test: TLRs activation measurement|Diagnostic Test: KIR phenotype evaluation,All,"Adult, Older Adult",,106.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 22, 2020","January 10, 2021"
4462,NCT04588415,Enrolling by invitation,No Results Available,Bereavement|Severe Grief Reaction,Other: Bereavement Virtual Support Group,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"January 3, 2021","January 1, 2022"
4463,NCT04575584,Recruiting,No Results Available,Coronavirus Disease (COVID-19),Drug: Molnupiravir|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,1300.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 19, 2020","December 30, 2021"
4464,NCT04405739,Recruiting,No Results Available,SARS-CoV 2,Drug: EIDD-2801|Drug: Placebo (PB0),All,"Adult, Older Adult",Phase 2,80.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 16, 2020","May 28, 2021"
4465,NCT04488549,Completed,No Results Available,Colo-rectal Cancer|Colon Cancer|Rectal Cancer|Oncology|Surgery,Other: Survey,All,"Child, Adult, Older Adult",,1051.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 20, 2020","June 10, 2020"
4466,NCT04390555,Recruiting,No Results Available,COVID-19|Cardiovascular Diseases|Cardiovascular Risk Factor|Heart Failure,,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 30, 2020",July 2021
4467,NCT04842734,"Active, not recruiting",No Results Available,Alzheimer Disease|Telerehabilitation|Online Physical Exercise|Computerized Cognitive Stimulation|Covid-19 Pandemic,Other: Physical exercise|Other: Physical exercise and computerized cognitive training,All,Older Adult,Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"March 27, 2021","June 27, 2021"
4468,NCT04603781,Recruiting,No Results Available,Anxiety Depression|Alcohol Abuse|Substance Abuse|Anger|Sleep Disturbance|Stress Reaction,Dietary Supplement: CBD Isolate|Dietary Supplement: Full Spectrum CBD Oil|Dietary Supplement: Broad-Spectrum CBD Oil|Dietary Supplement: Placebo Oil,All,"Adult, Older Adult",Phase 2|Phase 3,160.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 4, 2020","December 31, 2021"
4469,NCT04499677,Recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Lopinavir/ Ritonavir|Other: Favipiravir Placebo|Other: Lopinavir/ Ritonavir Placebo,All,"Adult, Older Adult",Phase 2,240.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 24, 2020","March 1, 2021"
4470,NCT04604743,Not yet recruiting,No Results Available,Vaccine Refusal,"Behavioral: Intervention, TBN",All,Child,Not Applicable,4.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 1, 2021","June 30, 2023"
4471,NCT04264858,Not yet recruiting,No Results Available,2019-nCoV|Immunoglobulin of Cured Patients,Drug: Immunoglobulin of cured patients|Drug: γ-Globulin,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 17, 2020","May 31, 2020"
4472,NCT04422522,"Active, not recruiting",No Results Available,"Fibromyalgia, Primary",,All,"Adult, Older Adult",,45.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 15, 2020","June 30, 2020"
4473,NCT04452708,Recruiting,No Results Available,Respiratory Failure,Device: HFNC,All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 11, 2020","June 10, 2021"
4474,NCT04338802,Not yet recruiting,No Results Available,COVID-19|Nintedanib|Safety|Effect of Drugs,Drug: Nintedanib 150 MG|Other: Placebo,All,"Adult, Older Adult",Phase 2,96.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 2, 2020","August 1, 2020"
4475,NCT04643678,Recruiting,No Results Available,Covid19|Pneumonia|Cytokine Release Syndrome|Corona Virus Infection|Viral Infection,Drug: Anakinra|Other: Standard of Care,All,"Adult, Older Adult",Phase 2|Phase 3,80.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 30, 2020","October 30, 2021"
4476,NCT04394377,"Active, not recruiting",No Results Available,Coronavirus Infection,Drug: Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed|Drug: Group 2: control group with enoxaparin 40mg/d,All,"Adult, Older Adult",Phase 4,615.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 21, 2020",March 2021
4477,NCT04332666,Not yet recruiting,No Results Available,Coronavirus|Respiratory Failure|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|SARS-CoV-2,Drug: Angiotensin 1-7|Drug: Placebos,All,"Adult, Older Adult",Phase 2|Phase 3,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 30, 2020","June 15, 2021"
4478,NCT04830800,Recruiting,No Results Available,"COVID-19 Disease|SARS Pneumonia|Pneumonia, Viral|COVID-19 Vaccine",Biological: COVIVAC|Biological: Phosphate-buffered saline,All,"Adult, Older Adult",Phase 1|Phase 2,420.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 10, 2021","September 30, 2022"
4479,NCT04498247,Terminated,No Results Available,Coronavirus Disease (COVID-19),Biological: V591|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,263.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 27, 2020","March 5, 2021"
4480,NCT04445324,"Active, not recruiting",No Results Available,Psychotic Disorders|Anxiety Depression,"Behavioral: Transitional Online Peer Support Group (n=20)|Other: Control Group (pharmacotherapy and/or psychotherapy, n=10)",All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Investigator)|Primary Purpose: Supportive Care","August 25, 2020",December 2020
4481,NCT04631497,Recruiting,No Results Available,Depression,Diagnostic Test: test,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","December 31, 2021"
4482,NCT04531254,Completed,No Results Available,Covid19|Schools,Behavioral: Personal behaviours,All,"Child, Adult",,190.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 10, 2020","August 31, 2020"
4483,NCT04361461,Withdrawn,No Results Available,Coronavirus Infections|SARS-CoV 2|SARS (Severe Acute Respiratory Syndrome)|Pulmonary Disease,Drug: Hydroxychloroquine Sulfate|Drug: Hydroxychloroquine Sulfate + Azythromycin,All,"Adult, Older Adult",Phase 3,0.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 30, 2020","November 4, 2020"
4484,NCT04346810,Not yet recruiting,No Results Available,"COVID-19|Burnout, Caregiver|Intensive Care Unit|Stress, Psychological",Other: Patient management suffering of coronavirus infection,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"April 15, 2020","September 1, 2020"
4485,NCT04356365,Completed,No Results Available,Depression|Generalized Anxiety|Adherence to Non-pharmacological Epidemiological Interventions (NPIs),Other: Cross-sectional study investigating the association of NPIs with mental health,All,"Adult, Older Adult",,10084.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 31, 2020","April 7, 2020"
4486,NCT04388514,Recruiting,No Results Available,SARS-CoV-2 Respiratory Failure,Procedure: Medical Ozone procedure,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"April 8, 2020","October 8, 2020"
4487,NCT04397835,Recruiting,No Results Available,COVID-19|Anxiety|Depression|Stress,,All,"Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 17, 2020","April 20, 2021"
4488,NCT04349163,Completed,No Results Available,Psychological,Other: Questionnaire,All,"Child, Adult, Older Adult",,280.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 10, 2020","June 25, 2020"
4489,NCT04415073,Suspended,No Results Available,Coronavirus|COVID|ARDS|Cytokine Storm|Cytokine Release Syndrome,Drug: SNDX-6352|Drug: Placebo,All,"Adult, Older Adult",Phase 2,186.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","May 30, 2020","November 15, 2020"
4490,NCT04251871,Recruiting,No Results Available,Pneumonia Caused by Human Coronavirus (Disorder),"Drug: Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and Traditional Chinese Medicines (TCMs) granules|Drug: Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir)",All,"Child, Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 22, 2020","January 22, 2021"
4491,NCT04496076,"Active, not recruiting",No Results Available,Sars-CoV2|Severe Neurologic Injury|Ischemic Stroke|Hemorrhagic Stroke|Intracerebral Hemorrhage|Subarachnoid Hemorrhage|Traumatic Brain Injury|Status Epilepticus,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 2, 2020","April 30, 2021"
4492,NCT04408027,Recruiting,No Results Available,Anxiety Disorder of Childhood or Adolescence,Behavioral: Virtual-Care Cognitive Behavioural Therapy,All,Child,Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 1, 2020","June 1, 2021"
4493,NCT04682197,Not yet recruiting,No Results Available,Health Personnel|Stress|Anxiety|Insomnia|Hyperarousal|Corona Virus Infection|Covid19,Device: Cereset Research,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,April 2021,April 2022
4494,NCT04453384,Recruiting,No Results Available,SARS Virus,Drug: XAV-19|Drug: Placebo,All,"Adult, Older Adult",Phase 2,414.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 1, 2020",December 2021
4495,NCT04335630,Recruiting,No Results Available,Cardiovascular Diseases|COVID,"Diagnostic Test: Electrocardiogram, telemetry, echocardiogram, laboratory values",All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 30, 2020",March 2022
4496,NCT04482686,Recruiting,No Results Available,COVID|Covid-19|Corona Virus Infection|Coronavirus Infection|Coronavirus-19|SARS-CoV2|SARS-CoV Infection,Drug: Ivermectin|Drug: Doxycycline Hcl|Dietary Supplement: Zinc|Dietary Supplement: Vitamin D3|Dietary Supplement: Vitamin C,All,"Adult, Older Adult",Phase 2,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","December 9, 2020",July 2021
4497,NCT04381013,Not yet recruiting,No Results Available,COVID-19,Device: Emergency Ventilator Splitter,All,"Adult, Older Adult",Not Applicable,4.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,March 2021,April 2021
4498,NCT04817280,Completed,No Results Available,"Covid19|SARS-CoV Infection|Resistance, Disease|Hypothermia|Hypothermia Due to Cold Environment",Other: Ice Swimming,All,"Child, Adult, Older Adult",,2534.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"December 1, 2020","March 1, 2021"
4499,NCT04435327,Recruiting,No Results Available,"COVID|Pneumonia, Viral|Barotrauma|Interstitial Lung Disease|Bronchiectasis Adult|Emphysema",,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 17, 2020",April 2021
4500,NCT04767477,Not yet recruiting,No Results Available,Covid19|Exercise Tolerance|Quality of Life|Lung Function|Fatigue Intensity,Other: Face-to-face rehabilitation|Other: Telerehabilitation,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 28, 2021",August 2021
4501,NCT04523246,Recruiting,No Results Available,Herpes Zoster|Allergy and Immunology|Corona Virus Infection,"Biological: SHINGRIX (Zoster Vaccine REcombinant, Adjuvanted)|Drug: Normal Saline",All,Older Adult,Early Phase 1,250.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science","September 1, 2020","September 1, 2021"
4502,NCT04530136,Recruiting,No Results Available,Confirmed Coronavirus Disease,Drug: Ruconest,All,"Adult, Older Adult",Phase 2,120.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"November 30, 2020","November 30, 2021"
4503,NCT04523571,"Active, not recruiting",No Results Available,SARS-CoV-2,Biological: BNT162b1|Other: Placebo,All,"Adult, Older Adult",Phase 1,144.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 28, 2020",August 2021
4504,NCT04661813,Recruiting,No Results Available,HIV-1-infection|Hypertension,Other: EXTRA-CVD Virtual Care,All,"Adult, Older Adult",Not Applicable,75.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"March 1, 2021","December 31, 2022"
4505,NCT04822818,Not yet recruiting,No Results Available,Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|Virus Diseases|Coronaviridae Infections|Nidovirales Infections|RNA Virus Infections|Respiratory Tract Infections|Respiratory Tract Diseases,Drug: BEVA+SOC|Drug: SOC,All,"Adult, Older Adult",Phase 3,174.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,June 2022
4506,NCT04414631,Recruiting,No Results Available,Coronavirus Infections,Drug: Conestat alfa,All,"Adult, Older Adult",Phase 2,120.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 6, 2020",July 2021
4507,NCT04748120,Enrolling by invitation,No Results Available,"Covid19|Appendicitis|Cholecystitis, Acute|Cholecystitis; Gallstone|Cholecystitis",Procedure: Operative management|Procedure: Non-operative management,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 28, 2020","September 28, 2021"
4508,NCT04341285,Not yet recruiting,No Results Available,"ARDS, Human|COVID-19",Procedure: ECMO Implantation,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","May 1, 2022"
4509,NCT04844307,Not yet recruiting,No Results Available,"COVID-19|Cardiopulmonary Disease|Weakness, Muscle|Hypoxia|Debility Due to Disease",Other: Shorter duration higher frequency PT|Other: Standard PT,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,May 2021,February 2022
4510,NCT04516824,Completed,No Results Available,Orthopaedic Disorders,Procedure: Orthopaedic Surgical Procedures,All,"Adult, Older Adult",,2160.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 19, 2020","August 15, 2020"
4511,NCT04531735,"Active, not recruiting",No Results Available,RSV Infection|Covid19,,All,Child,,28.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 1, 2020","August 31, 2020"
4512,NCT04366297,Completed,No Results Available,Cardiac Arrest|Emergencies,Device: Intravenous access|Device: Intraosseous access,All,"Adult, Older Adult",Not Applicable,41.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 12, 2020","February 25, 2020"
4513,NCT04452318,"Active, not recruiting",No Results Available,Healthy Participants,Drug: REGN10933 + REGN10987|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 3,3750.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 13, 2020","August 15, 2021"
4514,NCT04290780,Recruiting,No Results Available,Infection Viral,Other: nosocomial infection/hospital acquired infection,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 9, 2020","December 31, 2021"
4515,NCT04341519,Recruiting,No Results Available,Corona Virus Infection|Post-traumatic Stress Disorder,Behavioral: PTSD|Behavioral: Burnout,All,"Adult, Older Adult",,1464.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 6, 2020","December 31, 2021"
4516,NCT04741412,Recruiting,No Results Available,Hypohidrotic Ectodermal Dysplasia,,All,"Child, Adult, Older Adult",,230.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 3, 2020","May 31, 2021"
4517,NCT04627675,"Active, not recruiting",No Results Available,SARS-CoV-2,Drug: CORVax|Drug: IL-12 plasmid|Device: Cliniporator,All,"Adult, Older Adult",Phase 1,36.0,Other|Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"December 30, 2020",May 2022
4518,NCT04366908,Recruiting,No Results Available,SARS-CoV 2|COVID19|SARS (Severe Acute Respiratory Syndrome)|Cytokine Release Syndrome|Cytokine Storm,Drug: BAT + Calcifediol|Drug: BAT,All,"Adult, Older Adult",Phase 2,1008.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 7, 2020","June 30, 2021"
4519,NCT04395144,Completed,No Results Available,Coronavirus Infection|COVID|Severe Acute Respiratory Syndrome|Respiratory Failure|Respiratory Insufficiency|Respiratory Distress Syndrome|ARDS|Lung Diseases,Procedure: Awake Prone Positioning|Procedure: Standard care,All,"Adult, Older Adult",Not Applicable,13.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 15, 2020","March 15, 2021"
4520,NCT04409743,Recruiting,No Results Available,Sleep Disturbance|Insomnia,Behavioral: Remote Cognitive Behavioral Therapy for Insomnia,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"June 7, 2020",April 2022
4521,NCT04742712,Recruiting,No Results Available,SARS-CoV Infection,Device: CoronaCheck Device,All,"Child, Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 27, 2020","December 1, 2021"
4522,NCT04396210,Completed,No Results Available,Coronavirus|COVID|ART|Fertility Issues,Other: Questionnaire,All,Adult,,389.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 14, 2020","June 18, 2020"
4523,NCT04632368,Recruiting,No Results Available,"Burnout, Professional|Stress, Psychological",Behavioral: Transcendental Meditation,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"November 20, 2020",April 2021
4524,NCT04728594,Completed,No Results Available,Vaccination Refusal|Communication,Behavioral: Social Proof|Behavioral: Reframing|Behavioral: Scarcity Message,All,"Child, Adult, Older Adult",Not Applicable,9656.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention","January 15, 2021","January 20, 2021"
4525,NCT04453371,Withdrawn,No Results Available,Acute Respiratory Distress Syndrome,Drug: Tissue plasminogen activator|Drug: Ringer solution,All,"Adult, Older Adult",Phase 3,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","October 15, 2020","February 15, 2021"
4526,NCT04537962,Enrolling by invitation,No Results Available,Corona Virus Infection,Other: Colgate periogard mouthwash|Other: Colgate Peroxyl mouthwash|Other: Colgate Total mouthwash|Other: Placebo mouthwash (water),All,"Adult, Older Adult",Not Applicable,70.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"June 11, 2020","August 30, 2021"
4527,NCT04506515,Completed,No Results Available,"Covid19|Stress, Psychological|Work Related Stress|Epidemic Disease|SARS-CoV Infection",Diagnostic Test: Psychological stress and adaptation at work score (PSAS),All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"April 9, 2020","April 30, 2020"
4528,NCT04392869,Completed,No Results Available,Psychological Distress|Life Stress|Anxiety|Perfectionism|Emotional Intelligence|Creativity|Attention|Empathy,Behavioral: The CRAFT program (adapted due to COVID-19)|Behavioral: The MBSR program (adapted due to COVID-19),All,"Adult, Older Adult",Not Applicable,75.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","October 23, 2019","October 31, 2020"
4529,NCT04780152,Recruiting,No Results Available,Major Depressive Disorder,Device: Transcranial Direct Current Stimulation|Device: Placebo-simulation of transcranial direct current stimulation|Drug: Fluoxetine Tablets,All,Child,Phase 2|Phase 3,172.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",March 2021,September 2022
4530,NCT04306393,Recruiting,No Results Available,SARS (Severe Acute Respiratory Syndrome)|Coronavirus,Drug: Nitric Oxide Gas,All,"Adult, Older Adult",Phase 2,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"March 21, 2020","March 21, 2022"
4531,NCT04617535,Available,No Results Available,Covid19,Drug: REGN10933+REGN10987 combination therapy,,"Child, Adult, Older Adult",,,Industry,Expanded Access:Individual Patients,,,
4532,NCT04466098,"Active, not recruiting",No Results Available,Acute Respiratory Distress Syndrome|ARDS (Moderate or Severe)|COVID-19 Pneumonia,Biological: Mesenchymal stromal cells|Other: Placebo,All,"Adult, Older Adult",Phase 2,9.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","July 30, 2020","December 1, 2021"
4533,NCT04420806,Completed,No Results Available,Exercise|Detraining|Muscle Weakness|Muscle Atrophy,Other: HIT-exercise|Other: Sham intervention,Female,Adult,Not Applicable,21.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 14, 2020","October 30, 2020"
4534,NCT04364711,Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2,,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","April 30, 2022"
4535,NCT04459702,Withdrawn,No Results Available,COVID|COVID-19|Corona Virus Infection|Coronavirus Infection|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|Coronavirus-19|SARS-CoV 2|SARS Pneumonia,Drug: hydroxychloroquine|Drug: Azithromycin|Drug: Ritonavir|Drug: Lopinavir,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",July 2020,December 2021
4536,NCT04496245,"Active, not recruiting",No Results Available,Respiratory Viral Infection|Covid19,Drug: Broncho-Vaxom®,All,"Adult, Older Adult",Phase 3,59.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 24, 2020","June 30, 2021"
4537,NCT04346693,Completed,No Results Available,Acute Respiratory Tract Infection|Acute Respiratory Insufficiency|Pneumonia|Septic Shock|Hypoxemia,Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation.|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin inhalation|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection combined with Dalargin inhalation,All,"Adult, Older Adult",Phase 3,320.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 8, 2020","November 20, 2020"
4538,NCT04659772,Completed,No Results Available,Covid19|Respiratory Failure,Drug: Clazakizumab|Drug: Placebo,All,"Adult, Older Adult",Phase 2,1.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 3, 2020","February 1, 2021"
4539,NCT04778059,Not yet recruiting,No Results Available,"2019 Novel Coronavirus Infection|COVID-19 Virus Infection|SARS Coronavirus 2 Infection|SARS-CoV-2 Infection|Respiratory Distress Syndrome, Adult|Adult Respiratory Distress Syndrome",Drug: USB002|Drug: Placebo,All,"Adult, Older Adult",Phase 2,184.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",April 2021,March 2022
4540,NCT04402957,Recruiting,No Results Available,COVID|Severe Acute Respiratory Syndrome|Sars-CoV2|Acute Kidney Injury,Drug: LSALT peptide|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 14, 2020","June 30, 2021"
4541,NCT04726163,Recruiting,No Results Available,"Diabetic Patient (Type 1,2, MODY, Secondary) or With Corticosteroid-induced Diabetes Following Initiation of Corticosteroid Treatment",Device: Continuous blind glucose measurement device (Free style Pro),All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 29, 2021","June 14, 2021"
4542,NCT04361877,Recruiting,No Results Available,Cardiovascular Prevention Behaviour,,All,"Adult, Older Adult",,1900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2020","April 20, 2020"
4543,NCT04674566,Not yet recruiting,No Results Available,Covid19,Drug: COR-101|Drug: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,45.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 1, 2021","June 30, 2021"
4544,NCT04361474,"Active, not recruiting",No Results Available,Budesonide|Olfaction Disorders|SARS-CoV-2|Anosmia,Drug: Budesonide Nasal|Other: Physiological serum,All,"Adult, Older Adult",Phase 3,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"May 18, 2020","May 25, 2021"
4545,NCT04323761,Approved for marketing,No Results Available,SARS-CoV2 Infection,Drug: Remdesivir,All,"Child, Adult, Older Adult",,,Industry,Expanded Access:Treatment IND/Protocol,,,
4546,NCT04632706,Recruiting,No Results Available,Covid19,Drug: Ivermectin|Drug: Placebo,Male,Adult,Early Phase 1,24.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","September 22, 2020",May 2021
4547,NCT04379271,Recruiting,No Results Available,COVID-19,Drug: IMU-838|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,230.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","June 11, 2020",October 2020
4548,NCT04284046,Completed,No Results Available,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Other: CT score,All,"Child, Adult, Older Adult",,39.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 31, 2020","February 18, 2020"
4549,NCT04508920,Recruiting,No Results Available,Cardiovascular Diseases|Heart Failure,"Other: Symptomatology, Treatment. daily Activities and Anxiety for Cardiovascular patients Survey (STRATA)",All,"Adult, Older Adult",,76.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2019","July 15, 2021"
4550,NCT04497454,Recruiting,No Results Available,Respiratory Distress Syndrome|Severe Acute Respiratory Syndrome Due to Coronavirus (SARS-CoV2)|Mechanical Ventilation,Other: EIT-Group|Other: ARDSNet,All,"Adult, Older Adult",Not Applicable,128.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 8, 2020","December 1, 2021"
4551,NCT04433286,Not yet recruiting,No Results Available,Physical Stress|Career Burnout|Satisfaction,Other: Questionnaire,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 15, 2020","August 31, 2020"
4552,NCT04540419,"Active, not recruiting",No Results Available,Covid19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,All,"Adult, Older Adult",Phase 3,500.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 11, 2020","July 31, 2021"
4553,NCT04348929,Recruiting,No Results Available,Postpartum Depression,Other: Self-administered questionnaires,Female,"Adult, Older Adult",Not Applicable,927.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"April 16, 2020","October 1, 2021"
4554,NCT04597242,Available,No Results Available,MRSA Bloodstream Infection|MRSA Bacteremia|MRSA Right-sided Endocarditis|Covid19,Drug: Exebacase,All,"Adult, Older Adult",,,Industry,Expanded Access:Intermediate-size Population,,,
4555,NCT04412655,"Active, not recruiting",No Results Available,ST Elevated Myocardial Infarction Undergoing Mechanical Reperfusion,Device: Percutaneous Coronary Revascularization for STEMI,All,"Child, Adult, Older Adult",,6609.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 5, 2020","June 2, 2020"
4556,NCT04453540,Not yet recruiting,No Results Available,Infectious Disease|Pneumonia|Molecular Diagnosis|Covid-19|Antibiotic Stewardship,Diagnostic Test: FilmArray PCR on respiratory samples,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"July 1, 2020","August 30, 2020"
4557,NCT04548531,Enrolling by invitation,No Results Available,Colon Cancer,Behavioral: Shared Decision Making,All,"Adult, Older Adult",Not Applicable,800.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"September 10, 2020","May 30, 2021"
4558,NCT04391816,Recruiting,No Results Available,Alcohol Drinking|Alcohol-Related Disorders|Pandemic|Psychological Stress,,All,"Adult, Older Adult",,700.0,NIH,Observational,Observational Model: Other|Time Perspective: Prospective,"April 19, 2021","December 31, 2024"
4559,NCT04545749,Recruiting,No Results Available,COVID-19,Biological: UB-612,All,Adult,Phase 1,60.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 25, 2020","August 31, 2021"
4560,NCT04782739,Not yet recruiting,No Results Available,HIV Infections|Syphilis,Other: None - Descriptive study,All,"Child, Adult, Older Adult",,30.0,Other|Industry,Observational,Observational Model: Other|Time Perspective: Other,"March 1, 2021","April 19, 2022"
4561,NCT04826588,Recruiting,No Results Available,Paediatric Inflammatory Multisystem Syndrome - Temporally Associated With SARS-CoV-2 (PIMS-TS),Drug: Methylprednisolone sodium succinate|Biological: Human normal immunoglobulin (IVIg),All,"Child, Adult",Phase 3,75.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,April 2022
4562,NCT04532294,Recruiting,No Results Available,Covid19,Drug: BGB DXP593|Drug: Placebo,All,Adult,Phase 1,30.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science","September 8, 2020","June 15, 2021"
4563,NCT04594525,Not yet recruiting,No Results Available,Perinatal Depression|Specific Phobia|Perinatal Anxiety,Other: Low-Intensity Psychosocial Interventions through Telemental health,Female,Adult,Not Applicable,58.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,June 2021,June 2022
4564,NCT04384705,Recruiting,No Results Available,SARS-CoV Infection,Other: research specific blood sample,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 17, 2020",July 2021
4565,NCT03042143,Recruiting,No Results Available,Acute Respiratory Distress Syndrome,Biological: Human umbilical cord derived CD362 enriched MSCs|Biological: Placebo (Plasma-Lyte 148),All,"Child, Adult, Older Adult",Phase 1|Phase 2,75.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 7, 2019",October 2022
4566,NCT04410432,Recruiting,No Results Available,"SARS Cov2, Immune Response",Biological: Blood sample collection,All,"Adult, Older Adult",,63.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 29, 2020",August 2021
4567,NCT04402060,Recruiting,No Results Available,COVID|Covid-19|Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome|Severe Acute Respiratory Syndrome Coronavirus 2|Sars-CoV2|Ards|Acute Respiratory Distress Syndrome,Drug: APL-9|Other: Vehicle Control,All,"Adult, Older Adult",Phase 1|Phase 2,66.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","May 28, 2020",January 2021
4568,NCT04725110,Not yet recruiting,No Results Available,"Covid19|SARS-CoV Infection|ARDS|ARDS, Human",Drug: Instilled T3|Other: Placebo Therapy,All,"Adult, Older Adult",Phase 2,250.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment",March 2021,March 2024
4569,NCT04419870,Recruiting,No Results Available,Mitochondrial Disease,,All,"Child, Adult, Older Adult",,200.0,NIH,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 19, 2021","May 1, 2025"
4570,NCT04345861,Terminated,No Results Available,"Coronavirus Infection|Pneumonia, Viral",Drug: Hydroxychloroquine + placebo|Drug: hydroxychloroquine + azithromycin,All,"Adult, Older Adult",Phase 2|Phase 3,7.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 11, 2020","June 8, 2020"
4571,NCT04486417,Recruiting,No Results Available,Obesity|Telemedicine|Bariatric Surgery,,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 1, 2020","July 31, 2020"
4572,NCT04407260,Completed,No Results Available,COVID -19|Respiratory Failure|Hypoxia,Device: Oxygen Hood,All,"Child, Adult, Older Adult",,136.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 6, 2020","May 1, 2020"
4573,NCT04834583,"Active, not recruiting",No Results Available,Covid19,,All,"Adult, Older Adult",,703.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 2, 2020","December 31, 2023"
4574,NCT04844268,Not yet recruiting,No Results Available,SARS-CoV-2,Biological: Cohort 1 HDT 301 vaccine|Biological: Cohort 2 HDT 301 vaccine|Biological: Cohort 3 HDT 301 vaccine,All,Adult,Phase 1,78.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,May 2021,July 2022
4575,NCT04672343,Recruiting,No Results Available,SARS-CoV-2,Other: Data collection|Other: Querying the INSEE database,All,Older Adult,,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 19, 2020",January 2022
4576,NCT04556149,Completed,No Results Available,Corona Virus Infection|Coronavirus,Device: imPulse™ Una e-stethoscope|Device: Philips Lumify Ultrasound System,All,"Adult, Older Adult",,34.0,Industry|Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 1, 2020","December 2, 2020"
4577,NCT04584541,Recruiting,No Results Available,Spondyloarthritis|Rheumatoid Arthritis|Covid19,Biological: blood tests|Biological: Nasopharyngeal swabs|Biological: Stools,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"June 11, 2020",December 2023
4578,NCT04416360,Recruiting,No Results Available,Autism Spectrum Disorder|Attention-deficit Hyperactivity Disorder,Other: Interview by psychologists,All,Child,Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 5, 2020",January 2021
4579,NCT04376684,Recruiting,No Results Available,Severe Acute Respiratory Syndrome,Biological: Otilimab|Biological: Placebo 1|Biological: Placebo 2|Drug: Standard of care,All,"Adult, Older Adult",Phase 2,1150.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 28, 2020","August 23, 2021"
4580,NCT04391140,Recruiting,No Results Available,COVID|ARDS|Acute Respiratory Distress Syndrome|Acute Respiratory Failure|Corona Virus Infection,Other: Prone position,All,"Adult, Older Adult",Not Applicable,248.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 13, 2020",June 2021
4581,NCT04382768,Recruiting,No Results Available,Coronavirus Infection|Respiratory Disease|SARS (Disease),Drug: Inhaled Hypertonic ibuprofen,All,"Adult, Older Adult",Not Applicable,40.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020",January 2021
4582,NCT04748445,Not yet recruiting,No Results Available,Healthy,Diagnostic Test: SARS-CoV-2/Influenza/RSV RT-PCR,All,"Adult, Older Adult",,6250.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 15, 2021","October 15, 2021"
4583,NCT04594291,Recruiting,No Results Available,Acute Kidney Injury,Procedure: MRI scans,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 7, 2020",September 2023
4584,NCT04433754,Completed,No Results Available,Pancreatitis,Other: biochemical analysis,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 1, 2020","June 12, 2020"
4585,NCT04510493,Recruiting,No Results Available,"Coronavirus Infection|Diabetes Mellitus, Type 2",Drug: Canakinumab|Drug: Placebo,All,"Adult, Older Adult",Phase 3,116.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 23, 2020",September 2023
4586,NCT04669912,Completed,No Results Available,Type 1 Diabetes,Other: glucose control and sensor usage,All,"Child, Adult",,77.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 15, 2021","January 22, 2021"
4587,NCT04490473,Recruiting,No Results Available,Anxiety|SARS-CoV Infection,Other: survey work,All,Adult,Not Applicable,300.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 24, 2020","April 24, 2021"
4588,NCT04333368,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|Severe Acute Respiratory Distress Syndrome,Biological: Umbilical cord Wharton's jelly-derived human|Other: NaCl 0.9%,All,"Adult, Older Adult",Phase 1|Phase 2,47.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 6, 2020","April 6, 2022"
4589,NCT04338841,Completed,No Results Available,Coronavirus Infection,Other: HOME-CoV rule implementation,All,"Adult, Older Adult",Not Applicable,3133.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 9, 2020","June 17, 2020"
4590,NCT04584658,Recruiting,No Results Available,Dysphagia|Dysphonia|Subglottic Stenosis|Voice Disorders|Swallowing Disorder|Covid19|SARS (Severe Acute Respiratory Syndrome)|SARS Pneumonia|Quality of Life|SARS-CoV-2 Infection,Diagnostic Test: Fibreoptic Endoscopic Evaluation of Swallowing (FEES)|Diagnostic Test: Videofluoroscopy|Other: Dysphagia Handicap Index (DHI)|Other: Voice Symptom Scale (VoiSS),All,"Adult, Older Adult",,36.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 15, 2020",December 2021
4591,NCT04491071,Not yet recruiting,No Results Available,Stress Disorder,Diagnostic Test: Generalized Anxiety Disorder-7 (GAD 7)|Diagnostic Test: Background questionnaire|Diagnostic Test: Impact of COVID-19 questionnaire|Diagnostic Test: Confinement and Communication During the COVID-19 Pandemic|Diagnostic Test: Mental Health questionnaire|Diagnostic Test: Patient Health Questionnaire (PHQ-9)|Diagnostic Test: Post Traumatic Stress Disorder questionnaire (PTSD-8)|Diagnostic Test: Experiences in Close Relationship Scale questionnaire (ECR-S),All,"Adult, Older Adult",,405.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,September 2020,December 2020
4592,NCT04727372,Completed,No Results Available,"Social Acceptance, Social Anxiety",Other: Questionnaire,All,"Child, Adult, Older Adult",,986.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"January 23, 2021","February 23, 2021"
4593,NCT04340557,Recruiting,No Results Available,SARS-CoV Infection,Drug: Losartan,All,"Adult, Older Adult",Phase 4,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 27, 2020","December 31, 2020"
4594,NCT04370834,Terminated,No Results Available,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Pneumonia|Pneumonitis|Severe Acute Respiratory Distress Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed,Biological: Tocilizumab,All,"Child, Adult, Older Adult",Phase 2,1.0,NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 28, 2020","January 14, 2021"
4595,NCT04723550,Recruiting,No Results Available,Type 2 Diabetes Mellitus,Device: Hospital telemedicine management system|Other: Usual care,All,Adult,Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"January 5, 2021","January 5, 2022"
4596,NCT04420416,Recruiting,No Results Available,"Depression, Anxiety",Other: Survey,All,"Adult, Older Adult",,720.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 1, 2020","July 30, 2020"
4597,NCT04659460,Not yet recruiting,No Results Available,COVID|Corona Virus Infection|Acute Lung Injury|Ischemia Limb|Acute Respiratory Distress Syndrome,Device: Remote Ischemic Conditioning,All,"Child, Adult, Older Adult",Not Applicable,30.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 15, 2020","September 1, 2021"
4598,NCT04279782,Recruiting,No Results Available,Coronavirus,Other: Comprehensive treatment,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 20, 2020","February 28, 2021"
4599,NCT04408287,Recruiting,No Results Available,Spinal Cord Injuries,Other: WebEx Physical Activity Program,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 15, 2020","October 31, 2021"
4600,NCT04357314,Completed,No Results Available,Myocardial Infarction,,All,"Adult, Older Adult",,6332.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","May 31, 2020"
4601,NCT04712448,"Active, not recruiting",No Results Available,Healthy|Chronic Disease,Diagnostic Test: Anti-COVID test,All,"Adult, Older Adult",,3500.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"December 30, 2020","September 30, 2021"
4602,NCT04619680,Recruiting,No Results Available,Pulmonary Fibrosis|Interstitial Lung Disease|Respiratory Disease,Drug: Nintedanib|Drug: Placebo,All,"Adult, Older Adult",Phase 4,120.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","November 18, 2020",April 2024
4603,NCT04582318,Recruiting,No Results Available,SARS-CoV-2 Infection,Biological: NGM621|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,48.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 8, 2020",September 2021
4604,NCT04406545,Recruiting,No Results Available,Coronavirus Infection|Endothelial Dysfunction|Microvascular Rarefaction,Other: evaluation of skin microvascular flow and reactivity,All,"Adult, Older Adult",,25.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 15, 2020",December 2021
4605,NCT04324021,Terminated,No Results Available,SARS-CoV-2,Biological: Emapalumab|Biological: Anakinra,All,"Adult, Older Adult",Phase 2|Phase 3,16.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 2, 2020","November 13, 2020"
4606,NCT04323345,Recruiting,No Results Available,COVID-19,Dietary Supplement: Natural Honey|Other: Standard Care,All,"Child, Adult, Older Adult",Phase 3,1000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"April 15, 2020","January 15, 2021"
4607,NCT04444700,Recruiting,No Results Available,"COVID|Coronavirus Infection|Severe Acute Respiratory Syndrome|Thromboembolism, Venous|Anticoagulants and Bleeding Disorders",Drug: Therapeutic anticoagulation,All,"Adult, Older Adult",Phase 3,462.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 4, 2020","December 31, 2020"
4608,NCT04335162,Recruiting,No Results Available,COVID|Acute Coronary Syndrome|Myocardial Infarction|Myocarditis|Venous Thromboembolism|Deep Vein Thrombosis|Pulmonary Embolism,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 28, 2020","August 31, 2021"
4609,NCT04393792,Recruiting,No Results Available,Coronavirus Infection,Drug: Povidone-Iodine|Drug: Normal saline,All,"Adult, Older Adult",Phase 1,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,May 2020,August 2020
4610,NCT04383730,Recruiting,No Results Available,Critically Illness|Sedation|Invasive Mechanical Ventilation|Acute Respiratory Distress Syndrome,Drug: Intravenous sedation|Drug: Inhaled sedation,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 26, 2020","May 31, 2021"
4611,NCT04834375,Recruiting,No Results Available,Covid19,Drug: Weight-based dexamethasone dose,All,"Adult, Older Adult",Phase 4,142.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 19, 2021","April 19, 2022"
4612,NCT04374617,Completed,No Results Available,"COVID-19|Critical Illness|Venous Thromboembolism|Venous Thromboses|Venous Thromboses, Deep|Venous Thrombosis Pulmonary|Pulmonary Embolism|Pulmonary Embolism and Thrombosis|Sars-CoV2|SARS-CoV Infection",Diagnostic Test: Duplex ultrasound and Computed Tomography Angiography,All,"Adult, Older Adult",,230.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","May 1, 2020"
4613,NCT04342806,Recruiting,No Results Available,Health Care Worker (HCW)|COVID-19,,All,"Adult, Older Adult",,100000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 10, 2020","December 31, 2099"
4614,NCT04686708,Completed,No Results Available,Emergencies,Other: Emergency general surgical admissions,All,"Adult, Older Adult",,750.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 11, 2019","September 11, 2020"
4615,NCT04642950,Recruiting,No Results Available,COVID-19,Drug: Sargramostim|Drug: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 17, 2020","October 31, 2021"
4616,NCT04517097,Completed,No Results Available,Cancer,Biological: blood sample,All,"Adult, Older Adult",,1680.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 12, 2020","June 30, 2020"
4617,NCT04797624,Completed,No Results Available,Stomach Cancer|Corona Virus Infection,Procedure: Gastric cancer surgery,All,"Adult, Older Adult",,146.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 15, 2021","February 15, 2021"
4618,NCT04354818,Recruiting,No Results Available,HIV-1-infection|Cancer|Primary Immune Deficiency Disorder|Immunosuppression Disorders|COVID-19,,All,"Adult, Older Adult",,1000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","April 27, 2022"
4619,NCT04645563,Completed,No Results Available,Covid-19,Other: Sending thorax ct video images via smartphone applications,All,"Adult, Older Adult",,144.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 11, 2020","May 31, 2020"
4620,NCT04797936,Completed,No Results Available,Covid19|Nasopharyngitis|Anosmia|Fever|Myalgia|Cough|Nasal Congestion,Drug: BNO 1030|Other: Standard care,All,"Adult, Older Adult",Phase 4,133.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","January 8, 2021"
4621,NCT04443361,Not yet recruiting,No Results Available,Insomnia|Metacognitive Beliefs|Anxiety|Depression|Sleep,,All,"Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4622,NCT04448405,Completed,No Results Available,Deviant Sexual Fantasies,Behavioral: Questionnaire for evaluation of confinement on deviant sexual fantasies,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 18, 2020","October 30, 2020"
4623,NCT04385238,Completed,Has Results,COVID-19|Pregnancy Complications|Mental Health Wellness 1|Anxiety|Depression|Ptsd|Coronavirus,Other: This is an online survey with no intervention.,Female,"Adult, Older Adult",,6894.0,Industry|Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"May 15, 2020","June 20, 2020"
4624,NCT04269525,Recruiting,No Results Available,"Pneumonia, Viral|Pneumonia, Ventilator-Associated",Biological: UC-MSCs,All,"Adult, Older Adult",Phase 2,16.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 6, 2020","December 30, 2020"
4625,NCT04382131,Recruiting,No Results Available,Upper Respiratory Tract Infections|Virus|COVID|Virus Shedding|Virus Diseases,Other: NaCl Solution,All,"Adult, Older Adult",Not Applicable,405.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 23, 2020","October 31, 2020"
4626,NCT04373707,Recruiting,No Results Available,COVID|Thrombosis|Pulmonary Embolism|Deep Vein Thrombosis,Drug: Enoxaparin,All,"Adult, Older Adult",Phase 4,602.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"May 13, 2020",November 2021
4627,NCT04732702,Recruiting,No Results Available,Mother-Child Interaction,Other: no intervention,All,Child,,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 29, 2020","April 30, 2021"
4628,NCT04460027,Completed,No Results Available,Substance Use Disorders|Alcohol Use Disorder,Other: Woebot Substance Use Disorder,All,"Adult, Older Adult",Phase 1,180.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 22, 2020","November 30, 2020"
4629,NCT04376905,Completed,No Results Available,COVID-19|Pneumonia|Acute Respiratory Distress Syndrome,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","September 30, 2020"
4630,NCT04750759,Recruiting,No Results Available,Covid19,Drug: Niclosamide + Camostat|Other: Placebo,All,"Adult, Older Adult",Phase 2,40.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 3, 2021","June 30, 2021"
4631,NCT04587245,Recruiting,No Results Available,Covid19|Financial Disclosure,Other: Online questionnaire and interviews,All,"Child, Adult, Older Adult",,100.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 1, 2020","October 15, 2021"
4632,NCT04698798,Recruiting,No Results Available,Cachexia|Muscle Loss|Muscle Wasting|Muscle Atrophy|Critical Illness,Procedure: Muscle Biopsy,All,"Adult, Older Adult",Not Applicable,16.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"January 2, 2021",May 2021
4633,NCT04506632,Recruiting,No Results Available,COVID-19|Mental Health Burden,,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"June 2, 2020","April 26, 2022"
4634,NCT04401644,Not yet recruiting,No Results Available,Diagnoses Disease|Coronavirus,Diagnostic Test: Novel laser inferometry test for CORONA virus,All,"Adult, Older Adult",Not Applicable,250.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,June 2020,December 2021
4635,NCT04417673,Not yet recruiting,No Results Available,Isolation|Anxiety|Health Care Utilization|Sickle Cell Disease|Pain,,All,"Adult, Older Adult",,1000.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 19, 2021","December 31, 2024"
4636,NCT04659746,Recruiting,No Results Available,Quality of Life|Stress|Emotional Adjustment,Device: MejoraCare,All,"Adult, Older Adult",Not Applicable,96.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"December 9, 2020","December 9, 2021"
4637,NCT04365166,Recruiting,No Results Available,Respiratory Tract Infections|Respiratory Tract Disease,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 21, 2020","April 21, 2022"
4638,NCT04439006,Recruiting,No Results Available,Aplastic Anemia|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Monoclonal B-Cell Lymphocytosis|Monoclonal Gammopathy of Undetermined Significance|Myelodysplastic Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed,Other: Best Practice|Drug: Ibrutinib,All,"Adult, Older Adult",Phase 2,72.0,Other|NIH|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 22, 2020","December 31, 2022"
4639,NCT04471519,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV-2 Infection,Biological: BBV152A - Phase I|Biological: BBV152B - Phase I|Biological: BBV152C - Phase I|Biological: Placebo - Phase I|Biological: BBV152A - Phase II|Biological: BBV152B - Phase II,All,"Child, Adult, Older Adult",Phase 1|Phase 2,755.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 15, 2020","June 30, 2021"
4640,NCT04365153,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV 2,Drug: Canakinumab Injection 600mg|Drug: Canakinumab Injection 300mg|Drug: Placebos,All,"Adult, Older Adult",Phase 2,45.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 24, 2020","April 30, 2021"
4641,NCT04491318,Recruiting,No Results Available,Hemophilia Arthropathy,Other: Observational,Male,"Adult, Older Adult",,27.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","July 29, 2020"
4642,NCT04356833,Recruiting,No Results Available,COVID,Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 1|Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 2 IMV|Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 2 NIV,All,"Child, Adult, Older Adult",Phase 2,66.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 22, 2020","April 30, 2021"
4643,NCT04531774,Recruiting,No Results Available,Stress|Burnout|Anxiety|Depression|Covid19,Behavioral: RECHARGE|Behavioral: Self Study,All,"Adult, Older Adult",Not Applicable,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 28, 2020","June 1, 2021"
4644,NCT04371848,Completed,No Results Available,Eating Habits,,All,"Adult, Older Adult",,2465.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","May 7, 2020"
4645,NCT04715763,Not yet recruiting,No Results Available,Covid19,Drug: Telmisartan Oral Product|Drug: Placebo,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 1, 2021","December 31, 2022"
4646,NCT04479332,Not yet recruiting,No Results Available,Corona Virus Infection|Critical Illness,Procedure: Tracheal intubation and cardiopulmonary resuscitation,All,"Adult, Older Adult",Not Applicable,334.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","July 31, 2022"
4647,NCT04573062,Recruiting,No Results Available,Post-Coronavirus Disease 19,,All,"Adult, Older Adult",,1200.0,NIH,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"April 19, 2021","December 31, 2024"
4648,NCT04339387,Completed,No Results Available,Coronavirus|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere,,All,"Adult, Older Adult",,1326.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"March 1, 2020","April 26, 2020"
4649,NCT04345614,Recruiting,No Results Available,Pneumonia,Drug: Auxora|Drug: Placebo,All,"Adult, Older Adult",Phase 2,346.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 8, 2020",July 2021
4650,NCT04486521,Recruiting,No Results Available,Critical Illness|Corona Virus Infection|Cytokine Release Syndrome,Drug: Interleukin 6 (IL6) Antagonist|Drug: Interleukin 6 (IL6) Antagonist and corticosteroids|Drug: corticosteroid alone,All,"Child, Adult, Older Adult",,860.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"July 22, 2020","July 22, 2021"
4651,NCT04642040,Recruiting,No Results Available,Covid19|Covid19 Pneumonia|SARS-CoV 2 Pneumonia,Other: Pulmonary Rehabilitation,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 30, 2020",January 2021
4652,NCT04426266,Completed,No Results Available,Questionnaire Designs|COVID-19 Pandemic|Psychological Stress|Coping Skills|Two-Item Generalised Anxiety Disorder Scale|Patient Health Questionnaire Anxiety and Depression Scale|Health Status Index|Subjective Health Complaint|Mood,,All,"Adult, Older Adult",,441.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 1, 2020","September 28, 2020"
4653,NCT04520620,Withdrawn,No Results Available,Sars-CoV2,Drug: Lovenox 40 MG in 0.4 mL Prefilled Syringe|Device: Ultrasound of the lower limbs,All,"Adult, Older Adult",Phase 4,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 2, 2020","July 10, 2020"
4654,NCT04703907,Recruiting,No Results Available,Stress and Anxiety,Other: Auricular stimulation,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 3, 2020",August 2021
4655,NCT04749121,Completed,No Results Available,Covid19,Device: UVC Irradiation|Drug: UVC Irradiation|Device: Fit test|Device: Tensile strength,All,Adult,Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2020","February 5, 2021"
4656,NCT04587414,"Active, not recruiting",No Results Available,Type2 Diabetes,Behavioral: eHealth +counselling contacts|Behavioral: eHealth|Behavioral: Usual care,All,"Adult, Older Adult",Not Applicable,122.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 6, 2019","October 31, 2020"
4657,NCT04365361,Recruiting,No Results Available,Mental Health Wellness 1,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"April 26, 2020","March 31, 2021"
4658,NCT04811781,Recruiting,No Results Available,"Solid Tumor, Adult",,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 4, 2020","December 4, 2021"
4659,NCT04344041,Recruiting,No Results Available,Coronavirus,"Drug: cholecalciferol 200,000 IU|Drug: cholecalciferol 50,000 IU",All,Older Adult,Phase 3,260.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020",May 2021
4660,NCT04614844,Recruiting,No Results Available,Physician Stress Levels,Behavioral: Simulation Intervention|Behavioral: Control,All,"Adult, Older Adult",Not Applicable,84.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"January 6, 2021","November 15, 2022"
4661,NCT04376814,Completed,No Results Available,COVID-19|Favipiravir|Kaletra|Hydroxychloroquine|Lopinavir/Ritonavir,Drug: Favipiravir|Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir,All,"Child, Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 29, 2020","May 25, 2020"
4662,NCT04325893,Terminated,No Results Available,Coronavirus,Drug: Hydroxychloroquine|Drug: Placebo,All,"Adult, Older Adult",Phase 3,259.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 1, 2020","June 18, 2020"
4663,NCT04615416,Recruiting,No Results Available,"Distress, Emotional|Emotional Dysfunction|Anxiety|Depression",Behavioral: Emotion Regulation Training via Telehealth,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020",January 2023
4664,NCT04821531,Not yet recruiting,No Results Available,Corona Virus Infection,Other: PT Pal|Other: Exercise Manual,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,April 2021,December 2022
4665,NCT04594278,Not yet recruiting,No Results Available,Stress,Behavioral: Mindfulness Based Intervention,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,November 2021,July 2022
4666,NCT04698837,Not yet recruiting,No Results Available,SARS-CoV-2,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Other|Time Perspective: Other,January 2021,June 2021
4667,NCT04736680,Not yet recruiting,No Results Available,Telehealth,,All,"Child, Adult",,667.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2021","September 1, 2021"
4668,NCT04813796,Recruiting,No Results Available,SARS-CoV-2,Biological: mRNA-1283|Biological: mRNA-1273|Biological: Placebo,All,Adult,Phase 1,125.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 11, 2021","April 13, 2022"
4669,NCT04320953,Completed,No Results Available,Gastrointestinal Disease|Infectious Disease,Device: Non-contact MCE system,All,"Adult, Older Adult",Not Applicable,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 16, 2020","April 9, 2020"
4670,NCT04365335,Completed,No Results Available,Occupational Stress,Behavioral: Assessment of work-related stress|Biological: Saliva sample collection|Other: Cardiac and electrodermal recordings|Behavioral: Assessment of behavioral response to emotional stimulation,All,Adult,,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 25, 2020","June 12, 2020"
4671,NCT04619368,Recruiting,No Results Available,Human ARDS|Coronavirus Infection,Other: Follow up calls,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 27, 2020",July 2022
4672,NCT04377074,Completed,No Results Available,Parental Stress|Depression|Anxiety,,All,"Adult, Older Adult",,2880.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 31, 2020","April 7, 2020"
4673,NCT04365608,Completed,No Results Available,Intubation Complication|Intubation; Difficult or Failed|Cardiac Arrest|Influenza|Safety Issues,Procedure: Direct laryngoscopy|Procedure: Vie Scope laryngoscopy,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 20, 2020","December 10, 2020"
4674,NCT04426305,Enrolling by invitation,No Results Available,Covid 19|Social Isolation|Mental Health Impairment,Other: community health worker support|Other: care as usual,All,"Adult, Older Adult",Not Applicable,140.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care,"May 21, 2020","October 30, 2020"
4675,NCT04390126,"Active, not recruiting",No Results Available,Chronic Coronary Syndrome|Heart Failure|AMD and Macular Edema|Chronic Respiratory Failure|Hemophilia|Malignant Hemopathy|Multiple Sclerosis|Horton's Disease,Other: life questionnaires|Other: questionnaire,All,"Child, Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","November 7, 2021"
4676,NCT04772859,Recruiting,No Results Available,Childhood Obesity,Behavioral: Online Lifestyle Intervention|Other: Control Group,All,Child,Not Applicable,54.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"February 1, 2021",July 2021
4677,NCT04435275,Recruiting,No Results Available,COVID-19,"Other: Virtual Assistant first, then Human Coach|Other: Human Coach first, then Virtual Assistant",All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 2, 2021","May 1, 2021"
4678,NCT04840992,Not yet recruiting,No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation|Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo for Inhalation|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,840.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 20, 2021","July 15, 2022"
4679,NCT04474080,Not yet recruiting,No Results Available,Burnout,Behavioral: Virtual Peer Support Platform|Behavioral: Control Period,All,"Adult, Older Adult",Not Applicable,1080.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 15, 2021",July 2021
4680,NCT04442308,Not yet recruiting,No Results Available,Parenting|Anxiety|Depression|Anger,,All,"Adult, Older Adult",,1440.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4681,NCT04674410,"Active, not recruiting",No Results Available,Covid19|Coronavirus Infection|Pneumonia,Drug: Antibiotic,All,"Adult, Older Adult",,100000.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2020","March 31, 2021"
4682,NCT04410484,"Active, not recruiting",No Results Available,Inflammatory Bowel Diseases|Coronavirus Infection,,All,"Child, Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"May 22, 2020",August 2020
4683,NCT04592549,Recruiting,No Results Available,SARS-CoV-2,Drug: ADM03820|Other: Placebo,All,Adult,Phase 1,40.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 4, 2020","September 30, 2021"
4684,NCT04356885,Completed,No Results Available,Mental Disorder,,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","August 1, 2020"
4685,NCT04406909,"Active, not recruiting",No Results Available,Training,Other: Access to training facility,All,Adult,Not Applicable,4000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 22, 2020","May 19, 2022"
4686,NCT04761874,Completed,No Results Available,"Stroke, Acute",Other: Telestroke,All,"Adult, Older Adult",,296.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 1, 2019","September 29, 2020"
4687,NCT04591184,Not yet recruiting,No Results Available,SARS-CoV-2,Biological: Covigenix VAX-001 placebo|Biological: Covigenix VAX-001,All,"Adult, Older Adult",Phase 1,72.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",March 2021,August 2022
4688,NCT04673331,Recruiting,No Results Available,Cystic Fibrosis,Other: exercise capacity,All,"Adult, Older Adult",,24.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"November 4, 2020","November 4, 2021"
4689,NCT04452799,Not yet recruiting,No Results Available,Coronavirus Infection,Drug: Hesperidin and Diosmin mixture,All,"Adult, Older Adult",Early Phase 1,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","July 1, 2020","October 30, 2020"
4690,NCT04433078,Recruiting,No Results Available,Cytokine Storm|SARS-CoV-2,Drug: Doxycycline|Drug: Placebo,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","June 22, 2020",July 2021
4691,NCT04374097,Completed,No Results Available,Post Traumatic Stress Disorder|Anxiety|Depression,,All,"Adult, Older Adult",,1778.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 31, 2020","April 7, 2020"
4692,NCT04383457,Completed,No Results Available,Coronavirus Infections,Device: RIA-device (Remote Investigation and Assessment),All,"Adult, Older Adult",,214.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 15, 2020","October 8, 2020"
4693,NCT04378738,Enrolling by invitation,No Results Available,Social Media|Corona Virus Infection,Behavioral: survey,All,"Adult, Older Adult",Not Applicable,212.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 1, 2020","May 8, 2020"
4694,NCT04683224,Not yet recruiting,No Results Available,Covid-19|SARS-CoV-2|Coronavirus,Biological: UB-612|Other: Placebo,All,"Adult, Older Adult",Phase 2|Phase 3,7320.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 1, 2021","March 22, 2023"
4695,NCT04555122,Not yet recruiting,No Results Available,Social Distance,Behavioral: Social Distancing Advertisements,All,"Adult, Older Adult",Not Applicable,52500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","September 29, 2020","July 28, 2022"
4696,NCT04454606,Completed,No Results Available,COVID|Personal Protective Equipment,Device: Fit test|Device: Filtration Test,All,Adult,Not Applicable,43.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 1, 2020","May 31, 2020"
4697,NCT04652505,Recruiting,No Results Available,COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Other: Questionnaire Administration,All,"Adult, Older Adult",,700.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"July 13, 2020","March 31, 2021"
4698,NCT04690920,Completed,No Results Available,Corona Virus Disease 2019 (COVID-19),Drug: Tocilizumab,All,"Child, Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"July 23, 2020","December 10, 2020"
4699,NCT04604080,Completed,No Results Available,"Depression, Anxiety",Other: service of questionnaire,All,"Child, Adult, Older Adult",,390.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"November 1, 2020","November 18, 2020"
4700,NCT04758039,Completed,No Results Available,Corona Virus Infection,,All,"Adult, Older Adult",,395.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 13, 2020","July 10, 2020"
4701,NCT04345887,Not yet recruiting,No Results Available,"Respiratory Distress Syndrome, Adult",Drug: Spironolactone 100mg|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 4,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 21, 2020","October 21, 2020"
4702,NCT04368377,Completed,No Results Available,"Pneumonia, Viral|Corona Virus Infection|Respiratory Failure|Embolism and Thrombosis",Drug: Tirofiban Injection|Drug: Clopidogrel|Drug: Acetylsalicylic acid|Drug: Fondaparinux,All,"Adult, Older Adult",Phase 2,5.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 6, 2020","April 23, 2020"
4703,NCT04358003,Recruiting,No Results Available,Respiratory Failure|ARDS,Device: Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol),All,"Adult, Older Adult",Not Applicable,2000.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 20, 2020","December 1, 2021"
4704,NCT04668937,Completed,No Results Available,Number of Patients During the Studying Period|Reason for Consultation,,All,Child,,11000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 18, 2020","June 30, 2020"
4705,NCT04664101,Not yet recruiting,No Results Available,Covid19|Critical Illness|High Intensity Interval Training|ICU|Intensive Care Units|Fitness Trackers,"Behavioral: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)",All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2021","May 1, 2023"
4706,NCT04757883,Not yet recruiting,No Results Available,Kidney Transplant Recipients,Other: Study of the synthesis of antibodies directed against SARS,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","March 1, 2023"
4707,NCT04626050,Not yet recruiting,No Results Available,Post-traumatic Stress Disorder|Moral Injury,Behavioral: Medical Music|Behavioral: Narrative Writing|Behavioral: Prolonged Exposure Therapy|Behavioral: Interpersonal Psychotherapy,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,May 2021,January 2022
4708,NCT04569786,Terminated,No Results Available,Coronavirus Disease (COVID-19),Biological: V590|Other: Placebo,All,"Adult, Older Adult",Phase 1,232.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","October 29, 2020","February 18, 2021"
4709,NCT04376515,"Active, not recruiting",No Results Available,Anxiety,Behavioral: HOPE intervention,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"March 20, 2020","September 1, 2021"
4710,NCT04694482,Recruiting,No Results Available,Psychosis;Schizophrenic|Personality Disorders|Mood Disorders|Anxiety Disorders|Post Traumatic Stress Disorder,Other: Psychometric scale administration,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"November 12, 2020","January 31, 2021"
4711,NCT04375774,Recruiting,No Results Available,COVID,Device: FFP2|Device: Facial mask|Device: MFS,All,Adult,Not Applicable,10.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,May 2020,May 2020
4712,NCT04563065,Recruiting,No Results Available,"Pregnancy Complications|Pregnancy, High Risk|Pregnancy Induced Hypertension|Newborn Morbidity|Fetal Growth Retardation|Fetus Disorder|Weight Gain, Maternal|Maternal-Fetal Relations",Other: Exercise program|Other: Healthy lifestyle advise,Female,Adult,Not Applicable,280.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"August 1, 2020","December 31, 2023"
4713,NCT04438954,Completed,No Results Available,Multiple Sclerosis|Covid-19,,All,Adult,,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 5, 2020","June 18, 2020"
4714,NCT04531618,Recruiting,No Results Available,Child Development|Mother-Infant Interaction|COVID-19,Behavioral: Family Nurture Intervention (FNI),All,Child,Not Applicable,280.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 13, 2020",December 2021
4715,NCT04497467,Recruiting,No Results Available,Patient Preference,,All,"Child, Adult, Older Adult",,1200000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 1, 2020","December 31, 2020"
4716,NCT04489628,Not yet recruiting,No Results Available,SARS-CoV Infection,Drug: Vitamin D3 or Placebo|Device: Doctella telehealth monitoring,All,"Adult, Older Adult",Phase 1|Phase 2,110.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","August 1, 2020","August 1, 2021"
4717,NCT04583228,Not yet recruiting,No Results Available,COVID 19,Drug: HLX71|Other: Placebo,All,"Adult, Older Adult",Phase 1,40.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","November 30, 2020","May 31, 2021"
4718,NCT04574765,Recruiting,No Results Available,Healthcare Worker|Covid19,Diagnostic Test: Nasopharyngeal swab|Other: Questionnaire collection|Other: Optional blood completion|Other: Optional questionnaire completion,All,"Adult, Older Adult",,100000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020","April 16, 2021"
4719,NCT04444323,Not yet recruiting,No Results Available,"Telemedicine|Surgery, Plastic",Other: 3D Telemedicine,All,"Child, Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 1, 2020","January 1, 2021"
4720,NCT04789603,Not yet recruiting,No Results Available,Pulmonary Disease|Covid19|Physical Disability,Other: 6-min-walk surgical mask|Other: 6-min-walk Fpp2|Other: 6-min-walk without mask,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"March 9, 2021","April 10, 2021"
4721,NCT04581200,Recruiting,No Results Available,COVID-19|Cardiorespiratory Failure,Behavioral: Lift,All,"Adult, Older Adult",Not Applicable,300.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","January 25, 2021","September 30, 2021"
4722,NCT04453774,Not yet recruiting,No Results Available,Coronavirus,Device: Covidfree@home,All,"Child, Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"October 16, 2020",April 2023
4723,NCT04383483,Recruiting,No Results Available,Coronavirus as the Cause of Diseases Classified Elsewhere,Other: COVICU,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"June 15, 2020","February 28, 2022"
4724,NCT04373382,"Active, not recruiting",No Results Available,Burnout,Behavioral: Peer Resilience Champion|Behavioral: Enriched Survey Feedback,All,"Adult, Older Adult",Not Applicable,882.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 27, 2020",February 2022
4725,NCT04365348,Recruiting,No Results Available,Mental Health Wellness 1,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020","June 30, 2021"
4726,NCT04412343,Completed,No Results Available,Well-Being (Psychological Flourishing)|Depression|Quality of Life|Loneliness|Physical Activity|Social Identification|Physical Health,Behavioral: Virtual Group Intervention|Behavioral: Personal Exercise Intervention,All,Older Adult,Not Applicable,241.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"May 23, 2020","October 5, 2020"
4727,NCT04368676,"Active, not recruiting",No Results Available,Job Stress|Workplace Stress|Compassion Fatigue|Psychological Trauma|Healthcare Workers|Healthcare Providers,Other: Sudarshan Kriya Yoga (SKY)|Other: Health Enhancement Program,All,"Adult, Older Adult",Early Phase 1,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 25, 2020","June 30, 2022"
4728,NCT04346420,Completed,No Results Available,COVID|Hypoxemia,Other: Standard interface|Device: Double-Trunk Mask,All,"Adult, Older Adult",Not Applicable,12.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 9, 2020","May 1, 2020"
4729,NCT04644328,"Active, not recruiting",No Results Available,Covid19,Behavioral: Facebook Ads on the importance of staying safe during the Thanksgiving holiday,All,"Adult, Older Adult",Not Applicable,20000000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 14, 2020","November 26, 2021"
4730,NCT04798599,Recruiting,No Results Available,Dental Caries in Children|Dental Diseases,Other: Telemonitoring and teleorientation|Other: Control Group - Waiting list,All,Child,Not Applicable,368.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care","December 1, 2020","June 30, 2022"
4731,NCT04611399,Recruiting,No Results Available,Stress Related Disorder,Behavioral: VR for psychoeducation and relaxation|Behavioral: Text material for psychoeducation and audio for relaxation techniques,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 5, 2021","March 5, 2022"
4732,NCT04381000,Completed,No Results Available,Chronic Pain,Other: Exercise Group,All,"Adult, Older Adult",Not Applicable,170.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","June 10, 2020"
4733,NCT04327388,Completed,No Results Available,Corona Virus Infection,Drug: Sarilumab SAR153191|Drug: Placebo,All,"Adult, Older Adult",Phase 3,420.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 28, 2020","September 2, 2020"
4734,NCT04407598,"Active, not recruiting",No Results Available,COPD Exacerbation|COPD,,All,"Adult, Older Adult",,160.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 1, 2020",June 2021
4735,NCT04830761,Recruiting,No Results Available,Hand Hygiene,Behavioral: Motivation|Behavioral: Habit|Behavioral: Social,All,"Adult, Older Adult",Not Applicable,710.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","March 26, 2021","April 1, 2022"
4736,NCT04479540,Recruiting,No Results Available,"Pneumonia, Viral",Radiation: Angiography scanner,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 26, 2020","August 31, 2021"
4737,NCT04419623,Recruiting,No Results Available,COVID-19|Sars-CoV2|Cancer|Solid Tumor|Carcinoma|Blood Cancer,Drug: Part 1 - TL-895|Drug: Part 2 - TL-895|Drug: Part 2 - Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,146.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 9, 2020",July 2021
4738,NCT04435106,Completed,No Results Available,Coronavirus Infections,Drug: Opaganib|Drug: Standard of Care,All,"Adult, Older Adult",,23.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"April 3, 2020","May 15, 2020"
4739,NCT04813692,Recruiting,No Results Available,"Ventricular Septal Rupture|Papillary Muscle Rupture|Free Wall Rupture, Heart",Procedure: Surgical repair|Procedure: Percutaneous treatment|Procedure: Mitral valve surgery,All,"Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2021","July 31, 2021"
4740,NCT04727775,Recruiting,No Results Available,"Complication of Medical Care|Pneumonia, Viral",Drug: Favipiravir|Drug: Remdesivir,All,"Adult, Older Adult",Phase 1,300.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 25, 2020","March 20, 2021"
4741,NCT04806074,"Active, not recruiting",No Results Available,Food Literacy|Food Habits|Behavior and Behavior Mechanisms|Eating Behavior,Behavioral: Experimental Group|Behavioral: Comparison Group,All,"Adult, Older Adult",Not Applicable,215.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,"August 14, 2020","September 6, 2021"
4742,NCT04664296,Recruiting,No Results Available,Infection Viral,Other: Review of medical patient file|Other: Phone call interview,All,"Child, Adult, Older Adult",,75.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 21, 2020","March 21, 2021"
4743,NCT04715477,Recruiting,No Results Available,Anxiety,Behavioral: Hospital Anxiety Depression Measure,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 17, 2021","April 15, 2021"
4744,NCT04821921,Not yet recruiting,No Results Available,Type 2 Diabetes|Type 1 Diabetes Mellitus,Other: No intervention,All,"Adult, Older Adult",,750.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 15, 2021","June 30, 2022"
4745,NCT04476745,Enrolling by invitation,No Results Available,Cytokine Storm,Dietary Supplement: Vitamin D3,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 5, 2020","February 20, 2021"
4746,NCT04386460,Recruiting,No Results Available,Nutrition Poor|Infection Viral|Oral Disease,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","May 11, 2021"
4747,NCT04455360,Recruiting,No Results Available,Post Traumatic Stress Disorder|Intensive Care Psychiatric Disorder|Anxiety Disorders|Depression|Critical Care|COVID,Other: Eye Movement Desensitisation and Reprocessing Recent traumatic Event Protocol,All,"Adult, Older Adult",Not Applicable,26.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"October 1, 2020",September 2021
4748,NCT04372576,Recruiting,No Results Available,Ventilator Associated Pneumonia|Corona Virus Infection,Diagnostic Test: Assessment of ventilator-associated pneumonia criteria,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 16, 2020",August 2020
4749,NCT04475588,Completed,No Results Available,Acute Respiratory Distress Syndrome|Cytokine Release Syndrome|Covid19,"Drug: Itolizumab IV infusion|Drug: Best supportive care"" which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy",All,"Adult, Older Adult",Phase 2,30.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2020","July 8, 2020"
4750,NCT04583865,"Active, not recruiting",No Results Available,Anesthesia,Other: teleconsultation,All,"Child, Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 7, 2020","March 14, 2022"
4751,NCT04733846,Not yet recruiting,No Results Available,Eye Trauma,Other: data collection,All,"Adult, Older Adult",,9.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,February 2021,March 2021
4752,NCT04366947,Completed,No Results Available,Emergency Medicine|Cardiopulmonary Arrest|Shock,Device: NIO® (Intraosseous access)|Device: Standard of Care (Intravenous access),All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 14, 2020","October 30, 2020"
4753,NCT04368312,Not yet recruiting,No Results Available,Psychological Distress|Quality of Life,Other: No intervention,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 6, 2020","May 30, 2020"
4754,NCT04470544,Recruiting,No Results Available,Severe Acute Respiratory Syndrome,Drug: Camostat Mesilate|Other: Standard of Care,All,"Adult, Older Adult",Phase 2,264.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 28, 2020","September 15, 2022"
4755,NCT04568005,Completed,No Results Available,Lymphedema,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 1, 2020","August 1, 2020"
4756,NCT04422418,Recruiting,No Results Available,Cardiovascular Risk Factor|Burnout|Immune Deficiency,,All,"Adult, Older Adult",,200.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020","December 31, 2020"
4757,NCT04359225,Not yet recruiting,No Results Available,Telehealth,Other: 3D Telemedicine|Other: 2D Telemedicine,All,"Child, Adult, Older Adult",Not Applicable,80.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other","June 30, 2020","December 31, 2021"
4758,NCT04539821,Recruiting,No Results Available,Chronic Pain,Other: VCPM,All,"Adult, Older Adult",Not Applicable,60.0,U.S. Fed,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"October 1, 2020","June 30, 2021"
4759,NCT04747756,Not yet recruiting,No Results Available,"Hiv|Depression in Old Age|Isolation, Social|Aging",Other: Virtual Village,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,March 2021,December 2022
4760,NCT04818164,Completed,No Results Available,Acute Respiratory Distress Syndrome|Coronavirus|Mechanical Ventilation Complication|Ventilation Perfusion Mismatch,,All,"Adult, Older Adult",,22.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"September 1, 2020","March 20, 2021"
4761,NCT04570189,Recruiting,No Results Available,COVID-19,Device: Auscul-X,All,"Adult, Older Adult",,40.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 1, 2020",January 2021
4762,NCT04622332,Recruiting,No Results Available,Corona Virus Infection,Drug: SIR1-365|Drug: Matching Placebo,All,"Adult, Older Adult",Phase 1,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 18, 2020","December 15, 2021"
4763,NCT04423991,Completed,No Results Available,COVID-19|Coronavirus|Mortality,Device: COViage,All,"Child, Adult, Older Adult",Not Applicable,290.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 10, 2020","June 4, 2020"
4764,NCT04414319,Recruiting,No Results Available,SARS-CoV 2,,All,Older Adult,,350.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 15, 2020","April 15, 2023"
4765,NCT04320862,Recruiting,No Results Available,COVID-19|SARS-CoV-2|Coronavirus|Influenza -Like Illness|Lower Resp Tract Infection|Upper Resp Tract Infection,,All,"Child, Adult, Older Adult",,200000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 3, 2020","December 31, 2021"
4766,NCT04447404,Terminated,No Results Available,SARS-CoV 2,Drug: DUR-928|Drug: Placebo,All,"Adult, Older Adult",Phase 2,2.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 21, 2020","March 4, 2021"
4767,NCT04730934,Completed,No Results Available,Fibromyalgia|Chronic Low-back Pain,"Other: Perceived stress scale|Other: Fibromyalgia impact questionnaire|Other: The drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status",All,"Adult, Older Adult",,1360.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2021","February 25, 2021"
4768,NCT04526145,Not yet recruiting,No Results Available,"Stress, Psychological",Behavioral: Stress and emotion management,Female,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"April 1, 2021","January 30, 2022"
4769,NCT04363229,Not yet recruiting,No Results Available,Occupational Stress,Other: maslach burnout inventory questionnair,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,July 2020,June 2021
4770,NCT04442243,Not yet recruiting,No Results Available,Post Traumatic Stress Disorder|Anxiety|Depression,,All,"Adult, Older Adult",,889.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4771,NCT04524754,Recruiting,No Results Available,Anosmia,,All,"Adult, Older Adult",,218.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"July 11, 2020","November 30, 2020"
4772,NCT04407182,Completed,No Results Available,Covid-19|Sars-CoV2|Diabete Mellitus|Cardiopathy|Pulmonary Disease|Renal Disease|Liver Diseases,Dietary Supplement: Viusid and Asbrip,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","May 4, 2020","October 1, 2020"
4773,NCT04693975,Recruiting,No Results Available,Chronic Obstructive Pulmonary Disease|Idiopathic Pulmonary Fibrosis|Asthma Chronic,,All,"Child, Adult, Older Adult",,94.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"October 16, 2020",October 2022
4774,NCT04704544,Not yet recruiting,No Results Available,Rheumatic Diseases,Other: Tele-rheumatology,All,"Adult, Older Adult",Not Applicable,320.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,"March 1, 2021","November 30, 2022"
4775,NCT04444557,Completed,No Results Available,Depression|Hemodialysis,Other: Beck Depression Inventory (BDI),All,"Adult, Older Adult",,97.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 17, 2020","May 1, 2020"
4776,NCT04686760,Recruiting,No Results Available,Corona Virus Infection,Drug: Nitroglycerin,All,"Child, Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 15, 2020","January 15, 2021"
4777,NCT04350710,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID,Other: PEEP trial,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 18, 2020","December 31, 2020"
4778,NCT04342208,Not yet recruiting,No Results Available,Musculoskeletal Pain,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"April 10, 2020","July 1, 2020"
4779,NCT04443699,Not yet recruiting,No Results Available,Mental Well-being,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4780,NCT04679168,Recruiting,No Results Available,Covid19|Environmental Exposure|Chronic Kidney Diseases,,All,"Adult, Older Adult",,310.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","December 31, 2021"
4781,NCT04327479,Recruiting,No Results Available,Cardiovascular Diseases|Cardiovascular Risk Factor|SARS,Diagnostic Test: Assessment of cardiovascular diseases and cardiovascular risk factors,All,"Adult, Older Adult",,728.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 26, 2020","March 25, 2026"
4782,NCT04424082,Recruiting,No Results Available,"Coronavirus|ARDS, Human",Other: Removal of dead space filter,All,"Child, Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 9, 2020","November 7, 2020"
4783,NCT04682561,Not yet recruiting,No Results Available,Stress|Trauma|Mental Health Issue|Healthcare Workers,Behavioral: Supportive Trauma Exposure Preparation Program,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,February 2022
4784,NCT04363606,Recruiting,No Results Available,Chronic Fatigue Syndrome|Intensive Care Unit|Muscle,Other: Questionnaires|Biological: blood test|Other: Maximal effort test|Device: actigraphy|Device: Neuromuscular evaluation|Other: stool analysis|Other: food diary,All,"Adult, Older Adult",Not Applicable,82.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 27, 2020",December 2021
4785,NCT04595175,Recruiting,No Results Available,COVID-19 Infection,,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 10, 2020","December 30, 2021"
4786,NCT04261426,Not yet recruiting,No Results Available,2019-nCoV,Drug: Intravenous Immunoglobulin|Other: Standard care,All,"Adult, Older Adult",Phase 2|Phase 3,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 10, 2020","June 30, 2020"
4787,NCT04501445,Recruiting,No Results Available,Family Members|Post Intensive Care Unit Syndrome|Post Traumatic Stress Disorder,Behavioral: Written Summary of Rounds,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"September 14, 2020","September 15, 2021"
4788,NCT04476979,Recruiting,No Results Available,Coronavirus Infection|SARS (Severe Acute Respiratory Syndrome)|Virus Diseases|Coronaviridae Infections|Nidovirales Infections|RNA Virus Infections|Respiratory Tract Infections|Respiratory Tract Disease,Drug: Tocilizumab|Drug: Dexamethasone,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 16, 2020","December 31, 2021"
4789,NCT04319172,Recruiting,No Results Available,"Transplant Recipient|Infections, Coronavirus",,All,"Child, Adult, Older Adult",,50.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 12, 2020",April 2021
4790,NCT04404608,Not yet recruiting,No Results Available,Lymphopenia,"Diagnostic Test: Complete blood picture, bone marrow aspiration cytology",All,"Child, Adult, Older Adult",,90.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,June 2020,December 2021
4791,NCT04425005,Completed,No Results Available,Bariatric Surgery|Obesity,Other: Home-based exercise,All,"Adult, Older Adult",Not Applicable,55.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 10, 2020","December 7, 2020"
4792,NCT04548544,Completed,No Results Available,Healthy,"Behavioral: Training for Awareness, Resilience, and Action (TARA)",All,"Child, Adult",Not Applicable,21.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science,"October 18, 2019","May 20, 2020"
4793,NCT04342728,Completed,No Results Available,COVID|Corona Virus Infection,Dietary Supplement: Ascorbic Acid|Dietary Supplement: Zinc Gluconate|Dietary Supplement: Ascorbic Acid and Zinc Gluconate|Other: Standard of Care,All,"Adult, Older Adult",Not Applicable,214.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 8, 2020","February 11, 2021"
4794,NCT04635618,Enrolling by invitation,No Results Available,Mental Disorder|COVID|Emotional Distress|Depression|Anxiety|Irritable Mood,Behavioral: Cognitive Behavioral Brief-Telepsychotherapy|Behavioral: Brief Interpersonal Telepsychotherapy|Behavioral: Telepsychoeducation,All,"Child, Adult, Older Adult",Not Applicable,999.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 5, 2020","July 20, 2021"
4795,NCT04341714,Recruiting,No Results Available,"Efficacy, Self|Satisfaction, Patient|Telemedicine",Other: Satisfaction evaluation,All,"Adult, Older Adult",,450.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 16, 2020","June 15, 2020"
4796,NCT04659252,Recruiting,No Results Available,Multiple Myeloma,Other: n/a - samples collected along routine care samples only,All,"Adult, Older Adult",,70.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 4, 2021","December 1, 2021"
4797,NCT04357782,Completed,No Results Available,COVID-19|Hypoxia,Drug: L-ascorbic acid,All,"Adult, Older Adult",Phase 1|Phase 2,20.0,U.S. Fed|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","October 13, 2020"
4798,NCT04414371,Recruiting,No Results Available,Stress|Anxiety|Depression|Resilience|Wellbeing|Mood,Other: Yoga,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 20, 2020","December 31, 2020"
4799,NCT04357041,"Active, not recruiting",No Results Available,"ALL, Adult",,All,"Adult, Older Adult",,500.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Other,"April 17, 2020",December 2021
4800,NCT04344964,Completed,No Results Available,"Colon Polyp|Colon Disease|Reflux, Gastroesophageal|Varices, Esophageal",Other: None - NA,All,"Adult, Older Adult",,186.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 15, 2020","July 3, 2020"
4801,NCT04333849,Completed,No Results Available,Coronavirus,,All,Older Adult,,132.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 25, 2020","May 11, 2020"
4802,NCT04738721,Recruiting,No Results Available,"Assessment, Self",Behavioral: Evaluation,All,Adult,,87.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 5, 2021","April 15, 2021"
4803,NCT04678843,Enrolling by invitation,No Results Available,Anorexia Nervosa,Behavioral: Virtual Family-Based Treatment,All,"Child, Adult",Early Phase 1,36.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 9, 2021",December 2021
4804,NCT04842747,Not yet recruiting,No Results Available,SARS-CoV Infection,Drug: VERU-111,All,"Adult, Older Adult",Phase 3,300.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 30, 2021","March 19, 2022"
4805,NCT04385797,"Active, not recruiting",No Results Available,Mild Cognitive Impairment|Dementia,Other: Telephone interview,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"May 4, 2020","December 31, 2020"
4806,NCT04609332,Recruiting,No Results Available,Covid19|Angiogenesis|Endothelial Dysfunction|Cardiovascular Morbidity,Diagnostic Test: Endothelial damage and angiogenic biomarkers,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 10, 2020",November 2021
4807,NCT04517006,Not yet recruiting,No Results Available,Happiness|Anxiety|Depression|Morality,Behavioral: Self-focused acts|Behavioral: Prosocial acts,All,"Adult, Older Adult",Not Applicable,1542.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,January 2021,March 2021
4808,NCT04395430,Recruiting,No Results Available,Pediatric Obesity|Clinical Trial,Behavioral: Usual Care|Behavioral: online KKH Sports Singapore Program with Usual Care,All,Child,Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 18, 2020",October 2021
4809,NCT04400799,Recruiting,No Results Available,"COVID-19|Pulmonary Embolism, Deep Vein Thrombosis",Drug: Enoxaparin 40Mg/0.4Ml Inj Syringe 0.4Ml,All,"Adult, Older Adult",Phase 3,1000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 15, 2020","April 14, 2021"
4810,NCT04815057,Completed,No Results Available,Health Behavior,Behavioral: Wellness Education,All,"Child, Adult, Older Adult",Not Applicable,176.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"November 2, 2020","March 8, 2021"
4811,NCT04534400,Recruiting,No Results Available,SARS-CoV-2 Infection|Respiratory Failure With Hypoxia,Radiation: thoracic CT-scan,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"September 1, 2020","January 15, 2021"
4812,NCT04605588,Recruiting,No Results Available,SARS-CoV Infection|Covid19,Drug: Nitazoxanide|Drug: Placebo Nitazoxanide|Drug: Ribavirin|Drug: Placebo Ribavirin|Drug: Hydroxychloroquine|Drug: Placebo Hydroxychloroquine,All,"Adult, Older Adult",Phase 2,70.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 2, 2020",April 2021
4813,NCT04799704,Completed,No Results Available,Covid19|Eye Diseases,Diagnostic Test: swabbing of conjunctiva,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"September 11, 2020","December 13, 2020"
4814,NCT04548492,Not yet recruiting,No Results Available,the Use of Modern Technology Applications in Home Isolation,Other: Survey,All,"Adult, Older Adult",,175.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Prospective,"September 14, 2020",January 2021
4815,NCT04254874,Recruiting,No Results Available,2019-nCoV,Drug: Abidol hydrochloride|Drug: Abidol Hydrochloride combined with Interferon atomization,All,"Adult, Older Adult",Phase 4,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 1, 2020","July 1, 2020"
4816,NCT04342650,Completed,No Results Available,COVID-19|SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia|Clinical Trial,Drug: Chloroquine Diphosphate|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,152.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 8, 2020","June 8, 2020"
4817,NCT04482595,Recruiting,No Results Available,Pulmonary Fibrosis,Drug: BIO 300 Oral Suspension|Drug: Placebo,All,"Adult, Older Adult",Phase 2,66.0,Industry|Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 11, 2020",May 2022
4818,NCT04819282,Completed,No Results Available,Exercise Capacity|Geriatric|Mask,Diagnostic Test: Senior Fitness Test,All,Older Adult,,46.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"September 10, 2020","February 17, 2021"
4819,NCT04363047,Enrolling by invitation,No Results Available,SARS Virus,Other: 40ml blood sample,All,"Adult, Older Adult",,125.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 1, 2020","May 1, 2021"
4820,NCT04261270,Recruiting,No Results Available,2019-nCoV Pneumonia,Drug: ASC09F+Oseltamivir|Drug: Ritonavir+Oseltamivir|Drug: Oseltamivir,All,Adult,Phase 3,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 1, 2020","July 1, 2020"
4821,NCT04332042,Not yet recruiting,No Results Available,SARS-COv2 Related Interstitial Pneumonia,Drug: Tofacitinib,All,"Adult, Older Adult",Phase 2,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 10, 2020","July 10, 2020"
4822,NCT04369378,Recruiting,No Results Available,Anxiety|Well-being,Behavioral: Meditation app usage,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 19, 2020","April 30, 2021"
4823,NCT04337151,Recruiting,No Results Available,MAGEC Rod,Device: MAGEC Spine Rod|Diagnostic Test: Titanium blood test,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,April 2020,March 2021
4824,NCT04384965,Recruiting,No Results Available,Major Depressive Disorder,"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil",All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 12, 2020","November 1, 2022"
4825,NCT04524598,Recruiting,No Results Available,Depression,Device: Limbix Spark|Other: Psychoeducation,All,"Child, Adult",Not Applicable,410.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 20, 2020","December 31, 2020"
4826,NCT04442217,Not yet recruiting,No Results Available,Adherence to WHO-advised Hygiene-related Behavior|Adherence to Viral Mitigation Protocols,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4827,NCT04427137,Recruiting,No Results Available,Bipolar Depression,"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil",All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 9, 2020",December 2022
4828,NCT04326426,Enrolling by invitation,No Results Available,Coronavirus Infection,Drug: Tradipitant|Drug: Placebo,All,"Adult, Older Adult",Phase 3,300.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","April 13, 2020","August 31, 2020"
4829,NCT04351906,Recruiting,No Results Available,ARDS|Hypercapnic Respiratory Failure|AKI,Device: ECCO2R,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 3, 2020","October 1, 2021"
4830,NCT04556630,Not yet recruiting,No Results Available,Assisted Reproduction,,All,"Adult, Older Adult",,360.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,October 2020,December 2020
4831,NCT04682574,Recruiting,No Results Available,Corona Virus Infection,Drug: Vitamin C,All,"Child, Adult, Older Adult",Not Applicable,15.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 2, 2020","January 10, 2021"
4832,NCT04255017,Recruiting,No Results Available,2019-nCoV,Drug: Abidol hydrochloride|Drug: Oseltamivir|Drug: Lopinavir/ritonavir,All,"Adult, Older Adult",Phase 4,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 1, 2020","July 1, 2020"
4833,NCT04666779,"Active, not recruiting",No Results Available,Access to Chiropractic Care Services,Other: Chiropractic care,All,"Child, Adult, Older Adult",,399.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 18, 2020","February 28, 2021"
4834,NCT04516837,Recruiting,No Results Available,Immune Thrombocytopenia,Drug: Eltrombopag|Drug: rhTPO,All,"Adult, Older Adult",Phase 2,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 31, 2020",August 2022
4835,NCT04472559,Not yet recruiting,No Results Available,Quality of Life|Stress,Behavioral: Self-acupressure,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 25, 2020","February 25, 2021"
4836,NCT02735707,Recruiting,No Results Available,"Community-acquired Pneumonia, Influenza, COVID-19",Drug: Fixed-duration Hydrocortisone|Drug: Shock-dependent hydrocortisone|Drug: Ceftriaxone|Drug: Moxifloxacin or Levofloxacin|Drug: Piperacillin-tazobactam|Drug: Ceftaroline|Drug: Amoxicillin-clavulanate|Drug: Macrolide administered for 3-5 days|Drug: Macrolide administered for up to 14 days|Drug: Five-days oseltamivir|Drug: Ten-days oseltamivir|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Hydroxychloroquine + lopinavir/ritonavir|Drug: Interferon-β1a|Drug: Anakinra|Drug: Fixed-duration higher dose Hydrocortisone|Drug: Tocilizumab|Drug: Sarilumab|Drug: Vitamin C|Drug: Therapeutic anticoagulation|Drug: Simvastatin|Biological: Convalescent plasma|Other: Protocolised mechanical ventilation strategy|Drug: Eritoran|Drug: Apremilast|Drug: Aspirin|Drug: Clopidogrel|Drug: Prasugrel|Drug: Ticagrelor,All,"Adult, Older Adult",Phase 4,7100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 11, 2016",December 2023
4837,NCT04803812,Recruiting,No Results Available,Mental Health Wellness 1|Anxiety|Happiness,"Other: Remote SMS (short message service, also known as ""text message"") delivery",All,"Child, Adult, Older Adult",Not Applicable,19000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Other","January 26, 2021","May 4, 2021"
4838,NCT04370886,Completed,No Results Available,Blood Donation,Behavioral: blood donation SMS,All,Adult,Not Applicable,456517.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"April 30, 2020","May 10, 2020"
4839,NCT04645368,Recruiting,No Results Available,"Fibroses, Pulmonary",Drug: bovhyaluronidase azoxymer,All,"Adult, Older Adult",,160.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 1, 2020",July 2021
4840,NCT04652596,Enrolling by invitation,No Results Available,Food Insecurity,Other: Produce prescription program|Other: Grocery store gift cards,All,"Adult, Older Adult",Not Applicable,250.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"February 8, 2021",October 2022
4841,NCT04274322,"Active, not recruiting",No Results Available,Critically Ill|Coronavirus Infections,Other: Nutrition support,All,"Adult, Older Adult",,117.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 19, 2020",July 2020
4842,NCT04469621,Completed,No Results Available,Corona Virus Infection,Drug: SAR443122|Drug: Placebo,All,"Adult, Older Adult",Phase 1,68.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 17, 2020","October 23, 2020"
4843,NCT04384406,Completed,No Results Available,Chronic Disabling|COVID-19,,All,"Adult, Older Adult",,467.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","May 9, 2020"
4844,NCT04389333,Completed,No Results Available,Gastrointestinal Disease|Infectious Disease|Capsule Endoscopy,Device: non-contact magnetically-controlled capsule endoscopy,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 26, 2020","May 20, 2020"
4845,NCT04457505,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|Severe Pneumonia|Respiratory Failure,,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 8, 2020","May 31, 2021"
4846,NCT04263402,Recruiting,No Results Available,2019-nCoV Severe Pneumonia,Drug: Methylprednisolone,All,"Adult, Older Adult",Phase 4,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 1, 2020","July 1, 2020"
4847,NCT04324073,"Active, not recruiting",No Results Available,Corona Virus Infection,Drug: Sarilumab,All,"Adult, Older Adult",Phase 2|Phase 3,239.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 27, 2020","December 31, 2021"
4848,NCT04460196,Completed,No Results Available,Emergency Medicine,Other: survey,All,"Adult, Older Adult",,900.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 8, 2020","September 18, 2020"
4849,NCT04566770,Recruiting,No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo,All,"Child, Adult, Older Adult",Phase 2,481.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","September 24, 2020","October 20, 2022"
4850,NCT04728906,Not yet recruiting,No Results Available,Myocardial Infarction|Heart Diseases,Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells,All,Adult,Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 5, 2021","December 19, 2021"
4851,NCT04724616,Recruiting,No Results Available,Covid19|Pediatric Psychiatric Disorder|Psychological Stress,Other: Educational Program (CARTOON),All,Child,Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 6, 2021",June 2021
4852,NCT04836039,Completed,No Results Available,Physical Therapy,Other: A questionnaire and scales.,All,"Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 27, 2021","February 27, 2021"
4853,NCT04362358,Not yet recruiting,No Results Available,"Stress - Prevention of Sleep Disorders, PTSD and Depression",Behavioral: Online cognitive behavioral therapy (CBT)|Behavioral: Online bibliotherapy programme,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 1, 2020","October 1, 2021"
4854,NCT04526912,Recruiting,No Results Available,Acute Lung Injury,Drug: VIB7734|Drug: Placebo,All,"Adult, Older Adult",Phase 1,48.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 28, 2020",July 2021
4855,NCT04713540,Recruiting,No Results Available,Covid19,,All,"Adult, Older Adult",,58.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2021","May 1, 2021"
4856,NCT04346953,Not yet recruiting,No Results Available,Healthy Lifestyle,Behavioral: Video based exercise,All,Adult,Not Applicable,128.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"August 20, 2020","November 30, 2020"
4857,NCT04314817,Recruiting,No Results Available,"Coronavirus|Iatrogenic Disease|Acute Kidney Injury|ARDS, Human",Drug: Any drug used to treat Covid-19,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"March 17, 2020","January 1, 2023"
4858,NCT04445870,Recruiting,No Results Available,Cancer,Other: data record,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"May 1, 2020",December 2021
4859,NCT04615741,"Active, not recruiting",No Results Available,"Mental Health Wellness 1|Addiction|Stress, Psychological|Covid19",Behavioral: Trauma Informed Yoga|Behavioral: Trauma Informed Psychotherapy,Female,"Adult, Older Adult",Not Applicable,187.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 9, 2020","April 30, 2021"
4860,NCT04659109,Not yet recruiting,No Results Available,SARS-CoV Infection|Acute Respiratory Distress Syndrome|COVID-19|ARDS,Drug: glenzocimab|Drug: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",December 2020,July 2021
4861,NCT04442386,Not yet recruiting,No Results Available,Parental Burnout,Other: Prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4862,NCT04410458,Enrolling by invitation,No Results Available,Blood Donation,Behavioral: blood donation SMS,All,Adult,Not Applicable,506517.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 31, 2020","June 12, 2020"
4863,NCT04417270,Completed,No Results Available,Diabetes Mellitus,Device: Freestyle Libre 14 day CGM system|Device: Accuchek Inform II platform,All,"Adult, Older Adult",Not Applicable,52.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"June 12, 2020","November 30, 2020"
4864,NCT04334629,Recruiting,No Results Available,Coronavirus|Respiratory Distress Syndrome|SARS-CoV Infection,Drug: Ibuprofen,All,"Adult, Older Adult",Phase 4,230.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 26, 2020","September 25, 2021"
4865,NCT04466605,Completed,No Results Available,Chronic Musculoskeletal Pain,Other: Tele-yoga therapy|Other: Primary care,All,Adult,Not Applicable,64.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 30, 2020","July 6, 2020"
4866,NCT04407507,Not yet recruiting,No Results Available,COVID-19,Drug: Ivermectin|Drug: Placebo,All,"Adult, Older Adult",Phase 2,66.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,June 2020,October 2020
4867,NCT04343729,Completed,No Results Available,SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia,Drug: Methylprednisolone Sodium Succinate|Drug: Placebo solution,All,"Adult, Older Adult",Phase 2,416.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 18, 2020","October 20, 2020"
4868,NCT04431180,Enrolling by invitation,No Results Available,Blood Donation,Behavioral: blood donation SMS,All,Adult,Not Applicable,403535.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"June 13, 2020","June 30, 2020"
4869,NCT04728958,Not yet recruiting,No Results Available,"Wellbeing|Psychological Distress|Psychological Stress|Emotional Distress|Stress, Psychological|Stress|Anxiety|Depression|Happiness|Satisfaction|Occupational Stress|Affect",Behavioral: Gratitude,All,"Adult, Older Adult",Not Applicable,219.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,July 2021,September 2022
4870,NCT04661410,Recruiting,No Results Available,Bulimia Nervosa|Bulimia; Atypical|Binge Eating|Binge-Eating Disorder,Behavioral: Reward Re-Training|Behavioral: Supportive Therapy,All,"Adult, Older Adult",Not Applicable,60.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"December 1, 2020","March 30, 2022"
4871,NCT04645407,Completed,No Results Available,Novel Coronavirus Pneumonia,Drug: Fuzheng Huayu tablet,All,"Adult, Older Adult",Phase 4,66.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2020","April 15, 2020"
4872,NCT04392453,Recruiting,No Results Available,Stroke,Device: Robotic therapy,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 26, 2020",December 2021
4873,NCT04573361,Completed,No Results Available,Musculoskeletal Pain|Disability Physical|Psychological Distress,Other: Chiropractic care (one visit)|Other: Chiropractic care (more than one visit),All,"Child, Adult, Older Adult",Not Applicable,723.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 2, 2020","May 27, 2020"
4874,NCT04747678,Enrolling by invitation,No Results Available,Covid19|Ivermectin Poisoning|Drug Toxicity|Drug Side Effect,Drug: Ivermectin,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"February 3, 2021","March 1, 2021"
4875,NCT04643548,Recruiting,No Results Available,SARS-CoV-2 Infection|Intensive Care Unit Patient|Neurological Abnormality|Delirium|Encephalopathy,,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 13, 2020","August 13, 2021"
4876,NCT04444661,"Active, not recruiting",No Results Available,Osteoporosis|Sarcopenia,,Male,Older Adult,,21.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 10, 2020","December 31, 2020"
4877,NCT04399798,Not yet recruiting,No Results Available,Corona Virus Infection,Drug: Baricitinib,All,"Adult, Older Adult",Phase 2,13.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 15, 2020","November 15, 2020"
4878,NCT04391166,Completed,No Results Available,Visual Impairment,Other: Non invasive visual acuity testing,All,"Adult, Older Adult",,108.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 20, 2020","December 1, 2020"
4879,NCT04394403,Recruiting,No Results Available,"Stress|Stress, Psychological",Behavioral: Internet-based guided self-help based on CBT principles,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 14, 2020","June 30, 2022"
4880,NCT04402970,Completed,Has Results,SARS-CoV 2|ARDS,Drug: Dornase Alfa Inhalation Solution,All,"Adult, Older Adult",Phase 3,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 19, 2020","December 31, 2020"
4881,NCT04747132,Completed,No Results Available,Effectiveness,Other: Telegeriatric intervention,All,"Adult, Older Adult",Not Applicable,110.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,"July 20, 2020","November 16, 2020"
4882,NCT04702295,Not yet recruiting,No Results Available,Connective Tissue Diseases|Rare Diseases|Rheumatologic Disorder,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,February 2021,August 2023
4883,NCT04707339,Recruiting,No Results Available,Appendicitis Acute|Covid19,Procedure: Appendicectomy,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 30, 2020","January 30, 2021"
4884,NCT04379518,Recruiting,No Results Available,Malignant Neoplasm|SARS Coronavirus 2 Infection,Biological: Recombinant Interferon Alfa-2b|Drug: Rintatolimod,All,"Adult, Older Adult",Phase 1|Phase 2,44.0,Other|NIH|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"September 4, 2020","September 4, 2021"
4885,NCT04796896,Recruiting,No Results Available,SARS-CoV-2,Biological: mRNA-1273|Biological: Placebo,All,Child,Phase 2|Phase 3,6750.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 15, 2021","June 10, 2023"
4886,NCT04395508,Available,No Results Available,HER2-positive Breast Cancer,Drug: Pertuzumab and Trastuzumab Fixed-Dose Combination for Subcutaneous Administration (PH FDC SC),All,"Adult, Older Adult",,,Industry,Expanded Access:Treatment IND/Protocol,,,
4887,NCT04363632,Completed,No Results Available,Sars-CoV2|Cancer,,All,"Child, Adult, Older Adult",,1231.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 2, 2020","June 30, 2020"
4888,NCT04372043,Not yet recruiting,No Results Available,Sleep Hygiene,Other: Questionnaire,All,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 30, 2020","September 30, 2020"
4889,NCT04742842,Not yet recruiting,No Results Available,SARS-CoV2 COVID-19,Biological: COVIGEN 0.8 mg ID or Placebo ID|Biological: COVIGEN 2.0 mg IM or Placebo IM|Biological: COVIGEN 4.0 mg IM or Placebo IM,All,"Adult, Older Adult",Phase 1,150.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 15, 2021","December 31, 2022"
4890,NCT04638673,Recruiting,No Results Available,Coronavirus|Covid19,Device: Soterix taVNS model 0125-LTE Stimulator - Active-Active Group|Device: Soterix taVNS model 0125-LTE Stimulator - Sham-Active Group,All,"Adult, Older Adult",Phase 2,30.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 19, 2020",June 2021
4891,NCT04442360,Not yet recruiting,No Results Available,Depression|Generalized Anxiety|Health Anxiety,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4892,NCT04458246,Recruiting,No Results Available,Chronic Disease|Chronic Diseases in Adolescence|Chronic Disease of Immune System|Chronic Kidney Diseases,Other: Exercise training group,All,"Child, Adult",Not Applicable,140.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,July 2020,June 2021
4893,NCT04345549,Completed,No Results Available,Flu Like Symptom|Flu Like Illness,Other: Individualised Ayurveda,All,Adult,Not Applicable,18.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"February 26, 2020","March 30, 2020"
4894,NCT04442204,Not yet recruiting,No Results Available,Depression|Anxiety,Other: Prospective study across two time-points examining the impact of viral mitigation protocols on mental health,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4895,NCT04320056,Recruiting,No Results Available,Coronavirus|Pneumonia|Oxygen Toxicity,Other: Standard administration of oxygen flow|Device: Automated oxygen administration - FreeO2,All,"Adult, Older Adult",Not Applicable,216.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 20, 2020","October 31, 2021"
4896,NCT04661540,Recruiting,No Results Available,Pneumonia,Drug: CM4620-IE (Injectable Emulsion)|Drug: Placebo,All,"Adult, Older Adult",Phase 2,36.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"March 2, 2021",June 2021
4897,NCT04394013,Completed,No Results Available,Mental Health Issue,Behavioral: Mindfulness intervention|Behavioral: Non-Mindfulness intervention,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","August 26, 2020","December 31, 2020"
4898,NCT04685681,"Active, not recruiting",No Results Available,Covid19|Risk Reduction|Stress|Sleep,Behavioral: Hiking challenge|Other: Activity list,All,"Adult, Older Adult",Not Applicable,53.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 7, 2021","March 31, 2021"
4899,NCT04346082,Not yet recruiting,No Results Available,Stress,Behavioral: online mindfulness group,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2020","July 30, 2021"
4900,NCT04367636,Recruiting,No Results Available,Rumination|Anxiety|Stress|Depressive Symptoms,Behavioral: Behavioral: OCAT-sham|Behavioral: Behavioral: OCAT|Other: psycho-education video,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"April 30, 2020",September 2021
4901,NCT04417374,Completed,No Results Available,COVID 19|Disease Outbreak|Mental Disorders,Other: Description of groups caracteristics,All,"Adult, Older Adult",,94.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 1, 2020","June 30, 2020"
4902,NCT04442282,Not yet recruiting,No Results Available,Anxiety|Depression|Interpersonal Problem|Emotion Regulation,,All,"Adult, Older Adult",,5041.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4903,NCT04458948,"Active, not recruiting",No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,All,"Adult, Older Adult",Phase 2,10000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 24, 2020","March 24, 2025"
4904,NCT04441476,Completed,No Results Available,Psychological Strain,Other: Questionnaires|Other: psychological and sociological interviews,All,"Adult, Older Adult",,3080.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 21, 2020","December 21, 2020"
4905,NCT04385212,Completed,No Results Available,Coronavirus Infection|Sars-CoV2|Elderly Infection|Old Age; Debility,,All,Older Adult,,230.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 13, 2020","April 14, 2020"
4906,NCT04488796,Completed,No Results Available,Health Behaviour Change,Behavioral: Assigned Strategies: Opt-in|Behavioral: Assigned Strategies: Active Choice|Behavioral: Assigned Strategies: Enhanced Active Choice|Behavioral: Choice of Assignment: Opt-in|Behavioral: Choice of Assignment: Active Choice|Behavioral: Choice of Assignment: Enhanced Active Choice,All,"Adult, Older Adult",Not Applicable,148.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 7, 2020","December 16, 2020"
4907,NCT04443764,Not yet recruiting,No Results Available,Migrants|Anxiety|Depression,,All,"Adult, Older Adult",,287.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
4908,NCT04384419,Recruiting,No Results Available,Mental Disorder|General Population,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"May 29, 2020","June 1, 2021"
4909,NCT04821037,Not yet recruiting,No Results Available,Stress,Behavioral: ACT,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"June 1, 2021","August 1, 2021"
4910,NCT04602312,Recruiting,No Results Available,Catastrophizing Coronavirus (COVID-19),Other: Meditation (1 x 20-minute guided audio training),All,"Adult, Older Adult",Not Applicable,624.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 28, 2020",March 2021
4911,NCT04508868,Terminated,No Results Available,Depression|Depressive Symptoms,Behavioral: Brief Behavioral Activation with Mental Imagery|Behavioral: Minimal Attention Control Intervention,All,Older Adult,Not Applicable,41.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 31, 2020","December 23, 2020"
4912,NCT04425499,Not yet recruiting,No Results Available,Advanced Suturing Skills|Surgical Education,Other: Learning running subcuticular sutures on the Gamified Educational Network,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,June 2020,June 2020
4913,NCT04460014,Recruiting,No Results Available,Intrusive Memories of Traumatic Event(s)|Post Traumatic Stress Disorder,Behavioral: Simple cognitive task intervention|Behavioral: Attention Placebo,All,"Adult, Older Adult",Not Applicable,164.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"September 30, 2020","August 1, 2021"
4914,NCT04592705,Recruiting,No Results Available,COVID-19,Device: Therapeutic plasma exchange,All,"Adult, Older Adult",Phase 1,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,"September 11, 2020","August 30, 2021"
4915,NCT04389684,Recruiting,No Results Available,Chemeotherapy|Immunotherapy|Treatment Mofidied|Coronavirus|Quality of Life,Other: Psycho-Social Questionnaire,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 27, 2020","July 27, 2021"
4916,NCT04353245,Not yet recruiting,No Results Available,COVID19|Corona Virus Infection|Myocardial Injury|Pneumonia,Other: BIOMARKERS IN THE LONG TERM IMPACT OF CORONAVIRUS INFECTION IN THE CARDIORRESPIRATORY SYSTEM,All,"Adult, Older Adult",,130.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 1, 2020","September 30, 2021"
4917,NCT04618835,Recruiting,No Results Available,Covid19|Medical Emergencies,Diagnostic Test: 40-Steps-test,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 11, 2021","November 3, 2021"
4918,NCT04516668,Not yet recruiting,No Results Available,Post Partum Depression,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,November 2020,November 2020
4919,NCT04690400,Not yet recruiting,No Results Available,"Fibromyalgia|Fibromyalgia, Primary",Other: Experimental: Active care group|Other: Active Comparator: Self-care group,Female,Adult,Not Applicable,28.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 18, 2021","April 30, 2021"
4920,NCT04559074,Recruiting,No Results Available,Hypertension,Drug: Amlodipine,All,"Adult, Older Adult",Phase 4,1000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 23, 2020","July 31, 2021"
4921,NCT04295551,Not yet recruiting,No Results Available,COVID-19,Drug: Lopinavir / ritonavir tablets combined with Xiyanping injection|Drug: Lopinavir/ritonavir treatment,All,"Adult, Older Adult",Not Applicable,80.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 14, 2020","April 14, 2021"
4922,NCT04336410,"Active, not recruiting",No Results Available,Coronavirus Infection,Drug: INO-4800|Device: CELLECTRA® 2000,All,"Adult, Older Adult",Phase 1,120.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 3, 2020",January 2022
4923,NCT04426071,Recruiting,No Results Available,Brain Injuries|Stroke|Spinal Cord Injuries,,All,"Adult, Older Adult",,142.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020",December 2021
4924,NCT04479345,Not yet recruiting,No Results Available,"Knowledge, Attitudes, Practice",Other: Questionnaire,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,July 2020,September 2020
4925,NCT04844697,Not yet recruiting,No Results Available,Multiple Osteochondroma|Osteogenesis Imperfecta|Ollier Disease|Maffucci Syndrome,,All,"Child, Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,December 2021
4926,NCT04344106,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,All,"Adult, Older Adult",Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 1, 2020","May 1, 2020"
4927,NCT04488471,Recruiting,No Results Available,Inflammatory Bowel Diseases,,All,"Child, Adult, Older Adult",,232.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 30, 2020","June 30, 2022"
4928,NCT04513847,Completed,No Results Available,Psoriasis|Covid19,,All,"Child, Adult, Older Adult",,661.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"August 13, 2020","October 6, 2020"
4929,NCT04751682,"Active, not recruiting",No Results Available,SARS-CoV Infection,Biological: BBV154 Vaccine,All,Adult,Phase 1,175.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 1, 2021","November 30, 2021"
4930,NCT04621084,Recruiting,No Results Available,Nutrition,Behavioral: Eating habits,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 1, 2020","December 31, 2025"
4931,NCT04781400,Recruiting,No Results Available,HIV Infections|Covid19|Health Care Utilization|Gender-based Violence,Behavioral: Mobile phone support|Behavioral: Remote service delivery model,All,"Child, Adult",Not Applicable,600.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"February 8, 2021","February 8, 2022"
4932,NCT04754698,Recruiting,No Results Available,Rheumatic Disease|HIV Infections|AIDS|Safety Issues|Immunogenicity|COVID-19,Biological: CoronaVac,All,"Adult, Older Adult",Phase 4,2067.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 9, 2021",March 2023
4933,NCT04367168,Recruiting,No Results Available,COVID,Drug: Colchicine|Drug: Placebo oral tablet,All,"Adult, Older Adult",Phase 2,174.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 27, 2020","April 27, 2021"
4934,NCT04444297,Not yet recruiting,No Results Available,"Telemedicine|Surgery, Plastic",Other: 3D Telemedicine|Other: 2D Telemedicine,All,"Child, Adult, Older Adult",Not Applicable,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other","July 31, 2020","January 31, 2021"
4935,NCT04640194,Recruiting,No Results Available,Acute Respiratory Distress Syndrome,Drug: Alteplase|Procedure: Standard of care,All,"Adult, Older Adult",Phase 2|Phase 3,270.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 16, 2020","September 1, 2022"
4936,NCT04388826,"Active, not recruiting",No Results Available,"Respiratory Distress Syndrome, Adult",Drug: Veru-111,All,"Adult, Older Adult",Phase 2,40.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 18, 2020","May 8, 2021"
4937,NCT04623346,"Active, not recruiting",No Results Available,Ankle Fractures|Proximal Humeral Fracture|Wrist Fracture,Procedure: Observation for study group,All,Older Adult,,262.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 11, 2020","December 1, 2020"
4938,NCT04371250,"Active, not recruiting",No Results Available,"Resilience, Psychological|Loneliness|Youth|Surveys and Questionnaires",Other: Survey and Questionnaire,All,Adult,,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 30, 2020","December 30, 2020"
4939,NCT04540939,Recruiting,No Results Available,Trauma,Behavioral: Mindfulness-Based Cognitive Therapy|Behavioral: Muscle Relaxation Therapy,All,"Adult, Older Adult",Not Applicable,60.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 19, 2020",December 2021
4940,NCT04633772,Recruiting,No Results Available,"Infection, Coronavirus|Respiratory Failure",Drug: Angiotensin-(1-7)|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 1|Phase 2,130.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 5, 2020","February 28, 2021"
4941,NCT04280224,Recruiting,No Results Available,Novel Coronavirus Pneumonia,Biological: NK Cells,All,"Adult, Older Adult",Phase 1,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 15, 2020","December 30, 2022"
4942,NCT04811352,Recruiting,No Results Available,"Substance Abuse|Stress, Psychological",,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 1, 2021","June 1, 2021"
4943,NCT04372030,Not yet recruiting,No Results Available,Health Care Utilization,Other: Online questionnaire,All,"Adult, Older Adult",Not Applicable,10000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 1, 2020","October 31, 2021"
4944,NCT04453514,Recruiting,No Results Available,Anxiety,Behavioral: Trauma-informed yoga video recording,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"July 21, 2020",October 2020
4945,NCT04679493,"Active, not recruiting",No Results Available,Covid19|Healthy Volunteers,Drug: XC7 100 mg single|Drug: XC7 200 mg single|Drug: Placebo single|Drug: XC7 200 mg multiple|Drug: Placebo multiple,Male,Adult,Phase 1,16.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 24, 2020",April 2021
4946,NCT04365972,Completed,No Results Available,Anxiety,Behavioral: Attention Bias Modification (ABM),All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 23, 2020","April 30, 2020"
4947,NCT04315480,"Active, not recruiting",No Results Available,SARS Pneumonia,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 2,38.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 12, 2020",May 2020
4948,NCT04480957,Recruiting,No Results Available,SARS-CoV-2,Biological: ARCT-021 Dose 1|Biological: ARCT-021 Dose 2|Biological: ARCT-021 Dose 3|Biological: ARCT-021 Dose 4|Biological: ARCT-021 Dose Regimen 1|Biological: ARCT-021 Dose Regimen 2|Other: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,92.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","August 4, 2020",January 2021
4949,NCT04392115,Not yet recruiting,No Results Available,Comorbidities and Coexisting Conditions|Social Isolation,Behavioral: The PREPARE program,All,Older Adult,Not Applicable,372.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"June 15, 2020","September 15, 2021"
4950,NCT04382508,Enrolling by invitation,No Results Available,"Immune Suppression|Immune Deficiency|Infection|COVID|Children, Adult",Other: Questionnaire,,"Child, Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 22, 2020","March 21, 2021"
4951,NCT04810949,Terminated,No Results Available,Covid19|Influenza A|Influenza B|H1N1 Influenza,Dietary Supplement: Vitamine D3 supplementation|Dietary Supplement: Diet and sun exposure,All,"Adult, Older Adult",Not Applicable,41.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 5, 2020","March 1, 2021"
4952,NCT04425616,Recruiting,No Results Available,Cancer|COVID,Other: Exercise|Behavioral: Psychological and Behaviour Change Support|Other: Nutrition,All,"Adult, Older Adult",Not Applicable,1100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 4, 2020","November 30, 2022"
4953,NCT04282135,Completed,No Results Available,Influenza,Diagnostic Test: MCC IMS,All,"Adult, Older Adult",,76.0,Industry,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"February 15, 2020","June 30, 2020"
4954,NCT04751227,Completed,No Results Available,Critical Illness|COVID-19|Cognitive Dysfunction,Drug: Modafinil,All,"Adult, Older Adult",,8.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"November 22, 2020","January 30, 2021"
4955,NCT04341584,Completed,No Results Available,Corona Virus Infection,Drug: Anakinra,All,"Adult, Older Adult",Phase 2,161.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 8, 2020","July 25, 2020"
4956,NCT04739462,Recruiting,No Results Available,Pregnancy Complications|Birth Injuries,Behavioral: mHealth Platform,Female,"Adult, Older Adult",Not Applicable,248.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 3, 2021",February 2022
4957,NCT04519437,"Active, not recruiting",No Results Available,Healthy|Chronic Stable Illness,Drug: REGN10933+REGN10987|Drug: Placebo,All,"Adult, Older Adult",Phase 1,974.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 26, 2020","October 25, 2021"
4958,NCT04621058,Recruiting,No Results Available,SAR|SARS Pneumonia,Drug: Vitamin D|Drug: PLACEBO,All,"Child, Adult, Older Adult",Phase 3,108.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 9, 2020","November 30, 2021"
4959,NCT04548934,Completed,No Results Available,Cardiopulmonary Resuscitation|Personal Protective Equipment,Device: Personal protective equipment (PPE)|Device: No Personal protective equipment (PPE),All,Adult,Not Applicable,34.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 13, 2020","January 31, 2021"
4960,NCT04486729,Recruiting,No Results Available,"Covid19|ARDS, Human",Other: High PEEP with end inspiratory pause|Other: Low PEEP - FiO2 high|Other: High PEEP without end inspiratory pause|Other: Low PEEP - FiO2 low,All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"July 1, 2020","October 20, 2020"
4961,NCT04435379,"Active, not recruiting",No Results Available,"Infection, Respiratory Tract",Biological: VPM1002|Biological: Placebo,All,"Adult, Older Adult",Phase 3,2038.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 18, 2020","September 30, 2021"
4962,NCT04407663,Completed,No Results Available,Bariatric Surgery Candidate|Patient Underwent Bariatric Surgery,Other: Telemedicine to remote outpatient visit in bariatric patient,All,"Adult, Older Adult",,138.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 3, 2020","May 4, 2020"
4963,NCT04369690,Recruiting,No Results Available,COVID-19|Chronic Disease|Psychiatric Disorder|Cardiovascular Diseases,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 3, 2020","April 3, 2021"
4964,NCT04492527,Recruiting,No Results Available,"Chronic Disease|Aging|Aging Problems|Health Behavior|Multiple Chronic Conditions|Chronic Illness|Chronic Illnesses, Multiple|Healthy Lifestyle|Healthy Aging|Aging Well|Healthy Life Style|Self-management|Self Care",Behavioral: Telehealth coaching sessions,All,Older Adult,Not Applicable,75.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 28, 2020","July 31, 2021"
4965,NCT04393077,Completed,No Results Available,"Stress|Anxiety|Burnout, Caregiver",Behavioral: Emotional Freedom Technique,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"May 10, 2020","May 20, 2020"
4966,NCT04423042,Not yet recruiting,No Results Available,Covid19|COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Coronavirus|Inflammation,Biological: Tocilizumab,All,"Adult, Older Adult",Phase 3,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 30, 2020",June 2021
4967,NCT04693689,Recruiting,No Results Available,Trust,Other: RNA vaccine|Other: 20% adoption rate|Other: 40% adoption rate|Other: 60% adoption rate|Other: 80% adoption rate|Other: Conventional vaccine|Other: 0% adoption rate,All,"Adult, Older Adult",Not Applicable,32400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,"February 1, 2021","March 30, 2021"
4968,NCT04386291,Recruiting,No Results Available,Generalized Anxiety|Health Anxiety,Behavioral: Anxiety Reduction Training|Behavioral: Kundalini Yoga and Anxiety Reduction Training|Behavioral: Meditation and Anxiety Reduction Training,All,"Adult, Older Adult",Not Applicable,360.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 25, 2020","January 30, 2022"
4969,NCT04341012,Recruiting,No Results Available,Liver Diseases|Liver Cancer|COVID19,Diagnostic Test: Collection of breath sample,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 10, 2019","December 31, 2021"
4970,NCT04388644,Recruiting,No Results Available,Corona Virus Infection,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"February 20, 2020","May 30, 2020"
4971,NCT04337983,Recruiting,No Results Available,Coronavirus|SARS-CoV-2|COVID-19|Acute Respiratory Distress Syndrome|Shock|Acute Circulatory Failure|Left Ventricular Dysfunction|Fluid Overload,Device: Transpulmonary thermodilution|Device: Echocardiography,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 13, 2020",April 2021
4972,NCT04603651,No longer available,No Results Available,COVID-19,Drug: Bamlanivimab,All,"Child, Adult, Older Adult",,,Industry|Other,Expanded Access:Individual Patients,,,
4973,NCT04639349,Recruiting,No Results Available,Chronic Obstructive Pulmonary Disease,Behavioral: exercise group|Other: control group,Male,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","November 19, 2020","March 1, 2021"
4974,NCT03226886,Recruiting,No Results Available,Renal Cell Carcinoma|Cancer|Healthy Volunteers,,All,"Adult, Older Adult",,360.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 5, 2012","September 1, 2023"
4975,NCT04322773,Terminated,No Results Available,Corona Virus Disease,Drug: RoActemra iv|Drug: RoActemra sc|Drug: Kevzara sc|Other: Standard medical care,All,"Adult, Older Adult",Phase 2,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 5, 2020","October 8, 2020"
4976,NCT04702178,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Biological: COVAC-2|Biological: Saline Placebo,All,"Adult, Older Adult",Phase 1,108.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","February 10, 2021",February 2023
4977,NCT04426318,Completed,No Results Available,Anxiety|Depression|Psychological Stress|Psychological Distress|Well-being,Behavioral: Healthy Minds Program Foundations Training,All,"Adult, Older Adult",Not Applicable,733.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"June 14, 2020","January 12, 2021"
4978,NCT04679909,Recruiting,No Results Available,Healthy Volunteers,Biological: AdCOVID|Other: Placebo,All,Adult,Phase 1,180.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention",February 2021,February 2022
4979,NCT04255940,Recruiting,No Results Available,Cardiovascular Death; Major Adverse Cardiovascular Events,,All,"Child, Adult, Older Adult",,12000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"January 20, 2020","April 30, 2020"
4980,NCT04371601,"Active, not recruiting",No Results Available,COVID-19 Pneumonia,Drug: Oseltamivir|Drug: hormones|Device: oxygen therapy|Procedure: mesenchymal stem cells,All,"Adult, Older Adult",Early Phase 1,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 1, 2020","December 31, 2022"
4981,NCT04323527,Completed,No Results Available,SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia,Drug: Chloroquine diphosphate,All,"Adult, Older Adult",Phase 2,278.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 23, 2020","June 7, 2020"
4982,NCT04749173,Recruiting,No Results Available,Covid19,Drug: DWRX2003,All,Adult,Phase 1,24.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 21, 2020","June 30, 2021"
4983,NCT04607915,Not yet recruiting,No Results Available,Type 2 Diabetes,Behavioral: Intervention for TECC Model,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"February 5, 2021","March 31, 2021"
4984,NCT04781218,Not yet recruiting,No Results Available,COVID19,,All,"Child, Adult, Older Adult",,1000000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 15, 2021","March 15, 2026"
4985,NCT04460599,Recruiting,No Results Available,Encephalitis,Other: Observation,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 8, 2020","September 30, 2020"
4986,NCT04656626,Completed,No Results Available,"Stress, Psychological",Behavioral: brief mindfulness based intervention|Behavioral: Progressive muscle relaxation,All,"Adult, Older Adult",Not Applicable,146.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","July 7, 2020","September 5, 2020"
4987,NCT04480606,Not yet recruiting,No Results Available,Exercise Program,Behavioral: Home exercise program,All,Older Adult,Not Applicable,88.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"August 1, 2020","November 20, 2020"
4988,NCT04311398,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: New QIAstat-Dx fully automatic multiple PCR detection platform,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 13, 2020","December 1, 2020"
4989,NCT04578210,Recruiting,No Results Available,Corona Virus Infection,Biological: T memory cells and NK cells,All,"Child, Adult, Older Adult",Phase 1|Phase 2,58.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 4, 2020",March 2021
4990,NCT04747990,Not yet recruiting,No Results Available,Acute Pancreatitis|Acute Pancreatic Necrosis|Acute Pancreatitis Due to Gallstones|Acute Pancreatic Fluid Collection|Acute Pancreatitis With Infected Necrosis|Acute Pancreatitis Without Necrosis or Infection|Acute Pancreatitis Due to Common Bile Duct Calculus|Acute Pancreatitis Recurrent|Acute Pancreatitis Without Necrosis or Infection (Diagnosis)|Covid19,Procedure: Early Definitive Treatment,All,"Child, Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2021","September 1, 2021"
4991,NCT04393636,Recruiting,No Results Available,Cardiovascular Diseases|Cardiovascular Risk Factor,Other: Digital cardiac Counseling,All,"Adult, Older Adult",Not Applicable,394.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 5, 2020","December 31, 2022"
4992,NCT04408196,Completed,No Results Available,Rehabilitation,,All,"Adult, Older Adult",,121.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 26, 2020","February 22, 2021"
4993,NCT04333251,Not yet recruiting,No Results Available,"Pneumonia, Interstitial",Biological: high-titer anti-Sars-CoV-2 plasma|Other: oxygen therapy,All,"Adult, Older Adult",Phase 1,115.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","December 31, 2022"
4994,NCT04644172,Recruiting,No Results Available,Covid-19|Cognitive Impairment,Behavioral: Speed of Processing Training|Behavioral: Instrumental Activities of Daily Living Shaping|Behavioral: Transfer Package from CI Therapy|Other: Usual Care,All,"Adult, Older Adult",Phase 1|Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"November 1, 2020",November 2024
4995,NCT04760795,Recruiting,No Results Available,Psychiatric Disorder|Aging,Other: PTSD Check List (PCL) scale|Other: Brief COPE scale|Other: GAD-7 (Generalized Anxiety Disorder) scale (during containment)|Other: Analog scale|Other: GAD-7 (Generalized Anxiety Disorder) scale (post containment)|Other: Big Five Inventory (BFI) scale|Other: Relationship Scales Questionnaire (RSQ),All,Older Adult,,118.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"November 15, 2020",June 2021
4996,NCT04821986,Not yet recruiting,No Results Available,SARS-CoV Infection,,All,Adult,,600.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"April 1, 2021","June 15, 2021"
4997,NCT04617262,Recruiting,No Results Available,Depression|Anxiety Disorders|Psychological Distress,Behavioral: Remote Problem Management Plus,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 5, 2021",September 2021
4998,NCT04569266,Recruiting,No Results Available,Dyspnea,Other: specific exercise rehabilitation treatment,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 7, 2020","May 7, 2022"
4999,NCT04473300,Recruiting,No Results Available,Critical Illness|ARDS,,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 11, 2020","August 31, 2020"
5000,NCT04344184,Recruiting,No Results Available,"COVID-19|Lung Injury, Acute|Kidney Injury",Drug: L-ascorbic acid|Other: Placebo,All,"Adult, Older Adult",Phase 2,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 18, 2020",May 2021
5001,NCT04721444,Recruiting,No Results Available,Lung Cancer|Covid19|Pneumonitis,Diagnostic Test: Machine Learning Classification of parenchymal lung change cause|Diagnostic Test: Machine Learning Classification of recurrence and non-recurrence,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 1, 2021","January 1, 2023"
5002,NCT04061382,Recruiting,No Results Available,Serogroup C Meningococcal Meningitis|Diphtheria|COVID-19,Procedure: Venepuncture|Procedure: Oral fluid swab,All,"Child, Adult",,2800.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"October 15, 2019","June 30, 2021"
5003,NCT04416919,"Active, not recruiting",No Results Available,Coronavirus Infection|Disease Prevention,Other: Assembled mask,All,"Adult, Older Adult",Not Applicable,20.0,Other|U.S. Fed,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"May 20, 2020","July 1, 2021"
5004,NCT04342702,"Active, not recruiting",No Results Available,Follow-up|COVID-19|Infectious Diseases|Respiratory,,All,"Child, Adult, Older Adult",,504.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 16, 2020",March 2021
5005,NCT04424355,Recruiting,No Results Available,Coronavirus Infections|Pneumonia,Diagnostic Test: Chest MRI,All,"Adult, Older Adult",,115.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 19, 2020","December 20, 2021"
5006,NCT04535778,Recruiting,No Results Available,Treatment of Illness-related Distress in Physical LTCs,Behavioral: COMPASS|Behavioral: Standard charity resources,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"November 16, 2020","June 1, 2021"
5007,NCT04357340,Completed,No Results Available,Covid-19|Pneumonia|SARS Pneumonia,Other: Pulmonary Physiotherapy Techniques,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 2, 2020","May 30, 2020"
5008,NCT04361552,Withdrawn,No Results Available,Cerebrovascular Accident|Chronic Obstructive Pulmonary Disease|Chronic Renal Failure|Coronary Artery Disease|Diabetes Mellitus|Malignant Neoplasm|SARS Coronavirus 2 Infection,Other: Best Practice|Biological: Tocilizumab,All,"Adult, Older Adult",Phase 3,0.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 7, 2020","June 2, 2020"
5009,NCT04427631,Not yet recruiting,No Results Available,"Hearing Impaired Children|Glue Ear|Hearing Loss, Conductive",Device: Bone conduction headphones,All,Child,Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 22, 2020","June 1, 2021"
5010,NCT04347031,Completed,No Results Available,"Pneumonia, Viral|Respiratory Failure",Drug: Mefloquine|Drug: Hydroxychloroquine|Combination Product: Mefloquine + azithromycin + / - tocilizumab|Combination Product: Hydroxychloroquine + azithromycin + / - tocilizumab,All,Adult,Phase 2|Phase 3,320.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 8, 2020","November 20, 2020"
5011,NCT04389580,Not yet recruiting,No Results Available,COVID-19,Drug: Drug: Isotretinoin plus Tamoxifen|Drug: Aerosolized Isotretinoin plus Tamoxifen,All,"Adult, Older Adult",Phase 2,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2020,September 2020
5012,NCT04380701,Recruiting,No Results Available,"Infections, Respiratory|Virus Diseases|Infection Viral|Vaccine Adverse Reaction|RNA Virus Infections|Protection Against COVID-19 and Infections With SARS CoV 2",Biological: BNT162a1|Biological: BNT162b1|Biological: BNT162b2|Biological: BNT162c2,All,"Adult, Older Adult",Phase 1|Phase 2,456.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 23, 2020",April 2023
5013,NCT04665778,Recruiting,No Results Available,Covid19|Emergencies,Other: hospital bedroom booking,All,"Adult, Older Adult",,1516.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"December 4, 2020",March 2021
5014,NCT04615195,Recruiting,No Results Available,Post Traumatic Stress Disorder,Other: cries 13 questionnaire,All,Child,,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 10, 2020","November 30, 2020"
5015,NCT04419545,Recruiting,No Results Available,Radiology|Artificial Intelligence,Diagnostic Test: Neural network diagnosis algorithm,All,"Child, Adult, Older Adult",,2500.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"March 24, 2020","March 31, 2021"
5016,NCT04400279,Completed,No Results Available,Depressive Symptomatology|Psychological Distress|Health Behavior,Behavioral: Yoga group|Behavioral: High Intensity Interval Training group|Behavioral: Combination,All,Adult,Not Applicable,334.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","June 1, 2020","November 28, 2020"
5017,NCT04542538,"Active, not recruiting",No Results Available,"Sepsis|Corona Virus Infection|ARDS, Human","Other: No intervention, observational study",All,"Adult, Older Adult",,15000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"April 11, 2018","December 10, 2020"
5018,NCT04376034,Recruiting,No Results Available,COVID19|Coronavirus Infection|Coronavirus|Virus Diseases|RNA Virus Infections,Biological: Convalescent Plasma 1 Unit|Biological: Convalescent Plasma 2 Units|Other: Standard of Care,All,"Child, Adult, Older Adult",Phase 3,240.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 16, 2020","March 30, 2021"
5019,NCT02788903,"Active, not recruiting",No Results Available,Obesity|Diabetes|Covid19,Other: Weight Counseling|Other: Telemedicine,All,"Adult, Older Adult",,2000000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,March 2016,May 2021
5020,NCT04514705,Recruiting,No Results Available,Coronavirus Infection,Other: Exercise,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 11, 2020","December 31, 2021"
5021,NCT04480112,Enrolling by invitation,No Results Available,Memory Disorders|Alzheimer Disease|Mild Cognitive Impairment,Behavioral: Technology based social interactions|Other: No research related technology based social interactions,All,"Child, Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"June 2, 2020",May 2021
5022,NCT04762693,Recruiting,No Results Available,Covid19|Cough,Device: Hyfe cough tracker,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 11, 2020","November 1, 2021"
5023,NCT04448054,Recruiting,No Results Available,"Estimate, With the Contribution of Optimized MRI, the Prevalence of Neurological and Neurovascular Manifestations on Imaging in the Event of SARS-CoV-2",Other: MRI,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 20, 2020","November 20, 2021"
5024,NCT04799132,Completed,No Results Available,"Covid19|Obesity|Overweight|Pneumonia, Viral",,All,"Adult, Older Adult",,303.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"March 11, 2020","March 1, 2021"
5025,NCT04427813,Not yet recruiting,No Results Available,Sexual Behavior,Behavioral: questionaire to husband and wife,All,Adult,,400.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 11, 2020","July 12, 2020"
5026,NCT04385576,Recruiting,No Results Available,COVID-19|Airway,Device: Aerosol Box|Device: Intubation Box,All,"Child, Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"May 15, 2020","December 30, 2020"
5027,NCT04264533,Terminated,No Results Available,"Vitamin C|Pneumonia, Viral|Pneumonia, Ventilator-Associated",Drug: VC|Drug: Sterile Water for Injection,All,"Adult, Older Adult",Phase 2,56.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","February 14, 2020","March 29, 2020"
5028,NCT04348227,"Active, not recruiting",No Results Available,Ventilator Associated Pneumonia,Behavioral: Enhanced hygiene measures,All,"Child, Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 1, 2019","February 4, 2021"
5029,NCT04424836,Completed,No Results Available,"Coronavirus Infection|Pneumonia, Viral|Acute Respiratory Failure",Device: high flow nasal cannula device,All,"Adult, Older Adult",,43.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"May 15, 2020","June 5, 2020"
5030,NCT04516564,Recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19),Drug: AK119|Drug: Placebo,All,Adult,Phase 1,32.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Other",September 2020,April 2021
5031,NCT04429594,Recruiting,No Results Available,Coronavirus Infections,Other: blood sampling,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"July 28, 2020","December 31, 2025"
5032,NCT04308187,Not yet recruiting,No Results Available,"Stress, Psychological",,All,"Child, Adult, Older Adult",,50000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 11, 2020",March 2022
5033,NCT04632082,Enrolling by invitation,No Results Available,Mental Health Wellness 1|COVID|Emotional Distress|Depressive Symptoms|Anxiety Symptoms|Irritability|Telepsychotherapy,Behavioral: Telepsychoeducation with personalized videos|Behavioral: Telepsychoeducation without personalized videos,All,"Child, Adult, Older Adult",Not Applicable,2200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 5, 2020","July 20, 2021"
5034,NCT04678778,Recruiting,No Results Available,Healthy Aging,Behavioral: Physical and Cognitive Activity,All,"Adult, Older Adult",Not Applicable,11.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 19, 2019","February 17, 2021"
5035,NCT04379531,Completed,No Results Available,Pneumonia|Coronavirus Infection,Diagnostic Test: Low-dose Chest CT,All,"Adult, Older Adult",Not Applicable,230.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"April 25, 2020","May 22, 2020"
5036,NCT04532632,Completed,No Results Available,Smell Disorder|Taste Disorders|Coronavirus Infection,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"September 1, 2020","October 9, 2020"
5037,NCT04337047,Completed,No Results Available,"Stress, Psychological",Other: questionnaire assesment,All,"Adult, Older Adult",,2000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 31, 2020","May 3, 2020"
5038,NCT04734912,Recruiting,No Results Available,Endoscopy,Other: gastroscopy in transnasal techique,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"January 13, 2021","December 31, 2021"
5039,NCT04730284,Recruiting,No Results Available,Coronavirus,Other: Health supplements,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"August 25, 2020","March 31, 2022"
5040,NCT04766333,Not yet recruiting,No Results Available,Covid19|Health Care Seeking Behavior|Health Behavior,Behavioral: Healthcare Worker Focused Outreach|Behavioral: Community Organization Led Outreach,All,"Child, Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,March 2021,August 2022
5041,NCT04522492,"Active, not recruiting",No Results Available,Skin Picking,Behavioral: Internet-based Cognitive Behavioral Therapy|Other: Quality of life promotion,All,"Adult, Older Adult",Not Applicable,18.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"August 11, 2020",June 2021
5042,NCT04510519,Not yet recruiting,No Results Available,Major Depressive Disorder|Generalized Anxiety,,All,"Adult, Older Adult",,50.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","June 30, 2021"
5043,NCT04661423,Not yet recruiting,No Results Available,Post ICU Rehabilitation,Other: Remote Automated Monitoring System,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,January 2021,June 2022
5044,NCT04451694,Recruiting,No Results Available,Covid-19,Other: nutritional intervention,All,"Child, Adult, Older Adult",,800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","November 30, 2020"
5045,NCT04148430,Recruiting,No Results Available,B Cell ALL|B-Cell Lymphoma|B-cell Non Hodgkin Lymphoma,Drug: Anakinra,All,"Adult, Older Adult",Phase 2,90.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 30, 2019",October 2022
5046,NCT04341727,Suspended,No Results Available,Coronavirus Infection,Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Chloroquine Sulfate,All,"Adult, Older Adult",Phase 3,500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 4, 2020","August 1, 2021"
5047,NCT04498546,Recruiting,No Results Available,Exercise Test,,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"July 20, 2020","September 30, 2021"
5048,NCT04377607,Recruiting,No Results Available,Corona Virus Infection,Other: File scanning,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"November 1, 2020","December 30, 2020"
5049,NCT04817657,No longer available,No Results Available,Healthy,Biological: Ad26.COV2.S,,"Child, Adult, Older Adult",,,Industry,Expanded Access:Individual Patients,,,
5050,NCT04431297,Not yet recruiting,No Results Available,Chronic Stress,Other: Mindfulness Rounds,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 1, 2021",June 2022
5051,NCT04706299,Recruiting,No Results Available,Prevention of COVID-19,Other: Resistance Exercise,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 12, 2021","April 1, 2021"
5052,NCT04475484,Recruiting,No Results Available,Investigating Psychological Impact|Confinement Measures|Coronavirus Outbreak|School-age Children,Other: Online questionnaire,All,"Child, Adult",,30000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"June 10, 2020","December 31, 2020"
5053,NCT04447209,Recruiting,No Results Available,Dietary Diversity,"Other: Dietary counselling on Food Groups according to IYC Feeding practices, WHO",All,Child,,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 6, 2020","May 31, 2021"
5054,NCT04839146,Recruiting,No Results Available,Covid19|Severe Acute Respiratory Syndrome|SARS-CoV-2 Infection,Biological: ABNCoV2 Vaccine,All,Adult,Phase 1,42.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 11, 2021","December 20, 2021"
5055,NCT04260594,Not yet recruiting,No Results Available,2019-nCoV,Drug: Arbidol|Other: basic treatment,All,"Adult, Older Adult",Phase 4,380.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 7, 2020","December 30, 2020"
5056,NCT04409275,Recruiting,No Results Available,Pulmonary Fibrosis,,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 21, 2020","July 31, 2021"
5057,NCT04362059,Recruiting,No Results Available,Respiratory Infections,Device: COVSurf Drug Delivery System|Other: Standard of Care,All,"Adult, Older Adult",Not Applicable,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 18, 2020","November 16, 2021"
5058,NCT04433312,Not yet recruiting,No Results Available,"Satisfaction, Patient|Quality of Life",Other: Questionnaire,All,"Child, Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"July 1, 2020","December 1, 2020"
5059,NCT04360850,Recruiting,No Results Available,Online Therapy,Behavioral: online survey,All,"Adult, Older Adult",,10000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"April 24, 2020",October 2025
5060,NCT04558411,Recruiting,No Results Available,Emotional Regulation|Affect,Behavioral: Dialectical Behavioral Therapy (DBT) Skills,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 12, 2020","December 15, 2020"
5061,NCT04666493,Recruiting,No Results Available,Autism Spectrum Disorder,"Other: Cognitive behavior therapy (CBT), specifically using the Facing Your Fears (FYF) curriculum",All,Child,Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 4, 2020","November 30, 2021"
5062,NCT04456062,Recruiting,No Results Available,Psychiatric Hospitalization,Other: Caring Contacts,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"August 4, 2020",March 2021
5063,NCT04410536,Recruiting,No Results Available,"Migraine, Hemicrania",Drug: Symptomatic drugs|Drug: Bridge therapy|Behavioral: Mindfulness program,All,"Adult, Older Adult",Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 15, 2020",July 2022
5064,NCT04801667,Not yet recruiting,No Results Available,SARS-CoV Infection|Coronavirus Infection|Vaccine Adverse Reaction,Biological: Coronavac,All,"Adult, Older Adult",Phase 4,3780.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"March 20, 2021","March 1, 2022"
5065,NCT04822285,Completed,No Results Available,Psychological Distress|Resilience,Behavioral: Psychological Triaging Intervention|Behavioral: Routine psychological support,All,"Child, Adult, Older Adult",Not Applicable,64.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"January 22, 2020","March 21, 2021"
5066,NCT04597216,Recruiting,No Results Available,Covid19,Device: sample of blood and saliva,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"October 15, 2020","December 31, 2021"
5067,NCT04436276,"Active, not recruiting",No Results Available,Healthy,Biological: Ad26.COV2.S|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,1085.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","July 15, 2020","February 2, 2024"
5068,NCT04519216,Recruiting,No Results Available,"Breastfeeding|Breastfeeding, Exclusive|Breastfeeding Jaundice|Educational Problems",Behavioral: Telesimulation,All,"Adult, Older Adult",Not Applicable,39.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"July 31, 2020","September 30, 2021"
5069,NCT04357106,Recruiting,No Results Available,COVID-19,Biological: Convalescent plasma,All,"Adult, Older Adult",Phase 2,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 13, 2020",August 2020
5070,NCT04691180,Recruiting,No Results Available,COVID-19,Drug: BRII-196 and BRII-198|Drug: Placebo,All,Adult,Phase 1,24.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"January 5, 2021",August 2021
5071,NCT04409197,Completed,No Results Available,Comorbidities|Confinement|Obesity,,All,"Adult, Older Adult",,4789.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 8, 2020","July 11, 2020"
5072,NCT04382378,Recruiting,No Results Available,Mechanical Ventilation Complication|Muscle Weakness Condition|Covid19,Device: neuromuscular electrical stimulation,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"February 1, 2021","December 31, 2021"
5073,NCT04479644,Completed,No Results Available,COVID-19,Drug: BRII-198|Drug: Placebo,All,Adult,Phase 1,17.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"July 13, 2020","February 3, 2021"
5074,NCT04479631,Completed,No Results Available,COVID-19,Drug: BRII-196|Drug: Placebo,All,Adult,Phase 1,16.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"July 12, 2020","January 29, 2021"
5075,NCT04786080,Not yet recruiting,No Results Available,Child Behavior Problem|Mental Health Issue,Behavioral: Parent Positive,All,"Adult, Older Adult",Not Applicable,616.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 15, 2021","November 30, 2021"
5076,NCT04513561,Completed,No Results Available,Inflammatory Disease|Covid19,,All,"Adult, Older Adult",,921.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 21, 2020","August 27, 2020"
5077,NCT04779450,Recruiting,No Results Available,Breast Cancer,Other: Kinesiotherapy protocol|Other: Usual orientations,Female,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",March 2021,December 2021
5078,NCT04528329,Recruiting,No Results Available,Covid19|Anosmia,Drug: Early-Dexamethasone|Drug: Late dexamethazone,All,"Adult, Older Adult",Phase 4,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 30, 2020","April 15, 2021"
5079,NCT04386720,Recruiting,No Results Available,Acute Respiratory Distress Syndrome,,All,"Adult, Older Adult",,20.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"May 25, 2020","May 25, 2021"
5080,NCT04368832,"Active, not recruiting",No Results Available,Pregnancy Related|COVID,Other: Remote consultation,Female,"Adult, Older Adult",,108.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 25, 2020","September 30, 2021"
5081,NCT04728243,Not yet recruiting,No Results Available,Knowledge|Attitudes|Practices,Other: WHO QualityRights e-training|Other: WHO COVID-19 online training,All,"Adult, Older Adult",Not Applicable,216.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other",February 2021,February 2022
5082,NCT04338009,Completed,Has Results,COVID-19,Other: Discontinuation of ARB/ACEI|Other: Continuation of ARB/ACEI,All,"Adult, Older Adult",Not Applicable,152.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"March 31, 2020","August 20, 2020"
5083,NCT04453657,Enrolling by invitation,No Results Available,"Stress, Psychological|Child Behavior|Social Competence",Device: FamilyChildCare (provisional name of app),All,"Child, Adult, Older Adult",Not Applicable,270.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"February 4, 2021",September 2021
5084,NCT04837755,Recruiting,No Results Available,Covid19,Diagnostic Test: Cytokine measurements,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 1, 2020","December 31, 2025"
5085,NCT04681261,Completed,No Results Available,Covid19,Other: this study is not an intervention study,All,"Adult, Older Adult",,699.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"May 4, 2020","June 4, 2020"
5086,NCT04559542,Recruiting,No Results Available,Body Weight Changes|Eating Disorder Symptom|Sexual Harassment|Covid19|RED S,,Female,"Child, Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"September 10, 2020","December 31, 2021"
5087,NCT04802187,Recruiting,No Results Available,Covid19,Other: RADx CHCs testing intervention strategy|Other: Usual care control,All,"Child, Adult, Older Adult",Not Applicable,76300.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"December 1, 2020","August 31, 2022"
5088,NCT04334265,Recruiting,No Results Available,COVID-19,Drug: Anluohuaxian,All,"Adult, Older Adult",Not Applicable,750.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","December 1, 2020"
5089,NCT04842331,Recruiting,No Results Available,"Respiratory Viral Infections, in Particular SARS-CoV-2, for Prevention of Onward Transmission|Respiratory Tract Diseases","Drug: RESP301, a Nitric Oxide generating solution",All,"Adult, Older Adult",Phase 2|Phase 3,600.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,April 2021,January 2022
5090,NCT04566276,Not yet recruiting,No Results Available,COVID-19 Vaccine|Safety Issues,Biological: ChulaCov19 mRNA vaccine,All,"Adult, Older Adult",Phase 1,96.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Other,January 2021,June 2021
5091,NCT04302766,No longer available,No Results Available,Coronavirus Disease 2019,Drug: Remdesivir,All,"Child, Adult, Older Adult",,,U.S. Fed,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,
5092,NCT04844138,Not yet recruiting,No Results Available,Perinatal Anxiety|Perinatal Depression,Behavioral: Overcoming Anxiety in Pregnancy and Postpartum Online Self-Directed Program,Female,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 7, 2021","December 31, 2021"
5093,NCT04441632,Completed,No Results Available,"Burnout|Stress, Emotional",Behavioral: Positive feedback,All,"Adult, Older Adult",Not Applicable,24.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 15, 2020","July 30, 2020"
5094,NCT04763681,Recruiting,No Results Available,Posttraumatic Stress Disorder,"Behavioral: Couple HOPES Guided, Internet-Delivered, Self-Help Intervention",All,Adult,Not Applicable,140.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 1, 2021","August 31, 2021"
5095,NCT04683744,Recruiting,No Results Available,Colorectal Cancer Screening,Other: Semi-structured interviews-Patients|Other: Semi-structured interviews-Health system,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"January 11, 2021",July 2023
5096,NCT04281693,Not yet recruiting,No Results Available,Novel Coronavirus Infection Pneumonia,Diagnostic Test: Standard screening strategy|Diagnostic Test: New screening strategy,All,"Child, Adult, Older Adult",Not Applicable,230.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,February 2020,March 2020
5097,NCT03331445,Recruiting,No Results Available,Respiratory Tract Infections|Corona Virus Infection,Drug: Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation,All,"Adult, Older Adult",Phase 2,20.0,Industry,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 24, 2017","March 31, 2021"
5098,NCT04298060,Not yet recruiting,No Results Available,Influenza Infection|SAD-RV Infection and COVID-19,Drug: DAS181|Drug: Placebo,All,"Adult, Older Adult",Phase 2,280.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment",July 2020,September 2022
5099,NCT03963622,Recruiting,No Results Available,ARDS,Other: Respiratory Mechanics|Other: Standard Ventilation Strategy,All,"Adult, Older Adult",Not Applicable,740.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"November 23, 2020",November 2022
5100,NCT04509947,"Active, not recruiting",No Results Available,Healthy,Biological: Ad26.COV2.S|Biological: Placebo,All,"Adult, Older Adult",Phase 1,250.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","August 11, 2020","December 8, 2021"
5101,NCT04490239,"Active, not recruiting",No Results Available,Covid19,Drug: Intranasal heparin sodium (porcine),All,"Adult, Older Adult",Early Phase 1,6.0,Other,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 9, 2020",November 2020
5102,NCT04776174,Not yet recruiting,No Results Available,Covid19,Device: Ultrasound using the telerobotic Melody system,All,Child,Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 1, 2021",January 2022
5103,NCT04743609,Recruiting,No Results Available,"RSV Infection|Children, Only|Outpatient|Bronchiolitis|Otitis Media|Pneumonia",Diagnostic Test: nasopharyngeal samples,All,Child,,1600.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 8, 2021","January 11, 2023"
5104,NCT04740489,Not yet recruiting,No Results Available,Heart Diseases,Behavioral: Phase 3 Cardiac rehabilitation,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"February 1, 2021","June 1, 2022"
5105,NCT03262051,Recruiting,No Results Available,Inflammation,Diagnostic Test: CYP phenotyping,All,"Adult, Older Adult",,106.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2017","September 1, 2021"
5106,NCT04509986,Not yet recruiting,No Results Available,Surgery|Covid19|Post-Op Complication,,All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","December 1, 2020"
5107,NCT04260308,Recruiting,No Results Available,Virus; Pneumonia,,All,"Child, Adult, Older Adult",,30000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"February 3, 2020","April 20, 2020"
5108,NCT04485169,Completed,No Results Available,COVID-19|Cytokine Release Syndrome,Procedure: Therapeutic Plasma Exchange,All,"Adult, Older Adult",Not Applicable,280.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","July 31, 2020"
5109,NCT04657809,"Active, not recruiting",No Results Available,Anosmia,Combination Product: Insulin film|Device: Fast dissolving film,All,"Adult, Older Adult",Phase 2,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","October 1, 2020","February 20, 2021"
5110,NCT04449276,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome|Coronavirus|SARS-CoV-2|COVID-19,Biological: CVnCoV Vaccine|Drug: Placebo,All,Adult,Phase 1,280.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"June 18, 2020",December 2021
5111,NCT04415879,Completed,No Results Available,COVID-19,Device: N-95 Respirator|Device: Cloth Face Mask|Diagnostic Test: Graded exercise test,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"June 1, 2020","August 1, 2020"
5112,NCT04385836,Recruiting,No Results Available,Coronavirus,Drug: alpha one antitrypsin inhalation,All,"Adult, Older Adult",Early Phase 1,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"June 1, 2020","September 1, 2020"
5113,NCT04492189,Completed,No Results Available,Eating Disorders|COVID 19,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 1, 2020","June 30, 2020"
5114,NCT04374643,Recruiting,No Results Available,Depression|COVID 19,Other: Slef questionnaires fulfilment,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2020","December 30, 2021"
5115,NCT04758962,Recruiting,No Results Available,Virus Diseases,Biological: 1 µg CoV2 SAM (LNP)|Biological: 3 µg CoV2 SAM (LNP)|Biological: 10 µg CoV2 SAM (LNP)|Biological: 30 µg CoV2 SAM (LNP),All,Adult,Phase 1,40.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 15, 2021","May 9, 2022"
5116,NCT04683484,Recruiting,No Results Available,COVID-19,Biological: Nanocovax|Biological: Placebo,All,"Child, Adult, Older Adult",Phase 1|Phase 2,620.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","December 10, 2020","August 10, 2021"
5117,NCT04669509,Completed,No Results Available,Covid19; Liver Injury; Mortality,Diagnostic Test: Liver function tests,All,"Adult, Older Adult",,532.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 1, 2020","December 14, 2020"
5118,NCT04413877,Not yet recruiting,No Results Available,Frailty Syndrome|COVID-19|Healthy Aging|Old Age; Debility,,All,Older Adult,,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,October 2020,November 2021
5119,NCT04561076,Not yet recruiting,No Results Available,COVID 19,Drug: HLX70|Other: Placebo,All,Adult,Phase 1,24.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","December 9, 2020","September 18, 2021"
5120,NCT04483271,Enrolling by invitation,No Results Available,Cytokine Storm|Cytokines,Dietary Supplement: 300 mg of omega3-FA,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 2, 2020","February 10, 2021"
5121,NCT04755972,Recruiting,No Results Available,"Corona Virus Infection|Pneumonia, Ventilator-Associated","Other: Inhalation of N-acetylcysteine|Other: Inhalation of 5% sodium chloride|Other: Inhalation of 8,4% sodium bicarbonate",All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 29, 2021","August 29, 2021"
5122,NCT04536376,Recruiting,No Results Available,Resilience|Stress|Sleep,Behavioral: Resilience Program,All,"Adult, Older Adult",Not Applicable,10.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"January 15, 2021","December 31, 2021"
5123,NCT04567927,Completed,No Results Available,SARS Virus,Other: Ultrasonography,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 3, 2020","May 28, 2020"
5124,NCT04453527,Recruiting,No Results Available,Coronavirus,,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 28, 2020",September 2021
5125,NCT04398147,Not yet recruiting,No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,All,"Adult, Older Adult",Phase 1|Phase 2,696.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 1, 2020","December 30, 2021"
5126,NCT04490278,Recruiting,No Results Available,Post ICU Syndrome,Other: Medical Record Review - Inpatient Treatment|Other: Online Questionnaires,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"September 29, 2020","July 30, 2021"
5127,NCT04708457,Not yet recruiting,No Results Available,Mechanical Ventilation Complication|Severe Acute Respiratory Infection|Covid19,Other: VV-ECMO,All,"Adult, Older Adult",Not Applicable,12.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 1, 2021","January 31, 2022"
5128,NCT04786301,Recruiting,No Results Available,"Pneumonia, Viral",,Female,"Adult, Older Adult",,1200.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 30, 2020",March 2022
5129,NCT04346121,Completed,No Results Available,Patient Safety,"Other: GPs reports of potential patient safety incidents, non-COVID-19 related",All,"Child, Adult, Older Adult",,132.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 28, 2020","June 29, 2020"
5130,NCT04348552,Recruiting,No Results Available,Patient Safety,"Other: Primary care professionals reports of potential patient safety incidents, non-COVID-19 related",All,"Child, Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 28, 2020","June 28, 2020"
5131,NCT04419064,Completed,No Results Available,Critical Illness|Mechanical Ventilation,Diagnostic Test: Point of care ultrasound,All,"Adult, Older Adult",,118.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"January 1, 2019","May 30, 2020"
5132,NCT04593433,Not yet recruiting,No Results Available,Social Isolation|Quality of Life|Well Aging|Frailty,Other: Museum virtual guided tours,All,Older Adult,Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 4, 2021","September 4, 2021"
5133,NCT04396600,Enrolling by invitation,No Results Available,"Stress|Stress Disorder|Stress, Psychological|Trauma, Psychological|Anxiety|Anxiety State|Post Traumatic Stress Disorder|Secondary Traumatic Stress|Professional Quality of Life|Stress Related Disorder|Stress Reaction|Stress Risk|Mental Resilience|Emotional Resilience",Behavioral: MinnRAP Peer Support Program,All,"Adult, Older Adult",,1200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 8, 2020","May 25, 2022"
5134,NCT04590430,"Active, not recruiting",No Results Available,Healthy,Drug: HFB30132A|Other: Placebo,All,Adult,Phase 1,24.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 20, 2020",July 2021
5135,NCT04467112,Completed,No Results Available,COVID,Device: Breath Biopsy face masks with removable filters and fitted PVA strip,All,"Child, Adult, Older Adult",,8.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"July 30, 2020","December 19, 2020"
5136,NCT04657471,Completed,No Results Available,Coronavirus Infection,Other: revised HOME-CoV score,All,"Adult, Older Adult",Not Applicable,1300.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 8, 2020","March 8, 2021"
5137,NCT04523610,Recruiting,No Results Available,"Depression, Anxiety|Cognitive Impairment|Stress",Behavioral: Telehealth phone calls|Other: Volunteer of TIP-OA Program|Other: Stakeholder of TIP-OA Program,All,"Adult, Older Adult",Not Applicable,258.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"October 2, 2020",October 2022
5138,NCT04394039,Not yet recruiting,No Results Available,Stress|Anxiety,Other: Public space exposure,All,"Adult, Older Adult",Not Applicable,34.0,Other,Interventional,Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"June 1, 2020","December 31, 2020"
5139,NCT04785781,Recruiting,No Results Available,Covid-19,"Other: without masks|Other: Surgical face mask (Vheal Med Co., Ltd., Istanbul, Turkey)|Other: FFP2\N95 protective face mask (Musk protective technology, Gaziantep, Turkey)",All,Adult,Not Applicable,16.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,"February 1, 2021","April 15, 2021"
5140,NCT04445441,Completed,No Results Available,Coronavirus Infection,,All,"Adult, Older Adult",,153.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 24, 2020","November 30, 2020"
5141,NCT04550312,Recruiting,No Results Available,Lifestyle Alteration|Non-COVID Deaths,,All,"Child, Adult, Older Adult",,80000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,September 2020,October 2020
5142,NCT04382560,Completed,No Results Available,"Behavior, Social|Autonomic Imbalance",Other: Deep Breathing training|Other: Compassion focused intervention,All,Adult,Not Applicable,69.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other","May 2, 2020","May 31, 2020"
5143,NCT04816708,Not yet recruiting,No Results Available,"Covid19, Emotional Distress, Burnout, Healthcare Workers",Behavioral: LIFT Mindfulness,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2021","March 31, 2022"
5144,NCT04495543,Recruiting,No Results Available,Suicidal Ideation|Suicide|Mental Health Issue|Depression,Behavioral: Brief Skills for Safer Living,All,"Adult, Older Adult",Not Applicable,75.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"December 1, 2020",August 2021
5145,NCT04368299,Recruiting,No Results Available,SLE,Other: Telemedicine|Other: Standard care,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"May 1, 2020","December 31, 2021"
5146,NCT04453839,Available,No Results Available,Critical COVID-19 With Respiratory Failure,Drug: ZYESAMI (aviptadil acetate),All,"Child, Adult, Older Adult",,,Industry|Other,Expanded Access:Intermediate-size Population,,,
5147,NCT04818697,Completed,No Results Available,Heart Rhythm Disorder|Covid19|Social Isolation,,All,"Adult, Older Adult",,105.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"June 24, 2020","March 19, 2021"
5148,NCT04598763,Recruiting,No Results Available,Olfaction Disorders,Other: smell the odors of the olfactory rehabilitation kit according to the classic or intensive method,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 1, 2020","January 1, 2021"
5149,NCT04662008,Not yet recruiting,No Results Available,Multiple Sclerosis|Caregivers,Behavioral: Tele-coaching|Behavioral: Website,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"January 10, 2021","October 31, 2021"
5150,NCT04629755,Completed,No Results Available,"Depression|Loneliness|Relation, Interpersonal|Covid19",Behavioral: Intervention,All,"Adult, Older Adult",Not Applicable,1765.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 4, 2020","August 3, 2020"
5151,NCT04369599,Enrolling by invitation,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Device: V/Q System,All,"Adult, Older Adult",Not Applicable,36.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 11, 2020",July 2021
5152,NCT04601415,Not yet recruiting,No Results Available,Heart Failure,Diagnostic Test: ECG from handheld device,All,"Adult, Older Adult",,1500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2021","October 1, 2022"
5153,NCT04551274,Not yet recruiting,No Results Available,Mood|Emotional Stress,Behavioral: Music Therapy,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"October 1, 2020","November 30, 2020"
5154,NCT04369274,Not yet recruiting,No Results Available,Respiratory Failure,Device: Mechanical ventilation with the automated BVM compressor,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,November 2021
5155,NCT04766645,Not yet recruiting,No Results Available,Neurologic Manifestations,Device: Robotic assisted intervention|Genetic: epigenetic analyses|Diagnostic Test: biochemical analyses,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","July 7, 2022"
5156,NCT04753645,"Active, not recruiting",No Results Available,Hygiene Practices and Knowledge,Behavioral: Handwashing stations at the public places|Behavioral: No activities of the HBCC project,All,"Child, Adult, Older Adult",Not Applicable,3840.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"September 19, 2020",May 2021
5157,NCT04350723,Recruiting,No Results Available,Corona Virus Infection|Covid19,Procedure: Awake Proning,All,"Adult, Older Adult",Not Applicable,350.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 10, 2020","August 30, 2021"
5158,NCT04751474,"Active, not recruiting",No Results Available,Motivation|Optimism|Hopelessness|Life Satisfaction,Other: Motivational messages,All,"Adult, Older Adult",Not Applicable,93.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"February 1, 2021","March 31, 2021"
5159,NCT04644705,Recruiting,No Results Available,Healthy Volunteers,Drug: Niclosamide|Drug: Placebo,All,Adult,Phase 1,28.0,Other|Industry,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 2, 2020","May 31, 2021"
5160,NCT04399005,Completed,No Results Available,Daily Room Disinfection|After-each-case Room Disinfection,Other: after-each-case room disinfection|Other: daily room disinfection,All,"Child, Adult, Older Adult",Not Applicable,240.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"May 25, 2020","June 10, 2020"
5161,NCT04442958,Completed,No Results Available,Acute Respiratory Distress Syndrome,Other: Convalescent Immune Plasma,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","May 15, 2020","June 17, 2020"
5162,NCT04524962,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|Covid19,Biological: Descartes 30,All,"Adult, Older Adult",Phase 1|Phase 2,30.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 15, 2020","September 25, 2022"
5163,NCT04549350,Completed,No Results Available,Sleep Quality,Other: PSQI,All,Adult,,217.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"May 19, 2020","September 5, 2020"
5164,NCT04422769,"Active, not recruiting",No Results Available,Spinal Cord Injuries,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 22, 2020","March 31, 2021"
5165,NCT04684836,Not yet recruiting,No Results Available,Asthma|Chronic Obstructive Pulmonary Disease (COPD|Congestive Heart Failure|Diabetes|Hypertension,"Other: Exposure to telemedicine, after the onset of the pandemic",All,"Adult, Older Adult",,216000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,February 2021,December 2023
5166,NCT04406558,Recruiting,No Results Available,"Psychological Adaptation|Psychology, Social",Other: Questionnaire,All,"Child, Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 27, 2020",April 2021
5167,NCT04681365,Recruiting,No Results Available,Covid19,Other: Staff will wear and evaluate Bubble-PAPR (non-CE marked PAPR),All,"Adult, Older Adult",,66.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 24, 2021","June 2, 2021"
5168,NCT04695743,Recruiting,No Results Available,Dementia,Other: Online Cognitive Stimulation Therapy,All,"Child, Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 1, 2020","September 1, 2022"
5169,NCT04787536,Recruiting,No Results Available,Postoperative Cognitive Dysfunction|Depressive Symptoms|Postoperative Pain,Procedure: Non-cardiac surgery,All,Older Adult,,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 10, 2020","December 31, 2022"
5170,NCT04496466,Enrolling by invitation,No Results Available,Coronavirus,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 9, 2020",June 2021
5171,NCT04764422,Recruiting,No Results Available,"Covid-19|SARS Pneumonia|Pneumonia, Viral|Covid-19 Vaccine",Biological: Normal Saline|Biological: NDV-HXP-S vaccine,All,"Adult, Older Adult",Phase 1|Phase 2,460.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","March 20, 2021",April 2023
5172,NCT04363177,Not yet recruiting,No Results Available,Perinatal Depression|COVID19|Anxiety|PTSD|Pregnancy Related,Behavioral: Web-based psychosocial peer-to-peer support,Female,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"November 1, 2020",June 2023
5173,NCT04609371,Enrolling by invitation,No Results Available,"Mental Health Wellness 1|Coaching|Pandemic|Depression, Anxiety|Self-care Tools",Behavioral: self-care tools|Behavioral: lay telephone coaching,All,Older Adult,Not Applicable,176.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Supportive Care,"October 21, 2020","May 1, 2021"
5174,NCT04396314,Not yet recruiting,No Results Available,PostTraumatic Stress Disorder,Behavioral: Basic Body Awareness Therapy|Behavioral: Psychological treatment,All,"Adult, Older Adult",Not Applicable,54.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 1, 2021","April 30, 2022"
5175,NCT04618341,Completed,No Results Available,Anxiety|Depression,,All,Child,,32.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"March 30, 2020","July 28, 2020"
5176,NCT04394455,Enrolling by invitation,No Results Available,Anxiety|Depressive Symptoms|Post Traumatic Stress Symptoms|Perceived Stress,Behavioral: Brief cognitive behavioral therapy|Behavioral: Crisis intervention therapy,All,"Adult, Older Adult",Not Applicable,236.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"June 30, 2020","December 30, 2020"
5177,NCT04788433,Recruiting,No Results Available,"Chronic Pain|Morbidity, Multiple|Covid19",Diagnostic Test: glycomic analysis|Other: Phone interview,All,"Adult, Older Adult",,615.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"March 4, 2021","March 31, 2022"
5178,NCT04727762,Completed,No Results Available,Face Mask Squeeze,,All,"Adult, Older Adult",,629.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"February 4, 2021","March 30, 2021"
5179,NCT04789525,Completed,No Results Available,"Obesity, Childhood",Other: High-intensity aerobic training with high protein diet,Male,Child,Not Applicable,76.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"March 10, 2020","December 25, 2020"
5180,NCT04415359,Completed,No Results Available,Covid-19,,Female,Adult,,700.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"August 1, 2020","December 31, 2020"
5181,NCT04420273,Completed,No Results Available,Melanoma,Behavioral: SSE educational intervention|Other: Home sample collection of concerning mole with physician supervision|Behavioral: Active control:Healthy Living,Female,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","July 2, 2020","March 1, 2021"
5182,NCT04475185,Recruiting,No Results Available,Acute Respiratory Distress Syndrome,Device: MakAir,All,"Adult, Older Adult",Not Applicable,117.0,Other,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"July 20, 2020",December 2020
5183,NCT04688502,Not yet recruiting,No Results Available,Dyspnea,Other: High intensity interval training|Other: Continuous exercise training,All,"Adult, Older Adult",Not Applicable,24.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"January 11, 2021","March 15, 2021"
5184,NCT04457388,Completed,No Results Available,Chronic Pain,Other: Tele-Yoga Therapy,All,Adult,Not Applicable,18.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 25, 2020","June 15, 2020"
5185,NCT04498416,Recruiting,No Results Available,Mental Health Disorder,Diagnostic Test: Quantitative and qualitative assessments of mental health,All,Child,,70.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 27, 2020",July 2021
5186,NCT04821999,Not yet recruiting,No Results Available,SARS-CoV Infection,Device: a 940-nm diode laser,All,Adult,Not Applicable,150.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","April 15, 2021","June 1, 2021"
5187,NCT04776941,Recruiting,No Results Available,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Behavioral: Behavioral Intervention|Other: Quality-of-Life Assessment|Other: Questionnaire Administration,All,"Adult, Older Adult",Not Applicable,120.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","August 7, 2020","December 31, 2021"
5188,NCT04439825,Completed,No Results Available,Mood,Drug: Botulinum Neurotoxin|Drug: Placebo,All,"Child, Adult, Older Adult",Phase 1,45.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"July 20, 2020","December 1, 2020"
5189,NCT04828434,Not yet recruiting,No Results Available,"Dementia|Dementia, Vascular|Dementia, Mixed|Dementia With Lewy Bodies|Dementia Frontal|Dementia, Mild|Dementia Moderate|Dementia Alzheimers|Dementia of Alzheimer Type|Dementia, Multi-Infarct|Dementia Frontotemporal",Other: Virtual Individual Cognitive Simulation Therapy,All,"Adult, Older Adult",Not Applicable,34.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 1, 2021","September 1, 2025"
5190,NCT01306084,Recruiting,No Results Available,Anogenital Herpes|COVID-19|Herpes Labialis,,All,"Child, Adult, Older Adult",,1000.0,NIH,Observational,Observational Model: Other|Time Perspective: Prospective,"March 15, 2011",
5191,NCT04555954,Completed,No Results Available,"Health, Subjective|Healthy",Other: surveys and questionnaires,All,"Child, Adult, Older Adult",,205.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"April 11, 2020","August 20, 2020"
5192,NCT04233268,Recruiting,No Results Available,Lower Respiratory Tract Infection|Ventilator Associated Pneumonia|COVID19,Diagnostic Test: Rapid Pathogen Detection,All,Child,,250.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 6, 2020","February 28, 2025"
5193,NCT04765215,Not yet recruiting,No Results Available,Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy,Biological: CoronoVAC,All,"Adult, Older Adult",,291.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 31, 2021","March 31, 2022"
5194,NCT04733677,Recruiting,No Results Available,Covid19,,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 19, 2021",July 2021
5195,NCT04331808,"Active, not recruiting",No Results Available,Corona Virus Infection,Drug: Tocilizumab,All,"Adult, Older Adult",Phase 2,228.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 30, 2020","December 31, 2021"
5196,NCT04688840,Completed,No Results Available,Telemedicine,Procedure: hip arthropalsty,All,"Child, Adult, Older Adult",,167.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"January 1, 2020","December 1, 2020"
5197,NCT04413006,Recruiting,No Results Available,Chronic Pain,Behavioral: Self-Compassion for Chronic Pain Virtual Group Treatment Program,All,"Adult, Older Adult",Not Applicable,28.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 25, 2020","March 31, 2021"
5198,NCT04473599,Recruiting,No Results Available,Depressive Symptoms|Anxiety|COVID-19,Behavioral: Uniform random message delivery|Behavioral: Reinforcement learning message delivery,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"April 17, 2020","April 1, 2021"
5199,NCT04545242,Not yet recruiting,No Results Available,Acute Hypoxemic Respiratory Failure,Drug: Dexamethasone,All,"Adult, Older Adult",Phase 4,980.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 8, 2021","December 30, 2023"
5200,NCT04769999,Completed,No Results Available,Post Traumatic Stress Disorder,Behavioral: Simple cognitive task,All,"Adult, Older Adult",Not Applicable,14.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 4, 2020","October 30, 2020"
5201,NCT04826367,Recruiting,No Results Available,Breast Cancer,Other: Telerehabilitation-based relaxation exercise group (EG),Female,"Adult, Older Adult",Not Applicable,64.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"January 20, 2021",February 2022
5202,NCT04335851,Completed,No Results Available,Social Isolation|Physical Inactivity|Well-Being,Other: Video based aerobic exercise,All,Adult,Not Applicable,68.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"April 6, 2020","June 3, 2020"
5203,NCT04444713,Not yet recruiting,No Results Available,Depressive Symptoms|Metacognitive Variables,,All,"Adult, Older Adult",,10084.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"June 22, 2020","July 13, 2020"
5204,NCT04443075,Completed,No Results Available,"Stress Disorders, Post-Traumatic",Device: faecal sample collector,All,Adult,,180.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 24, 2020","December 24, 2020"
5205,NCT04636944,Recruiting,No Results Available,Heart Failure|Depression|Anxiety,Other: web-based COMPASS intervention,All,"Adult, Older Adult",,13.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"October 2, 2020","August 16, 2021"
5206,NCT04797208,Not yet recruiting,No Results Available,"Diabetes Mellitus, Type 2|Hyperglycemia Stress|Hypoglycemia",Device: Real-Time CGM|Device: Capillary blood glucose testing with masked CGM,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2021,March 2022
5207,NCT04763213,Completed,No Results Available,Myocard Infarctus,Diagnostic Test: Coronary Angiography,All,"Adult, Older Adult",,276.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 1, 2018","December 31, 2019"
5208,NCT04658979,Recruiting,No Results Available,Chronic Pulmonary Disease,Other: Pulmonary tele-rehabilitation,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,December 2020,January 2022
5209,NCT03708718,Recruiting,No Results Available,Systemic Sclerosis,Drug: Prednisolone 5 mg|Drug: Placebo oral capsule; From August 2020 'no additional treatment',All,"Adult, Older Adult",Phase 2,72.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","December 21, 2017",September 2021
5210,NCT04765540,"Active, not recruiting",No Results Available,Hand Washing|Handwashing|Covid19,Behavioral: Low Intensity Nudges|Behavioral: High Intensity Activities|Behavioral: BRAC's business-as-usual,All,"Child, Adult, Older Adult",Not Applicable,860.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 3, 2021","May 30, 2021"
5211,NCT04464460,Withdrawn,No Results Available,Coronavirus Disease,Drug: TAK-671|Drug: TAK-671 Placebo,All,"Adult, Older Adult",Phase 1,0.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 25, 2020","October 30, 2020"
5212,NCT04664075,Not yet recruiting,No Results Available,"Influenza|SARS (Severe Acute Respiratory Syndrome)|Respiratory Viral Infection|Respiratory Tract Infections|Infection, Bacterial|Infection Viral|Covid19|RNA Virus Infections",Biological: Respiratory infections,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,January 2021,"June 30, 2021"
5213,NCT04828902,Recruiting,No Results Available,Postoperative Delirium|Adult Cardiac Surgery|Covid19,Procedure: cardiac surgery,All,"Adult, Older Adult",,600.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 1, 2021","August 31, 2022"
5214,NCT04468789,Not yet recruiting,No Results Available,HIV,Other: Six-month ARV dispensing,All,"Adult, Older Adult",,150945.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,December 2022
5215,NCT04768413,Recruiting,No Results Available,Rheumatoid Arthritis,Other: Teleconsultation either by phone or by computer consultation. Quantitative and qualitative approaches to analysis|Other: Care modalities. Quantitative and qualitative approaches to analysis,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","June 30, 2021"
5216,NCT04752553,Not yet recruiting,No Results Available,"the Study Focus on the Uses of Telephone and Other New Technology in Medicine, Diagnosis and Treatment",,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"March 9, 2021","February 10, 2022"
5217,NCT03738774,Recruiting,No Results Available,Post Intensive Care Syndrome,,All,"Adult, Older Adult",,200.0,Other|U.S. Fed,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 2, 2019",July 2022
5218,NCT03852537,Completed,No Results Available,Pneumonia,Drug: Methylprednisolone|Other: Usual Care,All,"Adult, Older Adult",Phase 1,44.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","December 2, 2019","March 15, 2021"
5219,NCT04557605,Completed,No Results Available,Hypoxemia,Other: Progressive cycling exercise test to exhaustion,All,"Adult, Older Adult",Not Applicable,14.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 14, 2020","October 15, 2020"
5220,NCT04456933,Recruiting,No Results Available,Colon Cancer,Procedure: Extracorporeal left hemicolectomy anastomosis|Procedure: Intracorporeal left hemicolectomy anastomosis,All,"Adult, Older Adult",,148.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 29, 2020","February 28, 2022"
5221,NCT04290754,Recruiting,No Results Available,Depression,Behavioral: CATCH-IT|Behavioral: TEAMS,All,"Child, Adult",Not Applicable,664.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","January 1, 2020","March 1, 2024"
5222,NCT04505098,Recruiting,No Results Available,Covid19|Atherosclerosis|Cardiovascular Diseases|Upper Respiratory Tract Infections,Drug: Icosapent ethyl,All,"Adult, Older Adult",Phase 4,16500.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"August 7, 2020","February 28, 2023"
5223,NCT04468386,"Active, not recruiting",No Results Available,Focus in on Collecting Paired Specimens for Matrix Equivalency,,All,"Adult, Older Adult",,40.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 7, 2020","March 30, 2021"
5224,NCT04393649,Recruiting,No Results Available,COVID|Social Isolation|Anxiety|Frailty,Other: ESOGER,All,Older Adult,,20000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 20, 2020","April 19, 2021"
5225,NCT04434014,Recruiting,No Results Available,"Diet, Healthy",Dietary Supplement: proper diet,All,Adult,,300.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"June 8, 2020","June 28, 2020"
5226,NCT04728347,Recruiting,No Results Available,SARS-CoV-2,Biological: ARCT-021,All,"Adult, Older Adult",Phase 2,106.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 4, 2021",June 2022
5227,NCT04697654,"Active, not recruiting",No Results Available,COVID-19,Drug: TLC19|Drug: TLC19 Vehicle,All,"Adult, Older Adult",Phase 1,30.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 14, 2020","April 30, 2021"
5228,NCT03907891,Recruiting,No Results Available,Ischemic Heart Disease|Hopelessness|Physical Activity|Motivation|Social Support|Covid19,Behavioral: Motivational social support from nurse|Behavioral: Motivational social support from nurse with additional support from significant other|Behavioral: Attention control,All,"Adult, Older Adult",Not Applicable,225.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 1, 2019",May 2023
5229,NCT04387708,Not yet recruiting,No Results Available,Anorexia Nervosa,,All,"Child, Adult, Older Adult",,18.0,Other,Observational,Observational Model: Family-Based|Time Perspective: Cross-Sectional,"May 14, 2020","June 8, 2020"
5230,NCT04790851,Recruiting,No Results Available,"Influenza, Human|Pneumonia, Pneumococcal|Covid19",Biological: COVIV+IIV4; COVIV+PPV23|Biological: COVIV only (1st and 2nd dose)|Biological: IIV4 for the 1st dose and PPV23 for the 2nd dose,All,"Adult, Older Adult",Phase 4,1152.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"February 23, 2021",December 2021
5231,NCT04374058,"Active, not recruiting",No Results Available,End Stage Renal Disease,Other: less-frequency hemodialysis,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 20, 2020",March 2021
5232,NCT04441047,Not yet recruiting,No Results Available,Virus Diseases,Drug: AlloStim,All,Older Adult,Phase 1|Phase 2,40.0,Industry|Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 6, 2021","December 31, 2022"
5233,NCT04356144,Completed,No Results Available,"Disseminated Intravascular Coagulation|Critical Illness|Sars-CoV2|Viral Infection|Coagulation Disorder, Blood|Covid19",Diagnostic Test: Thrombin Generation Assay (TGA)|Diagnostic Test: Thrombomodulin Modified Thrombin Generation Assay (TGA-TM),All,"Adult, Older Adult",,58.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2020","February 1, 2021"
5234,NCT04261907,Not yet recruiting,No Results Available,2019-nCoV,Drug: ASC09/ritonavir group|Drug: lopinavir/ritonavir group,All,"Adult, Older Adult",Not Applicable,160.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 7, 2020","June 30, 2020"
5235,NCT04715854,"Active, not recruiting",No Results Available,Hypoxemic Respiratory Failure|Emergencies|Covid19,Device: Mask,All,"Adult, Older Adult",Not Applicable,15.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"February 19, 2021","July 1, 2021"
5236,NCT04687488,Completed,No Results Available,Aerosol Generation and Droplet Dispersion and Deposition During Naso-gastric Intubation for Gastrointestinal Motility Investigations,Other: Fluorescein|Other: Particle measurement,All,"Adult, Older Adult",Not Applicable,15.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 23, 2020","November 9, 2020"
5237,NCT04812184,Completed,No Results Available,Covid19,Device: Tape Face Mask,All,"Adult, Older Adult",Not Applicable,123.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","October 30, 2020"
5238,NCT04659928,Not yet recruiting,No Results Available,Covid19,Device: High volume evacuation (HVE)|Device: Extraoral vacuum aspirator (EVA)|Device: External evacuation device (EED)|Drug: Hydrogen Peroxide,All,"Adult, Older Adult",Phase 4,50.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","December 1, 2020","December 1, 2022"
5239,NCT04533048,Completed,No Results Available,Covid19,Combination Product: MW33 injection|Combination Product: MW33 injection placebo,All,Adult,Phase 1,42.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 7, 2020","December 2, 2020"
5240,NCT04501172,Completed,No Results Available,Covid19,Behavioral: Questionnaire completion,All,"Adult, Older Adult",,1214.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"June 25, 2020","August 14, 2020"
5241,NCT04497519,Completed,No Results Available,Covid19,Drug: inhaled hydroxychloroquine,All,"Adult, Older Adult",Phase 1,12.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 15, 2020","November 1, 2020"
5242,NCT04333589,Recruiting,No Results Available,COVID-19,Drug: Favipiravir,All,"Adult, Older Adult",Not Applicable,210.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2020","September 15, 2020"
5243,NCT04310228,Recruiting,No Results Available,COVID-19,Drug: Favipiravir Combined With Tocilizumab|Drug: Favipiravir|Drug: Tocilizumab,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 8, 2020",May 2020
5244,NCT04302519,Not yet recruiting,No Results Available,COVID-19,Biological: Dental pulp mesenchymal stem cells,All,"Adult, Older Adult",Early Phase 1,24.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 5, 2020","July 30, 2021"
5245,NCT02765191,Recruiting,No Results Available,"Sepsis, Severe|Acute Kidney Injury|COVID-19",Other: Plasma expansion with Ringer's Acetate,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,April 2016,October 2025
5246,NCT04806477,Completed,No Results Available,Respiratory Tract Infections,Other: Telemedicine Consultation|Other: Face-to-face Consultation,All,"Adult, Older Adult",Not Applicable,98.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 1, 2020","November 1, 2020"
5247,NCT04514900,"Active, not recruiting",No Results Available,Obesity,Behavioral: Video Chat +Personalized Feedback|Behavioral: Video Chat + Basic Feedback|Behavioral: Discussion Board for Social Support +Basic Feedback|Behavioral: Discussion Board for Social Support+Personalized Feedback,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 23, 2020","September 15, 2021"
5248,NCT04275388,Not yet recruiting,No Results Available,2019 Novel Coronavirus Pneumonia,"Drug: Xiyanping injection|Drug: Lopinavir / ritonavir, alpha-interferon nebulization,Abidor Hydrochloride",All,"Child, Adult, Older Adult",,426.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"May 15, 2020","December 14, 2021"
5249,NCT04731324,Recruiting,No Results Available,Healthy,Drug: ZYIL1 capsule,All,Adult,Phase 1,42.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 5, 2021","December 30, 2021"
5250,NCT04640064,Not yet recruiting,No Results Available,Type1diabetes|Childhood ALL,,All,Child,,500.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"November 22, 2020","April 22, 2021"
5251,NCT04409496,Completed,No Results Available,Smoking Cessation,Behavioral: Chat-based instant messaging support|Behavioral: SMS message support|Behavioral: Self-help booklet,All,"Adult, Older Adult",Not Applicable,108.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 2, 2020","January 22, 2021"
5252,NCT04363788,Completed,No Results Available,Cardiac Arrest|Needle Stick|Injuries|Glowe,Procedure: double gloves,,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 28, 2020","April 24, 2020"
5253,NCT04346940,Not yet recruiting,No Results Available,Telerehabilitation|Elderly People|Social Isolation,Other: Telerehabilitation|Other: Exercise brochure,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"August 10, 2020","November 30, 2020"
5254,NCT04640610,Not yet recruiting,No Results Available,Adenoidectomy|Tonsillectomy,Other: Storage of operating waste,All,"Child, Adult, Older Adult",,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,December 2020,September 2021
5255,NCT04816019,Enrolling by invitation,No Results Available,Coronavirus,Biological: ChAdOx1 nCov-19,All,Adult,Phase 1,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2021",October 2021
5256,NCT04592835,Not yet recruiting,No Results Available,COVID-19 Patients,Drug: DWRX2003,All,"Adult, Older Adult",Phase 1,24.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 19, 2020","June 30, 2021"
5257,NCT04262921,Recruiting,No Results Available,Coronavirus Infections,,All,"Child, Adult, Older Adult",,5000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 8, 2020","August 7, 2023"
5258,NCT04658550,Recruiting,No Results Available,Obesity,Other: Remote Behaviour Modification Program|Other: In Person Behaviour Modification Program,All,"Adult, Older Adult",,120.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"October 16, 2020",October 2021
5259,NCT04461353,Completed,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Drug: Aerolized Hydroxychloroquine Sulfate|Other: Placebo,All,"Adult, Older Adult",Phase 1,12.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 25, 2020","August 17, 2020"
5260,NCT04422275,Withdrawn,No Results Available,Anosmia,Drug: Budesonide|Behavioral: High-Concentration Essential Oil|Drug: Placebo|Behavioral: Low-Concentration Essential Oil,All,"Adult, Older Adult",Phase 2,0.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2021","December 31, 2023"
5261,NCT04379986,Not yet recruiting,No Results Available,Blood Pressure,Device: Sensbiosys,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility,"May 1, 2020","June 1, 2020"
5262,NCT04417153,Recruiting,No Results Available,"Stress, Psychological|Sleep Initiation and Maintenance Disorders",Behavioral: Mindfulness Based Intervention,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 20, 2019","June 30, 2022"
5263,NCT04474444,Recruiting,No Results Available,"Alcohol Use, Unspecified|Substance Use|Intoxication Alcohol|Emergencies|COVID-19 Pandemic|Treatment",Other: attendance by ambulance crew,All,"Child, Adult, Older Adult",,55000.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Retrospective,"March 23, 2019","March 23, 2021"
5264,NCT04025580,Recruiting,No Results Available,Healthy Volunteer|COVID-19,Biological: Flucelvax|Biological: Fluvirin|Biological: Fluzone High Dose,All,"Adult, Older Adult",Phase 2,300.0,NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"October 2, 2019","December 31, 2025"
5265,NCT04742049,Recruiting,No Results Available,Cystic Fibrosis|Covid19|Social Isolation,Other: Telerehabilitation-based|Other: Follow-up based,All,Child,Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"December 28, 2020",March 2021
5266,NCT04530448,Recruiting,No Results Available,COVID|Coronavirus|Coronavirus Infection|AKI|Acute Kidney Injury,Drug: Sodium bicarbonate|Other: Standard of Care,All,"Adult, Older Adult",Phase 4,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 5, 2020",March 2021
5267,NCT04600713,Not yet recruiting,No Results Available,Atrial Fibrillation Paroxysmal,Other: PT-X and IMT,All,"Adult, Older Adult",Not Applicable,180.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,September 2021,October 2025
5268,NCT03188796,Recruiting,No Results Available,Critical Illness|Vitamin D Deficiency|Covid19,Drug: Cholecalciferol|Drug: Placebo,All,"Adult, Older Adult",Phase 3,2400.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","October 10, 2017",February 2023
5269,NCT04536935,Enrolling by invitation,No Results Available,Depression|Anxiety|Emotional Regulation,Behavioral: Mobile Mental Health App - 1|Behavioral: Mobile Mental Health App - 2|Behavioral: Mobile Mental Health App - 3|Behavioral: Mobile Mental Health App - 4,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 30, 2020",April 2021
5270,NCT04804943,Recruiting,No Results Available,Acute Respiratory Distress Syndrome,Device: NOA-001,All,"Child, Adult, Older Adult",Not Applicable,35.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 19, 2021","October 31, 2022"
5271,NCT04353531,Recruiting,No Results Available,"Transmission, Patient Professional|High-flow Nasal Cannula",Device: High-flow nasal cannula|Device: Surgical mask|Procedure: bronchoscopy examination|Procedure: intubation|Procedure: tracheostomy|Device: nebulization|Diagnostic Test: Pulmonary function test,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 20, 2020","September 30, 2021"
5272,NCT04283838,Withdrawn,No Results Available,Coronavirus Disease 2019,Behavioral: Humanistic Care,All,"Child, Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 22, 2020","May 15, 2020"
5273,NCT04605172,Enrolling by invitation,No Results Available,Premature Birth|Preterm Labor,Other: hospitalization for premature birth,All,Child,,1000.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"November 2, 2020",May 2021
5274,NCT04355754,Recruiting,No Results Available,Respiratory Insufficiency,Device: Ventil - a gas flow divider,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 15, 2020","December 31, 2020"
5275,NCT03793673,"Active, not recruiting",No Results Available,Type 1 Diabetes Mellitus,Behavioral: CoYoT1 Care|Other: Standard Care,All,"Child, Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 20, 2019",June 2021
5276,NCT04666597,Recruiting,No Results Available,Dental Caries in Children,Procedure: Modified CariesCare International management,All,Child,,420.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"November 15, 2020","March 2, 2022"
5277,NCT04291534,Recruiting,No Results Available,Health Services Research|Quality of Life|Addiction|Substance-Related Disorders|Health Personnel,,All,"Child, Adult, Older Adult",,1800.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"June 15, 2020","June 1, 2023"
5278,NCT03966872,"Active, not recruiting",No Results Available,Mental Illness|Chronic Disease,Behavioral: Integrated Illness Management and Recovery|Behavioral: Chronic Disease Self-Management Program,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"September 2, 2019",March 2024
5279,NCT04547634,Enrolling by invitation,No Results Available,Cancer Metastatic|Cancer|Survivorship,Other: Therapeutic Exercise and Education,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"July 1, 2020",December 2020
5280,NCT04333875,"Active, not recruiting",No Results Available,Aortic Valve Stenosis,Device: TAVR or SAVR,All,"Adult, Older Adult",,71.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 20, 2020",December 2020
5281,NCT04634903,"Active, not recruiting",No Results Available,Depression,Behavioral: Supportive Therapy SSI|Behavioral: Behavioral Activation SSI|Behavioral: Growth Mindset SSI,All,Child,Not Applicable,2409.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","November 19, 2020","July 31, 2021"
5282,NCT03990662,Recruiting,No Results Available,Temporomandibular Disorders,Other: Physiotherapy - Manual Therapy,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 14, 2019","December 31, 2020"
5283,NCT04346966,Not yet recruiting,No Results Available,Social Isolation|Exercise|Healthy,Other: Study Group,All,Adult,Not Applicable,128.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention,"August 20, 2020","November 20, 2020"
5284,NCT04677842,"Active, not recruiting",No Results Available,HIV Infections|Tuberculosis Infection|Hepatitis C|Covid19,Drug: ART Therapy,All,Child,,10000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 1, 2013","January 1, 2025"
5285,NCT04565782,Recruiting,No Results Available,SARS-CoV Infection|Corona Virus Infection|Liver Transplant Recipient|COVID-19,,All,"Child, Adult, Older Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"September 15, 2020","December 31, 2020"
5286,NCT04447833,"Active, not recruiting",No Results Available,"ARDS, Human|COVID",Drug: Mesenchymal Stromal Stem Cells - KI-MSC-PL-205,All,"Adult, Older Adult",Phase 1,7.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 17, 2020","June 30, 2025"
5287,NCT04502433,Recruiting,No Results Available,Acute Respiratory Distress Syndrome,Drug: CUROSURF® (poractant alfa),All,"Adult, Older Adult",Phase 2,85.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 6, 2021","July 31, 2021"
5288,NCT04468581,Completed,No Results Available,Coronavirus,Behavioral: Use of mobile application,All,"Adult, Older Adult",,505.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"April 3, 2020","July 17, 2020"
5289,NCT04721730,Recruiting,No Results Available,Child Mental Disorder,Behavioral: PLH-YC|Behavioral: Lecture,All,"Adult, Older Adult",Not Applicable,864.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"December 7, 2020","January 30, 2022"
5290,NCT04392219,Completed,No Results Available,Coronavirus,Drug: EIDD-2801|Drug: Placebo,All,Adult,Phase 1,130.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","April 10, 2020","August 11, 2020"
5291,NCT04632875,Recruiting,No Results Available,Meditation,Behavioral: Loving-Kindness Meditation|Behavioral: Relaxation Meditation,All,Adult,Not Applicable,68.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"December 4, 2020","November 20, 2021"
5292,NCT04809272,Recruiting,No Results Available,Child Maltreatment|Positive Parenting,Behavioral: ParentChat for parents of children ages 2-17,All,"Adult, Older Adult",Not Applicable,900.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 8, 2021","September 1, 2021"
5293,NCT04317365,Completed,No Results Available,Respiratory Tract Infections,Other: Women receiving extra remembering by healthcare,Female,Adult,Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 24, 2020","May 25, 2020"
5294,NCT04649996,Completed,No Results Available,Acute Appendicitis,Procedure: Appendectomy,All,"Child, Adult, Older Adult",,532.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"September 1, 2020","November 30, 2020"
5295,NCT04473274,Completed,No Results Available,Coronavirus Infection|Diabetes,Drug: Pioglitazone,All,"Adult, Older Adult",Phase 4,10.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 21, 2020","December 1, 2020"
5296,NCT04765384,Not yet recruiting,No Results Available,Healthy,Biological: Ad26.COV2.S,Female,Adult,Phase 2,400.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"March 12, 2021","June 20, 2023"
5297,NCT04443179,Recruiting,No Results Available,Autism Spectrum Disorder|Attention Deficit Hyperactivity Disorder|Neurodevelopmental Conditions|COVID-19,,All,"Child, Adult, Older Adult",,790.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"April 5, 2013",December 2023
5298,NCT04703400,Completed,No Results Available,Surgical Education,Other: anonymous survey,All,Adult,,195.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 15, 2020","January 3, 2021"
5299,NCT04670484,Not yet recruiting,No Results Available,Hypoxia,Other: Wearing Mask,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"January 1, 2021","December 31, 2021"
5300,NCT04719468,Not yet recruiting,No Results Available,Parkinson Disease,Other: Dance with ballet elements,All,"Adult, Older Adult",Not Applicable,160.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"February 1, 2021","September 1, 2023"
5301,NCT04771585,Recruiting,No Results Available,Healthy,Other: Community Mask|Other: Surgical Mask|Other: FFP2 respirator|Other: FFP3 respirator,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"March 15, 2021","January 31, 2022"
5302,NCT04524052,Not yet recruiting,No Results Available,Healthy,Drug: DWRX2003|Drug: Placebo,All,Adult,Phase 1,32.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment",August 2020,December 2020
5303,NCT04797689,Not yet recruiting,No Results Available,"Mental Health Wellness 1|Eating Behavior|Stress, Psychological|Eating Habit",Behavioral: Trauma Informed Yoga|Behavioral: Trauma Informed Psychotherapy,Female,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,August 2021
5304,NCT04055376,"Active, not recruiting",No Results Available,Alzheimer Disease|Alzheimer Dementia,Device: GENUS device (Active Settings)|Device: GENUS device (Sham Settings),All,"Adult, Older Adult",Not Applicable,15.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","August 14, 2019","April 30, 2025"
5305,NCT04550351,"Active, not recruiting",No Results Available,Coronavirus,Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group|Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) high-dose group|Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) placebo group,All,"Adult, Older Adult",Phase 1,50.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","August 19, 2020","December 31, 2021"
5306,NCT04322786,"Active, not recruiting",No Results Available,"Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom",Drug: ACE inhibitor,All,"Adult, Older Adult",,1302508.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"January 1, 1998","March 31, 2021"
5307,NCT04643964,Recruiting,No Results Available,Depressive Symptoms,Behavioral: Entrée: Cognitive skills|Behavioral: Entrée: Behavioral skills|Behavioral: Entrée: Interpersonal skills|Behavioral: Sampler skills,All,"Adult, Older Adult",Not Applicable,501.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,November 2020,November 2020
5308,NCT04107402,Recruiting,No Results Available,Septic Shock|Platelet Signal Processing Defect|Inflammatory Response|Disseminated Intravascular Coagulation|Covid19|Neutrophil Extracellular Trap Formation,"Other: Assessment of coagulopathy, Platelets activation and Platelets-Neutrophils interplay",All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"March 15, 2019","March 15, 2024"
5309,NCT04378803,Completed,No Results Available,Well Aging,Behavioral: Mindfulness training (MT) Connect,All,"Adult, Older Adult",Not Applicable,53.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"May 13, 2020","August 4, 2020"
5310,NCT04799561,Not yet recruiting,No Results Available,Abdominal Cancer|Thoracic Cancer,Behavioral: Multimodal Teleprehabilitation,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 15, 2021","December 15, 2022"
5311,NCT04518514,Recruiting,No Results Available,Patients Undergoing Elective Surgery With Anesthesia,Device: TAPE-Software,All,"Child, Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 20, 2020","November 30, 2020"
5312,NCT04465435,Enrolling by invitation,No Results Available,Mental Health Issue|Musculoskeletal Pain,Other: Web-based self-report questionnaires|Other: Focus Group Interviews,All,"Adult, Older Adult",,5000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 19, 2019","January 31, 2032"
5313,NCT04329897,Completed,No Results Available,Hip Osteoarthritis|Knee Osteoarthritis|Mental Stress|Coronavirus,Behavioral: Software Messaging,All,"Adult, Older Adult",Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 5, 2020","June 1, 2020"
5314,NCT04414826,Recruiting,No Results Available,Loneliness,Behavioral: Mindfulness Alone (MO) Intervention|Behavioral: Mindfulness + Compassion Intervention (MC),All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 25, 2020",May 2021
5315,NCT04475913,Completed,No Results Available,Edentulous Mouth,Other: DIG Axial|Other: DIG Tilted|Other: CIG Axial|Other: CIG Tilted,All,"Adult, Older Adult",Not Applicable,56.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 11, 2018","August 20, 2020"
5316,NCT04602286,Recruiting,No Results Available,"Pain, Intractable|Pain, Chronic",Other: Meditation (1 x 20-minute guided audio training),All,"Adult, Older Adult",Not Applicable,292.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 28, 2020",March 2021
5317,NCT04748289,Recruiting,No Results Available,Clinical Decision Support System,Device: ICU Cockpit software testing,All,"Child, Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"March 1, 2021","January 31, 2023"
5318,NCT04552392,Completed,No Results Available,Quarantine,Other: No intervention,All,Adult,,176.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"September 20, 2020","October 20, 2020"
5319,NCT04800939,Recruiting,No Results Available,Sleep,Other: Acupressure|Other: Plasebo acupressure,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,"April 5, 2021","July 22, 2022"
5320,NCT04340414,Recruiting,No Results Available,COVID-19|ECMO,Device: Low flow ECMO driving by CVVH machine,All,"Child, Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 20, 2020","October 15, 2020"
5321,NCT04293887,Not yet recruiting,No Results Available,COVID-19|Recombinant Human Interferon α1β,Drug: Recombinant human interferon α1β,All,"Adult, Older Adult",Early Phase 1,328.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 1, 2020","June 30, 2020"
5322,NCT04760418,Not yet recruiting,No Results Available,PTSD|Opioid-use Disorder|Substance Use Disorders,Behavioral: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE),All,"Adult, Older Adult",Not Applicable,6.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 1, 2021","August 1, 2022"
5323,NCT04513496,Not yet recruiting,No Results Available,Telemedicine|HIV-1-infection,,All,"Adult, Older Adult",,4000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 1, 2020","July 1, 2022"
5324,NCT04757207,Recruiting,No Results Available,Sedentary Behavior|Covid19,Other: survey,All,"Child, Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"February 22, 2021","May 1, 2021"
5325,NCT04644276,Recruiting,No Results Available,Respiratory Failure|Covid19,Device: Mask with Mask Adhesive/Arm 1|Device: Mask without Mask Adhesive / Arm 2,All,"Adult, Older Adult",Not Applicable,30.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"February 17, 2021","May 30, 2021"
5326,NCT04389372,Recruiting,No Results Available,Migraine Headache,Behavioral: Mindfulness,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 15, 2020",December 2021
5327,NCT04574219,Recruiting,No Results Available,Anxiety|Surgery,Other: Use of Facetime with child and parents during induction,All,Child,Not Applicable,184.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"November 3, 2020",December 2022
5328,NCT04805489,Not yet recruiting,No Results Available,Cardiovascular Check-up,Other: Mask,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 26, 2021","November 25, 2021"
5329,NCT04564040,Completed,No Results Available,Mantle Cell Lymphoma|COVID-19,Drug: Acalabrutinib Treatment A|Drug: Acalabrutinib Treatment B|Drug: Acalabrutinib Treatment C|Drug: Acalabrutinib Treatment D,All,Adult,Phase 1,20.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 12, 2020","December 11, 2020"
5330,NCT04604977,Recruiting,No Results Available,Headaches Chronic,Behavioral: Mindfulness,All,"Child, Adult",Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 15, 2020",December 2021
5331,NCT04663594,Recruiting,No Results Available,Depression|Anxiety,Other: WofB|Other: Ashmolean Website,All,"Child, Adult",Not Applicable,400.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"December 4, 2020",March 2021
5332,NCT04418947,Completed,No Results Available,Communication Research,Other: Communication type,All,"Child, Adult, Older Adult",Not Applicable,11120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","June 15, 2020","July 17, 2020"
5333,NCT04482387,Recruiting,No Results Available,Visual Impairment|Amblyopia Suspect,Device: DigiVis visual acuity app,All,"Child, Adult, Older Adult",Not Applicable,250.0,Other,Interventional,Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"July 24, 2020","July 1, 2021"
5334,NCT04404192,Not yet recruiting,No Results Available,Adjustment Disorder With Anxious Mood,Drug: PH94B,All,"Adult, Older Adult",Phase 2,30.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,November 2020,September 2021
5335,NCT04428099,Recruiting,No Results Available,"Depressive Disorder, Treatment-Resistant",Behavioral: Lifestyle change promotion program|Behavioral: Mindfullness based cognitive program|Behavioral: Written Information,All,"Adult, Older Adult",Not Applicable,186.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 13, 2020","July 12, 2022"
5336,NCT04662021,Enrolling by invitation,No Results Available,Anxiety Depression Disorder,Other: Aerobic Exercises,Female,Adult,Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"December 10, 2020","February 25, 2021"
5337,NCT04370067,Recruiting,No Results Available,Coronavirus Infection,,All,"Child, Adult, Older Adult",,11200.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Other,"May 1, 2020","August 1, 2021"
5338,NCT04748536,Recruiting,No Results Available,Healthy Volunteer,Drug: IRL201104|Drug: Placebo,All,"Adult, Older Adult",Phase 1,18.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 29, 2021","April 5, 2021"
5339,NCT04435028,Completed,No Results Available,Breast Cancer|Iron Chelation,Drug: Ketotifen 1 MG,Female,Adult,,111.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"January 14, 2019","August 13, 2019"
5340,NCT04780425,"Active, not recruiting",No Results Available,"Diabetes Mellitus, Type 2",Behavioral: DESMOND|Other: usual care,All,"Adult, Older Adult",Not Applicable,206.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care,"January 26, 2021","May 31, 2021"
5341,NCT04470869,Recruiting,No Results Available,Post Traumatic Stress Disorder,Other: Phone call,All,"Adult, Older Adult",Not Applicable,130.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 12, 2020","October 12, 2021"
5342,NCT02027233,Recruiting,No Results Available,Severe Acute Respiratory Infection,Other: nasopharyngeal sample,All,"Adult, Older Adult",Not Applicable,2000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,January 2014,December 2022
5343,NCT04663776,Recruiting,No Results Available,Covid19|Influenza|Respiratory Tract Infections|Acute Respiratory Tract Infection|Acute Respiratory Distress Syndrome,,All,"Adult, Older Adult",,100000.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 4, 2020","December 8, 2021"
5344,NCT04737486,Completed,No Results Available,Covid19-associated ARDS|Covid19|ARDS,Drug: AV-001|Other: Placebo,All,"Adult, Older Adult",Phase 1,48.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 16, 2020","March 10, 2021"
5345,NCT04363775,Completed,No Results Available,Tracheal Intubation|Infection|Projection,Device: The standard Macintosh laryngoscope|Device: The Vie Scope laryngoscope,All,"Adult, Older Adult",Not Applicable,35.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 20, 2020","February 25, 2020"
5346,NCT04432038,Recruiting,No Results Available,Adult|Global Health,,All,"Adult, Older Adult",,50000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 19, 2020","June 30, 2021"
5347,NCT04591873,Not yet recruiting,No Results Available,"Critical Illness|Infections, Respiratory|Emergency Service, Hospital|Telemedicine",Other: telemedicine|Other: traditional communication tools,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 10, 2020","October 30, 2021"
5348,NCT04467086,Recruiting,No Results Available,Mechanical Ventilation|Sedation|Critical Illness|COVID,Drug: Propranolol Hydrochloride,All,"Adult, Older Adult",Phase 3,108.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"December 11, 2020",May 2021
5349,NCT04625465,Recruiting,No Results Available,"Alcohol Consumption|Violence, Domestic|Stress, Psychological|Aggression",Behavioral: CBT Text Messaging|Behavioral: Attention Control Text Messaging,All,"Adult, Older Adult",Not Applicable,480.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"November 12, 2020","September 30, 2022"
5350,NCT04497922,Recruiting,No Results Available,"Satisfaction, Patient|Covid19|Emergencies|Satisfaction|Information Disclosure",Device: e-ink screen|Behavioral: Treatment as usual,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 25, 2021","May 15, 2021"
5351,NCT04346979,Not yet recruiting,No Results Available,Telerehabilitation,Other: Telerehabilitation-Based|Other: Video-Based,Female,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"August 1, 2020","November 1, 2020"
5352,NCT04666558,Recruiting,No Results Available,Cancer|Lung Diseases|Liver Diseases,Other: Exercise & Nutrition,All,"Adult, Older Adult",Not Applicable,216.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"November 30, 2020","December 17, 2021"
5353,NCT04525079,Recruiting,No Results Available,SARS-CoV-2 Infection,Drug: CT-P59|Drug: Placebo,All,Adult,Phase 1,32.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Screening","July 18, 2020","November 30, 2020"
5354,NCT04842175,Not yet recruiting,No Results Available,Airway Disease,,All,"Child, Adult, Older Adult",,203.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"May 15, 2021","July 1, 2021"
5355,NCT04538495,Recruiting,No Results Available,Kawasaki Disease|Inflammation,,All,"Child, Adult, Older Adult",,100.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"August 1, 2020","July 1, 2021"
5356,NCT03583541,"Active, not recruiting",No Results Available,Control arm_Bolstered Care|Treatment arm_HIVRR+S+FL|Treatment arm_HIVRR+S+FLM,Behavioral: HIV Risk Reduction|Behavioral: Financial Literacy|Behavioral: Mentorship|Behavioral: Matched savings individual development account,Female,"Adult, Older Adult",Not Applicable,542.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","June 4, 2019",December 2022
5357,NCT03680274,Recruiting,No Results Available,Sepsis|Vitamin C|Intensive Care Unit|COVID-19|Pandemic|Coronavirus,Drug: Vitamin C|Other: Control,All,"Adult, Older Adult",Phase 3,800.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 8, 2018","December 31, 2022"
5358,NCT04582838,Recruiting,No Results Available,Respiratory Failure,Diagnostic Test: Pulse oximeter|Diagnostic Test: ECG,All,"Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","July 30, 2021"
5359,NCT04487483,"Active, not recruiting",No Results Available,Sleep,Behavioral: Sleep App,All,"Adult, Older Adult",Not Applicable,101.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"February 13, 2020","August 15, 2020"
5360,NCT04665557,Not yet recruiting,No Results Available,Body Image,Behavioral: Dove Confident Me Indonesia Single Session,All,Child,Not Applicable,2000.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,March 2021,October 2021
5361,NCT04761510,Completed,No Results Available,"Stress Disorders, Post-Traumatic|Stress Related Disorder",Behavioral: Mindfulness-SOS for Refugees,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 14, 2020","January 14, 2021"
5362,NCT04476719,"Active, not recruiting",No Results Available,Bioequivalence,Drug: ATAFENOVIR 200 MG KAPSUL|Drug: ARBIDOL 100 MG KAPSUL,Male,Adult,Phase 1,18.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 9, 2020","August 20, 2020"
5363,NCT04699942,Not yet recruiting,No Results Available,Hypoxemia,Device: Conventional (low flow) oxygen delivery via nasal cannula|Device: Revoxa Oxygen Rebrearther,All,"Adult, Older Adult",Not Applicable,23.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"January 4, 2021","July 1, 2021"
5364,NCT03117881,Recruiting,No Results Available,Multiple Sclerosis,Behavioral: DirectCAM|Behavioral: TeleCAM|Behavioral: rDirectCAM,All,"Adult, Older Adult",Not Applicable,833.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 8, 2018","January 31, 2023"
5365,NCT04566614,Recruiting,No Results Available,"Neoplasm, Colorectal|Neoplasm of Lung|Neoplasm, Bladder|Neoplasms Pancreatic|Biliary Tract Neoplasms|Gastro Intestinal Stromal Tumour",Other: ctDNA blood sampling,All,"Adult, Older Adult",,112.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 18, 2020","December 31, 2022"
5366,NCT04297904,Recruiting,No Results Available,Urinary Incontinence in Old Age|Sedentary Behavior,Behavioral: Sedentary behaviour|Diagnostic Test: Urinary Incontinence,All,Older Adult,,458.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"February 20, 2020","January 13, 2022"
5367,NCT04589923,Recruiting,No Results Available,Hypertension|Hypoxia|Hypotension,Device: Lifelight® Data Collect Blood Pressure Group|Device: Lifelight® Data Collect Oxygen Saturation Group,All,"Adult, Older Adult",,200.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 14, 2020",January 2022
5368,NCT04339842,Completed,No Results Available,Health Behavior|Eating Behavior,Other: Assessment of Dietary Changes in Adults in the Quarantine,All,"Adult, Older Adult",,673.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"April 10, 2020","May 31, 2020"
5369,NCT04569019,Recruiting,No Results Available,Vaccnation in HCW,Other: Vacciantion status in health care workers,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Cross-Sectional,"September 1, 2020","July 1, 2022"
5370,NCT03651622,"Active, not recruiting",No Results Available,"Diabetes Mellitus, Type 1|Overweight and Obesity","Behavioral: Hypocaloric, low carbohydrate diet|Behavioral: Hypocaloric, moderate low fat diet|Behavioral: Mediterranean diet, no caloric restriction",All,Adult,Not Applicable,69.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 12, 2018","July 1, 2021"
5371,NCT04502368,Recruiting,No Results Available,Fiberoptic Bronchoscopy (FOB)|Bronchoalveolar Lavage (BAL)|Respiratory Disease,Procedure: Fiberoptic Bronchoscopy (FOB)|Procedure: Bronchoalveolar Lavage (BAL)|Diagnostic Test: Electrical Impedance Tomography (EIT)|Diagnostic Test: Arterial Blood Gas test (ABG),All,"Adult, Older Adult",,15.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"September 1, 2020","April 30, 2021"
5372,NCT03136471,Completed,No Results Available,"Diabetes Mellitus, Type 2|Chronic Disease",,All,"Adult, Older Adult",,22242.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,January 2017,"March 1, 2021"
5373,NCT04591912,Recruiting,No Results Available,Eating Disorders in Adolescence,Behavioral: mind. body. voice,Female,"Child, Adult, Older Adult",Not Applicable,140.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 9, 2020","May 31, 2031"
5374,NCT03367845,Recruiting,No Results Available,"Behavior, Infant",Behavioral: Control|Behavioral: Sensitivity Intervention|Behavioral: Couples' Intervention|Behavioral: Sensitivity and Couples' Intervention,All,"Child, Adult, Older Adult",Not Applicable,1200.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Other","January 11, 2017","December 31, 2023"
5375,NCT04276987,Completed,No Results Available,Coronavirus,Biological: MSCs-derived exosomes,All,"Adult, Older Adult",Phase 1,24.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 15, 2020","July 31, 2020"
5376,NCT04826809,Recruiting,No Results Available,Covid19|Tuberculosis|Respiratory Viral Infection,Device: N95 mask|Device: Nordell single E-100 layer mask|Device: Nordell double E-100 layer mask,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,April 2021,"October 1, 2021"
5377,NCT04441164,Withdrawn,No Results Available,Weakness of the Lower Limbs,Other: Observation of Virtual Actions|Other: Relaxation|Other: Acceptability questionnaire|Other: Observation of Virtual Actions (step 4)|Other: Performing Virtual Actions|Other: Haptic stimulation|Other: Without haptic stimulation,All,"Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 1, 2020","August 1, 2023"
5378,NCT04596657,Recruiting,No Results Available,Respiratory Tract Infections|Covid19|Flu Like Illness,Dietary Supplement: Vitamin D supplementation,All,"Adult, Older Adult",Not Applicable,2099.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 27, 2020",November 2021
5379,NCT04568564,Recruiting,No Results Available,Lung Cancer|Physiotherapy,"Other: Breathing exercise, intensive spirometry use, supported cough, progressive mobilisation and ambulation|Other: Exercise booklet",All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"October 1, 2020","May 1, 2021"
5380,NCT04485741,Recruiting,No Results Available,Copd|Asthma|Covid19,Device: RESP,All,"Adult, Older Adult",,30.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"September 23, 2020","August 31, 2021"
5381,NCT04668820,Not yet recruiting,No Results Available,Musculoskeletal Abnormality|Pediatric,"Diagnostic Test: video Pediatric Gait, Arms, Legs and Spine (V-pGALS)",All,"Child, Adult",Not Applicable,15.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"February 1, 2021","April 1, 2021"
5382,NCT04276688,Completed,No Results Available,Novel Coronavirus Infection,Drug: Lopinavir/ritonavir|Drug: Ribavirin|Drug: Interferon Beta-1B,All,"Adult, Older Adult",Phase 2,127.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 10, 2020","March 31, 2020"
5383,NCT04743973,Not yet recruiting,No Results Available,"Stress, Emotional|Sleep|Quality of Life",Device: Muse S™ Headband system,All,"Adult, Older Adult",Not Applicable,20.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 15, 2021","January 15, 2023"
5384,NCT04411056,Completed,No Results Available,Intubation,Other: Barrier box,All,"Adult, Older Adult",Not Applicable,78.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 7, 2020","May 25, 2020"
5385,NCT03827109,Recruiting,No Results Available,Pediatric Crohns Disease|Pediatric Ulcerative Colitis|Inflammatory Bowel Diseases,Behavioral: Group educational activities|Behavioral: IBD educational website|Behavioral: Monthly check-in calls from program coordinator|Behavioral: Mentor|Behavioral: Fun group activities|Behavioral: Parent support group,All,Child,Not Applicable,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 12, 2019","February 23, 2023"
5386,NCT04411472,Recruiting,No Results Available,Acute Kidney Injury Due to Sepsis,Biological: Recombinant human alkaline phosphatase|Other: Placebo,All,"Adult, Older Adult",Phase 3,1600.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 2, 2020","February 15, 2024"
5387,NCT04783584,Recruiting,No Results Available,Difficult Intubation|Difficult Airway Intubation,,Female,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 1, 2020","August 15, 2021"
5388,NCT04817995,Recruiting,No Results Available,Perceived Stress,Behavioral: FOREST,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,April 2021,April 2022
5389,NCT04283825,Withdrawn,No Results Available,Coronavirus Disease 2019,Behavioral: Psychological and physical rehabilitation based humanistic care,All,"Child, Adult, Older Adult",Not Applicable,0.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"February 22, 2020","May 15, 2020"
5390,NCT04675658,"Active, not recruiting",No Results Available,Healthy Lifestyle|Sedentary Behavior,Behavioral: CBPA + family support|Behavioral: CBPA,All,"Child, Adult, Older Adult",Not Applicable,515.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Care Provider)|Primary Purpose: Prevention,"October 5, 2020","March 30, 2021"
5391,NCT04367922,Recruiting,No Results Available,Anxiety|Depression|Social Isolation,Behavioral: Positive Emotion Skills Course,All,"Adult, Older Adult",Not Applicable,1000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 27, 2020","February 28, 2022"
5392,NCT04508114,Recruiting,No Results Available,Hand Hygiene,Behavioral: Technology-assisted Index,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"August 10, 2020",May 2022
5393,NCT04648111,Not yet recruiting,No Results Available,"Blood Pressure, Heart Rate, Breathing Rate, Heart Rate Variability (HRV: Stress), and Oxygen Level",Diagnostic Test: Vital sign measurement,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 15, 2020","December 15, 2024"
5394,NCT04775524,Not yet recruiting,No Results Available,Stress|Post Traumatic Stress Disorder|Work Related Stress,Behavioral: Storytelling Through Music (STM)|Behavioral: Wait List / Storytelling Through Music-Hybrid,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,August 2021,"May 31, 2022"
5395,NCT04671602,Recruiting,No Results Available,Hypertension in Pregnancy,,Female,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"August 19, 2020","August 31, 2021"
5396,NCT04618926,Not yet recruiting,No Results Available,Difficult Airway,Device: Device intubating Laryngeal Tube Suction Disposable,All,"Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2021","December 31, 2021"
5397,NCT04558905,Enrolling by invitation,No Results Available,Rheumatoid Arthritis|Telehealth,Other: Face-to-face medical visits|Other: Alternating face-to-face medical visits and video medical consultations,All,"Adult, Older Adult",Not Applicable,156.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"October 1, 2020","May 31, 2022"
5398,NCT04349332,Recruiting,No Results Available,Mechanical Ventilation|Corona Virus Infection,Device: Helmet non-invasive ventilation (NIV),All,"Adult, Older Adult",Not Applicable,108.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 13, 2020","June 1, 2021"
5399,NCT02656381,Recruiting,No Results Available,Uveitis,,All,"Child, Adult, Older Adult",,650.0,NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 26, 2016","December 31, 2029"
5400,NCT04714164,Not yet recruiting,No Results Available,Major Depressive Disorder|Generalized Anxiety Disorder|Social Anxiety Disorder|Panic Disorder,Behavioral: Group Cognitive Behavioral Therapy,All,Older Adult,Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,February 2021,December 2021
5401,NCT04715906,Recruiting,No Results Available,Anxiety Disorders|Depression,Behavioral: UP-Caregiver,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 22, 2021","December 31, 2021"
5402,NCT04402801,Enrolling by invitation,No Results Available,Cystic Fibrosis,,All,"Adult, Older Adult",,140.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","May 31, 2021"
5403,NCT00571389,Recruiting,No Results Available,"Solid Tumor, Adult|Healthy Donors|COVID-19 Donors",,All,"Adult, Older Adult",,1000.0,Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,November 2007,February 2025
5404,NCT04818047,Recruiting,No Results Available,Post Partum Depression,Behavioral: VID-KIDS Intervention Program,Female,"Child, Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 15, 2021","August 31, 2021"
5405,NCT04790136,"Active, not recruiting",No Results Available,Comparative Bioavailability,"Drug: GLA-015|Drug: DAC C-052 ""Cannabidiol"" / NRF 22.10 ""Oily cannabidiol solution 100 mg/ml""",All,"Adult, Older Adult",Phase 1,18.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"March 17, 2021","April 29, 2021"
5406,NCT04628130,Completed,No Results Available,Chronic Pain,Other: Yoga Therapy,All,"Adult, Older Adult",,42.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Retrospective,"September 17, 2020","November 9, 2020"
5407,NCT04744805,Not yet recruiting,No Results Available,Dry Eye Syndromes,Other: face mask or not,All,"Child, Adult, Older Adult",,6262.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"January 29, 2021","February 6, 2021"
5408,NCT04330352,Completed,No Results Available,Face-touching Behavior,"Behavioral: Mindfulness-based ""STOP touching your face"" practice",All,"Adult, Older Adult",Not Applicable,1094.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"April 2, 2020","July 2, 2020"
5409,NCT04114864,Recruiting,No Results Available,Adolescent - Emotional Problem|Mental Health Wellness 1|Caregivers|Primary Prevention|Cognitive Therapy,Behavioral: Psycho-educational sessions,All,Child,Phase 1|Phase 2,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 20, 2019","May 31, 2021"
5410,NCT04424953,Completed,No Results Available,Coronavirus Infection|Ventilatory Failure|Anesthesia Intubation Complication,Device: McGrath videolaryngoscope|Device: Direct laryngoscope,All,"Adult, Older Adult",Not Applicable,28.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","June 1, 2020","September 25, 2020"
5411,NCT03826797,Recruiting,No Results Available,Acute Respiratory Failure,,All,"Adult, Older Adult",,70.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 16, 2016","December 31, 2022"
5412,NCT04518878,Recruiting,No Results Available,Immune Thrombocytopenia,Drug: Eltrombopag|Drug: rhTPO,All,"Adult, Older Adult",Phase 1,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 31, 2020",June 2022
5413,NCT03209713,Recruiting,No Results Available,Parents,Behavioral: HPV Vaccine Education|Behavioral: Text Messaging Reminder,All,"Adult, Older Adult",Not Applicable,800.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"June 28, 2017",June 2023
5414,NCT04489407,Not yet recruiting,No Results Available,Coronavirus|Cardiac Disease|Respiratory Disease|Vascular Diseases,Device: Remote Photoplethysmography (rPPG) vital sign acquisition,All,"Adult, Older Adult",Not Applicable,350.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"August 1, 2020","November 30, 2020"
5415,NCT04418934,Withdrawn,No Results Available,Whole Blood Donations and Leukoreduction,Device: Hemanext One,All,"Adult, Older Adult",Phase 2,0.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 1, 2020","May 1, 2021"
5416,NCT04772820,Not yet recruiting,No Results Available,Malnutrition|Isolation|Depression|Anxiety|Sedentary Behavior|Loneliness,Behavioral: Telephone-based coaching,All,Older Adult,Not Applicable,60.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,April 2021,"June 30, 2022"
5417,NCT04616586,Suspended,No Results Available,Acute Respiratory Distress Syndrome|Lung Diseases|Pneumonia|Respiratory Tract Infections|Respiratory Tract Disease,Drug: Siltuximab|Other: Normal Saline,All,"Child, Adult, Older Adult",Phase 3,555.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","November 13, 2020","June 30, 2022"
5418,NCT04546854,Completed,No Results Available,Influenza Vaccine,Behavioral: Appeals,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","September 21, 2020","September 21, 2020"
5419,NCT04225845,Recruiting,No Results Available,Loneliness,Behavioral: Phone therapy|Behavioral: Cash transfer,All,"Adult, Older Adult",Not Applicable,1250.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"November 1, 2020",December 2027
5420,NCT04445194,"Active, not recruiting",No Results Available,Coronavirus,Biological: Recombinant new coronavirus vaccine (CHO cell) low-dose group|Biological: Recombinant new coronavirus vaccine (CHO cells) high-dose group|Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group,All,Adult,Phase 1,50.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","June 22, 2020","September 20, 2021"
5421,NCT03964142,Recruiting,No Results Available,Cardiotoxicity|Cardiac Rehabilitation,Other: Cardiac rehabilitation,Female,"Adult, Older Adult",Not Applicable,340.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"August 1, 2018","March 1, 2022"
5422,NCT04473456,Completed,No Results Available,Procedure Time,Procedure: Simultaneous EGD and colonoscopy,All,"Adult, Older Adult",Not Applicable,51.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Diagnostic","June 13, 2020","September 23, 2020"
5423,NCT04440150,Completed,No Results Available,Acute Appendicitis,Procedure: Appendectomy,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 1, 2018","June 1, 2019"
5424,NCT04708509,Not yet recruiting,No Results Available,Airway Extubation,Device: Extubation Advisor,All,"Adult, Older Adult",Phase 1,72.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,March 2021,June 2021
5425,NCT04430387,Not yet recruiting,No Results Available,"Dental Plaque|Calculus, Dental|Aerosol Disease",Device: The saliva ejector|Device: The high-volume evacuator|Device: The DryShield,All,Child,Not Applicable,180.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"November 1, 2021",November 2022
5426,NCT04690829,Enrolling by invitation,No Results Available,Uveitis|Ocular Inflammation,,All,"Child, Adult, Older Adult",,1000.0,NIH,Observational,Observational Model: Other|Time Perspective: Retrospective,"April 19, 2021","December 31, 2025"
5427,NCT04562948,"Active, not recruiting",No Results Available,Anxiety|Depression|Anxiety Generalized|Anxiety Disorders and Symptoms,,All,"Adult, Older Adult",,250.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Prospective,"November 11, 2020","October 31, 2022"
5428,NCT04153864,Recruiting,No Results Available,Perinatal Depression,Behavioral: Brief Behavioral Activation Treatment,Female,"Adult, Older Adult",Not Applicable,1368.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 6, 2020","December 30, 2025"
5429,NCT04299711,Not yet recruiting,No Results Available,Mental Disorder,Other: Exposed to the novel coronavirus disease 2019,All,"Child, Adult",,3428.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"October 15, 2020","March 15, 2022"
5430,NCT03807804,"Active, not recruiting",No Results Available,"Respiratory Distress Syndrome, Adult",Biological: HLCM051,All,"Adult, Older Adult",Phase 2,35.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 1, 2019","September 30, 2021"
5431,NCT04437966,Recruiting,No Results Available,Hypertension,Behavioral: Enhanced Chronic Disease Self-management program,All,"Adult, Older Adult",Not Applicable,384.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 11, 2020",December 2021
5432,NCT04457765,Withdrawn,No Results Available,Rhinoplasty,Drug: Povidone-Iodine (PVP-I),All,"Adult, Older Adult",Early Phase 1,0.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,April 2021,September 2022
5433,NCT04437134,Recruiting,No Results Available,Knee Osteoarthritis,Other: On-line exercise and education|Other: On-site exercise and education,All,"Adult, Older Adult",,500.0,Other,Observational,Observational Model: Other|Time Perspective: Other,"June 12, 2020",December 2021
5434,NCT04385862,Not yet recruiting,No Results Available,Continuous Glucose Monitoring,,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"July 27, 2020","January 11, 2021"
5435,NCT04673513,Recruiting,No Results Available,Depression,Other: Psychotherapy,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 11, 2020","December 30, 2023"
5436,NCT04656288,Completed,No Results Available,Healthy,Drug: BI 764198 - Formula A|Drug: BI 764198 - Formula B|Drug: BI 764198 - Formula C|Drug: BI 764198 - Formula D,Male,Adult,Phase 1,28.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 15, 2021","March 15, 2021"
5437,NCT04739540,Not yet recruiting,No Results Available,Food Insecurity,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 30, 2021","September 1, 2021"
5438,NCT04526925,Completed,No Results Available,"Transmission, Patient-Professional",Device: Respiratory filter in-line placed with the standard mouthpiece|Other: Standard mouthpiece,All,"Adult, Older Adult",Not Applicable,10.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"August 29, 2020","September 18, 2020"
5439,NCT03029507,Recruiting,No Results Available,Obesity|Overweight,Behavioral: ACT Enhanced ShipShape|Behavioral: Standard ShipShape (SS),All,"Adult, Older Adult",Not Applicable,164.0,Other|U.S. Fed,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","December 8, 2017",July 2022
5440,NCT04654585,Recruiting,No Results Available,Smoking|Smoking Cessation,Other: The STOP intervention|Other: Standard Care,All,"Adult, Older Adult",Not Applicable,528.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","February 26, 2021","February 1, 2024"
5441,NCT04278404,Recruiting,No Results Available,Coronavirus Infection (COVID-19)|Pulmonary Arterial Hypertension|Urinary Tract Infections in Children|Hypertension|Pain|Hyperphosphatemia|Primary Hyperaldosteronism|Edema|Hypokalemia|Heart Failure|Hemophilia|Menorrhagia|Insomnia|Pneumonia|Skin Infection|Arrythmia|Asthma in Children|Bronchopulmonary Dysplasia|Adrenal Insufficiency|Fibrinolysis; Hemorrhage|Attention Deficit Hyperactivity Disorder|Multisystem Inflammatory Syndrome in Children (MIS-C)|Kawasaki Disease|Coagulation Disorder|Down Syndrome,"Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:",All,"Child, Adult",,5000.0,Other|Industry|NIH,Observational,Observational Model: Other|Time Perspective: Prospective,"March 5, 2020","April 24, 2024"
5442,NCT04655001,Recruiting,No Results Available,Pain|Obesity|Sedentary Behavior,Behavioral: MORPH,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 1, 2021",October 2022
5443,NCT04450303,"Active, not recruiting",No Results Available,Social Anxiety,Behavioral: Telehealth CBT,All,"Adult, Older Adult",Not Applicable,26.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 30, 2020","June 1, 2021"
5444,NCT04745364,"Active, not recruiting",No Results Available,Quality of Life|Cultural Competence|Stress,Behavioral: A 4-week Bharatanatyam course from the organization Mindful Kala,All,"Adult, Older Adult",Not Applicable,53.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"February 4, 2021","April 12, 2021"
5445,NCT02899754,Recruiting,No Results Available,Lung Cancer Screening,Behavioral: Lung Cancer Screening Decision Tool|Behavioral: Control Intervention,All,"Adult, Older Adult",Not Applicable,200.0,U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"January 28, 2019","November 30, 2021"
5446,NCT04576260,Recruiting,No Results Available,Sleep|Diet|Well Being,Behavioral: Cognitive Behavioural Therapy for Insomnia,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"October 16, 2020","June 1, 2021"
5447,NCT04521920,Recruiting,No Results Available,Opioid Use|Opioid-use Disorder|Risk Reduction|Hiv,Drug: Suboxone|Drug: PrEP,All,"Adult, Older Adult",Phase 4,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"November 9, 2020",May 2021
5448,NCT04563494,Not yet recruiting,No Results Available,"Nausea and Vomiting, Postoperative",Drug: dexamethasone,All,Child,Phase 4,126.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 1, 2021","January 1, 2022"
5449,NCT04741217,Not yet recruiting,No Results Available,Healthy|Respiratory Tract Infections|Lung Infection|Droplet Spread,Other: Not an interventional study,All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","September 1, 2021"
5450,NCT04511390,Recruiting,No Results Available,Personal Protective Equipment,"Device: Transparent, reusable respirator",All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 25, 2020",December 2020
5451,NCT02517489,Recruiting,No Results Available,Community Acquired Pneumonia,Drug: Hydrocortisone|Drug: Placebo,All,"Adult, Older Adult",Phase 3,1200.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","October 28, 2015",March 2021
5452,NCT04627493,Recruiting,No Results Available,Aging,Behavioral: Online exercise,All,Older Adult,Not Applicable,32.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,November 2020,August 2021
5453,NCT04496713,Recruiting,No Results Available,Telemedicine,Other: Internet-connected computer tablet,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"January 24, 2021","August 24, 2023"
5454,NCT04594785,Recruiting,No Results Available,Streptococcus Pneumonia|Streptococcus Pyogenes Infection|Neisseria Meningitides Meningitis,,All,"Child, Adult",,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 1, 2020","December 30, 2021"
5455,NCT03398135,Enrolling by invitation,No Results Available,Ulcerative Colitis (UC),Drug: risankizumab|Drug: placebo for risankizumab,All,"Child, Adult, Older Adult",Phase 3,942.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","August 28, 2018","May 23, 2024"
5456,NCT04432792,Not yet recruiting,No Results Available,Abortion Early,Other: Telehealth Consultation,Female,"Adult, Older Adult",Not Applicable,700.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,November 2020,October 2022
5457,NCT04685330,Not yet recruiting,No Results Available,Ultrasound Therapy; Complications,Procedure: Ultrasound guided procedure|Device: Portable ultrasound,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2021","December 31, 2023"
5458,NCT04742426,Not yet recruiting,No Results Available,Safety Issues|Communication|Cardiopulmonary Arrest,Other: WHO recommended PPE|Other: Super-safe setup,All,"Adult, Older Adult",Not Applicable,22.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"May 1, 2021","September 30, 2021"
5459,NCT04532112,Recruiting,No Results Available,Protective Device (Physical Object)|Aerosol Disease|Droplet Spread,Device: Biocontainment Device For Aerosol Generating Procedures (Biobox)|Device: Control for aerosol generating procedures,All,"Adult, Older Adult",Not Applicable,150.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"December 7, 2020",April 2021
5460,NCT04400734,Recruiting,No Results Available,"Aerosol-generating Procedure, Esophagogastroduodenoscopy","Other: No intervention, observational study",All,"Child, Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 7, 2020","January 31, 2021"
5461,NCT04423614,Not yet recruiting,No Results Available,Mechanical Ventilation Complication,Other: Inspiratory Muscle Training|Other: Relaxation Breathing,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,February 2021,December 2021
5462,NCT04765813,Not yet recruiting,No Results Available,Smoking,Behavioral: Cognitive-behavioral treatment to quit smoking along with an App with active therapeutic components|Behavioral: Cognitive-behavioral treatment to quit smoking along with a control App,All,"Adult, Older Adult",Not Applicable,270.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,April 2021,June 2023
5463,NCT04430231,Completed,No Results Available,Colorectal Cancer,Other: Wait list time,All,"Child, Adult, Older Adult",,602.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2012","April 1, 2020"
5464,NCT04632004,Enrolling by invitation,No Results Available,Dry Mouth|Halitosis,Other: Invitation to participate,All,"Child, Adult, Older Adult",Not Applicable,3000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 20, 2020","July 1, 2021"
5465,NCT04039243,Recruiting,No Results Available,Anxiety Disorder of Childhood|Fear|Shyness,Behavioral: Being Brave|Other: Parent Education,All,Child,Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 27, 2019","September 1, 2022"
5466,NCT04497753,Completed,No Results Available,Respiratory Infectious Diseases,,All,"Child, Adult, Older Adult",,6000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"June 19, 2020","August 31, 2020"
5467,NCT04497675,Completed,No Results Available,Respiratory Infectious Diseases,,All,"Child, Adult, Older Adult",,6000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"June 19, 2020","August 31, 2020"
5468,NCT04812899,Not yet recruiting,No Results Available,Eating Disorders,Behavioral: Parental guided self-help version of FBT-pre-recorded videos and readings from the book,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,April 2021,December 2021
5469,NCT04474028,Completed,No Results Available,Respiratory Infectious Diseases,,All,"Child, Adult, Older Adult",,6000.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"June 19, 2020","August 31, 2020"
5470,NCT04804072,Not yet recruiting,No Results Available,HIV Infections|Drug Use|Opioid Use|Opioid-use Disorder,"Drug: Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)|Diagnostic Test: HIV testing|Drug: HIV treatment for HIV-positive participants not already in care|Drug: PrEP for HIV-negative participants|Diagnostic Test: Testing and referral for vaccination or treatment for hepatitis A virus (HAV) and hepatitis B virus (HBV)|Diagnostic Test: Testing and referral for treatment for hepatitis C virus (HCV)|Diagnostic Test: Sexually transmitted infection (STI) testing and treatment|Other: Primary care|Behavioral: Harm reduction services|Behavioral: Peer navigation|Diagnostic Test: COVID-19 testing and referral for further evaluation, care and/or treatment",All,Adult,Not Applicable,860.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2021","October 1, 2024"
5471,NCT04714307,Recruiting,No Results Available,Spinocerebellar Ataxia Type 3|Machado-Joseph Disease|SCA3|MJD,Diagnostic Test: SCA3/MJD molecular diagnosis|Diagnostic Test: Cognitive Testing|Diagnostic Test: Psychiatric Evaluation|Diagnostic Test: Clinical Neurological Evaluation|Diagnostic Test: Emotional Attribution Evaluation|Diagnostic Test: Activities of Daily Living,All,"Adult, Older Adult",,144.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"December 13, 2019","August 1, 2023"
5472,NCT04794556,Completed,No Results Available,Infection,Device: tight-fitting of KF94 mask with clip,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 1, 2021","March 10, 2021"
5473,NCT04820387,Recruiting,No Results Available,Telemedicine|Physiology,,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Other,April 2021,September 2024
5474,NCT04834700,Recruiting,No Results Available,Emergencies,Other: online group,All,Adult,Not Applicable,32.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"December 17, 2020",April 2021
5475,NCT04501588,Recruiting,No Results Available,Autism Spectrum Disorder|Autism,Behavioral: Responsive training with no video feedback|Behavioral: Responsive training with video feedback,All,Child,Phase 2,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 6, 2020","September 30, 2021"
5476,NCT04767464,Not yet recruiting,No Results Available,Breast Cancer|Breast Neoplasm,Other: Compass Course,Female,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 1, 2021",March 2022
5477,NCT04770597,Enrolling by invitation,No Results Available,Healthcare Associated Infection,Device: Aranet4 Home CO2 monitor,All,"Child, Adult, Older Adult",Not Applicable,48.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"February 21, 2021",April 2021
5478,NCT04522713,Recruiting,No Results Available,Depression|Anxiety,"Behavioral: Behavioral activation, evidence-based sleep strategies including sleep restriction, exposure-based strategies, promotion of physical activity and recuperating activities, psychoeducational material",All,"Adult, Older Adult",Not Applicable,68.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 24, 2020",December 2021
5479,NCT04654637,Recruiting,No Results Available,Cancer,Behavioral: Nutrition and Exercise Strategies,All,"Adult, Older Adult",Not Applicable,128.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"November 1, 2020","November 30, 2023"
5480,NCT04542863,Recruiting,No Results Available,Solid Tumor,Other: 18F-DX600 PET/CT,All,"Child, Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"September 11, 2020",September 2022
5481,NCT03500328,Recruiting,No Results Available,"Multiple Sclerosis, Relapsing-Remitting",Other: Early Aggressive Therapy or Traditional Therapy,All,Adult,Not Applicable,900.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 2, 2018","August 1, 2023"
5482,NCT04422457,Recruiting,No Results Available,Solid Tumor,Other: 68Ga-DX600 PET/CT,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"June 13, 2020",June 2023
5483,NCT04536259,Completed,No Results Available,Hospital Outpatient Clinics|Chronic Disease,Behavioral: Video Default|Behavioral: In-Person Default|Behavioral: Active Choice,All,"Adult, Older Adult",Not Applicable,1481.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research","September 11, 2020","October 31, 2020"
5484,NCT04764539,Completed,No Results Available,Autism Spectrum Disorder|Apraxia of Speech,Behavioral: Video Assisted Speech Therapy (VAST),All,Child,Phase 1,6.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 1, 2019","November 30, 2020"
5485,NCT04843969,"Active, not recruiting",No Results Available,Cigarette Smoking|Addiction Nicotine|Tobacco Use,Behavioral: Stress induction|Behavioral: Control stress exposure|Behavioral: Cue induction|Behavioral: Neutral cue exposure,All,"Adult, Older Adult",Not Applicable,76.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"February 20, 2018","January 31, 2022"
5486,NCT04844294,Not yet recruiting,No Results Available,Suicide|Suicidal Ideation|Suicide Attempt,Behavioral: Brief Cognitive Behavioral Therapy (BCBT)|Behavioral: Present-Centered Therapy (PCT),All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,April 2021,April 2023
5487,NCT04344665,"Active, not recruiting",No Results Available,Surgery|Perioperative Complication|COVID,Other: Virtual Care and Remote Automated Monitoring,All,"Adult, Older Adult",Not Applicable,905.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"April 23, 2020",January 2021
5488,NCT04772677,Not yet recruiting,No Results Available,Maternal Depression,Behavioral: BEAM Mental Health and Parenting Program,Female,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 1, 2021","September 1, 2021"
5489,NCT04840498,Recruiting,No Results Available,Autism,Behavioral: Autism Research,All,"Child, Adult",,26.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 7, 2021","August 31, 2021"
5490,NCT04571593,Completed,No Results Available,Insomnia Due to Anxiety and Fear,Behavioral: Yoga Nidra,All,"Adult, Older Adult",Not Applicable,74.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"April 15, 2020","September 14, 2020"
5491,NCT04714606,Recruiting,No Results Available,Autism Spectrum Disorder,Other: Sibling support group|Other: None - control condition,All,Child,Not Applicable,25.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 14, 2020","April 30, 2021"
5492,NCT04402034,Completed,No Results Available,Disability Physical,Behavioral: Application of tele-rehabilitation,All,"Child, Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 15, 2020","October 21, 2020"
5493,NCT04029194,"Active, not recruiting",No Results Available,Aging,Behavioral: Assistance with old age pension application,All,"Adult, Older Adult",Not Applicable,1459.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"February 4, 2019","December 31, 2027"
5494,NCT04617132,"Active, not recruiting",No Results Available,Postpartum Depression|Postpartum Anxiety,Behavioral: MBCT/MBSR,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"October 20, 2020",August 2022
5495,NCT04687852,Recruiting,No Results Available,Pelvic Floor|Exercise|Telerehabilitation|Acupressure|Dysmenorrhea Primary|Drug Effect,Other: Conservative and Non-conservative treatments,Female,Adult,Not Applicable,85.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 9, 2020","December 9, 2021"
5496,NCT04485000,Completed,No Results Available,Postpartum Depression,Behavioral: Online 1-Day Cognitive Behavioural Therapy (CBT)-Based Workshop,Female,"Adult, Older Adult",Not Applicable,403.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","April 20, 2020","January 30, 2021"
5497,NCT04525521,Recruiting,No Results Available,Dermatitis Hand|Skin Abnormalities|Atopic Dermatitis|Atopic Dermatitis Eczema,Other: Hand sanitizer and hand washing,All,Adult,,40.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 1, 2020","August 20, 2021"
5498,NCT04461769,Completed,No Results Available,Sleep|Sleep Hygiene,Device: Transcranial Electrical Stimulation,All,"Adult, Older Adult",Early Phase 1,13.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","September 1, 2019","May 30, 2020"
5499,NCT04685759,Not yet recruiting,No Results Available,Cancer of Gastrointestinal Tract,Other: In-Person Exercise Protocol|Other: Virtual Exercise Protocol,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,March 2021,January 2022
5500,NCT03856749,Recruiting,No Results Available,Caregivers,Other: Remote wheelchair skills training,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"December 4, 2019",January 2022
5501,NCT04818008,Not yet recruiting,No Results Available,Multiple Sclerosis,Other: Otago Exercise Program,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,June 2021,December 2023
5502,NCT04586309,Not yet recruiting,No Results Available,"Burnout, Professional|Stress, Psychological|Depression|Job Stress",Behavioral: Transcendental meditation,All,"Child, Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,November 2020,December 2021
5503,NCT04173663,"Active, not recruiting",No Results Available,Autism Spectrum Disorder|Autism,Behavioral: ASSIST,All,"Child, Adult, Older Adult",Not Applicable,180.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"January 3, 2020","May 30, 2024"
5504,NCT04809961,Not yet recruiting,No Results Available,Peer Group,Other: I-care app,All,"Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"April 1, 2021","July 1, 2022"
5505,NCT04431323,Recruiting,No Results Available,Multiple Sclerosis,Behavioral: ESPRIMO,All,Adult,Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 13, 2020",August 2022
5506,NCT03821402,Completed,No Results Available,Upper Limb Spasticity,Biological: DAXI for injection dose LOW DOSE|Biological: DAXI for injection dose MEDIUM DOSE|Biological: DAXI for injection Dose HIGH DOSE|Other: Placebo,All,"Adult, Older Adult",Phase 2,83.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","December 12, 2018","November 23, 2020"
5507,NCT04386798,Recruiting,No Results Available,Newborn|Anxiety,Other: survey work,Female,Adult,Not Applicable,60.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"July 25, 2020","February 25, 2021"
5508,NCT04104321,Recruiting,No Results Available,Nonalcoholic Steatohepatitis (NASH),Drug: Aramchol|Drug: Placebo,All,"Adult, Older Adult",Phase 3,2000.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 23, 2019",June 2027
5509,NCT04362163,Completed,No Results Available,Healthy,Device: Snorkel-based improvised personal protective equipment,All,"Adult, Older Adult",,10.0,Other,Observational,Observational Model: Case-Crossover|Time Perspective: Prospective,"May 1, 2020","June 5, 2020"
5510,NCT04800861,Recruiting,No Results Available,Diabetes|Diabetes Mellitus,,All,"Child, Adult, Older Adult",,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"January 1, 2021","July 1, 2021"
5511,NCT04114110,"Active, not recruiting",No Results Available,Inpatients|Staff,Other: RTLS data,All,"Child, Adult, Older Adult",,2000.0,Other,Observational,Observational Model: Other|Time Perspective: Retrospective,"January 6, 2020",December 2020
5512,NCT04752683,Not yet recruiting,No Results Available,Work Related Stress,Other: MyBuddy Employee Wellbeing App,All,"Adult, Older Adult",,220.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,March 2021,June 2021
5513,NCT04719039,Not yet recruiting,No Results Available,Yoga,Behavioral: Restorative Yoga Internvention,All,Adult,Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,February 2021,May 2021
5514,NCT04672486,Recruiting,No Results Available,"Mental Health Issue|Depression, Anxiety|Stress",Behavioral: POD Adventures,All,"Child, Adult",Not Applicable,120.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","January 28, 2021","May 31, 2021"
5515,NCT04444128,Recruiting,No Results Available,Myocarditis|Heart Failure|Myocardial Fibrosis,Diagnostic Test: CMR with T1 and T2 mapping,All,"Adult, Older Adult",,3000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 15, 2016","November 15, 2026"
5516,NCT04539756,Recruiting,No Results Available,Healthy,Behavioral: positive psychological intervention|Behavioral: Active control condition,All,"Adult, Older Adult",Not Applicable,250.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science,"September 8, 2020","August 1, 2021"
5517,NCT04820257,Not yet recruiting,No Results Available,"COPD, Chronic Obstructive Pulmonary Disease",Behavioral: Home based exercise,All,"Adult, Older Adult",Not Applicable,80.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,March 2021,December 2022
5518,NCT04690517,Recruiting,No Results Available,Cardiopulmonary Arrest,Procedure: tracheal ultrasound,All,"Adult, Older Adult",Not Applicable,34.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"January 30, 2021",July 2021
5519,NCT04704570,Not yet recruiting,No Results Available,Healthy People,"Other: Exercise|Other: Remotely and face to face evaluation of Functional Capacity Level, Quality of life, Kinesophobia, Cognitive Level",All,Adult,Not Applicable,20.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"March 25, 2021","September 29, 2022"
5520,NCT04616768,Recruiting,No Results Available,Cancer|Lung Cancer|Gastro-intestinal,Other: PRO questionnaire|Other: Step monitoring|Other: Active nudge text feedback|Other: PROStep Dashboard (clinicians),All,"Adult, Older Adult",Phase 3,125.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"November 19, 2020","November 1, 2021"
5521,NCT04822090,"Active, not recruiting",No Results Available,Parvovirus B19 Infection,Other: Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG),All,"Child, Adult, Older Adult",,244.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 10, 2018","February 10, 2024"
5522,NCT04291638,Completed,No Results Available,Selective Mutism,Behavioral: Remote Caregiver Training|Behavioral: Remote Intensive Group Behavioral Treatment (IGBT),All,Child,Not Applicable,11.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"March 6, 2020","December 7, 2020"
5523,NCT04406363,Not yet recruiting,No Results Available,Chronic Low-back Pain,Other: non interventional,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"June 2, 2020","June 21, 2020"
5524,NCT04832152,Not yet recruiting,No Results Available,Autism Spectrum Disorder,Other: OT4ASD,All,Child,Not Applicable,10.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 1, 2021","June 30, 2022"
5525,NCT04136340,Recruiting,No Results Available,Cancer|Supportive Care,Other: In-person in clinic follow-up visit|Other: Telemedicine follow-up visit,All,"Adult, Older Adult",Not Applicable,466.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"October 24, 2019",October 2021
5526,NCT03681288,"Active, not recruiting",No Results Available,Substance Use Disorder|Post-traumatic Stress Disorder|Moral Injury,Behavioral: Mindful Self-Compassion,All,"Adult, Older Adult",Not Applicable,24.0,U.S. Fed,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 21, 2019","March 31, 2021"
5527,NCT04801316,Not yet recruiting,No Results Available,Community-dwelling Older Adults|Fall Risk,Behavioral: Steady Feet exercise programme|Behavioral: Steady Feet Video,All,"Adult, Older Adult",Not Applicable,290.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2021","March 31, 2023"
5528,NCT04020484,Recruiting,No Results Available,Epilepsy in Children|Mindfulness|Quality of Life,Behavioral: Making Mindfulness Matter© (M3),All,Child,Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Supportive Care","December 2, 2019","December 20, 2022"
5529,NCT04155463,Recruiting,No Results Available,Exposure to Herbicides,Other: Organic Diet|Other: Conventional Diet,Female,Adult,Not Applicable,40.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"February 23, 2021",August 2022
5530,NCT04524286,Recruiting,No Results Available,"Health Knowledge, Attitudes, Practice|Social Determinants|Public Health|Pregnancy Related",Other: Interviews only.,Female,"Child, Adult",,60.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Other,"November 6, 2020","March 18, 2022"
5531,NCT04498819,"Active, not recruiting",No Results Available,Type 2 Diabetes|Comorbidities and Coexisting Conditions,"Behavioral: Wearable Activity Trackers, Exercise Prescription and Virtual Care",All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"November 9, 2020","May 1, 2021"
5532,NCT04767568,Not yet recruiting,No Results Available,Colorectal Cancer,Diagnostic Test: Blood sample|Other: Tumor tissue,All,"Adult, Older Adult",Not Applicable,400.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,March 2021,September 2027
5533,NCT04662775,Completed,No Results Available,Physical Activity,Behavioral: HERizon Project,Female,Child,Not Applicable,42.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 15, 2020","July 8, 2020"
5534,NCT04772521,Not yet recruiting,No Results Available,Smoking Cessation,Behavioral: General health talk|Behavioral: Personalized chat-based interactions|Behavioral: Text message|Behavioral: Phone follow-up/counselling service|Drug: Mailed nicotine replacement therapy (NRT),All,"Adult, Older Adult",Not Applicable,735.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,"April 1, 2021","December 30, 2023"
5535,NCT04379622,Completed,No Results Available,"Diet, Healthy|Body Weight|Time Restricted Feeding|Sleep|Cardiovascular Risk Factor|Motivation","Other: Dietary intake, body composition, lifestyle, and CVD risk factors",All,"Adult, Older Adult",,93.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"May 22, 2020","August 5, 2020"
5536,NCT04168814,Completed,No Results Available,Malnutrition|Oncologic Complications|Oncology|Quality of Life,Other: Observational test,All,"Adult, Older Adult",,586.0,Other|Industry,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"June 10, 2020","December 15, 2020"
5537,NCT04323163,Recruiting,No Results Available,Aging|Cognitive Decline,Behavioral: Physical Activity,All,"Adult, Older Adult",Not Applicable,168.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 1, 2021","March 31, 2025"
5538,NCT04512378,Recruiting,No Results Available,Generalized Anxiety Disorder|Intolerance of Uncertainty|Anxiety,Behavioral: Behavioural Experiments for Intolerance of Uncertainty,All,"Adult, Older Adult",Not Applicable,20.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021",August 2021
5539,NCT04157296,Recruiting,No Results Available,Anxiety Disorders,Behavioral: Cognitive behavioral therapy (CBT)|Behavioral: computerized cognitive training (CCT),All,Child,Not Applicable,54.0,Other|NIH,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,"February 4, 2020",July 2021
5540,NCT04562350,Recruiting,No Results Available,Healthy,Other: XatJove Anoia Aplication,All,Child,Not Applicable,500.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"October 1, 2020","October 11, 2021"
5541,NCT04462250,Not yet recruiting,No Results Available,Opioid Use,Device: Prescription Opioid Management App,All,"Adult, Older Adult",Not Applicable,15.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Device Feasibility","March 1, 2021","June 30, 2021"
5542,NCT03680287,Recruiting,No Results Available,"Low Back Pain, Recurrent|Healthy",Drug: Within-Subject test of blinded study medication,All,Adult,Phase 2,250.0,Other|NIH,Interventional,"Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","October 7, 2019","February 29, 2024"
5543,NCT03105102,"Active, not recruiting",No Results Available,Crohn's Disease,Drug: Placebo for Risankizumab SC|Drug: Risankizumab IV|Drug: Placebo for Risankizumab IV|Drug: Risankizumab SC|Drug: Risankizumab On-Body Injector (OBI),All,"Adult, Older Adult",Phase 3,1337.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 9, 2018","June 9, 2026"
5544,NCT04540679,Not yet recruiting,No Results Available,Spinal Cord Injuries,Other: VIP4SCI,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 1, 2020","April 29, 2021"
5545,NCT04375657,Recruiting,No Results Available,Epigenetic Aging|Immunosenescence,Combination Product: TRIIM Treatment|Combination Product: Active Control,All,"Adult, Older Adult",Phase 2,85.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,October 2020,October 2022
5546,NCT03581123,Recruiting,No Results Available,"Acute Pain|Low Back Pain, Mechanical",Behavioral: Supported-Self Management (SSM)|Other: Spinal Manipulation Therapy (SMT)|Combination Product: SMT + SSM|Drug: Standard Medical Care (SMC),All,"Adult, Older Adult",Phase 3,1180.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","October 25, 2018",September 2023
5547,NCT04836026,Enrolling by invitation,No Results Available,Pediatric Kidney Disease|Acute Kidney Injury,Device: HF20™,All,"Child, Adult, Older Adult",,20.0,Other|Industry,Observational,Observational Model: Case-Only|Time Perspective: Prospective,"January 27, 2021","December 31, 2022"
5548,NCT03170882,"Active, not recruiting",No Results Available,Relapsed and/or Refractory Multiple Myeloma,Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexamethasone,All,"Adult, Older Adult",Phase 2,120.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 1, 2017","June 16, 2021"
5549,NCT04545424,Not yet recruiting,No Results Available,"Respiratory Distress Syndrome, Adult",Device: Hypothermia|Drug: Neuromuscular Blocking Agents|Device: Standard of care,All,"Adult, Older Adult",Phase 2,340.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 31, 2021","May 31, 2024"
5550,NCT03329677,Recruiting,No Results Available,Borderline Personality Disorder,Other: Transference-focused Psychotherapy (TFP),Female,Adult,Not Applicable,45.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 1, 2016","January 1, 2022"
5551,NCT03797378,Recruiting,No Results Available,Spinal Cord Injuries|Traumatic Brain Injury|Spina Bifida|Cerebral Palsy|Stroke|Parkinson Disease|Multiple Sclerosis,Other: eM2M,All,"Adult, Older Adult",Not Applicable,108.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"August 9, 2019","September 30, 2023"
5552,NCT03786315,Recruiting,No Results Available,Decision Making|Aged|Multimorbidity|General Practice,,All,Older Adult,,150.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"January 4, 2021",January 2022
5553,NCT04530188,Not yet recruiting,No Results Available,"ARDS|ARDS, Human",Drug: Sevoflurane|Drug: Propofol,All,"Adult, Older Adult",Phase 3,68.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,November 2020,November 2022
5554,NCT04234815,Recruiting,No Results Available,"Psychosocial Problem|Psychological Distress|Engagement, Patient",Behavioral: CETA Short Session (CSS)|Behavioral: Psychoeducation and Safety,All,"Adult, Older Adult",Not Applicable,1387.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 28, 2020",June 2021
5555,NCT04742270,Recruiting,No Results Available,Bronchiectasis Adult,Device: SIMEOX+ respiratory physiotherapy telecare,All,"Adult, Older Adult",Not Applicable,22.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 4, 2021",October 2021
5556,NCT04663685,Recruiting,No Results Available,Arthritis|Cancer|Cardiovascular Diseases|Chronic Lung Disease|Congestive Heart Failure|Diabetes|Hypertension|Kidney Diseases|Obesity|Osteoporosis|Stroke|Frailty,Other: Exercise program|Other: Nutrition education,All,"Adult, Older Adult",Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"October 5, 2020","April 1, 2021"
5557,NCT04797481,Not yet recruiting,No Results Available,Heart Failure,Procedure: Exercise|Procedure: Self-managed exercise,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","March 27, 2021","March 30, 2022"
5558,NCT04744272,Not yet recruiting,No Results Available,Asthma,Device: myAsthma,All,"Adult, Older Adult",Not Applicable,60.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,March 2021,February 2022
5559,NCT03881228,Recruiting,No Results Available,"Tuberculosis|Pediatric ALL|Behavior, Health",Behavioral: Increasing the completion of IPT,All,"Child, Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"December 1, 2019","December 15, 2023"
5560,NCT03959995,Completed,No Results Available,"Osteopenia, Osteoporosis",Other: High Intensity Resistance (HIT-RT) and Endurance exercise (HIIT)|Other: Wellness,Female,Adult,Not Applicable,27.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","January 15, 2019","June 5, 2020"
5561,NCT04639557,Enrolling by invitation,No Results Available,Dual-generation Intervention for Mothers With Depression,Behavioral: BRIDGE Therapy Program,Female,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 1, 2020",May 2021
5562,NCT04763889,Recruiting,No Results Available,Allergy|Anxiety,Behavioral: CBT,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2021","December 30, 2021"
5563,NCT04778930,Not yet recruiting,No Results Available,Physical Therapy|Cerebral Palsy|Therapeutic Education|Telehealth,Other: Physical Therapy|Other: THERAPEUTIC EDUCATION PROGRAM,All,Child,Not Applicable,66.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"September 1, 2021","December 31, 2022"
5564,NCT04659590,Recruiting,No Results Available,Bowel Cancer|Bowel Disease|Genomic|Epigenetic Disorder,,All,"Adult, Older Adult",,600.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 6, 2020",August 2021
5565,NCT03397108,Recruiting,No Results Available,Crohn's Disease|Ulcerative Colitis|Healthy Controls,,Female,"Adult, Older Adult",,160.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"July 4, 2017","June 30, 2021"
5566,NCT04558073,Recruiting,No Results Available,Body Dissatisfaction,Behavioral: Body Project (BP)|Behavioral: Healthy Weight Program (HW),Female,Adult,Not Applicable,90.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"January 1, 2021","February 28, 2022"
5567,NCT03827057,Recruiting,No Results Available,Posttraumatic Stress Disorder|Traumatic Brain Injury,Behavioral: Reconsolidation of Traumatic Memories (RTM)|Behavioral: Prolonged Exposure (PE),All,"Adult, Older Adult",Phase 2|Phase 3,108.0,U.S. Fed|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","June 12, 2019","March 31, 2022"
5568,NCT04840030,Not yet recruiting,No Results Available,"Dementia|Cognitive Decline|Prevention|Life Style|Risk Factor, Cardiovascular|Diet Habit|Cognitive Intervention|Behavioral Intervention",Behavioral: Multimodal intervention (MM-int),All,"Adult, Older Adult",Not Applicable,1094.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","June 1, 2021","April 30, 2025"
5569,NCT03276559,Recruiting,No Results Available,Critical Illness|Communication Disabilities,Behavioral: EMPOWER|Other: Enhanced Usual Care,All,"Adult, Older Adult",Not Applicable,155.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"July 12, 2017","May 31, 2021"
5570,NCT04833088,Not yet recruiting,No Results Available,"Stroke|Parkinson Disease|Covid19|Neglect, Hemispatial",Other: Focus group discussions,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 1, 2021","April 1, 2022"
5571,NCT03115359,Recruiting,No Results Available,Chronic Low Back Pain,Behavioral: Mindfulness Meditation|Behavioral: Cognitive Behavioral Therapy,All,"Adult, Older Adult",Not Applicable,766.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"June 30, 2017","July 15, 2021"
5572,NCT04725253,Not yet recruiting,No Results Available,Delirium Confusional State,Dietary Supplement: Nicotinamide|Other: Placebo tablets,All,Older Adult,Not Applicable,146.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention","January 21, 2021","April 30, 2022"
5573,NCT04076722,Completed,No Results Available,Weight Loss|Wait-List Control,Behavioral: Stress reactivity stimuli,Female,"Adult, Older Adult",Not Applicable,55.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","December 4, 2019","December 11, 2020"
5574,NCT04595695,Completed,No Results Available,Communication|Trust|Covid19|Surgery,Behavioral: Transparent mask|Behavioral: Typical surgical covered mask,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,"September 3, 2020","December 14, 2020"
5575,NCT04061785,Recruiting,No Results Available,Aging Problems|Frailty|Fall Injury|Accidental Fall|Fear of Falling,Other: Judo4Balance - 12 week judo inspired exercise program,All,"Adult, Older Adult",Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"September 30, 2019","July 31, 2022"
5576,NCT04737252,Recruiting,No Results Available,Self-injurious Thoughts and Behaviours|Borderline Personality Disorder,"Behavioral: Connecting, Overcoming and Moving Past Suicide and Self-Injury",All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 18, 2021","September 30, 2022"
5577,NCT04763746,Not yet recruiting,No Results Available,Respiratory Disorder|Diabetes|Cardiovascular Diseases|Critical Care|Trauma and Emergency Care|Primary Care,Device: Lifelight Data Collect Sub-protocol 1|Device: Lifelight Data Collect Sub-protocol 2|Device: Lifelight Data Collect Sub-protocol 3|Device: Lifelight Data Collect Sub-protocol 4,All,"Child, Adult, Older Adult",,9500.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2021","March 1, 2022"
5578,NCT04274621,Completed,No Results Available,Non-contact Infrared Thermometer; Rapid Screening,,All,"Adult, Older Adult",,572.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"February 14, 2020","February 20, 2020"
5579,NCT04799405,Recruiting,No Results Available,Major Depressive Disorder,Device: tDCS,All,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"September 24, 2020","September 24, 2023"
5580,NCT04833010,Recruiting,No Results Available,Cardiopulmonary|Exercise|Cognitive Performance|Covid19,Other: Cardiopulmonary Exercise Test|Other: Cognitive Performance Test,All,Adult,Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 20, 2021","September 1, 2021"
5581,NCT04829188,Recruiting,No Results Available,Sepsis|Pneumonia|Lower Resp Tract Infection|Covid19,Behavioral: Structured Telephone Support (STS)|Behavioral: Low-intensity Remote Patient Monitoring (RPM-Low)|Behavioral: High-intensity Remote Patient Monitoring (RPM-High)|Behavioral: Standard Response Team|Behavioral: Enhanced Response Team,All,"Adult, Older Adult",Not Applicable,1668.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","March 30, 2021",July 2023
5582,NCT04790864,Recruiting,No Results Available,"Anxiety, Social",Behavioral: Online large-group one-session treatment with post-treatment exercise targeting expectancy violation|Behavioral: Online large-group one-session treatment with post-treatment control exercise,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"January 1, 2021",October 2021
5583,NCT03710746,Recruiting,No Results Available,Overweight and Obesity,Behavioral: Project Health|Behavioral: Response and Attention Training,All,"Child, Adult",Not Applicable,450.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","October 8, 2018","July 31, 2023"
5584,NCT04477928,Recruiting,No Results Available,Type 1 Diabetes|Celiac Disease,Diagnostic Test: Sera and whole blood sampling|Diagnostic Test: Differential Gene Expression (DGE),All,Child,,3000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"July 17, 2020",December 2030
5585,NCT03917290,Recruiting,No Results Available,Brain Concussion|Musculoskeletal Injury|Locomotion|Postural Balance,Behavioral: Neuromuscular training,All,"Child, Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 2, 2019","April 30, 2022"
5586,NCT03175796,Completed,No Results Available,Infant Mental Health,Behavioral: Infant Mental Health-Home Visiting,All,"Child, Adult, Older Adult",Not Applicable,148.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 12, 2017","September 29, 2020"
5587,NCT03545282,Recruiting,No Results Available,Stress|Depression|Anxiety,Behavioral: Amigas Latinas Motivando el Alma (ALMA),Female,"Adult, Older Adult",Not Applicable,200.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","March 7, 2018","May 31, 2022"
5588,NCT04478851,Recruiting,No Results Available,Cancer|Head and Neck Cancer|Colon Cancer|Breast Cancer|Prostate Cancer|Cancer Caregivers,Behavioral: Group Exercise Classes,All,"Adult, Older Adult",Not Applicable,1500.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"September 2, 2020","December 31, 2027"
5589,NCT04713748,Enrolling by invitation,No Results Available,C3PI Study Testing Group,Device: Tasso-SST on Demand|Other: Regular Phlebotomy,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 15, 2021",December 2021
5590,NCT04787380,Recruiting,No Results Available,Heart Failure,Device: Heartfelt device,All,"Adult, Older Adult",Not Applicable,30.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","March 5, 2021","December 31, 2022"
5591,NCT03069690,Recruiting,No Results Available,Obesity|Pregnancy Related,Behavioral: HABITpreg|Behavioral: HABITpost,Female,"Child, Adult, Older Adult",Not Applicable,300.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 1, 2017","June 30, 2023"
5592,NCT04495387,Not yet recruiting,No Results Available,Colon Cancer|Breast Cancer|Chemotherapeutic Toxicity,Drug: Chemotherapy,All,"Adult, Older Adult",,100.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,January 2021,December 2022
5593,NCT04592224,Recruiting,No Results Available,Cancer,,All,"Adult, Older Adult",,40.0,Other,Observational,Observational Model: Case-Only|Time Perspective: Cross-Sectional,"November 12, 2020",August 2021
5594,NCT04413812,"Active, not recruiting",No Results Available,Bariatric Surgery|Physical Activity,Behavioral: FREEBASE exercise programme,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 1, 2020","January 17, 2021"
5595,NCT04831190,Not yet recruiting,No Results Available,"Cancer|Brain Tumor, Primary",Behavioral: Tailored Exercise Intervention,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"April 15, 2021","April 15, 2024"
5596,NCT04647760,Recruiting,No Results Available,Pediatric Obesity,Behavioral: JOIN for ME,All,Child,Not Applicable,128.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,January 2021,February 2023
5597,NCT02793921,Recruiting,No Results Available,Breast Cancer,Behavioral: Moderate-Intensity Aerobic Exercise Intervention,Female,"Adult, Older Adult",Not Applicable,182.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science,April 2016,March 2022
5598,NCT03584386,Recruiting,No Results Available,Suicide,Device: V-CAMS (aka Jaspr),All,"Adult, Older Adult",Not Applicable,303.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 1, 2018","March 31, 2021"
5599,NCT04779983,Not yet recruiting,No Results Available,Rheumatoid Arthritis,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 18, 2021","August 1, 2021"
5600,NCT02669394,Recruiting,No Results Available,Transient Ischemic Attack|Vascular Cognitive Impairment|Subcortical Vascular Dementia,Behavioral: Resistance exercise training|Behavioral: Control: stretching and relaxation program,All,"Adult, Older Adult",Not Applicable,88.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,January 2016,December 2022
5601,NCT04564586,"Active, not recruiting",No Results Available,"PreDiabetes|Metabolic Syndrome, Protection Against",Behavioral: DPPFit,All,Adult,Not Applicable,32.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 1, 2020","October 1, 2021"
5602,NCT04068922,Recruiting,No Results Available,Aging|Chronic Low-back Pain,Behavioral: Resilience Intervention,All,"Adult, Older Adult",Not Applicable,60.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 21, 2020","May 1, 2021"
5603,NCT04398472,Not yet recruiting,No Results Available,Loneliness|Social Isolation,Behavioral: KIND Challenge,All,"Adult, Older Adult",Not Applicable,9000.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 7, 2020",December 2020
5604,NCT03724045,Recruiting,No Results Available,Nutritional Deficiency|Hospitalism,Dietary Supplement: Back Side of the Moon,All,"Adult, Older Adult",Not Applicable,50.0,Other|Industry,Interventional,Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 1, 2019","October 1, 2021"
5605,NCT04405284,Completed,No Results Available,Toxicity by Bleach,Other: use and exposure to disinfectants during the coronavirus pandemic,Female,"Adult, Older Adult",,425.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"June 4, 2020","July 1, 2020"
5606,NCT04055948,Recruiting,No Results Available,Cancer,Behavioral: One-on-one teaching sessions|Behavioral: Telephone booster contact,All,"Adult, Older Adult",Not Applicable,180.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Supportive Care,"December 1, 2019","April 30, 2023"
5607,NCT03193866,"Active, not recruiting",No Results Available,Relapsing-remitting Multiple Sclerosis,Drug: Rituximab,All,"Adult, Older Adult",,3526.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"February 1, 2017","December 31, 2022"
5608,NCT01134172,"Active, not recruiting",No Results Available,Breast Cancer,Behavioral: survey web-based or telephone interview,Female,Adult,,935.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Prospective,May 2010,May 2021
5609,NCT04606407,Recruiting,No Results Available,"Viral Pneumonia|Nitric Oxide|Respiratory Disease|Pneumonia, Viral|Inhaled Nitric Oxide|Covid19|SARS-CoV Infection",Device: LungFit™,All,"Adult, Older Adult",Not Applicable,90.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 25, 2020","September 7, 2021"
5610,NCT04792450,"Active, not recruiting",No Results Available,Fever,Device: Thermography|Device: Tympanic Thermometer|Device: Forehead Thermometer|Device: 62 Max + Infra-red thermometer,All,"Child, Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 1, 2020",May 2021
5611,NCT04247620,Enrolling by invitation,No Results Available,Type 1 Diabetes,Behavioral: DiaBetter Together|Behavioral: Peer Mentor Delivery,All,"Child, Adult",Not Applicable,186.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"December 15, 2020",June 2024
5612,NCT04642807,Not yet recruiting,No Results Available,Elbow Fracture|Trauma,Procedure: Long arm soft cast|Procedure: Long arm full cast,All,Child,Not Applicable,52.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,January 2021,January 2023
5613,NCT04670315,Not yet recruiting,No Results Available,Stroke,Diagnostic Test: Telematic evaluation of motor function,All,"Adult, Older Adult",,50.0,Other,Observational,Observational Model: Other|Time Perspective: Cross-Sectional,"March 1, 2021","September 30, 2021"
5614,NCT04634851,Not yet recruiting,No Results Available,Technology|Diet Habit,Behavioral: Virtual home visits,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2021","December 1, 2024"
5615,NCT04480333,Recruiting,No Results Available,Covid19|Corona Virus Infection|Severe Acute Respiratory Syndrome|Severe Acute Respiratory Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia|Severe Acute Respiratory Syndrome of Upper Respiratory Tract|Neurodegeneration|Neuroinflammatory Response,Drug: Drug: NA-831 - 0.10 mg/kg|Drug: Placebo- 0.10 mg/kg|Drug: Drug: NA-831 - 0.20 mg/kg|Drug: Placebo- 0.20 mg/kg|Drug: Drug: GS-5734 - 1.00 mg/kg|Drug: Placebo- 1.00 mg/kg|Drug: Drug: GS-5734 - 2.00 mg/kg|Drug: Placebo- 2.00 mg/kg|Combination Product: Drugs: NA-831 (0.10 mg/kg) plus GS-5734 (1.00 mg/kg)|Combination Product: Placebo 0.10 mg + 1.00 mg/kg|Combination Product: Drugs: NA-831 (0.20 mg/kg) plus GS-5734 (2.00 mg/kg)|Combination Product: Placebo 0.20 mg + 2.00 mg/kg,All,Adult,Phase 1,45.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","September 15, 2020","March 31, 2021"
5616,NCT04778995,Completed,No Results Available,Pandemics|Crisis State|Nursing|Education,Other: Structured online training program for effective management of nursing services,All,"Child, Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"July 1, 2020","December 30, 2020"
5617,NCT04795999,Recruiting,No Results Available,Study Will Examine the Impact of Project With,Behavioral: Project With,All,"Child, Adult",Not Applicable,1500.0,Other|U.S. Fed,Interventional,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 1, 2021","July 15, 2023"
5618,NCT02875301,Recruiting,No Results Available,"Healthy|Cognitive Function 1, Social",Behavioral: 150 Minutes Week|Behavioral: 225 Minutes Week|Behavioral: Stretch and Tone,All,Older Adult,Phase 3,639.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","September 6, 2017",November 2023
5619,NCT04644640,Not yet recruiting,No Results Available,Meniscectomy,Other: Telerehabilitation Therapy|Other: In-person Rehabilitation Therapy,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"December 1, 2020","December 1, 2022"
5620,NCT04091893,"Active, not recruiting",No Results Available,Chronic Pain,Behavioral: Usual care/wait list|Behavioral: Art Rx|Behavioral: Artful Meditation,All,"Adult, Older Adult",Not Applicable,64.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"October 12, 2019","May 30, 2021"
5621,NCT04784338,Not yet recruiting,No Results Available,Metabolic Syndrome|Obesity,Behavioral: Virtual shared medical visit|Behavioral: Nutritional classes,All,"Adult, Older Adult",Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,April 2021,October 2022
5622,NCT04237883,Completed,No Results Available,Behavioral Economics|Primary Health Care|Health Maintenance|Diabetes|Colorectal Cancer Screening|Cervical Cancer Screening|Chlamydia Screening|HPV Screening,Behavioral: Standard communication email|Behavioral: Social comparison Intervention|Behavioral: Leadership Training,All,"Adult, Older Adult",Not Applicable,225.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research,"November 1, 2019","January 1, 2021"
5623,NCT04485377,Recruiting,No Results Available,Households,,All,"Adult, Older Adult",,530.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"August 1, 2020","June 30, 2022"
5624,NCT04527835,Recruiting,No Results Available,Viral Myocarditis,"Diagnostic Test: ELIZA, Extraction of nucleic acid ,Determination of viral genome by using PCR, Quantitative real-time PCR to assess viral load ,Immunohistochemistry analysis of EMB.",All,"Adult, Older Adult",,18.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"October 1, 2020","March 1, 2021"
5625,NCT03037164,Recruiting,No Results Available,Anemia,Device: INTERCEPT Blood System for Red Blood Cells|Device: Conventional (Control),All,"Child, Adult, Older Adult",Phase 3,600.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","May 11, 2017","January 30, 2022"
5626,NCT04570917,Not yet recruiting,No Results Available,Ageism,Behavioral: Online educational intervention to reduce ageism|Behavioral: Online educational intervention to enhance cultural competance,All,"Adult, Older Adult",Not Applicable,121.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care,"September 28, 2020","October 31, 2020"
5627,NCT04444986,Completed,No Results Available,Bioequivalence,Drug: FAVIR 200 MG FT|Drug: AVIGAN 200 mg FT,Male,Adult,Phase 1,30.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"June 5, 2020","June 13, 2020"
5628,NCT04787393,Not yet recruiting,No Results Available,Heart Failure,Device: Heartfelt device|Device: Connected weighing scales,All,"Adult, Older Adult",Not Applicable,30.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 3, 2021","December 31, 2022"
5629,NCT04769518,Not yet recruiting,No Results Available,Postoperative Complications|Cost-Benefit Analysis,Procedure: Advanced Recovery Room Care (ARRC),All,"Adult, Older Adult",Not Applicable,1314.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,March 2021,December 2022
5630,NCT04509206,Enrolling by invitation,No Results Available,Cardiac Health|Metabolic Syndrome,Behavioral: Nutritional education,All,"Adult, Older Adult",Not Applicable,25.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other,"September 28, 2020",September 2021
5631,NCT04644367,Not yet recruiting,No Results Available,Parkinson Disease,Other: Tai Chi intervention|Other: Regular Physical Activity (control) group,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,January 2021,December 2021
5632,NCT04714892,Not yet recruiting,No Results Available,Obesity,,All,Adult,,248.0,NIH,Observational,Observational Model: Case-Control|Time Perspective: Cross-Sectional,"April 19, 2021","December 30, 2022"
5633,NCT04829851,Not yet recruiting,No Results Available,Overweight|Nutritional Deficiency|Poor Nutrition|Iron-deficiency,Device: PROTEIN Mobile App|Device: Expert Dashboard,All,"Adult, Older Adult",,310.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,June 2021,December 2022
5634,NCT04816799,Recruiting,No Results Available,Stroke|Aphasia|Apraxia of Speech,Behavioral: Startle Adjuvant Rehabilitation Therapy (START),All,"Adult, Older Adult",Early Phase 1,54.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","July 22, 2020","December 1, 2021"
5635,NCT03758235,"Active, not recruiting",No Results Available,Overactive Bladder Syndrome,Drug: IncobotulinumtoxinA 100 UNT Injection [Xeomin]|Drug: OnabotulinumtoxinA 100 UNT [Botox],All,"Adult, Older Adult",Phase 3,140.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","September 1, 2018","September 1, 2021"
5636,NCT04532853,Recruiting,No Results Available,COPD,,All,"Adult, Older Adult",,1176.0,Other|Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"October 21, 2020","August 25, 2021"
5637,NCT04581681,Recruiting,No Results Available,Perinatal Anxiety,Behavioral: Group Cognitive Behaviour Therapy for Perinatal Anxiety (CBT-PA)|Other: No treatment (waitlist control),Female,"Adult, Older Adult",Not Applicable,50.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"December 2, 2020",September 2021
5638,NCT03576534,Recruiting,No Results Available,Congenital Heart Disease,Other: Use of prebypass ultrafiltration (PBUF),All,Child,Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 3, 2019",December 2021
5639,NCT04662593,Recruiting,No Results Available,"Obesity|Overweight|Diet, Healthy|Social Interaction|Weight Loss",Behavioral: Whole Health Program,Female,Adult,Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 4, 2021",September 2021
5640,NCT01603316,Recruiting,No Results Available,Cancer Patients,Behavioral: surveys|Behavioral: Focus groups,All,"Adult, Older Adult",Phase 2,668.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 8, 2012",May 2023
5641,NCT03260140,"Active, not recruiting",No Results Available,Obesity,Behavioral: behavioral lifestyle intervention,All,"Adult, Older Adult",Not Applicable,500.0,U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"February 15, 2018","June 30, 2021"
5642,NCT03923504,Recruiting,No Results Available,Hodgkin Lymphoma|Non-hodgkin Lymphoma|Lymphoma|Breast Cancer,Other: Physical Activity Intervention (PAI)|Other: Healthy Living Control,All,"Adult, Older Adult",Not Applicable,18.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 10, 2019","April 30, 2022"
5643,NCT04041453,Completed,Has Results,Trichuris Infection|Helminthiasis,Drug: Ivermectin|Drug: Albendazole,All,Child,Phase 2,176.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"October 9, 2019","March 7, 2020"
5644,NCT04673825,Recruiting,No Results Available,Spondyloarthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Spondyloarthropathy,Other: Patient initiated care + telemonitoring,All,"Adult, Older Adult",Not Applicable,200.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"December 2, 2020","July 31, 2022"
5645,NCT04566510,Recruiting,No Results Available,Malaria,"Other: long lasting insecticidal nets with alpha-cypermethrin + pyriproxyfen (PPF LLIN, Royal Guard))|Other: long lasting insecticidal nets with deltamethrin + piperonyl butoxide (PBO LLIN, PermaNet 3.0))|Behavioral: Social behaviour change communication",All,"Child, Adult, Older Adult",Not Applicable,200000.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"October 17, 2020","April 15, 2023"
5646,NCT04752787,Not yet recruiting,No Results Available,Breastfeeding,Other: Online breastfeeding training|Other: QR code supported online breastfeeding training,Female,"Adult, Older Adult",Not Applicable,102.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care,"March 1, 2021","March 1, 2022"
5647,NCT04702958,Enrolling by invitation,No Results Available,Heart Failure,,All,"Adult, Older Adult",,750.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"December 10, 2020","July 1, 2022"
5648,NCT04039165,Recruiting,No Results Available,Metabolic Syndrome,Behavioral: PP-MI Intervention,All,"Adult, Older Adult",Not Applicable,64.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 25, 2019","April 1, 2022"
5649,NCT04696107,Not yet recruiting,No Results Available,Chronic Pain|Musculoskeletal Diseases|Quality of Life|Pain Measurement,Behavioral: Psychoeducative intervention,All,"Adult, Older Adult",Not Applicable,144.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2021","December 31, 2022"
5650,NCT03256773,Recruiting,No Results Available,Cystic Fibrosis|COPD|PCD - Primary Ciliary Dyskinesia|Covid19|Sinusitis,,All,"Child, Adult, Older Adult",,60.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2016","December 31, 2022"
5651,NCT04660084,Recruiting,No Results Available,Pneumonia,Diagnostic Test: Ultra-rapid molecular point-of-care testing,All,"Adult, Older Adult",Not Applicable,1060.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic,"September 25, 2020","December 31, 2022"
5652,NCT04838288,Not yet recruiting,No Results Available,Renal Transplant,Drug: Change from Prograf to Envarsus XR,All,"Adult, Older Adult",Phase 4,60.0,Other|Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"May 1, 2021","December 31, 2022"
5653,NCT04408651,"Active, not recruiting",No Results Available,Chronic Medical Conditions,Behavioral: LIIT.CI ACT|Behavioral: LIIT.CI CFT,All,"Adult, Older Adult",Not Applicable,54.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","May 1, 2020","August 31, 2021"
5654,NCT03301922,Recruiting,No Results Available,Anxiety|Depression,Behavioral: Metacognitive therapy and work-focused interventions|Other: Waiting list,All,"Adult, Older Adult",Not Applicable,240.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 31, 2017",April 2023
5655,NCT03734237,Recruiting,No Results Available,Influenza|Influenza-like Illness,Biological: Egg based influenza vaccines|Biological: Recombinant influenza vaccines|Biological: Cell-culture based influenza vaccines,All,"Adult, Older Adult",Phase 4,15000.0,Other|NIH|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 6, 2018","May 31, 2022"
5656,NCT02737878,Recruiting,No Results Available,Mild Cognitive Impairment,Behavioral: Aerobic Training|Behavioral: Resistance Training|Behavioral: Balance and Tone Training,All,Older Adult,Not Applicable,216.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,April 2016,December 2021
5657,NCT04590066,Completed,No Results Available,"Influenza, Human",Behavioral: Flu shot text messages,All,"Adult, Older Adult",Not Applicable,734383.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Health Services Research","September 25, 2020","December 31, 2020"
5658,NCT03885232,Enrolling by invitation,No Results Available,Preventive Health Services (PREV HEALTH SERV),Behavioral: Experimental: PIVOT with MI|Other: Active Comparator: Control,All,Child,Not Applicable,1000.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Health Services Research","September 1, 2019","July 31, 2023"
5659,NCT03518216,Recruiting,No Results Available,Functional Abdominal Pain Syndrome|Anxiety,Behavioral: ADAPT,All,Child,Not Applicable,93.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","July 3, 2018",August 2022
5660,NCT04603092,Not yet recruiting,No Results Available,Health Literacy,Behavioral: Digital Health Literacy Intervention,Female,"Child, Adult",Not Applicable,1000.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"April 1, 2021","October 1, 2021"
5661,NCT04571853,Recruiting,No Results Available,Fibromyalgia,Behavioral: PNE-explained group|Behavioral: PNE-read group|Behavioral: TAU group,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 21, 2020","October 10, 2021"
5662,NCT04424212,"Active, not recruiting",No Results Available,Depression and Quality of Life Related to the Coronavirus Pandemic,Behavioral: Intervention group CoronaCope,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"June 10, 2020",August 2021
5663,NCT04193020,Recruiting,No Results Available,Uveitis,Other: Surveillance card,All,"Child, Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2020","January 1, 2026"
5664,NCT02901041,"Active, not recruiting",No Results Available,Alcohol Dependence,Drug: Zonisamide|Behavioral: Take Control|Drug: Placebo (for Zonisamide),All,"Adult, Older Adult",Phase 3,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 21, 2017",August 2021
5665,NCT04646421,Recruiting,No Results Available,Problem Gambling|Gambling Disorder,Behavioral: Motivational telephone intervention,All,"Adult, Older Adult",,3626.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Other,"March 15, 2021","November 30, 2021"
5666,NCT03343483,Recruiting,No Results Available,Loneliness|Quality of Life,Behavioral: Volunteering|Behavioral: Life Review,All,"Adult, Older Adult",Not Applicable,300.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 1, 2018","February 28, 2023"
5667,NCT04651959,"Active, not recruiting",No Results Available,Bioequivalence,Drug: AVICOD 200 MG Film Tablet|Drug: AVIGAN 200 MG Film Tablets,Male,Adult,Phase 1,30.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"November 13, 2020","December 20, 2020"
5668,NCT04406194,Completed,Has Results,Bioequivalence,Drug: FAVICOVIR 200 mg Film Tablet|Drug: AVIGAN 200 mg Film Tablets,Male,Adult,Phase 1,30.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 14, 2020","June 19, 2020"
5669,NCT04400682,Completed,Has Results,Bioequivalence,Drug: FAVIRA 200 MG Film Tablet|Drug: AVIGAN 200 MG Film Tablets,Male,Adult,Phase 1,30.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"May 28, 2020","June 18, 2020"
5670,NCT04828070,Recruiting,No Results Available,Pregnancy Related|Cardiac Disease,Other: Observation,Female,Adult,,75.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"December 1, 2020","December 30, 2026"
5671,NCT04542642,Recruiting,No Results Available,Opioid-use Disorder,Device: reSET-O|Device: PEAR-008,All,Adult,Not Applicable,130.0,Industry|Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,February 2021,July 2021
5672,NCT03683394,"Active, not recruiting",No Results Available,Dementia|Alzheimer Disease,Behavioral: SMARRT Intervention|Behavioral: Health Education Intervention,All,Older Adult,Not Applicable,172.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"August 30, 2018","March 31, 2022"
5673,NCT04144231,Recruiting,No Results Available,Insomnia|Schizophrenia|Schizoaffective Disorder,Behavioral: iCBT-I|Behavioral: GCBT-I,All,"Adult, Older Adult",Not Applicable,120.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"December 19, 2019","September 6, 2024"
5674,NCT04624087,Recruiting,No Results Available,Overweight and Obesity,Behavioral: food-specific go/no-go computerized training|Behavioral: nonfood-specific go/no-go computerized training,All,"Adult, Older Adult",Not Applicable,100.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","October 19, 2020","October 1, 2021"
5675,NCT04209998,Recruiting,No Results Available,Critical Limb Ischemia,Diagnostic Test: transcutaneous oximetry,All,"Adult, Older Adult",,300.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"January 16, 2020",December 2022
5676,NCT04448028,Not yet recruiting,No Results Available,Liver Cirrhosis,Drug: Placebo|Drug: Esomeprazole 20mg,All,"Adult, Older Adult",Phase 4,476.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention",January 2021,December 2024
5677,NCT04475718,Recruiting,No Results Available,Pregnancy Related|Postpartum Sadness,Behavioral: Fourth Trimester Mobile Tool,Female,"Adult, Older Adult",Not Applicable,85.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"July 6, 2020","September 22, 2021"
5678,NCT03620409,Recruiting,No Results Available,Sepsis|Septic Cardiomyopathy|Cardiomyopathies,,All,"Adult, Older Adult",,290.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"May 9, 2018",June 2021
5679,NCT04390542,Not yet recruiting,No Results Available,Blood Cancer,Behavioral: Psychoeducation,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,June 2021,September 2021
5680,NCT04240886,Recruiting,No Results Available,Invasive Fungal Infections,Drug: fosmanogepix,All,"Adult, Older Adult",Phase 2,50.0,Industry,Interventional,Allocation: N/A|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"January 4, 2020",October 2021
5681,NCT04535453,Recruiting,No Results Available,Healthy,Biological: Ad26.COV2.S|Other: Placebo,All,"Child, Adult, Older Adult",Phase 2,1210.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","August 28, 2020","August 15, 2023"
5682,NCT04680845,Recruiting,No Results Available,Hearing Loss,Behavioral: Self-affirmation,All,"Adult, Older Adult",Not Applicable,3000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","January 18, 2021","July 31, 2021"
5683,NCT04326309,Recruiting,No Results Available,COVID-19|Coronavirus Infections|Hay Fever|Asthma|Chronic Obstructive Pulmonary Disease|Influenza|Common Cold|Respiratory Tract Infections|Healthy,,All,"Adult, Older Adult",,1000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 25, 2020","September 25, 2022"
5684,NCT04302987,Recruiting,No Results Available,Bone Strength|Growth|Body Composition|Infection|Allergic Diseases|Dental Health,,All,Child,,832.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 1, 2019",October 2021
5685,NCT04586192,Recruiting,No Results Available,Depressive Symptoms|Anxiety,Other: Common Elements Toolbox- Adult version (COMET-A)|Other: Self-awareness Control,All,"Adult, Older Adult",Not Applicable,2500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","January 31, 2021","June 1, 2021"
5686,NCT03684980,Recruiting,No Results Available,Central Nervous System Lymphoma,Drug: Voraxaze|Drug: Methotrexate|Drug: Rituximab|Drug: leucovorin|Drug: Glucarpidase,All,"Adult, Older Adult",Early Phase 1,44.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"November 14, 2018",October 2021
5687,NCT04378530,"Active, not recruiting",No Results Available,Stress|Habits,Behavioral: Personalized Anchoring Strategy|Behavioral: Non-Anchoring Strategy Control|Behavioral: Fixed Anchoring Strategy,All,Adult,Not Applicable,174.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other,"July 27, 2020",June 2021
5688,NCT04447690,Completed,No Results Available,"Student|Mental Health|Depression, Anxiety|Depression|Anxiety|College Drinking|Stress",,All,"Adult, Older Adult",,5553.0,Other,Observational,Observational Model: Ecologic or Community|Time Perspective: Cross-Sectional,"August 3, 2020","December 31, 2020"
5689,NCT04763304,Completed,No Results Available,Personal Protective Equipment|Self Contamination,Other: Gown personal protective equipment (PPE-G) suit|Other: Coverall personal protective equipment (PPE-C) suit,All,"Adult, Older Adult",Not Applicable,60.0,Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention,"September 1, 2020","November 18, 2020"
5690,NCT03925272,Recruiting,No Results Available,Immune System and Related Disorders,"Procedure: Collection of samples (blood, stool, etc.)|Genetic: Genetic determinants analysis|Procedure: Sample obtained after surgery performed in the context of care",All,"Adult, Older Adult",Not Applicable,2200.0,Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science,"February 2, 2011","December 2, 2023"
5691,NCT03540706,Recruiting,No Results Available,Respiratory Infection|Respiratory Infections in Children,Diagnostic Test: Care with C-reactive protein assay in micro method,All,"Child, Adult, Older Adult",Not Applicable,406.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic,"May 1, 2018","June 15, 2022"
5692,NCT04696406,Not yet recruiting,No Results Available,Respiratory Failure,Device: RESPINOR DXT,All,"Adult, Older Adult",,250.0,Industry|Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 1, 2021","September 30, 2021"
5693,NCT04787809,Recruiting,No Results Available,Depressive Symptoms|Anxiety|Emotional Disorders,Behavioral: Living Well,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"February 19, 2021",December 2022
5694,NCT04661189,Recruiting,No Results Available,Cardiovascular Diseases,Behavioral: Physical exercise training|Behavioral: Cognitive training,All,"Adult, Older Adult",Not Applicable,122.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","May 18, 2020","December 1, 2022"
5695,NCT04574050,Not yet recruiting,No Results Available,Cancer|COPD|Asthma|Bronchiectasis Adult|Interstitial Lung Disease|Cystic Fibrosis|Chronic Heart Failure|Sickle Cell Disease|Renal Failure|Liver Failure|Post COVID-19|Dyspnea,Other: SELF-BREATHE,All,"Adult, Older Adult",Not Applicable,40.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"December 3, 2020","June 30, 2022"
5696,NCT04621552,Completed,No Results Available,Aneurysm|Intracranial Aneurysm,Device: WEB embolization,All,"Adult, Older Adult",,186.0,Other,Observational,Observational Model: Case-Control|Time Perspective: Retrospective,"January 1, 2015","October 30, 2020"
5697,NCT04407000,Completed,No Results Available,Bioequivalence,Drug: Test: Favipiravir 200 mg (LOQULAR)|Drug: Reference: Favipiravir 200 mg (Avigan),Male,Adult,Phase 1,30.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"June 23, 2020","August 8, 2020"
5698,NCT04604821,Not yet recruiting,No Results Available,Language Impairment,Behavioral: Enhanced Milieu Teaching|Behavioral: Parent Education,All,Child,Not Applicable,28.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"October 20, 2020","December 31, 2021"
5699,NCT04421690,Recruiting,No Results Available,Generalized Anxiety Disorder,Behavioral: Cognitive Training|Behavioral: Trivia Training,All,Adult,Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"June 8, 2020","May 31, 2021"
5700,NCT04740411,Not yet recruiting,No Results Available,Depression|Anxiety|Well-being,Behavioral: The Common Elements Toolbox (COMET),All,"Adult, Older Adult",Not Applicable,850.0,Other,Interventional,Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 18, 2021","March 1, 2022"
5701,NCT04838236,Not yet recruiting,No Results Available,"Smoking, Tobacco",Other: MASP app|Other: QuitGuide app,All,Adult,Not Applicable,225.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,June 2021,October 2023
5702,NCT04592588,Recruiting,No Results Available,Depressive Symptoms|Anxiety|Happiness,Behavioral: Common Elements Toolbox|Behavioral: Wait-list control,All,"Adult, Older Adult",Not Applicable,500.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 19, 2020","June 30, 2021"
5703,NCT04648293,Recruiting,No Results Available,Hemodynamic Monitoring,Device: Starling,All,"Adult, Older Adult",,1000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"November 2, 2020","July 31, 2022"
5704,NCT04480255,Recruiting,No Results Available,Premature Birth|NICU|Premature|Infant,Other: Group 1: Standard of Care|Other: Group 2: NICU2HOME+ app,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 3, 2020",June 2022
5705,NCT04564183,Recruiting,No Results Available,IPF|Pulmonary Fibrosis|ILD,Other: Sample collection|Other: Questionnaires|Radiation: High resolution CT scan of the chest|Diagnostic Test: Pulmonary Function Test,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 22, 2021","October 1, 2024"
5706,NCT04545593,Recruiting,No Results Available,Depression|Anxiety|Physical Disability,Behavioral: Positive Minds Strong Bodies Enhanced|Behavioral: Enhanced Usual Care,All,"Adult, Older Adult",Not Applicable,450.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"February 11, 2021","September 30, 2024"
5707,NCT04025151,Not yet recruiting,No Results Available,Alcohol Misuse,Behavioral: Alcohol brief intervention|Behavioral: 12-page health warning leaflet|Behavioral: Regular messages through Instant Messaging (IM)|Behavioral: Real-time chat-based support through IM Apps|Behavioral: General health through IM Apps|Behavioral: AUDIT score interpretation sheet adapted from the Department of Health of Hong Kong,All,"Adult, Older Adult",Not Applicable,770.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","September 30, 2020","November 30, 2022"
5708,NCT04688567,"Active, not recruiting",No Results Available,Anxiety Disorders and Symptoms|Internet-Based Intervention,Behavioral: Patient-driven iCBT|Behavioral: Standardized iCBT (TAU),All,"Adult, Older Adult",Not Applicable,56.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment,"November 1, 2019","March 30, 2021"
5709,NCT04181021,Enrolling by invitation,No Results Available,Abortion|Contraception,Behavioral: Values Clarification and Attitudes Transformation (VCAT) Workshop,Female,"Child, Adult, Older Adult",Not Applicable,100.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"November 25, 2019",December 2020
5710,NCT04772807,Recruiting,No Results Available,Atrial Fibrillation|Hypertension|Heart Failure,Device: Kinocardiograph,All,"Adult, Older Adult",,320.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"February 5, 2021","December 31, 2022"
5711,NCT03716869,"Active, not recruiting",No Results Available,Major Depressive Disorder|Major Depressive Episode,Other: Universal Screening Arm,All,"Child, Adult, Older Adult",Not Applicable,12506.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening,"July 1, 2018",February 2021
5712,NCT03929393,"Active, not recruiting",No Results Available,Physical Inactivty|Wellbeing|Mindfulness,Behavioral: Mindful Movement|Other: Keys to Health & Wellbeing,All,"Adult, Older Adult",Not Applicable,176.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other","July 17, 2019","March 31, 2022"
5713,NCT04734288,"Active, not recruiting",No Results Available,Immune Response,"Dietary Supplement: Vit.D3 5000 IU, Immune Active",All,"Adult, Older Adult",Not Applicable,7.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"January 22, 2021","July 31, 2023"
5714,NCT01087333,Recruiting,No Results Available,Hairy Cell Leukemia (HCL)|Chronic Lymphocytic Leukemia (CLL)|Non-Hodgkins Lymphoma (NHL)|Cutaneous T Cell Lymphoma (CTCL)|Adult T Cell Lymphoma (ATL),,All,"Adult, Older Adult",,1263.0,NIH,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"March 2, 2010",
5715,NCT04684602,Recruiting,No Results Available,Autoimmune Diseases|Cardiovascular Disorders|Diabetes Complications|Integumentary Disease|Musculoskeletal Disorders|Neurodegenerative Disorders|Neurologic Disorders|Pulmonary Disorders|Sexual Dysfunction|Urologic Disorders|Viral Illness,Biological: PrimePro™/ PrimeMSK™,All,"Adult, Older Adult",Phase 1|Phase 2,5000.0,Industry|Other,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 9, 2020","December 9, 2030"
5716,NCT03871491,Recruiting,No Results Available,Maternal Death|Maternal Infections Affecting Fetus or Newborn|Neonatal SEPSIS|Maternal Sepsis During Labor|Neonatal Death|Postpartum Sepsis,Drug: Azithromycin|Drug: Placebo,Female,Adult,Phase 3,34000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","September 1, 2020","September 1, 2023"
5717,NCT03474965,Recruiting,No Results Available,Sickle Cell Disease (SCD),Drug: Crizanlizumab,All,Child,Phase 2,100.0,Industry,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2018","November 20, 2024"
5718,NCT04386876,Completed,No Results Available,Bioequivalence,Drug: Lopinavir/Ritonavir 200 mg/50 mg Film Tablet|Drug: Lopinavir/Ritonavir 200 mg/50 mg Film Coated Tablet,Male,Adult,Phase 1,30.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"April 30, 2020","June 11, 2020"
5719,NCT02549664,"Active, not recruiting",No Results Available,Hypertrophic Cardiomyopathy|Long QT Syndrome,,All,"Child, Adult",,4299.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,May 2015,"December 30, 2021"
5720,NCT04813068,Not yet recruiting,No Results Available,Lung Cancer|Recurrence,Other: Semi-structured interview,All,"Adult, Older Adult",,30.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,March 2021,June 2022
5721,NCT04043364,"Active, not recruiting",No Results Available,Dementia|Home-dwelling|Caregiver,Behavioral: LIVE,All,Older Adult,Not Applicable,280.0,Other,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"August 1, 2019",June 2021
5722,NCT04753307,Recruiting,No Results Available,Postoperative Complications|Cardiovascular Complication|Myocardial Ischemia|Inflammation,Diagnostic Test: Laboratory measurements,All,"Adult, Older Adult",,1400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 19, 2021","January 31, 2024"
5723,NCT04449744,Recruiting,No Results Available,Opioid-use Disorder,Other: MySafeRx Inspire Plus|Other: MySafeRx Inspire Flex,All,"Adult, Older Adult",Not Applicable,30.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 13, 2020","March 1, 2021"
5724,NCT03184662,Recruiting,No Results Available,Type2 Diabetes|Diabetic Kidney Disease,Other: HIPA|Other: Counseling PA,All,"Adult, Older Adult",Not Applicable,300.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"February 12, 2018","December 31, 2023"
5725,NCT03452774,Recruiting,No Results Available,"Cancer, Metastatic|Cancer|Cancer of Pancreas|Cancer of Liver|Cancer of Stomach|Cancer Liver|Cancer of Rectum|Cancer of Kidney|Cancer of Esophagus|Cancer of Cervix|Cancer of Colon|Cancer of Larynx|Cancer, Lung|Cancer, Breast|Cancer, Advanced|Cancer Prostate|Cancer of Neck|Cancer of Skin|Neuroendocrine Tumors|Carcinoma|Mismatch Repair Deficiency|BRCA Gene Rearrangement|Non Hodgkin Lymphoma|Leukemia|Non Small Cell Lung Cancer|Cholangiocarcinoma|Glioblastoma|Central Nervous System Tumor|Melanoma|Urothelial Carcinoma|Bladder Cancer|Ovarian Cancer|Endometrial Cancer|Testicular Cancer|Breast Cancer|COVID",Other: Clinical Trial Matching,All,"Child, Adult, Older Adult",,1500.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"January 1, 2018",December 2022
5726,NCT04231097,"Active, not recruiting",No Results Available,Acute Coronary Syndrome|Depression|Myocardial Infarction|Unstable Angina|STEMI|NSTEMI - Non-ST Segment Elevation MI,Other: MBCT intervention for ACS patients,All,"Adult, Older Adult",Not Applicable,7.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 24, 2020","April 1, 2021"
5727,NCT04828018,Not yet recruiting,No Results Available,Quality of Life|Aging Well,Other: Coffee Morning|Other: Recruitment Leaflets|Other: Consent Form completion|Other: Participant Information Sheet|Other: New In-Pensioner Resident Information Pack|Other: Key Staff Interviews|Other: In-Pensioner Resident Interviews|Other: ICECAP-A Quality of Life Questionnaire|Other: WHOQOL-BREF Quality of Life Questionnaire,All,"Child, Adult, Older Adult",,80.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,April 2021,May 2022
5728,NCT01435018,Completed,Has Results,HIV-1 Infection,Drug: Etoposide (ET)|Drug: Bleomycin and Vincristine (BV)|Drug: Paclitaxel (PTX)|Drug: Co-formulated Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF),All,"Adult, Older Adult",Phase 3,334.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"October 1, 2013","August 29, 2019"
5729,NCT03464097,Recruiting,No Results Available,Crohn Disease,Drug: Ozanimod|Other: Placebo,All,"Child, Adult, Older Adult",Phase 3,485.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","June 27, 2018","September 24, 2024"
5730,NCT03440385,Recruiting,No Results Available,Crohn Disease,Drug: Ozanimod|Other: Placebo,All,"Child, Adult, Older Adult",Phase 3,600.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","March 7, 2018","July 10, 2023"
5731,NCT03440372,Recruiting,No Results Available,Crohn Disease,Drug: Ozanimod|Other: Placebo,All,"Child, Adult, Older Adult",Phase 3,600.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 27, 2018","September 25, 2023"
5732,NCT04807972,Not yet recruiting,No Results Available,Pancreatic Cancer,Drug: ABBV-927|Drug: Budigalimab|Drug: modified FOLFIRINOX,All,"Adult, Older Adult",Phase 2,129.0,Industry,Interventional,Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"April 13, 2021","October 15, 2024"
5733,NCT03916224,Completed,No Results Available,Intubation; Difficult or Failed|Intubation Complication|Intubation,,All,"Adult, Older Adult",,1800.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 15, 2019","October 31, 2020"
5734,NCT04709263,Recruiting,No Results Available,Heart Failure,,All,"Adult, Older Adult",,20000.0,Industry,Observational,Observational Model: Case-Control|Time Perspective: Prospective,"December 23, 2020","December 31, 2023"
5735,NCT04212442,Recruiting,No Results Available,Physical Disability|Cognitive Impairment|Physical Activity,Behavioral: Independent Living Program for Affordable Housing.,All,"Adult, Older Adult",Not Applicable,70.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other,"January 13, 2020","June 30, 2021"
5736,NCT04199169,Recruiting,No Results Available,Nipah Virus Infection,Biological: HeV-sG-V|Biological: Normal Saline Placebo,All,Adult,Phase 1,274.0,Industry|Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","February 18, 2020",October 2021
5737,NCT04735835,Recruiting,No Results Available,Diabetes|Heart Diseases|Diet Habit|Diet Modification|Healthy|Obesity|Metabolism|Microbial Colonization,Other: Dietary Intervention,All,"Adult, Older Adult",Not Applicable,3000.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"July 20, 2020","December 20, 2021"
5738,NCT03483935,Completed,Has Results,Actinic Keratoses|Precancerous Skin Lesion,Other: Microwave treatment,All,"Adult, Older Adult",Not Applicable,18.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 7, 2018","February 28, 2019"
5739,NCT03983733,"Active, not recruiting",No Results Available,Diabetes|Heart Diseases|Diet Habit|Diet Modification|Microbial Colonization|Healthy|Obesity|Metabolism,Other: Dietary Intervention,All,"Adult, Older Adult",Not Applicable,1139.0,Other,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"June 10, 2019","November 1, 2021"
5740,NCT04602520,Recruiting,No Results Available,"Death|Communication, Multidisciplinary|Empathy|Compassion|Family Members|Bereavement|Empowerment|Patient Engagement",Behavioral: 3 Wishes Project,All,"Adult, Older Adult",,135.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"March 16, 2020","June 1, 2021"
5741,NCT03951454,Enrolling by invitation,No Results Available,Cancer Survivorship,Behavioral: Conexiones|Behavioral: Taking Time,Female,Adult,Not Applicable,156.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other","April 16, 2019","August 31, 2021"
5742,NCT04565353,Recruiting,No Results Available,"Influenza, Human",Behavioral: Flu shot text messages,All,"Adult, Older Adult",Not Applicable,80000.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Health Services Research","September 20, 2020",March 2021
5743,NCT03768544,Recruiting,No Results Available,Generalized Anxiety Disorder,Behavioral: Self-help guided by a lay provider|Behavioral: Waiting list where participants wait for delayed treatment,All,"Adult, Older Adult",Not Applicable,130.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 11, 2019",March 2023
5744,NCT03102034,Completed,Has Results,Respiratory Syncytial Virus Infections,Biological: D46/NS2/N/ΔM2-2-HindIII|Biological: Placebo,All,Child,Phase 1,32.0,NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","April 6, 2017","May 25, 2018"
5745,NCT04781504,Recruiting,No Results Available,Cardiovascular Diseases|Coronary Heart Disease,Behavioral: Exercise,Female,"Adult, Older Adult",Not Applicable,172.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment,"March 5, 2021",July 2021
5746,NCT04608994,Recruiting,No Results Available,Post Intensive Care Unit Syndrome,,All,"Child, Adult, Older Adult",,160.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"June 1, 2020","July 1, 2021"
5747,NCT04723602,Recruiting,No Results Available,Ebola Virus Disease|Marburg Virus Disease,Biological: cAd3-Marburg|Biological: cAd3-EBO-S,All,Adult,Phase 1,32.0,Other|Industry,Interventional,Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"January 6, 2021","December 6, 2021"
5748,NCT04026152,Completed,No Results Available,Anxiety Disorders|Posttraumatic Stress Disorder|Obsessive-Compulsive Disorder,Behavioral: Resistance training|Behavioral: Unified Protocol,All,"Adult, Older Adult",Not Applicable,59.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"July 14, 2019","September 1, 2020"
5749,NCT04000035,Recruiting,No Results Available,Musculoskeletal Pain|Mental Health Wellness 1|Work-Related Condition,Other: Health and work environment information and processes,All,"Adult, Older Adult",Not Applicable,1000.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"March 1, 2019","June 30, 2035"
5750,NCT04520815,Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult",,All,Older Adult,,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Other,"June 24, 2020","June 30, 2022"
5751,NCT04515771,Recruiting,No Results Available,Healthcare Disparities|Mental Health,Behavioral: PARTNER-MH,All,"Adult, Older Adult",Not Applicable,50.0,U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"August 17, 2020","January 3, 2022"
5752,NCT02868983,"Active, not recruiting",No Results Available,Arthritis|Asthma|Chronic Obstructive Lung Disease|Diabetes|Heart Failure|Hypertension|Anxiety|Chronic Pain|Depression|Fibromyalgia|Insomnia|Irritable Bowel Syndrome|Problem Drinking|Substance Use Disorder,Other: Integration,All,"Adult, Older Adult",Not Applicable,4025.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research,April 2016,April 2021
5753,NCT03261050,Recruiting,No Results Available,Eating Disorder,Behavioral: Counter Attitudinal Therapy|Behavioral: Interpersonal Therapy,Female,Adult,,180.0,Other|NIH,Observational,Observational Model: Cohort|Time Perspective: Prospective,"July 10, 2017",June 2022
5754,NCT04646291,Completed,No Results Available,"Infertility|Infertility, Female|Infertility, Male",Device: Insemination with the Mosie Baby Kit,,"Child, Adult, Older Adult",,350.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"August 5, 2020","September 1, 2020"
5755,NCT04735406,Not yet recruiting,No Results Available,Multiple Sclerosis,,All,"Adult, Older Adult",,10000.0,Industry,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 7, 2021","January 31, 2024"
5756,NCT02495753,"Active, not recruiting",No Results Available,Complications; Cesarean Section,Procedure: Vaginal Cleansing|Procedure: Abdominal Cleansing,Female,"Child, Adult, Older Adult",Not Applicable,608.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,August 2015,June 2021
5757,NCT03465280,Recruiting,No Results Available,Recurrent Respiratory Papillomatosis|Human Papilloma Virus,Procedure: Microdebrider|Procedure: Cold-steel surgery (forceps)|Procedure: Carbon dioxide laser|Procedure: Potassium titanyl phosphate (KTP) laser|Procedure: Pulsed dye laser|Procedure: Radiofrequency ablation|Procedure: Monopolar suction diathermy|Procedure: Plasma coagulation|Procedure: Other|Other: Adjuvant therapies,All,"Child, Adult, Older Adult",,400.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,"April 1, 2018","August 31, 2021"
5758,NCT04576377,Recruiting,No Results Available,"Influenza, Human",Biological: FluBlok|Other: Placebo,All,Adult,Phase 4,820.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","October 5, 2020","December 31, 2024"
5759,NCT04713735,Recruiting,No Results Available,Immune Health,Dietary Supplement: Control: Placebo|Dietary Supplement: bovine lactoferrin supplement,All,"Adult, Older Adult",Not Applicable,140.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","December 28, 2020","April 30, 2021"
5760,NCT03873467,"Active, not recruiting",No Results Available,Stroke,Behavioral: Group Lifestyle Balance|Other: Usual Care,All,"Adult, Older Adult",Not Applicable,65.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"July 8, 2019","September 30, 2021"
5761,NCT03594734,"Active, not recruiting",No Results Available,Traumatic Brain Injury,Behavioral: Group Lifestyle Balance™|Other: Attention Control Group,All,Adult,Not Applicable,57.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other,"January 8, 2019","September 30, 2022"
5762,NCT03728257,Recruiting,No Results Available,Exercise|Lung Transplantation,Behavioral: LTGO-Home Based Exercise|Behavioral: Enhanced Usual Care,All,"Adult, Older Adult",Not Applicable,112.0,Other|NIH,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","April 1, 2019","March 31, 2022"
5763,NCT04782518,Recruiting,No Results Available,Parkinson Disease,,All,"Adult, Older Adult",,1000.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"February 19, 2021","February 18, 2025"
5764,NCT04783454,Recruiting,No Results Available,Neck Pain|Low Back Pain|Back Pain,Other: Exercise program,All,"Adult, Older Adult",Not Applicable,600.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","November 12, 2020","December 31, 2028"
5765,NCT03823469,Recruiting,No Results Available,Overweight|Obesity,Behavioral: CCTP|Behavioral: Nutritional counseling,All,"Adult, Older Adult",Not Applicable,78.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"May 20, 2019",February 2022
5766,NCT04429061,Recruiting,No Results Available,HIV Infections|Pregnancy Related|STI|Mental Health Wellness 1,Behavioral: SKILLZ-Girl Enhanced football curriculum,Female,"Child, Adult, Older Adult",Not Applicable,3200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"March 1, 2020","June 30, 2023"
5767,NCT04184895,Recruiting,No Results Available,Allergic to House Dust Mites,Biological: ASP2390|Biological: Placebo,All,"Adult, Older Adult",Phase 1,28.0,Industry,Interventional,"Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","October 7, 2020","August 31, 2026"
5768,NCT03922334,Recruiting,No Results Available,Postpartum Health|Breastfeeding|Contraception|Preventive Care / Anticipatory Guidance|Retention in Care,Behavioral: Patient Navigation Program,Female,"Child, Adult",Not Applicable,400.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"January 21, 2020",December 2024
5769,NCT04734795,Recruiting,No Results Available,Dysfunctional Breathing|Asthma in Children|Asthma,,All,Child,,500.0,Other,Observational,Observational Model: Cohort|Time Perspective: Cross-Sectional,"February 5, 2021",December 2022
5770,NCT04190368,Not yet recruiting,No Results Available,Type 1 Diabetes,Other: Team Clinic Care|Other: Standard Care,All,Child,Not Applicable,200.0,Other,Interventional,Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 1, 2021","December 30, 2022"
5771,NCT03392883,"Active, not recruiting",No Results Available,Depression|Problematic Alcohol Use,Behavioral: Laddr,All,"Adult, Older Adult",Not Applicable,3091.0,Other|NIH,Interventional,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research,"February 13, 2018",April 2021
5772,NCT04301518,Recruiting,No Results Available,Preterm Labor|Preterm Birth,Other: Multimodal intervention strategy,Female,"Adult, Older Adult",Not Applicable,6500.0,Industry|Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"November 6, 2020","June 30, 2025"
5773,NCT04607902,Recruiting,No Results Available,Depression,Behavioral: Supportive Therapy SSI|Behavioral: Behavioral Activation SSI|Behavioral: Growth Mindset SSI,All,Child,Not Applicable,216.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 15, 2021",August 2024
5774,NCT04639661,Enrolling by invitation,No Results Available,Periodontal Diseases|Periodontal Pocket,,All,"Adult, Older Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Retrospective,"November 25, 2020",December 2021
5775,NCT04180709,Recruiting,No Results Available,Psychotic Disorders|Psychosis|Sleep,Device: Sleepio,All,"Adult, Older Adult",Not Applicable,44.0,Other|Industry,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care,"October 30, 2020","November 30, 2022"
5776,NCT04335643,Recruiting,No Results Available,Systemic Lupus Erythematosus,Behavioral: TEACH,All,"Child, Adult",Not Applicable,75.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"August 4, 2020",December 2021
5777,NCT04589377,Recruiting,No Results Available,Stress,Behavioral: Mindfulness Training,All,"Adult, Older Adult",Not Applicable,150.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment,"October 26, 2020","December 31, 2022"
5778,NCT04574466,Recruiting,No Results Available,Distress|PTSD|Anxiety|Depression|Trauma|Functional Disabilities|Common Mental Health Problems,Behavioral: Problem Management Plus,All,"Adult, Older Adult",Not Applicable,380.0,Other,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment,"August 25, 2020",June 2022
5779,NCT04011644,Recruiting,No Results Available,Alcohol Drinking|Telemedicine,Behavioral: A-CHESS self-monitored|Behavioral: A-CHESS peer-supported|Behavioral: A-CHESS clinically-integrated,All,"Adult, Older Adult",Not Applicable,566.0,Other|NIH,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"March 23, 2020",April 2023
5780,NCT04681339,Not yet recruiting,No Results Available,Community Acquired Pneumonia in Children|Antibiotic Stewardship,Other: Antibiotic treatment|Other: No antibiotic treatment,All,"Child, Adult",,200.0,Other,Observational,Observational Model: Cohort|Time Perspective: Prospective,April 2021,December 2024
5781,NCT04740229,Recruiting,No Results Available,Stress|Psychological,Behavioral: Yoga,All,Adult,Not Applicable,88.0,Other,Interventional,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","February 10, 2021",July 2021
5782,NCT04804917,Recruiting,No Results Available,Emotional Problem|Anxiety Disorder of Childhood|Depressive Symptoms|Behavior Problem of Childhood and Adolescence|Mental Health Disorder,,All,"Child, Adult",,396.0,Other,Observational,Observational Model: Other|Time Perspective: Prospective,"March 22, 2021","December 31, 2022"
5783,NCT04680000,Not yet recruiting,No Results Available,Chronic Pain,Behavioral: Brief Cognitive Behavioral Therapy for Chronic Pain (BCBT-CP)|Other: BCBT-CP Booster,All,"Adult, Older Adult",Not Applicable,716.0,Other|U.S. Fed,Interventional,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,February 2021,February 2025
